{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "qwen3-32b",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_2hop_cross_year",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 1000,
    "successful_questions_in_experiment": 1000,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 1000,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/qwen3-32b/e4_page_window_relevance_desc/qualitative_2hop_cross_year.json",
    "timestamp": "2026-02-05T05:07:50.660754"
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for LMT's nonqualified defined benefit pension plans decreased from $1.0 billion as of December 31, 2023, to $905 million as of December 31, 2024. Additionally, the actuarial losses recorded in accumulated other comprehensive loss (AOCL) for these plans decreased from $347 million in 2023 to $303 million in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the gross benefit obligation decreased from $1.0 billion in 2023 to $905 million in 2024, and actuarial losses declined from $347 million to $303 million. These values exactly match the original answer, with acceptable formatting (e.g., 'as of December 31' adds precision without altering meaning). (2) The answer is complete, addressing both parts of the question—the evolution of the gross benefit obligation and the actuarial losses—over the specified time period. (3) Entity accuracy is correct: LMT refers to Lockheed Martin, and the financial metrics (gross benefit obligation, actuarial losses in AOCL) are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across the two years and two financial metrics, correctly identifying the direction and magnitude of change. (5) The semantic meaning is equivalent to the original answer, with slightly more detail (mentioning AOCL) that enhances clarity without introducing error. All criteria for a perfect score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 322,
        "total_tokens": 1500
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "General Motors' long-term rate of return assumption for U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This upward adjustment indicates a strategic shift toward a more optimistic long-term return outlook, likely driven by changes in capital market assumptions and a revised asset mix. The increase in the rate of return assumption aligns with a higher allocation to alternative investments (29% in 2024) and a reduced emphasis on equity investments (11% in 2024) compared to previous years, reflecting a strategy to balance growth and risk mitigation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in General Motors' long-term rate of return assumption from 6.3% in 2023 to 6.5% in 2024, which aligns with the ground truth for the 2024 period. However, it omits the 2022 information from the original answer—specifically, the decrease from 5.6% (2020) to 5.4% (2021) reported in 2022. This omission is significant because the question asks about the evolution *between 2022 and 2024*, requiring both time points for full completeness. (2) The quantitative data provided (6.3% to 6.5%) is accurate and correctly dated. The additional details about alternative investments (29%) and equity (11%) in 2024 are plausible but not present in the ground truth, so they cannot be verified and slightly reduce confidence in qualitative accuracy. (3) The reasoning about a strategic shift toward optimism is consistent with the ground truth and shows sound multi-hop synthesis regarding asset mix implications. However, the failure to contrast the conservative 2022 assumption with the more optimistic 2024 assumption weakens the full evolutionary narrative required by the question. (4) The answer is contextually relevant and well-articulated, but the missing 2022 data limits completeness and correctness. Quantitative accuracy is high due to correct percentages and dates for the 2024 portion. Qualitative accuracy is reduced due to unverified specifics about investment allocations and incomplete comparative analysis across the full time range.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 415,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved significantly between 2023 and 2024, as Chevron acquired PDC Energy in a business combination during 2023. This acquisition is reflected in the 2024 10-K, where PDC's operations are fully integrated into Chevron's financial and operational reporting. The operational impact includes a 19% increase in U.S. upstream net oil-equivalent production, driven by the full-year inclusion of legacy PDC assets and growth in the Permian Basin. Financially, this acquisition contributed to a $3.5 billion increase in U.S. upstream earnings, primarily from higher sales volumes and the absence of decommissioning charges related to previously divested assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the acquisition of PDC Energy by Chevron in 2023 and the full integration by 2024, which aligns with the ground truth. It also correctly notes the 19% increase in net oil-equivalent production due to legacy PDC assets, matching the original answer. However, the financial impact is incorrect: the LLM states a $3.5 billion increase in U.S. upstream earnings, while the ground truth reports $2.2 billion—a significant discrepancy. This error undermines the quantitative accuracy. (2) The $3.5B figure is not supported by the ground truth and appears to be fabricated or misremembered; no calculation or source in the provided data justifies this number. The 19% production increase and full-year contribution from PDC are correctly cited. (3) The multi-hop reasoning is sound—LLM connects the 2023 acquisition to 2024 financial and operational outcomes, correctly synthesizing cause and effect across time and entities (Chevron, PDC, upstream earnings, production). It also appropriately links integration to performance metrics. (4) While the narrative and structure are strong, and most qualitative elements (timing, integration status, operational impact) are accurate, the major financial figure is wrong, leading to a moderate correctness score. The answer is contextually relevant and well-reasoned but factually flawed in a key metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 385,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "Between 2022 and 2024, Southern Company's treatment and valuation of energy-related derivatives showed changes in the presentation of unrealized gains and losses, particularly in the balance sheet classification and netting of derivative instruments. In 2024, the net amounts recognized in the balance sheets for energy-related derivatives increased compared to 2023, with a total of $28 million in assets and $84 million in liabilities for Southern Company, up from $21 million in assets and $87 million in liabilities in 2023. Additionally, the presentation of unrealized gains and losses became more detailed, with a breakdown of regulatory hedges, cash flow hedges, and non-designated derivatives, reflecting a more transparent and segmented approach to derivative valuation and risk management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Southern Company changed its disclosure approach between 2022 and 2024, shifting from reporting pre-tax effects of unrealized gains (losses) on regulatory hedging instruments (as of 2021 and 2020) to presenting fair values in the balance sheet under 'Other' or 'Risk Management Activities' by 2024. However, the LLM introduces specific dollar amounts for 2024 and 2023 ($28M assets, $84M liabilities in 2024; $21M assets, $87M liabilities in 2023) that are not present in the original answer and cannot be verified from the provided ground truth. These numbers are likely fabricated or misattributed. (2) There is no mention in the original answer of year-over-year comparisons between 2023 and 2024, nor any quantitative data about derivative positions. Thus, the quantitative accuracy is very low. (3) The qualitative reasoning partially captures a shift in presentation and increased transparency, which aligns with the ground truth’s indication of a change in valuation and presentation. However, it mischaracterizes the nature of the change—focusing on netting and segmentation into hedge types—whereas the original emphasizes a shift from deferring unrealized gains (losses) of regulatory hedges to fair value presentation across multiple derivative types. The multi-hop synthesis is flawed because it fails to correctly identify the core change: from deferral of regulatory hedge gains/losses to fair value recognition in the balance sheet. (4) Contextual relevance is moderate because the answer discusses derivative presentation and changes over time, which is relevant, but it introduces unsupported specifics that distort the actual change described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 484,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Between 2022 and 2024, Chevron's investment carrying value in Tengizchevroil (TCO) increased from $23,727 million in 2022 to $27,368 million in 2024. Additionally, Chevron's equity earnings from TCO decreased from $4,386 million in 2022 to $3,033 million in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key trends in Chevron's financial relationship with Tengizchevroil (TCO) between 2022 and 2024: an increase in investment carrying value and a decline in equity earnings. The final investment value of $27,368 million in 2024 and the decline in equity earnings from $4,386 million in 2022 to $3,033 million in 2024 are accurate per the ground truth. However, the LLM states the 2022 carrying value as $23,727 million, which is not mentioned in the original answer. The ground truth does not provide a total carrying value for 2022 but notes that Chevron's carrying value was about $100 higher than its underlying equity in TCO's net assets, with a significant portion tied to a $4,500 million loan. This specific nuance and the $23,727 million figure are not supported by the original, indicating a potential fabrication or misattribution. While the directional trends and some numbers are correct, the absence of the $23,727 million figure in the ground truth and the omission of the explanation regarding the loan and valuation difference reduce quantitative accuracy. The reasoning is otherwise sound, and the answer addresses the core aspects of investment value and earnings evolution, making it contextually relevant and qualitatively strong despite missing some detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 365,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart's ownership stake in Alert Innovation evolved from fiscal 2023 to fiscal 2024 as the company completed a $0.4 billion acquisition of Alert Innovation during fiscal 2023, becoming a 100% owner. However, this entity was subsequently sold and deconsolidated in fiscal 2025. No further transactions involving Alert Innovation are mentioned for fiscal 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion acquisition in fiscal 2023 and Walmart becoming a 100% owner, which matches the ground truth. However, it incorrectly states that the sale and deconsolidation occurred in fiscal 2025, while the original answer clearly states this happened in fiscal 2024. This is a critical error in temporal accuracy that undermines the core timeline of the ownership evolution. (2) Quantitatively, the $0.4 billion figure is accurate and properly formatted. There are no calculation errors, but the misplacement of the sale to fiscal 2025 introduces a factual inaccuracy in timing. (3) The multi-hop reasoning is partially sound—Walmart’s initial acquisition and full ownership are correctly linked, and the concept of deconsolidation is appropriately used. However, the failure to correctly place the divestiture in fiscal 2024 (not 2025) breaks the correct synthesis of events across the two fiscal years, leading to an incorrect narrative of the ownership transition. (4) The answer is contextually relevant and addresses the two main parts of the question—ownership evolution and transaction type—but the incorrect fiscal year for the sale significantly reduces factual correctness. The claim that 'no further transactions are mentioned for fiscal 2024' directly contradicts the ground truth, which explicitly states the deconsolidation occurred in that year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 391,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "Starbucks' foreign currency - other derivative asset positions decreased significantly from fiscal year 2022 to 2023, dropping from $39.9 million in 2022 to $1.9 million in 2023, while the liability positions increased from $0.3 million to $4.7 million. This shift suggests a reduction in the company's open foreign currency exposure, indicating a more proactive approach to hedging and managing currency risks, likely through the execution of additional hedging contracts or adjustments to existing positions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, in fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in AOCI (not $39.9 million as stated), with $32.5 million expected to be reclassified into earnings. The LLM incorrectly reports the 2022 asset value and introduces a $0.3 million liability in 2022, which is not mentioned in the original answer—there is no mention of derivative liabilities in 2022 in the ground truth. In 2023, the LLM correctly identifies the $1.9 million in current assets but fails to mention the $1.7 million in long-term assets and incorrectly omits the $4.1 million in long-term liabilities, only citing $4.7 million in current liabilities. (2) The calculation and comparison of changes are therefore flawed: the drop from $55.3M to $1.9M in assets is more dramatic than the incorrect $39.9M cited, and the emergence of liabilities is understated. (3) The reasoning about exposure management strategy—suggesting a more proactive hedging approach—is semantically plausible and aligns with the general implication of reduced net asset exposure, so the qualitative interpretation is partially sound. However, the multi-hop synthesis is incomplete: the model fails to integrate the full balance sheet positioning (current vs. long-term, assets vs. liabilities) and misrepresents the starting point in 2022. (4) The contextual relevance is high because the answer addresses both parts of the question—changes in positions and strategic implication—and attempts appropriate financial interpretation. However, due to major numerical inaccuracies and incomplete data representation, the correctness and quantitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 486,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Between fiscal years 2022 and 2024, Medtronic's A Preferred Shares remained non-outstanding, with no shares issued as of both April 29, 2022, and April 26, 2024. In 2022, the company redeemed the previously outstanding 1,872 A Preferred Shares for $0.075 million during the third quarter.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Medtronic redeemed 1,872 A Preferred Shares for $0.075 million in the third quarter of fiscal year 2022, and no shares were outstanding as of April 29, 2022. The answer correctly notes that no A Preferred Shares were outstanding as of April 26, 2024, aligning with the original answer's conclusion that no shares remained in 2024. (2) Quantitative accuracy is perfect: the number of shares (1,872), dollar amount ($0.075 million), and dates (April 29, 2022; April 26, 2024) match the ground truth. Format variations (e.g., 'April 26, 2024' vs. implied 2024 date) are acceptable and contextually equivalent. (3) The multi-hop reasoning is sound—linking the 2022 redemption to the continued non-outstanding status in 2024 shows correct synthesis across fiscal years. The only minor omission is that the LLM does not explicitly state that the shares were *not reissued or reintroduced* after 2022, which slightly weakens the qualitative explanation of the 'evolution' between 2022 and 2024. However, stating that no shares were outstanding in both years implies this continuity. (4) The answer is fully relevant, directly addressing both parts of the question: the 2022 action and the treatment across years. Overall, the response is factually complete and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction for the missing explicit commentary on non-reissuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 422,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Between 2022 and 2023, Comcast's financial relationship with Atairos evolved significantly in terms of equity income (losses) driven by fair value adjustments on underlying investments. In 2023, Comcast reported equity income from Atairos of $1.1 billion, a substantial improvement from a loss of $434 million in 2022. This shift reflects positive fair value adjustments on Atairos' underlying investments in 2023 compared to negative adjustments in 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $434 million loss in 2022 and $1.1 billion income in 2023 from Atairos are correctly stated, with proper sign usage (negative for loss, positive for income). (2) Quantitative accuracy is perfect—both figures match the original answer exactly, and the comparison between years is correctly framed as a turnaround from loss to income. (3) The multi-hop reasoning is sound: the answer correctly attributes the change in equity income to fair value adjustments on underlying investments, identifying the shift from negative adjustments in 2022 to positive ones in 2023. (4) The response is contextually relevant, directly addressing the evolution of Comcast's financial relationship with Atairos in terms of equity income driven by fair value changes. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 269,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region remained at zero for both 2023 and 2024, as indicated in the reserve tables for both years. This suggests that the company does not hold direct natural gas reserves in this region and instead focuses on equity affiliates for its presence in Asia Pacific/Middle East. The lack of direct reserves highlights that COP's strategic positioning in this geographic area is primarily through joint ventures and equity investments rather than direct ownership of natural gas assets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that COP's natural gas reserves in the Asia Pacific/Middle East region were zero in both 2023 and 2024. The ground truth states reserves were 312 billion cubic feet in 2023 and declined to 296 billion cubic feet in 2024. This major quantitative error undermines the entire response. (2) The numbers provided by the LLM (zero reserves) directly contradict the ground truth (312Bcf and 296Bcf), making the quantitative accuracy very low. There are no correct figures or calculations. (3) The reasoning is flawed because it assumes zero reserves imply no direct ownership and a strategy based on equity affiliates, but this conclusion is not supported by the actual data showing significant direct reserves. The multi-hop synthesis failed—instead of identifying a slight decline and interpreting strategic reallocation, the model incorrectly inferred no presence. (4) While the LLM attempts to address the strategic positioning aspect of the question, its conclusions are based on false premises. The contextual relevance is moderate because it discusses strategy, but the factual foundation is entirely wrong, leading to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 341,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL's revenue in Canada declined significantly from $113 million in 2022 to $73 million in 2023, representing a 35% decrease, and further dropped to $28 million in 2024, a 40% decrease from 2023. This consistent decline indicates a deteriorating market trajectory for ENBREL in Canada, likely due to factors such as lower net selling prices, reduced inventory, and increased competition.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 revenue ($113 million) and the 2024 revenue ($28 million), which match the ground truth. However, it incorrectly states the 2023 revenue as $73 million, whereas the ground truth reports $47 million. This is a significant factual error affecting quantitative accuracy. (2) The percentage decreases are therefore also incorrect: the LLM claims a 35% drop from 2022 to 2023 and a 40% drop from 2023 to 2024. The actual decline from $113M to $47M is approximately 58.4%, and from $47M to $28M is about 40.4%. The second percentage is close but still inaccurate due to the wrong base. (3) The reasoning about a deteriorating market trajectory is sound and aligns with the downward trend, and the mention of factors like competition and pricing is plausible context, though not in the original answer. The model synthesizes a logical conclusion from the trend, even if the numbers are wrong. (4) The answer is contextually relevant and addresses both parts of the question—revenue evolution and market trajectory. However, the major numerical inaccuracy in 2023 revenue undermines the correctness score, preventing it from being higher than 6. The qualitative and contextual scores are higher because the structure, logic, and intent are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 363,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "Qualcomm's approach to linking human capital advancements with executive compensation in fiscal 2024 involved using progress toward human capital goals as a non-financial performance modifier for executives' bonuses. Specifically, for fiscal 2024, this modifier could adjust bonus payouts by a multiple ranging from 0.9 to 1.1. This indicates a more direct and quantifiable integration of human capital metrics into executive compensation compared to prior periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the key evolution in Qualcomm's approach: from considering human capital advancements in determining fiscal 2024 bonuses (as stated in fiscal 2023) to implementing a defined non-financial performance modifier with a 0.9 to 1.1 multiplier range in fiscal 2024. All numeric values (0.9 to 1.1 range) are correct and match the ground truth. The entity (Qualcomm), time period (fiscal 2024), and performance modifier structure are accurately identified. The answer correctly captures the shift toward a more quantifiable integration, though it does not explicitly contrast fiscal 2023 (general consideration) with fiscal 2024 (structured modifier) as clearly as the original answer. This minor omission in comparative depth prevents a perfect 10 on qualitative accuracy, but the core multi-hop reasoning—linking the evolution across fiscal years and compensation design—is sound. The response is fully relevant and semantically equivalent to the ground truth in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 290,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "Between 2022 and 2024, the therapeutic scope of Breyanzi expanded significantly. In 2022, Breyanzi was being studied for B-cell malignancies, particularly in late-stage trials targeting diseases like chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and mantle cell lymphoma (MCL). By 2024, Breyanzi received FDA approvals for relapsed or refractory CLL/SLL, FL, and MCL, making it the CAR-T cell therapy with the broadest array of B-cell malignancy indications. Additionally, in 2024, Breyanzi received approval in Japan for FL and was granted FDA approval for MCL with specific prior therapy requirements, further expanding its global and therapeutic reach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly notes that Breyanzi expanded its therapeutic scope by 2024, it falsely claims FDA approvals for mantle cell lymphoma (MCL) and a broad approval across CLL/SLL, FL, and MCL. According to the ground truth, Breyanzi received FDA accelerated approvals in 2024 only for relapsed or refractory FL (May 2024) and CLL/SLL (March 2024), with specific prior therapy requirements for the latter. There is no mention of MCL approval in the ground truth, nor was MCL part of the 2022 trial scope. Additionally, the claim of approval in Japan for FL is not supported by the original answer. (2) The dates mentioned (March and May 2024) align partially with the ground truth, but the LLM fabricates additional approvals without basis. The 2022 trial information is generally accurate—Breyanzi was indeed in trials for CLL and FL—but the inclusion of MCL is not documented in the original answer. (3) The multi-hop reasoning is flawed: the model incorrectly infers that because Breyanzi was being studied for multiple B-cell malignancies in 2022, it must have gained approvals for all of them by 2024. This is an unsupported leap. The ground truth shows a precise evolution from two specific late-stage trials (CLL and FL) to two corresponding accelerated approvals, not a broad expansion into MCL. (4) The contextual relevance is high because the answer addresses the evolution of therapeutic scope and uses appropriate terminology. However, the correctness score is low due to major factual errors in indications and approvals, particularly the invention of MCL and Japan approvals. Quantitative accuracy is poor due to incorrect dates and non-existent approvals. Qualitative accuracy is moderate because the general direction of expansion is correct, but entity and reasoning accuracy suffer from hallucination.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 511,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "From 2023 to 2024, Disney's Resorts and Vacations segment revenue increased by 5%, driven by higher average daily hotel room rates, occupied room nights, and cruise line ticket prices, partially offset by lower Disney Vacation Club unit sales. This growth aligns with the overall 5% revenue growth of the broader Parks & Experiences segment, which was fueled by higher theme park admissions, merchandise, food, and beverage sales. Both segments experienced positive performance, with international parks contributing significantly to the growth in both areas.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 5% revenue growth for both the Resorts and Vacations segment and the overall Parks & Experiences segment, which aligns with the ground truth. However, it omits the actual dollar figures ($7,949M in 2023 and $8,375M in 2024 for Resorts and Vacations; $32,549M to $34,151M for Parks & Experiences), which are key quantitative details from the original answer. While the percentage growth is accurate, the absence of absolute values reduces completeness and precision. (2) The calculation of 5% growth is consistent for both segments and matches the ground truth, so the quantitative reasoning is sound. The LLM does not attempt to recalculate or misrepresent growth rates, which supports a high quantitative accuracy score. (3) The multi-hop reasoning is partially sound: the model correctly links Resorts and Vacations performance to the broader Parks & Experiences segment and notes similar growth rates. However, it fails to mention that Resorts and Vacations maintained a consistent proportion of total revenue, a key comparative insight in the original answer. Additionally, the LLM introduces drivers like higher room rates and cruise prices, which may be plausible but are not present in the ground truth, adding unsupported qualitative detail. (4) The answer is highly contextually relevant, addressing both parts of the question—evolution of Resorts and Vacations and comparison to overall segment growth. Despite missing specific figures and adding unverified drivers, the core conclusion about aligned 5% growth is correct, justifying a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 446,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "Between 2023 and 2024, the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved as follows: In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., receiving 80% of the shares upfront (17.4 million shares) and the remaining 20% (5.4 million shares) in February 2023. The forward contract was initially recorded as an equity instrument within capital surplus and later reclassified to treasury stock. In 2024, CVS executed a $3.0 billion ASR with Morgan Stanley, receiving 85% of the shares upfront (31.4 million shares) in January 2024 and the remaining 15% (8.3 million shares) in March 2024. The structure remained similar, with the forward contract initially recorded in capital surplus and reclassified to treasury stock upon conclusion. The notional value of the 2024 ASR was higher than in 2023, reflecting a larger repurchase commitment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and key details. While it correctly identifies the $2.0 billion 2023 ASR with Citibank, N.A. and the $3.0 billion 2024 ASR with Morgan Stanley, it incorrectly states that the forward contract was 'reclassified to treasury stock'—the ground truth specifies the forward contract was classified as an equity instrument and recorded in capital surplus, with no mention of reclassification. This misrepresents the accounting treatment, a critical aspect of the question. Additionally, the LLM introduces specific share counts (e.g., 17.4 million, 5.4 million, 31.4 million, 8.3 million) that are not present in the original answer and cannot be verified, suggesting fabrication or inference beyond the source data. (2) The dollar amounts of the ASRs ($2.0B and $3.0B) are correct, and the timing of final share receipt (February 2023, March 2024) is accurate. However, the original answer emphasizes that the forward contract value remained constant at $0.4 billion in both years despite the larger ASR, which the LLM fails to mention—a key point about the evolution of the structure. The LLM instead focuses on the notional increase without noting the stable forward value, missing a central insight. (3) The reasoning is partially sound in recognizing the similarity in structure and timing, but it fails the multi-hop synthesis by not comparing the proportion of the ASR allocated to the forward contract. The original answer highlights that although the total ASR increased, the forward component stayed at $0.4B, indicating a shift in allocation (from 20% to 15% of total). The LLM notes the percentage of shares received upfront but does not connect this to the forward contract value or explain the structural shift. (4) The contextual relevance is high as the answer addresses ASRs, forward contracts, timing, and structure. However, due to missing the constant $0.4B forward value, incorrect accounting treatment, and unverified share numbers, the correctness score is reduced to 6. Quantitative accuracy is low due to unsupported figures and omission of the key $0.4B consistency. Qualitative accuracy is moderate—entities and years are correct, and the general logic follows, but reasoning gaps exist. Contextual relevance is strong as the response stays on topic and addresses the evolution question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 633,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology showed increased transparency in 2024 compared to 2023 in terms of fair value categorization. In 2024, the \"Not Categorized\" amount decreased from $179 million in 2023 to $178 million in 2024, indicating a slight reduction in assets not categorized in the fair value hierarchy. Additionally, the 2024 disclosures provided more clarity on the valuation methodologies for different asset classes, such as equity securities, corporate debt securities, and short-term investment funds, aligning with Level 1, Level 2, and Level 3 fair value measurements. This suggests a more detailed and transparent approach to categorizing and explaining the fair value of pension assets in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Duke Energy did not provide specific dollar amounts like '$179 million' or '$178 million' in its disclosures; instead, it only noted that certain investments using the net asset value (NAV) practical expedient were 'not categorized' in the fair value hierarchy. The LLM fabricates precise dollar figures not present in the original data, which severely undermines factual correctness. (2) There is no mention in the ground truth of a reduction from $179M to $178M — these numbers are entirely incorrect and not supported by the source. Additionally, while the 2024 filing did improve transparency, the key enhancement was the addition of a Level 3 reconciliation for beginning and ending balances of pension assets, not a general 'decrease in Not Categorized' assets or more detailed methodology descriptions per asset class. (3) The multi-hop reasoning is partially sound in that the model identifies increased transparency in 2024, but it fails to correctly identify the nature of the new disclosure (i.e., the Level 3 reconciliation), instead inventing unsupported details about quantitative reductions and expanded asset-class-level explanations. (4) The contextual relevance is moderate because the answer addresses the general topic of improved transparency in fair value categorization, but the qualitative and quantitative inaccuracies — especially the made-up numbers — result in a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 419,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial obligations and revenue recognition related to Paxlovid changed significantly due to the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile (SNS). In 2023, a non-cash revenue reversal of $3.5 billion was recorded, reflecting the expected return of 6.5 million EUA-labeled treatment courses by the U.S. government. In 2024, a favorable adjustment of $771 million was recorded as 5.1 million courses were returned by February 29, 2024. Additionally, in the third quarter of 2024, Pfizer created the U.S. SNS with 1.0 million treatment courses and recognized $442 million in revenue for this contribution, which will support pandemic preparedness through 2028. These adjustments reflect the transition of Paxlovid from government contracts to commercial markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key facts from the ground truth: the $3.5 billion non-cash revenue reversal in 2023 due to the expected return of 6.5 million EUA-labeled Paxlovid courses, the $771 million favorable adjustment in 2024 based on the actual return of 5.1 million courses, and the $442 million revenue recognized in 2024 related to the creation of the 1.0 million course U.S. Strategic National Stockpile. All dollar amounts and quantities are accurate. (2) Quantitative accuracy is perfect: $3.5 billion, $771 million, $442 million, 6.5 million, 5.1 million, and 1.0 million are all correctly reported. The mention of 'by February 29, 2024' adds specificity not in the original but does not contradict it. (3) The reasoning is sound and reflects proper multi-hop synthesis across 2023 and 2024 events, correctly framing the shift from revenue reversal to revenue recognition. The addition that the stockpile will support preparedness 'through 2028' is extra detail not in the ground truth but is plausible and not factually incorrect. (4) The answer is contextually fully relevant, directly addressing the changes in financial obligations and revenue recognition. The only minor deviation is the added detail about the third quarter and the 2028 timeline, which are not in the original answer but do not detract from factual correctness. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 due to slight over-specification without error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 414,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA's financial performance improved significantly between 2022 and 2023, with sales increasing by 26.9% (from $1,881 million to $2,387 million). This growth was driven by continued share gains and market expansion in metastatic castration-resistant prostate cancer. This strong performance highlights ERLEADA's growing importance within J&J's oncology portfolio, which saw overall sales growth of 10.5% in 2023, driven by key products like DARZALEX and CARVYKTI. ERLEADA's role as a next-generation androgen receptor inhibitor positions it as a key contributor to J&J's oncology segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: ERLEADA sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. These numbers exactly match the ground truth, and the percentage increase is accurately calculated ((2,387 - 1,881) / 1,881 ≈ 0.269 or 26.9%). The overall oncology portfolio growth of 10.5% in 2023 is also correctly cited. (2) The answer addresses both parts of the question: the financial performance evolution of ERLEADA and its role in J&J's oncology portfolio. The growth rate and sales figures are accurate, and the interpretation of ERLEADA's increasing importance is consistent with the ground truth. (3) Entity accuracy is strong: ERLEADA, J&J, and the correct time frame (2022–2023) are properly identified. The mention of DARZALEX and CARVYKTI as growth drivers is factually plausible and does not contradict the ground truth, though the original answer contrasts ERLEADA’s growth with declining products like IMBRUVICA and ZYTIGA, which the LLM omits. (4) The reasoning is sound and reflects multi-hop synthesis—linking ERLEADA’s performance to the broader oncology portfolio trends. However, the LLM misses the contrast with declining products, which is a key element in the original answer for emphasizing ERLEADA’s rising strategic importance. This omission slightly weakens the qualitative depth but does not introduce inaccuracy. Overall, the answer is factually correct, well-reasoned, and highly relevant, warranting a high score with only minor room for improved contextual contrast.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 435,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "From 2022 to 2023, ERLEADA's global sales increased from $1,881 million to $2,387 million, representing a 26.9% growth. This significant increase indicates strong market trajectory driven by continued share gains and market growth in metastatic castration-resistant prostate cancer.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2022 sales figure: it states $1,881 million instead of the correct $1,291 million from the ground truth. This leads to an incorrect baseline for the year-over-year comparison. However, the 2023 sales figure ($2,387 million) and the 26.9% growth rate from 2022 to 2023 are accurate. The calculation of 26.9% growth is correct based on the erroneous 2022 number, but if calculated from the true $1,291 million, the actual growth rate would be approximately 84.9%, which contradicts the stated 26.9%. (2) The ground truth reports 70.0% growth from 2021 to 2022 and 26.9% from 2022 to 2023, indicating a deceleration in growth. The LLM answer omits the 2021–2022 performance and incorrectly implies that 26.9% is the growth from $1,881M to $2,387M, which is mathematically correct but based on a wrong input. (3) The reasoning about strong market trajectory is partially sound and contextually appropriate, but the LLM fails to capture the multi-hop insight that growth is decelerating (from 70% to 26.9%), which the original answer identifies as a sign of maturing growth phase. This missing nuance affects the qualitative interpretation. (4) The contextual relevance is high because the answer addresses global sales evolution and market trajectory. Qualitative accuracy is moderate due to correct use of terminology and logical direction, but flawed inputs undermine the conclusion. Quantitative accuracy is low due to the incorrect 2022 sales figure, despite correct 2023 value and growth percentage. Correctness score is 5 due to partial factual correctness but significant error in a key data point and missing comparative context across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 466,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "Between fiscal years 2023 and 2024, NVDA's debt management strategy regarding the 0.584% Notes Due 2024 involved holding the notes until their maturity in 2024, as reflected in the 2023 10-K. In fiscal year 2024, the company repaid the $1.25 billion in principal amount of these notes, as indicated in the 2024 10-K. This repayment marked the completion of the debt obligation for these notes, aligning with the maturity date and demonstrating a straightforward approach to debt management for this specific issue.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.25 billion principal amount (equivalent to $1,250 million) and the existence of the 0.584% Notes Due 2024, which aligns with the ground truth. However, it incorrectly states that the repayment occurred in fiscal year 2024 and that the notes matured in 2024. According to the original answer, NVDA disclosed repayment in fiscal year 2025, with the balance reported as zero as of January 26, 2025—indicating the repayment occurred in fiscal year 2025, not 2024. This misalignment affects the core timeline of the debt management strategy. (2) Quantitatively, the dollar amount is accurate ($1.25 billion = $1,250 million), and the interest rate is not mentioned in the LLM answer but is not falsely stated—this is an omission rather than an error. The key error is the fiscal year of repayment: the LLM claims repayment in FY2024, while the ground truth specifies disclosure of repayment in FY2025. (3) The multi-hop reasoning is partially sound—the model connects the 2023 and 2024 10-K filings to track the debt balance and repayment—but fails to correctly interpret the timing of the repayment event based on the disclosed date (January 26, 2025). This undermines the conclusion about the strategy being executed 'by' FY2024. (4) The contextual relevance is high because the answer addresses the evolution of debt management and focuses on the correct instrument. However, the qualitative accuracy is reduced due to the incorrect inference about when the repayment occurred, leading to an inaccurate characterization of the strategy as 'straightforward' without acknowledging the post-maturity repayment timing. The ground truth emphasizes a strategic choice to retire the debt 'before or shortly after' the due date, which the LLM answer oversimplifies and misdates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 495,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Between 2022 and 2023, Honeywell's investment in Mortgage/Asset-backed securities for its U.S. pension plans decreased from $1,119 million to $676 million, representing a reduction of $443 million. For non-U.S. plans, the investment in Mortgage/Asset-backed securities decreased from $31 million to $10 million, a reduction of $21 million. Thus, the overall magnitude of the decline in Mortgage/Asset-backed securities across both U.S. and non-U.S. plans was approximately $464 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Honeywell reported $982 million invested in Mortgage/Asset-backed securities in 2022 under U.S. Plans, which dropped to $10 million in 2023 under Non-U.S. Plans. However, the LLM claims U.S. plans decreased from $1,119 million to $676 million and non-U.S. from $31 million to $10 million—none of which match the ground truth. The reported overall decline of $464 million is incorrect; the actual reduction was $972 million (from $982M to $10M), a drop of over 98%. (2) The calculations in the LLM answer are internally consistent but based on incorrect input values. The claimed $443M (U.S.) and $21M (non-U.S.) reductions do not reflect the true data. The correct calculation is $982M - $10M = $972M reduction. (3) The multi-hop reasoning is partially sound in structure—attempting to compare across years and plan types—but fails because it uses incorrect source data. The model incorrectly splits the change between U.S. and non-U.S. plans, while the ground truth indicates the 2022 figure was under U.S. Plans and 2023 under Non-U.S. Plans, suggesting a strategic shift, not a parallel decline across both. (4) The contextual relevance is moderate—the answer addresses investment evolution and magnitude of change—but due to severe quantitative and entity-level errors, the correctness and accuracy scores are low. The model misunderstood or misextracted the core data, leading to a factually incorrect conclusion about the nature and scale of the investment change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 432,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations increased in terms of fair value, rising from $16,918 million in 2022 to $18,067 million in 2023. These obligations were consistently classified under Level 2 of the fair value hierarchy, indicating they were valued using observable market inputs. As part of the company's funding mix, securitized debt obligations remained a significant component alongside senior and subordinated notes and deposits, reflecting their role in maintaining a diversified funding strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claim that securitized debt obligations rose from $16,918 million in 2022 to $18,067 million in 2023. The original answer (ground truth) does not provide the 2022 carrying or fair value of securitized debt obligations, so the $16,918 million figure is unsupported and likely incorrect. The only verified number is the 2023 fair value of $18,067 million, which matches the ground truth. However, the ground truth specifies the 2023 *carrying value* as $18,043 million and *fair value* as $18,067 million—both figures should have been included for completeness and accuracy. The LLM omits the carrying value entirely and incorrectly implies a year-over-year comparison is possible. (2) The classification under Level 2 of the fair value hierarchy is correctly stated and aligns with the original answer. The role of securitized debt in the funding mix—mentioned as part of a diversified strategy with deposits, notes, etc.—is qualitatively accurate and contextually relevant. (3) The multi-hop reasoning is partially sound: the model correctly identifies securitized debt as a persistent component of the funding mix and attempts to show evolution via valuation changes. However, it fabricates a 2022 value without source support, undermining the comparison and indicating a failure in proper synthesis across years. The ground truth does not state any 2022 valuation data, so asserting a specific number is a critical error. (4) The contextual relevance is high because the answer addresses both parts of the question—funding mix role and fair value classification—but the quantitative inaccuracy severely undermines correctness. The qualitative accuracy is moderate due to correct terminology and conceptual framing, but the unsupported number reduces reliability. Correctness score is 4 due to major factual error in numbers despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 529,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules transitioned from a $1.4 billion CET1 capital benefit in 2023 to a $720 million CET1 capital benefit in 2024, reflecting a reduction of $680 million during this period. This change is attributed to the ongoing phase-in of the CECL provisions, which were fully phased in by January 1, 2025.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $1.4 billion in 2023 and $720 million in 2024 are accurately reported. The implied reduction of $680 million ($1.4B - $720M = $680M) is correct and properly calculated. (2) The answer addresses both parts of the question: the evolution of JPMorgan's treatment of CECL capital transition provisions (phased reduction) and the quantitative change in benefit ($680 million decrease). (3) Entities are accurate: JPMorgan, CECL capital transition provisions, CET1 capital, and the timeline (2023 to 2024, with full phase-in by January 1, 2025) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the declining capital benefit to the regulatory phase-in process under U.S. capital rules, concluding with the full phase-in date. The semantic meaning is equivalent to the original answer, with no factual or interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 284,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolved significantly. In fiscal 2023, the agreement (entered into in December 2020) provided a $3.0 billion unsecured revolving credit facility maturing in December 2025. By fiscal 2024, Salesforce replaced this with a new Revolving Loan Credit Agreement in October 2024, increasing the capacity to $5.0 billion and extending the maturity to October 2029. The new facility remained unsecured and was intended for general corporate purposes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: All numbers and dates are correct — $3.0 billion capacity in fiscal 2023 with maturity in December 2025, replaced by a $5.0 billion facility maturing in October 2029. The fiscal years and timing (October 2024 agreement) align with the knowledge graph. (2) Completeness: The answer addresses both the change in capacity and the evolution of terms (maturity date, security status, purpose). It includes additional but accurate context (e.g., the original agreement date in December 2020, general corporate purposes) that enhances clarity without introducing error. (3) Entity accuracy: 'Salesforce', 'Revolving Loan Credit Agreement', fiscal 2023 and 2024, and the financial figures are all correctly identified. (4) Reasoning: The multi-hop synthesis — comparing the two fiscal years' credit facilities — is sound and accurately reflects the replacement and enhancement of the agreement. (5) Semantic equivalence: The LLM conveys the same core information as the original answer, with slightly more detail but no deviation in meaning. Minor wording differences (e.g., 'strategic enhancement' vs. 'intended for general corporate purposes') do not affect factual correctness. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 366,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "Between 2022 and 2024, UPS's relationship with Coyote evolved from operating Coyote as part of its Supply Chain Solutions segment to divesting the business. In 2022, Coyote was described as a truckload brokerage service under UPS's offerings. By 2024, UPS completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) in the third quarter. This divestiture had a positive financial impact on UPS in 2024, contributing to its non-GAAP adjusted results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: UPS operated Coyote as a truckload brokerage in 2022 and divested it by 2024, recording a pre-tax gain of $156 million ($152 million after tax). These figures match the original answer exactly, satisfying quantitative accuracy. (2) The mention of the gain occurring in the third quarter adds specificity not present in the ground truth; however, since the original does not specify timing within 2024, this addition is not incorrect—just more detailed—and doesn't detract from accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of the relationship (from operational integration to divestiture) and links it to the financial impact in 2024. (4) The only minor shortcoming is that the LLM omits some contextual detail about Coyote’s geographic reach (U.S. and Europe) and its integration into UPS’s broader supply chain offerings using both UPS and third-party fleets. While not critical to the core question, this contextual richness is present in the original. Otherwise, the answer fully addresses both parts of the question—evolution of the relationship and financial impact—with precise, semantically equivalent information. Hence, a score of 9 is warranted for overall correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 387,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "Between 2023 and 2024, Union Pacific's relationship with chassis evolved in terms of total units and ownership structure. In 2023, the company owned 30,635 chassis and leased 17,705, totaling 48,340 units. By 2024, the number of owned chassis increased to 4,356, while leased chassis decreased to 1,197, resulting in a total of 5,553 chassis. This indicates a significant shift toward reducing reliance on leased chassis and increasing ownership.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in reporting the 2024 owned chassis count. It states that 'the number of owned chassis increased to 4,356', which is incorrect—the original answer shows that owned chassis decreased from 30,635 in 2023 to 4,356 in 2024, not increased. This misrepresents the trend. The leased and total numbers for 2024 (1,197 leased, 5,553 total) are correct and match the ground truth. (2) Quantitative accuracy is compromised because while the 2023 numbers and 2024 totals are correct, the characterization of 'increase' in owned units is factually wrong—the number of owned units dropped by over 26,000. The calculation of totals is accurate (30,635 + 17,705 = 48,340; 4,356 + 1,197 = 5,553), but the interpretation is flawed. (3) The multi-hop reasoning is partially sound—LLM correctly identifies the shift in scale and attempts to interpret ownership trends—but draws an incorrect conclusion about increasing ownership. The actual shift is a massive reduction in total chassis footprint, not a strategic increase in ownership. (4) Contextual relevance is high as the answer addresses both total units and ownership structure over the two years. However, due to the significant factual error in interpreting the direction of change in owned units, the correctness score is reduced to 6—partially correct but with a major error affecting the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 388,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "Between 2022 and 2024, Boeing's treatment and disclosure of aluminum agreements remained consistent in their classification as derivatives for accounting purposes, but there was a slight evolution in the time horizon for these agreements. In 2022, Boeing stated that these agreements were priced at prevailing market prices and did not qualify for hedge accounting treatment. By 2024, the disclosures expanded to clarify that these aluminum agreements, along with certain foreign exchange contracts, were not designated for hedge accounting treatment and were used to address long-term strategic sourcing objectives and non-U.S. business requirements. Additionally, the time horizon for forecasted transactions covered by commodity contracts was extended, with Boeing noting that commodity contracts hedge forecasted transactions through 2028 in 2024, compared to less specific references in prior years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Boeing's treatment and disclosure of aluminum agreements between 2022 and 2024. (1) It correctly states that in 2022, the aluminum agreements were classified as derivatives but not designated for hedge accounting, with changes in fair value recorded in earnings—this aligns with the ground truth. It also accurately notes the shift by 2024 to include these agreements as part of commodity contracts hedging forecasted transactions through 2028, indicating a more structured hedging strategy. (2) The quantitative accuracy is high: the time horizon 'through 2028' is correctly reported, and the years 2022 and 2024 are properly referenced. There are no calculation errors. (3) The multi-hop reasoning is sound—information is synthesized across two years and disclosures, correctly identifying both continuity (classification as derivatives, no hedge accounting) and evolution (expanded disclosure, longer time horizon). However, the LLM slightly understates the significance of the shift: the original answer emphasizes a strategic shift from 'purely strategic sourcing' to a 'structured hedging strategy,' while the LLM frames it as a 'slight evolution' and does not fully emphasize the change in purpose. This nuance affects qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing classification, accounting treatment, and time horizon as asked. Minor deduction in correctness due to downplaying the strategic shift, but core facts and synthesis are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 426,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble's exposure to currency rate risk remained relatively stable between the fiscal years ended June 30, 2023, and June 30, 2024, with the company continuing to leverage its diversified portfolio as a natural hedge. For both years, P&G stated that near-term changes in currency rates would not materially affect its financial statements, based on a 95% confidence level using historical data. The company primarily uses forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk associated with its operations. There were no significant changes in hedging instruments or confidence in mitigating near-term exchange rate fluctuations during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: P&G's currency risk exposure remained stable between FY2023 and FY2024, it used forward contracts and currency swaps with maturities under 18 months, and it maintained a 95% confidence level assessment that near-term exchange rate fluctuations would not materially affect financial statements. (2) Quantitative elements—'95% confidence level', 'less than 18 months'—are correctly reported with no calculation errors. (3) The multi-hop reasoning is sound: the answer synthesizes information across two fiscal years regarding hedging instruments and risk assessment, correctly concluding no significant changes occurred. (4) The only minor deviation is the mention of a 'diversified portfolio as a natural hedge', which is not present in the original answer; while plausible and consistent with P&G's strategy, it introduces a detail not confirmed in the ground truth, slightly affecting qualitative precision. However, this does not contradict the original and does not impact the overall correctness. All parts of the question are addressed: evolution of risk exposure, hedging instruments, and confidence in mitigation. Wording differs slightly but maintains semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 362,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "Between 2022 and 2024, Adobe has expanded Frame.io's functional scope and integration with its creative tools. Frame.io is now described as a cloud-native creative collaboration platform that supports video workflows beyond post-production, including casting, location scouting, and marketing campaign management, as well as still images, design files, and PDFs. It is directly integrated with Adobe Premiere Pro, Adobe After Effects, Adobe Photoshop, Adobe Lightroom, and Adobe Workfront, allowing for streamlined frame-specific feedback. Additionally, Frame.io is part of Adobe GenStudio, which enables content production at scale, highlighting its role in Adobe's broader creative ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io evolved from a trademarked asset in 2022 to a cloud-native creative collaboration platform by 2024, with expanded functionality and deep integration into Adobe's product suite. The functional scope includes real-time collaboration, frame-accurate commenting, and support for video, images, design files, and PDFs. The integrations with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront are correctly listed, as is its inclusion in Adobe GenStudio for large-scale content production. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2022 and 2024), which are accurate. (3) The multi-hop reasoning is sound—synthesizing Frame.io’s evolution in functional scope and integration across Adobe products over time. The only minor omission is the absence of explicit mention of 'Camera to Cloud' functionality, which is included in the ground truth. However, the broader capabilities like real-time upload and review are implied through 'cloud-native' and 'streamlined feedback'. (4) The answer is contextually excellent, directly addressing the evolution in positioning and integration, and conveying semantic equivalence to the original answer with only slight variation in emphasis. The inclusion of casting and location scouting adds detail not in the original but does not contradict it and fits within the expanded workflow description. Thus, the answer is factually correct, comprehensive, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 479,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "Between the 2022 and 2023 fiscal years, AMD's carrying value of its investment in the ATMP JV increased from approximately $63 million to $69 million in 2022, and further to $99 million in 2023, reflecting growing equity income from the joint venture. Financial disclosures became more detailed in 2023, with specific figures on purchases, payables, and gains from the ATMP JV, indicating a more transparent and expanded reporting approach compared to the prior year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both factual content and interpretation. The original answer states that in the 2022 filing, AMD reported a carrying value of $69 million as of December 25, 2021, and $63 million as of December 26, 2020 — meaning the value decreased from 2020 to 2021. The LLM incorrectly claims the value increased from $63M to $69M in 2022 and further to $99M in 2023, which is unsupported by the ground truth and reverses the actual timeline. Moreover, the 2023 filing does not report any carrying value or transaction figures at all, contrary to the LLM’s claim of increased disclosure. (2) All numeric values in the LLM answer are wrong: there is no $99 million carrying value reported in 2023, and no detailed 2023 transaction data (purchases, payables, gains) was disclosed. The original answer emphasizes the *absence* of such data in 2023, while the LLM claims the opposite. (3) The multi-hop reasoning is fundamentally flawed. The question asks about the evolution of AMD's financial relationship and disclosure practices. The correct inference is that while the equity stake remained unchanged, financial transparency *decreased* in 2023. The LLM incorrectly infers increased investment value and enhanced disclosure, which contradicts the evidence. (4) The contextual relevance is moderate because the answer addresses the right topic (AMD’s relationship with ATMP JV) and mentions relevant concepts (carrying value, disclosures), but the factual inaccuracies and reversed conclusions make it highly misleading. Thus, the correctness and quantitative accuracy scores are very low; qualitative accuracy is slightly higher only because the model attempts the right type of analysis, albeit incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 478,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline indicates a slight reduction in demand or market share for new equipment in the commercial aviation sector, which may reflect broader industry challenges such as slower aircraft production or a shift in customer focus toward aftermarket services. Despite this, Honeywell maintains a significant presence in the aerospace sector, particularly in defense and space, where its revenue grew.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for Commercial Aviation Original Equipment—$2,397 million in 2023 and $2,223 million in 2024—matching the ground truth exactly. The decrease is accurately implied, and no calculation is required beyond the comparison, which is correctly interpreted as a decline. (2) All numeric values are correct and presented in a consistent format; no calculation errors exist. (3) The multi-hop reasoning is sound: the model identifies the trend in the specified segment and connects it to broader implications in the aerospace sector. While the ground truth emphasizes 'contraction in this segment despite overall growth in the Aerospace Technologies division' and suggests 'potential weakening in original equipment demand or supply constraints,' the LLM offers a semantically similar interpretation—'slight reduction in demand or market share' and references 'broader industry challenges'—which is reasonable and consistent. The LLM adds context about growth in defense and space, which is plausible and enhances relevance without contradicting the ground truth. (4) The answer is fully contextually relevant, addressing both parts of the question: the revenue evolution and its implication for Honeywell’s position in aerospace. The only minor difference is that the LLM does not explicitly mention the contrast with overall Aerospace Technologies growth, slightly reducing qualitative accuracy, but the core reasoning remains strong. Thus, the answer is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 431,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The global revenue contribution from Heart Failure Devices increased from $1,161 million in 2023 to $1,279 million in 2024, representing a 10.2% total change and a 10.3% increase when excluding the impact of foreign exchange.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the global revenue figures for Heart Failure Devices in 2023 ($1,161 million) and 2024 ($1,279 million), which match the ground truth. The percentage change is stated as 10.2%, which is accurate and matches the ground truth calculation: ((1,279 - 1,161) / 1,161) * 100 ≈ 10.16% → rounded to 10.2%. However, the LLM introduces an additional claim that the increase was 10.3% when excluding foreign exchange impact, which is not mentioned in the original answer and cannot be verified from the provided ground truth. This introduces a minor factual overreach. (2) Quantitative accuracy is high—revenue numbers and the primary percentage change are correct. The unsupported 10.3% figure slightly undermines precision. (3) The reasoning is mostly sound: the model correctly computes the percentage increase and tracks revenue evolution across years. However, the addition of 'excluding foreign exchange' suggests inference beyond the provided data, failing the multi-hop synthesis test as no source supports this adjustment. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question: revenue evolution and percentage change. The extra detail about FX is contextually relevant but unverified, hence not penalized heavily. Overall, core facts are correct, but the unsupported refinement reduces correctness slightly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 386,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "IBM's treatment of the 0.300% Notes due 2028 remained consistent between the 2022 and 2023 filings. In both years, the notes were listed as being traded under the ticker symbol \"IBM 28B\" on the New York Stock Exchange. There were no notable changes in the terms or presentation of these notes between the two filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims the treatment of the 0.300% Notes due 2028 remained consistent between 2022 and 2023, but the original answer shows a clear evolution: in 2022, the notes were only incorporated by reference from a prior Form 8-K (filed February 10, 2020), with no explicit trading symbol or formal registration details provided in the filing itself. By 2023, the notes were explicitly listed in the table of registered securities with the trading symbol IBM 28B and noted as registered on the NYSE—a significant change in disclosure and registration status. (2) The LLM incorrectly states that the ticker 'IBM 28B' was listed in both years, but the ground truth confirms this explicit listing only occurred in 2023. There are no numeric values (e.g., percentages, dollar amounts) in dispute, so quantitative accuracy is not the main issue, but the misrepresentation of facts and timing undermines correctness. (3) The multi-hop reasoning failed: the model did not recognize the shift from incorporation by reference to formal registration and explicit disclosure, which is the core of the question. (4) Contextual relevance is moderate because the answer addresses the right topic (the notes and their ticker), but the conclusion about consistency is factually wrong, making the response misleading despite some relevant terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 386,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple's financial performance in the Rest of Asia Pacific region improved from 2022 to 2023, with net sales increasing from $29,375 million in 2022 to $29,615 million in 2023, and operating income rising from $11,569 million in 2022 to $12,066 million in 2023. This indicates modest growth in both revenue and profitability for the region during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and matches the ground truth in all quantitative aspects: net sales values ($29,375 million in 2022 and $29,615 million in 2023) and operating income figures ($11,569 million in 2022 and $12,066 million in 2023) are accurately reported. The answer correctly identifies the upward trend in both metrics, indicating improved financial performance. While the LLM does not explicitly calculate the dollar or percentage changes (e.g., $240 million increase in net sales, 0.8% growth, $497 million increase in operating income, 4.3% growth), it appropriately characterizes the change as 'modest growth,' which aligns with the ground truth's 'moderate growth.' This omission of specific calculations prevents a perfect score, but since all core data points are correct and the qualitative assessment is sound, the answer is highly accurate. The entities (Apple, Rest of Asia Pacific region), time periods (2022 to 2023), and financial metrics (net sales, operating income) are correctly identified and synthesized. The reasoning is logical and contextually appropriate, directly addressing the evolution of financial performance. Thus, the answer is semantically equivalent to the ground truth, with only minor lack of detail in the quantitative changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 357,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The vesting period for stock options issued under the 2007 Omnibus Incentive Plan changed between grants made prior to 2022 and those made after December 31, 2021. Stock options granted prior to 2022 generally vested pro rata over a five-year period and terminated ten years from the grant date. In contrast, stock options granted subsequent to December 31, 2021, generally vested pro rata over a four-year period and also terminated ten years from the grant date. Executive officers and certain other employees may still receive options with different vesting criteria in both periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all key quantitative aspects: it correctly states that stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested over a five-year period, while those granted after December 31, 2021, vested over a four-year period. The mention of the ten-year termination period is consistent with typical option terms and does not contradict the ground truth, which focuses on vesting. The LLM also correctly identifies that exceptions may apply for executive officers and certain employees, which aligns with common disclosure practices and adds contextual nuance without distorting the core facts. The ground truth emphasizes consistency in these terms as confirmed in both the 2022 and 2024 10-Ks, which the LLM does not explicitly mention but implies through its definitive phrasing. While the LLM answer does not explicitly reference the 2024 10-K confirmation (a minor omission), it accurately captures the evolution and current state of the vesting terms based on the multi-hop comparison across time periods and plan amendments. All entities (2007 Omnibus Incentive Plan, pre-2022 vs post-2021 grants) and timeframes are correctly identified. The reasoning is sound, and the semantic meaning matches the original answer. The slight deduction in qualitative accuracy is due to the lack of explicit confirmation from the 2024 filing, but the core multi-hop synthesis is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 396,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "From 2022 to 2023, CVS maintained a consistent approach to validating the fair value estimates for its Level 2 debt securities, with no adjustments made to the prices obtained from primary sources in either year. The Company continued to compare a sample of Level 2 debt security prices to secondary sources on a quarterly basis, reviewing variances exceeding a specified threshold to ensure the primary source prices represented appropriate fair value estimates. Additionally, the internal investment team compared these prices to their own independent fair value estimates. No price adjustments were necessary in either 2023 or 2022, indicating continued reliability in the primary pricing sources and validation processes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CVS obtained one price per Level 2 debt security in both 2022 and 2023, made no price adjustments at year-end (specifically December 31, 2022 or 2023), and continued quarterly comparisons of sample prices to secondary sources with threshold-based variance reviews. The statement that no adjustments were necessary supports the consistency of the methodology. (2) Quantitative elements—years (2022, 2023, December 31), frequency (quarterly), and the absence of adjustments—are all factually correct and consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time periods and validation steps, noting the sustained process. The only minor gap is that the LLM mentions the internal investment team comparing prices to 'independent fair value estimates,' which, while plausible and contextually consistent, is slightly more specific than the original answer’s phrasing about 'emphasis on consistent internal validation.' This addition does not contradict but adds a detail not explicitly confirmed in the ground truth, slightly affecting qualitative precision. (4) Despite this nuance, the answer fully addresses the evolution (or lack thereof) in CVS’s approach, correctly concluding that the methodology remained unchanged, which matches the core conclusion of the original answer. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly responsive to the question about evolution, price adjustments, and secondary source comparisons.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 448,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "Between 2022 and 2023, CVS maintained its classification of privately-placed equity securities in Level 3 of the fair value hierarchy due to the absence of active markets. The valuation methodology remained consistent, relying on internal analysis of each investment's financial statements and cash flow projections. Key unobservable inputs included earnings and revenue multiples, discounts for lack of marketability, and comparability adjustments. In 2023, the fair value of Level 3 equity securities increased to $79 million from $60 million in 2022, reflecting changes in these unobservable inputs and investment performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that CVS classified privately-placed equity securities as Level 3 in both 2022 and 2023 and used internal financial analysis and cash flow projections for fair value determination. It accurately lists the key unobservable inputs (earnings and revenue multiples, discount for lack of marketability, comparability adjustments), which aligns with the ground truth. However, the LLM introduces a quantitative claim not present in the original answer — that the fair value increased from $60 million in 2022 to $79 million in 2023 — which is factually unsupported by the provided ground truth. There is no mention of dollar amounts in the original answer, so this addition is incorrect and undermines factual accuracy. (2) The quantitative accuracy is low because the introduced figures ($60M and $79M) cannot be verified and are likely hallucinated. No such values appear in the ground truth, and no calculation or source is provided. (3) The qualitative reasoning is strong: the model correctly synthesizes the consistent classification, valuation approach, and unobservable inputs across years. It also implicitly captures a shift in emphasis by linking changes in inputs to valuation changes, which aligns with the original answer’s point about increased scrutiny or sensitivity analysis in 2023. However, it fails to explicitly mention the enhanced focus on sensitivity or impact of input changes, instead substituting that with a numerical claim. (4) Contextual relevance is high because the response stays focused on the evolution of methodology and addresses classification, valuation, and inputs. The core conceptual progression is sound, but the inclusion of unsupported numbers reduces overall correctness. Thus, while the qualitative and contextual aspects are mostly accurate, the introduction of unverified financial figures significantly harms quantitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 524,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue from Alphagan/Combigan decreased by 8.8% in 2024 compared to 2023. In terms of international revenue, it slightly increased by 1.5% in 2024, following a 4.9% increase in 2023. Thus, the international revenue for Alphagan/Combigan showed a positive trend during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 8.8% decline in total net revenue and the 1.5% increase in international revenue, which aligns with the ground truth. However, it introduces an incorrect detail — 'following a 4.9% increase in 2023' — which is not present in the original answer and not supported by the question context. This suggests flawed reasoning or hallucination about prior-year trends. (2) The core numbers — $272M to $248M (8.8% drop) and $151M to $153M (1.5% growth) — are accurate in the ground truth, but the LLM does not report the actual dollar amounts, only percentages, reducing completeness. The 8.8% and 1.5% figures are quantitatively correct if derived from those amounts, so the percentages themselves are accurate, but the added 4.9% figure is extraneous and incorrect. (3) The multi-hop reasoning is partially sound: the model correctly infers the trend from year-to-year changes and synthesizes the direction of revenue movement. However, the inclusion of unsupported prior-year growth undermines the reasoning quality. (4) Scores reflect that the key facts are present and the main trends are correctly identified (hence a 7 on correctness), but the addition of false quantitative details and omission of dollar values reduce quantitative accuracy. The answer remains contextually relevant and qualitatively reasonable in structure and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 384,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved significantly from 2023 to 2024, as PDC became a wholly-owned subsidiary of Chevron in 2023. This acquisition contributed to Chevron's production performance, with the full-year of PDC's production driving a seven percent increase in Chevron's worldwide oil-equivalent production in 2024 compared to 2023. Specifically, the United States production saw a substantial rise, partly attributed to PDC's contribution, as reflected in the increased net production figures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 acquisition of PDC Energy by Chevron and the resulting 7% increase in worldwide oil-equivalent production in 2024, which matches the ground truth. The percentage (7%) and the time frame (2023 acquisition, 2024 full-year contribution) are accurate. (2) Quantitatively, the 'seven percent increase' is correctly stated and aligns with the ground truth's '7% increase'. No calculations are required beyond this, and the numbers are presented accurately. (3) The multi-hop reasoning is sound: the model connects the 2023 acquisition to the 2024 production impact, recognizing PDC’s transition from a newly acquired entity to a key operational contributor. It appropriately infers that the full-year inclusion of PDC’s operations contributed to production growth. The only minor omission is that the LLM does not mention PDC being excluded from internal control assessment in 2023, which is a detail from the original answer but not critical to the core question about operational impact on production. (4) The answer is semantically equivalent to the ground truth in terms of the key facts and synthesis. The addition of 'United States production saw a substantial rise' is plausible and consistent with PDC’s operational focus, though not explicitly stated in the original. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight lack of completeness regarding non-operational details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 418,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "UPS's investment in cold-chain logistics capabilities significantly evolved from 2023 to 2024, primarily through strategic acquisitions. In 2023, UPS acquired MNX Global Logistics, a global time-critical and temperature-sensitive logistics provider, and Bomi Group, which expanded UPS's international cold-chain logistics presence in Europe and Latin America. In 2024, UPS further enhanced its cold-chain logistics capabilities by acquiring Frigo-Trans and Biotech & Pharma Logistics, a leading complex healthcare logistics provider in Germany. These acquisitions reflect UPS's focus on strengthening its healthcare and life sciences logistics services both domestically and internationally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities are correct: Bomi Group, MNX Global Logistics (2023), and Frigo-Trans and Biotech & Pharma Logistics (2024) are accurately identified as the key acquisitions. The years are correctly assigned. (2) Quantitative accuracy is perfect: while the LLM does not mention the $440 million figure from the ground truth, it does not make any numerical claims, so no inaccuracy is introduced. The omission is minor given that the focus is on the evolution and specific acquisitions. (3) Reasoning and synthesis are sound: the LLM correctly infers a strategic evolution in UPS's cold-chain logistics, emphasizing international and healthcare-focused expansion, which matches the ground truth's narrative of a shift toward high-value international acquisitions. (4) The answer is contextually relevant and addresses both parts of the question—evolution from 2023 to 2024 and the specific acquisitions involved. The only minor shortcoming is the lack of explicit mention of the $440 million investment in 2024, which adds quantitative weight to the 'significant increase' claim. However, since the LLM does not misstate any facts and captures all key events and strategic direction, the correctness score is 9 rather than 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 361,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "Between 2022 and 2024, Linde plc's non-employee director restricted stock unit (RSU) award program remained under the framework of the 2021 Linde plc Long Term Incentive Plan. In 2024, the program included a formalized deferral mechanism, as evidenced by the adoption of the Linde plc Non-employee Director Deferral Program on July 30, 2024, which allowed for long-term alignment with shareholder interests by deferring compensation. Additionally, the 2021 Long Term Incentive Plan was amended on March 21, 2024, indicating ongoing adjustments to governance and alignment mechanisms. The program continued to emphasize equity-based compensation for non-employee directors, reflecting a commitment to tying director compensation to company performance and shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the program operates under the 2021 Linde plc Long Term Incentive Plan, the Non-employee Director Deferral Program was adopted on July 30, 2024, and it enhances long-term shareholder alignment through deferral of stock units. The mention of the March 21, 2024 amendment to the 2021 plan is an additional detail not in the original answer but does not contradict it and may reflect a real update consistent with ongoing governance adjustments. (2) Quantitative accuracy is perfect: dates (July 30, 2024; March 21, 2024) are correctly stated, and no financial figures are misreported. Format and specificity match expectations. (3) Multi-hop reasoning is sound—LLM correctly synthesizes the evolution from a basic RSU award in 2022 to a more structured deferral program in 2024, linking governance changes to shareholder alignment. (4) The only reason for not scoring a 10 is minor: the original answer emphasizes the 2022 introduction of the RSU award as a new initiative, while the LLM treats it as pre-existing under the 2021 plan without explicitly noting its implementation in 2022. This slightly downplays the evolutionary step in 2022, though the overall trajectory is correctly captured. Otherwise, the answer is contextually complete, factually precise, and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 384,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "Between 2022 and 2024, General Motors' financial and legal relationship with Stellantis evolved primarily through indemnification obligations stemming from the 2017 sale of the Opel/Vauxhall business. GM agreed to indemnify Stellantis for certain losses related to emissions claims, product liabilities, and recalls. In 2024, GM acknowledged an immaterial indemnification payment for certain Takata-related recalls conducted by Stellantis. However, GM believes further indemnification obligations are remote. Additionally, GM faced potential exposure from ongoing investigations by the European Commission and UK CMA related to Opel's past conduct, though no material accrual was recorded as of December 31, 2024. Investment gains were not explicitly detailed, but GM recorded a gain related to Stellantis warrants in 2021, indicating a prior positive financial interaction.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core evolution of GM's relationship with Stellantis, focusing on indemnification obligations from the 2017 Opel/Vauxhall sale and potential liabilities from European investigations. It accurately notes the shift from financial gains to legal risks. However, there are key factual inaccuracies: the warrant gain is stated as occurring in 2021 in the LLM answer, while the ground truth specifies 2022 (a one-year error). Additionally, the LLM mentions an 'immaterial indemnification payment' for Takata-related recalls in 2024, which is not present in the original answer and introduces unverified detail. (2) Quantitative accuracy is partially compromised: the $0.2 billion gain in 2022 is misattributed to 2021, and no dollar amount is provided for the gain despite it being specified in the ground truth. The lack of the $0.2 billion figure reduces precision. (3) The multi-hop reasoning is sound—linking the 2017 sale to later indemnification duties and connecting ongoing investigations to contingent liabilities shows good synthesis. The shift in nature of the relationship over time is logically conveyed. (4) Despite minor factual errors and omission of the exact gain amount, the answer captures the essential qualitative shift from financial benefit to legal exposure. The contextual relevance is high as it directly addresses both indemnification and investment aspects, though 'investment gains' are underdeveloped. The introduction of a specific but immaterial payment not in the original answer slightly undermines factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 439,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "From 2022 to 2024, Southern Company's treatment and disclosure of energy-related derivatives showed a shift in financial presentation and categorization. In 2022, energy-related derivatives were categorized under regulatory, cash flow, and fair value hedges, with detailed breakdowns of gains and losses impacting income and AOCI. By 2024, the disclosures became more granular, with separate reporting for each subsidiary (Southern Company, Alabama Power, Georgia Power, Mississippi Power, and Southern Power), and more emphasis on netting arrangements and collateral impacts. Additionally, the 2024 disclosures included more detailed fair value and hedge maturity information, reflecting a more transparent and structured approach to derivative reporting.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects. While both mention a shift in disclosure practices, the original answer emphasizes a clear transition from income statement focus (2022) to balance sheet presentation (2024), specifically highlighting categorization under 'Other' or 'Risk Management Activities'. The LLM answer instead claims increased granularity by subsidiary and more focus on netting and collateral, which is not supported by the ground truth. (2) There are no explicit numbers, dollar amounts, or percentages in either answer, so quantitative accuracy is not heavily penalized; however, the LLM introduces unverified details (e.g., breakdown by subsidiaries, collateral impacts) that cannot be confirmed and appear to be fabricated or inferred beyond the data. (3) The multi-hop reasoning is partially sound—recognizing an evolution in disclosure—but fails to correctly identify the nature of the shift. The core transformation from income-based to balance-sheet-oriented reporting is missed, which is the central point in the ground truth. Instead, the LLM invents dimensions (subsidiary-level reporting, netting) not present in the original. (4) Contextual relevance is high because the response stays on topic and addresses the evolution of derivative treatment. However, correctness score is low due to factual misrepresentation of the nature of the change. The answer sounds plausible but does not reflect the actual shift described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 427,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "Between 2023 and 2024, GILD's strategic relationship with Arcus evolved significantly in terms of equity ownership and governance influence. As of December 31, 2023, GILD owned approximately 19.9% of Arcus, with two designees on Arcus' board of directors. In January 2024, GILD increased its ownership to 33% through a $320 million equity investment and expanded its board representation to three designees under an amended Collaboration Agreement. This marked a substantial increase in both equity ownership and governance influence over Arcus.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 19.9% ownership in 2023, the $320 million investment in January 2024, and the resulting 33% ownership are correctly reported. The board representation—two designees in 2023 increasing to three in 2024—is also accurate. (2) The answer is complete, addressing both equity ownership and governance influence across both years as required by the question. (3) Entities are correctly identified: GILD and Arcus are accurately named, and the timeframes (December 31, 2023, and January 2024) align with the ground truth. (4) The reasoning is sound and reflects proper multi-hop synthesis—connecting the equity investment to increased ownership and governance rights, and interpreting the strategic significance. The mention of the 'amended Collaboration Agreement' adds contextual detail consistent with the type of documentation that would govern such a relationship. (5) The semantic meaning is equivalent to the original answer, with no factual discrepancies. Minor wording differences (e.g., 'expanded its board representation' vs 'expanded to three designees') do not affect accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 350,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "The maturity date of the 2021 Multicurrency Credit Facility was extended from June 28, 2024, in 2022 to July 1, 2026, in 2023. The borrowing capacity remained unchanged at $6.0 billion during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the borrowing capacity remained unchanged at $6.0 billion, which matches the ground truth. However, it incorrectly reports the 2022 maturity date as June 28, 2024, whereas the ground truth specifies June 30, 2025. The 2023 maturity date is correctly stated as July 1, 2026. This error in the 2022 maturity date is a significant factual inaccuracy. (2) Quantitatively, the dollar amount ($6.0 billion) is correct, but the 2022 maturity date is off by over a year (June 2024 vs June 2025), which is a major error in date precision. The extension is from 2025 to 2026, not 2024 to 2026 as implied. (3) The reasoning correctly identifies that the borrowing capacity did not change and that the maturity date was extended, which shows sound multi-hop synthesis across years. However, the incorrect starting date undermines the accuracy of the evolution narrative. (4) The answer is contextually relevant and addresses both parts of the question (maturity date and borrowing capacity), but the incorrect 2022 maturity date reduces factual correctness significantly. While the direction of change (extension by about a year) is correct, the specific dates are not, warranting a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 351,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron's utilization of imported crude oil in U.S. refining operations remained relatively stable between 2023 and 2024, with imported crude oil accounting for approximately 60% of refinery inputs in both years. However, refinery capacity utilization in the U.S. decreased from an average of 90.8% in 2023 to 86.6% in 2024, indicating a decline in operational efficiency or demand during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron's use of imported crude oil remained at approximately 60% in both 2023 and 2024, matching the ground truth. It also accurately reports the refinery capacity utilization figures: 90.8% in 2023 and 86.6% in 2024. All numeric values are correct and properly attributed to the right years and metrics. (2) Quantitative accuracy is perfect—percentages and years are exact, and no calculations were required beyond correct reporting. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two metrics (imported crude oil reliance and capacity utilization) and two years, addressing both parts of the question. The conclusion that operational intensity declined is logically supported, though the LLM slightly overreaches by suggesting it may reflect a decline in 'operational efficiency or demand'—the ground truth attributes the decline to reduced operational intensity without specifying cause, so this interpretation introduces a minor assumption. (4) Despite this small interpretive leap, the answer is factually correct, complete, and highly relevant. The core facts, numbers, and synthesis are accurate, warranting a high score. The only reason for not giving a 10 is the slight speculative phrasing around 'efficiency or demand,' which isn't in the original and slightly deviates from the neutral tone of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 391,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS's hedging position in British Pound Sterling decreased from £856 million in 2022 to £663 million in 2023 and further to £536 million in 2024. This reduction suggests a strategic adjustment in the company's currency risk management approach, potentially reflecting a lower exposure to GBP-denominated cash flows or a shift in focus to other currencies like the Chinese Renminbi, which appeared in 2024. The shift indicates a more dynamic and responsive hedging strategy aligned with evolving operational and financial exposures.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 and 2024 GBP hedge positions as £663 million and £536 million, matching the ground truth. However, it introduces a 2022 figure (£856 million) not present in the original answer or required by the question, which risks misleading the user. The reduction from 663M to 536M is accurate (127M decrease, ~19.15%), but the LLM does not explicitly calculate or mention the percentage change, slightly reducing completeness. (2) Quantitatively, the 2023 and 2024 values are correct, but the inclusion of an unsupported 2022 figure lowers accuracy. No calculation of the 19.15% decrease is provided, though the direction and magnitude of change are correctly described. (3) The reasoning is sound in interpreting the reduction as a strategic shift in currency risk management, and the mention of potential shifts to other currencies (e.g., Chinese Renminbi) adds context not in the ground truth but plausibly inferred. However, this addition, while reasonable, is speculative and not grounded in the provided truth. (4) The answer is highly relevant and addresses both parts of the question—evolution of the hedging position and its strategic implication. The core facts are correct, but the extra 2022 data and lack of explicit quantitative analysis prevent a higher score. Overall, the answer is factually solid on the key years but includes unverified information and omits a key calculation, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 408,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion in 2023 to $1.3 billion in 2024. This slight increase suggests a modest expansion in the company's short-term investment holdings, potentially reflecting a strategy to maintain or slightly increase liquidity in response to market conditions or regulatory requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the fair value of money market investments increased from $1.2 billion in 2023 to $1.3 billion in 2024, matching the ground truth in both amount and direction of change. The dates are slightly generalized (using '2023' and '2024' instead of 'December 31, 2023' and 'December 31, 2024'), but this does not affect factual accuracy. (2) All numeric values are accurate: $1.2 billion and $1.3 billion are correctly reported with acceptable formatting. The implied increase of $0.1 billion is correct. (3) The reasoning is sound: the LLM correctly infers a modest expansion in short-term investment holdings and links it to liquidity management or strategic capital deployment. While the original answer references 'liquidity management or short-term capital deployment,' the LLM offers a plausible interpretation involving 'market conditions or regulatory requirements,' which is contextually reasonable and does not contradict the ground truth. (4) The answer is semantically equivalent and fully addresses both parts of the question—evolution of fair value and its strategic implication. The only minor difference is in the nuance of interpretation, not factual content, justifying a high score but not perfect due to slight softening of the specific strategic indication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 369,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas subject to physical supply contracts with sell-back options for Southern Company's subsidiaries decreased from 26 million mmBtu in 2022 to 15 million mmBtu in 2024. Specifically, the reduction was observed across Alabama Power (from 6 million mmBtu to 4 million mmBtu), Georgia Power (from 8 million mmBtu to 6 million mmBtu), Mississippi Power (from 4 million mmBtu to 2 million mmBtu), and Southern Power (from 8 million mmBtu to 3 million mmBtu).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values for both 2022 and 2024 are accurate: company-wide totals (26 million mmBtu to 15 million mmBtu) and subsidiary-specific volumes (Alabama Power: 6 to 4, Georgia Power: 8 to 6, Mississippi Power: 4 to 2, Southern Power: 8 to 3 million mmBtu) are correctly reported. (2) The quantitative accuracy is perfect—no calculation errors, and the reductions per entity and overall are consistent with the original data. (3) The multi-hop reasoning is sound: the model correctly synthesized data across Southern Company and its four subsidiaries over two years, capturing the trend of reduction across all entities. (4) The answer is semantically equivalent to the original, clearly conveying the decrease in volume over time and across all subsidiaries without omissions or distortions. All entities, metrics, and years are correctly identified. The response is concise, factually complete, and directly addresses the question's focus on changes over time and across subsidiaries.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 304,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "Adobe's Firefly Vector Model has seen expanded integration across its product suite between 2023 and 2024, particularly within Adobe Illustrator, Adobe Express, and Adobe Stock. In 2023, Firefly's vector capabilities were introduced to enable text-prompt-driven generation of fully editable vector graphics. By 2024, these features were further enhanced and extended, allowing for seamless use in creative workflows. For instance, Adobe Illustrator added Firefly-powered Generative Recolor, and Adobe Express incorporated Firefly to generate custom vector-based design elements and text effects. Additionally, Firefly Vector Model became part of Adobe Firefly Services, enabling enterprises to automate content creation while maintaining brand consistency. This evolution reflects Adobe's commitment to embedding generative AI capabilities into its tools to enhance creative productivity and accessibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the 2023 integration of the Firefly Vector Model into Adobe Express for generating vector graphics and text effects from text prompts, including multilingual support (implied by 'text-prompt-driven generation'). In 2024, it accurately notes the expansion to Adobe Illustrator with the Generative Recolor feature. The mention of Adobe Stock and Adobe Firefly Services adds context not in the original answer but does not contradict it—these are plausible extensions of Firefly’s ecosystem and do not introduce factual errors. All dates and product names (Adobe Express, Illustrator) are correct. There are no numerical inaccuracies (quantitative accuracy is perfect). The reasoning is sound: it traces the evolution from 2023 to 2024, showing expansion across products and use cases. The only minor shortcoming is that the original answer emphasizes the shift from a single-app (Express) to multi-app professional tools, which the LLM answer implies but doesn't explicitly frame as a strategic expansion in reach. Still, the core facts, timeline, and feature developments are correct and semantically equivalent. Thus, the answer is factually complete and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 362,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "Based on the data provided in the financial tables, Biktarvy's commercial significance for GILD increased from 2023 to 2024. In 2023, Biktarvy generated $11,850 million in total product sales, and by 2024, it rose to $14,848 million. This growth indicates that Biktarvy has become a more dominant product in GILD's HIV portfolio, likely reinforcing the company's strategy to focus on innovative, single-tablet regimens for HIV treatment. The continued success of Biktarvy supports GILD's HIV business strategy by maintaining market leadership and potentially offsetting challenges from competition and patent expirations of older HIV products.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. While it correctly states that Biktarvy generated $11,850 million in 2023 (matching the ground truth), it falsely claims that sales rose to $14,848 million in 2024, which is not supported by the original answer or any provided data. The ground truth does not provide 2024 sales figures, but instead emphasizes increasing risks to Biktarvy's dominance due to generic competition and treatment shifts—indicating potential revenue pressure, not growth. Thus, the reported 2024 number is fabricated or misattributed. (2) Quantitative accuracy is severely compromised: the $14,848 million figure has no basis in the source material and represents a significant overstatement. No calculation or comparison involving 2024 data can be considered valid. (3) The reasoning is flawed in its multi-hop synthesis: instead of recognizing the strategic concern about overreliance on TAF-based HIV products like Biktarvy, the model incorrectly infers that rising sales reinforce GILD's strategy. This contradicts the original answer’s implication that GILD must diversify due to looming threats. The model fails to identify the shift from performance to risk assessment between years. (4) Despite incorrect facts and reasoning, the answer remains contextually relevant by addressing the evolution of Biktarvy's role and its strategic implications for GILD’s HIV business. It correctly identifies Biktarvy as central to the HIV portfolio and references single-tablet regimens, which aligns with GILD's known strategy. However, the conclusion is opposite in tone and substance to the ground truth. Hence, low scores for correctness and quantitative accuracy, moderate for qualitative reasoning, and mid-range for relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 481,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "The Series 2018-1A Securities had an outstanding principal amount of $496.8 million as of December 31, 2023, compared to $496.1 million as of December 31, 2022, indicating a slight increase in principal. The interest rate for these securities remained at 3.652% during this period, with an anticipated repayment date of March 15, 2028, though the final legal maturity is March 15, 2048.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key quantitative data. According to the ground truth, the outstanding principal in 2022 was $500.0 million, not $496.1 million as stated by the LLM. In 2023, the correct principal is $496.8 million, which the LLM correctly reports. However, the LLM incorrectly states that the principal increased from $496.1 million to $496.8 million, when in fact it decreased from $500.0 million. The interest rate of 3.652% is correctly reported as unchanged. (2) The calculation of principal change is flawed due to incorrect input values. The actual reduction is $3.2 million ($500.0M - $496.8M), whereas the LLM implies a negligible increase based on wrong figures. The inclusion of repayment and maturity dates (March 15, 2028, and 2048) adds detail but is not part of the original question or ground truth, suggesting potential hallucination or misattribution. (3) The multi-hop reasoning is partially sound in comparing two years and identifying stable interest rates, but the core financial data synthesis is incorrect due to reliance on inaccurate principal amounts. The model fails to accurately retrieve the 2022 principal, undermining the comparative analysis. (4) The correctness score is low due to major quantitative inaccuracies despite correct interest rate reporting. Quantitative accuracy is severely penalized because the principal figures are factually wrong. Qualitative accuracy is moderate as the structure of the response and recognition of relevant metrics (principal, rate, trend) are appropriate. Contextual relevance is acceptable since the answer addresses the right securities and time frame, even with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 464,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "UPS's relationship with Coyote evolved significantly from 2023 to 2024, both financially and strategically. In 2023, UPS recorded a $111 million impairment charge for the Coyote trade name due to declining revenues and challenging market conditions, and began evaluating strategic alternatives for the business. By 2024, UPS completed the divestiture of Coyote, which contributed a $156 million gain on the divestiture and led to a $976 million revenue decline in the Forwarding segment. The divestiture marked a strategic shift, reducing financial exposure and aligning with UPS's focus on higher-growth areas within Supply Chain Solutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite capturing the general strategic direction. The $111 million impairment charge in 2023 is correctly stated, but the 2024 divestiture details are wrong: the gain on divestiture ($156 million) and the $976 million revenue decline in the Forwarding segment are not supported by the ground truth and contradict it. The original answer states that Coyote's exit contributed to a revenue decrease in Supply Chain Solutions, but does not specify a $976 million decline or attribute it to the Forwarding segment. Additionally, no gain on divestiture is mentioned in the ground truth. (2) Quantitative accuracy is low: while $111 million is correct, the $156 million gain and $976 million revenue drop are fabricated or misattributed numbers. There is no indication in the ground truth that the divestiture generated a gain—instead, the focus is on the impairment and revenue impact from exiting the business. (3) The multi-hop reasoning is partially sound—the model correctly identifies a shift from impairment in 2023 to divestiture in 2024 and infers strategic realignment. However, it introduces unsupported financial figures that undermine the correctness of the synthesis. The strategic direction is plausibly interpreted but overstated with incorrect metrics. (4) Contextual relevance is high because the answer addresses both financial impact and strategic direction across 2023–2024 and focuses on the right entities (UPS, Coyote, Supply Chain Solutions). However, the inclusion of false quantitative data severely reduces overall correctness, warranting a score of 4—partially correct but with major factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 462,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "Linde plc's Performance Share Unit Awards for grants beginning in 2019 utilized two performance metrics: Return on Capital and Total Shareholder Return. These metrics were specified in the forms of the Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan, as detailed in the 2018 Annual Report on Form 10-K. There is no indication of a change in these metrics by 2024, as the 2024 document pages do not mention any amendments to these specific performance metrics for the 2019 grants.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the two performance metrics used for Linde plc's Performance Share Unit Awards for grants beginning in 2019: Return on Capital and Total Shareholder Return. It also correctly references the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan, which aligns with the ground truth. The conclusion that there was no change in these metrics by 2024 is consistent with the original answer. However, the LLM incorrectly cites the 2018 Annual Report as the source for the 2019 grant details, while the ground truth relies on 2022 and 2024 filings (Exhibits 10.11k/l and 10.10l/m) to confirm continuity. This misattribution weakens the multi-hop reasoning, as the evolution between 2022 and 2024 should be supported by those specific years' disclosures, not an earlier report. Additionally, the LLM does not explicitly confirm that the same award structures were maintained in 2022 and 2024 through direct exhibit mapping, which is a key part of the ground truth's evidence. While the core facts about the metrics and their persistence are correct, the supporting documentation and logical flow across years are less precise, leading to a partial deduction in qualitative accuracy. Quantitative accuracy is high as no numerical errors are present, and contextual relevance is strong since the answer addresses the evolution and metrics directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 382,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "Between 2023 and 2024, the regulatory status of Trodelvy (sacituzumab govitecan-hziy) evolved significantly, indicating a continued and expanding development trajectory. In 2023, Trodelvy received FDA approval for the treatment of unresectable locally advanced or metastatic HR+/HER2- breast cancer and was approved by the European Commission for similar indications in the EU. In 2024, Gilead further advanced Trodelvy's regulatory profile by securing Breakthrough Therapy designation from the FDA for the treatment of adult patients with extensive-stage small cell lung cancer whose disease has progressed on or after platinum-based chemotherapy. This designation highlights the drug's potential to substantially improve clinical outcomes and expedites its development and regulatory review. These developments demonstrate Gilead's ongoing commitment to expanding Trodelvy's therapeutic applications and reinforcing its role in addressing unmet medical needs across multiple cancer types.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 2024 Breakthrough Therapy designation by the FDA for Trodelvy in extensive-stage small cell lung cancer after platinum-based chemotherapy, which matches the original answer. It also accurately reflects the 2023 indications, specifically mentioning HR+/HER2- breast cancer, though it omits explicit mention of triple-negative breast cancer and urothelial cancer—minor omissions that do not undermine the core message but slightly reduce completeness. (2) There are no numerical values requiring calculation, but all dates (2023, 2024) and regulatory actions (FDA approval, Breakthrough Therapy designation) are factually correct. The mention of European Commission approval adds context not in the ground truth but does not contradict it. (3) The multi-hop reasoning is sound: the answer synthesizes regulatory developments across years and indications, correctly inferring an expanding development trajectory. The conclusion about addressing unmet medical needs and strategic expansion is logically supported. (4) The answer is contextually excellent, directly addressing the evolution of regulatory status and its implications. The only reason for not scoring a 10 is the partial omission of the full 2023 indication scope, which slightly affects qualitative completeness despite strong overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 389,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "From 2023 to 2024, the Vertex AI platform within Google Cloud has evolved significantly in terms of its capabilities and integration with generative AI models. In 2023, Vertex AI enabled developers to train, tune, augment, test, and deploy applications using generative AI models like Gemini and Imagen. By 2024, the platform had expanded to include Gemini 2.0, Google's most capable model, and introduced pre-packaged AI agents such as Duet AI and Gemini for Google Cloud. These enhancements allowed developers to more efficiently write, document, test, and operate software, as well as assist cybersecurity teams in threat detection and response.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in entity identification and capabilities evolution. While it correctly notes Vertex AI's role in training, tuning, and deploying generative AI models, it incorrectly states that Gemini and Imagen were available on Vertex AI in 2023 — the ground truth specifies that Gemini integration came in 2024, not 2023. Additionally, the LLM introduces 'Gemini 2.0', 'Duet AI', and 'pre-packaged AI agents' which are not mentioned in the ground truth and lack support from the provided knowledge. The 2024 enhancements described (e.g., assisting cybersecurity teams) go beyond the documented scope of vector search, grounding, and distillation for model optimization. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable — no errors in this regard, scoring 10 by default. (3) The multi-hop reasoning is partially sound — the model recognizes a progression from 2023 to 2024 in Vertex AI’s capabilities and attempts to describe an evolution in generative AI integration. However, it fabricates specific models and services not present in the original answer, failing to accurately synthesize the documented advancements like 'vector search', 'grounding', and 'distillation' for cost and quality improvement. (4) The contextual relevance is high because the answer addresses the evolution of Vertex AI in the correct timeframe and general domain (generative AI integration), but correctness and qualitative accuracy are reduced due to factual inaccuracies and hallucinated details. Thus, the correctness score is 5 — partially correct but with significant factual deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 463,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "The treatment and valuation of weather derivatives in SO's financial disclosures from 2022 to 2024 indicate that the immaterial premium and intrinsic value associated with weather derivatives have consistently been excluded from derivative valuations. In 2022, the 10-K mentions that these immaterial amounts were excluded for all periods presented in the fair value measurements. In 2024, a similar exclusion is noted, with the net amounts of derivative instruments outstanding explicitly excluding immaterial premium and intrinsic value associated with weather derivatives for all periods presented. There is no indication of a material change in the treatment or valuation approach for weather derivatives between 2022 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that SO consistently excluded the premium and intrinsic value of weather derivatives as immaterial in both 2022 and 2024, which aligns with the ground truth. However, it fails to mention the new quantitative disclosures in 2024 related to cash collateral in broker margin accounts ($17 million at end of 2024 and $62 million at end of 2023), which is a key evolution in SO's derivative disclosures. This omission affects completeness and quantitative accuracy. (2) No incorrect numbers are stated, but the LLM does not report the $17M and $62M figures from 2024 and 2023, respectively, which were explicitly included in the ground truth and represent a material enhancement in disclosure detail. These values are critical to assessing changes in treatment over time. (3) The reasoning is sound in noting consistency in the treatment of weather derivatives as immaterial, but it misses the multi-hop nuance that while the weather derivatives themselves remain immaterial, SO’s overall derivative disclosure framework has become more detailed—evidenced by the new collateral disclosures. This reflects a structural shift in transparency, even if the specific treatment of weather derivatives hasn’t changed. (4) The answer is contextually relevant and accurately captures the consistent immateriality stance, warranting high scores for qualitative accuracy and relevance. However, the lack of specific dollar amounts related to collateral in 2023 and 2024 reduces quantitative accuracy and overall correctness, preventing a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 433,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "Between 2023 and 2024, Biktarvy's regulatory and market positioning evolved with the FDA approving an expanded indication to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the label was updated with new data reinforcing its safety and efficacy for treating pregnant individuals with HIV-1. These updates enhance Biktarvy's market position by broadening its applicability to more complex patient scenarios and supporting its use in pregnancy, reinforcing its role as a versatile and trusted treatment option in the HIV therapeutic landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory developments for Biktarvy in 2024—specifically, the FDA's expanded indication for patients with suppressed viral loads and M184V/I resistance, as well as the updated label supporting use in pregnant individuals with HIV-1. These points are factually aligned with the ground truth. However, the LLM omits the 2023 patent expiration detail (2033 U.S. patent expiry), which was part of the original answer and relevant to market positioning based on exclusivity. This is a minor omission affecting completeness but not the core regulatory evolution. (2) There are no numeric values, dates, or calculations in the LLM answer that conflict with the ground truth. The absence of the 2033 patent date is a missing fact, not an incorrect one, so quantitative accuracy remains high. (3) The multi-hop reasoning is mostly sound—the model synthesizes the 2024 regulatory updates correctly and draws a reasonable conclusion about enhanced market positioning. It fails to contrast 2023 (patent protection focus) with 2024 (expanded indications), slightly weakening the comparative analysis implied in the question. (4) Despite the omission, the answer is contextually relevant, well-reasoned, and factually accurate on the points it covers. The core of the question—how regulatory and market positioning evolved—is addressed with correct qualitative insights, warranting a high score but not perfect due to the missing 2023 context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 411,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "AMT's utilization of the 2021 Multicurrency Credit Facility changed between 2022 and 2023 in terms of borrowing and facility amendments. In 2023, AMT borrowed an aggregate of $3.0 billion and repaid $6.1 billion, including 842.6 million EUR ($919.1 million), under the 2021 Multicurrency Credit Facility, primarily to repay existing indebtedness and for general corporate purposes. Additionally, the facility was amended in June 2023, extending its maturity date to July 1, 2026, maintaining a $6.0 billion borrowing capacity, and replacing the LIBOR pricing benchmark with an Adjusted Term SOFR benchmark.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: $3.0 billion borrowed and $6.1 billion repaid in 2023, including the 842.6 million EUR ($919.1 million) repayment. It accurately notes the June 2023 amendment that extended the maturity to July 1, 2026, maintained the $6.0 billion commitment, and replaced LIBOR with SOFR (specified as Adjusted Term SOFR, which is semantically acceptable). The only minor omission is that the 2022 net borrowings of $850.0 million are not mentioned in the LLM answer, despite being part of the original answer and directly relevant to the question about changes between 2022 and 2023. (2) All numbers and dates are factually correct and match the ground truth. The EUR-to-USD conversion is consistent. No calculation errors. (3) The multi-hop reasoning is largely sound—synthesizing borrowing activity, repayment, and facility amendments across years. However, the absence of 2022 borrowing data weakens the comparative analysis, which is central to the question. (4) Scores reflect near-perfect quantitative accuracy and contextual relevance. Qualitative accuracy is slightly reduced due to the omission of 2022 data, affecting completeness in the multi-hop comparison. Correctness score is 9 because the core transformation in 2023 is well-explained, but the lack of 2022 utilization details prevents a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 384,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "Between 2023 and 2024, Google Ad Manager's role in Alphabet's advertising revenue recognition strategy remained central as a key platform for customers to purchase advertising inventory. The integration with revenue reporting models continued to follow a gross reporting basis for ads placed on Google Network properties, where Alphabet controls the advertising inventory before transferring it to customers. There is no indication of a material change in this approach between the two periods, suggesting consistency in how Google Ad Manager contributes to revenue recognition under Alphabet's existing models.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that there was no material change between 2023 and 2024. The ground truth explicitly states a strategic evolution in 2024, where Alphabet shifted from a transactional gross reporting model to a more control-based justification for gross revenue recognition, emphasizing its role as principal. The LLM incorrectly asserts consistency, missing this key evolution. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations are present, hence a score of 10. (3) The multi-hop reasoning is flawed: the question requires synthesizing changes in revenue recognition strategy over time, particularly in how Google Ad Manager integrates with reporting models. The LLM fails to identify the shift in language and strategic framing described in the ground truth, indicating a failure in qualitative synthesis. (4) While the LLM correctly identifies Google Ad Manager as central and mentions gross reporting and inventory control—elements present in both years—it omits the critical 2024 shift toward a control-based evaluation, which is the main point of the original answer. This omission results in a partially correct but misleading response, warranting a correctness score of 4. Contextual relevance is high because the answer addresses the right topic and entities, but accuracy suffers due to the failure to capture the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 410,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "Between 2023 and 2024, UPS's financial exposure and strategic positioning regarding Roadie evolved as follows: In 2023, UPS recorded a $56 million goodwill impairment charge for Roadie, indicating financial stress, while in 2024, no impairment was recorded, but Roadie was identified as one of three reporting units with limited excess fair value, signaling continued risk of future impairment. The 2024 assessment highlighted that a 10% reduction in projected cash flows or a 100 basis point increase in the cost of capital could reasonably lead to impairment, reflecting ongoing strategic and financial risk monitoring for Roadie.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $56 million goodwill impairment in 2023 is accurately reported, and the absence of further impairment in 2024 is correctly stated. The 2024 risk thresholds—a 10% reduction in projected cash flows and a 100 basis point increase in cost of capital—are precisely reflected, aligning with the original answer's emphasis on sensitivity to cost of capital and performance forecasts. (2) The answer is complete, addressing both financial exposure (impairment charge, risk of future impairment) and strategic positioning (ongoing monitoring due to limited excess fair value). (3) Entity accuracy is correct: UPS, Roadie, 2023, 2024, goodwill impairment, fair value, and reporting units are all properly identified. (4) The multi-hop reasoning is sound—synthesizing the 2023 impairment event with the 2024 risk assessment shows an evolution from active impairment to continued vulnerability, which reflects the intended inference. The LLM adds contextual detail (the specific 10% and 100 bps thresholds) that enriches the answer without deviating from the truth. Semantic equivalence is strong, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 341,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "From 2022 to 2024, Linde's relationship with helium has shown a negative impact on the company's sales and operating profit. In 2024, sales for the \"Other\" segment, which includes global helium wholesale, decreased by $32 million, or 2%, compared to 2023, primarily due to lower volumes in global helium. Additionally, operating profit in the \"Other\" segment increased by $19 million, or 44%, in 2024 versus 2023, driven by insurance recovery for LAMT, but partially offset by higher costs due to helium. This indicates that while there were some positive factors, the helium segment still faced challenges impacting sales and profit.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that helium had a negative impact on Linde's sales in 2024 due to lower volumes in global helium and mentions the 2% underlying sales decrease in the 'Other' segment, which aligns with the ground truth. However, it introduces a specific dollar amount of $32 million in sales decline, which is not present in the original answer and cannot be verified from the provided truth. More critically, the LLM states that operating profit in the 'Other' segment increased by $19 million (44%) in 2024 vs 2023, which contradicts the ground truth: the original answer indicates that operating profit was negatively impacted by increased helium-related costs, with only a partial offset from insurance recovery. The increase in operating profit is misleading and misrepresents the negative impact of helium on profitability. (2) Quantitative accuracy is partially correct: the 2% sales decline is accurate, but the $32 million figure is unverified. The $19 million and 44% operating profit increase are factually inconsistent with the ground truth, which emphasizes cost pressure, not profit growth. (3) The multi-hop reasoning is partially sound—LLM connects helium volumes to sales impact and references LAMT and insurance recovery—but fails to correctly synthesize the net effect on operating profit. It incorrectly implies helium’s cost impact was outweighed by recovery, while the truth states costs increased and were only partially offset. (4) Scores reflect that core elements (segment, direction of sales impact, LAMT, insurance) are present, but key quantitative and qualitative inaccuracies—especially the erroneous operating profit increase—undermine the correctness. Contextual relevance is high as the answer addresses the evolution and impact of helium as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 506,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The total value of loans covered under long-term credit protection agreements with FNMA and FHLMC decreased from $8.7 billion at December 31, 2023, to $8.0 billion at December 31, 2024. This decline suggests a reduction in the Corporation's credit risk exposure on residential mortgage loans, as these loans are fully insured and do not require an allowance for credit losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the quantitative evolution of loans covered under credit protection agreements—$8.7 billion in 2023 decreasing to $8.0 billion in 2024—matching the ground truth exactly. The dates (December 31, 2023, and December 31, 2024) are appropriately specified and align with standard reporting periods. (2) All numbers and dates are accurate, and no calculations are required beyond the stated decrease, which is factually correct. Format is consistent and clear. (3) The reasoning correctly identifies that the decrease indicates reduced credit risk exposure, linking it to the fact that these loans are fully protected and do not require an allowance for credit losses. This reflects sound multi-hop reasoning: connecting the drop in protected loans to implications for risk management and accounting treatment. However, the LLM omits a subtle but important nuance from the original answer: the decline reflects a reduction in reliance on full credit protection, which may suggest a strategic or portfolio shift away from high-risk residential mortgage loans. While the conclusion about reduced risk exposure is valid, the deeper implication about changing reliance on protection mechanisms is slightly underdeveloped. (4) Despite this minor omission, the answer is factually correct, contextually appropriate, and synthesizes the necessary financial concepts accurately. Hence, full marks for quantitative accuracy and contextual relevance, a 9 for qualitative accuracy due to the missing nuance, and a 9 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 431,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "Between 2023 and 2024, Adobe Firefly's strategic positioning evolved to emphasize competitive differentiation through its integration of generative AI capabilities into Adobe's creative ecosystem, such as Photoshop, Illustrator, and Adobe Express, while ensuring these tools are safe for commercial use. This differentiation is further enhanced by Firefly's support for over 100 languages and its availability as a standalone web app for creative exploration. However, the 2024 filing highlights increased regulatory risks, particularly with the EU AI Act and evolving global AI regulations, which could impose compliance costs, require costly changes to Firefly's offerings, and introduce uncertainties in its development and monetization strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Adobe emphasized Firefly's integration into its creative suite (Photoshop, Illustrator, etc.) and commercial safety in 2023, and by 2024, highlighted regulatory risks, especially from the EU AI Act. The mention of over 100 languages and standalone web app adds contextual detail not in the original but does not contradict it. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is unaffected. (3) The multi-hop reasoning is sound—correctly synthesizing Firefly’s strategic evolution across two years, competitive differentiation, and emerging regulatory risks. The only minor gap is that the original specifies the EU AI Act was 'adopted in 2024', which the LLM notes but without confirming adoption (only referencing it as a risk), slightly weakening the precision of the regulatory timeline. (4) The answer is fully relevant, directly addressing both competitive differentiation and regulatory risks across 2023–2024. The added details enhance rather than distract. Overall, the semantic meaning matches the ground truth with high fidelity, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 354,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "Between 2023 and 2024, Trodelvy's financial performance and regulatory trajectory showed notable developments. In 2023, Trodelvy's product sales increased by 56% to $1.1 billion compared to 2022, driven by higher demand in new and existing geographies. In 2024, the drug received Breakthrough Therapy designation from the FDA for the treatment of adult patients with extensive-stage small cell lung cancer whose disease has progressed on or after platinum-based chemotherapy, marking the second such designation for Trodelvy. This regulatory milestone reflects its potential to improve clinical outcomes in a serious condition and could expedite its development and approval process.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures both the financial performance and regulatory trajectory of Trodelvy between 2023 and 2024. The 2023 product sales are reported as $1.1 billion, which is a rounded version of the exact $1,063 million in the ground truth. This is acceptable under semantic equivalence and common financial reporting practices. The 56% year-over-year increase is accurately stated. In 2024, the FDA granted a second Breakthrough Therapy designation for extensive-stage small cell lung cancer after platinum-based chemotherapy, which the LLM correctly identifies, including the indication and patient population. (2) Quantitatively, the $1.1 billion figure is a standard rounding of $1,063 million and does not constitute a factual error. All percentages and timeframes are accurate. (3) The multi-hop reasoning is sound: the model synthesizes financial data from 2023 and regulatory developments in 2024, correctly attributing both to Trodelvy and linking them to broader implications for clinical impact and development. (4) The answer is contextually relevant, complete, and conveys the same core information as the ground truth with only minor, acceptable rewording and rounding. No critical information is missing or incorrect. A score of 9 is given instead of 10 because the exact figure ($1,063 million) was slightly rounded without noting the precision, though this is common and not misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 397,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "Chevron's financial involvement in Angola LNG decreased slightly from 2022 to 2024, with its equity in earnings dropping from $1,857 million in 2022 to $405 million in 2024. Additionally, its investments and advances in Angola LNG decreased from $1,762 million in 2023 to $1,665 million in 2024, indicating a reduced capital commitment during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) Quantitatively, the LLM claims Chevron's equity earnings from Angola LNG dropped from $1,857M in 2022 to $405M in 2024, and that investments decreased from $1,762M in 2023 to $1,665M in 2024. However, the original answer states that in 2022, Chevron reported $5,657 million in total income from *all* equity affiliates (including Angola LNG), not $1,857 million specifically from Angola LNG. No earnings figure for Angola LNG alone in 2024 is provided in the ground truth, nor is there any mention of a decline. The specific $1,857M and $405M figures appear fabricated. Similarly, the investment amounts ($1,762M and $1,665M) are not present in the original answer and contradict the narrative of stable or growing strategic positioning. (2) The entity 'Angola LNG Limited' is correctly identified, and the timeframe (2022–2024) is addressed, but the financial data is entirely inaccurate. (3) The reasoning is flawed: the LLM infers a 'decrease' in involvement based on incorrect numbers, while the ground truth shows Chevron maintained a 36.4% stake in 2024 and highlighted Angola LNG as a key strategic entity, indicating stability or strengthening, not reduction. (4) The answer fails on multi-hop synthesis—instead of connecting disclosures about earnings in 2022 and ownership stake in 2024 to show evolving clarity in strategic positioning, it invents a narrative of financial retreat unsupported by evidence. The contextual relevance is moderate because it addresses Chevron’s involvement in Angola LNG over time, but the factual foundation is wrong, making the conclusion invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 451,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "From 2023 to 2024, the value of META's Fixed-Rate Senior Unsecured Notes increased significantly from $18.50 billion to $29.0 billion. This increase was primarily driven by the issuance of $10.50 billion in new notes during August 2024. The 2024 issuance added notes with maturities ranging from 2029 to 2064 and stated interest rates between 4.30% and 5.55%. The overall interest expense also rose, reflecting the larger debt balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the increase in total value from $18.50 billion (end of 2023) to $29.0 billion (end of 2024), and the $10.50 billion issuance in August 2024. These match the ground truth exactly. It also correctly references the 2023 starting value and 2024 issuance, showing accurate multi-hop synthesis. (2) All numbers, dates, and dollar amounts are accurate. The $10.50 billion issuance aligns with the $10.50 billion increase ($29.0B - $18.50B = $10.50B), confirming calculation accuracy. The mention of maturities (2029–2064) and interest rates (4.30%–5.55%) adds detail not in the ground truth but does not contradict it and is likely correct based on typical SEC filing disclosures. (3) The reasoning is sound: the LLM correctly infers that the increase in total value was driven by the 2024 issuance, demonstrating proper synthesis across years. However, it omits the 2023 issuance of $8.46 billion in May, which is part of the full evolution of issuance activity. While the focus is on the balance change and 2024 issuance, the absence of the 2023 issuance detail slightly reduces completeness. (4) Despite this minor omission, the answer is highly accurate, relevant, and conveys the core evolution of value and issuance. The added detail on maturities and interest rates enhances context without introducing error. Thus, quantitative accuracy is perfect, qualitative accuracy is slightly reduced due to partial omission, and overall correctness is excellent but not complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 426,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "LIN's financial exposure to helium shifted from being categorized as a \"supply\" in 2023 to a \"dependency\" in 2024, indicating a heightened reliance on helium as a critical raw material. In 2023, the company's raw material and supplies inventory included $614 million, with no specific mention of helium's cost or sourcing risk. However, by 2024, the inventory for raw materials and supplies decreased to $529 million, and helium was explicitly identified as a dependency, reflecting increased sourcing challenges or cost volatility. This change suggests a growing financial exposure due to helium's essential role in operations and potential price or supply instability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that helium costs were 4.2% of total raw material expenses in 2023 and increased to 6.8% in 2024, but the LLM does not mention these percentages at all. Instead, it introduces dollar values for raw material inventory ($614M in 2023 and $529M in 2024) that are not present in the original answer and are factually unsupported by the ground truth. These figures misrepresent the data and suggest a decline in inventory, which may be true but is irrelevant to the specific question about helium's cost exposure. (2) Quantitatively, the answer fails completely: no correct percentages are reported, and invented numbers undermine credibility. There is no evidence in the original answer that total raw material inventory was disclosed, let alone those specific amounts. (3) Qualitatively, the reasoning partially captures the conceptual shift from 'supply' to 'dependency' and links it to increased strategic importance and sourcing challenges, which aligns with the ground truth's interpretation of the categorization change. However, it fails to connect this to the actual metric used—percentage of raw material costs—which is central to measuring financial exposure. (4) Contextually, the answer addresses the question's focus on changing exposure and correctly identifies the shift in categorization across years, but replaces precise, relevant metrics with irrelevant aggregate inventory figures, leading to a misleading response. While the direction of reasoning (increased reliance = greater exposure) is sound, the lack of correct data and substitution of incorrect numbers severely undermines accuracy. The answer gets partial credit for recognizing the conceptual shift but is marked down heavily for fabricating quantitative details and omitting the key performance indicators from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 514,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "Between 2022 and 2023, PayPal's utilization of European customer balances for credit activities increased. In 2022, the total amount approved for such activities was $3.8 billion, representing 37% of European customer balances made available for corporate use. In 2023, this amount was reduced to $3.0 billion, representing 39% of European customer balances. The percentage change in the approved amount was a decrease of approximately 21%.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the dollar amounts ($3.8 billion in 2022 and $3.0 billion in 2023) and percentages (37% and 39%) from the ground truth, satisfying quantitative accuracy. The percentage change calculation is also correct: (3.0 - 3.8) / 3.8 ≈ -21%, so the stated decrease of approximately 21% is accurate. (2) However, the LLM makes a critical qualitative error by stating that 'utilization... increased' when in fact the absolute amount approved decreased. This contradicts the ground truth, which correctly interprets the reduction in approved funds as a more conservative approach despite the slight rise in percentage of balances used. The LLM fails to reconcile the drop in absolute terms with the increase in relative percentage, leading to an incorrect overall conclusion. (3) The multi-hop reasoning is partially sound—data from both years are correctly cited and synthesized—but the interpretation of 'utilization' is flawed. Utilization should be assessed both in absolute and relative terms, and the LLM incorrectly prioritizes the percentage increase while ignoring the drop in actual funding, which is the primary indicator of reduced credit activity. (4) Scores reflect high quantitative accuracy and contextual relevance (all data points are on-topic and correctly referenced), but lower qualitative accuracy due to flawed reasoning and misinterpretation of trends. The correctness score is moderate because while numbers are right, the core conclusion is misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 415,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Between 2023 and 2024, Starbucks' exposure to foreign currency - other instruments showed a significant decline in fair value. The fair value of these instruments dropped from $1,164 million in 2023 to $920 million in 2024. Additionally, the expected reclassification impact on earnings shifted from a negative $3.6 million in 2023 to a positive $0.1 million in 2024, indicating a reversal in the direction of the impact on earnings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the drop in fair value from $1,164 million in 2023 to $920 million in 2024, which matches the ground truth and is accurate. However, it introduces incorrect information about the 'expected reclassification impact on earnings'—stating it changed from -$3.6 million in 2023 to +$0.1 million in 2024. This is factually wrong. According to the ground truth, the expected reclassification from AOCI into earnings within 12 months was $55.3 million in 2023 (a gain) and dropped to $9.5 million in 2024, not a negative or near-zero value. Additionally, the LLM omits the key data point about the net gain in AOCI decreasing from $39.6 million to $11.5 million, which is a critical part of the evolution of exposure. (2) The fair value numbers are correct, but the reclassification figures are entirely inaccurate and appear fabricated. There is no mention of $3.6 million or $0.1 million in the original answer. The calculation or reporting of a 'negative' impact in 2023 contradicts the ground truth, which reports a net gain and a much larger expected reclassification. (3) The reasoning is partially sound in noting a decline in exposure, but the multi-hop synthesis fails—instead of pulling the correct reclassification figures from AOCI, the model invents incorrect values and misrepresents the direction of earnings impact. It also fails to connect the reduced reclassification amount to the reduced short-term earnings impact as stated in the original. (4) The contextual relevance is high because the answer addresses the evolution of foreign currency instruments and focuses on fair value and earnings impact. However, due to major quantitative errors and omission of key facts, the correctness score is low. The qualitative accuracy is moderate because the entity (Starbucks), metric (fair value), and years are correct, but reasoning breaks down on the second key metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 520,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives held by Alabama Power decreased from $15 million to $13 million, while Georgia Power's decreased from $13 million to $15 million. Both companies experienced a reduction in their asset positions, with Alabama Power shifting from a net asset position to a smaller asset position and Georgia Power maintaining a minor asset position. Neither company had significant liability positions related to energy-related derivatives in either year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both factual content and reasoning. It reports that Alabama Power's derivatives decreased from $15M to $13M and Georgia Power's from $13M to $15M, which completely misrepresents the actual values. In reality, Alabama Power had $55M in assets and $11M in liabilities in 2022, shifting to $15M in assets and $110M in liabilities in 2023. Georgia Power had $75M in assets and $8M in liabilities in 2022, shifting to $13M in assets and $124M in liabilities in 2023. The LLM reverses the years and assigns incorrect values, even mixing up assets and liabilities. (2) All numerical values are wrong: the LLM fails to report any correct asset or liability figures for either company in either year. There are no accurate calculations or comparisons. For example, it claims both companies had only asset positions with no significant liabilities, while in fact both flipped to large net liability positions in 2023. (3) The multi-hop reasoning is completely flawed. The question requires comparing fair values and directional changes in asset vs. liability positions across two companies and two years. The LLM fails to identify the correct entities, time periods, or financial positions, and does not recognize the critical shift from net asset to net liability status. (4) The contextual relevance is low but not zero because the answer at least addresses energy-related derivatives and the two companies mentioned. However, due to pervasive factual errors and lack of correct synthesis, the answer is substantively irrelevant. Correctness, quantitative, and qualitative accuracy scores are near the minimum.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 454,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "The asset allocation strategy for the U.S. Retiree Health Care Plan remained consistent between 2022 and 2023 in terms of the percentage distribution between fixed income securities and equity securities. In both years, the weighted average allocation was 80% in fixed income securities and 20% in equity securities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the asset allocation remained consistent between 2022 and 2023. According to the ground truth, there was a significant shift: in 2022, the allocation was 65% fixed income and 35% equity, while in 2023 it changed to 80% fixed income and 20% equity. The LLM incorrectly claims both years had 80% fixed income and 20% equity, which contradicts the original data. (2) Quantitatively, all percentages are wrong for 2022 and misrepresented for 2023. The LLM fails to report the actual 65/35 split in 2022 and falsely asserts consistency across years. (3) The reasoning is flawed as it misses the multi-hop aspect of identifying change over time. The question asks how the strategy evolved, requiring comparison across years, but the model incorrectly concludes no change occurred. (4) Contextual relevance is partially met since the answer discusses asset allocation between fixed income and equity securities for the correct plan and time frame, but the core factual error renders the response substantially incorrect. Thus, the correctness and quantitative accuracy scores are very low, qualitative accuracy is poor due to faulty synthesis, and contextual relevance is minimal but present due to topic alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 358,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "Between 2022 and 2023, Trodelvy received new regulatory approvals in 2023 for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the advanced setting. This represents an expansion of its approved indications beyond its prior approvals for triple-negative breast cancer and urothelial cancer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and captures the key evolution in Trodelvy's regulatory approval status between 2022 and 2023. It correctly identifies the new indication granted in 2023: for HR+/HER2-negative breast cancer patients who have received endocrine-based therapy and at least two prior systemic therapies. It also accurately references the prior indications (triple-negative breast cancer and urothelial cancer) from 2022, satisfying the multi-hop requirement across time and indications. The answer mentions 'advanced setting' instead of 'metastatic setting,' which is a minor imprecision but semantically close enough to not undermine the overall correctness. The original answer specifies both FDA and EC approvals in 2023, while the LLM answer does not explicitly name the regulatory bodies—this is a minor omission but does not detract significantly from the core factual accuracy. All entities (drug name, cancer types, biomarker status) are correct. No numerical data is present, so quantitative accuracy is scored based on correct use of years (2022, 2023), which are accurate. The reasoning is sound and the response is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 330,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "Meta's disclosure regarding user perception as a risk factor evolved between 2023 and 2024 to emphasize the growing impact of regulatory and geopolitical factors on user engagement and platform trust. In 2023, the focus was on factors like user behavior shifts, competitive pressures, and content moderation challenges affecting user growth and engagement. By 2024, the risks highlighted expanded to include more specific regulatory impacts, such as data transfer restrictions in Europe, privacy laws, and potential service limitations, which could directly affect Meta's ability to operate and monetize its platforms. Additionally, 2024 emphasized the potential for user disengagement due to policy changes and the broader implications of compliance with evolving global regulations on business operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in terms of the core evolution of Meta's risk disclosures regarding user perception. (1) What was correct: The answer correctly identifies that in 2023, Meta highlighted risks related to user behavior, content moderation, and competitive pressures affecting engagement—this aligns with the original answer’s mention of privacy, safety, and content quality. It also appropriately notes increased emphasis on regulatory factors in 2024, such as data transfer restrictions and privacy laws, which are contextually relevant risks. (2) Quantitative accuracy: There are no numeric values in the question or answers, so this dimension is neutral; no errors present. (3) Multi-hop reasoning assessment: The model synthesizes a plausible narrative across years and risk themes, showing understanding of how risk disclosures can evolve. However, it fails the key multi-hop insight from the ground truth: that Meta *reduced* explicit mention of user perception as a risk factor in 2024 and shifted focus toward *internal operational and financial risks* (e.g., acquisition integration, tax liabilities, investor sentiment). Instead, the LLM claims the 2024 focus *expanded* to include regulatory impacts on user disengagement—implying continued emphasis on user perception, which contradicts the ground truth. (4) Justification for scores: Correctness is scored 5 due to partial factual alignment but major omission of the strategic downgrading of user perception in disclosures. Qualitative accuracy is 5 because while reasoning is coherent, entity and thematic synthesis is flawed. Contextual relevance is 8 because the answer addresses the question’s intent and timeframe with relevant risk categories, even if misaligned with actual disclosure trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 493,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "The notional amount of Lockheed Martin's variable interest rate swaps decreased from $500 million in 2021 to $1.3 billion in 2024. This indicates that the company has maintained a relatively stable interest rate risk management strategy, using these swaps to hedge against interest rate fluctuations by converting fixed-rate borrowings to variable-rate borrowings. The consistent notional amount suggests a balanced approach to managing exposure to interest rate changes without significant expansion or contraction in hedging activities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that the notional amount 'decreased from $500 million in 2021 to $1.3 billion in 2024', which is logically and factually incorrect—$1.3 billion is an increase, not a decrease. The ground truth confirms the notional amount increased from $500 million to $1.3 billion, so the direction of change is wrong. (2) Quantitatively, while the dollar amounts ($500 million and $1.3 billion) and years (2021 and 2024) are correctly cited, the comparison (decrease vs. increase) is fundamentally flawed, rendering the quantitative interpretation incorrect. Calculations or directional trends are essential components of quantitative accuracy and are wrong here. (3) The reasoning is partially sound in identifying that the swaps are used to convert fixed-rate to variable-rate debt, which aligns with the ground truth. However, the conclusion that the company has a 'stable' strategy or 'consistent notional amount' contradicts the actual significant increase, leading to an incorrect inference about the strategy's evolution. The multi-hop synthesis fails because the model misinterprets the trend despite having correct base numbers. (4) Contextual relevance is moderate—the response addresses interest rate risk management and the use of swaps appropriately, but the incorrect trend undermines the strategic interpretation. The answer would have been stronger if it recognized the expansion in swap usage as a strategic shift, as stated in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 419,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "Between 2022 and 2023, PayPal's financial provisions for transaction losses related to its Seller Protection Programs remained relatively stable. The allowance for transaction losses was $66 million at the end of 2022 and slightly decreased to $64 million by the end of 2023. The provision for transaction losses increased slightly from $1,170 million in 2022 to $1,192 million in 2023, indicating a modest increase in the estimated financial provisions for transaction losses during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the allowance for transaction losses decreasing from $66 million in 2022 to $64 million in 2023, which matches the ground truth. However, it introduces a new and unsupported figure—the 'provision for transaction losses' increasing from $1,170 million to $1,192 million—which is not mentioned in the original answer and contradicts the focus on allowances (not provisions) in the context of Seller Protection Programs. This figure appears to conflate transaction loss allowances with broader provisions, which are not part of the ground truth and misrepresent the financial narrative. (2) The allowance numbers ($66M to $64M) are accurate and correctly compared. However, the inclusion of the $1.17B/$1.192B figures is factually unsupported in the context and introduces significant quantitative inaccuracy. These figures may relate to other financial line items (e.g., total transaction and loan loss expense), but they are not relevant to the Seller Protection Program's allowance, which is the focus. (3) The multi-hop reasoning is partially sound—there is recognition of a shift toward more structured financial disclosure in 2023 versus qualitative risk discussion in 2022. However, the LLM fails to capture the qualitative evolution described in the ground truth (from discussing historical loss rates of 0.09%-0.15% of TPV and macro risks in 2022 to a more defined allowance in 2023). Instead, it invents a new metric that undermines the reasoning. (4) The contextual relevance is high because the answer addresses the timeframe, program, and financial provisions. However, correctness is reduced due to the introduction of incorrect financial data and failure to reflect the true nature of the evolution—from qualitative risk disclosure to quantified allowance—undermining the qualitative and quantitative accuracy. Hence, a mid-range score of 5 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 518,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "Starbucks' derivative asset position for foreign currency - other decreased significantly from fiscal year 2023 to 2024. In 2023, it was $32.0 million in prepaid expenses and other current assets and $22.9 million in other long-term assets, totaling $54.9 million. In 2024, the total was $3.6 million ($1.9 million in current assets and $1.7 million in long-term assets), representing a decrease of $51.3 million on the balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Starbucks reported a derivative asset of $1,164 million (not $54.9 million) for 'Foreign currency - other' in fiscal year 2023. The LLM incorrectly breaks this into $32.0 million in current assets and $22.9 million in long-term assets, which contradicts the ground truth. In 2024, the correct derivative asset is $1.9 million, which the LLM correctly reports, but it misrepresents the 2023 figure, leading to an incorrect total decrease of $51.3 million instead of the actual decrease of approximately $1,162.1 million. Additionally, the LLM completely omits the derivative liability change—from $2.0 million in 2023 to $4.7 million in 2024—which is a key part of the question. (2) The calculations in the LLM answer are internally consistent (e.g., $32.0M + $22.9M = $54.9M; $54.9M - $3.6M = $51.3M), but they are based on incorrect input data, making the quantitative output invalid. The correct magnitude of change in assets is a reduction of about $1,162.1 million, not $51.3 million. (3) The reasoning is partially sound in that it attempts to synthesize asset positions across balance sheet categories and compute a net change, but it fails at multi-hop accuracy because it uses incorrect source data and ignores the liability side entirely. (4) The contextual relevance is moderate because the answer addresses the general topic—change in derivative asset positions in foreign currency—but fails on both quantitative accuracy and completeness, especially by missing the liability component and misstating the asset values. Due to major factual and calculation errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 467,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "From 2022 to 2023, the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions for Southern Company and its subsidiaries showed a significant decline. In 2022, the gain (loss) on energy-related cash flow hedges for the total cost of natural gas was $37 million, but this turned into a loss of $44 million in 2023. Similarly, for Southern Company Gas, the gain (loss) on energy-related cash flow hedges for the total cost of natural gas shifted from a $37 million gain in 2022 to a $44 million loss in 2023. This indicates a worsening financial impact on natural gas cost and revenue hedging positions in 2023 compared to 2022.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and direction of financial impacts. The original answer states that in 2022, derivatives had a $117 million negative impact on natural gas revenues and $27 million negative impact on cost, while in 2023, there was a $59 million gain on cost and $0 impact on revenue. The LLM instead reports a $37 million gain turning into a $44 million loss for both Southern Company and Southern Company Gas, which contradicts the ground truth. (2) The numbers provided in the LLM answer ($37M gain in 2022, $44M loss in 2023) do not match any values in the original answer and appear to be fabricated or misattributed. There is no mention of revenue impacts in the LLM response aligning with the $117M loss in 2022 or the neutral $0 in 2023. Calculations and comparisons are therefore entirely inaccurate. (3) The multi-hop reasoning failed completely — the LLM introduced entities (Southern Company, Southern Company Gas) not mentioned in the question or original answer, and incorrectly characterized the trend as worsening when the ground truth shows a clear improvement in cost impact (from negative to positive) and stabilization in revenue. (4) The contextual relevance is low because the answer discusses different companies and incorrect metrics, but it does attempt to address the evolution of financial impact over time, hence a minimal score of 3 for relevance. Overall, the answer is largely irrelevant and factually wrong, warranting a correctness score of 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 421,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "Walmart's Deferred Compensation Matching Plan was amended and restated effective November 8, 2023, as indicated in the 2024 10-K filing (page 84). In the 2023 10-K filing (page 84), no specific mention of this plan's amendment or restatement was made, indicating that the documentation status and effective date were updated in the 2024 filing.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the effective date of the Deferred Compensation Matching Plan as November 8, 2023, which matches the ground truth. However, it incorrectly states that the 2023 10-K did not mention the plan's amendment or restatement, which contradicts the ground truth stating that the plan was explicitly introduced in the 2023 10-K as 'amended and restated effective November 8, 2023.' This is a critical factual error. (2) The date (November 8, 2023) is accurate and correctly formatted; no numerical calculations were required. (3) The multi-hop reasoning is flawed: the model fails to recognize that the 2023 filing was where the plan was first documented with that effective date, and instead implies the update occurred in the 2024 filing. It also misses the key evolution in documentation status—from being newly introduced in 2023 to being incorporated by reference in 2024—indicating integration into ongoing disclosures. This reflects a failure to synthesize the treatment change across filings. (4) While the answer references correct document types (10-K) and pages, and the effective date is right, the reversal of the timeline and omission of the shift in documentation status (newly introduced → incorporated by reference) significantly undermines factual correctness and reasoning quality. The answer is partially relevant but contains a major misrepresentation of the information flow between the two filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 402,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Between 2023 and 2024, there was no material change in the dilutive effect of LTIP Units, as neither year reported any material dilutive impact from these units. Additionally, the accrual policy remained consistent, with dividends being accrued when declared for both periods. The treatment of LTIP Units as potentially dilutive securities also remained unchanged, with no adjustments made to net income or weighted average shares for dilutive impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core information from the ground truth. (1) All factual elements are correct: the absence of material dilutive effect in both 2023 and 2024, the consistent accrual policy (distributions accrued when declared), and the unchanged treatment of LTIP Units as potentially dilutive securities without adjustment to net income or shares. (2) There are no numeric values requiring calculation, but the years referenced (2023, 2024, and prior years) are correctly aligned with the disclosure periods in the original answer. (3) The multi-hop reasoning is sound—information is synthesized across two reporting years and consistent treatment is correctly inferred. (4) The only minor shortcoming is that the LLM omits the slight evolution in disclosure language (i.e., the 2024 simplification of wording), which is a nuance but not central to the overall treatment. However, since the substance of the disclosure and policy remained stable, this omission does not undermine the correctness. The answer is semantically equivalent and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 310,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved significantly between 2023 and 2024 in response to regulatory actions and decisions. In 2023, the EU-U.S. DPF was formally established following the invalidation of the prior Privacy Shield framework, with the European Commission issuing an adequacy decision in July 2023. Meta implemented steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) related to data transfers, leveraging the new framework. By 2024, Meta had further adapted its compliance strategy, including engaging with regulators on a \"subscription for no ads\" model and addressing concerns from the European Commission and the European Data Protection Board regarding compliance with the Digital Markets Act (DMA) and GDPR. These actions reflect Meta's ongoing efforts to align with evolving regulatory expectations and mitigate risks associated with data transfers and privacy laws in the EU.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Meta's compliance approach to the EU-U.S. DPF between 2023 and 2024. It correctly identifies the July 2023 adequacy decision by the European Commission as a key milestone, which aligns with the ground truth. It accurately notes Meta's implementation of corrective measures in response to the Irish Data Protection Commission (IDPC) and references the 'subscription for no ads' model introduced in late 2023 and under scrutiny in 2024. The mention of regulatory engagement with the European Commission and European Data Protection Board under the Digital Markets Act (DMA) and GDPR is factually sound. However, the LLM omits the specific €1.2 billion fine, a key quantitative and contextual detail from the original answer, which is a significant regulatory action shaping Meta’s compliance posture. While it references DMA and GDPR concerns, it does not mention the July 2024 preliminary findings of non-compliance issued by the European Commission, which is a critical update in the timeline. These omissions affect completeness and precision but do not undermine the overall correctness of the narrative. The reasoning is logically structured and synthesizes multi-hop elements (regulatory actions, framework changes, business model adjustments), though with slightly less specificity than the ground truth. Wording is semantically equivalent in most places, and entity names (Meta, IDPC, EU-U.S. DPF, DMA) are accurate. Dates are mostly correct, with the July 2023 adequacy decision properly cited. The answer remains highly relevant to the question and effectively conveys the shift from foundational compliance to ongoing regulatory scrutiny.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 465,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "Between 2023 and 2024, Linde has increased its emphasis on green hydrogen production by explicitly highlighting the use of electrolysis powered by renewable energy as a primary method for producing green hydrogen. In 2023, the company described green hydrogen as being produced \"from the steam methane reformation of biomethane\" or through electrolysis using renewable energy. By 2024, the description evolved to clarify that green hydrogen is produced \"by electrolysis using renewable energy and water as feedstock,\" with a stronger emphasis on renewable energy sources as the key input. This shift reflects a more focused commitment to renewable-based production methods for clean hydrogen.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Linde's approach to green hydrogen between 2023 and 2024. It correctly identifies that in 2023, Linde described green hydrogen as being produced via electrolysis using renewable energy or via steam methane reforming of biomethane, and that by 2024, the company emphasized electrolysis using renewable energy and water as feedstock. The shift toward a clearer focus on renewable-based production is accurately conveyed. The only minor omission is that the 2024 description included a more explicit differentiation between green (renewable) and blue (low-carbon) hydrogen, as well as the increased use of carbon intensity as a metric to distinguish production methods—details present in the original answer but not mentioned in the LLM response. However, this does not undermine the overall correctness of the key points. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Linde, green hydrogen, electrolysis, renewable energy, years 2023 and 2024) are correctly identified. The reasoning is sound and reflects proper synthesis across the two time points. The answer is fully contextually relevant, directly addressing the question about changes in production methods and emphasis on renewable energy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 363,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company completed the sale of Sequent to Williams Field Services Group on July 1, 2021, resulting in a pre-tax gain of $121 million ($92 million after tax). This transaction marked the end of Southern Company's relationship with Sequent. The sale also led to $85 million in additional tax expense due to changes in state apportionment rates. As a result of the sale, Sequent was no longer a reportable segment in 2023 or 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, most critically the sale date. The ground truth states the sale occurred in 2022, but the LLM claims it happened on July 1, 2021—this incorrect timeline undermines the entire response. The question specifically asks about the evolution between 2022 and 2023, but the LLM implies the relationship ended before 2022, which contradicts the original answer. (2) Quantitative accuracy: The pre-tax gain of $121 million and the $85 million additional tax expense are correctly stated. However, the after-tax gain of $92 million is not mentioned in the ground truth and appears to be an unsupported inference. The core numbers (gain and tax expense) are correct, but the erroneous date invalidates their contextual accuracy. (3) Multi-hop reasoning is flawed: The model fails to correctly trace the evolution from ownership in 2022 to divestiture completion in 2023. Instead, it asserts the sale occurred in 2021, which breaks the logical timeline and misrepresents the nature of the relationship during the specified period. The statement that Sequent was not a reportable segment in 2022 or 2023 is partially correct but misleading, as the sale was completed in 2022, not before. (4) Contextual relevance is moderate—the answer discusses the right entities and financial impacts but applies them to the wrong timeframe, severely limiting usefulness. Due to the critical error in timing and incorrect narrative of the relationship evolution, the correctness score is low despite some accurate financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 433,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Between 2023 and 2024, Walmart has continued to emphasize the Allswell brand as part of its private brand portfolio, indicating its strategic importance in offering high-quality, affordable products to customers. In both years, Allswell is listed among the key private brands marketed by Walmart U.S., alongside other well-known private labels like \"Equate,\" \"Great Value,\" and \"Sam's Choice.\" The consistent inclusion of Allswell in these lists suggests that Walmart views it as a core component of its private label strategy, likely due to its focus on home goods and wellness products that align with customer demand for value and convenience. This reflects Walmart's broader strategy of leveraging private brands to enhance price leadership and customer trust under its EDLP (Everyday Low Price) model.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its overall message and contextually relevant, but contains a key factual inaccuracy in the qualitative reasoning. (1) Correct elements: The answer correctly identifies Allswell as part of Walmart's private brand portfolio in both 2023 and 2024 and appropriately situates it alongside other major private labels like 'Equate' and 'Great Value.' It also accurately reflects Walmart's strategic use of private brands to support EDLP and customer value. (2) Quantitative accuracy is perfect: no numerical data is misstated, and the years 2023 and 2024 are used correctly. (3) Multi-hop reasoning is partially sound but flawed: the original answer emphasizes that Allswell was *introduced* in 2023 and then *retained and elevated* to mature brand status by 2024, indicating evolution from new to established. The LLM answer treats Allswell as consistently emphasized in both years but fails to capture this progression—specifically missing the nuance that 2023 was the launch year and 2024 represented consolidation and maturation. Instead, it implies continuity without acknowledging the initial introduction phase. (4) This omission reduces qualitative accuracy, as the strategic significance lies in the *evolution* from new to core brand, not just consistent presence. The LLM answer also incorrectly includes 'Sam's Choice'—which is a Costco brand, not a Walmart brand—indicating an entity error. Despite this, the overall strategic interpretation aligns with the ground truth. Hence, correctness is reduced to 7 due to missing the developmental trajectory and one incorrect entity, though core facts and reasoning remain largely intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 454,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "The strategic importance of Embedded Processing products increased slightly from 2022 to 2023, as evidenced by a 3% revenue growth in this segment despite an overall revenue decline for the company. However, operating profit for Embedded Processing decreased by 20%, primarily due to higher manufacturing costs, which offset some of the gains from increased revenue. This suggests that while the segment maintained its strategic relevance, cost pressures impacted profitability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific revenue figures were disclosed for Embedded Processing in 2022, and there is no mention of a 3% revenue growth or a 20% decline in operating profit in the original answer. These specific quantitative claims (3% growth, 20% profit decline) are not supported by the ground truth and appear to be hallucinated. (2) The original answer emphasizes that Embedded Processing partially offset a decline in Analog revenue and contributed to a total revenue of $17.52 billion in 2023, but the LLM does not mention this key point. Instead, it introduces unsupported financial metrics, failing to verify or reflect the actual disclosed data. (3) While the LLM correctly identifies that Embedded Processing remained strategically important, it misrepresents the reasoning: the strategic evolution was due to its compensatory role in revenue, not due to segment growth or cost pressures, which are not mentioned in the ground truth. The model fails to perform the correct multi-hop synthesis between revenue composition and strategic emphasis as reflected in the knowledge graph. (4) Despite the incorrect numbers and reasoning, the LLM does capture the general idea that Embedded Processing maintained strategic relevance, which keeps the answer contextually relevant. However, the hallucinated metrics severely undermine factual correctness, warranting a low correctness score. Quantitative accuracy is very low due to unsupported percentages; qualitative accuracy is partially preserved by correct entity and year identification but penalized for flawed reasoning; contextual relevance is moderate as the topic focus is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 472,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "Chevron's involvement in Angola LNG has remained consistent in terms of its equity stake, holding a 36.4% interest in Angola LNG Limited, as noted in both the 2022 and 2024 filings. This ongoing participation indicates Chevron's strategic commitment to the LNG market, particularly in Africa, where it continues to play a key role in processing and liquefying natural gas for international delivery. The stability of its investment suggests a long-term focus on LNG as a core component of its global energy portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Chevron held a 36.4% interest in Angola LNG Limited in both 2022 and 2024, but the ground truth indicates that while Chevron was operationally involved in 2022, the 36.4% stake was only explicitly stated in 2024. There is no evidence in the ground truth that this specific percentage was disclosed in 2022 filings. This misrepresents the evolution of Chevron's involvement. (2) The percentage value of 36.4% is accurate for 2024, but its attribution to 2022 is unsupported, leading to a partial quantitative error. No calculations were required, but the incorrect temporal assignment of a key metric undermines factual accuracy. (3) The multi-hop reasoning is flawed: the question asks about the evolution from 2022 to 2024, requiring recognition of a shift from operational participation to a formally defined equity stake. The LLM instead asserts consistency, missing the strategic shift entirely. This reflects a failure to synthesize the change over time. (4) Despite the factual inaccuracy, the answer remains contextually relevant by addressing Chevron’s LNG strategy in Africa and long-term positioning. However, the core reasoning is incorrect, warranting a moderate score of 4 for correctness. Quantitative accuracy is scored at 6 because the number itself is correct for 2024, but misapplied in time. Qualitative accuracy is low due to flawed reasoning and entity-year linkage. Contextual relevance is high as the response stays on-topic and discusses strategic implications appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 427,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "The CH-53K program has seen a notable increase in production volume and financial contribution within Lockheed Martin's RMS division between 2021 and 2024. In 2021, RMS reported higher net sales of $540 million for Sikorsky helicopter programs, including the CH-53K, due to increased production volume. By 2024, the CH-53K program continued to contribute to RMS's product sales growth, with higher production volume partially offsetting lower volume on the VH-92A program. This evolution indicates that the CH-53K program has become a more significant and stable contributor to RMS's financial performance, reflecting its growing importance in the division's portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the CH-53K's increasing financial and production role within Lockheed Martin's RMS division between 2021 and 2024, and captures the general trend of growing importance. However, it lacks full quantitative precision. In 2021, the ground truth specifies a $540 million increase in RMS net sales attributed to the CH-53K (alongside Black Hawk and CRH), but the LLM answer generalizes this as 'Sikorsky helicopter programs, including the CH-53K,' which dilutes the specific attribution to CH-53K. More critically, the 2024 financial contribution of $1.1 billion to product sales is missing entirely in the LLM answer, which only mentions 'continued contribution' without citing the key figure. Additionally, the 2021 $140 million increase in operating profit due to risk retirements and production volume is omitted. (2) The only number explicitly mentioned—$540 million—is correct in value but slightly misrepresented in scope (applied to broader Sikorsky programs rather than specifically tied to CH-53K's contribution within that group). The absence of the $1.1 billion 2024 figure and $140 million profit impact constitutes significant quantitative omissions. (3) The multi-hop reasoning is partially sound: the model infers increased importance from production ramp-up and sales growth, and correctly contextualizes the program’s maturation. However, it fails to synthesize the full evolution from risk retirement in early years to high-volume production by 2024, which is central to the ground truth’s conclusion. (4) Despite missing key numbers and some nuance, the LLM answer remains contextually relevant and conveys a qualitatively accurate narrative of growing significance. The reasoning is logical and addresses the question’s intent, warranting a solid but not high score. Correctness score is 7 due to accurate directional insight but incomplete and slightly imprecise quantitative support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 526,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "Between 2022 and 2023, PayPal updated its expected credit loss models for revolving consumer receivables in the second quarter of 2023. In 2022, the reasonable and supportable forecast period for revolving consumer products was 2 years. By 2023, this period had been extended to approximately 5 years. Additionally, the macroeconomic factors considered in 2023 included forecasted trends in household disposable income and retail e-commerce sales, whereas in 2022, unemployment rates were also included. These changes reflect an expanded and more nuanced approach to incorporating macroeconomic factors into loss curves for revolving consumer credit products.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in PayPal's use of macroeconomic factors in its loss curves between 2022 and 2023, correctly identifying the shift from unemployment rates to household disposable income and retail e-commerce sales as key indicators. It also accurately notes the update occurred in 2023. However, the LLM introduces specific details not present in the ground truth: (1) the claim that the change occurred in the 'second quarter of 2023' is more precise than the original, which only states the shift happened 'by 2023' and that unemployment was replaced 'after the first quarter of 2023'—this partial alignment allows some credit; (2) the extension of the forecast period from 2 to 5 years is not mentioned in the original answer and thus appears to be an addition not supported by the ground truth. While the qualitative shift in macroeconomic indicators is correctly conveyed (supporting a score of 8 in qualitative accuracy), the inclusion of unsupported quantitative details (forecast period length, exact timing) reduces quantitative accuracy to 6. Contextual relevance is perfect—every part of the answer addresses the question. Overall, the answer is partially correct with key factual additions, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 351,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "Starbucks' foreign currency debt-related gains or losses included in AOCI decreased from a pre-tax gain of $19.1 million in 2023 to a loss of $6.3 million in 2024. This shift suggests increased exposure to foreign currency fluctuations in 2024, likely due to adverse movements in exchange rates impacting the company's foreign currency-denominated debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, Starbucks reported a loss of $6.3 million in 2023 and a gain of $135.2 million in 2024. However, the LLM incorrectly states a gain of $19.1 million in 2023 and a loss of $6.3 million in 2024—reversing both the direction and magnitude of the actual figures. The only correct number is $6.3 million, but it is misassigned to 2024 instead of 2023. (2) The quantitative inaccuracies are severe: the 2023 value is wrong in both sign and amount, and the 2024 value is entirely incorrect (reports a loss instead of a $135.2 million gain). There is no indication of the actual $135.2 million gain in 2024. (3) The reasoning is flawed due to incorrect data. The LLM concludes increased exposure due to adverse movements, but the ground truth shows a large gain, indicating favorable currency movements and reduced adverse exposure. The multi-hop synthesis failed—correctly comparing AOCI items across years requires accurate retrieval from both years, which did not occur. (4) Scores reflect major factual errors in numbers and direction of change, leading to an incorrect conclusion. The answer is contextually relevant in discussing AOCI and foreign currency exposure but fails on correctness, which is critical in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 370,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "Between 2022 and 2023, the fair value of energy-related derivatives for Alabama Power decreased from $15 million to $13 million, while for Georgia Power, it remained relatively stable at $13 million in 2023 compared to $15 million in 2022. The combined liabilities related to these derivatives showed a declining trend, decreasing from $210 million in 2022 to $110 million for Alabama Power and $124 million for Georgia Power in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the fair value of energy-related derivatives for Alabama Power decreased from $15 million to $13 million, which misrepresents the data — these are asset values, not the fair value of derivatives overall, and Alabama Power's 2022 data is entirely missing. The LLM also falsely claims Georgia Power had $15 million in 2022, but no 2022 data for Georgia Power is provided in the ground truth. The combined liabilities are miscalculated: it states $210 million in 2022, but the correct combined net liability in 2022 is $255 million (Alabama Power's $144M + Georgia Power's implied $111M not yet reported, but only Alabama Power reported a net liability in 2022). In 2023, the LLM correctly reports Alabama Power's $110M and Georgia Power's $124M liabilities but fails to compute the correct combined net liability of $206M. (2) Key numbers are wrong: 2022 combined liability is stated as $210M (incorrect), actual is $255M; Alabama Power’s 2022 net liability was $144M (not mentioned); the LLM confuses asset values with total derivative values. Calculations are flawed and lack proper multi-year, multi-entity synthesis. (3) The reasoning is unsound: the model fails to perform the correct multi-hop synthesis — it does not calculate net liabilities per entity, does not sum them across years correctly, and invents data for Georgia Power in 2022. It also misinterprets 'fair value' as asset values only, ignoring liabilities and net positions. (4) Scores are low due to major factual and computational errors. Contextual relevance is moderate because the answer addresses the right topic and entities, but correctness and quantitative accuracy are severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 479,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Walmart acquired Alert Innovation in fiscal 2023 for $0.4 billion, bringing its ownership to approximately 100%. The entity was subsequently sold and deconsolidated in fiscal 2025, indicating that Walmart disposed of its ownership in Alert Innovation during that period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion acquisition of Alert Innovation in fiscal 2023 and Walmart's 100% ownership, which matches the ground truth. However, it incorrectly states the disposition occurred in fiscal 2025 instead of fiscal 2024, which is a significant factual error in timing. This misstatement affects the core evolution timeline described in the question. (2) The dollar amount ($0.4 billion) is accurate and properly formatted. The error lies solely in the fiscal year of divestiture—fiscal 2024 per ground truth vs. fiscal 2025 in the LLM answer. No calculations are required, so numerical accuracy is otherwise preserved. (3) The multi-hop reasoning is mostly sound: the model correctly links acquisition and disposition as part of Walmart's financial relationship with Alert Innovation. However, the incorrect fiscal year for deconsolidation breaks the 'one-year span' evolution emphasized in the original answer, weakening the logical synthesis. (4) Scores reflect that core facts (acquisition amount, ownership, and eventual sale) are correct, but the key temporal element of the evolution—between fiscal 2023 and 2024—is flawed. Contextual relevance is perfect as the answer directly addresses the question's focus on acquisition and disposition dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 364,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "Between 2022 and 2023, the regulatory approval status of Trodelvy expanded significantly, with the drug receiving additional approvals for new indications and patient populations. In 2022, Trodelvy was already approved for metastatic triple-negative breast cancer (TNBC) and urothelial cancer (UC). By 2023, it received FDA approval for the treatment of adult patients with unresectable locally advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer who had received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. Additionally, the European Commission approved Trodelvy as monotherapy for a similar HR+/HER2- breast cancer indication. These developments indicate that Gilead is actively expanding Trodelvy's therapeutic utility within oncology, reflecting a strategy to broaden its market reach and solidify its position in diverse cancer treatment areas.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, Trodelvy was already marketed (though the LLM adds specific indications—metastatic TNBC and urothelial cancer—not contradicted by the original answer but not explicitly stated in the ground truth). The key regulatory advancement in 2023 is accurately described: FDA and EC approvals for HR+/HER2- breast cancer in patients with prior endocrine-based therapy and at least two systemic therapies. (2) There are no numeric values requiring calculation, but all dates (2022, 2023) and regulatory bodies (FDA, EC) are correct. (3) The multi-hop reasoning is sound—synthesizing Trodelvy’s status evolution and inferring Gilead’s oncology strategy. The LLM adds slightly more detail on prior indications, which is plausible and consistent with external knowledge, though not in the original answer. (4) The conclusion about Gilead’s strategy to expand Trodelvy’s utility and strengthen its oncology footprint matches the original answer’s interpretation. The only minor deviation is the inclusion of 2022 indications not mentioned in the ground truth, but this does not contradict it and may reflect additional context; thus, the answer remains factually consistent. Overall, the response is complete, accurate, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 373,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's financial relationship with ABG evolved significantly, particularly through capital transactions and strategic repositioning. In 2023, Simon experienced multiple dilutions of its ownership in ABG due to capital transactions, which resulted in non-cash gains on deemed disposals, including a $157.1 million gain from selling a portion of its interest. By 2024, Simon fully exited its remaining interest in ABG, selling it for $1.2 billion and recording a pretax gain of $414.8 million. This strategic move reflects a shift in Simon's focus, likely reallocating capital to other investment opportunities or strengthening its balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group (SPG) did not fully exit its interest in ABG in 2024, nor did it sell its remaining stake for $1.2 billion or record a $414.8 million pretax gain. These figures and events are entirely fabricated. In reality, SPG recognized non-cash gains of $36.4 million in Q2 2023 and $145.8 million in Q3 2023 due to dilution from equity issuances by SPARC Group, not from selling a portion of its interest. The LLM incorrectly aggregates these into a single $157.1 million gain, which does not match the sum of the actual gains ($36.4M + $145.8M = $182.2M), making the number wrong both in source and amount. (2) The quantitative inaccuracies are severe: the $1.2 billion sale and $414.8 million gain in 2024 are not supported by the original answer, which states that SPG reported no active capital transactions with ABG in 2024. Instead, 2024 filings only referenced historical transactions like the 2021 sale for $18.8 million gain and the 2022 Reebok acquisition. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the evolution from active 2023 dilution gains to passive, historical references in 2024. Instead, it invents a full exit event, reversing the actual trend of decreasing engagement into a dramatic financial transaction that did not occur. (4) While the answer addresses the question's theme—evolution of financial relationship and strategic positioning—the core facts are incorrect. The contextual relevance is moderate because it attempts to discuss capital transactions and strategy, but the qualitative and quantitative inaccuracies severely undermine correctness. Correctness score is low due to major factual and numerical errors, despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 496,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "Between 2022 and 2024, Chevron's relationship with Chevron Phillips Chemical Company LLC remained stable in terms of financial reporting and investment value. In 2022, Chevron's investment in Chevron Phillips Chemical Company LLC was part of its downstream segment, with a loan of $669 to fund a portion of the Golden Triangle Polymers Project. The equity in earnings for Chevron Phillips Chemical Company LLC was $867 million in 2022. By 2024, the investment balance increased to $8,571 million, with equity in earnings rising to $903 million, indicating a stronger financial contribution from the joint venture during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it fails to identify the fundamental change in Chevron's accounting treatment of Chevron Phillips Chemical Company LLC between 2022 and 2024. According to the ground truth, in 2022 the entity was a consolidated subsidiary (included in consolidated financials, Note 8, page 70), but by 2024 it was reclassified as an equity method investee. The LLM incorrectly implies continuity in reporting method, stating only changes in investment value and earnings, which misrepresents the nature of the relationship evolution. (2) Quantitatively, the LLM correctly reports the 2024 investment value of $8,571 million and mentions an increase from prior years, but incorrectly omits the 2023 value ($7,765 million) as context. The $867 million equity earnings in 2022 and $903 million in 2024 may be plausible figures, but they are not mentioned in the ground truth and cannot be verified; more importantly, they distract from the core issue of consolidation change. The mention of a $669 loan for the Golden Triangle Polymers Project is not present in the original answer and appears to be fabricated or misattributed. (3) The multi-hop reasoning is flawed: the question asks about evolution in financial reporting and investment value, requiring synthesis of accounting method changes and financial data across years. The LLM focuses only on investment value and earnings trends, completely missing the shift from consolidation to equity method accounting—a key qualitative and accounting distinction. (4) The contextual relevance is moderate because the answer discusses financial aspects of the relationship and includes some correct figures (e.g., $8,571 million), but it fails the primary requirement of identifying the accounting change. Due to major factual and conceptual errors, especially the omission of the consolidation-to-equity-method shift, the correctness score is low despite partial numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 538,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "Between the end of 2023 and the end of 2024, Meta's Facilities Consolidation Strategy transitioned from partial completion to full completion. As of December 31, 2023, the company had substantially completed the facilities consolidation initiatives, and by December 31, 2024, it had fully completed all 2022 restructuring initiatives, including the facilities consolidation. Financially, the strategy incurred $389 million in pre-tax charges for 2024, all related to facilities consolidation, while the total restructuring charges for 2023 were $2.255 billion, with a significant portion attributed to this strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the progression of Meta's Facilities Consolidation Strategy from 'substantially completed' in 2023 to 'fully completed' in 2024, aligning with the ground truth's key qualitative evolution. However, it introduces specific financial figures—$389 million in pre-tax charges for 2024 and $2.255 billion for 2023—that are not present in the original answer and cannot be verified from the provided ground truth. The original answer states that a retrospective summary of pre-tax charges across 2022–2024 was disclosed in 2024, but does not specify annual breakdowns or amounts, making the LLM's precise numbers unsupported. (2) The quantitative inaccuracies are significant: the LLM fabricates exact dollar amounts without grounding in the source, failing the quantitative accuracy check. Even if the numbers were approximately correct, the original does not provide them, so inclusion constitutes a factual overreach. (3) The reasoning is sound in terms of multi-hop synthesis—correctly identifying the timeline and completion status across two years and linking facilities consolidation to the broader 2022 restructuring. The model captures the evolving disclosure maturity (from ongoing to completed status and enhanced financial retrospection), which shows good qualitative understanding. (4) Contextual relevance is high because the answer directly addresses the question’s focus on status evolution and financial impact. However, the correctness score is limited to 6 due to the unsupported financial figures, which undermine trust and factual accuracy, despite otherwise solid reasoning and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 450,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs from 2022 to 2024 has shown a strategic focus on advancing capabilities for the U.S. military. In 2022, the company emphasized developing hypersonic strike weapons for the U.S. Army and Navy as part of its broader innovation efforts. By 2024, the hypersonics programs were explicitly mentioned under the Missiles and Fire Control segment, highlighting collaborations with the U.S. Air Force and Army to design, develop, and build hypersonic strike weapons, indicating an expansion in strategic partnerships and program scope.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Lockheed Martin's increasing strategic focus on hypersonics and its collaboration with U.S. military branches, which aligns with the ground truth. However, it omits a key evolution highlighted in the original answer: the shift from a funding-dependent, uncertain development phase in 2022 to active production by 2024. This is a significant omission in terms of program status progression. The LLM mentions 'design, develop, and build' in 2024 but does not explicitly state that the company was in active production, which is a core factual advancement. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information across years and programs and identifies relevant military branches. However, it fails to capture the critical transition from development/funding uncertainty to production, which is central to the evolution in program status. (4) The answer is contextually relevant and well-structured, but the lack of emphasis on the shift to production reduces its qualitative and overall correctness. The strategic focus and partnerships are accurately described, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 380,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "From 2022 to 2023, Southern Company's treatment and disclosure of energy-related derivatives showed a shift in both designation and financial impact. In 2023, energy-related derivatives designated as hedging instruments under regulatory purposes showed significant unrealized losses, with Southern Company reporting a total loss of $257 million, compared to a net gain of $9 million in 2022. Additionally, the financial impact of energy-related cash flow hedges on income decreased, with Southern Company reporting a loss of $44 million in 2023, compared to a gain of $37 million in 2022. These changes reflect a more volatile and challenging market environment for energy-related derivatives in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—$257 million loss in 2023 and $9 million gain in 2022 for designated hedging instruments, and $44 million loss vs. $37 million gain for cash flow hedges—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers are likely fabricated or misattributed, severely undermining factual accuracy. (2) The original answer does not mention any specific dollar amounts or quantitative financial impacts; instead, it focuses on the evolution of disclosure practices—specifically, that Southern Company expanded its reporting in 2023 to include derivatives not designated as hedging instruments, with retrospective data for 2021–2022. The LLM fails to mention this key qualitative shift in disclosure policy, which is the central point of the ground truth. (3) The multi-hop reasoning is flawed: while the question asks about changes in treatment and disclosure (a procedural/accounting focus), the LLM interprets it as a request for financial impact trends, misaligning with the core intent. It incorrectly assumes that changes in gains/losses reflect a change in accounting treatment, when the original answer emphasizes a change in transparency and scope of reporting. (4) Despite this, the response is contextually relevant—it discusses Southern Company, energy-related derivatives, hedging designations, and year-over-year changes—so it stays on topic. However, the absence of the key disclosure evolution and the invention of unsupported financial data result in a low correctness score. Minor credit is given for recognizing that hedging designations and financial impacts were part of the discussion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 468,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "Between 2022 and 2023, Gilead's intellectual property strategy regarding Truvada remained relatively stable in terms of patent disclosures, as no new patents or extensions specific to Truvada were highlighted in the 2023 filing. However, the 2023 document emphasized the importance of patent term extensions and supplementary protection certificates for other key products, indicating a continued focus on maximizing IP protection across the portfolio. Notably, the 2023 filing included updated patent expiration dates for various products, reflecting ongoing efforts to secure and extend IP rights where possible, though Truvada's patent landscape was not specifically expanded upon compared to 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses the core evolution in Gilead's strategy between 2022 and 2023. While it correctly notes that no new Truvada patents were highlighted in 2023, it inaccurately frames the strategy as 'relatively stable,' which contradicts the ground truth showing a clear shift in disclosure approach. In 2022, Gilead acknowledged the past loss of exclusivity (post-October 2020) as a headwind, but in 2023, it adopted a more structured, forward-looking disclosure of patent expirations for key products including Truvada—this strategic shift is entirely missed in the LLM response. (2) Quantitatively, the answer does not introduce incorrect dates or numbers; it avoids specifying the October 2020 expiration but does not contradict it, so numerical accuracy is acceptable. However, it fails to mention the specific focus on U.S. and EU expiration timelines in 2023, which is a key factual omission. (3) The multi-hop reasoning is flawed: the model fails to synthesize the change from reactive acknowledgment of past patent loss (2022) to proactive, structured disclosure of future IP timelines (2023). Instead, it concludes stability, which is a misinterpretation of the strategic evolution. (4) Contextual relevance is moderate—the answer discusses IP strategy and patent disclosures in the correct timeframe and company context, but misses the central point of strategic evolution. The focus on portfolio-wide IP protection is relevant but distracts from the specific shift in Truvada-related disclosures. Thus, while some facts are accurate, the core reasoning and conclusion are misaligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 456,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "Between 2022 and 2024, SPG's use of the Supplemental Facility evolved with significant borrowing and repayment activities. In 2022, SPG drew $1.05 billion under the Supplemental Facility to fund the early extinguishment of mortgages, and subsequently repaid the full $1.05 billion in January 2022 using proceeds from new senior unsecured notes. By 2024, SPG had increased its borrowing capacity under the Supplemental Facility, which was extended to 2029, and used it for various strategic purposes, including refinancing. Notably, in November 2023, SPG repaid €750 million ($815.4 million) under the Supplemental Facility using proceeds from a new bond issuance. Overall, SPG utilized the Supplemental Facility for both short-term liquidity needs and long-term debt restructuring, while maintaining compliance with covenants and managing interest rate risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key borrowing and repayment events for SPG's Supplemental Facility in 2022 and 2024. In 2022, it accurately states that SPG borrowed $1.05 billion to extinguish mortgages and repaid it using proceeds from new senior unsecured notes. In 2024, it correctly notes the repayment of €750 million ($815.4 million) in November 2023 using bond proceeds. However, the original answer specifies that the 2024 borrowing occurred in November 2023 and was repaid on November 17, 2023—this exact repayment date is missing in the LLM answer, though the event is otherwise correctly described. (2) All numeric values—$1.05 billion, €750 million, $815.4 million—are accurate and match the ground truth. The dollar equivalent is correctly reported. The LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is sound: it connects the use of the Supplemental Facility to refinancing activities and links repayment to new bond issuances. It also correctly infers a strategic shift toward using the facility for both short-term and restructuring purposes. However, it adds that the facility was 'extended to 2029' and that borrowing capacity 'increased,' which is not mentioned in the original answer and cannot be verified from the provided ground truth—this is an unsupported addition. (4) Despite this minor overreach, the answer remains highly relevant and factually aligned with the core developments. The evolution in SPG’s use of the facility—short-term borrowing followed by prompt repayment via capital markets—is accurately captured. The conclusion about strategic use and covenant compliance is reasonable but slightly extends beyond the original answer’s scope. Overall, the answer is factually strong with minor embellishments, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 497,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "From 2022 to 2024, MetLife has maintained a strong focus on liquidity and capital management, emphasizing the role of cash buffer needs in its strategy. In 2022, the company highlighted its substantial short-term liquidity positions of $12.4 billion and liquid assets of $223.0 billion, which were used to support capital allocation decisions and meet liquidity needs under various scenarios. By 2024, the emphasis remained on maintaining adequate liquidity to address potential stress scenarios, with continued monitoring of cash flow and stress testing. The cash buffer has been critical in enabling MetLife to manage capital effectively, support dividends, and maintain financial strength ratings, while also allowing flexibility for strategic initiatives and shareholder returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the quantitative figures from 2022—$12.4 billion in short-term liquidity and $223.0 billion in total liquid assets—which match the ground truth exactly. No numeric inaccuracies are present, and the years (2022 and 2024) are correctly referenced. However, the qualitative evolution of MetLife’s capital management strategy is misrepresented. The ground truth indicates a shift in tone by 2024, where maintaining or increasing cash buffers is seen as potentially limiting capital for innovation, acquisitions, and shareholder returns. In contrast, the LLM answer portrays the 2024 stance as unchanged, emphasizing continued flexibility for strategic initiatives and shareholder returns—this directly contradicts the ground truth’s implication of trade-offs and constraints. (2) All numbers are accurate and properly attributed to 2022; no calculations are required. (3) The multi-hop reasoning fails: while the model correctly retrieves 2022 liquidity data, it does not synthesize the strategic evolution—specifically, the growing concern in 2024 about opportunity costs of high cash buffers. This missing nuance breaks the chain of correct inference across time periods. (4) The answer is contextually relevant and well-structured, addressing liquidity, capital allocation, and strategic priorities. However, the failure to capture the strategic trade-off in 2024 significantly undermines the qualitative accuracy, warranting a moderate correctness score despite perfect numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 420,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Between 2022 and 2023, Starbucks' exposure to 'Foreign currency - other' derivatives showed a significant shift in asset and liability classifications. In 2022, 'Foreign currency - other' derivative assets were $39.9 million in prepaid expenses and other current assets and $33.5 million in other long-term assets, while derivative liabilities were $0.3 million in accrued liabilities. By 2023, derivative assets were $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets, with liabilities increasing to $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This indicates a reduction in asset exposure and an increase in liability exposure for 'Foreign currency - other' derivatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Starbucks had *no* 'Foreign currency - other' derivative assets—only a $0.3 million liability. However, the LLM claims there were assets of $39.9 million (current) and $33.5 million (long-term), which is completely incorrect. Similarly, in 2023, the ground truth reports only a $1.9 million asset (current) and $4.7 million liability (current), with no long-term components. The LLM incorrectly adds $1.7 million in long-term assets and $4.1 million in long-term liabilities, which are not present in the original data. (2) All key numbers are wrong except for the $0.3 million (2022 liability), $1.9 million (2023 asset), and $4.7 million (2023 liability) figures, which are correct. The rest are fabricated or misattributed. Calculations and comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning fails because the model invents asset and liability classifications that do not exist in the source data. It incorrectly suggests a 'reduction in asset exposure' when in fact there was no asset in 2022—only an emergence of one in 2023. The shift toward balance is misrepresented due to erroneous data synthesis. (4) The contextual relevance is moderate because the answer addresses the right topic (evolution of derivative exposure) and uses appropriate financial classifications, but the factual foundation is severely flawed, undermining correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 418,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "The Coca-Cola Company's relationship with Coca-Cola FEMSA from 2023 to 2024 has remained stable in terms of strategic engagement and financial stake. As of December 31, 2024, The Coca-Cola Company owned 28% of Coca-Cola FEMSA's outstanding shares, maintaining its equity method investment. The financial stake is reflected in the carrying value of equity method investments, with Coca-Cola FEMSA's fair value at $4,544 million compared to a carrying value of $1,786 million as of December 31, 2024. There is no indication of significant changes in strategic engagement during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that the relationship remained stable, while the ground truth states a significant evolution in the relationship from 2023 to 2024. In 2023, Coca-Cola FEMSA was a top independent bottling partner, contributing to the 42% of worldwide unit case volume from the top five bottlers. By 2024, it transitioned to an equity method investee with Coca-Cola holding a 28% stake, indicating a strategic shift. The LLM incorrectly asserts no significant change in strategic engagement, contradicting the ground truth. (2) Quantitatively, the 28% ownership stake is correctly stated, and the fair value ($4,544 million) and carrying value ($1,786 million) figures may be accurate based on external data, but these were not present in the original answer and are not required for correctness in this context. However, the original answer did not include these values, so their presence is extraneous but not inherently wrong. The key issue is the misrepresentation of the relationship's evolution. (3) The multi-hop reasoning is flawed: the model failed to recognize that the shift from 'top bottler' to 'equity method investee with 28% ownership' represents a strategic and financial evolution, not a static relationship. This requires synthesizing operational role changes with ownership data, which the model did not do. (4) The contextual relevance is moderate because it discusses the right companies and time frame and includes financial stake details, but it misses the central point of strategic evolution, leading to a fundamentally incorrect conclusion. Thus, while some numbers are accurate, the overall correctness is low due to the failure to capture the key transformation in the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 479,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "Between 2022 and 2024, Intel's strategic positioning of FPGAs evolved by integrating them more closely with adjacent products and broader production initiatives. In 2022, FPGAs were highlighted as part of Intel's programmable solutions, supporting diverse applications. By 2024, FPGAs were emphasized within Intel's broader architecture strategy, including roles in AI, edge computing, and high-performance computing, reflecting a shift toward leveraging FPGAs as key accelerators in Intel's expanding product ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a strategic evolution in Intel's positioning of FPGAs between 2022 and 2024 and notes increased integration into broader product strategies. However, it misses the specific structural change highlighted in the ground truth: in 2022, FPGAs were categorized under 'adjacent products' within CCG, DCG, and IOTG, and by 2024, they were elevated to direct product definitions, indicating a shift from supplementary to core. The LLM instead describes a general strategic emphasis on AI, edge computing, and accelerators, which, while plausible, is not supported by the ground truth and introduces unverified details. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model infers a strategic shift, which is correct, but fails to anchor this in the organizational reporting structure and product classification changes that are central to the ground truth. It does not synthesize the specific evolution from 'adjacent' to 'core' as defined in the knowledge graph. (4) The contextual relevance is high because the answer addresses the evolution of FPGA positioning and ties it to broader initiatives, but the lack of precise structural details and introduction of unsupported focus areas (e.g., AI, HPC) reduces factual accuracy. Thus, correctness and qualitative accuracy are moderate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 415,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips' financial activity in the Lower 48 region showed a decline in asset acquisition activity, as evidenced by a reduction in capital expenditures from $5,630 million in 2022 to $6,487 million in 2023. Additionally, depreciation, depletion, and amortization (DD&A) expenses for the Lower 48 increased from $4,854 million in 2022 to $5,729 million in 2023, reflecting higher asset utilization or impairment charges in the region during 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the capital expenditures data: it claims a reduction from $5,630 million in 2022 to $6,487 million in 2023, which is incorrect because $6,487 million is actually higher than $5,630 million, so this implies an increase, not a decline. Moreover, the original answer (ground truth) does not mention capital expenditures at all—instead, it references the Concho acquisition as the driver of 2022 activity. Thus, the LLM fabricates a narrative about declining acquisition activity based on incorrect interpretation of capex numbers not present in the ground truth. (2) The DD&A expenses are correctly stated: $4,854 million in 2022 and $5,729 million in 2023, with the correct upward trend. The increase of $875 million is accurate ($5,729M - $4,854M = $875M), so quantitative accuracy for these figures is correct. However, the erroneous capex comparison undermines overall correctness. (3) The multi-hop reasoning is flawed: the original answer links the 2022 acquisition (Concho) to ongoing financial impacts in 2023, showing cause and effect. The LLM fails this synthesis, instead inventing a contradictory trend in acquisition activity despite rising DD&A suggesting continued investment. (4) Contextual relevance is high because the answer addresses both asset acquisition and DD&A as asked, and focuses on the Lower 48 region and correct years. However, due to the major error in interpreting financial activity direction and introducing unsupported data, the correctness and qualitative accuracy scores are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 438,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Between 2022 and 2024, Emerson's ownership in AspenTech increased from 55% to 57%, with Emerson proposing to acquire the remaining shares in November 2024. Financially, the integration of AspenTech positively impacted gross margins, contributing a 0.6 percentage point increase in 2023 and partially offsetting margin pressures in 2024 due to acquisition-related inventory step-up amortization. The 2024 gross margin was 50.8%, up from 49.0% in 2023, reflecting the ongoing influence of the AspenTech acquisition.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Emerson's ownership increased from 55% to 57% between 2022 and 2024, while the ground truth indicates Emerson owned 55% by 2024 (not starting at 55% in 2022). The original answer does not mention a proposed acquisition of remaining shares in November 2024, nor any increase to 57%, making this a significant error. (2) Quantitatively, the LLM correctly notes the 0.6 percentage point gross margin contribution in 2023 and the 50.8% gross margin in 2024. However, it fails to mention the $6.0 billion cash payment, $87.69 per share, $168 million retained balance, or the $231 million inventory step-up amortization that reduced margins by 1.3 percentage points—key financial details from the acquisition. While it correctly identifies the 2024 margin impact, it omits the full context that the 1.8 percentage point positive contribution was partially offset by the 1.3 point negative impact. The claim that 2023 gross margin was 49.0% is unsupported by the original answer, which does not state the prior year's overall margin. (3) The multi-hop reasoning is partially sound—linking ownership evolution and financial impact on margins—but fails to accurately synthesize the timeline and ownership progression. The assertion about a November 2024 proposal is not in the ground truth, indicating fabrication or misattribution. (4) Despite these issues, the answer is contextually relevant, addressing both ownership and margin impact. The qualitative reasoning about offsetting margin pressures is plausible but incomplete without full data. Scores reflect partial correctness on core financial impacts but major errors in ownership timeline and missing key figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 480,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "Between 2022 and 2024, the 2015 Director Stock Plan saw an increase in share availability due to share recovery mechanisms, with total shares recovered for issuance rising from 31,545,071 in 2021 to 37,608,213 by 2024. Shares remaining available for future issuance under the plan decreased from 34,073,114 in 2021 to 30,660,961 in 2024, reflecting both share recoveries and the issuance of new awards. The issuance mechanics remained consistent, with shares issued under the plan reducing available shares by one per share, and recovered shares from forfeitures, cash settlements, or other non-share awards becoming available for future grants.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the share recovery and issuance mechanics, noting that shares issued reduce availability by one and recovered shares (from forfeitures, cash settlements) become available again—this aligns with the ground truth. It also accurately states the 2024 figures: 37,608,213 shares recovered and 30,660,961 shares available for future issuance. However, it introduces data not present in the ground truth: specifically, the '34,073,114 shares available in 2021' and '31,545,071 shares recovered in 2021' are not mentioned in the original answer and cannot be verified from the provided context. The ground truth does not provide 2021 data or suggest an increase in availability due to recovery—on the contrary, it emphasizes a net reduction in available shares over time despite recovery. (2) The quantitative values for 2024 (37.6M recovered, 30.66M available) are correct, but the use of 2021 baselines for comparison is unsupported, leading to a potentially misleading narrative of increasing availability. The ground truth states that 42,343,146 shares were covered by new awards and reinvested dividends since 2015, which the LLM omits—this is a key part of the multi-hop reasoning explaining why availability decreased despite recovery. (3) The reasoning is partially sound: the mechanics are correctly described, and the synthesis of recovery and issuance is reasonable, but the conclusion that share availability increased due to recovery is contradicted by the net reduction described in the ground truth. The LLM misinterprets the trend by focusing on rising recovery totals without contextualizing the larger volume of new issuances. (4) Scores reflect that core facts and mechanics are correct (qualitative accuracy high), but unsupported numbers and incorrect trend interpretation reduce quantitative accuracy. Contextual relevance is full—answer directly addresses the question's focus on evolution between 2022 and 2024, even if with flawed data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 541,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "Starbucks' relationship with the Global Coffee Alliance (GCA) showed increased strategic emphasis and revenue contribution from fiscal 2022 to 2023. In fiscal 2022, revenue from the GCA contributed $216 million to the \"Other\" revenue category, reflecting growth in product sales and royalty revenue. By fiscal 2023, the GCA remained a key part of Starbucks' expansion strategy, with the company continuing to leverage the partnership to drive growth in coffee and tea products through grocery, foodservice, and other channels. The Channel Development segment, which includes the GCA, saw a 16% revenue increase in fiscal 2022 compared to the prior year, though its operating margin declined due to inflationary pressures and supply chain constraints. This indicates a stronger focus on the GCA as a growth driver in fiscal 2023, despite margin challenges.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth states that the Channel Development segment saw a $250 million increase in revenue in fiscal 2022 due to the Global Coffee Alliance (GCA), but the LLM incorrectly reports $216 million attributed to the 'Other' revenue category, which does not align with the original answer. Additionally, the 16% revenue increase mentioned in the LLM answer for Channel Development is not present in the ground truth and cannot be verified, making it a fabrication or misattribution. (2) The calculation of revenue contribution is incorrect—$216M vs. the correct $250M—and the categorization of this revenue under 'Other' contradicts the ground truth, which explicitly ties the $250M increase to the Channel Development segment. There is no mention in the original answer of margin decline due to inflation or supply chain issues, which introduces unsupported qualitative claims. (3) While the LLM captures the general direction of strategic evolution—continued importance of the GCA in product distribution and expansion—it fails to accurately reflect the shift in strategic emphasis from revenue driver to strategic enabler via the Nestlé licensing relationship, a key multi-hop insight in the original answer. The deeper integration with Nestlé is entirely omitted. (4) Despite these errors, the answer is contextually relevant, addressing both strategic emphasis and revenue contribution over the two fiscal years, and attempts to synthesize trends across time. However, due to significant quantitative inaccuracies and incomplete or incorrect reasoning about the strategic evolution, the overall correctness score is low. Minor credit is given for recognizing the ongoing role of GCA in product expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 493,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "Between 2022 and 2023, NEE's financial stake in the Mountain Valley Pipeline (MVP) significantly declined, as the company completely wrote off its investment in the project in early 2022 due to impairment charges. This indicates a strategic shift away from high-risk or underperforming infrastructure projects, aligning with NEE's broader focus on renewable energy and regulated utility growth. The write-off reflects a decision to prioritize investments in more stable, regulated assets and clean energy initiatives over natural gas pipeline projects facing regulatory or operational challenges.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) Quantitatively, the claim that NEE 'completely wrote off its investment in the project in early 2022 due to impairment charges' is false. The ground truth states that in 2022, NEE's equity method investments totaled $6,159 million, with MVP listed as an active equity method investee with a 32%–55% ownership stake. In 2023, equity method investments were $6,156 million, with a slightly adjusted stake of 32.8%–52.6%, indicating continued ownership, not a write-off. There is no mention of impairment or disposal. (2) The answer fails to report any correct numbers or trends—instead, it fabricates a narrative of divestment. (3) Qualitatively, the reasoning is flawed: the LLM infers a strategic shift away from natural gas pipelines, but the ground truth shows NEE maintained its stake and even highlighted MVP in 2023 under Nonrecurring Fair Value Measurements, suggesting ongoing financial engagement, not exit. (4) Contextually, while the question asks about evolution and investment strategy, the LLM invents a response unsupported by data. The only partial relevance is the attempt to interpret strategy, but it is based on false premises. Thus, the answer is mostly incorrect with no valid numerical or factual alignment to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 369,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Medtronic's InterStim Therapy product line has seen continued growth and expansion in therapeutic indications. In 2022, the product line included the recently launched InterStim Micro neurostimulator and SureScan MRI leads, targeting overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line had expanded to include InterStim X and InterStim II recharge-free neurostimulators, as well as the InterStim Micro rechargeable neurostimulator, offering more options for patients with similar conditions. This evolution reflects Medtronic's ongoing commitment to enhancing pelvic health therapies through diversified neurostimulator offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the neurostimulator offerings in 2022 (InterStim Micro, InterStim II, and InterStim X) and notes the presence of SureScan MRI leads, which aligns with Medtronic's product enhancements. It also correctly states that by 2024, InterStim II and InterStim X were labeled as 'recharge-free,' which matches the ground truth. However, a critical error is the claim that the InterStim Micro became a 'rechargeable neurostimulator' in 2024—this contradicts the ground truth, which does not mention such a shift and instead emphasizes the recharge-free nature of the main devices. Additionally, while the LLM mentions continued targeting of overactive bladder and urinary retention, it fails to explicitly note the expansion to 'chronic fecal incontinence' as a formal therapeutic indication in 2024, instead vaguely referring to 'similar conditions.' This omission of a key clinical expansion significantly undermines completeness. (2) There are no explicit numerical values, dates, or calculations in the question or answers, so quantitative accuracy is high by default—dates (2022, 2024) are used correctly. (3) The multi-hop reasoning is partially sound: the model connects product evolution across years and identifies device types, but incorrectly infers a rechargeable upgrade for InterStim Micro not supported by the ground truth, and misses the precise broadening of indications to chronic fecal incontinence. (4) The contextual relevance is strong—the response stays on topic and addresses product line evolution in both devices and indications. However, due to the missed indication expansion and incorrect characterization of InterStim Micro, the correctness and qualitative accuracy scores are reduced to 6. Minor wording differences are acceptable, but missing a key therapeutic expansion and introducing an unsupported device feature constitute significant factual shortcomings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 522,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "From 2022 to 2024, Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolved significantly. In 2022, Simon sold a portion of its interest in ABG for $65.5 million while acquiring additional interests for $100.0 million, increasing its ownership to approximately 10.4%. By 2023, Simon further increased its stake through multiple transactions, including a capital transaction that diluted ABG's ownership to approximately 9.6%, and recognized gains from deemed disposals. Finally, in 2024, Simon sold all of its remaining interest in ABG for $1.2 billion, resulting in a pretax gain of $414.8 million, marking the end of its direct financial stake in ABG.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Simon held a 1.37% interest in ABG and was involved in merging Forever 21 into SPARC Group with ABG. However, the LLM claims Simon sold part of its stake for $65.5M and increased ownership to 10.4% in 2022 — none of which is supported by the original answer. The LLM also states Simon sold all remaining interest in ABG in 2024 for $1.2 billion with a $414.8M gain, but the ground truth reports only a partial sale with an $18.8M pre-tax gain. Additionally, the $100M cash investment in ABG is correctly mentioned but miscontextualized as increasing ownership to 10.4%, which is unsupported. (2) Quantitative accuracy is very low: none of the dollar amounts (except the $100M) or percentages (10.4%, 9.6%) match the original. The $18.8M gain in the truth is misrepresented as $414.8M, and no mention of the 1.37% starting stake is made. (3) The reasoning is flawed — the LLM fabricates a narrative of increasing then fully exiting the stake with large transactions and gains not present in the ground truth. It fails to capture the actual dynamic: a minor stake in 2022, a partial sale with small gain, and a reinvestment in 2024 — not a full exit. (4) Contextual relevance is moderate because the answer addresses the evolution of the relationship and mentions correct entities (Simon, ABG, SPARC) and time frame, but the core financial and strategic narrative is incorrect. The multi-hop synthesis is unsound due to reliance on fabricated data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 428,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses for the Lower 48 region increased from $4,067 million in 2021 to $4,854 million in 2022, and further to $5,729 million in 2023. This upward trend reflects increased investment activity and asset utilization in the region during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the DD&A expenses for ConocoPhillips in the Lower 48 region as $4,067 million in 2021, $4,854 million in 2022, and $5,729 million in 2023. These values match the ground truth data, with the 2021 and 2023 figures explicitly confirmed and the 2022 figure being an accurate intermediate data point not contradicted by the original answer. The upward trend and conclusion about increased investment activity are consistent with the ground truth. (2) All numeric values are factually correct and properly formatted; the increase from 2021 to 2023 is accurately represented, and the intermediate 2022 value is correctly stated. (3) The reasoning is sound: the model correctly infers that rising DD&A expenses indicate increased asset utilization or investment, which aligns with the multi-hop synthesis required to interpret financial trends from expense data over time. (4) The answer is fully relevant and addresses both parts of the question—evolution of investment activity and DD&A expenses. The only minor limitation is that the original answer emphasizes the 2021-to-2023 jump without the 2022 detail, but including it improves completeness without introducing error, warranting a high but not perfect qualitative score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 356,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "From 2023 to 2024, Verizon's treatment and valuation approach for international bonds remained consistent, with both years categorizing them under Level 2 of the fair value hierarchy. In 2023, international bonds were valued using matrix prices with input from independent third-party valuation sources, and the total value was $341 million. In 2024, the valuation methodology remained unchanged, and the total value of international bonds was $113 million. The slight decrease in value reflects changes in the pension plan's asset allocation rather than a change in valuation approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. According to the ground truth, in 2023, Verizon used matrix pricing with third-party inputs for international bonds as part of fixed income securities, but did not report a total value of $341 million—this number is incorrect and unsupported by the original answer. In 2024, the ground truth states the total value was $12 million ($10M Level 1, $2M Level 2), whereas the LLM claims $113 million and asserts it remained in Level 2 only, which contradicts the segmentation into Level 1 and Level 2. (2) The quantitative values are entirely incorrect: $341M (claimed) vs. no specific total mentioned in 2023 in the original (though implied under broader category), and $113M (claimed) vs. $12M (actual in 2024). The LLM also fails to mention the breakdown of $10M Level 1 and $2M Level 2, a key detail. (3) The reasoning is flawed: the original answer identifies a shift from general description in 2023 to specific itemization and improved transparency in 2024, indicating a change in disclosure and possibly valuation approach. The LLM incorrectly asserts the methodology 'remained unchanged' and attributes value changes to asset allocation, which is not supported by the ground truth and misses the core evolution in disclosure granularity. (4) The contextual relevance is moderate because the answer addresses Verizon and international bonds across 2023–2024, but the factual and reasoning errors severely undermine correctness. Due to major errors in numbers, entities, and logical synthesis, the overall correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 441,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Between 2022 and 2024, Emerson's relationship with AspenTech evolved significantly in terms of financial stake and operational integration. In May 2022, Emerson acquired a majority stake in Heritage AspenTech, owning 55% of its shares on a fully diluted basis. By November 2024, Emerson increased its ownership to approximately 57% and announced a proposal to acquire the remaining shares of AspenTech for $240 per share in cash, signaling a move toward full integration. Operationally, AspenTech's industrial software businesses were integrated into Emerson's portfolio, with the combined entity operating under the AspenTech brand and its stock traded under the ticker 'AZPN.' This evolution reflects Emerson's strategic focus on strengthening its industrial software capabilities through deeper ownership and operational alignment with AspenTech.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Emerson had a financial stake in AspenTech valued at $8,326 million on its balance sheet, not a 55% ownership acquired in May 2022 as claimed. The LLM incorrectly states that Emerson acquired a 55% stake in 'Heritage AspenTech' in May 2022, which contradicts the ground truth where the 55% ownership arises only in 2024 through the formation of 'New AspenTech'. Furthermore, the LLM claims ownership increased to 57% by November 2024 and that a $240 per share acquisition offer was made, none of which is supported by the original answer. Instead, the ground truth states that Emerson contributed the AspenTech Industrial Software Business and $6.0 billion in cash to form 'New AspenTech' and retained a 55% stake—this key restructuring event is entirely misrepresented. (2) Quantitatively, the $8,326 million stake in 2022 is ignored; instead, fabricated figures like $240 per share and 57% ownership are introduced. The $6.0 billion cash contribution in 2024 is not mentioned, and the 55% stake is misattributed to 2022 rather than 2024. (3) The multi-hop reasoning is flawed: the model fails to connect the 2022 financial stake with the 2024 structural transformation. It invents a narrative of gradual ownership increase rather than recognizing the strategic restructuring event. The operational integration is partially correct—mentioning integration into Emerson’s portfolio—but incorrectly states the combined entity operates under AspenTech with ticker 'AZPN', which is not in the ground truth. (4) The contextual relevance is moderate because the answer addresses financial stake and operational integration, but the factual foundation is incorrect, leading to a low correctness score. The qualitative reasoning is poor due to fabricated events and misattribution of ownership changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 515,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "Between 2022 and 2023, Starbucks' position in interest rate swaps shifted significantly. In 2022, interest rate swaps were classified as derivative assets under \"Other long-term assets\" with a value of $22.7 million and as derivative liabilities under \"Other long-term liabilities\" with a value of $34.0 million. By 2023, interest rate swaps were still listed as derivative assets under \"Prepaid expenses and other current assets\" with a value of $0.4 million and as derivative liabilities under \"Other long-term liabilities\" with a value of $41.4 million. This indicates a reduction in asset value and an increase in liabilities, suggesting a more challenging financial position for the interest rate swaps in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 2022 long-term liability value of $34.0 million, it incorrectly states that interest rate swaps were classified as derivative assets in 2022 under 'Other long-term assets' with a value of $22.7 million — this is not supported by the ground truth. The original answer makes no mention of any asset classification or positive asset value for interest rate swaps. In 2023, the LLM claims a derivative asset of $0.4 million under 'Prepaid expenses and other current assets' and a liability of $41.4 million — both figures are incorrect. The ground truth reports total liabilities of $19.6 million ($0.4 million current, $19.2 million long-term), not $41.4 million. The LLM incorrectly concludes an increase in liabilities when there was actually a net decrease from $34.0 million to $19.6 million. (2) Quantitative accuracy fails on multiple counts: the $22.7M asset in 2022, $0.4M asset in 2023, and $41.4M liability in 2023 are all fabricated or misread. Only the $34.0M 2022 liability is correct. Calculations and comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed — the model misidentifies the nature of the instruments (introducing non-existent asset classifications), misrepresents the evolution of liabilities, and draws the opposite conclusion (increasing liability vs. actual decrease). It fails to recognize the reclassification from solely long-term to split between current and long-term. (4) Contextual relevance is moderate because the answer addresses the topic of interest rate swap classification changes over time and attempts to compare years, but the factual foundation is unsound, leading to a misleading interpretation. The structure follows the question's intent, but correctness is severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 507,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolved significantly from 2022 to 2023. In 2022, due to continued legal and regulatory challenges, including the U.S. Court of Appeals for the Fourth Circuit vacating key permits, NextEra Energy Resources determined that the probability of pipeline completion was very low. As a result, it recorded an impairment charge of approximately $0.8 billion ($0.6 billion after tax) in the first quarter of 22, writing off its equity method investment of approximately $0.6 billion and recording a liability of $0.2 billion for future ARO costs. By 2023, Mountain Valley Pipeline remained a focus of commitments, with NextEra Energy Resources contributing equity in 2024 and entering into a 20-year natural gas transportation agreement (approximately $70 million per year) subject to the pipeline's completion.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $0.8 billion impairment charge in 2022 and the $70 million annual obligation under a 20-year transportation agreement in 2023, which aligns with the ground truth. However, it introduces inaccuracies by stating the impairment included a $0.6 billion after-tax amount and a breakdown of $0.6 billion equity write-off and $0.2 billion ARO liability, which are not present in the original answer and cannot be verified from the provided ground truth. These specific sub-components of the impairment are unsupported and represent over-precision or fabrication. Additionally, the LLM mentions 'contributing equity in 2024,' which is outside the 2022–2023 scope and not mentioned in the original, introducing a factual error. (2) The $0.8 billion and $70 million figures are correct in magnitude and context, but the breakdown of the impairment charge lacks verification and deviates from the original's simpler 'approximately $0.8 billion' statement. The mention of 'first quarter of 22' adds temporal detail not in the original, which may be accurate but is unverifiable and not essential. (3) The multi-hop reasoning is generally sound—connecting 2022 impairment due to low completion probability to continued 2023 commitment via transportation agreement and maintained investment. The core evolution of financial involvement is captured: write-off in 2022 but ongoing contractual commitment in 2023. However, the erroneous 2024 equity contribution undermines the temporal accuracy. (4) Despite the quantitative overreach and one forward-looking error, the answer remains contextually relevant and captures the key narrative shift: financial loss recognition in 2022 but continued strategic involvement in 2023. Hence, correctness is reduced to 7 due to significant but not central factual deviations, quantitative accuracy to 6 due to unsupported breakdowns, qualitative reasoning to 8 for sound logic despite errors, and full marks for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 541,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company, which reinsures group annuity insurance contracts covering obligations of certain European and Canadian pension plans, increased from $1,643 million as of December 31, 2023, to $1,883 million as of December 31, 2024. This represents an increase of $240 million over the one-year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1,643 million (2023) and $1,883 million (2024) are accurately reported with correct dates (December 31, 2023, and December 31, 2024). The calculated increase of $240 million ($1,883M - $1,643M) is accurate. (2) The answer is complete, addressing the evolution of investments between 2023 and 2024, including both data points and the direction and magnitude of change. (3) Entity accuracy is correct: The Coca-Cola Company, its captive insurance company, and the context of reinsuring group annuity contracts for European and Canadian pension plans are properly identified and contextually relevant. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers growth in investment over time based on year-over-year data from the knowledge graph. (5) Semantic equivalence is maintained — while the LLM adds minor contextual detail (geographic scope of pension plans), this is consistent with typical 10-K disclosures and does not contradict or distort the ground truth. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 324,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "Intel's approach to the Intel 4 process node evolved significantly from 2022 to 2024. In 2022, Intel 4 was in development, with early production efforts and integration into the 12th Gen Intel Core processors. By 2024, Intel 4 had transitioned to high-volume manufacturing, with production shifted to Ireland and used in the Intel Core Ultra Series 1, marking Intel's first high-volume client product on this node. Intel 4, as the company's first EUV lithography node, was strategically positioned to deliver a 20% performance-per-watt improvement over Intel 7 and became a key part of Intel's roadmap for 2025 and beyond.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Intel's approach to the Intel 4 process node from 2022 to 2024. It correctly identifies the transition from early production/ramp-up in 2022 to high-volume manufacturing in 2024, with specific mention of Ireland as the production location and the use of Intel 4 in the Intel Core Ultra Series 1, aligning with the ground truth. The strategic importance is accurately conveyed through the mention of EUV lithography and the 20% performance-per-watt improvement over Intel 7, which contextualizes its roadmap significance. However, there is a minor inaccuracy: the claim that Intel 4 was integrated into the 12th Gen Intel Core processors in 2022 is incorrect—Intel 4 was not used in 12th Gen Core processors (which were on Intel 7); the first high-volume client product on Intel 4 was the Intel Core Ultra, as correctly noted for 2024. This misstatement affects the timeline and early-stage application, but not the overall trajectory. The quantitative details (20% improvement) are accurate and relevant, though not present in the original answer—this is acceptable as supplementary context. The reasoning is sound, showing a logical progression from development to volume production, and the answer addresses both production status and strategic positioning. The synthesis across time and strategy is strong, though the early product misattribution prevents a top score. Contextual relevance is excellent, directly addressing the question with appropriate detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 419,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Between 2022 and 2024, Emerson's strategic relationship with AspenTech evolved significantly in terms of ownership and financial integration. In May 2022, Emerson contributed two of its industrial software businesses to Heritage AspenTech and received approximately $6.0 billion in cash, acquiring 55% of AspenTech's outstanding shares. By November 2024, Emerson proposed to acquire the remaining 43% of AspenTech not already owned by Emerson for $240 per share, increasing its ownership to 100% and fully integrating AspenTech into its portfolio. Financially, AspenTech's results were included in Emerson's operations from 2022 onward, with Emerson recognizing gains and losses related to its equity investment and financial instruments tied to AspenTech.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Emerson did not own 55% of AspenTech yet—AspenTech was a strategic partner with no ownership stake mentioned. The 55% ownership came only after the 2024 merger forming 'New AspenTech.' The LLM incorrectly states that Emerson acquired 55% in May 2022 and contributed software businesses for $6.0 billion, which contradicts the ground truth. Additionally, the claim that Emerson proposed to acquire the remaining 43% in November 2024 for $240 per share and reach 100% ownership is false—the ground truth states Emerson retained 55%, not that it moved to full ownership. (2) Quantitative inaccuracies include: the $6.0 billion cash figure, the 43% remaining stake (should be 45%), the $240 per share price, and the timing of transactions. The ground truth does not mention any of these numbers. The correct financial impacts were a 0.6 percentage point increase in gross margins in 2023 and SG&A influence in 2024—these are entirely missing from the LLM answer. (3) The multi-hop reasoning is flawed: the model fails to correctly trace the evolution from partnership (2022) to partial ownership (55% in 2024 post-merger), instead fabricating a timeline involving an early 2022 acquisition and a later full buyout. It also incorrectly asserts financial integration 'from 2022 onward,' while the ground truth confirms integration only began in 2024 after the merger. (4) Despite these major errors, the answer is contextually relevant—it addresses ownership structure and financial integration as asked, and mentions correct entities (Emerson, AspenTech) and approximate timeframes. However, the core facts, numbers, and reasoning are largely incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 488,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "Intel's approach to the Intel 4 process node evolved significantly from 2022 to 2024, with a focus on manufacturing readiness and performance improvements. In 2022, the Intel 4 process was in development and marked as the company's first EUV lithography node. By 2024, Intel 4 had moved to high-volume manufacturing in Ireland, with the Intel Core Ultra processor as its first high-volume client product, delivering approximately 20% performance-per-watt improvement over Intel 7. This transition reflects Intel's progress in adopting EUV lithography and scaling production capacity to meet growing demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel 4 was introduced as Intel's first EUV lithography node, achieved high-volume manufacturing in Ireland by 2024, and delivered a 20% performance-per-watt improvement over Intel 7. The use of the Intel Core Ultra processor as the first high-volume product is correctly identified, and the timeline from development in 2022 to production by 2024 is accurately represented. (2) Quantitative accuracy is perfect: the 20% performance-per-watt gain is correctly stated, and the years (2022, 2024) match the original answer. No calculations were required, but all metrics and dates are consistent with the ground truth. (3) The multi-hop reasoning is sound—information is synthesized across time (2022 to 2024), technology (EUV adoption), manufacturing (Ireland ramp-up), and product integration (Core Ultra). The only minor omission is that the original answer notes the Core Ultra began shipping in 2023, which the LLM answer does not mention, slightly reducing completeness. (4) Contextual relevance is excellent—the response directly addresses the evolution in manufacturing readiness and performance improvements as asked. The wording differs but the semantic meaning is equivalent. Overall, this is a strong, factually correct response with only a slight gap in completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 382,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "Between 2022 and 2024, the InterStim Micro has been positioned as a key component of Medtronic's Pelvic Health therapies, with continued acceptance and growth highlighted in the 2024 report. Specifically, it is noted as part of Medtronic's Pelvic Health offerings, which include the InterStim X, InterStim II, and InterStim Micro neurostimulators, aimed at treating conditions such as overactive bladder, non-obstructive urinary retention, and chronic fecal incontinence. The 2024 report emphasizes its role in the broader Pelvic Health portfolio, indicating a strategic focus on its growth and integration within the Neuromodulation division.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities, years, and product indications, correctly identifying InterStim Micro, InterStim X, and InterStim II as part of Medtronic's Pelvic Health portfolio used to treat overactive bladder, urinary retention, and fecal incontinence. The timeline (2022 to 2024) is appropriately referenced, and there are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10). Contextual relevance is high, as the response directly addresses the evolution of InterStim Micro’s role within Pelvic Health therapies. However, the key strategic shift—InterStim Micro being specifically positioned as the *rechargeable* option by 2024, in contrast to the *recharge-free* InterStim X and II—is missing. This is a critical qualitative detail present in the ground truth that defines the product's evolved positioning. The LLM mentions 'continued acceptance and growth' and 'strategic focus on integration,' but fails to capture the differentiation based on rechargeability, which represents a core aspect of the multi-hop reasoning required. Thus, while the answer is largely correct and well-structured, it omits a key differentiating factor in the product's strategic repositioning, reducing qualitative accuracy and overall correctness. This omission prevents a score above 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 367,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "The disclosure around the dilutive effect of LTIP Units from 2022 to 2024 indicates that no securities, including LTIP Units, had a material dilutive effect on earnings per share or per unit in any of the reported periods (2024, 2023, or 2022). The company consistently stated that potentially dilutive securities, such as LTIP Units, did not result in a material impact on diluted earnings per share or per unit across all reporting periods. This suggests that the dilutive impact of LTIP Units remained immaterial throughout the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that no securities, including LTIP Units, had a material dilutive effect in the reporting periods 2022, 2023, and 2024, which aligns with the ground truth. The dates and conclusion about immaterial dilution are factually accurate (supporting a high quantitative accuracy score). However, the LLM fails to capture the evolution in disclosure detail — specifically, the removal of the explicit mention of LTIP units' exchangeability into common stock in the 2024 filing compared to 2022. This reduction in descriptive detail about the conversion feature is a key aspect of how the disclosure evolved, and its omission represents a significant gap in qualitative accuracy. The answer incorrectly implies consistency in disclosure language rather than noting the simplification and reduced specificity over time. While the core conclusion about dilutive impact is correct, the multi-hop reasoning required to compare the nature and level of disclosure across years is incomplete. Thus, despite correct dates and facts, the answer lacks the comparative disclosure analysis central to the question, warranting a moderate overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 330,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "From 2022 to 2024, MetLife's approach to managing cash buffer needs in relation to stock repurchases has shown a focus on balancing liquidity and regulatory requirements. In 2022, the company had a $3.0 billion repurchase authorization, with $1.5 billion remaining as of December 31, 2021, and emphasized maintaining a cash buffer to meet liquidity needs and regulatory capital standards. By 2024, the company continued to highlight the importance of liquidity and capital management, noting that cash buffer requirements and regulatory constraints could limit repurchase activity. This suggests a more cautious approach, with repurchase activity being subject to ongoing evaluation of financial conditions, market opportunities, and regulatory environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that MetLife had a $3.0 billion repurchase authorization with $1.5 billion remaining as of December 31, 2021, which aligns with the ground truth for the 2022 context. The 2024 shift toward increased caution due to liquidity and regulatory constraints is accurately reflected. (2) All numeric values and dates are correct: $3.0 billion total authorization and $1.5 billion remaining are accurately reported. The date reference 'as of December 31, 2021' is correctly used in context to describe the starting point for 2022 activity, which is consistent with the original answer. (3) The multi-hop reasoning is sound—information from two time points (2022 and 2024) is synthesized to show an evolution in strategy. The LLM correctly infers a more cautious stance in 2024 based on liquidity and regulatory considerations, matching the ground truth's conclusion of a shift toward conservatism. (4) The only minor shortcoming is that the LLM does not explicitly mention 'innovation' or 'acquisitions' as areas potentially limited by buffer needs, which the original answer includes. While the core message about constrained repurchases due to liquidity buffers is preserved, this omission slightly reduces completeness in qualitative synthesis. Otherwise, the answer is factually accurate, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 390,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "From fiscal year 2022 to 2023, Starbucks' foreign currency - other derivative positions shifted significantly in both asset and liability classifications. In 2022, foreign currency - other derivative assets were $39.9 million in current assets and $33.5 million in long-term assets, while liabilities were $0.3 million in current liabilities and $- in long-term liabilities. By 2023, the asset positions decreased to $1.9 million in current assets and $1.7 million in long-term assets, while liabilities increased to $4.7 million in current liabilities and $4.1 million in long-term liabilities, reflecting a shift from asset to liability positions and a reduction in overall magnitude.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values for Starbucks' foreign currency - other derivative assets and liabilities in fiscal year 2022. According to the ground truth, in 2022, Starbucks reported $103.9 million in foreign currency - other derivative assets recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings — not balance sheet line items of $39.9 million in current assets and $33.5 million in long-term assets as stated by the LLM. These figures do not appear in the ground truth and are incorrect. The 2023 figures ($1.9M current assets, $1.7M long-term assets, $4.7M current liabilities, $4.1M long-term liabilities) are correctly reported by the LLM and match the ground truth. (2) The calculation and comparison between years are flawed due to incorrect 2022 baselines. The claim of a shift from asset to liability positions is partially reasonable given the reduction in assets and emergence of liabilities, but this conclusion is based on wrong inputs. (3) The multi-hop reasoning fails because the model incorrectly interprets the 2022 data — it treats OCI-recognized derivatives as balance sheet line items with incorrect allocations to current/long-term categories, showing a failure to synthesize the correct context (OCI vs. balance sheet presentation). The 2023 classification is accurately described, showing partial multi-hop capability. (4) Despite correct framing and relevance to the question’s intent, the severe numerical inaccuracies in the 2022 data severely undermine factual correctness, warranting a low correctness and quantitative accuracy score. Qualitative reasoning is partially sound but based on false premises. Contextual relevance is high as the structure and focus align well with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 496,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "Procter & Gamble's global cash management strategy evolved between fiscal 2022 and fiscal 2024 by emphasizing liquidity management, economic factors, and tax considerations, while aligning with restructuring activities to enhance productivity and cost savings. In fiscal 2024, the company incurred significant restructuring costs, including a $659 million charge, driven by the substantial liquidation of operations in certain Enterprise Markets, such as Nigeria. This restructuring was part of a broader initiative to optimize manufacturing and workforce efficiency. The company's cash flow improved significantly, with operating cash flow increasing by 18% to $19.8 billion in fiscal 2024, and adjusted free cash flow rising by 21% to $16.9 billion. These improvements reflect the effectiveness of the restructuring efforts and the company's disciplined approach to managing cash, which supports dividends, share repurchases, and strategic investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures and trends. While it correctly identifies increased restructuring costs in fiscal 2024 ($659 million before tax), it omits key details such as the $216 million in non-cash foreign currency translation losses and the $1.4 billion Gillette intangible asset impairment charge, which were central to the decline in corporate net earnings. Instead, the LLM claims operating cash flow increased by 18% to $19.8 billion and adjusted free cash flow rose by 21% to $16.9 billion in fiscal 2024—these figures are not supported by the ground truth and contradict the reported $1.0 billion decrease in corporate net earnings due to restructuring and impairments. (2) The ground truth states corporate net earnings *decreased* by $1.0 billion in fiscal 2024, yet the LLM portrays a positive financial trajectory with improved cash flow, which is factually incorrect. There is no mention of the $872 million improvement in fiscal 2022 turning into a $1.0 billion decline in 2024, nor the rise in restructuring accruals from $147 million to $659 million. (3) The reasoning is partially sound in linking restructuring to cash management and mentioning Nigeria as an Enterprise Market affected, but fails the multi-hop synthesis by not connecting the increased restructuring charges and impairment to negative impacts on earnings and cash pressure. Instead, it incorrectly infers that higher restructuring spending led to improved cash flow, which contradicts the cause-effect relationship in the original data. (4) Contextual relevance is strong—the answer addresses Procter & Gamble, fiscal years 2022–2024, restructuring, and cash management strategy. However, due to major quantitative errors and flawed financial conclusions, the correctness score is low. The qualitative accuracy is moderate because some entities and strategic themes are correctly identified, but the overall narrative misrepresents the financial reality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 543,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's positioning and application of Omniverse evolved significantly in terms of integration with enterprise solutions and simulation technologies. In 2022, Omniverse was highlighted as a real-time 3D design collaboration and virtual world simulation tool for artists and designers, with applications in industrial digitalization and simulation of autonomous systems. By 2023, Omniverse had expanded into enterprise use as a development platform and operating system for building virtual world simulation applications, including digital twins of factories, real-time 3D product configurators, and testing autonomous robots and vehicles. Additionally, Omniverse was integrated with NVIDIA DRIVE Sim and DRIVE Constellation for simulation and validation of autonomous driving systems, demonstrating deeper integration with enterprise and simulation technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual information is correct: the evolution of Omniverse from a collaboration/simulation platform in 2022 to a development platform and operating system in 2023 is accurately described. Key applications such as digital twins of factories, real-time 3D product configurators, and autonomous vehicle/robot testing are correctly identified. Integration with enterprise solutions and simulation technologies like DRIVE Sim and DRIVE Constellation is properly noted. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022, 2023), which are accurate. (3) The multi-hop reasoning is sound—information is synthesized across time periods and use cases, correctly showing progression in positioning and integration. The mention of DRIVE Constellation adds detail not in the original answer but is factually consistent with NVIDIA's ecosystem and does not introduce error. (4) The only minor shortcoming is that the LLM omits specific 2022 use cases mentioned in the ground truth (e.g., virtual car showrooms, surgical training, architectural walkthroughs) and does not explicitly mention free access for individuals or subscription model for enterprises. However, the core evolution and enterprise integration are well captured. Semantic equivalence is high, and the answer remains contextually excellent. Thus, a score of 9 is justified for minor completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 422,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "AMT's financial commitments related to communications sites from 2023 to 2024 show a significant increase in anticipated spending and future obligations. In 2023, the company's total capital expenditures were estimated to be between $1,545 million and $1,655 million, covering discretionary projects, ground lease purchases, capital improvements, and redevelopment. By 2024, the anticipated spending rose to between $1,545 million and $1,655 million, with a notable focus on the construction of approximately 2,500 to 3,500 communications sites globally and $450 million allocated for data-center assets. Additionally, future obligations, including debt and operating lease commitments, increased from $36,756.3 million in 2024 compared to the prior year, reflecting ongoing financial commitments tied to communications infrastructure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, AMT anticipated spending $450 million specifically on data center assets for 2,500 to 3,500 communications sites. However, the LLM incorrectly claims that total capital expenditures in 2023 were between $1,545M and $1,655M, which is unrelated to the $450M data center allocation and not mentioned in the original answer. Furthermore, the LLM states that anticipated spending in 2024 was in the same $1,545M–$1,655M range, which contradicts the ground truth that highlights a $4.5 billion asset retirement obligation (ARO) in 2024 — a completely different and much larger financial commitment. The LLM fails to mention the $4.5 billion ARO, which is the key evolution in financial obligations. Instead, it cites an incorrect total obligation of $36,756.3 million in 2024 for debt and leases, which is not in the original answer and appears fabricated or misattributed. (2) Quantitative accuracy is very low: the $450M data center figure is mentioned but miscontextualized as part of broader capex, while the critical $4.5B ARO is entirely omitted. The $36,756.3M figure has no basis in the ground truth. (3) Multi-hop reasoning is flawed: the model fails to connect the shift from near-term construction spending (2023) to long-term liability recognition (2024). It conflates capital expenditures with future obligations and does not distinguish between operational spending and asset retirement liabilities. (4) Contextual relevance is moderate because the answer discusses financial commitments and time periods correctly, but the core financial evolution — the emergence of a $4.5B long-term obligation — is missing, making the response substantially incorrect despite some relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 489,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil's characterization of asset divestitures evolved by incorporating \"divestment-related reductions\" into its definition of structural cost savings in 2024, which was not explicitly mentioned in 2023. Additionally, in 2024, the proceeds from asset sales were more closely tied to broader cost-saving initiatives, emphasizing sustainability and alignment with strategic objectives, while in 2023, the focus was more on the disciplined review process to ensure assets contributed to strategic goals.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and reasoning, despite being internally consistent and contextually relevant to the question's theme. (1) The key claim that ExxonMobil incorporated 'divestment-related reductions' into 'structural cost savings' in 2024 is not supported by the ground truth and introduces concepts (e.g., structural cost savings) that are absent from the original answer. The original answer focuses solely on the evolution of language describing the proceeds from asset sales, not cost-saving classifications. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the LLM invents a new narrative about cost-saving initiatives and sustainability that is not present in the ground truth. The actual evolution noted is a linguistic streamlining—from a detailed breakdown of proceeds (subsidiaries, PPE, investments) in 2023 to a more consolidated 'proceeds from asset sales and returns of investments' in 2024—while maintaining the same strategic alignment rationale. The LLM misses this core point entirely. (4) Contextual relevance is moderate because the answer addresses the general topic of evolving language around divestitures and strategy, but it does so with incorrect specifics and introduces unsupported strategic linkages to cost savings and sustainability. Thus, while the direction of inquiry is relevant, the substance is factually inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 423,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort decreased from 2022 to 2023. In 2022, the consolidated assets and liabilities of Universal Beijing Resort were $9.7 billion and $8.1 billion, respectively. By 2023, these amounts were reduced to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a decline in Comcast's consolidated financial exposure to the resort.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures from the ground truth: $9.7 billion in assets and $8.1 billion in liabilities for 2022, and $7.8 billion in assets and $7.2 billion in liabilities for 2023. These values match the original answer exactly, with no discrepancies in numbers or years. (2) All numeric values are accurate and properly attributed to the correct years and financial categories (assets and liabilities). The reductions are correctly implied through the presentation of lower figures in 2023, though no explicit calculation (e.g., $1.9B asset decrease) is made, which is acceptable as the question does not require it. (3) The reasoning is sound: the LLM correctly infers a decrease in financial exposure based on declining asset and liability amounts, which aligns with the multi-hop synthesis required (comparing two years of balance sheet data across consolidated statements). However, the LLM omits the interpretive possibilities mentioned in the original answer—such as asset depreciation, debt repayment, or strategic reduction—which slightly weakens the qualitative depth. (4) Despite this minor omission, the answer is factually correct, contextually relevant, and conveys the core conclusion: a reduction in Comcast's financial exposure. The wording differs slightly but maintains semantic equivalence. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy, and a 9 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 413,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's Customer Demand Volatility risk factor has evolved to reflect heightened uncertainty in global economic conditions and supply chain disruptions. In 2023, the focus was on how demand fluctuations could lead to excess inventories and increased costs, particularly in the context of macroeconomic factors like interest rates and government fiscal policies. By 2024, the risk has expanded to include more pronounced impacts from geopolitical instability, trade policy shifts, and the lingering effects of global pandemics, which have further strained supply chains and labor availability. This evolution indicates a growing complexity in managing demand volatility, with a stronger emphasis on its cascading effects on financial performance, operational flexibility, and supply chain stability.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Customer Demand Volatility as a risk factor between 2023 and 2024 and correctly identifies that it impacts financial performance and supply chain stability. However, it diverges from the ground truth in key specifics. In 2023, the original answer emphasizes economic uncertainties from the lingering pandemic, inflationary pressures, supply chain disruptions, and labor inefficiencies limiting Caterpillar’s ability to meet demand. The LLM instead cites 'excess inventories' and 'interest rates and government fiscal policies'—details not present in the ground truth. In 2024, the ground truth highlights a shift toward commodity price changes, material price increases, and supply-side disruptions (labor/material shortages), whereas the LLM emphasizes 'geopolitical instability' and 'trade policy shifts,' which are not mentioned in the original. These represent significant qualitative inaccuracies in the drivers identified. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the model correctly infers a broadening of the risk profile over time and connects demand volatility to financial and operational impacts. However, it fails to accurately synthesize the specific risk drivers documented in the knowledge graph, substituting plausible but incorrect factors. (4) Correctness is scored 6 due to partial factual alignment—core idea of evolving risk is correct, but key details are inaccurate or invented. Qualitative accuracy is 6 for similar reasons: reasoning structure is logical but based on incorrect inputs. Contextual relevance is high (9) because the answer stays on topic and addresses all parts of the question, just with inaccurate content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 515,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "The fair value of Net derivative assets (liabilities) increased from $5 million at December 31, 2023, to $69 million at December 31, 2024. The valuation methodology for these derivatives remained consistent, relying on discounted cash flows with swap rates as the primary unobservable input, which had a weighted average of 4% for both periods.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The fair value figures are incorrect: the ground truth states $19 million as of December 31, 2021 (reported in 2022), and $58 million as of December 31, 2023 (reported in 2024), whereas the LLM claims $5 million at December 31, 2023, and $69 million at December 31, 2024—dates and values are both wrong. (2) The quantitative inaccuracies are severe: the LLM misstates the base value, end value, and time periods. The ground truth shows a change from $19M to $58M over two years, while the LLM reports a change from $5M to $69M in one year—neither the starting point, ending point, nor duration align. Additionally, the LLM incorrectly labels swap rates as 'unobservable inputs,' while the ground truth specifies they are 'observable inputs,' which is a critical distinction in valuation methodology. (3) The reasoning is flawed: the LLM claims the methodology 'remained consistent,' but the ground truth explicitly states a shift occurred—from being based on gains/losses in net income to using discounted cash flows with observable inputs. This represents a major methodological evolution that the LLM completely misses. (4) Contextual relevance is moderate because the answer addresses fair value and valuation methodology, which are relevant topics, but the incorrect entities (dates, values, input observability) and failure to capture the methodological shift undermine the response. The answer synthesizes no correct multi-hop information and contradicts the ground truth on key points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 430,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "From 2022 to 2023, NVIDIA's GeForce NOW cloud gaming offering evolved from being a complementary cloud gaming service to a more integrated component of the company's broader GPU and cloud platform ecosystem. In 2022, GeForce NOW was positioned primarily as a service for playing PC games on underpowered devices. By 2023, it was highlighted as part of NVIDIA's unified strategy to enable interactive graphics applications to be accessed from almost any device, leveraging the company's GPU-powered cloud infrastructure and software stacks, including vGPU and AI-enhanced platforms. This shift reflects GeForce NOW's growing role in supporting NVIDIA's vision of accessible, high-performance computing across gaming, professional visualization, and cloud environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: GeForce NOW's evolution from a device-accessibility-focused service in 2022 to a more strategically integrated component of NVIDIA’s broader GPU and cloud ecosystem in 2023 is accurately described. The mention of vGPU and AI-enhanced platforms reflects correct entity usage and contextual integration. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the shift in positioning from standalone cloud gaming to integration within NVIDIA’s larger accelerated computing and cloud infrastructure narrative, including alignment with AI and professional visualization. The only minor shortcoming is that the LLM does not explicitly name NVIDIA DGX Cloud as a specific platform linked to GeForce NOW in 2023, which was included in the original answer as a key detail showing strategic alignment. (4) Despite this slight omission, the answer captures the core evolution and strategic repositioning with strong semantic equivalence. Contextual relevance is excellent, directly addressing the question about ecosystem integration across years. Thus, the correctness score is 9 due to high accuracy with a minor detail missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 384,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Between 2022 and 2023, Inlyta's revenue increased by 3% globally, with a 4% increase in the U.S. and a 7% increase in international markets. The growth in the U.S. was driven by the adoption of combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced RCC. However, this was partially offset by lower volumes and lower net price in certain European markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3% global revenue growth for Inlyta between 2022 and 2023, which aligns with the ground truth (from $1,003M to $1,036M). However, it introduces incorrect breakdowns of 4% U.S. growth and 7% international growth, which are not present in the original answer and contradict the provided data. These specific sub-regional percentages are unsupported and factually inaccurate based on the ground truth. (2) The revenue figures themselves ($1,003M in 2022 and $1,036M in 2023) are not mentioned in the LLM response, which omits the actual dollar amounts—a key quantitative detail. While the 3% global growth is correctly stated, the absence of absolute values reduces completeness and precision. (3) The reasoning around drivers of growth is accurate: the U.S. adoption of Inlyta in combination with immune checkpoint inhibitors for first-line advanced RCC treatment is correctly identified as a growth driver, and the offsetting impact of lower volumes and net prices in certain European markets is properly acknowledged. This shows sound multi-hop reasoning in linking clinical use to commercial performance. (4) The answer is contextually relevant and addresses both parts of the question—revenue evolution and influencing factors—with mostly accurate qualitative synthesis. However, the introduction of unverified regional growth percentages (4% U.S., 7% international) undermines quantitative accuracy. The core facts are mostly right, but the added numerical details are incorrect, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 435,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "From 2023 to 2024, the amortization assumptions for network location intangibles evolved as the Company extended the estimated useful life of its tower assets from 20 to 30 years, which correlated to a similar adjustment for related intangible assets. This change, effective January 1, 2024, reduced amortization expense for the year. In terms of impairment review processes, the Company continued evaluating network location intangibles on an individual tower basis, focusing on factors such as tenant leases and revenue-expense dynamics. No significant changes to the impairment methodology were noted in 2024 compared to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the company extended the estimated useful life of tower assets from 20 to 30 years effective January 1, 2024, which directly contradicts the ground truth stating a weighted average amortization period of 15 years as of December 31, 2023, with no mention of a change to 30 years. This error fundamentally misrepresents the amortization assumptions. Additionally, the LLM states there were 'no significant changes to the impairment methodology,' while the ground truth explicitly notes a more detailed impairment review process was introduced in 2024, including individual tower assessments and identification of specific triggers like lack of leases or expenses exceeding revenues. (2) Quantitatively, the LLM invents numbers not present in the original (20- to 30-year life extension) and omits the $470 million increase in asset retirement obligations, which is a key financial figure impacting valuation assumptions. The ground truth does not mention any change in amortization period or useful life extension, nor does it support the claim of reduced amortization expense. (3) The multi-hop reasoning is flawed: the LLM fails to connect the expanded impairment disclosures and the indirect impact of increased asset retirement obligations on useful life assumptions, which are critical synthesis points. Instead, it fabricates a change in useful life without evidence. (4) While the answer is contextually relevant—focusing on amortization and impairment of network location intangibles—the severe factual and quantitative errors, especially the invented useful life change and omission of key 2024 developments, result in a low correctness score. The answer conveys a narrative opposite to the ground truth regarding evolution in treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 495,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil has significantly advanced its strategic emphasis on Guyana as a core component of its upstream growth portfolio. In 2023, Guyana's production exceeded 390 thousand barrels of oil per day (kbd), with the Prosperity FPSO reaching nameplate capacity in early 2024. By the fourth quarter of 2023, combined gross production from the three operating FPSO vessels on the Stabroek Block reached nearly 440 kbd. In 2024, the focus has shifted to scaling production further, with the Yellowtail and Uaru developments progressing on schedule and expected to add approximately 250 kbd each. ExxonMobil anticipates having six FPSO vessels in operation on the Stabroek Block by year-end 2027 and is working with the government of Guyana to secure approvals for a sixth project at Whiptail. This evolution underscores Guyana's growing importance in ExxonMobil's global production mix and its role in driving long-term upstream growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the strategic evolution of ExxonMobil's focus on Guyana correctly in qualitative terms, noting its growing importance in the upstream portfolio and production scaling. However, there are key quantitative inaccuracies. The ground truth states that in Q4 2023, production reached nearly 440 kbd, which the LLM correctly notes. But it incorrectly claims that in 2023, production 'exceeded 390 kbd'—this figure is not in the original and appears speculative. Additionally, the LLM introduces forward-looking production additions of 'approximately 250 kbd each' for Yellowtail and Uaru and plans for six FPSOs by 2027 and a sixth project at Whiptail—details not present in the original answer and thus unsupported by the ground truth. (2) The Prosperity FPSO startup is correctly tied to early 2024 operations, aligning with the original's mention of startup in 2023 leading into 2024 capacity. However, the original does not mention nameplate capacity timing or specific project output forecasts, making those additions unverified. (3) The multi-hop reasoning is sound in recognizing Guyana’s strategic elevation from a growth project in 2023 to a core advantaged asset in 2024, but the LLM overextends by adding specific future production plans and FPSO counts not confirmed in the ground truth. The original emphasizes a categorization shift in earnings drivers (to 'Advantaged Assets') alongside Permian and LNG, which the LLM omits entirely—this is a significant qualitative gap. (4) Despite missing the key strategic reclassification in 2024 and introducing unsupported numerical projections, the LLM maintains contextual relevance by focusing on upstream growth and production capacity. The core idea of strategic elevation is conveyed, but the absence of the 'Advantaged Assets' reclassification—a central point in the original—reduces qualitative accuracy. Quantitative accuracy is lowered due to unverified numbers like 390 kbd and 250 kbd additions. Correctness score is 7 because the main thrust is directionally accurate but lacks key factual precision and omits a critical strategic update.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 573,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "Between 2022 and 2023, the X1 platform's integration with third-party streaming services has expanded significantly, with enhanced access to services like Disney+, Netflix, and Peacock, as well as integrated search functionality and voice-activated remote control. This evolution reflects Comcast's strategy to reduce cord-cutting by offering a unified, flexible viewing experience that combines traditional cable with popular streaming options. By integrating these services into the X1 platform and offering bundled services like Xumo Stream Box and NOW TV, Comcast aims to increase customer retention and boost average revenue per user (ARPU) through expanded service offerings and enhanced user engagement.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in intent and captures the strategic direction of Comcast's X1 platform evolution, but contains some inaccuracies in entity details and misses key aspects of the 2023 developments. (1) Correctly identifies the integration of Disney+, Netflix, and Peacock in the X1 platform and links this to reducing cord-cutting and increasing ARPU—this aligns with the ground truth. However, it omits the specific 2022 detail that Comcast earned commission revenue from selling third-party services, which is a key financial component. (2) Quantitatively, there are no explicit numbers (e.g., revenue figures, percentages), so no numerical inaccuracies exist—this earns full marks for quantitative accuracy. (3) The LLM incorrectly implies that Xumo Stream Box and NOW TV were part of the 2022–2023 X1 evolution, whereas the ground truth specifies that in 2023, Xumo Play, NBC, and Sky were integrated into NOW TV for broadband customers—a more precise multi-hop detail that the LLM misrepresents. It also fails to mention that NOW TV was specifically marketed to residential broadband customers, a crucial strategic nuance. (4) Despite these omissions and slight mischaracterizations, the overall reasoning about bundling, integration, and ARPU growth is sound and contextually relevant. The answer captures the strategic rationale but lacks precision in entity and feature evolution, warranting a 7 for qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 403,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's relationship with FG Wilson, in terms of distribution network coverage for electric power generation systems, evolved from covering 109 countries with 110 distributors in 2023 to covering 158 countries with 108 distributors in 2024. This indicates an expansion in geographic reach despite a slight reduction in the number of distributors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: in 2023, 110 distributors covered 109 countries; in 2024, 108 distributors covered 158 countries. These numbers exactly match the ground truth. (2) Quantitative accuracy is perfect—no calculation errors, and the values for distributors and countries per year are correct. (3) The reasoning is sound: the model correctly infers that the geographic reach expanded despite a slight reduction in distributor count, which aligns with the multi-hop synthesis required. However, the LLM omits the explicit mention of a 'strategic shift toward optimizing distributor efficiency while broadening market access,' which is part of the original conclusion and adds interpretive depth. While the core inference is present, this minor omission in qualitative nuance prevents a full 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of Caterpillar's relationship with FG Wilson through distribution network changes. Overall, the response is factually complete and accurate with only a slight reduction in elaboration on strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 326,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Based on the provided information:\n\nIn 2022 (COF_10k_2022.pdf), Capital One's securitized debt obligations had a carrying value of $12,393 million and a fair value of $12,393 million as of December 31, 2020. By 2024 (COF_10k_2024.pdf), the carrying value of securitized debt obligations had decreased to $14,335 million, while the fair value was $14,335 million as of December 31, 2024. This indicates an increase in both the carrying value and fair value of these obligations by approximately $1,942 million over the two-year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, in 2024, the carrying value of securitized debt obligations was $18,043 million with a fair value of $18,067 million. However, the LLM incorrectly states both values as $14,335 million. Additionally, the LLM references data 'as of December 31, 2020' when discussing 2022, which is factually incorrect and irrelevant to the 2022–2024 comparison. There is no mention of 2022 values in the ground truth, but the LLM fabricates a 2022 carrying and fair value of $12,393 million, which does not appear in the original answer. (2) The calculation of a '$1,942 million increase' is based on these incorrect numbers and is therefore invalid. The correct trend cannot be assessed due to fabricated baseline data. (3) The multi-hop reasoning is flawed: the model fails to correctly extract or synthesize actual values from 2022 and 2024, and instead introduces data from 2020 without justification. It also misrepresents the nature of Capital One's exposure by omitting the key point about VIEs and Level 2 classification, which are central to understanding the stability and categorization of these obligations. (4) The contextual relevance is moderate because the answer addresses securitized debt obligations and attempts a year-over-year comparison, but the severe quantitative inaccuracies and use of incorrect years undermine the entire response. The qualitative reasoning is weak due to incorrect entity alignment and missing key conceptual details from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 430,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "Between 2023 and 2024, McDonald's continued to utilize line of credit agreements as part of its financing activities and cash flow management. As of December 31, 2024, the Company had $4.0 billion available under a committed line of credit agreement, along with uncommitted foreign currency line of credit agreements used by its subsidiaries. This reflects a strategic focus on maintaining liquidity and flexibility to meet short-term funding needs, particularly as the Company increased capital expenditures and returned significant amounts to shareholders through dividends and share repurchases. The line of credit agreements remain a key component of McDonald's broader financing strategy, complementing its access to commercial paper and debt markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key quantitative and comparative information from the ground truth. It correctly states that McDonald's uses line of credit agreements as part of its financing strategy and mentions $4.0 billion available under a committed line of credit as of December 31, 2024 — however, this specific figure is not present in the original answer and cannot be verified against the provided ground truth, making it potentially inaccurate or unsupported. The original answer does not mention any committed line amount, so this number appears to be fabricated or sourced from outside the provided data. (2) The original answer emphasizes a shift in financing dynamics: in 2023, cash used for financing was $4.4B, decreasing from 2022 due to increased bond issuances, with year-end cash of $4.6B. In 2024, cash used rose to $7.5B due to decreased bond issuances, and cash dropped to $1.1B. The LLM answer omits all these critical figures and trends, including the $3.1B increase in cash outflows and the significant drop in cash reserves. These omissions severely limit quantitative accuracy. (3) The multi-hop reasoning required — comparing two years’ financing activities, cash flow changes, and linking them to line of credit reliance — is partially addressed but not synthesized correctly. The LLM notes continued use of credit lines but fails to explain the shift from surplus liquidity in 2023 to a cash-constrained environment in 2024, which is central to the original answer. It incorrectly frames the increased use of credit as tied to capital expenditures and shareholder returns without evidence from the ground truth. (4) While the answer is contextually relevant and uses appropriate financial terminology, it lacks the factual backbone and comparative analysis needed for full accuracy. The correctness score is 5 due to partial factual alignment but major omissions and unverified numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 530,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "The role of the Worldwide Business Conduct Manual in reinforcing internal controls remained consistent between 2022 and 2024, as both years' Management Reports on Internal Control Over Financial Reporting emphasized its foundational role in upholding integrity, compliance, and governance. However, the 2024 report reflects a more active engagement with internal control challenges, particularly in evaluating the Gillette intangible asset impairment. This indicates that Procter & Gamble continues to prioritize governance and transparency, with a heightened focus on addressing complex financial judgments and ensuring alignment with both legal and ethical standards.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains significant inaccuracies in the qualitative evolution of the Worldwide Business Conduct Manual. While it correctly notes the consistent foundational role of the manual in reinforcing integrity and compliance, it fabricates a specific example about the 'Gillette intangible asset impairment' in the 2024 report, which is not mentioned in the ground truth and not supported by the knowledge graph. This undermines the reasoning and factual basis of the evolution claim. (2) There are no numeric values, dates, or calculations in either the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the ground truth highlights a shift toward structured governance mechanisms (e.g., Global Leadership Council, Disclosure Committee) in 2024, but the LLM instead invents a financial judgment example unrelated to the manual’s role in governance. It fails to identify the correct linkage between the manual and evolving governance frameworks. (4) Contextually, the answer addresses the question’s focus on governance evolution and internal controls, but the incorrect example and missed synthesis of actual governance bodies reduce accuracy. The conclusion about prioritizing governance is directionally plausible but not fully aligned with the evidence. Thus, correctness is moderate due to core omissions and a fabricated detail, despite some relevant themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 419,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "Exxon's strategic positioning in Guyana has significantly strengthened between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions. Long-lived assets in Guyana increased from $4,892 million in 2021 to $6,766 million in 2022 and further to $9,689 million in 2023, indicating substantial capital investment in the region. Additionally, Guyana is explicitly highlighted as an \"advantaged asset\" in the 2024 earnings driver definitions, underscoring its role in driving volume growth and high returns. This reflects Exxon's growing emphasis on Guyana as a key growth driver within its strategic portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $9,689 million in long-lived assets in Guyana for 2023, which matches the ground truth. However, it introduces extraneous data—$4,892 million in 2021 and $6,766 million in 2022—that are not present in the original answer and were not requested by the question, potentially misleading the reader. While these numbers may be factually correct in external sources, they are not part of the ground truth and distract from the core comparison between 2023 and 2024. (2) The key quantitative point—the 2023 asset value—is accurate. However, the answer fails to mention any 2024 long-lived asset figure (if available) or clarify that the strategic shift is reflected more in qualitative disclosures (earnings drivers) than in new asset numbers. The absence of a 2024 asset value is not penalized if not in the ground truth, but the inclusion of incorrect or unsupported earlier years reduces quantitative accuracy. (3) The reasoning correctly captures the multi-hop element: Guyana evolved from a quantitatively significant asset in 2023 to a strategically emphasized one in 2024 via its inclusion in the 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver. This synthesis of asset disclosures and strategic framing is well executed and aligns with the ground truth. (4) Contextual relevance is high—the answer directly addresses Exxon’s strategic positioning evolution using both asset data and earnings driver language. The core conclusion about Guyana becoming a key growth driver is semantically equivalent to the ground truth. However, the addition of unsupported historical asset values reduces quantitative precision, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 472,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "Capital One's reliance on securitized debt obligations as a funding source increased from 2022 to 2024. In 2022, securitized debt obligations were $6.25 billion in issuances, while in 2024, the fair value of securitized debt obligations rose to $14.264 billion. This indicates a significant growth in the use of securitized debt obligations as a funding source over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. In 2022, the original answer states that no specific dollar value for securitized debt obligations was disclosed, but the LLM incorrectly claims $6.25 billion in issuances, which is not supported by the ground truth. For 2024, the LLM states the fair value is $14.264 billion, but the ground truth reports a carrying value of $14,264 million and a fair value of $14,335 million — the LLM conflates the two figures and misrepresents the unit (using billion instead of million). (2) Quantitative accuracy is severely compromised: $14,264 million is $14.264 billion, but this was the carrying value, not the fair value as stated. The LLM incorrectly attributes growth from $6.25 billion to $14.264 billion, which is unsupported due to the lack of 2022 data. (3) The reasoning is flawed in the multi-hop synthesis: the model assumes a quantitative increase in reliance based on incomplete and incorrect data. The ground truth emphasizes increased transparency and continued use, not necessarily increased reliance. The LLM overinterprets and fabricates a trend. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant — it addresses the evolution of securitized debt obligations as a funding source and attempts to compare across years, aligning with the question's intent. However, the core factual errors severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 396,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "Between fiscal years 2022 and 2023, NVIDIA's Omniverse platform evolved from being a real-time 3D design collaboration and virtual world simulation tool to a more enterprise-focused solution for building and operating metaverse and 3D internet applications. In 2022, Omniverse was highlighted as a platform for industrial digitalization and digital twins, while by 2023, it was positioned as an enterprise software solution for complex workflows in design, manufacturing, and simulation, emphasizing its role in enabling digital transformation across industries.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of NVIDIA's Omniverse platform from a 3D collaboration tool to an enterprise-focused platform for digital twins and industrial applications between fiscal years 2022 and 2023. It correctly identifies the shift in positioning toward enterprise use, digital transformation, and industrial workflows. However, it slightly misrepresents the timeline: the original answer states that in 2022, Omniverse was primarily described as a 'real-time 3D design collaboration' tool for creators, while the LLM claims it was already highlighted for 'industrial digitalization and digital twins' in 2022—this broader enterprise focus was more characteristic of 2023. Additionally, the LLM omits key details such as the introduction of a software subscription model for enterprises and free access for individuals, which is a concrete indicator of the strategic shift. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and the reasoning is mostly sound with good multi-hop synthesis across years and use cases. The answer remains contextually relevant and conveys a semantically close summary, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 344,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Between 2022 and 2023, the net amounts due under Pfizer's agreements with Viatris decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. These amounts relate to various post-separation agreements, including manufacturing, supply, and transitional services, and are included in net cash provided by operating activities, with the exception of specific payments reported elsewhere.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the net amounts due from Pfizer to Viatris as $94 million as of December 31, 2022, and $33 million as of December 31, 2023, matching the ground truth exactly. These figures reflect a decrease of $61 million over the period, which is accurately implied through direct comparison. (2) All numeric values, dates, and dollar amounts are factually correct and presented with proper context. There are no calculation errors, and the format ($94 million, $33 million) is consistent with acceptable variations. (3) The reasoning is sound: the LLM correctly identifies that these amounts arise from post-separation agreements (e.g., manufacturing, supply, transitional services), which aligns with the multi-hop context of Pfizer’s ongoing financial relationship with Viatris following their corporate separation. While the original answer interprets this trend as indicating a 'winding down or stabilization' of arrangements, the LLM omits this qualitative inference but still provides relevant operational context (e.g., inclusion in cash flow reporting). This minor omission affects depth but not factual correctness. (4) The answer is fully contextually relevant, directly addressing the evolution of financial obligations between 2022 and 2023. The absence of the interpretive phrase 'winding down' does not detract from core accuracy, as the numerical trend itself supports that conclusion. Overall, the response is factually complete and precise, warranting a high correctness score with only slight room for enhanced interpretive reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 436,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana intensified between 2023 and 2024, as reflected in the classification of Guyana as part of the \"Advantaged Assets\" category in the 2024 earnings drivers, indicating its significance for volume and earnings growth. In 2023, Guyana saw the completion of 12.6 net exploratory and development wells, with the Payara development commencing operations and the Uaru project funded. By 2024, Guyana was explicitly highlighted as a core growth driver, signaling a shift toward prioritizing high-return projects like those in Guyana to enhance integrated segment performance and earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 12.6 net exploratory and development wells in 2023 are accurately reported. (2) The entity identification is correct—ExxonMobil, Guyana, Payara, Uaru, and the timeline (2023–2024) are properly referenced. (3) The multi-hop reasoning is sound: the answer correctly synthesizes operational activity in 2023 (well completions, project progress) with the strategic reclassification in 2024 into 'Advantaged Assets' under 'Advantaged Volume Growth', reflecting a shift from operational to strategic emphasis. (4) The only minor omission is that the original answer explicitly names Yellowtail and Uaru as projects 'underway' in 2023, while the LLM only notes Uaru was funded and Payara commenced operations—slightly less detail on project status. Additionally, the LLM does not explicitly name the Permian Basin and LNG as peer assets in the 'Advantaged Assets' category, which slightly weakens the completeness of the strategic comparison. However, the core strategic evolution—elevation to a core growth asset within a prioritized portfolio—is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. No calculation errors. Contextual relevance is excellent as all information directly addresses the evolution in strategic emphasis and project-level changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 388,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "The weighted-average interest rate for senior notes with maturities greater than 10 years remained stable at 3.8% in both 2023 and 2022. The face value of these senior notes increased slightly from $52.8 billion in 2022 to $53.4 billion in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the interest rate and face value figures. According to the ground truth, the 2022 weighted-average interest rate was 3.67%, not 3.8% as stated for both years in the LLM answer. While the 2023 rate is correctly reported as 3.8%, the 2022 figure is inaccurate, making the claim of 'stable at 3.8%' incorrect. Additionally, the face value in 2022 is reported as $52.8 billion in the LLM answer, but the correct value is $54.536 billion. The 2023 face value of $53.4 billion is correct. (2) Quantitative accuracy is low: the 2022 face value is off by over $1.7 billion, and the interest rate is misstated for 2022. The direction of change in face value (increase vs. decrease) is also reversed—LLM claims an increase, but the truth is a decrease. (3) The reasoning is partially sound in that it attempts to compare year-over-year changes, but the multi-hop synthesis fails because it uses incorrect base values. The conclusion about stability in interest rates is partially valid (rates are similar), but the claim of stability at 3.8% in both years is factually wrong. (4) Contextual relevance is high—the answer addresses the right metric, time frame, and debt category. However, due to major numerical inaccuracies and incorrect trend direction, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 377,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "Between 2023 and 2024, Alabama Power's nuclear decommissioning trusts shifted their domestic equity investment allocation from $443 million in Level 2 inputs to $443 million in Level 1 inputs, indicating a reclassification of these investments to those with quoted prices in active markets. Georgia Power's trusts maintained a Level 2 classification for domestic equity at $321 million in 2024, consistent with the $321 million in Level 2 inputs in 2023, showing no significant shift in valuation methodology for this category.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Alabama Power shifted from $443 million in Level 2 to $443 million in Level 1, which is false—Alabama Power had $396M in Level 1 and $169M in Level 2 in 2023, and increased to $443M in Level 1 and $208M in Level 2 in 2024. The LLM falsely implies a full reclassification of $443M from Level 2 to Level 1, when in reality Level 1 increased by only $47M and Level 2 increased by $39M. For Georgia Power, the LLM claims $321M in Level 2 in both years, but ground truth shows Georgia Power had only $1M in Level 2 in both years, while Level 1 increased from $255M to $321M. The LLM completely misattributes Georgia Power’s increase to Level 2 instead of Level 1. (2) Quantitative accuracy is severely compromised: all key numbers are wrong—Alabama Power’s 2023 and 2024 allocations are misrepresented, and Georgia Power’s Level 2 allocation is off by hundreds of millions. No correct calculations or comparisons are made. (3) Multi-hop reasoning fails: the model does not correctly synthesize data across years and companies, misidentifies the direction and nature of shifts in investment allocations, and draws incorrect conclusions about valuation methodology stability. It misses the actual trend—increased Level 1 allocations in both companies, especially Alabama Power’s significant increase in both Level 1 and Level 2. (4) Contextual relevance is moderate because the answer addresses the general topic (shifts in domestic equity allocations and Level 1/Level 2 classifications), but the factual foundation is so flawed that the response is misleading. Due to major errors in numbers, entities, and logic, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 474,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "From 2022 to 2023, NVIDIA's strategic positioning of CUDA evolved to become a more central and foundational element of its full-stack computing platform, emphasizing its role in enabling AI and accelerated computing across diverse end markets. In 2022, CUDA was highlighted as a key programming model supporting hundreds of acceleration libraries and SDKs for compute-intensive workloads. By 2023, CUDA was explicitly positioned as the fundamental building block of NVIDIA's unified architecture, underpinning not only its GPU-based solutions but also expanding into data center CPUs like Grace, and enabling cross-industry applications in AI, autonomous vehicles, healthcare, and more. This evolution reflects CUDA's broader integration as a core enabler of NVIDIA's ecosystem across multiple markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of CUDA's strategic positioning from 2022 to 2023. (1) It correctly identifies that CUDA evolved from a key programming model in 2022 to a more foundational, central component of NVIDIA's full-stack computing platform in 2023. The integration across end markets such as AI, autonomous vehicles, healthcare, and telecom is accurately noted. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only years (2022, 2023), which are correctly used. Thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes CUDA’s role across time and markets, correctly inferring a strategic shift toward deeper vertical integration. However, the LLM slightly misrepresents the timeline: it claims in 2022 that CUDA already supported 'hundreds of acceleration libraries and SDKs,' which was actually a point emphasized in 2023 in the ground truth. Conversely, the 2022 description in the original answer does not include that detail, making this a minor factual inversion. Additionally, the mention of 'data center CPUs like Grace' is plausible but not present in the ground truth and represents an extrapolation not supported by the provided knowledge. (4) Despite these minor inaccuracies, the answer remains semantically close to the original, with strong contextual relevance and correct overall trajectory. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 437,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "From 2022 to 2023, Pfizer's financial obligations and contractual relationships with Viatris, particularly under transitional service agreements (TSAs) and master services agreements (MSAs), saw significant progress. As of December 31, 2023, services under the TSAs were largely completed, and the net amounts due to Viatris under all agreements were $33 million, compared to $94 million as of December 31, 2022. This reduction reflects the completion of most TSA services by the end of 2023 and the ongoing transition of operations post-separation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and dates are correct: the net amounts due to Viatris are accurately reported as $94 million as of December 31, 2022, and $33 million as of December 31, 2023. The reduction from $94M to $33M is correctly implied, reflecting a $61M decrease. (2) The statement that TSA services were 'largely completed' by the end of 2022 in the original answer is updated to 'fully completed as of December 31, 2023'—the LLM correctly notes that services were 'largely completed' by end-2023, which is slightly less precise than the ground truth stating they were 'fully completed,' but this is a minor wording difference without material factual inaccuracy. (3) The multi-hop reasoning is sound: the answer synthesizes information across years (2022 to 2023), entities (Pfizer and Viatris), and agreement types (TSAs and MSAs), correctly linking the decline in net amounts owed to the winding down of transitional services post-spin-off. (4) Contextually, the answer fully addresses the evolution of financial obligations and contractual relationships, particularly focusing on TSAs and net amounts owed. The only minor shortcoming is the use of 'largely completed' for 2023 instead of 'fully completed,' which slightly underrepresents the finality stated in the original. However, this does not undermine the overall correctness. Hence, a score of 9/10 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 422,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "From 2022 to 2023, Duke Energy faced evolving pressures from retail deregulation and environmental regulation compliance costs. In 2022, the company highlighted ongoing costs related to CCR management, including landfill and surface impoundment requirements under EPA and state regulations, with significant AROs and the need for cost recovery through regulatory processes. By 2023, Duke Energy emphasized increased regulatory scrutiny and the potential for higher compliance costs due to stricter environmental and climate change regulations, including carbon reduction goals and GHG emission restrictions. Additionally, the company noted the risk of delayed or incomplete cost recovery amid shifting regulatory frameworks, which could impact cash flows and financial performance. Thus, while compliance costs remained high, the regulatory environment became more complex and uncertain in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Duke Energy and the relevant time frame (2022 to 2023), and accurately reflects increasing environmental compliance costs and regulatory complexity. However, it fails to address the core multi-hop element of the question: the evolving *relationship* between *retail deregulation pressures* and *environmental compliance cost recovery*. The original answer specifically links deregulation (e.g., PURPA-related above-market power commitments) to challenges in recovering environmental costs through regulated rates. The LLM answer mentions 'risk of delayed or incomplete cost recovery' but attributes it to 'shifting regulatory frameworks' rather than retail deregulation. It substitutes CCR (coal combustion residuals) management as a cost driver, which is accurate but not tied to deregulation. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored 10 by default as no numbers were misstated. (3) The reasoning is partially sound: the LLM correctly notes rising environmental costs and cost recovery risks, but fails to synthesize the key connection between retail deregulation and cost recovery limitations, which is central to the question. This represents a significant gap in multi-hop reasoning. (4) Contextual relevance is high because the answer discusses Duke Energy, environmental compliance, cost recovery, and regulatory changes across 2022–2023. However, the absence of retail deregulation’s specific impact—especially PURPA and competitive market constraints—reduces factual completeness and lowers the correctness and qualitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 453,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline of 1.7 share points. This contrasts with the pricing strategy applied to Skoal during 2023, which included multiple price increases, such as a $0.10 per can increase in April 2023 and a $0.09 per can increase in August 2023. Despite these price hikes, Skoal's retail share continued to decline, likely due to competition from oral nicotine pouches and shifting consumer preferences.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in retail share from 9.3% in 2023 to 7.6% in 2024, which is accurate and matches the ground truth. However, the pricing strategy details are incorrect. The LLM claims two price increases in 2023: $0.10 in April and $0.09 in August, but the ground truth states that the only 2023-announced increase was $0.11 effective January 23, 2024. The earlier increases cited in the ground truth occurred in 2022 (January, February, May), not in 2023. Thus, the LLM fabricates or misattributes price hikes to 2023 that are not supported by the data. (2) The calculation of the 1.7 percentage point decline is correct (9.3% - 7.6% = 1.7%), but the dollar amounts and dates for price increases are factually wrong. The $0.10 and $0.09 increases in April and August 2023 do not appear in the ground truth. (3) The multi-hop reasoning is partially sound—linking price increases to declining market share is logical and contextually appropriate—but it is based on incorrect pricing data. The model fails to correctly synthesize the actual timing and magnitude of price changes from the knowledge graph. (4) The contextual relevance is high because the answer addresses both parts of the question and attempts to explain the contrast. However, due to significant factual errors in the quantitative details of the pricing strategy, the correctness score is reduced to 6, reflecting partial accuracy with major flaws in key details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 406,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen's investment in 'Other short-term interest-bearing securities' slightly decreased from $138 million as of December 31, 2023, to $135 million as of December 31, 2024. This minimal change suggests that Amgen maintained a stable allocation to this category of short-term investments, consistent with its strategy of prioritizing safety of principal, liquidity, and acceptable risk levels. The slight reduction does not indicate a significant shift in strategy but rather reflects normal fluctuations in investment management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Amgen's investment decreased from $138 million in 2023 to $135 million in 2024, while the ground truth confirms the amount remained unchanged at $138 million in both years. This is a critical factual error in the core quantitative claim. (2) The numbers are factually wrong—there is no $135 million figure in the ground truth, and the difference of $3 million is not supported by data. Calculations or comparisons based on this are invalid. (3) While the LLM attempts correct multi-hop reasoning by interpreting the implication of investment changes on strategy, the flawed premise (a decrease) undermines the conclusion. The reasoning about 'stable allocation' and 'normal fluctuations' would be reasonable if the numbers were correct, but it contradicts the actual stability (no change) in the data. (4) Despite accurate entity identification (Amgen, 'Other short-term interest-bearing securities', correct years) and relevant discussion of investment strategy, the answer fails on factual correctness due to the incorrect dollar amount in 2024. The contextual interpretation is plausible but built on false data, warranting low scores on quantitative and overall correctness, moderate qualitative score for correct framing, and high relevance for addressing the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 373,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "General Dynamics' involvement in Abrams Main Battle Tank Upgrades has evolved from 2022 to 2024 with an increase in contract value and expanded scope. In 2021 (as referenced in 2022 filings), the company secured a $360 million contract for Abrams tank upgrades, mission control units, and technical support. By 2024, the contract value had increased significantly, with General Dynamics awarded $350 million for Abrams main battle tank upgrades, including engineering, logistics support, and system technical support services, indicating both a broader scope and higher investment in modernization efforts.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $360 million 2022 contract and the $350 million 2024 contract for Abrams upgrades and support services, which aligns with the ground truth. However, it incorrectly references '2021 (as referenced in 2022 filings)' instead of clearly stating the 2022 contract award, introducing ambiguity about timing. More critically, the LLM omits the separate $285 million contract for producing Abrams SEPv3 tanks for Romania, which is a key part of the evolution in contract scope and total value. (2) The numerical values for the $360M and $350M contracts are accurate and correctly attributed, but the absence of the $285M contract results in an incomplete picture of total contract value growth. The claim of 'increased significantly' in contract value is misleading since $350M is actually less than $360M, and without including the $285M, the overall trend cannot be properly assessed. (3) The reasoning captures the broadening scope from upgrades to include support services, but fails to fully synthesize the multi-hop element involving the new production contract for Romania, which represents a qualitative shift toward manufacturing new configurations, not just upgrades. This weakens the conclusion about scope evolution. (4) Despite the omission, the answer remains contextually relevant and captures part of the trend. The scores reflect mostly correct facts with a significant omission affecting completeness and quantitative accuracy, but sound reasoning on the available data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 422,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "From 2023 to 2024, AIG's financial relationship with Corebridge shifted significantly. In 2023, AIG had guaranteed Corebridge's debt, including CRBGLH notes and junior subordinated debt, with collateral agreements in place if credit ratings fell below specified levels. By 2024, following the deconsolidation of Corebridge, AIG no longer guaranteed Corebridge's debt, and its retained interest was accounted for under the equity method, with changes in Corebridge's stock price impacting AIG's net investment income. Additionally, AIG recognized a $4.8 billion loss on the deconsolidation, primarily due to accumulated comprehensive losses, and subsequently sold portions of its Corebridge stake, including a $3.8 billion transaction with Nippon Life in late 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies not present in the ground truth. The original answer states that in 2023, Corebridge had the ability to borrow through February 25, 2025, indicating a borrowing arrangement, and in 2024, AIG began recognizing equity method income tied to stock price changes and dividends starting June 9, 2024. However, the LLM introduces unverified details: it claims AIG 'guaranteed Corebridge’s debt' including specific instruments (CRBGLH notes, junior subordinated debt) and collateral agreements based on credit ratings—none of which are in the ground truth. It also states AIG recognized a $4.8 billion loss on deconsolidation and sold $3.8 billion of stake to Nippon Life in late 2024—specific figures and transactions absent from the original answer and not supported by the provided truth. These are significant quantitative and factual additions. (2) The dates in the LLM answer (e.g., deconsolidation in 2024, stake sales) are plausible but lack alignment with the original’s key date: June 9, 2024, when equity income recognition began. The $4.8B loss and $3.8B sale are entirely unsupported numerically. (3) The multi-hop reasoning is partially sound—the shift from a borrowing-based to equity-based relationship is correctly inferred and the use of equity method accounting is consistent with the original. The conceptual transformation post-deconsolidation is logically structured. However, the model overextends by fabricating specific financial instruments, guarantees, and transactions, undermining factual reliability. (4) Correctness is scored 6 because the core idea of a shift from debt-linked to equity-based accounting is accurate and contextually relevant, but major unsupported numbers and entities reduce quantitative accuracy (score 4). Qualitative reasoning is solid (7) due to correct conceptual framing, and relevance is high (9) as the answer directly addresses the evolution in financial relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 535,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Solar Roof product has evolved with a greater emphasis on production scalability and strategic dependencies. In 2022, the company highlighted ongoing challenges related to manufacturing complexities, including supply chain constraints and the need to ramp production capabilities for proprietary components. By 2024, Tesla has shifted focus toward improving installation efficiency and expanding collaboration with real estate developers and builders to integrate Solar Roof into new home projects, indicating progress in addressing earlier production bottlenecks and a strategic move toward broader market adoption.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the evolution of Tesla's Solar Roof strategy between 2022 and 2024. The original answer states that in 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders, while emphasizing engineering for aesthetics and durability. By 2024, the focus had shifted to overcoming production ramp challenges—bottlenecks, supplier risks, cost control—indicating increased strategic dependencies and unresolved production issues. However, the LLM answer incorrectly reverses this trajectory: it claims that in 2022, Tesla faced manufacturing complexities and supply chain constraints, and by 2024, it had progressed to improving installation efficiency and expanding collaborations, suggesting resolution of earlier bottlenecks. This misrepresents the actual shift from development/sales emphasis in 2022 to heightened production challenges in 2024. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the temporal shift in strategic focus. Instead of identifying that production challenges became a greater dependency by 2024 (per the 10-K), it implies progress and resolution, which contradicts the ground truth. The model confuses the direction of evolution—portraying improvement where the source indicates growing concern. (4) Correctness and qualitative accuracy are low due to this core factual reversal. Contextual relevance is moderate because the answer addresses the right topic (Solar Roof evolution, production, collaborations) and uses appropriate terminology, but the conclusion is factually inverted. Semantic equivalence is not achieved due to the incorrect causal and temporal logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 520,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "The retail share of Skoal in the U.S. oral tobacco market decreased from 9.3% in 2023 to 7.6% in 2024. This decline indicates a loss of competitive positioning for Skoal, likely due to market shifts toward oral nicotine pouches and increased competition from other brands like on!.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Skoal's retail share decreased from 9.3% in 2023 to 7.6% in 2024, matching the ground truth exactly. This addresses the first part of the question about how the share changed. The conclusion that this indicates a weakening in competitive positioning is accurately reflected as 'loss of competitive positioning,' which is semantically equivalent. (2) All numeric values—9.3% and 7.6%—are correct, and the time frame (2023 to 2024) is accurately cited. No calculations are required beyond the implied decrease, which is correctly interpreted. (3) The multi-hop reasoning is sound: the model infers competitive implications from market share changes. While the original answer contrasts Skoal’s decline with on!’s growth (6.8% to 8.3%), the LLM answer does not include this specific comparison but still provides valid context by referencing market shifts toward nicotine pouches and competition from brands like on!, which aligns with the broader competitive dynamics. (4) The answer is factually complete and highly accurate; the only minor shortcoming is the omission of the specific comparative data point about on!’s growth, which adds contextual depth in the original. However, the core facts, numbers, and interpretation are correct, and the added reasoning about market trends is plausible and relevant. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 414,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "The risk associated with the concentration of device share among premium tier companies has increased between 2023 and 2024, with potential negative implications for Qualcomm's pricing power and revenue stability. In 2024, the concentration of device share among a few companies, particularly at the premium tier, has intensified, driven by the dominance of certain Chinese OEMs and global market dynamics. Additionally, geopolitical factors, such as the U.S. revoking Qualcomm's export license to Huawei in May 2024, have further exacerbated the risk. This loss of a customer and the potential for Chinese OEMs to develop their own integrated circuits (as encouraged by policies like Made in China 2025) could reduce Qualcomm's pricing power and create revenue instability. The increased reliance on a small number of premium-tier customers, combined with vertical integration by key clients, heightens the vulnerability of Qualcomm's business to shifts in customer strategy and geopolitical tensions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the persistence and intensification of the risk related to device share concentration among premium tier companies, particularly Chinese OEMs, and its impact on Qualcomm's pricing power and revenue stability—this aligns with the original answer. However, it introduces a specific event not present in the ground truth: the U.S. revoking Qualcomm's export license to Huawei in May 2024. This event is factually unsupported in the provided context and represents a significant factual overreach, undermining the correctness. Additionally, while the original answer notes a shift in emphasis in 2024 toward broader implications like revenue fluctuation due to product timing and customer self-sufficiency, the LLM overemphasizes geopolitical factors and 'Made in China 2025' policy encouragement without grounding in the source. (2) There are no explicit numbers, percentages, or dollar amounts in either answer, so quantitative accuracy is not compromised—minor details like 'May 2024' are plausible but unverified and not directly contradicted, hence a score of 8. (3) The multi-hop reasoning is partially sound: the model connects customer concentration to pricing pressure and revenue risk, and infers potential threats from vertical integration. However, it fails to accurately reflect the evolution described in the original—i.e., a shift in emphasis in risk disclosure rather than the introduction of new external events—thus weakening the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the core issue—evolving risk from customer concentration—and links it appropriately to pricing and revenue. The incorrect addition of unverified geopolitical events prevents a higher correctness score, but the overall structure and intent match the question's requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 501,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen's allocation to money market mutual funds increased between 2023 and 2024. As of December 31, 2023, the fair value of money market mutual funds was $10,266 million, while as of December 31, 2024, it rose to $10,354 million. This indicates a slight increase in Amgen's allocation to money market mutual funds during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states that Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. However, the LLM claims the amount increased from $10,266 million in 2023 to $10,354 million in 2024, which contradicts the original data. (2) The quantitative values are wrong—the 2024 figure of $10,354 million is not supported by the ground truth, which explicitly states no change in allocation. There is no indication of an increase, so the calculation or comparison of values is invalid. (3) The multi-hop reasoning is flawed because the model failed to correctly retrieve and compare the disclosed investment values for the two years. Instead, it introduced a number not present in the original answer, suggesting a failure in data synthesis or retrieval. (4) While the LLM addresses the question's topic (allocation to money market mutual funds) and uses the correct company and time frame, the core factual claim (an increase) is false. Hence, the correctness and quantitative accuracy scores are very low. Contextual relevance is moderate because the response is on-topic and discusses the right metric and timeframe, but the conclusion is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 351,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "General Dynamics' participation in the Capital Construction Fund (CCF) saw an increase in the amount of U.S. government accounts receivable pledged to the fund between 2022 and 2024. In 2022, the pledged amount was $295 million, and by 2024, it had increased to $333 million. This indicates a $38 million growth in the value of receivables pledged to the CCF over the two-year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All numeric values are correct: $295 million in 2022 (as of Dec 31, 2021) and $333 million in 2024 (as of Dec 31, 2024) are accurately reported. The calculated increase of $38 million ($333M - $295M) is correct. (2) The answer omits the intermediate 2023 figure ($315 million as of Dec 31, 2023), which is part of the original answer and shows the steady progression. While not strictly necessary to answer the trend question, its absence slightly reduces completeness. (3) The reasoning is sound—correctly identifying an increasing trend in pledged receivables and linking it to CCF participation. The multi-hop synthesis across years is accurate, though slightly less detailed than the original. (4) The semantic meaning is equivalent: the core message of increasing participation via higher pledged receivables is preserved. Wording differences are acceptable. The answer is fully relevant and addresses the evolution between 2022 and 2024. A score of 9 is justified due to the omission of the intermediate data point, but all other aspects are factually and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 330,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly following Corebridge's IPO and subsequent deconsolidation. In 2024, AIG deconsolidated Corebridge, resulting in a $4.8 billion after-tax loss, primarily driven by the recognition of accumulated comprehensive losses. Post-deconsolidation, AIG accounted for its retained interest in Corebridge using the equity method, recognizing $601 million in equity method income (based on dividends and stock price changes). Tax implications were influenced by the deconsolidation, with Corebridge's tax attributes no longer being part of AIG's consolidated U.S. federal income tax group. Investment income from Corebridge was reflected in AIG's net investment income, including a $282 million gain from the sale of a 21.6% stake to Nippon Life in late 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in key quantitative figures and timing. The original answer states that AIG's ownership dropped below 80% after Corebridge's IPO on September 19, 2022, triggering tax deconsolidation in 2023. However, the LLM incorrectly claims deconsolidation occurred in 2024 and attributes a $4.8 billion after-tax loss to that year, which is not supported by the ground truth. The $601 million equity method income is specific to the period June 10–December 31, 2024, but the original answer uses a placeholder '$X', so this figure cannot be verified as correct from the provided truth. The $282 million gain from the sale of a 21.6% stake to Nippon Life in late 2024 is entirely absent from the original answer and introduces unverified information. (2) Quantitative accuracy is low: the $4.8B loss and $282M gain are unsupported; the timing of deconsolidation (2024 vs. 2023) is incorrect. The equity method income amount may be plausible but cannot be confirmed and is presented as definitive. (3) The multi-hop reasoning is partially sound—LLM correctly identifies the shift from consolidation to equity method accounting and tax deconsolidation implications—but misrepresents the timeline and financial impact. It fails to mention the five-year restriction on consolidated tax filings and the retention of NOLs and tax credits by Corebridge, which are key tax implications. (4) Contextual relevance is high as the answer addresses tax implications, investment income, IPO, and deconsolidation. However, due to major factual and quantitative errors, especially around timing and financial figures, the overall correctness score is low despite structurally addressing the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 477,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "Tesla's approach to Solar Roof production and its dependencies from 2022 to 2024 has evolved with a focus on improving production capabilities and addressing supply chain challenges. In 2022, Tesla emphasized increasing Solar Roof production by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs, while also noting sensitivity to global component constraints. By 2024, Tesla continued to emphasize enhancing installation capabilities and price efficiencies for Solar Roof, highlighting efforts to scale production and deployment. Supply chain challenges remained a concern, with Tesla working to maintain adequate battery cell supply and manage dependencies on skilled labor, particularly electricians, to support the ramp of Solar Roof.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative evolution of Tesla's Solar Roof strategy from 2022 to 2024. (1) What was correct: The answer correctly identifies Tesla's 2022 focus on onboarding and training installers, collaborating with real estate developers, and addressing skilled labor needs (electricians), as well as sensitivity to global component constraints. It also correctly notes ongoing supply chain concerns and production scaling efforts by 2024. (2) Quantitative accuracy: There are no numeric values in the question or answers, so this aspect is not applicable; no errors in dates (2022 and 2024 are correctly referenced). (3) Multi-hop reasoning assessment: The LLM fails to accurately capture the strategic shift described in the ground truth. While the original answer emphasizes a clear evolution from localized installer development in 2022 to systemic supply chain and global procurement risks in 2024, the LLM incorrectly suggests continuity in focus—claiming Tesla in 2024 still emphasized 'enhancing installation capabilities' and 'price efficiencies'—which contradicts the ground truth that the focus had shifted to broader manufacturing scalability and supplier failure risks. The LLM also incorrectly repeats the 2022 concern about battery cell supply and electricians as if still central in 2024, whereas the original answer reframes 2024 risks around global component procurement, inflation, and cost-effective production at scale. (4) Justification for scores: Correctness is 6 due to accurate mention of some elements but failure to correctly represent the strategic evolution. Qualitative accuracy is 6 because core entities and general themes are present but misaligned in time and emphasis. Quantitative accuracy is 10 because no numbers are involved and no factual dates are wrong. Contextual relevance is 9 as the answer stays on topic and addresses the question's scope, albeit with incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 533,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "From 2022 to 2023, Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina decreased from $8 billion to $9 billion to $7 billion to $8 billion. This reduction indicates progress in the company's compliance with the Coal Ash Act, as it reflects cost savings achieved through updated plans and settlements, such as the 2019 agreement with NCDEQ. The company has already spent approximately $4 billion through 2023, and the majority of the remaining costs are expected to be incurred over the next 10 years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the evolution of Duke Energy's cost estimates from $8B-$9B in 2022 to $7B-$8B in 2023, matching the ground truth. It also accurately states that approximately $4 billion had been spent through 2023, which aligns with the original answer (the original notes $3.1B through 2021 and $4B through 2023; the LLM correctly updates the spent amount without needing to restate the 2021 figure). All numeric values and ranges are correct. (2) Quantitative accuracy is perfect: dollar amounts and timeframes match the ground truth, with acceptable format consistency. There are no calculation errors. (3) The reasoning is sound—LLM correctly infers that the cost reduction indicates progress under the Coal Ash Act and ties it to updated plans and settlements (e.g., the 2019 NCDEQ agreement), which is a reasonable interpretation supported by context. It slightly omits the explicit mention that the cost refinement is due to more basins being excavated and plans advancing, but this does not undermine the overall logical synthesis. (4) The answer is contextually relevant, fully addressing both parts of the question: the cost evolution and what it indicates about progress. The only minor shortcoming is the lack of direct mention of increased excavation activity as a driver of cost refinement, but the conclusion about progress remains valid. Thus, the answer is factually complete and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 413,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024, indicating a strengthening market position within the overall oral tobacco product segment during this period. This growth in share suggests that 'on!' gained traction, likely benefiting from the overall expansion of the oral nicotine pouch category, which grew significantly in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the retail share increase for 'on!' from 6.8% in 2023 to 8.3% in 2024, which matches the ground truth exactly. However, it fails to mention the key comparative data point about the overall oral tobacco segment declining from 42.5% to 37.5% during the same period, which is central to the question's second part about market position relative to the broader segment. (2) All numeric values related to 'on!' are accurate—6.8% and 8.3%—and the years 2023 and 2024 are correctly referenced. There are no calculation errors. (3) The reasoning is partially sound: the conclusion that 'on!' strengthened its position is correct, but the LLM incorrectly attributes the growth to 'overall expansion of the oral nicotine pouch category,' whereas the ground truth indicates the total oral tobacco segment actually declined, making the growth of 'on!' more significant as it gained share despite a shrinking segment. This reflects a failure in multi-hop reasoning by not contrasting product performance with category performance. (4) The correctness score is 7 because core facts about 'on!' are accurate, but the answer omits critical comparative context and introduces misleading reasoning about category expansion. Quantitative accuracy is perfect (10). Qualitative accuracy is reduced due to flawed reasoning and missing synthesis (7). Contextual relevance remains high as the answer addresses the main topic and evolution of 'on!' share, but misses the relative market dynamics (9).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 418,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "Qualcomm's reliance on Chinese OEMs for revenue has increased from 2023 to 2024, with a significant portion of its revenues derived from a small number of Chinese OEMs and non-Chinese OEMs selling devices into China. This concentration is exacerbated by geopolitical tensions, such as U.S.-China trade policies and the Made in China 2025 initiative, which encourage Chinese OEMs to develop their own integrated circuit products. These factors pose risks to business stability, including potential revenue declines due to government restrictions, vertical integration by customers, and shifts in market dynamics.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Qualcomm's reliance on Chinese OEMs for revenue and the associated business risks, which aligns with the ground truth. It accurately reflects the ongoing nature of this dependency and mentions relevant geopolitical factors such as U.S.-China trade tensions, contributing to contextual relevance. However, the key factual inaccuracy lies in stating that reliance has 'increased' from 2023 to 2024, while the original answer indicates that the dependency 'persisted'—i.e., remained significant but not necessarily growing. This misrepresents the evolution of the relationship, introducing a trend (increase) not supported by the source. Additionally, the LLM introduces 'non-Chinese OEMs selling devices into China' and the 'Made in China 2025 initiative' as specific drivers, which are not mentioned in the ground truth and represent unsupported extrapolations. While these points are plausible, they go beyond the provided information and introduce speculative elements. There are no numerical figures in either answer, so quantitative accuracy is scored as 10 by default. The reasoning is partially sound but includes incorrect inference about trend direction and adds unverified factors, reducing qualitative accuracy. The answer addresses the implications for business stability correctly, maintaining relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 374,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Between 2022 and 2023, Amgen's total available-for-sale investments shifted primarily in terms of composition, with a significant increase in money market mutual funds and a reduction in U.S. Treasury bills. In 2022, the total available-for-sale investments were $4,335 million, composed of $1,676 million in U.S. Treasury bills and $2,659 million in money market mutual funds. By 2023, the total available-for-sale investments rose to $10,404 million, with no U.S. Treasury bills and $10,266 million in money market mutual funds. This indicates a strategic reallocation from short-term U.S. Treasury instruments to money market funds during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the composition of Amgen's 2022 investments. It incorrectly states that the $2,659 million in 2022 was in 'money market mutual funds', while the ground truth specifies that $2,659 million was in 'cash and cash equivalents' and makes no mention of money market funds in 2022. Additionally, the LLM incorrectly claims that the $1,676 million in 2022 was in 'U.S. Treasury bills', but the original answer states it was in 'marketable securities' and explicitly notes that by 2023, Amgen held no U.S. Treasury bills—implying they were not a component in 2022 either. (2) The total investment amounts are correct: $4,335 million in 2022 and $10,404 million in 2023. The 2023 breakdown of $10,266 million in money market mutual funds is accurate. However, the 2022 composition is entirely misrepresented, leading to incorrect synthesis. The LLM also omits the $138 million in 'other short-term interest-bearing securities' in 2023, which is a notable omission. (3) The reasoning is partially sound in identifying a shift toward money market funds, but the multi-hop synthesis fails because it misattributes the 2022 components. The conclusion about a shift from U.S. Treasury bills to money market funds is not supported by the ground truth, which indicates a shift from marketable securities and cash equivalents to money market funds and other short-term interest-bearing securities. (4) The contextual relevance is high as the answer addresses the evolution of investment composition over time and attempts to interpret strategic intent. However, due to major quantitative and qualitative errors in entity and metric identification, the correctness and accuracy scores are low. Minor wording differences would be acceptable, but here the misassignment of financial categories undermines the answer's validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 509,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "Shake Shack was present at SPG's premium outlet properties in 2022, as it is listed as a tenant at Las Vegas Outlets North in Nevada. However, in the 2023 document, Shake Shack is no longer explicitly listed as a tenant at any of the premium outlet properties, indicating that its presence may have been reduced or removed from SPG's premium outlet portfolio during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) It falsely claims that Shake Shack was present at Las Vegas Outlets North in 2022, when in fact it was not listed there until 2023. Conversely, it omits that Shake Shack was a tenant at Woodbury Common Premium Outlets in New York in 2022, which is a key fact in the original answer. (2) The dates and locations are critical quantitative and qualitative elements, and the reversal of presence across years and properties constitutes major factual errors. There are no correct numerical values or time-bound placements. (3) The reasoning is flawed: the model incorrectly infers a reduction in presence when the ground truth shows an expansion—from one location in 2022 (Woodbury Common) to two locations in 2023 (Woodbury Common and Las Vegas Outlets North). This fails the multi-hop synthesis of tenant presence across years and properties. (4) While the answer addresses the general topic of Shake Shack's presence in SPG outlets, its factual inaccuracies and incorrect conclusion severely undermine its relevance and correctness. The contextual relevance is low but not zero because it attempts to discuss tenant changes over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 339,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "Between 2022 and 2024, retirement annuity contracts remained classified as Level 3 assets within the fair value hierarchy, indicating that they are valued using significant unobservable inputs. This classification suggests that GD's valuation methodology for these assets relies on internal models or assumptions not derived from active markets, likely due to the lack of observable market data for such contracts. The consistent placement in Level 3 reflects a stable approach to valuing these less liquid, customized instruments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that retirement annuity contracts remained in Level 3 of the fair value hierarchy between 2022 and 2024, which aligns with the ground truth. It accurately states that Level 3 classification implies the use of significant unobservable inputs and correctly interprets this as reflecting a stable valuation methodology relying on internal models or assumptions. This demonstrates strong quantitative and entity accuracy, as the years (2022–2024), classification (Level 3), and company (GD) are all correct, with no numerical or factual errors in those aspects.\n\nHowever, the LLM answer omits a key qualitative point present in the original answer: the evolution in disclosure practices regarding the inclusion of investments valued using net asset value (NAV) as a practical expedient in the reconciliation tables by 2024, which was not explicitly stated in 2022. This omission affects completeness and reasoning, as the question specifically asks how the classification *evolved*—not just whether the level changed. The ground truth emphasizes that while the hierarchy classification did not change, there was a refinement in transparency and reporting. The LLM fails to mention this nuance, implying no evolution occurred beyond continued Level 3 classification, which understates the change in disclosure rigor.\n\nThus, while the core facts and reasoning about valuation methodology are sound and contextually relevant, the lack of acknowledgment of improved disclosure practices reduces the qualitative accuracy. The answer is factually correct but incomplete in its synthesis of the multi-hop aspect—linking changes in reporting detail across years—even though the main conclusion about stable methodology is valid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 475,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly. In 2023, AIG owned 52.2% of Corebridge and recognized net income attributable to AIG of $902 million from Corebridge's operations. However, in 2024, AIG deconsolidated Corebridge after reducing its ownership stake to 22.7% by the end of the year. This deconsolidation led to a $4.8 billion loss, primarily due to the recognition of accumulated comprehensive losses. Post-deconsolidation, AIG accounted for its retained interest using the equity method, recognizing $601 million in equity method income from Corebridge's stock price changes and dividends.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the timeline and nature of AIG's relationship with Corebridge. The original answer states that the IPO occurred on September 19, 2022, which terminated Blackstone's exchange right—this is a critical event that the LLM answer omits entirely. Instead, the LLM claims that in 2023, AIG owned 52.2% of Corebridge and recognized $902 million in net income, and that deconsolidation occurred in 2024. However, the ground truth indicates that the IPO and termination of dilution risk occurred in 2022, not 2024, and there is no mention of a $4.8 billion loss or ownership percentages like 52.2% or 22.7% in the original answer. These figures are unsupported by the provided truth. (2) Quantitative accuracy is low: the LLM introduces specific numbers—$902M income, 52.2%, 22.7%, $601M equity income, $4.8B loss—that are not present or verifiable in the original answer. The only potentially consistent concept is the shift to equity method income in 2024, but even the timing (from June 9, 2024 onwards) is missing in the LLM response. (3) The multi-hop reasoning is flawed: the LLM fails to connect the 2022 IPO termination of exchange rights to the elimination of dilution risk, which is central to the evolution of the financial relationship. Instead, it fabricates a 2024 deconsolidation narrative with unsupported financials. The shift from potential dilution to equity income is partially recognized but misattributed in cause and timing. (4) Contextual relevance is high because the LLM attempts to address the evolution of the financial relationship, equity treatment, and income recognition. However, the factual foundation is incorrect, leading to a low correctness and quantitative accuracy score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 494,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort remained consistent at its 30% ownership interest from 2022 to 2024, with no liquidity arrangements, guarantees, or other financial commitments beyond this stake. The debt of Universal Beijing Resort decreased slightly from $3.5 billion in 2023 to $3.4 billion in 2024, and its assets and liabilities were consolidated into Comcast's financial statements, totaling $7.3 billion and $7.0 billion, respectively, as of December 31, 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly states that Universal Beijing Resort had $3.4 billion in debt as of December 31, 2024, and $3.5 billion as of December 31, 2023, which aligns with the ground truth. It also correctly notes that the resort's assets and liabilities are consolidated into Comcast’s financial statements, with $7.3 billion in assets and $7.0 billion in liabilities as of 2024. However, it incorrectly claims Comcast has a '30% ownership interest' and 'no liquidity arrangements, guarantees, or other financial commitments beyond this stake,' which contradicts the ground truth that Comcast consolidates the resort as a VIE—implying control and full financial exposure, not a minority stake. This misrepresents the nature of Comcast's financial exposure. (2) Quantitatively, the debt figures for 2023 and 2024 are accurate, but the answer omits the earlier disclosed debt levels from 2020 and 2021 ($2.5B and $3.6B), which are part of the evolution. The omission weakens the longitudinal analysis. The $7.3B assets and $7.0B liabilities are correctly reported. (3) The multi-hop reasoning is flawed: while the model identifies consolidation, it incorrectly infers a 30% ownership and lack of commitment, which is inconsistent with VIE consolidation under accounting rules (consolidation requires control, not just equity stake). The synthesis between debt trends and consolidation treatment is partially correct but undermined by the erroneous ownership characterization. (4) The contextual relevance is high—the answer addresses debt evolution and consolidation—but the core qualitative error regarding ownership and financial exposure significantly reduces correctness. Hence, a mid-range score of 5 is justified due to partial factual accuracy offset by major conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 506,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "Between 2022 and 2023, the structure of aircraft trade-in commitments remained largely consistent in terms of customer eligibility, as they were still primarily offered to Gulfstream customers in connection with new-aircraft orders. However, there was no specific mention of expanded or restricted eligibility criteria in 2023. In terms of risk exposure, the 2023 disclosure noted that trade-in commitments structured to guarantee a predetermined value present more risk in the event of adverse market changes, similar to the 2022 description. The materiality of risk remained unchanged, with both years stating that estimated changes in fair market values from the date of commitments were not material.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual inaccuracy regarding customer eligibility. The ground truth states that in 2022, trade-in options were available to 'some customers' broadly, while in 2023 they were narrowed to 'some Gulfstream customers,' indicating a restriction in eligibility. However, the LLM incorrectly claims eligibility 'remained largely consistent' and that they were 'primarily offered to Gulfstream customers' in both years, which contradicts the narrowing of eligibility described in the original answer. This misrepresents a key structural change. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the shift in customer eligibility from a general to a more specific (Gulfstream-focused) group between 2022 and 2023. It also misses the implication that highlighting Gulfstream in 2023 may indicate strategic focus or increased risk concentration, which is a qualitative nuance present in the ground truth. (4) Contextual relevance is high because the answer addresses both customer eligibility and risk exposure as asked, and correctly notes the unchanged materiality of fair value changes. However, due to the major error in interpreting eligibility changes, the overall correctness and qualitative accuracy are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 412,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Tesla Semi evolved from being in the development phase to entering pilot production, as noted in the 2024 10-K. In 2022, the Semi was listed as a future commercial electric vehicle in the \"Future Consumer and Commercial Electric Vehicles\" section, with no specific production status mentioned. By 2024, the Semi was explicitly noted to be in \"Pilot production\" at the Nevada Gigafactory. Strategically, the Semi remains a part of Tesla's broader product roadmap focused on leveraging proprietary technologies like battery cells and Full Self-Driving (FSD), but it has not yet transitioned to full-scale production or delivery, indicating a cautious and iterative approach to its commercialization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that in 2022, the Tesla Semi was in the development/conceptual phase, listed under 'Future Consumer and Commercial Electric Vehicles,' and by 2024 had advanced to 'pilot production' at the Nevada Gigafactory—this matches the original answer's key facts. (2) There are no numeric values requiring calculation, but the years (2022, 2024) and production status terms ('pilot production') are factually correct and consistent with the knowledge graph. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two time points (2022 vs 2024 filings), identifies the change in production status, and contextualizes it within Tesla's strategic product roadmap. (4) The LLM adds slightly more detail than the ground truth (e.g., mentioning FSD and proprietary tech), but this is contextually appropriate and does not introduce inaccuracies. The only minor point preventing a perfect 10 is that the original answer emphasizes the strategic shift toward commercialization more explicitly, while the LLM frames it as a 'cautious and iterative approach'—a valid interpretation but a slight divergence in emphasis. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 362,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "The valuation allowance related to Altria's investment in Cronos decreased from $379 million in 2022 to $397 million in 2023, and then to $402 million in 2024. This minimal increase indicates that Altria continued to maintain a valuation allowance against the deferred tax assets associated with its investment in Cronos, suggesting uncertainty about the realizability of these assets. The small changes reflect ongoing assessments of Cronos' performance and the likelihood of future taxable income to utilize these deferred tax assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative evolution of the valuation allowance. The ground truth states the allowance increased from $379 million in 2022 to $402 million in 2024, but the LLM incorrectly claims a decrease from $379M in 2022 to $397M in 2023, which contradicts the actual upward trend. The final 2024 figure ($402M) is correct, but the intermediate 2023 value is fabricated and not supported by the ground truth, which does not mention a 2023 figure at all. (2) The calculation and direction of change are wrong: the LLM implies a decrease from 2022 to 2023, when the actual trend is an increase over the period. This undermines the accuracy of the financial narrative. (3) The reasoning about Altria's uncertainty and cautious stance is qualitatively aligned with the ground truth and shows correct multi-hop synthesis regarding the implication of maintaining a valuation allowance. The interpretation that this reflects uncertainty about realizability of deferred tax assets is sound. (4) Contextual relevance is high as the answer addresses both parts of the question—evolution of the allowance and its implication—using appropriate financial terminology. However, the quantitative inaccuracies severely limit correctness, warranting a low overall score despite reasonable qualitative logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 377,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "Amgen changed the financial treatment of its investment in BeiGene in 2023 by switching from the equity method of accounting to recording the investment at fair value, with changes in fair value recognized in earnings. This change resulted in gains being recognized in 2023. In 2024, the impact of this change continued, as reflected in net unrealized losses on strategic equity investments, including BeiGene, which contributed to a decrease in the effective tax rate compared to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key accounting change in 2023—Amgen's shift from the equity method to fair value accounting for its BeiGene investment, resulting in recognized gains. This matches the original answer. (2) It accurately reflects the 2024 impact: net unrealized losses on strategic equity investments, including BeiGene, which is consistent with the ground truth's statement about unrealized losses in 'Other income (expense), net'. (3) The multi-hop reasoning is sound—connecting the accounting change in 2023 to its financial impact and then tracking the evolution into 2024. (4) The only minor shortcoming is that the LLM introduces an additional detail—'contributed to a decrease in the effective tax rate compared to 2023'—which is not present in the ground truth and cannot be verified from the provided information. While this doesn't contradict the original answer, it adds unconfirmed context. Otherwise, all entities (Amgen, BeiGene), years (2023, 2024), and financial treatments are correct. Number formats and dates are accurate. Semantic equivalence is strong, with appropriate flexibility in wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 336,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar's positioning and market strategy evolved through a consolidation of services and a focus on regional branding. In July 2024, Disney merged its Latin American services, including Star+, into a unified Disney+ offering, streamlining its product structure. In India and Southeast Asia, Disney+ Hotstar maintained its distinct branding but was excluded from multi-product offerings, emphasizing its standalone identity in key regional markets. This strategy reflects a shift toward simplifying service structures while preserving localized branding to better serve regional audiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key strategic shift: the consolidation of Star+ and Disney+ in Latin America into a single Disney+ offering by mid-2024. The mention of July 2024 is slightly off from the ground truth's 'by the end of June 2024,' which is a minor timing discrepancy but within reasonable approximation. (2) All entities—Disney+ Hotstar, Star+, Disney+, regions (India, Southeast Asia, Latin America)—are correctly identified and contextualized. There are no financial figures requiring numerical verification, so quantitative accuracy is based on date precision, which is mostly correct. (3) The reasoning is sound: the LLM correctly infers a strategic trend toward service consolidation while maintaining regional branding in key markets. It accurately reflects the multi-hop synthesis that Disney is streamlining global offerings but preserving local brand identity where established. (4) The answer is contextually excellent, addressing both regional branding and service structure evolution as asked. The only minor shortcoming is the July 2024 date versus 'by end of June 2024,' which prevents a perfect 10. Overall, the semantic meaning and factual content match the ground truth very closely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 358,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "Between 2023 and 2024, PayPal's approach to its Protection Programs evolved to address increasing fraud risks and transaction losses. In 2023, the company emphasized the role of its purchase and seller protection programs in mitigating losses from unauthorized and fraudulent transactions, as well as disputes filed by customers. However, it acknowledged the challenges in recovering losses from merchants, especially in cases involving fraudulent or insolvent merchants. By 2024, PayPal expanded its focus to include the impact of evolving fraud schemes and regulatory changes on its protection programs. The company highlighted the need for continuous improvement in fraud detection and prevention, while also noting the potential for increased exposure to fraud losses due to changes in chargeback requirements by regulators and card networks. Additionally, PayPal outlined the importance of its credit risk models and underwriting standards in managing losses from its credit products, reflecting a more proactive approach to risk exposure and loss recovery.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PayPal's Protection Programs between 2023 and 2024 with accurate qualitative details. It correctly notes that in 2023, PayPal acknowledged challenges in recovering losses from merchants, especially insolvent or fraudulent ones, and that protection program costs were part of transaction and credit losses. In 2024, it accurately reflects PayPal's increased focus on evolving fraud schemes and regulatory changes affecting chargeback requirements. However, the LLM answer omits the specific 2023 disclosure that PayPal did not provide a separate service to customers under these programs, which is a minor but relevant contextual detail from the ground truth. (2) There are no numeric values, percentages, or dollar amounts in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the model synthesizes changes in risk exposure and loss recovery mechanisms across two years, correctly identifying shifts in disclosure and risk management strategy. The logic connecting fraud trends, regulatory changes, and loss recovery challenges is coherent and aligned with the source. (4) The contextual relevance is high—the response directly addresses the question about evolution in risk exposure and loss recovery. The inclusion of credit risk models and underwriting standards, while not in the original, adds reasonable context without distorting the meaning. The answer is semantically close to the ground truth but misses one specific disclosure nuance, justifying a slightly lower qualitative and overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 462,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "NextEra Energy's relationship with solar generation facilities from 2022 to 2024 has evolved with a shift in ownership structure and increased financial exposure. In 2022, NextEra Energy Resources sold several solar generation facilities, including a 90% noncontrolling interest in a portfolio of solar facilities and a 100 MW solar-plus-storage facility, indicating a divestiture strategy. By 2024, NextEra Energy Resources consolidated ownership in multiple solar generation facilities, with eight indirect subsidiaries owning between 50% to 67% of entities operating solar facilities with approximately 765 MW of generating capacity. Additionally, NextEra Energy Resources consolidated 30 variable interest entities (VIEs) owning solar generation facilities with approximately 3,485 MW of generating capacity, reflecting a strategic shift toward retaining and expanding ownership in solar assets. Financial exposure increased as these consolidated VIEs had total assets of approximately $23,902 million and liabilities of $1,546 million at December 31, 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic shift from divestiture in 2022 to increased consolidation and financial exposure by 2024, which aligns with the ground truth. However, there are significant factual inaccuracies. In 2022, the LLM correctly notes the sale of a 90% interest in a solar portfolio but incorrectly refers to a '100 MW solar-plus-storage facility'—the ground truth specifies a 100 MW solar facility in Arizona with no mention of storage. This is a material detail change. (2) Quantitative accuracy issues are severe: the LLM claims NextEra consolidated 30 VIEs with ~3,485 MW capacity in 2024, while the ground truth states 8 VIEs with ~765 MW. These numbers are completely mismatched. Additionally, the LLM introduces financial figures—$23,902 million in assets and $1,546 million in liabilities—that are not present in the original answer and cannot be verified against the provided ground truth, suggesting fabrication. (3) The reasoning partially reflects multi-hop synthesis: the shift from divestiture to consolidation via VIEs is correctly inferred. However, the nature of the 2024 structure is misrepresented—ground truth emphasizes a 10% direct ownership stake alongside VIE consolidation, which the LLM omits entirely. Instead, it incorrectly frames the 2024 model as majority (50%-67%) ownership through subsidiaries, which contradicts the ground truth’s description of noncontrolling, leveraged stakes. (4) Contextual relevance is high—the answer addresses ownership structure and financial exposure over the 2022–2024 period as asked. However, due to major quantitative errors and omission of key structural details (e.g., 10% direct stake, correct VIE count and capacity), the correctness score is limited to 5. The qualitative accuracy is moderate because the strategic narrative is plausible but based on incorrect data. Quantitative accuracy is low due to fabricated and incorrect numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 524,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "ACN's investment in Mutual Fund Debt Securities decreased from 2022 to 2023, with the fair value dropping from $484,182 as of August 31, 2021, to $379,989 as of August 31, 2022. The valuation methodology remained consistent, with Mutual Fund Debt Securities classified under Level 2 of the fair value hierarchy, indicating they were valued using quoted prices for similar instruments in active markets or model-derived valuations with observable inputs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly reports the 2022 value as $379,989 but references a prior year (August 31, 2021) value of $484,182, which is not part of the question's scope. The question asks about the evolution from 2022 to 2023, but the LLM fails to mention the 2023 value of $253,025 entirely. Instead, it only discusses 2021 and 2022, misaligning the time frame. (2) Quantitative accuracy is low: the correct 2022 value is $379,989 (which the model mentions, but in the wrong context), and the correct 2023 value is $253,025 (which the model omits completely). The model introduces a number ($484,182) not present in the ground truth for the relevant period, creating confusion. (3) The reasoning is partially sound in describing the Level 2 classification, which matches the ground truth — the valuation methodology remained under Level 2 in both years. However, the model fails the multi-hop requirement by not comparing 2022 to 2023 and instead regresses to 2021 data. (4) Contextual relevance is moderate because it discusses the right company (ACN), the correct financial instrument (Mutual Fund Debt Securities), and the fair value hierarchy, but it answers a different question than the one asked. The omission of the 2023 data and introduction of irrelevant prior-year figures severely undermine correctness. Thus, the overall correctness score is low at 3, with corresponding penalties in quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 413,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron's financial stake and involvement in Tengizchevroil (TCO) remained stable between 2022 and 2023, with its equity investment increasing slightly from $26,534 million in 2022 to $26,954 million in 2023. Chevron's share of earnings from TCO also rose from $3,375 million in 2022 to $3,375 million in 2023. The company maintains a 50% equity ownership in TCO, which operates the Tengiz and Korolev crude oil fields in Kazakhstan. The carrying value of Chevron's investment in TCO exceeded the underlying equity in TCO's net assets by about $80 million at the end of 2023, primarily due to the acquisition of its interest at a value higher than the book value of TCO's net assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million in 2022, not $26,534 million as stated. The 2023 carrying value is not explicitly provided in the ground truth, but the LLM claims $26,954 million, which is inconsistent with the known $23.7B baseline and the $80M excess over equity. Additionally, the LLM reports Chevron's equity earnings as $3,375 million in both years, which directly contradicts the ground truth figure of $1,238 million in 2022. The ground truth does not provide 2023 earnings, but the LLM's repetition of the same number suggests fabrication. (2) The only partially correct quantitative point is the $80 million excess of carrying value over underlying equity in net assets in 2023, which aligns with the ground truth. However, this is overshadowed by the incorrect investment values and earnings figures. (3) The multi-hop reasoning is flawed: the LLM fails to mention the critical new $4,500 million loan provided by Chevron in 2023 to fund the FGP/WPMP projects—a key indicator of deepened financial involvement. This omission severely undermines the qualitative assessment of evolving involvement. Instead, the LLM incorrectly frames the change as a 'slight increase' in equity investment, missing the strategic shift. (4) While the LLM correctly identifies Chevron's 50% ownership and the location of operations, these correct contextual details do not compensate for the core factual errors in financial data and the absence of key developments. The answer incorrectly suggests stability rather than the significant deepening of involvement described in the ground truth. Thus, the correctness score is low due to major quantitative and qualitative inaccuracies, despite some relevant context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 503,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "Between 2023 and 2024, Disney's relationship with the ABC Network has evolved as part of its broader entertainment ecosystem by enhancing integration with Disney's Direct-to-Consumer (DTC) platforms and expanding its role in content distribution. ABC Network continues to serve as a key component of Disney's Domestic Linear Networks, providing primetime, news, daytime, and sports programming, with ESPN programming the sports daypart as \"ESPN on ABC.\" Additionally, ABC's content is available on Hulu and Disney+ in certain markets, reinforcing its role in cross-platform distribution. The network's strategic positioning is further solidified by its reach to nearly 100% of U.S. television households through owned stations and affiliated stations, supporting Disney's broader goals of audience retention and advertising revenue growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies ABC Network as part of Disney's Domestic Linear Networks and mentions its integration with Hulu and Disney+, which aligns with the ground truth. However, it misses the key strategic shift emphasized in the original answer: the specific change in ABC's role from being primarily a linear network generating affiliate fees in 2023 to a content supplier for streaming platforms (especially Hulu's SVOD service) in 2024, with next-day availability of content. This evolution is central to the question and is underemphasized in the LLM response. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the LLM recognizes ABC’s integration with Hulu and Disney+, but fails to highlight the temporal shift between 2023 and 2024 in strategic positioning—specifically the pivot from linear distribution and affiliate revenue to digital integration and streaming contribution. The answer treats ABC’s role as consistent rather than evolving. (4) Contextual relevance is high because the response addresses ABC’s role in Disney’s ecosystem and cross-platform distribution, but it lacks the comparative, time-based strategic evolution that is the core of the question. Thus, while factually plausible, it does not fully capture the transformation described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 403,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "Between 2022 and 2023, General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio remained relatively stable, as it continued to be highlighted as a key product offering under European Land Systems (ELS). The ASCOD, a versatile tracked combat vehicle with multiple variants such as the Spanish Pizarro and Austrian Ulan, was mentioned in both years as part of ELS's global portfolio of armored vehicles. However, there was no specific increase in emphasis or investment allocation directed toward ASCOD in 2023 compared to 2022. This suggests that while ASCOD remains an important product for international markets, General Dynamics has not shifted significant production focus or investment toward it in the recent year, instead prioritizing other platforms like the Abrams and Stryker upgrades and the M10 Booker program.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about the evolution of ASCOD's positioning. The ground truth states that in 2022, General Dynamics was 'producing and upgrading' ASCOD, but by 2023, it only mentioned 'offering' it—indicating a reduction in active development. The LLM incorrectly asserts that the positioning 'remained relatively stable' and does not acknowledge this significant shift in language or its implications. This misrepresents the key factual development. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is flawed: the model fails to synthesize the change in disclosure language between 2022 and 2023, which is central to the question. It also incorrectly identifies Abrams, Stryker, and M10 Booker as the prioritized platforms, while the ground truth points to Piranha 5 and AJAX as the consistently emphasized programs in both years. This reflects a failure to correctly identify the comparative entities and infer strategic shifts. (4) While the answer is contextually relevant—discussing ASCOD, Land Systems, and investment focus—it misses the critical change in corporate disclosure and draws an incorrect conclusion about stability. The answer provides plausible context but lacks factual alignment with the source data, warranting a low correctness and qualitative accuracy score despite good structure and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 414,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal's utilization of European customer balances for credit activities decreased from $3.0 billion in 2023 to $2.0 billion in 2024, representing a reduction from 39% to 26% of European customer balances available for corporate use. This decline indicates a strategic shift toward potentially diversifying credit funding sources or exercising caution in leveraging customer balances, possibly due to regulatory constraints or a focus on external capital partnerships to support credit activities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all quantitative facts: the decrease in approved European customer balances from $3.0 billion (39%) in 2023 to $2.0 billion (26%) in 2024 is accurate. All numbers, percentages, and years match the ground truth exactly. (2) Quantitative accuracy is perfect—no calculation errors, and the figures are presented clearly and correctly. (3) The reasoning is mostly sound and identifies the strategic shift in funding, but it omits a key piece of multi-hop evidence from the ground truth: PayPal's multi-year agreement to sell consumer installment receivables, with a significant increase from $5.5 billion in 2023 to $20.8 billion in 2024. This data point strongly supports the shift toward external financing, which the LLM only vaguely references as 'external capital partnerships' without citing the specific mechanism. (4) While the core facts and numerical accuracy are excellent, the qualitative reasoning is slightly less complete due to the missing linkage to the receivables sale program, which weakens the explanatory depth. However, the answer remains contextually relevant and correctly infers a strategic shift. Thus, correctness is high but not perfect due to the omission of a critical supporting fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 354,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "Between 2022 and 2024, the valuation and categorization of equity securities within NEE's Special Use Funds show a shift in the distribution between Level 1, Level 2, and Level 3 fair value measurements. In 2022, equity securities were primarily categorized as Level 1 ($2,538 million for NEE and $862 million for FPL), with no Level 3 allocations. By 2024, the Level 1 allocation remained significant ($2,614 million for NEE and $1,028 million for FPL), but Level 2 increased notably ($3,321 million for NEE and $2,987 million for FPL), and Level 3 also rose ($229 million for NEE and $204 million for FPL). This evolution suggests a diversification in the investment composition, with a greater portion of the portfolio being invested in commingled funds (Level 2) and some less observable investments (Level 3). The increased use of Level 2 and Level 3 categorizations indicates a potential decrease in direct market transparency and a shift toward more complex or less liquid investment vehicles.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (fair value $907 million), and FPL reported $672 million (fair value $672 million), with no detailed categorization by valuation levels (Level 1, 2, or 3). However, the LLM incorrectly states that in 2022, NEE had $2,538 million in Level 1 and FPL had $862 million in Level 1, which is factually wrong and not supported by the original data. These numbers appear to be fabricated or misattributed. (2) For 2024, the LLM correctly reports NEE's Level 1 equity securities as $2,614 million and FPL's as $1,028 million, which matches the ground truth. However, it introduces Level 2 and Level 3 values for both entities (e.g., $3,321M Level 2 for NEE, $229M Level 3 for NEE), which are not present in the original answer and contradict the ground truth that only Level 1 values were specified — the original mentions 'more granular disclosures that included Level 2 and Level 3 valuations' but does not provide specific numbers. The LLM invents precise figures that are not in the source. (3) The multi-hop reasoning is flawed: the original answer emphasizes increased transparency and growth in equity investments, while the LLM concludes a 'decrease in direct market transparency' due to higher Level 2/3 allocations — a conclusion based on fabricated data. The reasoning is internally logical but built on false premises. (4) Contextual relevance is moderate because the LLM addresses valuation levels and investment composition, but the incorrect data undermines the entire analysis. The qualitative accuracy is low due to incorrect entity-level data and flawed synthesis. The correctness score is low because the core quantitative facts are wrong, despite some correct 2024 Level 1 numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 510,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Accenture's share purchase program saw an increase in the total shares acquired under the public program, with $2,482 million spent in fiscal 2023 compared to $576 million in fiscal 2022. The shares acquired under the public program in fiscal 2023 were significantly higher than those acquired through employee-related transactions, which were not explicitly quantified but noted as being part of share withholding for payroll tax obligations. The increase in the public program spending reflects a broader and more active share repurchase strategy in fiscal 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, Accenture spent $576 million to purchase 1,964,612 shares under its public share purchase program in fiscal 2022, with no mention of any public program activity in fiscal 2023. However, the LLM claims that $2,482 million was spent in fiscal 2023 under the public program, which is factually wrong and not supported by the original answer. There is no indication in the ground truth of an increase in public share purchases; in fact, the opposite is implied — the public program saw reduced or no activity. (2) The quantitative inaccuracies are severe: the LLM fabricates a $2,482 million expenditure in fiscal 2023 with no basis in the provided data. It also falsely implies that more shares were bought in 2023 than in 2022, when the original answer states there was no mention of public purchases in 2023. Employee-related transactions were correctly identified as involving share withholding for tax obligations, but the LLM fails to note that 97,251 shares were acquired in 2022 under this category and does not confirm whether similar activity occurred in 2023 beyond vague reference. (3) The multi-hop reasoning is flawed: the question asks for a comparison of scope and utilization across two years between public and employee-related transactions. The LLM incorrectly infers increased public program activity when the ground truth indicates a decline or pause. It fails to recognize the key evolution — reduction in public repurchases while maintaining employee-related acquisitions. (4) Despite the factual errors, the answer remains contextually relevant by addressing the right company, time frame, and types of share acquisition programs. It attempts to compare public vs. employee-related transactions, fulfilling the structure of the question, but with incorrect data and conclusions. Hence, low scores on correctness and quantitative accuracy, slightly higher on qualitative for using correct terminology, and moderate on relevance for staying on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 562,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC (CPChem) remained consistent between 2022 and 2023 in terms of its consolidation status and investment accounting approach. Chevron maintains a 50% equity ownership interest in CPChem and accounts for it using the equity method. The total net equity attributable to CPChem increased from $13,569 million at December 31, 2022, to $14,683 million at December 31, 2023, reflecting continued investment and operational performance, but there was no change in Chevron's consolidation or accounting treatment during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that Chevron *changed* its accounting treatment for Chevron Phillips Chemical Company LLC (CPChem) from consolidation in 2022 to equity method in 2023. The LLM incorrectly asserts that the accounting approach 'remained consistent' and that Chevron has always used the equity method, which directly contradicts the original answer. This is a fundamental error in the main point of the question. (2) Quantitatively, the LLM provides specific equity values ($13,569 million and $14,683 million) which may be accurate figures from the filings, and the increase is correctly directional. These numbers are plausible and format-compliant, so quantitative accuracy is partially correct. However, they are used to support an incorrect narrative about unchanged accounting treatment. (3) The multi-hop reasoning is flawed: the question requires identifying a change in consolidation status across two years based on disclosure notes (e.g., presence of CPChem in consolidated subsidiaries in 2022 vs. explicit equity method disclosure in 2023). The LLM fails to detect or report this shift, indicating a failure in synthesizing cross-year disclosures. (4) Contextual relevance is moderate because the answer discusses CPChem, Chevron’s ownership, and financial data, but it misses the central evolution the question asks about. The qualitative reasoning is poor due to the incorrect conclusion about no change. Thus, despite some correct numbers, the answer is substantively wrong on the key issue, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 445,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "From 2022 to 2023, the role of Hydra-70 rockets in General Dynamics' Combat Systems segment remained significant, particularly in munitions production. In 2022, the segment received a contract for $175 million for Hydra-70 rocket production. By 2023, OTS (a business unit within Combat Systems) highlighted its market-leading position in supplying Hydra-70 rockets and secured awards to expand production capacity, including increasing metal parts production from 18,000 to 86,000 rounds per month by 2025, reflecting a strategic emphasis on scaling output to meet growing demand, especially for U.S. Army artillery modernization efforts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $175 million contract in 2022 for Hydra-70 rocket production and accurately reports the expansion of metal parts production capacity from 18,000 to 86,000 rounds per month by 2025 under OTS, a unit within General Dynamics' Combat Systems segment. All key facts from the ground truth are present and factually correct. (2) Quantitative accuracy is perfect: the dollar amount ($175 million), production capacity figures (18,000 to 86,000 rounds/month), and the 2025 completion timeline are all correctly stated and match the original answer. Format variations are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—information is synthesized across time (2022 to 2023), entities (General Dynamics, OTS), and operational developments (contract award to capacity expansion). The mention of U.S. Army artillery modernization adds contextual insight not in the original but is plausible and does not contradict it. (4) The only minor shortcoming is that the original specifies Hydra-70 rockets are part of a broader munitions portfolio, while the LLM implies the capacity expansion is specifically for Hydra-70; however, the LLM does say 'including' which allows for broader interpretation. This slight over-attribution does not materially misrepresent the facts. Overall, the answer is semantically equivalent, highly accurate, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 394,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) is listed as part of the 2015 Equity Incentive Award Plan, with the last incorporated by reference on May 14, 2015. By the 2024 filing, it remains under the same plan but is now dated April 30, 2024, indicating an amendment or restatement. This suggests an update to the terms or structure of the agreement in 2024, reflecting ongoing adjustments to PayPal's equity incentive practices.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but includes a significant error regarding the documentation status of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) in the 2024 filing. According to the ground truth, the 2024 filing retains the same form of Exhibit 10.07+, incorporated by reference from the May 14, 2015 10-12B/A, with no indication of a new date or amendment for that specific exhibit. However, the LLM incorrectly states that the notice is 'now dated April 30, 2024,' which is false for the standard RSU notice. The April 30, 2024 date applies only to the updated Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which the LLM fails to mention entirely. This omission undermines completeness and qualitative accuracy. While the LLM correctly identifies the 2015 plan and the initial incorporation by reference, it misattributes the 2024 update to the wrong exhibit, leading to incorrect reasoning about the evolution of the agreement. The conclusion that there was an amendment in 2024 for the base RSU notice is unsupported. Quantitative accuracy is partially correct—dates like May 14, 2015 are accurate, but the erroneous assignment of April 30, 2024 to Exhibit 10.07+ is a critical factual flaw. Contextual relevance is high as the response addresses the general topic and evolution of equity awards, but the failure to distinguish between standard and performance-based RSU notices results in a misleading synthesis. The multi-hop reasoning is flawed because the model conflates two distinct exhibits and does not accurately reflect the unchanged status of the base grant notice.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 451,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within Bristol-Myers Squibb's portfolio has evolved both in terms of regulatory approvals and its contribution to revenue. In 2022, Opdivo generated $7,523 million in revenue, maintaining a strong position in the portfolio. By 2024, Opdivo received multiple new regulatory approvals, including FDA approval for Opdivo Qvantig in December 2024 for subcutaneous use across most previously approved indications, as well as approvals in combination with Yervoy for colorectal cancer and in urothelial carcinoma. These approvals expanded Opdivo's therapeutic applications and reinforced its position as a key immunotherapy product in BMS's oncology portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Opdivo's 2022 revenue of $7,523 million, which matches the ground truth and is a key quantitative fact. However, it introduces inaccuracies regarding regulatory approvals. The ground truth states that Opdivo received FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma. In contrast, the LLM claims multiple approvals in 2024, including Opdivo Qvantig in December 2024 for subcutaneous use, and combinations with Yervoy for colorectal cancer—details not present in the original answer and potentially incorrect or unverified. There is no mention of Opdivo Qvantig or colorectal cancer indications in the ground truth. (2) The revenue figure is accurate and correctly formatted. However, the dates of approvals are factually inconsistent: the ground truth specifies March 2024, while the LLM cites December 2024 for a different approval, which contradicts the provided information. (3) The reasoning partially captures the evolution of Opdivo’s role through expanded indications, which aligns with the intent of the question. However, the multi-hop synthesis is flawed because it fabricates or misattributes approvals not supported by the original data, undermining the factual basis of the conclusion. (4) The contextual relevance is high because the answer addresses both revenue performance and regulatory evolution. However, correctness and qualitative accuracy are reduced due to the inclusion of unsupported approvals, leading to a score of 6—partially correct but with significant factual errors in critical details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 458,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC (CPChem) between 2022 and 2023 evolved with increased investment and project funding. As of 2023, Chevron's investment in CPChem rose to $7,765 million from $6,843 million in 2022. Additionally, Chevron provided a loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Texas, where CPChem owns 51 percent. This indicates a strategic focus on expanding CPChem's petrochemical capabilities through targeted capital support for major projects.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It claims Chevron's investment in CPChem rose from $6,843 million in 2022 to $7,765 million in 2023, but this data is not present in the ground truth and cannot be verified from the provided context. The only specific financial figure confirmed in the ground truth is the $387 million loan in 2023, which the LLM correctly identifies. (2) The $387 million loan amount and its purpose—to fund part of the Golden Triangle Polymers Project in Orange, Texas, where CPChem owns 51%—are accurately reported and match the original answer. However, the large investment figures ($6.8B to $7.8B) are unsupported and likely incorrect, as the ground truth does not mention total investment values for those years. (3) The reasoning is partially sound: the LLM correctly infers a strategic shift toward direct financial support via the loan, aligning with the multi-hop synthesis of evolving involvement from equity ownership to targeted funding. It captures the essence of increased strategic focus on petrochemical expansion. (4) While the qualitative narrative and contextual relevance are strong—correctly identifying CPChem, the project, location, ownership stake, and directional shift in support—the inclusion of unverified, specific dollar amounts severely undermines factual accuracy. The answer would have been stronger by focusing only on the verified loan and project details. Thus, correctness is penalized heavily due to unsupported numerical claims, despite correct identification of key strategic developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 436,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, PayPal's protection programs saw an increase in financial commitments, as evidenced by the allowance for transaction losses rising from $64 million to $86 million, and the allowance for negative customer balances increasing from $218 million to $256 million. The provision for transaction losses also increased from $1,192 million in 2023 to $1,114 million in 2024, while realized losses decreased slightly from $1,313 million to $1,218 million. These figures indicate a higher level of anticipated and actual financial exposure related to transaction loss reserves in 2024 compared to 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in the allowance for transaction losses from $64 million to $86 million and for negative customer balances from $218 million to $256 million, which aligns with the ground truth. However, it introduces two figures not present in the original answer — the provision for transaction losses ($1,192M in 2023 and $1,114M in 2024) and realized losses ($1,313M to $1,218M) — which are not mentioned in the ground truth and cannot be verified from the provided information. These additions suggest potential hallucination or incorrect sourcing. (2) The core dollar amounts for allowances are accurate and correctly compared year-over-year, but the inclusion of unverified provisions and losses undermines quantitative accuracy. Additionally, the claim that the provision increased from $1,192M to $1,114M is numerically incorrect as $1,114M is less than $1,192M, contradicting the stated 'increase'. (3) The reasoning correctly infers increased financial commitment from rising allowances, demonstrating sound qualitative logic for the verified data. However, the synthesis is flawed by incorporating unsupported metrics, weakening the multi-hop reasoning integrity. (4) The answer is contextually relevant and addresses the evolution of financial commitments and disclosures, but the addition of incorrect figures reduces overall correctness. The core improvement in disclosure detail from 2023 to 2024 is implied but not explicitly stated as in the original answer (i.e., that 2023 lacked specific disclosures while 2024 included them).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 437,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "Between 2022 and 2024, McDonald's has reinforced its strategic framing of franchising as a core business model, emphasizing collaboration and co-investment with franchisees. In 2024, the company highlights that franchisees are responsible for reinvesting capital in their businesses, and McDonald's may co-invest with franchisees to accelerate initiatives that modernize restaurants and enhance brand value. This reflects a continued commitment to a franchising model that leverages franchisee investment while aligning with consumer preferences and operational improvements. The emphasis on co-investment and collaboration underscores McDonald's view of franchisees as key partners in driving long-term value and brand strength.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic shift in McDonald's framing of franchisees between 2022 and 2024. It accurately identifies franchising as a core business model and highlights the increased emphasis on franchisee co-investment by 2024. The answer correctly notes that co-investment supports modernization and brand value, reflecting a partnership model. However, it does not fully capture the contrast in tone and framing between the two years as described in the original answer—specifically, the shift from neutral, structural language in 2022 (e.g., 'division of responsibilities', 'license agreements') to the 2024 characterization of franchising as 'paramount' to food quality, customer experience, and profitability. This nuance in rhetorical evolution—from descriptive to strategic and value-laden—is missing, which slightly weakens the qualitative accuracy. There are no numerical values in the question or answer, so quantitative accuracy is not applicable but assumed perfect. Contextual relevance is strong, as the response directly addresses the question’s focus on strategic framing and co-investment. The reasoning is sound and synthesizes the intended multi-hop insight, though with minor omission of precise linguistic shifts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 363,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "Between 2022 and 2023, the FDA authorized three new tobacco-flavored varieties of Marlboro HeatSticks in March 2022, but no further authorizations or exemptions for Marlboro HeatSticks were taken as of February 2024. Additionally, in 2023, the FDA did not exempt Marlboro HeatSticks from graphic health warning requirements. This indicates that Altria's regulatory progress with heated tobacco products has been limited, as the FDA has not expanded authorization or provided regulatory relief for Marlboro HeatSticks beyond initial approvals, and the product remains subject to ongoing regulatory scrutiny.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the FDA authorized three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, not March 2022. The LLM incorrectly places the authorization in 2022, reversing the timeline and misrepresenting the regulatory progression. Additionally, the claim that 'no further authorizations...were taken as of February 2024' is speculative and not supported in the original answer, which focuses on progress made by early 2023. The statement that the FDA did not exempt HeatSticks from graphic health warnings in 2023 is partially accurate but framed negatively, while the original emphasizes positive progress. (2) The key date error (March 2022 vs January 2023) and misattribution of the authorization timing severely undermine quantitative accuracy. There are no correct calculations in either answer, but the LLM invents a timeline that contradicts the ground truth. (3) The reasoning is flawed: instead of concluding that Altria made notable regulatory progress—a key point in the original—the LLM concludes progress was 'limited,' which contradicts the ground truth. This indicates a failure in multi-hop synthesis: the model must connect the authorization event to Altria’s innovation strategy, which it does not. (4) While the LLM addresses the general topic (FDA authorization of HeatSticks and implications for Altria), its incorrect timeline and resulting negative interpretation reduce qualitative and overall correctness. Contextual relevance is moderate because it discusses the right entities and regulatory context, but factual errors dominate the assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 459,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "The valuation of mutual fund equity securities held by ACN in non-U.S. pension plans decreased from $273,541 as of August 31, 2021, to $239,293 as of August 31, 2022. This decline suggests a reduction in the market value of these investments during the period, potentially indicating a more conservative investment positioning or market volatility impacting the company's pension fund holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of the time period and values referenced. The question asks about the evolution between 2022 and 2023, but the LLM provides data from 2021 to 2022, which is irrelevant to the query. The ground truth states that ACN's mutual fund equity securities were $239,293 million in 2022 and decreased to $196,226 million in 2023. The LLM instead reports a decrease from $273,541 million (as of August 31, 2021) to $239,293 million (as of August 31, 2022), which pertains to a prior year and includes a starting value not mentioned in the ground truth. (2) The only numerically correct value is $239,293 million, but it is misattributed to the wrong year (2022 in the answer vs. correct 2022 value in ground truth), while the 2023 value of $196,226 million is entirely missing. The claimed reduction is not calculated or verified for the correct period. (3) The reasoning is flawed because the LLM fails the multi-hop requirement—instead of analyzing the 2022–2023 shift as required, it discusses 2021–2022, possibly confusing pension plan data with total holdings. It also introduces 'non-U.S. pension plans' not mentioned in the original answer, adding unsupported context. (4) The conclusion about a 'reduction' or 'conservative positioning' might seem plausible, but it is based on incorrect data and timeframe, undermining validity. Due to major factual errors, incorrect dates, missing 2023 data, and failure to address the correct period, the overall correctness score is low at 2. Quantitative accuracy is 3 because one number matches but the rest are wrong. Qualitative accuracy is 2 due to incorrect entity scoping and flawed logic. Contextual relevance is 4 because the topic is related (mutual fund equities and trends), but the specifics are off-track.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 492,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "Chevron's involvement in Angola LNG Limited remained consistent from 2022 to 2023, with the company maintaining a 36.4 percent interest in the entity, which operates an onshore natural gas liquefaction plant in Soyo, Angola. In 2023, the focus continued on processing and liquefying natural gas, primarily sourced as a byproduct of crude oil production, with efforts progressing toward developing non-associated gas in offshore Angola to supply the plant. Investment emphasis remained on ensuring the plant's operational efficiency and securing additional gas supplies to support its 1.1 billion cubic feet per day processing capacity.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron maintained a 36.4% interest in Angola LNG Limited from 2022 to 2023, which matches the ground truth. The description of the plant's location in Soyo, Angola, and its function in processing and liquefying associated natural gas is factually accurate. However, the key evolution in Chevron's involvement—specifically the shift in disclosure emphasis from operational development in 2022 to financial stake and portfolio integration in 2023—is entirely missing. Instead, the LLM claims that 'the focus continued' on operational activities, which contradicts the ground truth that the emphasis in disclosures shifted. (2) All numeric values (36.4%, 1.1 billion cubic feet per day) are accurate and correctly presented; no calculation errors. (3) The multi-hop reasoning fails: the model does not synthesize the change in reporting focus between years, which is central to the question. It incorrectly assumes continuity in operational emphasis rather than identifying the shift in disclosure strategy. (4) While quantitatively accurate and contextually relevant, the answer misses the core qualitative shift described in the original answer, leading to a moderate correctness score due to significant omission of the evolving narrative in Chevron's reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 367,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "MMM's investment in Certificates of Deposit/Time Deposits increased from $21 million in 2022 to $49 million in 2023, representing a $28 million increase.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 value: it states $21 million instead of the correct $14 million from the ground truth. The 2023 value is correct at $49 million. The calculated increase of $28 million is therefore incorrect; the true increase is $35 million (from $14M to $49M), which also corresponds to a 250% growth. (2) Quantitative accuracy is compromised due to the wrong baseline value and resulting miscalculation. While $49 million in 2023 is accurate, the $21 million figure for 2022 contradicts the ground truth, leading to an incorrect delta. The model’s implied percentage increase (~133%) is not stated but would be inaccurate if calculated. (3) The reasoning shows partial multi-hop capability—correctly identifying the 2023 value and computing a difference—but fails on accurate data retrieval for 2022, undermining the synthesis. (4) Scores reflect that core elements (direction of change, 2023 value) are correct, but major quantitative inaccuracies reduce overall correctness. Contextual relevance is high as the answer addresses the evolution and magnitude as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 321,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "Between 2021 and 2024, the percentage of franchised restaurants in McDonald's system increased from 93% (37,295 out of 40,031 restaurants in 2021) to 95% (41,303 out of 43,477 restaurants in 2024), indicating a continued emphasis on and growth of the franchising model during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages (93% in 2021 and 95% in 2024) are accurate and match the original answer. The absolute numbers provided (37,295 out of 40,031 in 2021 and 41,303 out of 43,477 in 2024) are consistent with the reported percentages—verifying: 37,295 / 40,031 ≈ 93.16% (rounded to 93%) and 41,303 / 43,477 ≈ 94.99% (rounded to 95%). These minor rounding differences are acceptable and common in financial reporting. (2) The answer is complete, addressing the evolution of McDonald's relationship with franchisees through the key metric of franchised restaurant percentage across the specified time frame (2021–2024). (3) Entity accuracy is correct: McDonald's is the right company, years are accurate, and the metric (percentage of franchised restaurants) is appropriate. (4) The reasoning is sound—by citing both percentages and absolute figures, the LLM demonstrates multi-hop synthesis (aggregating data across years and calculating proportions), and correctly infers the strategic trend toward increased franchising. (5) The semantic meaning is equivalent to the original answer, with slightly more detail (absolute restaurant counts), enhancing clarity without introducing error. All scores are maximized due to factual precision, completeness, and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 378,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective March 31, 2021, as noted in the 2022 filing. Between 2022 and 2023, no further amendments to the effective date were made, but the plan remained in effect as of March 31, 2021, and continued to be referenced in the 2023 filing. The structure of the plan, as outlined in the filings, remained consistent, focusing on stock compensation for non-employee directors.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect regarding the evolution of the plan between 2022 and 2023. The ground truth states that the plan was further amended and restated with a new effective date of 'October 26, 2022' as reflected in the 2023 filing, indicating a structural update. However, the LLM claims that 'no further amendments to the effective date were made' between 2022 and 2023, which directly contradicts the ground truth. The only correct element is the mention of the March 31, 2021 effective date as noted in the 2022 filing. The LLM fails to report the October 26, 2022 amendment, which is central to the question about how the plan evolved. This is a critical factual omission that undermines the correctness of the response. The structure and focus on stock compensation for non-employee directors is contextually relevant but does not compensate for the missing key update. Multi-hop reasoning failed: the model should have compared the 2022 and 2023 filings to detect the change in effective date and infer an amendment occurred. Quantitative accuracy is low due to the incorrect handling of the effective dates. Qualitative accuracy is poor because the reasoning and synthesis are flawed. Contextual relevance is moderate since the topic and entities are correct, but the answer misrepresents the timeline and changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 370,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "Between fiscal years 2022 and 2023, Accenture's financial relationship with Duck Creek Technologies evolved in terms of investment valuation and reported financial impact as follows: In fiscal 2022, Accenture's investment in Duck Creek Technologies, accounted for under the equity method, had a carrying amount of $138,902 and an estimated fair value of $223,166 for its approximately 16% ownership. In fiscal 2023, Accenture recognized a $253 million investment gain related to its stake in Duck Creek Technologies, which positively impacted its adjusted earnings per share and operating margin. This gain was a significant factor in the financial impact reported for fiscal 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: the 2022 carrying amount ($138,902), fair value ($223,166), ~16% ownership, equity method accounting, and the $253 million gain in fiscal 2023. The financial impact on adjusted earnings per share and operating margin is accurately noted. The original answer also mentions impact on effective tax rate, which the LLM omits—this is a minor omission but does not undermine the core accuracy. (2) All numeric values match the ground truth exactly or are correctly reformatted (e.g., $253 million). No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across fiscal years and entities (Accenture and Duck Creek Technologies), identifies the shift from passive equity investment to financial gain realization, and contextualizes the impact on financial statements. (4) The answer is highly relevant, directly addressing the evolution in investment valuation and financial impact. The only reason for not scoring a 10 is the slight incompleteness regarding the tax rate effect, but the core facts and synthesis are fully accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 322,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "Between 2022 and 2024, Breyanzi's therapeutic application has expanded significantly, particularly in the treatment of B-cell malignancies. In 2024, specific new FDA approvals expanded its market potential by authorizing Breyanzi for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after at least two prior lines of therapy, and for relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after two or more lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor. These approvals extended Breyanzi's use to a broader range of patients with B-cell lymphomas, enhancing its position as a leading CAR-T therapy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Breyanzi's therapeutic applications between 2022 and 2024. It correctly identifies the two new indications approved in 2024: relapsed or refractory follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), both after at least two prior lines of therapy. The dates (March and May 2024) are not explicitly mentioned, which is a minor omission, but the key approvals are correctly reported. The LLM adds specific detail about prior therapies including Bruton tyrosine kinase inhibitor and BCL-2 inhibitor for the CLL/SLL indication, which is consistent with FDA labeling and adds clinical context not in the original answer—this is a value-add, not an error. All entities (Breyanzi, FL, CLL, SLL) and years (2022, 2024) are correct. The reasoning is sound, showing multi-hop synthesis of label expansions over time. The answer is semantically equivalent to the ground truth, with slightly enhanced clinical detail. Quantitative accuracy is high—no numerical errors, and timeframes are generally correct. One point is deducted from correctness and quantitative accuracy for not specifying the exact approval months, though this does not undermine the factual core. Qualitative accuracy is excellent due to correct synthesis and terminology. Contextual relevance is perfect—the answer directly addresses both parts of the question: evolution over time and new indications expanding market potential.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 412,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "Between 2022 and 2023, 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 remained consistent in its core principles but showed specific developments in the context of respirator mask/asbestos litigation. In both years, 3M estimates insurance receivables based on an analysis of policy terms, case law, and historical experience, and records amounts it concludes are recognizable under ASC 450. However, in 2023, the company increased its respirator mask/asbestos liabilities by $57 million due to updated claims data and higher resolution costs for serious injury claims, such as mesothelioma. Despite this, 3M reported only an immaterial insurance receivable for these matters in 2023, indicating limited expected recoveries, and noted that it has largely collected its remaining insurance coverage for these claims.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and omits key aspects of the evolution in 3M's approach to estimating insurance receivables under ASC 450 between 2022 and 2023. (1) Quantitatively, the $57 million increase in liabilities and claimant count (4,042 in 2023) are not supported by the ground truth, which only mentions the increase in claimants from 4,028 to 4,042 but does not reference a $57M liability adjustment. This number is therefore incorrect and unsupported. (2) The core qualitative error is that the LLM claims 3M used the same methodology in both years—analyzing policy terms, case law, and historical experience—while the ground truth states that in 2022, 3M did *not* specify its methodology for estimating insurance receivables, but in 2023 *explicitly adopted* the loss recovery/gain contingency models under ASC 450 and ASC 610-30. This represents a significant evolution in disclosure and methodology that the LLM incorrectly frames as consistent. (3) The LLM introduces the idea of an 'immaterial insurance receivable' and that 'remaining insurance coverage has been largely collected,' which are not mentioned in the ground truth and contradict the implication that growing exposure (rising claimants) led to a more detailed estimation approach in 2023. (4) While the LLM correctly identifies the context of respirator mask/asbestos litigation and mentions relevant standards (ASC 450), it fails to capture the multi-hop reasoning that increased claimant numbers (from 4,028 to 4,042) likely drove the more detailed 2023 methodology. Thus, while contextually relevant and partially accurate in topic alignment, the answer is factually flawed in key details and reasoning, warranting a moderate correctness score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 474,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "Between 2022 and 2023, PepsiCo's relationship with Naked evolved as part of the sale of its Tropicana, Naked, and other select juice brands to PAI Partners in the first quarter of 2022. While PepsiCo no longer owned Naked directly, it retained a 39% noncontrolling interest in the newly formed joint venture, Tropicana Brands Group (TBG), which operates across North America and Europe. Additionally, PepsiCo continued to act as the exclusive distributor for TBG's portfolio, including Naked, for small-format and foodservice customers with chilled direct-store-delivery in the United States. Thus, PepsiCo maintained a limited operational and financial stake in Naked through its role as distributor and minority shareholder in TBG.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 sale of Tropicana, Naked, and other juice brands to PAI Partners and PepsiCo's retention of a 39% noncontrolling interest in TBG, which aligns with the ground truth. The entity name 'Tropicana Brands Group (TBG)' is correctly inferred (though not explicitly named in the original answer, it is a known fact). However, the key error lies in the operational involvement: the LLM states that PepsiCo 'continued to act as the exclusive distributor' in 2023, which contradicts the ground truth that by 2023, PepsiCo no longer directly distributed Naked products. This misrepresents the evolution of the relationship, failing to capture the shift from operational to purely financial involvement. (2) Quantitatively, the 39% stake and 2022 transaction timing are accurate. No calculations are involved, but the numbers presented are correct. (3) The multi-hop reasoning is partially sound—correctly linking the sale, retained stake, and initial distribution role—but fails in synthesizing the change in distribution role between 2022 and 2023. The answer does not reflect the discontinuation of distribution duties in 2023, a critical part of the evolution. (4) Scores reflect high factual accuracy on numbers and entities (hence high quantitative and contextual scores), but the qualitative and overall correctness are reduced due to the significant omission of the cessation of distribution activities in 2023, which is central to the question about how the relationship evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 420,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "Between 2023 and 2024, there is no material change in the accounting treatment or disclosure around the ExtraBucks Rewards program regarding revenue recognition and performance obligations. In both years, ExtraBucks Rewards are treated as a separate performance obligation, with revenue allocated based on the relative standalone selling price and recognized upon redemption. Unredeemed rewards are reflected as a contract liability. The 2024 disclosures align with 2023 in terms of methodology and treatment.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative changes in the accounting treatment and disclosure between 2023 and 2024, which were central to the question. (1) What was correct: The core accounting treatment — treating ExtraBucks as a separate performance obligation, allocating revenue based on standalone selling prices, recognizing revenue upon redemption, and reporting unredeemed rewards as a contract liability — is accurately described and consistent with the ground truth. There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all factual assertions about the treatment are technically accurate. (2) What was incorrect: The LLM claims there is 'no material change' between 2023 and 2024, which contradicts the ground truth. The original answer specifies that while the core revenue recognition timing and liability treatment remained consistent, the 2024 disclosure showed a refinement in language around performance obligations — specifically tying them to customers who accumulate ExtraBucks based on historical spending levels — and included more structured, mature language around transaction price allocation and standalone selling price evaluation. These represent meaningful enhancements in disclosure clarity and accounting formalization, which the LLM incorrectly dismisses. (3) Multi-hop reasoning assessment: The question requires comparing disclosures across two years to identify evolution in accounting treatment and language. The LLM fails to synthesize this evolution, instead asserting continuity without acknowledging the nuanced but important improvements in specificity and formalization noted in the ground truth. (4) Justification for scores: Correctness is scored 5/10 because the answer gets the baseline treatment right but misses the key evolution in disclosure and reasoning maturity. Quantitative accuracy is 10/10 because there are no numerical errors (and no numbers involved). Qualitative accuracy is 5/10 due to the failure to capture the refined language and enhanced structure in 2024 disclosures. Contextual relevance is 8/10 because the answer addresses the right topic and framework but lacks the comparative depth required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 596,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Based on the cost of revenues section, Netflix's reliance on integrated payment partners decreased between 2023 and 2024. In 2023, cost of revenues was 58% of total revenues, while in 2024, it decreased to 54% of total revenues. This reduction indicates a decreased proportion of expenses related to integrated payment partners and other cost components in 2024 compared to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that Netflix continued its relationship with integrated payment partners in 2024 but reduced the level of disclosure in the cost of revenues section. The LLM incorrectly claims that reliance decreased based on a drop in cost of revenues from 58% to 54%, which is not supported by the original answer and introduces unverified financial figures. These percentages (58%, 54%) do not appear in the ground truth and are factually unsupported in this context. (2) The quantitative inaccuracies are significant: the LLM fabricates cost of revenues as a percentage of total revenues for both years without any basis in the provided answer. There is no mention of such percentages in the original answer, nor is there any data to support a calculation linking these metrics to payment partner reliance. (3) The multi-hop reasoning is flawed. The question asks about evolution in reliance based on specific details in the cost of revenues section. The correct answer hinges on qualitative disclosure changes, not aggregate cost percentages. The LLM fails to recognize that payment processing fees were still part of other operating costs in 2024 and incorrectly infers a reduction in reliance from a general cost ratio change, which may reflect many factors beyond payment partners. (4) The contextual relevance is moderate because the answer addresses Netflix and the cost of revenues, but it misinterprets the nature of the evidence and introduces irrelevant metrics. Due to major factual and reasoning errors, the correctness score is low at 2, with similarly low scores for quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 469,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "From 2022 to 2023, 3M's approach to managing PFAS contamination in Minnesota evolved significantly in response to regulatory changes and new health-based standards. In 2022, the company was actively addressing compliance issues at its Cottage Grove facility, including self-reporting violations and working with the MPCA to resolve Clean Water Act and RCRA issues. By 2023, 3M had increased its PFAS-related environmental liabilities by $10.6 billion, reflecting the growing financial and regulatory pressures. Additionally, Minnesota issued updated, more stringent Health-Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the impact on its obligations under the 2007 Settlement Agreement and Consent Order. The company also faced stricter permit conditions for its Cottage Grove facility, including significantly revised PFAS discharge limits, and was working to address stormwater discharges containing PFAS at multiple Minnesota facilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the mention of updated Health-Based Values (HBVs) for PFOA and PFOS issued by Minnesota in January 2024 and 3M’s evaluation of their impact on obligations under the 2007 Settlement Agreement and Consent Order. It also correctly notes increased regulatory scrutiny at Cottage Grove and stormwater issues at Minnesota facilities. However, a major factual error undermines the answer: the $10.6 billion increase in PFAS-related environmental liabilities was not reported in 2023 in the context of Minnesota-specific actions—it was a global liability adjustment announced in 2023 but not tied specifically to Minnesota regulatory changes or the time frame of the question. This figure is misattributed in context and timing. (2) Quantitative accuracy is low because the $10.6 billion figure, while a real number from 3M’s 2023 disclosures, is inaccurately presented as a direct response to Minnesota regulatory changes from 2022–2023, which the ground truth does not support. The ground truth does not mention this liability increase at all in the Minnesota context. Dates are mostly correct (January 2024 HBV update, December 2022 and March 2023 MPCA orders), though the LLM implies the HBVs were issued in 2023 when they were issued in January 2024. (3) The multi-hop reasoning is partially sound—LLM connects regulatory changes (HBVs, MPCA actions) to 3M’s evolving compliance posture and liability reassessment. However, it fails to mention key details from the ground truth such as the 2007 Settlement Agreement’s ongoing role, the Decatur, Alabama connection under a 2020 Consent Order, and specific operational status at Oakdale and Woodbury. It also omits the December 2022 Cottage Grove stormwater order and the January 2024 proposed Clean Water Act permit with strict limits. (4) Despite the significant error in liability attribution, the answer captures the general trend of tightening regulation and 3M’s responsive posture, earning moderate scores in qualitative accuracy and high relevance. Correctness is limited by the misleading use of a large financial figure outside its proper context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 583,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "Between 2022 and 2023, PepsiCo's use of foreign currency derivatives increased, with the notional value rising from $3.0 billion to $3.8 billion. This indicates a more active approach to managing foreign exchange risk, likely in response to increased volatility or expansion in international markets. The company continues to use forward contracts and net investment hedges to offset currency exposure on foreign subsidiaries and transactions, reflecting a strategic focus on mitigating foreign exchange risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in notional value of foreign currency derivatives from $3.0 billion in 2022 to $3.8 billion in 2023, matching the ground truth exactly. All numeric values and years are accurate, satisfying quantitative accuracy. (2) The answer addresses the evolution in usage (increase in notional value) and interprets it as a more active foreign exchange risk management strategy, which aligns with the ground truth's indication of strategic expansion. It also correctly references the use of derivatives to hedge currency exposure on foreign subsidiaries and transactions, including forward contracts and net investment hedges. (3) The multi-hop reasoning is sound—connecting the increase in derivative usage over two years to a strategic shift in risk management. However, the LLM omits the specific point from the original answer that there was 'no material net impact on earnings in 2023' due to the hedging effectiveness. This is a minor but notable omission affecting completeness and qualitative accuracy. (4) Despite this omission, the answer is factually correct, contextually relevant, and semantically equivalent in intent and meaning. The scores reflect high accuracy with a slight deduction in qualitative accuracy due to missing a key detail about earnings impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 371,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil's approach to capitalizing on improving living standards evolved by focusing on expanding high-value chemical production capacity and strengthening its geographic footprint. In 2022, the company emphasized optimizing existing production and leveraging feedstock advantages in North America. By 2023, ExxonMobil made significant capacity additions, such as new performance polymers and linear alpha olefins units in Baytown, Texas, and advanced plans for a major petrochemical complex in China's Dayawan Industrial Park. This shift reflects a more proactive strategy to meet rising demand in growth markets like China, where improving living standards are driving demand for high-performance materials.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution in ExxonMobil's approach between 2022 and 2023, noting the shift from North American feedstock optimization and advanced recycling plans to high-performance polymers and a major foreign investment in China. However, it omits specific quantitative details from the ground truth: the 500,000 metric tons per year of advanced recycling capacity planned for Baytown by 2026 and the over 2.5 million metric tons per year of polyethylene and polypropylene capacity in Dayawan, China. These are key metrics that were present in the original answer and directly address the 'capacity additions' part of the question. (2) While the LLM mentions 'new performance polymers and linear alpha olefins units in Baytown, Texas'—which aligns with the 2023 focus—the absence of the 2.5+ million metric tons figure reduces quantitative accuracy. Similarly, the 2022 Corpus Christi ethane cracker completion and the joint venture context are not mentioned, which are important factual elements. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift from domestic U.S. projects to international expansion, particularly in China, and links this to rising living standards driving demand for advanced materials. The synthesis across years and geographies is logically presented. (4) The answer is contextually excellent—directly relevant, well-structured, and focused on the evolution in strategy. Due to missing key numbers and some project specifics, the correctness and quantitative scores are reduced, but qualitative reasoning and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 448,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "From 2022 to 2023, 3M's investment in Certificates of Deposit/Time Deposits increased significantly, from $21 million to $49 million. This shift suggests that the company is prioritizing short-term, low-risk investments in 2023, likely to enhance liquidity and preserve capital amid uncertain economic conditions. The increase indicates a more conservative approach to managing short-term funds compared to the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that 3M's investment in Certificates of Deposit/Time Deposits increased from $21 million in 2022 to $49 million in 2023, which matches the ground truth exactly. The quantitative evolution is accurately represented, including the correct dollar amounts and years. (2) The calculation implied — a significant increase (more than doubling) — is factually correct: $49M is over 130% of $21M, confirming the increase is substantial. No mathematical errors. (3) The reasoning is sound and aligns with the ground truth: the shift indicates a change in short-term investment strategy. While the original answer emphasizes 'increasing liquidity or reallocating into more stable or higher-yielding instruments,' the LLM interprets this as a 'conservative approach' to 'preserve capital amid uncertain economic conditions.' This is a reasonable and plausible interpretation, though slightly more speculative than the original. It does not contradict the ground truth and adds contextual inference consistent with the data. (4) All entities — 3M, Certificates of Deposit/Time Deposits, 2022, 2023 — are correctly identified. The answer fully addresses both parts of the question: the evolution of investment and its strategic implication. The wording differs but maintains semantic equivalence. Minor deduction in qualitative accuracy due to interpretive addition ('uncertain economic conditions') not present in the original, but not enough to undermine correctness. Overall, the answer is factually precise, contextually appropriate, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 435,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "Mastercard's approach to proprietary insights in 2023 emphasized a stronger focus on data responsibility and trust-building compared to 2022. In 2023, the language explicitly highlights \"principled and responsible use of secure consumer and merchant data,\" reflecting a more deliberate commitment to ethical data practices. This evolution indicates a shift toward reinforcing trust with stakeholders by emphasizing security and transparency in data usage, which was not as prominently articulated in the 2022 disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 language ('principled use of consumer and merchant data') and the 2023 evolution ('principled and responsible use of secure consumer and merchant data') are accurately represented. The emphasis on data responsibility, security, and trust-building is correctly identified. (2) There are no numeric values requiring calculation, but the years 2022 and 2023 are correctly referenced. (3) The multi-hop reasoning—comparing Mastercard's disclosures across two years to infer a strategic shift in tone and focus—is sound and well-supported. The LLM correctly synthesizes the evolution in language to conclude a stronger emphasis on security and stakeholder trust. (4) The only minor shortcoming is that the LLM does not explicitly state that the addition of 'secure' and 'responsible' reflects a 'broader narrative around cybersecurity and stakeholder confidence' as directly mentioned in the original answer, slightly reducing qualitative precision. However, the core meaning is preserved. Wording differences are acceptable under semantic equivalence. All parts of the question are addressed with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 344,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "Between 2022 and 2023, the factors influencing the accounting estimates for pension and retiree medical plans evolved due to the broader economic environment, particularly the high interest rate and inflationary cost environment. In 2022, the impact of these plans on financial results was noted as a 0.3% reduction in ROIC, while in 2023, there was no direct impact listed. This shift indicates that the external environment, including macroeconomic conditions and interest rate changes, significantly affects the assumptions and estimates used for these plans, potentially altering their financial impact over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces a specific quantitative metric—'0.3% reduction in ROIC' in 2022 and 'no direct impact listed' in 2023—that is not present in the original answer and cannot be verified from the provided ground truth. This is a significant factual error, as the original answer makes no mention of ROIC or any percentage impact on financial performance. (2) Quantitatively, the numbers cited (0.3%, ROIC impact) are unsupported and likely hallucinated, failing the quantitative accuracy check. There are no correct numerical values from the ground truth to validate, as the original answer contains no numbers. (3) Qualitatively, the LLM captures a partial truth by referencing the 'high interest rate and inflationary cost environment' as a 2023 factor, which aligns with the original. However, it completely omits the key 2022 factor—uncertainties from the ongoing impacts of the COVID-19 pandemic—and fails to mention the geopolitical conflicts in Ukraine and the Middle East as new 2023 influences. This represents a major gap in multi-hop reasoning, as the model does not correctly identify the shift from health-related to macroeconomic/geopolitical risks. (4) Contextually, the answer addresses the evolution of external factors and attempts to link them to accounting estimates, which is relevant. However, due to the inclusion of fabricated metrics and the omission of critical causal factors, the overall correctness is low. The reasoning is partially sound but built on incorrect premises, warranting a score of 4 for correctness—partially correct but with significant factual and completeness deficiencies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 452,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 32,441 gross thousand acres (15,838 net) in 2022 to 30,773 gross thousand acres (15,012 net) in 2023, representing a reduction in both gross and net acreage. This decline suggests a strategic evaluation or potential relinquishment of certain acreage positions, possibly due to completed evaluations or shifts in exploration priorities. However, the company's continued significant holdings in the region indicate ongoing exploration potential, supported by its ability to secure extensions and manage acreage effectively.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numeric values provided. According to the ground truth, ExxonMobil's undeveloped acreage in the Other Americas region was 25,096 gross and 11,977 net thousand acres in 2022, decreasing to 24,221 gross and 11,548 net thousand acres in 2023. However, the LLM reports 32,441 gross (15,838 net) in 2022 and 30,773 gross (15,012 net) in 2023—values that are substantially higher and incorrect. These numbers do not match the ground truth data, indicating a failure in retrieving accurate figures from the source material. (2) The calculation of the reduction is numerically consistent within the LLM’s own incorrect numbers (a decrease of ~1,668 gross and ~826 net thousand acres), but since the base figures are wrong, the entire quantitative foundation is flawed. (3) The qualitative reasoning—interpreting the decrease as a possible sign of strategic evaluation, relinquishment, or shift in exploration priorities—is partially sound and aligns with the type of inference in the original answer. The mention of continued exploration potential due to significant holdings is also contextually appropriate. However, the model fails to mention the possibility of acreage transitioning to developed status, which is a key point in the ground truth. (4) While the answer addresses both parts of the question (evolution of acreage and implications for exploration), the severe numerical inaccuracies severely undermine the correctness score. The contextual relevance is fair because the structure and intent of the response are appropriate, but the factual core is incorrect. Thus, the correctness score is low due to critical errors in quantitative data, despite reasonable reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 481,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "From 2022 to 2023, the use of foreign currency contracts not designated in hedging relationships by 3M evolved with a significant reduction in their gross notional amounts, decreasing from $2,816 million in 2022 to $1,023 million in 2023. The fair value of these contracts also dropped from $73 million in 2022 to $5 million in 2023, indicating a reduced financial impact. These contracts are used to offset changes in value of non-functional currency denominated items, such as intercompany financing balances, and their gains and losses are directly recorded in earnings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, MMM used foreign exchange contracts not designated in hedging relationships with a gross notional amount of $3.7 billion, but the LLM claims $2,816 million (i.e., $2.816 billion), which is incorrect. The 2023 figure of $1,023 million is also not supported by the ground truth, which does not provide specific notional amounts for 2023. Additionally, the LLM introduces specific fair value figures—$73 million in 2022 and $5 million in 2023—which are not present in the original answer and appear to be fabricated. (2) The quantitative inaccuracies are severe: the notional amounts are off by nearly $900 million in 2022, and the fair value numbers have no basis in the ground truth. There is no indication in the original answer that there was a reduction in notional amounts, let alone to the extent claimed. (3) The reasoning is partially sound in that the LLM correctly identifies the purpose of the contracts—offsetting changes in value of non-functional currency denominated items like intercompany balances—and notes that gains/losses impact earnings directly. However, it fails to capture the key qualitative evolution described in the original answer: a strategic shift from designated hedging relationships to a broader use of derivatives not designated as hedging instruments, reflecting a change in financial exposure management approach. Instead, the LLM fabricates a narrative of quantitative reduction without evidence. (4) The contextual relevance is moderate because the answer addresses the right topic and entities (3M, foreign currency contracts, non-functional currency items, earnings impact), but the incorrect data and misrepresentation of the trend undermine the overall correctness. The qualitative accuracy is low due to the failure in multi-hop synthesis—instead of identifying a shift in accounting and risk management strategy, it invents numerical trends. The correctness score is low due to major factual and quantitative errors despite some relevant context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 564,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "Between 2022 and 2023, the role and emphasis of Cyber and Intelligence Solutions within Mastercard's value proposition evolved to become a more integral part of its broader security and data-driven offerings. In 2022, these solutions were primarily highlighted as part of Mastercard's value-added services aimed at preventing, detecting, and responding to fraud. By 2023, the emphasis expanded to position Cyber and Intelligence Solutions as foundational to enabling secure, confident, and principled use of consumer and merchant data, aligning with Mastercard's strategic focus on innovation in open banking, digital identity, and secure transaction ecosystems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the evolution of Cyber and Intelligence Solutions within Mastercard's value proposition between 2022 and 2023. In 2022, the solutions were part of value-added services focused on fraud prevention, detection, and response—consistent with the original answer's description of being grouped among other services. By 2023, the LLM correctly notes a strategic elevation, describing the solutions as foundational to secure and confident data use, enabling secure transactions, which matches the ground truth's emphasis on being 'core' and enabling 'secure, easy, and confident transactions.' The LLM adds contextual detail about alignment with open banking and digital identity, which is plausible and consistent with Mastercard's strategic direction, though not explicitly in the original answer. There are no numerical values in the question or answers, so quantitative accuracy is scored based on correct use of years (2022, 2023), which are accurate. The reasoning is sound, demonstrating multi-hop understanding by contrasting the two years and inferring increased strategic importance. The answer is semantically equivalent to the ground truth, with slightly enhanced framing but no factual deviation. One point was deducted from qualitative accuracy only because the LLM introduces 'principled use of data' and 'open banking' as explicit linkages not present in the original, which, while reasonable, go beyond the provided evidence. Otherwise, the response is complete, relevant, and correctly structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 438,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "The treatment and disclosure of Income Tax Expense and Accruals in the list of critical accounting policies remained consistent between 2022 and 2023, as both years include it explicitly in the list of critical accounting policies and estimates. In 2022, it is mentioned on page 59, and in 2023, it is listed on page 33. The content of the disclosure regarding the determination of the annual tax rate, judgment in evaluating tax positions, and the establishment of reserves for potential tax challenges appears to align between the two years.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key aspect of the evolution in disclosure structure between 2022 and 2023. Quantitatively, the answer correctly identifies that Income Tax Expense and Accruals was listed in both years and provides specific page numbers (59 in 2022, 33 in 2023), which aligns with factual data and shows accurate retrieval. Entity accuracy is maintained—correct metric (Income Tax Expense and Accruals), correct years (2022 and 2023), and correct section (critical accounting policies). Contextually, the response is relevant and addresses the question's focus on treatment and disclosure. However, the qualitative accuracy is lower because the LLM fails to capture the key evolution noted in the ground truth: in 2023, the policy was restructured into a subsection under 'Our Critical Accounting Policies and Estimates' with enhanced linkage to detailed disclosures such as Note 5 - Income Taxes, indicating improved organization and transparency. The LLM incorrectly states that the treatment 'remained consistent,' which contradicts the ground truth that highlights a shift toward more detailed and structured reporting. This omission represents a failure in multi-hop reasoning—while the model confirms presence in both years, it does not synthesize the change in presentation and depth of disclosure. Thus, despite correct facts and context, the conclusion is misleading, warranting a mid-range correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 398,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "Between 2023 and 2024, Intel advanced the Universal Chiplet Interconnect Express (UCIe) standard as a key component of its systems of chips strategy. In 2023, Intel demonstrated UCIe in silicon, showcasing its capability for high-performance communication between chips in a system. By 2024, the company emphasized driving standards like UCIe to optimize systems of chips, particularly for AI applications, and integrated these capabilities into its foundry offerings to support both internal and external customers. This evolution reflects Intel's broader focus on enabling optimized, scalable, and interoperable chiplet-based systems through advanced packaging and industry collaboration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Intel introduced and demonstrated UCIe in silicon in 2023 and advanced to production and integration into foundry offerings by 2024. The focus on systems of chips, advanced packaging, and industry collaboration is correctly conveyed. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years 2023 and 2024 are used accurately and consistently with the original answer. (3) The multi-hop reasoning is sound—LLM correctly synthesizes Intel's progression from demonstration to production and links UCIe to its broader strategy, including AI applications and foundry services. The mention of 'driving standards like UCIe' and integration into foundry offerings slightly reframes but does not distort the original point about inclusion in 'advanced semiconductor assembly and test offerings.' (4) The only minor gap is that the LLM answer does not explicitly state that Intel was 'actively producing based on this standard' in 2024, instead emphasizing strategy and integration. This omission is minor given the overall accurate trajectory described. Wording differences (e.g., 'optimized, scalable, interoperable systems') reflect semantic equivalence. Scores reflect high factual accuracy, strong reasoning, and full contextual relevance with only a slight reduction in qualitative accuracy due to minor incompleteness in describing 2024 production status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 409,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment for CVS's Accelerated Share Repurchase (ASR) transactions remained consistent, with the initial portion of shares being recorded as a treasury stock transaction and the remaining shares treated as a forward contract classified as an equity instrument within capital surplus. However, the completion timelines evolved slightly: in 2023, the remaining shares were received in February following the January payment, whereas in 2024, the remaining shares were received in March following the January payment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the accounting treatment remained consistent between 2023 and 2024, with the forward contract portion classified in capital surplus and later reclassified to treasury stock upon completion. It also correctly notes the timing of final share receipts—February 2023 and March 2024—after January payments. However, it omits key quantitative details from the ground truth: the dollar amounts ($2.0 billion in 2023, $3.0 billion in 2024), the number of shares received initially and finally (17.4M + 5.4M in 2023; 31.4M + 8.3M in 2024), and the percentage of notional amount received upfront (80% in 2023, 85% in 2024). These omissions significantly reduce quantitative accuracy. (2) The dates are partially correct—while it correctly states final shares were received in February 2023 and March 2024, it fails to specify that the initial transactions occurred in January of each year, which is implied but not confirmed. The lack of dollar values and share counts means critical financial scale differences between the two ASRs are missing. (3) The multi-hop reasoning is sound in comparing the accounting treatment and timeline evolution across years, and the synthesis of consistent equity classification and reclassification is accurate. However, the model fails to incorporate specific data points from both years that are necessary for a complete comparison. (4) The answer is contextually relevant and addresses both parts of the question—accounting treatment and timeline—though incompletely. The qualitative reasoning is strong, but the absence of key numbers limits the depth and usefulness of the response. Hence, correctness is reduced to 7 due to significant but not fundamental omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 477,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "From 2022 to 2023, UPS refined its financial exposure and reporting approach related to the Central States Pension Fund (CSPF) by adjusting its actuarial estimates and enhancing sensitivity analysis. In 2022, UPS recorded a $2.3 billion pre-tax actuarial loss related to coordinating benefits for the CSPF, based on its best estimate of potential coordinating benefits. By 2023, this estimate was significantly reduced, resulting in a $5.1 billion pre-tax actuarial gain, reflecting a downward revision in the potential coordinating benefits obligation. Additionally, UPS provided a sensitivity analysis in 2023, illustrating the impact of changes in discount rates and return on assets on pension obligations and expenses, offering greater transparency into how assumptions affect financial results.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. While it correctly states that UPS disclosed a $2.3 billion pre-tax actuarial loss in 2022 related to coordinating benefits for the Central States Pension Fund, it falsely claims a $5.1 billion pre-tax actuarial gain in 2023. The ground truth does not mention any such gain, nor a reduction in obligation—instead, it states that UPS shifted focus to sensitivity analysis in 2023, particularly around a 25 basis point change in expected and actual returns on assets. There is no mention of a $5.1 billion gain in the original answer or supporting data. (2) The quantitative inaccuracies are severe: the $5.1 billion figure is entirely fabricated, and the implication of a reversal or reduction in liability is unsupported. The only correct number is the $2.3 billion 2022 loss. (3) The reasoning is flawed: the LLM incorrectly infers a direct quantitative evolution (loss to gain) between 2022 and 2023, whereas the actual evolution was a shift in reporting approach—from disclosing a specific actuarial loss to emphasizing sensitivity analysis. The model fails to capture this conceptual shift and instead invents a narrative of liability reduction. (4) Contextual relevance is moderate because the answer addresses the right topic (CSPF reporting evolution) and mentions sensitivity analysis, but the core factual claims about financial changes are incorrect. The mention of sensitivity to discount rates and returns is partially aligned, but the emphasis on returns (25 bps change) is more specific in the ground truth and tied to Note 5, which the LLM omits. Overall, the answer is misleading due to invented figures and incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 466,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "Between 2022 and 2023, Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved to highlight their role in enabling secure and confident transactions across the payments ecosystem. In 2022, the value proposition focused on these solutions as part of broader value-added services that provide proprietary insights using consumer and merchant data. By 2023, the emphasis expanded to position Cyber and Intelligence Solutions as integral to the company's mission of making payments \"safe, simple, smart, and accessible,\" underscoring their importance in protecting stakeholders and strengthening the global payments ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Mastercard's messaging around Cyber and Intelligence Solutions between 2022 and 2023. It correctly identifies that in 2022, these solutions were framed as value-added services leveraging proprietary data insights, aligning with the ground truth's emphasis on 'principled use of consumer and merchant data' and enabling confident transactions. In 2023, the LLM accurately notes an expanded role, positioning the solutions as integral to Mastercard's broader mission of making payments 'safe, simple, smart, and accessible' and strengthening the payments ecosystem—consistent with the ground truth's claim of greater integration into the company's infrastructure narrative. The only minor omission is that the LLM does not explicitly mention the linkage to strategic investments in new networks like open banking and digital identity, which is a specific detail included in the original answer and contributes to the fuller picture of integration into infrastructure. However, the essence of increased strategic importance and ecosystem-level impact is preserved. There are no numerical values in this question, so quantitative accuracy is not applicable but assumed perfect. The reasoning is sound, entities (Mastercard, Cyber and Intelligence Solutions, years 2022 and 2023) are correct, and the synthesis across years reflects appropriate multi-hop understanding. The answer is contextually fully relevant and communicates the shift in value proposition effectively.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 420,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In PepsiCo's 2022 SEC filing, the 4.450% Senior Note due 2046 was referenced as Exhibit 4.11, incorporated by reference to a Form 8-K filed on October 14, 2015. In the 2023 filing, it was reclassified as Exhibit 4.60, incorporated by reference to a Form 8-K filed on February 15, 2023, indicating an updated reference to more recent documentation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in the 2022 filing, the note was listed as Exhibit 4.12 (not 4.11) and incorporated by reference from a Form 8-K filed on October 14, 2015 (date correct). In the 2023 filing, it was reclassified as Exhibit 4.13 (not 4.60) and referenced a Form 8-K from February 24, 2016 (not February 15, 2023). The LLM incorrectly states the 2023 reference is to a 2023 filing, which contradicts the ground truth that the referenced document is from 2016. (2) Quantitative accuracy is low: two exhibit numbers are wrong (4.11 vs 4.12, 4.60 vs 4.13), and the date of the Form 8-K in the 2023 filing is entirely incorrect (February 15, 2023 vs February 24, 2016). Only the October 14, 2015 date is correct. (3) The multi-hop reasoning is flawed: the model fails to correctly track the evolution of exhibit numbering and source documentation across years. It incorrectly implies an update to a 2023 filing, suggesting a misunderstanding of how SEC exhibits are incorporated by reference over time. The actual shift is between two historical filings (2015 and 2016), not a recent update. (4) Contextual relevance is moderate because the answer addresses exhibit referencing and documentation dates as asked, but the incorrect data undermines the analysis. The conclusion about 'updated reference to more recent documentation' is factually wrong since the 2016 filing predates the 2022 filing. Thus, the reasoning and factual basis are unsound, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 429,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Between 2023 and 2024, Intel's engagement with Positive Technologies, a Russian IT security firm sanctioned by the U.S., remained limited and authorized under OFAC licensing. In both years, Intel disclosed that it communicated with Positive Technologies regarding IT security research and coordinated disclosure of security vulnerabilities identified by the firm. These activities were conducted under OFAC licenses and did not generate any gross revenues or net profits for Intel. The company confirmed its intention to continue such communications in compliance with the terms of the OFAC license in both reports.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative and entity-related aspects: it correctly identifies Intel and Positive Technologies, references OFAC licensing, confirms no gross revenues or net profits, and accurately represents the nature of communications around IT security research and vulnerability disclosure in both 2023 and 2024. The dates and context are correct, and there are no numerical inaccuracies (though no specific numbers beyond zero revenue/profits are present, which matches the ground truth). The answer is contextually relevant and fully addresses the question’s focus on the evolution of the relationship under U.S. sanctions and OFAC licensing. However, the LLM slightly underrepresents the qualitative evolution emphasized in the original answer: while it notes Intel's intent to continue communications in both years, it does not clearly highlight the shift from *disclosing past communication* in 2023 to a *forward-looking, sustained partnership posture* in 2024. This nuance in the evolution of tone and strategic posture is present in the ground truth but not fully captured in the LLM response, resulting in a minor gap in qualitative accuracy. Still, the core facts and reasoning are sound, and the answer is semantically close to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 358,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million between 2023 and 2024, as noted in the borrowings tables for both years. This stability indicates that the company has not refinanced or redeemed this specific long-term debt obligation, suggesting a consistent long-term debt structure with no immediate plans to alter this particular component of its debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million in both 2023 and 2024, which matches the ground truth exactly. All numeric values (amount, interest rate, maturity date, years) are accurate. (2) Quantitative accuracy is perfect: $5,000 million is correctly reported, and no erroneous calculations were made. Format is consistent with ground truth. (3) The reasoning is sound—the stability of the debt balance is correctly interpreted as an indication that CVS did not retire or issue additional amounts of this note, reflecting a stable component of its long-term debt structure. However, the LLM answer omits the comparative context provided in the original answer about the 2.7% senior notes due August 2040, which decreased significantly. This contrast helps highlight that while this specific note was stable, other debt instruments were actively managed, suggesting selective refinancing. The omission reduces completeness and depth of multi-hop synthesis, though the core reasoning remains valid. (4) The answer is highly relevant, factually correct, and well-reasoned, but loses one point for not fully capturing the comparative insight that strengthens the interpretation of CVS's overall debt strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 364,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835% Notes due 2032 were listed as securities registered pursuant to Section 12(b) of the Exchange Act in both the 2022 and 2024 SEC filings, with the trading symbol XOM32 on the New York Stock Exchange. There is no indication of any material change in the status of these notes between the two filings, suggesting they remained outstanding and publicly traded during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 0.835% Notes due 2032 were listed in both the 2022 and 2024 filings with the trading symbol XOM32, which matches the ground truth. All numeric values—interest rate (0.835%), maturity year (2032), and trading symbol—are accurate. (2) Quantitative accuracy is perfect: percentages, years, and symbols are correctly reported with no calculation errors. (3) However, the LLM answer is incomplete in its reasoning and misses a key multi-hop insight present in the original answer. While it correctly states that the 2032 notes remained registered under Section 12(b), it fails to note the contextual change in Exxon’s debt structure—specifically, that the 0.142% Notes due 2024 (XOM24B), mentioned alongside the 2032 notes in 2022, were no longer present in the 2024 filing. This omission weakens the qualitative analysis, as the evolution of the 2032 notes’ status should be understood in relation to changes in the broader debt portfolio. The original answer uses this contrast to infer that the 2024 notes were likely redeemed, thereby enriching the interpretation of the 2032 notes’ continued presence. The LLM answer, while factually correct about the 2032 notes, does not engage in this comparative reasoning. (4) The correctness score is 7 because the core facts are accurate and the answer addresses the primary status of the notes, but it lacks the deeper synthesis of changes in the debt landscape between filings. Contextual relevance is high as the response directly addresses the question, and qualitative accuracy is reduced only due to incomplete multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 446,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "Between 2022 and 2024, American Express significantly reduced its fair value allocation to U.S. Government treasury obligations, from $1,704 million in 2022 to $287 million in 2024. The maturity distribution also shifted, with a larger portion of the 2024 holdings maturing within one year ($189 million) compared to 2022, where most treasury obligations ($832 million) were due within five years. This suggests a move toward shorter-term treasury investments in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 American Express held $477 million in short-term U.S. Treasury obligations with no long-term exposure, but the LLM claims $1,704 million in 2022 and $832 million maturing within five years—both figures are incorrect and unsupported. In 2024, the correct fair value is $189 million (short-term) + $98 million (intermediate-term) = $287 million total, which the LLM correctly states as $287 million, but misrepresents the composition and trend. (2) The LLM incorrectly states that most 2022 holdings ($832 million) were due within five years, while the ground truth confirms all 2022 holdings were short-term (less than 12 months) with no intermediate-term exposure. It also falsely claims a reduction in allocation as a strategic shift toward shorter-term instruments, when in fact the company expanded into intermediate-term holdings in 2024—indicating a move toward longer, not shorter, maturities. (3) The multi-hop reasoning is flawed: the model fails to recognize that the introduction of intermediate-term obligations ($98 million) in 2024 represents a diversification of maturity profile, not a shortening. It incorrectly infers that $189 million maturing in one year in 2024 is a larger portion than 2022, when in 2022 the entire $477 million was short-term. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant—it addresses investment strategy evolution, fair value, and maturity distribution. However, due to major quantitative and qualitative errors, especially in core financial data and directional interpretation of strategy, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 465,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon introduced the 2.500% Note due 2050 on June 3, 2020, as part of a series of debt offerings (AMZN_10k_2022.pdf, page 71). Between 2022 and 2024, there is no specific mention of changes to the terms or treatment of this note in the provided pages. However, the note remained outstanding as part of Amazon's long-term debt structure, with no indication of redemption, refinancing, or material modification during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the introduction date of the 2.500% Note due 2050 as June 3, 2020, which matches the ground truth. It also correctly states that there were no changes to the note's terms or treatment between 2022 and 2024, and that it remained part of Amazon's long-term debt. However, the LLM omits the key detail from the ground truth about the note being reintroduced in Exhibit 4.6 in 2024 as an exact replication of Exhibit 4.5 from 2020. This is a significant omission because it reflects the formal documentation and reaffirmation of the note in Amazon's capital structure, which is central to the evolution described in the original answer. (2) Quantitatively, all dates and percentages (2.500%, June 3, 2020) are accurate. There are no calculations, but the factual numbers are correct. (3) The reasoning is sound in concluding no changes occurred, but it fails to synthesize the multi-hop detail about the exhibit replication across filings (2020 → 2022 → 2024), which is necessary to fully address the 'evolution' of the note's treatment. The model relies on absence of change rather than positive evidence of reaffirmation via exhibit replication. (4) The answer is contextually relevant and mostly accurate, but the missing exhibit-level detail reduces completeness and qualitative accuracy, preventing a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 378,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "Between 2022 and 2023, the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement increased by one. In 2022, there were eight amendments (10.8.1 through 10.8.8), while in 2023, there were nine amendments (10.8.1 through 10.8.9).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both the number of amendments and the timeline. According to the ground truth, the Eighth Amendment was filed in March 2022, and by October 11, 2023, the Twelfth Amendment had been filed, indicating four additional amendments (from the 8th to the 12th), not just one. The LLM incorrectly states that there were nine amendments in 2023 (implying only one new amendment), when in fact four new amendments were made between 2022 and 2023. (2) The quantitative inaccuracies are significant: the LLM reports 8 amendments in 2022 and 9 in 2023, suggesting only one new amendment, whereas the correct count is an increase from the 8th to the 12th, meaning four new amendments (9th through 12th). The dates (March 10, 2022, and October 11, 2023) are not mentioned in the LLM answer, missing key temporal markers. (3) The multi-hop reasoning is flawed: the model fails to correctly interpret the amendment numbering as cumulative and sequential across years. It incorrectly assumes that 'Eighth Amendment' means eight total by 2022 and 'Twelfth Amendment' means twelve total by 2023, but then only counts a one-amendment increase, which is illogical. The correct inference is a four-amendment increase. (4) Contextual relevance is moderate—the answer addresses the evolution of amendments and the time frame, but due to major factual and numerical errors, the conclusion is misleading. The structure and intent are appropriate, but the core data is wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 423,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's approach to CUDA has evolved significantly, particularly in its integration with new computing architectures and software ecosystems. In 2022, CUDA was highlighted as the foundational parallel programming model for NVIDIA GPUs, supporting a broad range of compute-intensive applications. By 2024, CUDA's role expanded as it became a core component of NVIDIA's full-stack computing platform, now integrated with new architectures like the Blackwell GPU and Grace CPU, as well as DPUs. CUDA-X, a collection of acceleration libraries, APIs, and SDKs, was further enhanced to support generative AI and domain-specific applications, reinforcing CUDA's central role in enabling AI and high-performance computing across diverse industries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: CUDA's foundational role in 2022 across GPU computing is accurately described, and its evolution by 2024 into a full-stack platform integrated with CPUs (Grace), GPUs (Blackwell), and DPUs is consistent with the original answer. The mention of CUDA-X libraries, APIs, and SDKs enhancing support for generative AI and domain-specific applications reflects the expanded software ecosystem. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2022, 2024) are correct and consistent. (3) Multi-hop reasoning is sound: the model synthesizes CUDA’s evolution across time, architecture (heterogeneous computing), and software (CUDA-X, AI frameworks), correctly linking it to NVIDIA's broader platform strategy. (4) The only minor shortcoming is that the original answer specifically notes CUDA’s role in NVIDIA’s 'target markets' (Gaming, Data Center, etc.) in 2022 and the fiscal 2024 introduction of CPUs, which the LLM omits. However, the core evolution—integration with CPUs, DPUs, and full-stack expansion—is correctly captured. Wording differs slightly but maintains semantic equivalence. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 373,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial relationship with Paxlovid evolved significantly in terms of revenue recognition and contractual obligations. In 2023, Paxlovid generated $1,279 million in revenue, but this was heavily impacted by a $3.5 billion non-cash revenue reversal in the fourth quarter due to expected returns of EUA-labeled U.S. government inventory. By 2024, Paxlovid revenue increased to $5,716 million, driven by a transition to traditional commercial markets and the inclusion of $442 million in revenue related to the U.S. Strategic National Stockpile (SNS). Additionally, deferred revenues for Paxlovid decreased from $5.1 billion in 2023 to $2.2 billion in 2024, as revenue was recognized upon product delivery. Contractual obligations also shifted, with a focus on commercial market sales and reduced government contracts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in key financial figures. While it correctly states that Paxlovid generated $1.279 billion in revenue in 2023 and mentions the $3.5 billion non-cash revenue reversal due to expected returns of EUA-labeled U.S. government inventory, it incorrectly claims that Paxlovid revenue increased to $5.716 billion in 2024. The ground truth does not state total 2024 revenue; instead, it reports a favorable adjustment of $771 million and an additional $442 million from the SNS, but no total revenue figure for 2024. The LLM fabricates a total revenue number not present in the original data. Additionally, the claim that deferred revenues decreased from $5.1 billion in 2023 to $2.2 billion in 2024 is unsupported by the ground truth, which does not mention deferred revenue balances at all. (2) The only correct numbers are the $1.279 billion 2023 revenue and the $3.5 billion reversal. The $442 million SNS revenue is correctly cited. However, the $5.716 billion 2024 revenue and deferred revenue figures ($5.1B and $2.2B) are entirely incorrect. The favorable adjustment of $771 million due to lower-than-expected returns (5.1M vs 6.5M courses) is omitted, which is a key multi-hop element. (3) The reasoning is partially sound in identifying a shift from government to commercial markets, and the mention of performance obligations shifting aligns with the theme, but the model fails to accurately synthesize the evolution: it misses the core point that the $771M adjustment refined the prior year's reversal, rather than driving new commercial revenue growth. It also invents metrics (deferred revenue) not in the source. (4) Contextual relevance is strong—the answer addresses revenue recognition and contractual obligations as asked, and frames the evolution appropriately. However, due to major quantitative errors and invented data, the correctness score is low despite relevant structure and partial factual grounding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 540,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "The availability of shares under the 2003 Incentive Program decreased from 65,754,069 shares available in 2022 to 47 million shares available by the end of 2024. The structure remained consistent, with a maximum of 220 million shares allowed for issuance, and awards forfeited, expired, or settled in cash not counting against the limit. The program continued to issue restricted stock and restricted stock units with graded vesting periods, including the addition of converted Pioneer awards following the 2024 acquisition.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the 'availability of shares decreased' from ~65.75M in 2022 to 47M in 2024. While 47 million shares were indeed available by the end of 2024, this does not represent a decrease in availability over time without context — the total maximum number of shares was increased to 220 million, meaning the program's capacity expanded significantly. The original answer correctly frames this as a net expansion, despite moderate usage. The LLM incorrectly implies a reduction in availability, which misrepresents the trend. (2) Numeric values are partially correct: 65,754,069 shares in 2022 is accurate; 47 million available in 2024 is correct; 220 million maximum in 2024 is correct; restricted stock units increasing from 9,392 thousand (9.392M) to 10,393 thousand (10.393M) is accurate but omitted in the LLM answer. However, the LLM fails to mention this increase in RSUs, which is a key part of the evolution. (3) Multi-hop reasoning is partially sound — the model correctly identifies structural continuity (e.g., forfeitures not counting against limit, vesting structure), and references the Pioneer acquisition, which adds contextual detail not in the ground truth but may be plausible. However, it fails to synthesize the correct narrative of expansion: more shares authorized overall, even if remaining availability is lower due to grants. (4) Scores reflect that core numbers are mostly present (with correct formats allowed), but the central conclusion about share availability decreasing is misleading and factually incomplete, warranting a moderate correctness score. Contextual relevance is high as the answer addresses program structure and availability as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 476,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "AdSense's role within Google's advertising revenue streams has seen a nuanced evolution between 2022 and 2024. In 2021 (as referenced in the 2022 filing), AdSense was a contributor to the growth of Google Network revenues, which increased by $8.6 billion from 2020 to 2021. However, by 2024, AdSense is mentioned less prominently in the context of Google's broader advertising technology portfolio, with a greater emphasis on AI-driven innovations like Gemini and Performance Max. This shift suggests that while AdSense remains part of Google's advertising ecosystem, its relative strategic focus has diminished compared to newer, AI-centric advertising solutions that are central to Google's growth narrative in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of AdSense's role within Google's advertising revenue streams, noting its prominence in earlier growth (2021) and reduced emphasis by 2024 in favor of AI-driven tools like Performance Max. However, there is a minor but notable error in the time frame: the ground truth states that the $8.6 billion year-over-year increase occurred between 2022 and the prior year (i.e., 2021 to 2022), but the LLM incorrectly attributes this growth to the period 'from 2020 to 2021' and references it as 'in the 2022 filing' when the context implies it should be growth reported in 2022 for the prior year. This misalignment affects quantitative accuracy. (2) The dollar amount ($8.6 billion) is correct, but the time period to which it applies is off by a year, which impacts precision. No other numbers are present, so this is the sole quantitative issue. (3) The multi-hop reasoning is strong: the model correctly infers a strategic shift from AdSense to newer AI-powered products by comparing disclosures across years, identifying the change in narrative focus even without explicit revenue breakdowns in 2024. It synthesizes information about AdSense’s role in the Google Network and contrasts it with the rising importance of Performance Max and AI innovations. (4) Despite the date misstatement, the overall qualitative assessment and contextual relevance are excellent—the answer addresses the evolution, identifies key products, and correctly interprets the strategic shift. The core message aligns with the ground truth, warranting a high correctness score with a slight deduction for the temporal inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 456,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "Between 2022 and 2023, the UPS Retirement Plan's benefit accrual structure changed significantly for non-union participants. Effective January 1, 2023, the UPS Retirement Plan and the UPS Excess Coordinating Benefit Plan ceased future benefit accruals for non-union participants. This means that non-union employees hired before July 1, 2016, no longer earned additional retirement benefits based on future service or compensation. Instead, future retirement contributions for non-union employees are now provided through the UPS 401(k) Savings Plan, where UPS contributes 5% to 8% of eligible compensation based on years of vesting service.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core transformation in the UPS Retirement Plan's benefit accrual structure between 2022 and 2023. It correctly identifies the key date—January 1, 2023—as when future benefit accruals ceased for non-union participants, which aligns with the ground truth. The eligibility detail (non-union employees hired before July 1, 2016) is accurately included. The shift to the UPS 401(k) Savings Plan with employer contributions of 5% to 8% of eligible compensation based on vesting service is factually correct and adds valuable context not explicitly detailed in the original answer but consistent with UPS's benefit strategy. All quantitative elements (dates, percentages) are correct and match the expected data. The reasoning is sound and reflects proper multi-hop synthesis: connecting the freeze in accruals with the transition to a defined contribution model. The only minor shortcoming is that the LLM answer does not explicitly mention the 'noncontributory' nature of the original plan or the IRS limits, which were part of the 2022 plan description in the ground truth. Additionally, while the mention of the UPS Excess Coordinating Benefit Plan is likely accurate, it was not referenced in the original answer and slightly extends beyond the provided ground truth without confirmation. However, this does not introduce inaccuracy but adds detail. Overall, the answer is semantically equivalent in substance, highly relevant, and factually precise, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 417,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "Between 2022 and 2024, Amazon's short-term credit facilities evolved in several key ways. In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with a term extending to June 2023, featuring an interest rate of the applicable benchmark rate plus 0.50% and a commitment fee of 0.04%. By 2024, the credit facility was expanded to $15.0 billion with a term extending to November 2028, and the interest rate was adjusted to the applicable benchmark rate plus 0.45%, with a reduced commitment fee of 0.03%. Additionally, in October 2024, Amazon introduced a $5.0 billion unsecured 364-day revolving credit facility with a similar interest rate structure. Outstanding borrowings under these facilities remained minimal, with no borrowings under the main credit agreement and only small amounts under other short-term credit facilities as of December 31, 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the key evolution in Amazon's short-term credit facilities between 2022 and 2024. (1) Quantitatively, all major figures are correct: the $7.0 billion 2022 facility, expansion to $15.0 billion in 2024, the new $5.0 billion 364-day facility in October 2024, interest rates (0.50% to 0.45%), and commitment fees (0.04% to 0.03%) are all accurately reported. The mention of no borrowings under the main credit agreements and small amounts under other facilities aligns with the ground truth, including the presence of $147 million and $151 million in borrowings under other short-term facilities in 2023 and 2024, though the exact figures are not specified in the LLM answer. (2) The LLM omits the specific amounts of unused letters of credit ($7.2 billion in 2021 and $8.3 billion in 2024), which were part of the original answer and relevant to credit utilization. This is a minor omission affecting completeness but not core correctness. (3) The qualitative reasoning is sound: the LLM correctly synthesizes multi-hop information across years and facilities, noting the expansion, improved terms, and introduction of the 364-day facility. The logic around minimal borrowings and facility usage is consistent with the ground truth. (4) Contextual relevance is excellent—the response directly addresses credit capacity, interest rate terms, and outstanding borrowings as asked. The only minor gap is the omission of exact letters of credit figures and precise outstanding borrowing amounts, which prevents a perfect 10. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 459,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Between 2022 and 2023, Costco continued to use variable-priced contracts for energy purchases, particularly for natural gas and fuel for gas stations, on an index basis. This approach remained consistent, as these contracts generally qualify for the 'normal purchases and normal sales' exception and do not require mark-to-market adjustments. The continued use of variable-priced contracts, alongside fixed-price contracts, indicates that Costco's commodity price risk management strategy involves a balanced approach to mitigate exposure to energy price fluctuations while maintaining flexibility in its procurement strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly states that Costco used variable-priced contracts in both 2022 and 2023 for natural gas and fuel for gas stations on an index basis, and that these contracts qualify for the 'normal purchases and normal sales' exception, avoiding mark-to-market adjustments. The evolution is accurately portrayed as consistent, with no significant shift. The only minor difference is that the original answer explicitly mentions electricity in 2022, which the LLM omits, but correctly emphasizes natural gas and fuel in 2023. The LLM adds that fixed-price contracts are also used, implying a 'balanced approach'—a reasonable inference not contradicted by the ground truth, though not explicitly stated. This addition does not introduce error but slightly extends beyond the provided data. All entities (Costco, variable-priced contracts, natural gas, fuel, index basis, accounting exception) and years (2022–2023) are correct. There are no numerical inaccuracies (quantitative accuracy is perfect). The reasoning is sound, showing continuity in strategy and correct multi-hop synthesis across years and contract types. The answer is highly contextually relevant, directly addressing both the evolution and strategic implication. The correctness score is 9 due to the slight omission of electricity in 2022, but overall the answer is semantically equivalent and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 399,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "NVIDIA AI Enterprise has evolved from being a comprehensive suite of enterprise-grade AI software in 2022 to becoming a more integral and expanded part of NVIDIA's data center offerings by 2024. In 2022, it was positioned as a key software component of the data center platform, providing tools for AI development and deployment. By 2024, it was described as an essential operating system for enterprise AI applications, with enhanced capabilities such as NVIDIA NIM, NeMo, and AI Blueprints, which streamline the development, deployment, and optimization of generative AI models. This evolution reflects NVIDIA's broader strategy to solidify its leadership in AI by offering end-to-end solutions that span hardware, software, and cloud services.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of NVIDIA AI Enterprise between 2022 and 2024 and captures the general trajectory—from a foundational software offering to a more central role in NVIDIA's data center strategy. However, it inaccurately states that in 2022 it was already a 'comprehensive suite of enterprise-grade AI software,' which contradicts the ground truth that this characterization emerged by 2024, not 2022. In 2022, it was introduced as part of the Compute & Networking segment, emphasizing strategic positioning rather than commercial maturity. The LLM reverses the timeline of this characterization. (2) There are no numeric values, dollar amounts, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model correctly infers increased strategic and commercial importance over time and links it to broader data center offerings. However, it introduces specific technologies (NVIDIA NIM, NeMo, AI Blueprints) not mentioned in the ground truth, which, while plausible, are not supported by the provided knowledge and represent unsupported elaboration. This affects qualitative accuracy. (4) Contextual relevance is high—the response directly addresses the evolution of the product's strategic and commercial role within NVIDIA's data center offerings. Despite incorrect attribution of the 'comprehensive suite' label to 2022 and the addition of unverified technical components, the core idea of increased integration and strategic importance by 2024 aligns with the ground truth. Hence, correctness is scored 7 for core accuracy with notable factual and chronological inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 477,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "Between 2023 and 2024, Pfizer's contractual obligations related to Paxlovid evolved significantly as the product transitioned from government contracts to commercial markets. In 2023, most Paxlovid revenue came from government contracts, particularly the U.S. government, with a revenue reversal of $3.5 billion due to expected returns of EUA-labeled inventory. By 2024, the U.S. government's role diminished, and commercial sales began, supported by negotiated pricing and a copay assistance program. Additionally, Pfizer supplied 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) at no cost, recording $442 million in revenue. These changes indicate a strategic shift toward commercial market adoption, suggesting that future revenue expectations for Paxlovid are more reliant on commercial demand and market pricing rather than government contracts.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of Pfizer's transition from government to commercial sales for Paxlovid and correctly identifies the $3.5 billion revenue reversal in 2023 due to expected returns of EUA-labeled inventory. However, it introduces a specific figure of $442 million in revenue from supplying 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) at no cost, which contradicts the concept of 'no cost' and is not present in the ground truth. This number appears fabricated or misattributed, as the original answer does not mention this transaction or revenue recognition. Additionally, the ground truth states that remaining performance obligations were $1 billion as of December 31, 2024, but the LLM answer does not include this key forward-looking contractual obligation metric, instead focusing on commercial transition details not in the original. (2) The $3.5 billion reversal is correctly stated, but the $442 million figure is unsupported and likely incorrect. The 1.0 million treatment courses to SNS may be factual but is not in the ground truth and presented with misleading revenue implications. The critical $1 billion remaining performance obligation for 2024 is omitted entirely. (3) The reasoning about a strategic shift toward commercial markets is plausible and aligns with broader industry trends, but the answer fails to synthesize the key multi-hop insight from the ground truth: the shift from uncertainty (reversal) to stabilization (defined $1B obligation). Instead, it substitutes this with a narrative about commercial adoption not fully supported by the provided truth. (4) The contextual relevance is high because the answer addresses the evolution of contractual obligations and future revenue expectations. Qualitative accuracy is moderate due to correct identification of the 2023 reversal and general market transition, but quantitative accuracy is low due to the inclusion of unsupported numbers and omission of the critical $1B forward obligation. Correctness score is 6 due to partial factual alignment but significant omissions and introduction of unverified data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 578,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "Between 2022 and 2024, Google's exposure to new regulatory costs in international markets evolved in both scope and nature. In 2022, the focus was on general regulatory challenges such as data transfer restrictions between the EU and the UK, evolving foreign policy landscapes, and new customer requirements. By 2024, the scope expanded to include geopolitical tensions, such as conflicts in the Middle East and Ukraine, which introduced risks like sanctions, import/export controls, and disruptions to business continuity. Additionally, the nature of the challenges became more complex, with increased emphasis on compliance with anti-corruption laws, labor regulations, and the impact of AI-related regulations. These developments reflect a broader and more dynamic regulatory environment that Google must navigate in its international operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in describing the evolution of Google's regulatory challenges between 2022 and 2024. While the original answer (ground truth) states that in 2022, Google specifically cited data transfers between the EU and UK and new customer requirements as sources of regulatory cost, and in 2024 expanded to include 'uncertainty regarding regulatory outcomes' and risks under local laws lacking due process, the LLM introduces entirely unsupported elements. It claims that by 2024, geopolitical conflicts in the Middle East and Ukraine, sanctions, import/export controls, anti-corruption laws, labor regulations, and AI-related regulations were emphasized — none of which are mentioned in the ground truth. These additions reflect a plausible but fabricated narrative not grounded in the actual filings. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable; however, the years 2022 and 2024 are correctly referenced, earning full marks here. (3) The multi-hop reasoning is flawed: the model fails to accurately synthesize the actual progression from data-specific to broader legal and procedural uncertainties, instead inventing a new set of geopolitical and compliance risks not present in the source. The core shift — from data transfer issues to systemic legal unpredictability — is missed entirely. (4) Despite being relevant to the general topic of international regulatory risk, the answer diverges substantially from the documented scope and nature of Google’s disclosed risks. The contextual relevance is moderate because it addresses regulatory evolution, but the specifics are incorrect, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 486,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "Between 2022 and 2023, UPS's approach to funding postretirement medical benefits remained consistent in that expected benefit payments were funded from both plan trusts and corporate assets. No significant changes were indicated in the sources used for these payments, as outlined in both the 2022 and 2023 disclosures. The company continues to follow its funding policy of contributing amounts required by applicable laws and regulations, with potential discretionary contributions to meet long-term obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that UPS's funding approach for postretirement medical benefits remained unchanged between 2022 and 2023, with expected benefit payments funded from both plan trusts and corporate assets—this matches the original answer exactly in substance. (2) There are no numerical figures requiring calculation in this question, but the years (2022 and 2023) and entities (UPS, plan trusts, corporate assets) are correctly identified. (3) The multi-hop reasoning—comparing UPS's disclosures across two years to assess evolution—is sound: the model correctly infers that no change occurred based on consistent language in disclosures. (4) The LLM adds minor contextual detail about regulatory requirements and discretionary contributions, which is consistent with typical 10-K disclosures and does not contradict or distort the core answer. All aspects of the question are addressed with factual accuracy, proper synthesis, and appropriate relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 297,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "The role and scope of NVIDIA AI Enterprise evolved significantly from 2022 to 2024. Introduced in 2022 as a comprehensive suite of enterprise-grade AI software, it was designed to simplify the development and deployment of generative AI applications. By 2024, its integration expanded with the launch of the NVIDIA Blackwell architecture, which provided a full-stack infrastructure for data center-scale AI and accelerated computing. This advancement enabled broader supply and adoption across industries, supporting a diverse range of AI and HPC use cases with enhanced performance and efficiency.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of NVIDIA AI Enterprise from 2022 to 2024 and captures the general direction of enhanced capabilities and broader deployment. However, it introduces the 'NVIDIA Blackwell architecture' as a key driver in 2024, which is not mentioned in the ground truth and represents a factual inaccuracy. The ground truth specifies concrete components added by 2024—NVIDIA NIM, NVIDIA NeMo, and AI Blueprints—and a specific performance improvement of 2.5x token throughput, none of which are mentioned in the LLM answer. Instead, the LLM refers to 'full-stack infrastructure for data center-scale AI' and 'accelerated computing' in general terms, missing the specific software advancements. (2) Quantitatively, the LLM does not include any incorrect numbers (so no direct contradiction), but it fails to report the key 2.5x performance improvement cited in the ground truth, which is a significant omission. Dates (2022 introduction, 2024 evolution) are correct. (3) The reasoning is partially sound—there is recognition of multi-hop evolution in scope and integration over time—but the synthesis is flawed due to reliance on an incorrect architectural driver (Blackwell) not present in the source. The answer fabricates a causal link between Blackwell and the software suite's expansion without evidence in the ground truth. (4) Correctness is scored 6 due to accurate timeline and general intent but major omissions and one key hallucination. Quantitative accuracy is 8 because no numbers are wrong, but key metrics are missing. Qualitative accuracy is 5 due to incorrect entity (Blackwell) and lack of specific component integration details. Contextual relevance is 9 as the response stays on-topic and addresses the evolution question appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 489,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "From 2022 to 2024, ExxonMobil's proved reserves through equity companies increased from 2,478 million barrels of oil-equivalent (MMBOE) in 2022 to 1,481 MMBOE in 2024. The majority of this increase was driven by growth in Asia, where equity company reserves rose significantly. This indicates a strategic focus on expanding reserves in Asia, likely through joint ventures and partnerships, while maintaining a presence in other regions like Europe and Africa. The shift highlights ExxonMobil's emphasis on high-potential growth areas and collaboration in key markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the quantitative data. According to the ground truth, in 2022, ExxonMobil's proved reserves from equity companies were 14 million barrels gross (1 million net), not 2,478 MMBOE as claimed. By 2024, the correct figures are 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas—none of which are reflected in the LLM's response, which instead reports a nonsensical drop from 2,478 to 1,481 MMBOE. These numbers are entirely inconsistent with the ground truth and suggest a fundamental error in data sourcing or synthesis. (2) The calculation of reserves is incorrect: the LLM implies a decrease over time, while the ground truth shows a massive increase, especially in Asia. Additionally, the LLM aggregates everything into MMBOE without breaking down oil, NGLs, and gas as required by the original answer, and provides no conversion basis. (3) The qualitative reasoning about strategic focus on Asia is partially correct and aligns with the ground truth—this is the only accurate element. The mention of joint ventures and partnerships as a mechanism is a reasonable interpretation. However, the model fails to mention the minimal scale of 2022 reserves or the dramatic expansion by 2024, missing the significance of the shift. (4) Contextual relevance is moderate because the answer addresses the right topic—ExxonMobil’s equity reserves and regional strategy—and attempts multi-hop reasoning across years and regions. However, due to severe numerical inaccuracies and incorrect trends, the overall correctness score is very low. The answer misrepresents the core facts and thus cannot be considered factually reliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 477,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "Based on the provided information, Google Network Partners have primarily influenced Google's revenue generation through advertising. In 2024, advertising revenues from Google Network properties remained a significant contributor, with Google typically reporting these revenues on a gross basis, indicating its role as the principal in these transactions. Additionally, payments to Google Network partners are recorded as cost of revenues, suggesting that while these partners contribute to revenue generation, they also represent a cost component. There is no specific mention of changes in the role or financial impact of Google Network Partners between 2022 and 2024, but their continued presence in cost and revenue structures highlights their ongoing significance.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Google Network Partners contribute to revenue generation through advertising and that Google reports revenues on a gross basis with payments to partners recorded as cost of revenues. These facts are consistent with the ground truth for both 2022 and 2024. However, the LLM fails to capture the key evolution between 2022 and 2024 — specifically, the shift in financial reporting emphasis from revenue generation (in 2022) to cost structure and cash flow impact (in 2024). The original answer notes that by 2024, the relationship was framed more around net cash flow, with payments to partners highlighted as a primary use of operating cash, which the LLM omits entirely. (2) There are no numerical inaccuracies, as the answer does not introduce any incorrect figures or misstate dates; thus, quantitative accuracy is high. (3) The multi-hop reasoning is partially sound — the model correctly synthesizes the role of Google Network Partners in revenue and cost structures — but it fails to compare the two time periods as required by the question. The absence of any mention of changing emphasis over time represents a significant gap in qualitative reasoning. (4) Contextual relevance is strong because the answer discusses the right entities and financial concepts, but the lack of temporal comparison and evolving framing reduces correctness. The answer is factually plausible but incomplete in capturing the evolution, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 415,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "Between 2022 and 2023, UPS's financial impact from undesignated foreign currency forward contracts on earnings volatility significantly decreased. In 2023, the amount of losses recognized in income related to these contracts was $7 million, compared to $69 million in 2022, indicating a substantial reduction in earnings volatility from these instruments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces specific numerical values ($7 million in 2023 and $69 million in 2022) that are not present in the original ground truth answer. The ground truth does not provide any actual dollar amounts related to gains or losses from undesignated foreign currency forward contracts for either year, nor does it state that the financial impact on earnings volatility decreased. Instead, the original answer focuses on the evolution of UPS's disclosure practices—specifically, increased transparency, structured presentation, and explicit linkage of undesignated derivatives to earnings volatility in the 2023 filing. The LLM incorrectly shifts focus to a quantitative reduction in earnings volatility, which is unsupported by the provided information. While the LLM correctly identifies the topic (foreign currency forward contracts and earnings volatility), it fabricates key financial figures and misrepresents the nature of the evolution (quantitative change vs. qualitative/disclosure improvement). This constitutes a major factual error in both quantitative accuracy and qualitative reasoning. The contextual relevance is moderate because the general subject matter and entities (UPS, foreign currency forward contracts, earnings volatility) are correct, and the time frame (2022–2023) is appropriately addressed, but the core of the answer is factually baseless.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 387,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Between 2022 and 2023, Costco's membership format continued to play a central role in its profitability strategy by reinforcing member loyalty and generating consistent fee revenue. In 2022, membership fee revenue increased by 9% to $4,224, driven by new member sign-ups, upgrades to Executive memberships, and a higher renewal rate. In 2023, this trend continued, with membership fee revenue rising 5% to $4,828, fueled by new member growth and Executive upgrades, despite one fewer week of sales. This evolution highlights Costco's focus on expanding its membership base and enhancing the value proposition of its Executive tier to sustain and grow fee revenue as a key component of its profitability.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers. According to the ground truth, the focus was on qualitative evolution in language and strategic concerns, not specific revenue figures. However, the LLM fabricates precise numbers: it claims membership fee revenue increased from $4,224 (implied $4.224 billion) in 2022 to $4,828 (implied $4.828 billion) in 2023, representing a 5% increase. In reality, Costco's 2022 membership fees were approximately $3.98 billion and $4.43 billion in 2023 — neither the base numbers nor the percentages are accurate. The 9% and 5% growth rates are also incorrect; actual growth was around 13% year-over-year. (2) The calculation of a 5% increase from $4,224 to $4,828 is mathematically incorrect (it would be ~14.2%), compounding the quantitative error. (3) Qualitatively, the LLM captures the continuity of membership importance and mentions Executive upgrades and new sign-ups, which aligns with the general strategy. However, it misses the key multi-hop insight: the evolution in language from 'significant effect on profitability' in 2022 to 'integral part of profitability' in 2023, indicating deeper integration into the financial model. More critically, it fails to mention the new 2023 concern about lower renewal rates in newer markets affecting the worldwide renewal rate — a crucial strategic shift highlighted in the ground truth. (4) While the answer is contextually relevant and addresses membership's role in loyalty and fee revenue, the severe quantitative inaccuracies and omission of key strategic nuances reduce correctness. The answer fabricates data not present in the source, which undermines trustworthiness despite some correct thematic elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 473,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's approach to CUDA has evolved to become more deeply integrated within its broader data center platform and software ecosystem. In 2022, CUDA was highlighted as a foundational parallel programming model that supported a broad range of compute-intensive applications and was central to NVIDIA's full-stack accelerated computing platform. By 2024, CUDA's role had expanded to support not only GPUs but also a full set of data center-scale infrastructure, including CPUs, DPUs, interconnects, and switch chips, as part of the NVIDIA Blackwell architecture. This evolution reflects CUDA's integration into a more comprehensive, full-stack computing platform, enabling enhanced performance and efficiency for AI and accelerated computing workloads across diverse industries.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of CUDA from a foundational programming model to a more deeply integrated component of NVIDIA's full-stack data center platform between 2022 and 2024. It correctly identifies the expansion of CUDA beyond GPUs to include CPUs, DPUs, and other infrastructure elements, aligning with the 2024 strategic shift described in the ground truth. The answer also accurately reflects CUDA's role in accelerated computing and AI workloads. However, it omits specific quantitative and programmatic details present in the original answer, such as the 3 million developers using CUDA in 2022 and the mention of key developer programs like the Deep Learning Institute and Inception, which are important for completeness. While the reference to the NVIDIA Blackwell architecture adds context not in the ground truth, it does not contradict it and may reflect up-to-date knowledge. The reasoning is sound, and the answer remains semantically aligned with the original in terms of strategic evolution. All entities (CUDA, GPUs, CPUs, DPUs) and timeframes (2022–2024) are accurate. No numerical inaccuracies are present, hence full marks for quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 339,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid evolved significantly from 2023 to 2024. In 2023, Paxlovid generated $1,279 million in revenue, but the company recorded a non-cash revenue reversal of $3.5 billion due to expected returns of EUA-labeled U.S. government inventory. By 2024, Paxlovid revenue increased to $5,716 million, with a $771 million favorable adjustment reflecting fewer returned treatment courses than estimated. Additionally, Pfizer supplied 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) at no cost, recognizing $442 million in revenue. Remaining performance obligations for Paxlovid totaled $1 billion as of December 31, 2024, with expected delivery from 2025 through 2028.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite addressing the correct topic and timeframe. The ground truth states that in 2023, Pfizer recorded a $3.5 billion non-cash revenue reversal due to expected returns of 6.5 million treatment courses from U.S. government inventory — this part is correctly mentioned. However, the LLM claims Paxlovid generated $1,279 million in revenue in 2023 and $5,716 million in 2024, with a $771 million favorable adjustment and $442 million recognized from supplying 1.0 million courses to the SNS. These figures are not present in the original answer and contradict the core narrative of revenue reversal and uncertain realization. The original answer does not mention any positive revenue figures for 2023 or 2024, nor does it reference a favorable adjustment or SNS supply at no cost with revenue recognition — these are fabrications or hallucinations. (2) The only correct quantitative element is the $3.5 billion non-cash reversal in 2023 and the $1 billion remaining performance obligations as of end-2024, with delivery expected from 2025–2028. All other numbers ($1,279M, $5,716M, $771M, $442M) are unsupported by the ground truth and incorrect. (3) The multi-hop reasoning is partially sound in structure — the model attempts to show evolution from 2023 reversals to 2024 forward obligations — but fails because it introduces false revenue data that distorts the actual financial trajectory. The original answer emphasizes a shift from uncertainty and reversals to a more defined outlook via firm contracts, not a rebound in reported revenue. (4) Correctness is scored low (4) due to major factual errors in financial figures, despite capturing the $3.5B reversal and $1B forward obligations. Quantitative accuracy is poor (3) because most numbers are wrong. Qualitative accuracy is moderate (5) as the reasoning framework is logical but built on false data. Contextual relevance is high (8) — the answer stays on topic and attempts the right synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 545,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "ExxonMobil has significantly increased its strategic emphasis on Guyana between 2022 and 2024, as evidenced by the inclusion of Guyana in the \"Advantaged Assets\" category in 2024 earnings driver definitions, highlighting its role as a key growth project. In 2022 disclosures, Guyana was mentioned in the context of reserves development, with 1.3 billion oil-equivalent barrels added to proved undeveloped reserves, partly from Guyana. By 2024, Guyana is explicitly positioned as a core component of ExxonMobil’s advantaged asset strategy, signaling a shift toward leveraging its high-value, high-return projects for earnings growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Guyana contributed to 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves, and by 2024, it was explicitly listed as a core 'Advantaged Asset' in earnings drivers. The phrasing 'partly from Guyana' is slightly less definitive than the original answer's attribution of the full 1.3 GOEB to Guyana, but this does not materially misrepresent the data. (2) Quantitative accuracy is perfect: the 1.3 billion oil-equivalent barrels figure is correctly cited, and the years 2022 and 2024 are accurately referenced. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across two years and two strategic reporting frameworks (reserves development vs. advantaged assets), capturing the evolution from reserves growth to earnings-driven positioning. (4) The answer is contextually relevant and fully addresses the question about strategic evolution based on disclosures. The only minor shortcoming is a slight softening of the 2022 contribution ('partly from Guyana' vs. 'Guyana was a key contributor'), which slightly underrepresents the centrality of Guyana in the original answer. However, the core message—that Guyana transitioned from a reserves growth story to a strategic advantaged asset—is preserved with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 380,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "The planned utilization of the ATR 72-600F aircraft declined significantly from 2022 to 2024. In 2022, FedEx was committed to purchasing 24 ATR 72-600F aircraft, with deliveries scheduled through 2026. By 2024, this number had dropped to just 10 aircraft, with all deliveries expected in 2025. This reduction indicates a diminished role for the ATR 72-600F in the company's fleet strategy, likely due to a shift toward other aircraft types, such as the more fuel-efficient Boeing 767F and 777F, which align with long-term modernization goals.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative details and overall trend interpretation. The ground truth states that in 2022, the company projected a decline from 11 units in 2023 to just 1 by 2026, but by 2024, the projection shifted to 7 units in 2025 and 3 by 2026—indicating a *less rapid* phaseout. In contrast, the LLM claims FedEx was committed to purchasing 24 ATR 72-600F aircraft in 2022 and reduced to 10 by 2024, with all deliveries in 2025—none of which matches the ground truth. These numbers (24, 10, 'deliveries in 2025') are factually wrong. (2) There are no correct calculations or accurate dates presented; the entire numerical foundation is fabricated or misremembered. The format variations are irrelevant here because the numbers themselves are entirely incorrect. (3) The multi-hop reasoning fails: the question requires comparing fleet projections across years (2022 vs 2024 views) to assess strategic evolution. The LLM instead invents a narrative about FedEx purchasing decisions and fuel-efficient replacements without grounding in the provided data. While it attempts to infer strategic implications (shift to 767F/777F), this is speculative and not supported by the ground truth, which focuses on a moderation in phaseout pace, not a major strategic pivot. (4) The contextual relevance is moderate because the answer addresses fleet strategy and aircraft utilization, but the factual inaccuracies severely undermine correctness. The qualitative reasoning is flawed due to incorrect entity usage (e.g., introducing Boeing 767F/777F not mentioned in ground truth) and false causality. Thus, the correctness score is low at 2—only minimal credit for addressing the general topic of fleet role evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 477,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's approach to offering Omniverse evolved significantly, particularly in its integration with AI and simulation platforms. In 2022, Omniverse was described as a virtual world simulation and collaboration platform for 3D workflows, primarily used for enterprise applications like virtual car showrooms and architectural walkthroughs. By 2024, Omniverse had expanded beyond 3D design collaboration to become a core component of NVIDIA's AI and simulation ecosystem. It was integrated with NVIDIA DRIVE for autonomous vehicle simulation, NVIDIA Avatar Cloud Engine (ACE) for generative AI-powered avatars, and was used for real-time 3D product configurators and testing autonomous systems. This evolution reflects NVIDIA's broader strategy to position Omniverse as a foundational platform for building and operating industrial AI and digital twin applications, both on-premises and in the cloud.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: the description of Omniverse in 2022 as a 3D collaboration platform for enterprise use, including applications like virtual car showrooms, matches the original answer. The evolution by 2024 into a more comprehensive platform integrated with AI and simulation tools is also correctly portrayed. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the shift in strategic positioning of Omniverse from a 3D collaboration tool to a foundational platform for industrial AI and digital twins. It adds specific integrations—NVIDIA DRIVE and NVIDIA Avatar Cloud Engine (ACE)—that are consistent with the broader trend described in the ground truth, even if those specific names weren't in the original. These additions are plausible and contextually accurate, reflecting real integrations NVIDIA has promoted, thus enhancing rather than distorting the answer. (4) The only reason for not scoring a perfect 10 is that the original answer emphasizes the shift toward digital twins of factories and testing autonomous robots/vehicles powered by accelerated computing infrastructure, which the LLM mentions in spirit but frames more around ecosystem integrations. However, the semantic meaning and strategic evolution are equivalent. Wording differs slightly but meaning is preserved. The answer is fully relevant and addresses both the temporal evolution and integration aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 454,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "The role of Google Play in generating non-advertising revenue between 2022 and 2023 remained a consistent contributor, as it is categorized under \"Google subscriptions, platforms, and devices\" revenues. In 2023, consolidated non-advertising revenue growth was driven by increases in Google subscriptions, platforms, and devices, though specific figures for Google Play alone were not provided. However, the 2023 10-K noted that non-advertising revenues, including those from Google Play, have grown over time and are expected to continue expanding as part of Alphabet's broader strategy to diversify beyond advertising.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses key qualitative evolution described in the ground truth. While it correctly states that Google Play contributes to non-advertising revenue and is part of 'subscriptions, platforms, and devices,' it fails to capture the strategic shift between 2022 and 2023—specifically, the transition from being a diversification effort to a more defined and structured revenue stream under 'platforms.' The ground truth emphasizes a categorization change and strategic repositioning, which the LLM answer omits. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is weak: the question asks about the evolution (change) in role between two years, requiring synthesis of strategic intent and structural changes across time. The LLM answer treats the role as 'consistent,' which contradicts the ground truth's emphasis on evolution and strategic refinement. This misrepresents the core reasoning required. (4) Contextual relevance is high because the answer discusses Google Play’s role in non-advertising revenue and references the correct business segment and time frame, but it lacks depth on the transformation aspect central to the question. Thus, correctness is reduced to 6 due to significant omission of the strategic evolution, despite factually accurate statements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 395,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods in workers' compensation reserving for guaranteed cost and excess of deductible business evolved as follows:\n\n1. **Guaranteed Cost Business**: For guaranteed cost business, expected loss ratio methods are generally given significant weight only in the most recent accident year. This approach reflects AIG's reliance on historical data and consistent loss development patterns for this type of business. The expected loss ratios for recent years are adjusted for rate changes, loss trends (including inflation), and changing market conditions.\n\n2. **Excess of Deductible Business**: For excess of deductible business, expected loss ratio methods are given significant weight in the most recent five accident years. This is due to the delayed emergence of claims in these structures, which often take longer to report and settle. The increased proportion of large deductible business has further slowed claim reporting patterns, making expected loss ratio methods more relevant for recent years.\n\nIn 2023, AIG continued to refine its reserving approach by incorporating updated assumptions for medical development patterns, legal costs (particularly in California), and the impact of risk retention structures such as high deductible policies. These adjustments reflect the evolving nature of the business mix and the need to account for longer development periods and changing market dynamics.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts and reasoning. (1) It accurately states that in 2022, AIG gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, and for excess of deductible business, in the most recent five accident years—this matches the original answer exactly. The explanation about delayed claim emergence and slower reporting due to large deductible business is also consistent. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the question or ground truth, so quantitative accuracy is not applicable in a strict sense, but all descriptive timeframes (e.g., 'most recent accident year', 'five accident years') are correctly reported—hence a score of 10. (3) The LLM adds detail not present in the original—such as adjustments for medical development patterns, legal costs in California, and risk retention structures—which, while plausible and contextually relevant, are not mentioned in the ground truth. This reflects a minor overreach in specificity, slightly reducing qualitative accuracy. However, the core multi-hop reasoning—comparing AIG’s reserving methodology across two years and two business lines—is sound and correctly synthesized. (4) The 2023 continuity in methodology is correctly noted, though the LLM omits the specific point about incurred and paid losses now being presented net of reinsurance and undiscounted, which is a notable reporting refinement mentioned in the original. This is a meaningful omission but does not undermine the overall correctness. Contextual relevance is perfect—the response directly addresses the evolution of expected loss ratio methods in both years and both business types.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1627,
        "completion_tokens": 484,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco's product category segmentation evolved significantly between fiscal 2022 and fiscal 2024. In fiscal 2022, Cisco reported under categories such as \"Secure, Agile Networks,\" \"Internet for the Future,\" \"Collaboration,\" \"End-to-End Security,\" and \"Optimized Application Experiences.\" By fiscal 2024, the company restructured its product categories to \"Networking,\" \"Security,\" \"Collaboration,\" and \"Observability,\" aligning with strategic priorities and streamlining reporting. The Collaboration category saw a 2% growth in fiscal 2024 compared to fiscal 2023, driven by growth across the portfolio except for Meetings, while in fiscal 2023 compared to 2022, it experienced a 9% decline primarily due to declines in Collaboration Devices and Meetings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the evolution in Cisco's product category segmentation between fiscal 2022 and 2024, noting the shift from six categories to four and the retention of 'Collaboration' alongside new groupings like 'Observability'. It accurately names the 2022 categories including 'Secure, Agile Networks', 'Internet for the Future', and 'Optimized Application Experiences', and correctly reports the 2024 categories as 'Networking', 'Security', 'Collaboration', and 'Observability'. However, it introduces quantitative data not present in the ground truth: specifically, the 2% growth in Collaboration in fiscal 2024 and 9% decline in fiscal 2023. These figures are factually unsupported by the original answer and represent a significant overreach, as the question focuses on structural evolution, not financial performance. (2) The numbers cited (2% growth, 9% decline) are entirely absent from the ground truth and cannot be verified; thus, quantitative accuracy is low. The original answer contains no financial metrics related to Collaboration revenue trends, so their inclusion is incorrect. (3) The qualitative reasoning is mostly sound: the model correctly synthesizes the reorganization of product categories across years and identifies the strategic consolidation. It correctly notes the introduction of 'Observability' and the removal of categories like 'Internet for the Future' and 'Optimized Application Experiences'. However, it fails to mention that 'End-to-End Security' was also part of the 2022 structure and is subsumed into the broader 'Security' category in 2024, which slightly weakens completeness. (4) Contextual relevance is high because the answer directly addresses the structural evolution of product categories over time and centers on Collaboration. The core structural changes are accurately conveyed, but the addition of unsupported financial metrics undermines factual correctness. Hence, correctness is scored at 6 due to partial factual accuracy with significant extraneous and unverified data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 553,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "Amgen's disclosure regarding the 3.125% 2025 Notes from 2022 to 2023 shows that the notes remained part of their debt portfolio with a consistent principal amount of $1,000 million in both years. In 2023, the effective interest rate on the 3.125% 2025 Notes was SOFR + 2.1%, reflecting a shift from LIBOR-based rates in 2022 to SOFR-based rates in 2023, indicating an evolution in the interest rate framework due to the transition from LIBOR to SOFR. This change aligns with broader market practices and regulatory shifts toward SOFR as the preferred benchmark rate.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1,000 million carrying value of the 3.125% 2025 Notes in both years, which matches the ground truth. However, it incorrectly states that the interest rate framework in 2023 was SOFR + 2.1% *on the 3.125% 2025 Notes*, which contradicts the ground truth: the 3.125% 2025 Notes are fixed-rate notes and would not have a SOFR-based floating rate. The ground truth states that in 2023, Amgen included these notes in a new table that disclosed SOFR + 2.1% — but this likely refers to a different debt instrument or a broader framework, not the 3.125% fixed-rate note itself. The LLM misattributes the SOFR-based rate to the fixed-rate note. (2) Quantitatively, the $1,000 million amount is correct, and the mention of SOFR + 2.1% appears in the correct year (2023), but its application to the 3.125% 2025 Notes is factually wrong. There is no indication in the ground truth that the 3.125% note itself has a floating rate. (3) The reasoning is flawed in the multi-hop synthesis: the LLM assumes that because SOFR + 2.1% appeared in the 2023 disclosure alongside the 3.125% 2025 Notes in a table, it applies to them, but the ground truth only says the note was included in a table that outlined the interest rate mechanism — not that the mechanism applied to that note. The transition from LIBOR to SOFR is contextually plausible, but the LLM incorrectly maps it onto a fixed-rate note. (4) The answer is contextually relevant and addresses the evolution of disclosure, but the core qualitative error — misrepresenting a fixed-rate note as floating-rate under SOFR — undermines the correctness. Hence, partial credit is given for accurate numbers and structure, but significant deduction for factual misinterpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 478,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region remained at zero for the years 2022 to 2024, as indicated in both the natural gas and natural gas liquids reserve tables. This suggests that the company does not hold any direct natural gas reserves in this region, and its exposure to the region is primarily through equity affiliates, where reserves are reported separately. The lack of direct reserves in the region indicates that COP's strategic positioning in Asia Pacific/Middle East is likely focused on equity investments and partnerships rather than direct exploration or production of natural gas in the region.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative claims. According to the ground truth, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region in 2022 and 296 billion cubic feet in 2024, indicating a decline of 30 billion cubic feet. The LLM incorrectly states that reserves were zero for all years from 2022 to 2024, which directly contradicts the verified data. This error invalidates the entire response, as it misrepresents the core facts. The reasoning and qualitative analysis are therefore also flawed: the conclusion that COP has no direct reserves and relies on equity affiliates is unsupported by the provided truth, which confirms the existence of direct reserves. While the LLM attempts to address the strategic implications (contextually relevant), the analysis is based on false premises. The multi-hop reasoning fails because the model did not correctly extract or synthesize the actual reserve figures. Even though the structure of the answer attempts to respond to both parts of the question (evolution and strategic positioning), the factual foundation is entirely incorrect, leading to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 333,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "In 2022, Alphabet repurchased $59.3 billion of Class C shares, and in 2023, this increased to $52.9 billion. The slight decrease in the dollar value of repurchases in 2023, despite a higher number of shares repurchased, suggests a potential shift in the company's capital allocation strategy, possibly due to market conditions or a focus on maintaining financial flexibility amid regulatory and legal challenges.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It states that Alphabet repurchased $52.9 billion in 2023, which is incorrect—the ground truth is $62.2 billion. This is a major quantitative error. Additionally, the LLM incorrectly claims there was a decrease in repurchase activity, when in fact there was an increase from $59.3 billion to $62.2 billion. The LLM also fails to mention the April 2023 authorization of an additional $70.0 billion for buybacks and the $36.3 billion remaining as of year-end, which are key components of the capital allocation signal. (2) The dollar amounts are not accurate: $52.9B vs. correct $62.2B in 2023; the 2022 figure ($59.3B) is correct. The comparison (decrease vs. actual increase) is therefore flawed. (3) The multi-hop reasoning is unsound—the LLM incorrectly infers a strategic pullback due to a supposed decrease, which contradicts the actual trend of increasing buybacks and expanded authorization. The reasoning about 'higher number of shares repurchased' is unsupported and not in the original data. (4) Scores are low due to major factual inaccuracies in numbers and direction of change. Contextual relevance is moderate because the answer addresses share repurchases and capital allocation strategy, but the incorrect data undermines the analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 368,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "AIG's use of frequency/severity methods between 2022 and 2023 remained limited to short-tail lines of business, such as U.S. Property, where these methods are applied in combination with loss development and IBNR factor methods. Notably, frequency/severity methods were not used for aviation exposures due to the high severity and variable mix of claims. In 2023, AIG continued to apply these methods primarily for short-tail classes where claim frequency and severity patterns are more predictable. The reasoning for their usage centered on the nature of these lines, where losses emerge quickly and are more amenable to frequency/severity modeling compared to long-tail casualty lines. There is no indication of a significant expansion or contraction in the lines of business where these methods are applied during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that AIG did not expand the use of frequency/severity methods in 2023. The ground truth states that AIG expanded these methods to U.S. Workers' Compensation, a long-tail line, in 2023, which represents a significant evolution. The LLM incorrectly asserts there was 'no indication of a significant expansion,' directly contradicting the documented strategic shift. (2) There are no numeric values in this question, so quantitative accuracy is not applicable—no numbers were misstated, hence a score of 10. (3) The multi-hop reasoning failed: the question requires synthesizing changes across years and lines of business, particularly recognizing the shift from short-tail only (2022) to including long-tail (2023). The LLM missed this key development, showing flawed qualitative reasoning. (4) Contextual relevance is moderate because the answer discusses the correct company, methods, and some accurate applications (e.g., exclusion of aviation), but fails to address the central evolution in usage, making it partially relevant but ultimately misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 320,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "From 2022 to 2023, Amgen's financial relationship with BeiGene showed a decline in cost recovery, with net costs recovered from BeiGene for oncology product candidates decreasing from $199 million in 2022 to $109 million in 2023. Product sales from Amgen to BeiGene increased from $64 million in 2022 to $125 million in 2023. Profit and loss share expenses also decreased from $53 million in 2022 to $40 million in 2023, reflecting shared commercialization costs during the initial product-specific period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $199M to $109M cost recovery (2022 to 2023), $64M to $125M product sales, and $53M to $40M profit and loss sharing expenses—exact matches to the original answer. (2) The answer addresses all three components of the question: cost recovery, product sales, and profit and loss sharing, with correct figures and directional changes. (3) Entities are correctly identified: Amgen, BeiGene, and the relevant financial metrics are accurately attributed. (4) The reasoning is sound—while the LLM does not explicitly state the 'maturation of the collaboration' interpretation, it correctly reports the trends (declining cost recovery and P&L expenses, rising product sales), which support that conclusion. The mention of 'shared commercialization costs during the initial product-specific period' adds contextually appropriate qualitative insight. The answer is semantically equivalent to the ground truth, with no factual errors, omissions, or calculation issues.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 306,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region remained at zero for all years from 2022 to 2024, as no natural gas reserves are reported for this region in the provided data. However, the region did experience changes in equity affiliate reserves, which are entirely located in Asia Pacific/Middle East. In 2022, equity affiliate reserves increased by 1 due to purchases and revisions, while in 2023, they slightly decreased by 2 due to production and sales. In 2024, equity affiliate reserves increased by 14 due to purchases and extensions and discoveries, primarily in the Middle East.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim that COP's natural gas reserves in the Asia Pacific/Middle East region were zero from 2022 to 2024. The ground truth states that reserves were 326 billion cubic feet in 2022 and decreased to 296 billion cubic feet in 2024, which directly contradicts the LLM's assertion. The LLM incorrectly shifts focus to 'equity affiliate reserves' and reports changes in those (e.g., +1 in 2022, -2 in 2023, +14 in 2024), but these figures are not part of the original question and do not align with the ground truth data on total natural gas reserves. There is no mention of the 9 billion cubic feet added by revisions in 2023 or the 25 billion cubic feet subtracted due to production in 2024, nor the absence of purchases in 2024. The answer fails to address the actual reserves evolution and instead fabricates a narrative around equity affiliates that is irrelevant to the question. Multi-hop reasoning is absent, as the model did not synthesize correct data across years and categories. While the mention of the Middle East shows some regional awareness, the overall response is factually wrong, quantitatively inaccurate, and contextually misaligned. The only minor redeeming aspect is the attempt to discuss regional activity, but it does not compensate for the complete factual divergence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 372,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "From 2022 to 2024, FedEx's planned usage of the B767F aircraft evolved significantly. In 2022, FedEx was committed to purchasing 38 B767F aircraft across 2023, 2024, and 2025. By 2024, the total planned purchases had decreased to 14 B767F aircraft, with deliveries scheduled for 2025 and 2026. This reduction indicates a shift in strategic fleet planning, likely reflecting a focus on more fuel-efficient aircraft like the B777F and a recalibration of long-term fleet modernization priorities to optimize operational efficiency and cost-effectiveness.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, FedEx projected using 14 B767F aircraft in 2023 and 2024, with a reduction to 10 by 2025. By 2024, this projection changed to 11 for 2025 and only 3 by 2026. In contrast, the LLM claims FedEx was committed to purchasing 38 B767Fs across 2023–2025 in 2022, which is not supported by the ground truth. The LLM also states that by 2024, 14 were planned for delivery in 2025–2026, conflating usage projections with purchase/delivery plans not mentioned in the original. (2) Quantitative accuracy is severely lacking: the numbers 38 and 14 (as purchase counts) are incorrect in context—14 was the projected usage in 2023/2024, not a purchase total. The original does not mention any purchases, only planned usage. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a purchase commitment and misrepresents the timeline and nature of fleet planning. While it correctly identifies a strategic shift toward reducing B767F reliance, the evidence used is fabricated. (4) Contextual relevance is moderate because the answer addresses fleet planning strategy and correctly infers a move toward efficiency, but the factual foundation is wrong, undermining the conclusion. The mention of B777F and fuel efficiency is plausible but not present in the original answer, adding unsupported speculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 391,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "AIG's use of Expected Loss Ratio Methods between 2022 and 2023 evolved in terms of application across lines of business and reasoning as follows:\n\n1. **Lines of Business**: The Expected Loss Ratio method was primarily applied to business written in excess of a deductible, particularly in the most recent five accident years. This was especially relevant for lines like U.S. Excess Casualty and U.S. Workers' Compensation, where claims often emerge slowly or with inconsistent patterns due to high deductibles and reliance on underlying policies.\n\n2. **Reasoning**: The method was used when loss development patterns were inconsistent, losses emerged slowly, or there was limited historical data. For example, in U.S. Excess Casualty, the high attachment points and variability in claims timing made the Expected Loss Ratio method more suitable for recent accident years. Similarly, in U.S. Workers' Compensation, the method was used alongside loss development and frequency/severity methods due to the long-tail nature of the business and the complexity of risk-sharing features like high deductibles.\n\nOverall, AIG's application of the Expected Loss Ratio method became more weighted in recent years for lines with these characteristics, reflecting a strategic shift to adapt to evolving underwriting practices and market conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies U.S. Workers' Compensation as a key line of business where Expected Loss Ratio (ELR) methods were applied in 2023, aligning with the ground truth. It also accurately notes the use of ELR in conjunction with other methods due to long-tail characteristics and complex policy features. However, the original answer specifies that in 2022, ELR was primarily used for the latest accident year and in aviation exposures due to high severity and varying claim mix—this is missing in the LLM response. Instead, the LLM emphasizes 'excess of deductible' business and mentions U.S. Excess Casualty, which is not referenced in the ground truth. While U.S. Workers' Compensation is correctly highlighted for 2023, the evolution from 2022 is misrepresented by not acknowledging the prior focus on aviation and high-severity contexts. (2) There are no numeric values or dates in dispute; all references to years (e.g., 'recent five accident years') are qualitative and consistent with the original answer’s timeframe (2022–2023), so quantitative accuracy is fully preserved. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that ELR methods are used in long-tail, complex lines like Workers' Compensation due to slow loss emergence and risk-sharing structures. However, it fails to capture the shift *from* aviation/high-severity in 2022 *to* broader long-tail application in 2023, weakening the comparative analysis across years. The synthesis across time periods and lines of business is incomplete. (4) The correctness score is 7 because core facts about 2023 usage are accurate and well-reasoned, but the 2022 context is misaligned, affecting the completeness of the evolution narrative. Quantitative accuracy is 10 as no numbers are incorrect. Qualitative accuracy is 7 due to correct reasoning on Workers' Comp but incorrect emphasis on Excess Casualty and omission of aviation. Contextual relevance is 9—response stays on topic and addresses the question’s intent, albeit with some misattribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 555,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "Cisco's positioning around Enterprise Data Center Transformation between 2022 and 2024 has evolved to emphasize strategic alliances and adapt to a more competitive landscape. In 2022, Cisco highlighted the convergence of technologies in the enterprise data center and the increasing competition from entities that were also strategic alliance partners. By 2024, Cisco expanded its strategic alliances with companies like Google LLC and International Business Machines Corporation, while also acknowledging the growing trend of alliance partners potentially becoming competitors. This evolution reflects a more proactive approach to managing alliances and addressing the intensifying competition, especially from firms leveraging cloud computing, virtualization, and integrated solutions to offer end-to-end data center services.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Cisco's positioning on Enterprise Data Center Transformation from 2022 to 2024. It accurately captures the core idea that in 2022, Cisco emphasized technological convergence and the complexity introduced by strategic partners also acting as competitors. By 2024, the shift toward broader strategic alliances and recognition of changing competitive dynamics is correctly conveyed. The mention of Google LLC and IBM as alliance partners is plausible and contextually relevant, though the original answer does not specify these companies but instead highlights the emergence of Nvidia Corporation as a new competitive entrant—a key detail missing in the LLM response. While the LLM correctly identifies the trend of partners becoming competitors, it does not explicitly note Cisco’s strategic pivot toward industry advancement and new market creation through alliances, nor does it mention Nvidia as a newly acknowledged competitor, which is a significant update in the competitive landscape. There are no numerical values in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all stated facts are consistent with the timeline and conceptual framing. The reasoning is sound and synthesizes multi-hop concepts (evolution over time, alliance dynamics, competition), though with minor incompleteness in entity identification. The answer remains contextually relevant and semantically close to the original, warranting a high correctness score with a slight deduction for missing key entity and strategic emphasis updates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 451,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "The effective interest rate for the 3.125% 2025 Notes remained unchanged at LIBOR + 1.8% in 2022 and SOFR + 2.1% in 2023, while the notional amount stayed constant at $1,000 million in both years.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the effective interest rate was LIBOR + 1.8% in 2022, but the ground truth does not mention this rate or LIBOR at all for that year; instead, it states that new swaps were entered on a $5.2 billion principal due to low interest rates, implying a different or variable rate environment. The 2023 effective rate of SOFR + 2.1% is correct. However, the notional amount is wrong: the LLM claims it was $1,000 million (i.e., $1.0 billion) in both years, but in 2022 the hedged notional was $5.2 billion, not $1.0 billion. The reduction to $1.0 billion occurred only in 2023. (2) Quantitative accuracy fails on the 2022 notional amount ($5.2B vs $1.0B reported), and introduces an unsupported rate (LIBOR + 1.8%) not in the original. The 2023 values (SOFR + 2.1% and $1.0B) are correct. (3) Multi-hop reasoning is flawed: the model fails to capture the evolution — a decrease from $5.2B to $1.0B — and incorrectly assumes stability. It also misrepresents the interest rate benchmark transition, inserting LIBOR where the source discusses swaps in a low-rate environment without specifying the 2022 effective rate. (4) Scores are low due to major factual and quantitative errors, especially in the notional amount for 2022 and the invented interest rate. Contextual relevance is moderate because the answer addresses the right note and general topic (hedging evolution), but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 406,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "Cisco's strategic positioning of AppDynamics within its product portfolio has evolved to emphasize its role in observability offerings, particularly from 2022 to 2024. In 2022, AppDynamics was highlighted as a key element in delivering full-stack observability from the application to the infrastructure. By 2024, AppDynamics was explicitly included in the Observability product category, which saw a 27% revenue increase, driven by growth in offerings like ThousandEyes and the contribution from Splunk. This integration reflects Cisco's focus on enhancing application performance monitoring and observability across hybrid and multicloud environments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of AppDynamics' strategic positioning from 2022 to 2024, noting its increasing integration into Cisco's observability offerings. It accurately reflects that in 2022, AppDynamics was a key component of full-stack observability, and by 2024, it was formally included in a dedicated 'Observability' category. However, the LLM introduces a specific revenue increase of 27% and attributes growth to ThousandEyes and Splunk, which are not mentioned in the ground truth. These additions, while plausible, are factually unsupported by the provided ground truth and introduce quantitative inaccuracies. (2) The 27% revenue increase and the mention of Splunk's contribution are unverified numeric and entity claims not present in the original answer, reducing quantitative accuracy. The ground truth does not provide any revenue figures or mention Splunk in this context. (3) The multi-hop reasoning is generally sound—correctly synthesizing the shift from AppDynamics as a standalone tool to part of a broader observability strategy. The logical flow from 2022 positioning to 2024 structural reporting change is accurate and well-reasoned. (4) The correctness score is 7 because the core strategic evolution is accurately conveyed, but the inclusion of unsupported quantitative data reduces precision. Qualitative accuracy is high due to correct entity and timeline identification. Contextual relevance is strong as the answer directly addresses the question's focus on strategic evolution in observability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 429,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The effective interest rate for the 4.663% 2051 Notes increased from 5.6% in 2022 to 5.6% in 2023, remaining unchanged. The notional amount associated with these notes was $1,500 million in both 2022 and 2023, indicating no change in the notional amount during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It claims the effective interest rate was 5.6% in both 2022 and 2023, which contradicts the ground truth stating that in 2023 the effective rate was SOFR + 4.3%, with no mention of a 5.6% rate in either year. The original 4.663% appears to be the coupon rate, not the effective rate, and the LLM incorrectly reports a flat 5.6% for both years. The notional amount is partially correct for 2023 ($1.5 billion = $1,500 million), but the LLM falsely states it was the same in 2022, whereas the ground truth indicates that in 2022 the 2051 Notes were part of a broader $5.2 billion hedged portfolio without specifying the 2051 Notes' standalone notional amount. (2) Quantitative accuracy fails: the effective interest rate numbers are fabricated (5.6%), and the 2022 notional amount is incorrectly specified. Only the 2023 notional amount is correct. (3) Multi-hop reasoning is absent: the LLM fails to recognize that the 2022 data does not isolate the 2051 Notes’ notional amount and misrepresents the hedging evolution involving swap terminations and resets. It also ignores the shift to SOFR-based pricing in 2023. (4) Scores are low because the answer fabricates key financial figures, omits critical context about hedging changes, and fails to reflect the partial and evolving disclosure between years. Contextual relevance is slightly higher only because the answer addresses the right instrument and time frame, albeit incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 412,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods has remained consistent in its core application, particularly in projecting ultimate losses by multiplying premiums by an expected loss ratio. However, the segmentation criteria have evolved, with more refined approaches to categorizing business lines and accident years. In 2023, there is a greater emphasis on applying these methods to business written in excess of a deductible, especially in the most recent five accident years, with adjustments for rate changes, loss trends, and market conditions. Additionally, the segmentation by lines of business, such as U.S. Excess Casualty and U.S. Workers' Compensation, has become more granular, reflecting the long-tail nature of these lines and the need for more precise assumptions about loss cost trends and development factors.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative description of AIG's evolving use of expected loss ratio methods between 2022 and 2023, with accurate emphasis on more granular segmentation and application to long-tail lines like U.S. Workers' Compensation. It correctly identifies increased granularity in segmentation by lines of business and accident years, and notes contextual factors like rate changes and loss trends. However, it introduces 'U.S. Excess Casualty' as a line of business to which the method was explicitly applied in 2023, which is not mentioned in the ground truth—only U.S. Workers' Compensation is specified. Additionally, the ground truth highlights specific segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities, whereas the LLM answer generalizes to 'business written in excess of a deductible' and recent accident years without fully capturing the breadth of new segmentation dimensions. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning reflects a sound understanding of the methodological evolution. The answer is contextually relevant and captures the core progression from general sensitivity analysis in 2022 to more structured application in 2023, but misses precise entity details and overgeneralizes segmentation criteria, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 394,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 2.850% Senior Notes due 2026 remained consistent as part of its broader debt issuance strategy. In 2023, the 2.850% Senior Notes due 2026 were listed among the notes authorized under Board resolutions, reflecting their inclusion in the company's ongoing capital structure. In 2024, the 2.850% Senior Notes due 2026 were again referenced in the context of additional notes introduced, indicating that PepsiCo continued to utilize this issuance as part of its diversified debt portfolio. The introduction of new notes in 2024, such as the 4.650%, 4.550%, and 4.700% Senior Notes, suggests a strategic effort to manage maturity profiles and interest rate exposure, while maintaining the 2.850% Senior Notes as a component of its existing obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details of the new senior notes introduced in 2024. The ground truth states that PepsiCo introduced higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035. However, the LLM incorrectly lists the 4.650%, 4.550%, and 4.700% Senior Notes, which are not mentioned in the original answer and contradict the specific instruments cited in the ground truth. These percentages and maturities are materially different and suggest a different debt strategy than the one described in the original. (2) The dates (2026, 2029, 2035) are correctly used in context, and the 2.850% Senior Notes due 2026 are accurately referenced in both years. However, the core error lies in the misrepresentation of the 2024 new issuances, which undermines the quantitative accuracy. (3) The reasoning is partially sound: the LLM correctly infers that PepsiCo maintained the 2.850% notes as part of its capital structure and is managing maturity and interest rate exposure. It also correctly identifies a diversification strategy. However, it fails the multi-hop synthesis by not accurately linking the specific new instruments (7.00%, 5.50%) to the broader strategic shift toward longer-term, higher-yield debt, which is central to the original answer. (4) Contextual relevance is high because the answer addresses the evolution of debt strategy and the role of the 2.850% notes. However, due to the incorrect specification of the new notes, the qualitative and quantitative accuracy scores are reduced. The answer is partially correct but contains key factual errors that affect the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 467,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco's exposure to channel partner financing guarantees increased from fiscal 2022 to 2024, with the maximum potential future payments rising from $188 million in 2024 to $188 million in 2024 (data from 2022 and 2024 filings). This suggests that while the absolute exposure remained stable, the company continues to manage its financial risk by guaranteeing a portion of short-term financing for channel partners. The consistent level of guarantees indicates a measured approach to supporting partners while maintaining control over potential liabilities, reflecting a balanced financial risk management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in fiscal year 2022, the balance of financing subject to guarantees was $1.4 billion (not $188 million), and the total channel partner financing volume was $27.9 billion. The LLM incorrectly states that maximum potential future payments were $188 million in both 2022 and 2024, which contradicts the original data. Moreover, the ground truth explicitly states that in fiscal year 2024, Cisco no longer disclosed specific figures for channel partner financing or guaranteed balances, making any claim about 'increased exposure' or specific dollar amounts in 2024 factually incorrect. (2) The quantitative inaccuracies are severe: the correct guaranteed balance in 2022 is $1.4 billion, not $188 million, and there is no disclosed figure for 2024 to support a comparison. The repetition of '$188 million in 2024 to $188 million in 2024' suggests a data error or hallucination. (3) The multi-hop reasoning is flawed. The original answer requires synthesizing changes in disclosure practices over time and interpreting the implications of reduced transparency. The LLM fails this by asserting numerical continuity where no data exists for 2024, thus misrepresenting the evolution of risk exposure. It also draws a confident conclusion about a 'balanced strategy' based on false numerical stability. (4) While the LLM attempts to address the question's intent regarding risk management, its conclusions are based on incorrect data and flawed logic. The contextual relevance is moderate because it discusses the right topic (guarantees and risk management), but the factual foundation is unsound, leading to a largely incorrect response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 472,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "The 2.45% 2030 Notes had a principal amount of $1,250 million in both 2022 and 2023, indicating no change in the outstanding principal. In 2022, the effective interest rate on the 2.45% 2030 Notes was LIBOR + 1.0% under an interest rate swap, while in 2023, the effective rate was updated to SOFR + 1.3%. This reflects a shift from LIBOR-based to SOFR-based swaps, aligning with the broader market transition from LIBOR to SOFR. Otherwise, no other material changes to the interest rate structure of the 2.45% 2030 Notes were reported between 2022 and 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the principal amount and interest rate details. The ground truth states the notional amount was $1.0 billion, but the LLM claims $1,250 million, which is incorrect. Additionally, the 2022 effective rate is stated as LIBOR + 1.0%, but the original answer does not specify the spread—only that the fixed rate was converted to a floating LIBOR-based coupon. The LLM fabricates the '1.0%' figure. The 2023 rate of SOFR + 1.3% is correctly reported. (2) Quantitative accuracy is low: the $1,250 million vs. $1.0 billion discrepancy is material, and the unsupported 1.0% spread undermines numerical correctness. The SOFR + 1.3% figure is accurate. (3) The reasoning correctly identifies the shift from LIBOR to SOFR as part of the broader market transition, which shows sound qualitative understanding. However, it fails to mention that the swap was entered into in 2022 (a key development), and incorrectly implies the floating rate structure was already in place with a defined spread, when the ground truth does not specify the exact floating formula in 2022. (4) Contextual relevance is high—the answer addresses the evolution of the note's status and interest rate structure over time and correctly frames the LIBOR-to-SOFR transition. However, due to key factual errors in numbers and unsupported specifics, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 397,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "Between 2022 and 2023, FedEx's relationship with Pass-Through Certificates remained consistent in terms of financial guarantees and obligations. In both years, FedEx Express issued $970 million of Pass-Through Certificates, Series 2020-1AA, with a fixed interest rate of 1.875% due in February 2034. These certificates are secured by 19 Boeing aircraft, with a net book value of $1.7 billion in 2023 and $1.8 billion in 2022. Importantly, the payment obligations under these certificates are fully and unconditionally guaranteed by FedEx in both years, indicating no material change in the nature of the guarantees or obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $970 million Pass-Through Certificates, Series 2020-1AA, and the 19 Boeing aircraft as collateral, it incorrectly states that FedEx maintained full and unconditional guarantees in both 2022 and 2023. The ground truth explicitly states that in 2023, FedEx clarified these certificates were *not* direct obligations nor guaranteed by FedEx or FedEx Express—indicating a major shift from 2022. The LLM instead claims 'no material change,' which directly contradicts the ground truth. (2) Quantitatively, the $970 million issuance amount and aircraft count are correct. The net book value is approximately accurate ($1.8B in 2022, $1.7B in 2023 cited by LLM), though the ground truth only specifies $1.8B in 2022 and does not mention 2023 value, so the $1.7B is unverified. The interest rate (1.875%) and maturity (February 2034) are not present in the ground truth and thus appear to be hallucinated. (3) The multi-hop reasoning is flawed: the question asks about the *evolution* of the relationship, requiring comparison across years and synthesis of changes in guarantees. The LLM fails this core requirement by asserting consistency where there was a clear policy shift. (4) Contextual relevance is moderate—the answer discusses the correct financial instrument and collateral—but misses the key point of changing liability status, which is central to the question. Due to major factual and reasoning errors, especially on the guarantee status, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 435,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "From 2023 to 2024, Mastercard's use of risk mitigation arrangements to manage gross settlement exposure increased from $12,167 million to $13,466 million, resulting in a reduction of net settlement exposure from $62,856 million to $64,919 million. This indicates that Mastercard enhanced its risk management strategy by applying more extensive risk mitigation tools, such as cash collateral and credit enhancements, to reduce potential settlement risks. The company's proactive approach reflects a stronger focus on safeguarding against customer settlement failures and maintaining financial stability.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in risk mitigation arrangements from $12,167 million in 2023 to $13,466 million in 2024, which matches the ground truth. However, it incorrectly calculates net settlement exposure: in 2023, $75,023M - $12,167M = $62,856M (correct), but in 2024, $78,385M - $13,466M = $64,919M is presented as a 'reduction' in net exposure, when in fact it is an increase from 2023. This mischaracterization undermines the quantitative accuracy. (2) The dollar amounts for gross exposure and mitigated amounts are accurate and correctly attributed to the right years. The error lies in the interpretation of net exposure trend — it increased, not decreased, so stating a 'reduction' is factually wrong. (3) The multi-hop reasoning is mostly sound: the model connects gross exposure, mitigation, and net exposure across two years and infers strategic intent. However, the flawed conclusion about reduced net exposure weakens the logical chain. (4) Despite the calculation misinterpretation, the answer addresses both parts of the question — evolution of mitigation use and implications for risk strategy — and provides relevant context (e.g., cash collateral, credit enhancements), earning full marks for contextual relevance. The qualitative assessment remains high because the direction of strategy (increased mitigation) is correctly interpreted, even if one inference is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 394,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Between 2022 and 2024, Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments decreased from $48 million to $77 million. This indicates a reduction in the company's hedged foreign exchange exposure, potentially reflecting a shift in strategy or a decrease in anticipated foreign currency transactions during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. According to the ground truth, Nike's total liabilities for foreign exchange forwards and options designated as hedging instruments increased from $48 million in 2022 to $115 million in 2024. However, the LLM incorrectly states that liabilities decreased from $48 million to $77 million. This misrepresents the core quantitative facts. (2) Specific number verification: 2022 total is correctly implied as $48M in the LLM answer (though not broken down), but 2024 figures are wrong — ground truth shows $110M under accrued liabilities and $5M under deferred income taxes, totaling $115M, not $77M. The LLM’s $77M figure has no basis in the provided data. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the two liability components across years and draws an incorrect conclusion about decreasing exposure, when the actual increase suggests either greater FX risk or more aggressive hedging. The reasoning is internally consistent with its false premise but contradicts the evidence. (4) Scores justified as follows: correctness is low (2/10) due to major factual and directional errors; quantitative accuracy is poor (2/10) because of incorrect totals and missing breakdowns; qualitative accuracy is slightly higher (3/10) as the model understands the conceptual link between hedging liabilities and FX exposure, but applies it incorrectly; contextual relevance is acceptable (7/10) because the answer addresses the right topic, time frame, and general concept, even if the facts are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 441,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "Between 2022 and 2023, Bounty's representation within P&G's Baby, Feminine & Family Care segment remained consistent, as it was listed as a major brand in both years. In 2022, the segment included \"Bounty, Charmin, and Puffs\" under Family Care, and in 2023, the same brands were mentioned. This consistency suggests that Bounty maintained a stable position within the segment, with no notable changes in its brand visibility or strategic importance during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim. According to the ground truth, Bounty was *not* explicitly listed as a major brand in the 2022 10-K filing, but *was* explicitly included in the 2023 filing. The LLM incorrectly states that Bounty was listed as a major brand in both years, claiming consistency, when in fact there was a notable change in representation. This misrepresents the evolution of Bounty's visibility. There are no numeric values in the question or answer, so quantitative accuracy is not applicable—however, the model did not fabricate numbers, so it scores highly on that dimension by default. The reasoning is flawed because it fails to recognize the multi-hop nuance: comparing the level of brand mention across two filings to infer visibility changes. Instead, it asserts continuity without evidence, contradicting the ground truth. Contextually, the answer addresses the right segment and company, so it is relevant, but draws the wrong conclusion due to incorrect data interpretation. The semantic meaning is not equivalent to the original answer, as it conveys the opposite trend (stable vs. increased visibility).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 325,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "Oracle's approach to its hardware business, particularly Oracle Engineered Systems, showed a slight decline in revenue between fiscal 2022 and fiscal 2023, with hardware revenues dropping from $3,183 million in fiscal 2022 to $3,183 million in fiscal 2023 (no change as per the data provided). In terms of strategic emphasis, the hardware business represented 6% of total revenues in both fiscal 2024 and 2023, indicating a consistent but smaller portion of Oracle's overall revenue compared to its cloud and license business. Revenue recognition for hardware products occurs at the point in time when the hardware and related software are delivered to the customer, while hardware support contracts are recognized ratably over the contractual term. Oracle continues to invest in research and development for hardware improvements and new offerings, but the business is expected to have lower operating margins due to higher production and support costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and introduces data not present in the ground truth. It claims hardware revenue was $3,183 million in both fiscal 2022 and 2023, implying no change, but this specific revenue figure is not mentioned in the original answer and cannot be verified from the provided ground truth. Furthermore, the LLM references fiscal 2024 (e.g., hardware as 6% of total revenues in 'fiscal 2024 and 2023'), which is outside the scope of the question and not supported by the original answer. These numerical claims undermine quantitative accuracy. (2) The original answer does not provide any revenue figures or percentages—its focus is on changes in revenue recognition methodology and strategic emphasis. Thus, the inclusion of precise dollar amounts and percentages in the LLM answer represents fabrication or hallucination, severely penalizing quantitative accuracy. (3) On qualitative aspects, the LLM correctly identifies that revenue for hardware and related software is recognized at the point of delivery, which aligns with the 2023 update in the original answer. It also correctly notes Oracle’s continued R&D investment in hardware, which matches the strategic emphasis shift mentioned in the ground truth. However, it fails to contrast the absence of such R&D emphasis in 2022, missing a key multi-hop element: the evolution *between* years. The reasoning is partially sound but lacks direct comparison across years as required by the question. (4) Contextually, the answer addresses revenue recognition and strategic emphasis, so it stays on topic. But due to fabricated numbers and incorrect timeframes, the overall correctness score is low. While some semantic elements are correct (e.g., point-in-time recognition, R&D investments), the inclusion of unsupported metrics and erroneous fiscal year data results in a score of 4 for correctness—partially right but significantly flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 526,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "ERLEADA (apalutamide) sales increased by 26.9% in 2023 compared to 2022, driven by continued share gains and market growth in Metastatic Castration-Resistant Prostate Cancer. This significant growth indicates a strong market trajectory for the product, reflecting its increasing adoption and effectiveness in its target indication.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the 26.9% sales growth for ERLEADA from 2022 to 2023, which matches the ground truth calculation based on $1,881 million (2022) and $2,387 million (2023). All quantitative figures—though not explicitly listed as dollar amounts—are accurate in percentage terms. (2) The percentage growth is correctly calculated: ($2,387M - $1,881M) / $1,881M ≈ 26.9%, confirming quantitative accuracy. While the LLM does not explicitly mention the dollar figures, the percentage is correct and sufficient to address the comparative performance. (3) The reasoning is sound: the answer attributes growth to 'continued share gains and market growth in Metastatic Castration-Resistant Prostate Cancer,' which aligns with the ground truth's implication of increasing adoption and commercial performance. It synthesizes the trend correctly and infers a strong market trajectory, fulfilling the multi-hop requirement of interpreting numerical change as an indicator of market momentum. (4) The only minor shortcoming is the omission of the exact sales figures in dollars, which slightly reduces completeness but does not negate the correctness of the core facts or interpretation. However, since the percentage is accurate and the conclusion is valid, this does not warrant a major deduction. The answer remains semantically equivalent in meaning and highly contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 390,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "CMCSA's relationship with local broadcast television stations from 2023 to 2024 has shown increased financial dependency and negotiation pressures. Programming expenses, particularly retransmission consent payments to local broadcast stations, have continued to rise per subscriber, driven by market dynamics and industry consolidation. This dependency is compounded by the shift in content distribution toward DTC streaming services like Peacock, which reduces reliance on traditional multichannel providers but increases the need to secure carriage agreements with local stations for broadcast network programming. The competitive positioning has become more complex as CMCSA faces demands for higher payments and concessions from stations, while also navigating evolving distribution models and the decline of traditional linear television subscribers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolving relationship between CMCSA and local broadcast television stations from 2023 to 2024, emphasizing increased dependency due to retransmission consent payments and shifting distribution models. It accurately reflects the financial pressures and negotiation dynamics, which aligns with the ground truth's emphasis on dependency. However, it omits the key point from the original answer that in 2023, CMCSA's Media segment was in direct competition with local broadcast stations for viewers and advertising revenue—a critical contrast that defines the 'shift' in relationship. While the LLM mentions complexity in competitive positioning, it does not explicitly state the transition from competition to dependency, which is central to the multi-hop reasoning required. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and the context around DTC streaming and Peacock is relevant and accurate. The reasoning is sound but incomplete in synthesizing the full evolution of the relationship. Thus, the answer is factually consistent but lacks a key element of the transformation described in the ground truth, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 354,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "The value of Held-to-Maturity (HTM) securities held by Mastercard (MA) decreased significantly between 2023 and 2024, from $306 million at the end of 2023 to $38 million at the end of 2024. This sharp decline indicates a strategic shift in the company's investment approach, likely reflecting a decision to reduce its holdings in HTM securities—primarily time deposits maturing within one year—and reallocate capital to other investment opportunities or liquidity needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in HTM securities from $306 million in 2023 to $38 million in 2024, matching the ground truth exactly in both values and direction of change. (2) All numeric values are accurate—$306 million and $38 million—and the time periods (end of 2023 and end of 2024) are correctly referenced. No calculations are required beyond the implied comparison, which is accurately described as a 'significant decrease' or 'sharp decline,' consistent with the magnitude of the change. (3) The reasoning is sound: the answer correctly infers a strategic shift in investment approach due to the reduction in HTM holdings. It adds contextual detail—identifying the securities as primarily 'time deposits maturing within one year'—which is plausible and enhances the explanation without contradicting the ground truth. The conclusion about reallocating capital to other opportunities or liquidity needs is a reasonable extension of the data and aligns with the ground truth's interpretation of a move toward more liquid positions. (4) The only reason for not scoring a perfect 10 is that the LLM slightly extends the interpretation by specifying 'time deposits maturing within one year'—a detail not present in the ground truth—though this does not appear incorrect, just additional. Overall, the answer is factually correct, complete, and contextually appropriate, with excellent multi-hop synthesis between financial data and strategic implication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 412,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "Between 2022 and 2023, the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment was repositioned from being listed under a broader \"Feminine Care\" category (which included Adult Incontinence and Feminine Care) to a more specific \"Feminine Care\" category in 2023 that was further divided into subcategories. In 2022, Always was grouped under \"Feminine Care (Adult Incontinence, Feminine Care)\" and \"Family Care (Paper Towels, Tissues, Toilet Paper).\" By 2023, Always was explicitly positioned under \"Feminine Care (Adult Incontinence, Menstrual Care)\" and was separated from the Family Care sub-category, which was listed separately as \"Family Care (Paper Towels, Tissues, Toilet Paper).\" This change reflects a more distinct categorization of Always as a brand focused on menstrual care and adult incontinence, separate from the family care products like Bounty and Charmin.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the shift in categorization of the Always brand from 2022 to 2023 within Procter & Gamble's Baby, Feminine & Family Care segment and notes the increased specificity in positioning under Menstrual Care. However, it introduces significant inaccuracies in entity and structural understanding. The claim that Always was grouped under 'Family Care (Paper Towels, Tissues, Toilet Paper)' in 2022 is incorrect—Always has no association with Family Care product lines like Bounty or Charmin, which are separate brands. The original answer confirms Always was always under Feminine Care, not split across categories. Additionally, the LLM incorrectly states that 'Feminine Care (Adult Incontinence, Menstrual Care)' was a 2023 subcategory structure, while the ground truth indicates a repositioning emphasis on 'Menstrual Care' as a more targeted focus within Feminine Care—not a formal renaming of the category to include Adult Incontinence and Menstrual Care as subcomponents. The reasoning is partially sound in identifying a strategic refinement, but the multi-hop synthesis fails by conflating brand portfolios and misrepresenting category hierarchies. Quantitative accuracy is not applicable here (no numbers), but all mentioned years and category names are otherwise factually plausible. Contextually, the answer addresses the evolution in positioning, so relevance is high despite factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 393,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Oracle's Oracle Engineered Systems, which are part of the hardware business, represented 6% of total revenues in both fiscal 2024 and 2023, indicating a stable financial contribution during this period. Revenue recognition for Oracle Engineered Systems occurs at the point in time when the hardware product and related software are delivered to the customer and ownership is transferred. There is no explicit mention of a significant strategic shift in positioning for Oracle Engineered Systems between 2022 and 2023, but the continued inclusion of these systems in Oracle's hardware offerings suggests they remain a consistent part of the company's product portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Oracle Engineered Systems were part of hardware revenues representing 6% of total revenue in fiscal 2023 and 2024, which matches the ground truth. It also accurately describes revenue recognition as occurring at the point in time when the product and related software are delivered. However, it omits a key point from the original answer: in 2022, no specific percentage was disclosed for Engineered Systems' contribution, which marks a shift in transparency by 2023. This missing context weakens the comparative evolution between 2022 and 2023. (2) All numeric values (6%, fiscal 2023 and 2024) are correct and properly contextualized. There are no calculation errors. (3) The reasoning is partially sound but incomplete. While the LLM correctly identifies continuity in financial contribution, it fails to highlight the strategic evolution noted in the ground truth—specifically, Oracle’s increased strategic emphasis in 2023 through R&D investments and discussion of factors affecting hardware revenue predictability (e.g., manufacturing partners, competition with cloud infrastructure). This reflects a multi-hop gap: synthesizing changes in disclosure practices and strategic language across years. (4) The answer is contextually relevant and factually accurate where provided, but lacks completeness in capturing the full scope of Oracle's evolving positioning. Hence, correctness is reduced to 7 due to missing key qualitative developments that define the 'evolution' asked in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 426,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Between 2023 and 2024, Comcast's relationship with representation firms in advertising sales has evolved to include a more collaborative approach. Specifically, the company works with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to it. Revenue from these arrangements is recorded net of agency commissions, indicating a shift toward a more agency-based model for certain advertising sales.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Comcast's use of representation firms as an extension of its sales force and notes that revenue is recorded net of agency commissions, which aligns with the 2023 arrangement described in the ground truth. However, it fails to accurately describe the evolution in 2024. The ground truth states that by 2024, Comcast had shifted to formal representation agreements where it sells advertising on behalf of third parties—indicating a more strategic, expanded role for these firms. Instead, the LLM implies the co-selling model (extension of sales force) is the evolved state, suggesting the shift was toward an 'agency-based model' without clarifying that Comcast now represents third parties, not just uses agencies to sell its own inventory. This misrepresents the direction of the evolution. There are no numerical inaccuracies (quantitative accuracy is high), but the qualitative reasoning is flawed in terms of multi-hop synthesis: the model does not correctly infer the strategic shift from a co-selling to a formal representation model. Contextually, the response is relevant and addresses the topic, but misses the key strategic transformation in 2024, resulting in partial correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 342,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Oracle's approach to its industry-specific hardware offerings between fiscal 2022 and fiscal 2023 shows a consistent strategic emphasis on providing hardware products and related software as highly integrated solutions, with revenue generally recognized at the point of delivery. In fiscal 2023, Oracle reiterated its focus on maintaining and developing hardware offerings, including industry-specific hardware, while acknowledging the challenges of lower operating margins due to production and support costs. There is no significant shift in revenue recognition practices, as hardware revenue continues to be recognized upon delivery, and hardware support is recognized ratably over the contract term. The strategic emphasis remains on supporting customer needs through a broad range of hardware and related services, though the business is positioned as a smaller portion of total revenue compared to cloud and license offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses key qualitative shifts described in the ground truth. While it correctly states that revenue recognition for hardware remains at the point of delivery in both years, it fails to mention Oracle's more detailed explanation in fiscal 2023 about combined performance obligations (hardware plus related software) and the emphasis on ownership transfer, which represents a refinement in disclosure. This omission reduces qualitative accuracy. Additionally, the LLM answer does not capture the strategic shift in R&D emphasis: in 2023, Oracle explicitly highlighted ongoing investments to improve and develop new hardware products, indicating a more innovation-focused strategy, whereas in 2022 the description was more general. The LLM instead emphasizes 'challenges of lower operating margins' and positions hardware as a smaller revenue segment—information that may be contextually relevant but is not part of the original answer and distracts from the actual evolution described in the ground truth. (2) There are no numerical values in this question, so quantitative accuracy is not applicable; however, the answer contains no incorrect dates or fiscal periods, preserving full quantitative accuracy. (3) The multi-hop reasoning is partially sound—the model correctly identifies continuity in revenue recognition and strategic continuity in integrated solutions—but fails to synthesize the nuanced evolution in both revenue recognition detail and strategic emphasis on R&D and innovation in 2023. (4) Correctness is scored at 6 due to missing key differentiators between 2022 and 2023; qualitative accuracy is 6 for incomplete reasoning, while contextual relevance is high because the answer stays on topic and discusses relevant aspects of Oracle's hardware business.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 496,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "IMBRUVICA (ibrutinib) sales declined by 13.7% in 2023 compared to 2022, primarily due to global competitive pressures. In 2022, IMBRUVICA sales had increased by 5.8% compared to 2021, driven by market leadership and share gains, but this growth was partially offset by competitive pressures and market dynamics. The decline in 2023 reflects the intensifying competition from novel oral agents in the oncology space.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 13.7% decline in IMBRUVICA sales from 2022 to 2023 and the $3.784B to $3.264B drop (3.784B * (1 - 0.137) ≈ 3.264B), which matches the ground truth. However, the LLM introduces information not present in the original answer—specifically, that IMBRUVICA sales increased by 5.8% in 2022 compared to 2021. While this may be factually accurate, it is not part of the provided ground truth and adds unsupported context, which affects completeness and reasoning fidelity. (2) The core quantitative claim—the 13.7% decline between 2022 and 2023—is accurate and correctly calculated from the given figures. All dollar amounts and percentages related to the 2022–2023 change are correct. (3) The reasoning for the decline—intensifying competition from novel oral agents—is consistent with the ground truth. However, the LLM omits mention of pandemic-related delays in new patient starts (a factor noted for 2022) and does not reference market saturation or treatment shifts in 2023, which are key elements in the original answer. This makes the explanation less complete in terms of contributing factors. (4) The answer is contextually relevant and addresses the main trend and contributing factors, but the addition of unverified prior-year growth and omission of specific 2023 dynamics (e.g., sustained competitive pressure leading to significant drop) reduce qualitative accuracy. The multi-hop synthesis is partially sound but lacks full alignment with the source truth's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 418,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "From 2023 to 2024, Comcast's involvement with Universal Beijing Resort showed slight reductions in debt levels, with outstanding debt decreasing from $3.5 billion to $3.4 billion. Ownership structure remained unchanged, with Comcast maintaining a 30% interest. Financial risk exposure also decreased slightly, as the total assets and liabilities of Universal Beijing Resort reported on Comcast's consolidated balance sheets dropped from $7.8 billion and $7.2 billion in 2023 to $7.3 billion and $7.0 billion in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in debt from $3.5 billion to $3.4 billion and accurately states Comcast's unchanged 30% ownership stake, which aligns with the ground truth. However, it introduces new financial figures—total assets and liabilities on Comcast's consolidated balance sheets ($7.8B/$7.2B in 2023 and $7.3B/$7.0B in 2024)—that are not present in the original answer and cannot be verified against the provided ground truth. These numbers may be factually incorrect or misattributed, as the ground truth does not mention them. (2) The core debt figures (total debt and term loan reduction) are mostly accurate: $3.5B to $3.4B decrease is correct; the term loan dropped from $3.1B to $3.0B, but this detail is omitted in the LLM answer. The added asset/liability figures lack corroboration and introduce quantitative inaccuracies by implying a broader financial shift not supported in the truth. (3) The multi-hop reasoning is partially sound—Comcast’s continued consolidation of Universal Beijing Resort as a VIE and stable risk exposure due to limited liability are implied through the unchanged ownership, but the LLM incorrectly suggests financial risk exposure 'decreased slightly' based on balance sheet item changes, whereas the ground truth explicitly states risk remains 'limited to its 30% equity interest' and 'stable'. This misrepresents the nature of Comcast's risk profile. (4) The correctness score is 6 due to accurate high-level trends but significant issues with unverified numbers and incorrect inference about risk exposure. Quantitative accuracy is penalized (5) for unsupported asset/liability data. Qualitative accuracy is moderate (7) as reasoning follows logical structure but misinterprets risk. Contextual relevance is high (9) as all question aspects are addressed with mostly relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 506,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "From 2022 to 2023, FedEx's financial commitment for future lease payments related to build-to-suit facilities and equipment decreased significantly, from $3.4 billion in 2022 to $0.9 billion in 2023. This reduction suggests that FedEx may have either delayed or completed the commencement of these leases during this period. The shift indicates a potential strategic adjustment in leasing activity, possibly reflecting a more measured approach to capital allocation or a shift in priorities for facility expansion and equipment acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the dollar amounts are correct: $3.4 billion in 2022 and $0.9 billion in 2023, with no calculation errors. These figures match the original answer exactly, and format is consistent. (2) The answer correctly identifies the significant reduction in future lease commitments, which is the core trend. (3) The reasoning is sound: the LLM infers a strategic adjustment in leasing, which is supported by the data. It accurately reflects a shift in leasing strategy, though it does not explicitly mention the extended timeline (commencement shifting from 2023–2024 to 2025–2027), which is a minor omission. (4) The entities (FedEx, build-to-suit facilities and equipment, future lease payments) and years (2022 to 2023) are correctly identified. (5) The answer is contextually relevant and addresses both parts of the question—evolution of financial commitment and implications for leasing strategy. The only reason for not scoring a 10 is the lack of specific mention of the delayed commencement timeline, which is a key indicator of the strategic shift toward fewer long-term commitments and phased asset utilization. However, the conclusion about a more measured approach is semantically equivalent and logically derived.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 364,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Between 2023 and 2024, Mastercard's relationship with Dynamic Yield LTD remained static, as no new acquisitions or developments involving Dynamic Yield were mentioned in the 2024 10-K filing. The 2023 10-K notes that Mastercard acquired Dynamic Yield in 2022 for $325 million, primarily to enhance its digital engagement and personalization capabilities. Since there is no mention of further integration or new initiatives related to Dynamic Yield in 2024, it suggests that the company focused on consolidating and leveraging existing acquisitions, such as Recorded Future in 2024, to expand its cybersecurity and threat intelligence offerings during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Mastercard acquired Dynamic Yield in 2022 for $325 million, aligning with the ground truth. It accurately notes the absence of new developments or mentions in the 2024 10-K, indicating a stable, post-integration relationship. The strategic pivot toward cybersecurity via the Recorded Future acquisition in 2024 is correctly inferred. However, the LLM omits the specific detail that $200 million of goodwill was attributed to synergies, which is a minor but relevant financial nuance from the original answer. (2) All numeric values—acquisition year (2022), acquisition price ($325 million)—are correct and match the ground truth. No calculations were required, but factual consistency is maintained. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across 2023 and 2024 filings, infers integration completion from lack of updates, and connects the shift in focus to the Recorded Future acquisition. The omission of the goodwill detail slightly weakens completeness but does not impair overall reasoning. (4) The answer is contextually fully relevant, directly addressing the evolution of the relationship and strategic implications. The conclusion about strategic focus on cybersecurity is well-supported and semantically equivalent to the original. Minor omission prevents a perfect 10, but the answer is factually strong and logically coherent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 397,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Severance Plan for Senior Officers at Lowe's was amended and restated on May 26, 2022, as noted in the 2024 filing (page 79). This amendment was incorporated by reference from a 10-Q filing with a reported filing date of November 27, 2024, indicating a subsequent update or reference to the plan in 2024. No further amendments between 2022 and 2024 are explicitly mentioned in the provided pages.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all key aspects: it correctly identifies the most recent amendment date of the Severance Plan for Senior Officers as May 26, 2022, and notes the November 27, 2024 filing date (Exhibit 10.28), matching the ground truth. The reference to the 2024 filing (page 79) and incorporation by reference from a 10-Q aligns with the disclosure pattern in SEC filings. The only minor shortcoming is that it does not explicitly mention the prior version of the plan (amended May 29, 2020, filed August 26, 2020, Exhibit 10.29) referenced in the 2022 context, which limits completeness slightly on the 'evolution' aspect of the question. However, the core evolution — the 2022 amendment and its 2024 disclosure — is accurately captured. All dates and filing references are correct (quantitative accuracy is perfect). The reasoning is sound, correctly interpreting the amendment date versus the filing date. The answer is contextually relevant and conveys the essential evolution of the plan. Thus, while slightly less complete than the original answer, it retains high factual and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 318,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $830 million as of December 31, 2022, to $872 million as of December 31, 2023. This increase in fair value suggests that market perceptions of Netflix's debt improved during this period, likely reflecting greater confidence in the company's financial stability or creditworthiness.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states the fair value decreased from $999 million on December 31, 2021, to $872 million on December 31, 2023. The LLM incorrectly reports a starting value of $830 million on December 31, 2022 (wrong year and wrong amount), and frames the change as an increase, when it was actually a decrease. This misrepresents both the direction and magnitude of the change. (2) The numbers are quantitatively incorrect: the correct starting value is $999M (not $830M), and the time period should be 2021–2023 (not 2022–2023). The final value ($872M) is correct. The calculation of change is therefore wrong: actual change is a decrease of $127M, not an increase of $42M. (3) The multi-hop reasoning is flawed. The question asks for the evolution between 2021 and 2023, requiring retrieval of two specific data points across years. The LLM fails to retrieve the 2021 value and substitutes a 2022 figure not mentioned in the ground truth, introducing a non-existent data point. The conclusion about improving market perceptions contradicts the ground truth interpretation, which associates the decline in fair value with reduced market confidence or higher required yields. (4) Scores are low due to major factual and directional errors in financial data and misinterpretation of market implications. Contextual relevance is moderate because the answer addresses the right type of metric and company, and attempts correct interpretation logic, albeit on wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 423,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "Between 2022 and 2023, IMBRUVICA (ibrutinib) sales declined by 13.7%, from $3.784 billion to $3.264 billion. This decline was primarily driven by global competitive pressures in the oncology segment. This indicates that IMBRUVICA is facing increasing competition, which is eroding its market position despite continued market growth in its therapeutic areas.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. It states that IMBRUVICA sales in 2022 were $3.784 billion, but the ground truth is $4,369 million ($4.369 billion), which is a substantial difference of nearly $585 million. The 2023 sales figure of $3.264 billion is correct. As a result, the calculated decline of 13.7% is incorrect. The correct decline is (4,369 - 3,264) / 4,369 = 1,105 / 4,369 ≈ 25.2%, as stated in the original answer. The LLM's calculation based on its incorrect starting number is internally consistent (from $3.784B to $3.264B is ~13.7%), but the input data is wrong, leading to a misleading conclusion. (2) The qualitative reasoning about competitive pressures and eroding market position aligns with the ground truth and is plausible, especially given that other oncology drugs like DARZALEX and ERLEADA are growing. However, the LLM omits the comparative context explicitly mentioned in the original answer, which strengthens the inference about weakening market position. (3) The multi-hop reasoning is partially sound—linking sales decline to competitive dynamics in oncology—but fails to incorporate cross-product performance data that supports the conclusion, which was present in the knowledge graph. (4) The contextual relevance is high because the answer addresses both parts of the question: sales evolution and market position implication. However, due to the critical error in the 2022 sales figure and the resulting incorrect percentage decline, the overall correctness score is significantly reduced. Quantitative accuracy is low due to the wrong sales number and incorrect percentage. Qualitative accuracy is moderate because the reasoning direction is valid but lacks supporting evidence from other products. Contextual relevance is strong as the response stays on topic and attempts a synthesized interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 514,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million in 2022 to $427 million in 2024, while the LCNRV reserve decreased from $168 million in 2022 to $222 million in 2024. The increase in the shrink reserve suggests higher estimated shrinkage rates or inventory volumes, while the LCNRV reserve decrease implies improved inventory valuation or lower markdown expectations. A 10% change in the shrink reserve would have impacted net earnings by approximately $31 million in 2022 and $32 million in 2024, indicating a growing sensitivity to shrinkage adjustments. The LCNRV reserve changes had a smaller impact, with a 10% change affecting net earnings by about $17 million in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the LCNRV reserve 'decreased' from $168 million to $222 million, when in fact it increased. This misrepresents the direction of change and undermines the accuracy of the response. All other numerical values are correct: the shrink reserve increased from $414M to $427M, and the sensitivity impacts on net earnings ($32M for a 10% change in shrink, $17M for LCNRV) are accurately reported. (2) Quantitative accuracy is partially compromised due to the incorrect characterization of the LCNRV reserve trend, even though the dollar amounts themselves are correctly cited. The calculation implications for net earnings are accurate. (3) The reasoning is mostly sound—correctly inferring that higher reserves imply greater sensitivity of net earnings to inventory assumptions—but the erroneous claim about the LCNRV reserve decreasing leads to incorrect qualitative interpretation (e.g., 'improved inventory valuation or lower markdown expectations' is unsupported and false). (4) Contextual relevance is high as the answer addresses both reserves, their evolution, and earnings implications. However, the directional error in the LCNRV trend significantly reduces factual correctness, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 368,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "Qulipta's status and financial contribution evolved significantly from 2022 to 2023. In 2022, Qulipta's U.S. net revenues were $158 million, and it had no international sales. By 2023, Qulipta's U.S. net revenues surged to $405 million, and international sales reached $3 million, representing a more than 100% increase overall. This growth was driven by strong market share uptake, market expansion, and regulatory approvals, including FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for migraine prevention in the EU.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 revenue figure. The ground truth states that in 2022, Qulipta contributed to the reclassification of $1.0 billion in R&D intangible assets upon regulatory approval, but does not report any specific revenue for 2022. However, the LLM claims Qulipta had $158 million in U.S. net revenues in 2022, which is not supported by the original answer and contradicts the narrative that it was transitioning from development to commercialization. The 2023 figures ($405 million U.S., $3 million international) are correct. (2) The calculation of 'more than 100% increase' is based on incorrect prior-year data and is therefore misleading. Additionally, the mention of FDA approval in April 2023 and EC approval in August 2023 is not present in the original answer and introduces unverified details—while plausible, they are not part of the ground truth and represent unsupported additions. (3) The multi-hop reasoning is partially sound in linking development to commercialization, but fails in accurately representing the nature of Qulipta’s 2022 status. The original answer emphasizes that 2022 marked a reclassification due to regulatory approval (indicating transition), not commercial revenue generation. The LLM incorrectly portrays 2022 as already having substantial revenue, undermining the evolution narrative. (4) Scores reflect major quantitative errors (especially the unsupported $158M), partial qualitative accuracy in describing commercialization progress, and high contextual relevance as the answer addresses the evolution of status and financial contribution, albeit with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 461,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Between 2022 and 2023, Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent in terms of quarterly reimbursements, which were $140 million in both years. However, the recorded receivable from Resideo increased from $615 million at the end of 2022 to $641 million by the end of 2023. This suggests that Honeywell incurred higher environmental costs in 2023, which were partially offset by Resideo's reimbursement obligations. Despite this increase, the capped reimbursement of $140 million per year limits the extent to which Resideo can mitigate Honeywell's exposure. This indicates that while Resideo provides some financial relief, Honeywell still retains significant risk exposure for environmental liabilities beyond what Resideo is obligated to cover.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Resideo is obligated to pay 90% of Honeywell's annual net spending on environmental matters up to a maximum of $140 million per year, not that Resideo paid $140 million in quarterly reimbursements. The LLM incorrectly claims that 'quarterly reimbursements' were $140 million in both years, which is false—$140 million is the annual cap, not a quarterly amount. This misrepresents the financial arrangement and introduces a major quantitative error. Additionally, the ground truth does not mention a receivable of $615 million or $641 million, nor does it state that the receivable increased; these figures are unsupported and likely hallucinated. (2) The numbers cited in the LLM answer—$140 million quarterly (implying $560 million annually), $615M, and $641M—are all incorrect or misrepresented. The $140 million figure is an annual maximum, not quarterly, so stating it as such is a critical error. The receivable amounts are not present in the ground truth and contradict the known terms of the agreement. (3) The multi-hop reasoning is partially sound in that the model attempts to assess risk exposure over time and links Resideo's payments to Honeywell's cost mitigation. However, because the underlying data is wrong, the conclusion about increased costs in 2023 and rising dependency is unfounded. The actual answer emphasizes consistency in the arrangement, which the LLM fails to convey. (4) The contextual relevance is high because the answer addresses the evolution of dependency and risk exposure as asked. However, due to severe quantitative inaccuracies and incorrect entity relationships (especially the mischaracterization of the $140M cap), the correctness and qualitative accuracy scores are low. The answer appears plausible but is factually incorrect on key financial terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 513,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target's definition of 'original maturity' for cash equivalents has remained consistent between 2022 and 2024, defined as highly liquid investments with an original maturity of three months or less from the time of purchase. This consistency indicates no material change in Target's cash management strategy regarding short-term liquidity. However, the increase in short-term investments from $4,985 million in 2022 to $3,893 million in 2024 suggests a potential reallocation or management of cash reserves, though the core treatment of cash equivalents remains unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Target's definition of 'original maturity' for cash equivalents remained at three months or less from 2022 to 2024, which aligns with the ground truth. However, it introduces incorrect quantitative data: it claims short-term investments increased from $4,985 million in 2022 to $3,893 million in 2024, which is factually wrong—$3,893 million is less than $4,985 million, so this is a decrease, not an increase. Additionally, these specific figures are not present in the ground truth and appear to be fabricated or misstated, severely undermining quantitative accuracy. (2) The ground truth highlights that in 2024, Target added broader discussion around fair value measurements for short-term assets and liabilities, indicating a more comprehensive financial framework. The LLM answer omits this key qualitative evolution and instead incorrectly infers a 'reallocation of cash reserves' based on flawed numbers, missing the actual nuance about enhanced disclosure and valuation practices. (3) While the LLM correctly identifies the consistent three-month threshold (correct single-hop fact), it fails in multi-hop synthesis by not connecting the definitional consistency with the expanded context in 2024 filings regarding fair value. Instead, it introduces irrelevant and incorrect numerical trends to suggest strategic shifts, demonstrating flawed reasoning. (4) The contextual relevance is fair because the answer addresses the core concept of cash equivalent treatment and attempts to infer strategy, but the incorrect numbers and missed qualitative development reduce overall correctness. The answer is partially right on definition but significantly flawed in data and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 474,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "The valuation of NVDA's 3.50% Notes Due 2040 decreased slightly from $870 million in 2023 to $851 million in 2024, indicating a minor decline in fair value, likely due to interest rate fluctuations. These notes are classified as Level 2 liabilities and are carried at original issuance value, net of unamortized debt discount and issuance costs. The consistent presence of these long-term notes in both years, alongside other long-term debt instruments, suggests that NVDA maintains a stable and diversified long-term debt strategy to manage its capital structure and funding needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It states that the valuation of NVDA's 3.50% Notes Due 2040 decreased from $870 million in 2023 to $851 million in 2024, which is incorrect. According to the ground truth, the carrying value was $851 million as of January 28, 2024 (reporting 2023 data), and increased to $1,000 million as of January 26, 2025 (reporting 2024 data). The LLM incorrectly reports a decrease when there was actually a substantial increase. Additionally, the LLM invents a $870 million figure not present in the original data. (2) The quantitative inaccuracies are severe: the direction of change (decrease vs. actual increase), the starting value ($870M vs. $851M), and the ending value ($851M vs. $1,000M) are all wrong. The effective interest rate (3.54%) and remaining term (15.2 years) mentioned in the ground truth are omitted. (3) The reasoning is flawed: the conclusion about 'minor decline in fair value due to interest rate fluctuations' is based on incorrect data. While the LLM correctly identifies the Level 2 classification and general idea of long-term debt strategy, it fails the multi-hop synthesis—comparing valuation changes over time—due to incorrect numbers. (4) The contextual relevance is moderate because it addresses the right topic (debt strategy and classification), but the factual foundation is unsound, undermining the analysis. Correctness is severely penalized due to wrong numbers and direction of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 409,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Venclexta's financial performance improved between 2022 and 2023, with total global revenue increasing by 15%. In the United States, revenue grew by 8%, driven by market growth, market share gains, and favorable pricing. Internationally, revenue increased by 22%, primarily due to market share gains and continued growth across all indications.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative metrics. According to the ground truth, Venclexta's total global revenue was $2,009 million in 2022 and $2,288 million in 2023, representing a year-over-year growth rate of 13.9% in 2023 (and 10.4% in 2022). The LLM incorrectly states that revenue increased by 15% globally, which does not match the actual growth rate (13.9%) or the exact dollar increase ($279 million, which is ~13.9%, not 15%). Additionally, the LLM introduces U.S. and international revenue growth figures (8% and 22%) that are not present in the original answer and were not asked for in the question, suggesting potential hallucination or misattribution. (2) The calculation of growth rate is inaccurate: ($2,288M - $2,009M) / $2,009M = 0.1386 (~13.9%), not 15%. The LLM’s 15% figure is materially off. (3) While the LLM correctly infers an upward trend in performance, it fails to report the actual revenue figures and correct growth rates required by the question. It also does not mention the 2022 growth rate (10.4%), omitting a key part of the multi-hop comparison. The reasoning is partially sound in identifying improvement, but lacks fidelity to the source data. (4) The answer is contextually relevant—addressing revenue evolution between 2022 and 2023—but fails on quantitative precision and completeness. Due to major errors in core numbers and missing required metrics, the correctness score is low despite some directional accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 416,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "Between 2022 and 2023, Netflix amended its Executive Severance and Retention Incentive Plan, with the Amended and Restated version effective as of January 1, 2024, as disclosed in the 2023 filing. This represents an update to the prior plan, which was last amended and restated on September 10, 2021, according to the 2022 filing. No other specific changes to severance or retention incentives were detailed in the provided pages.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key dates and plan names are correct: the 2022 filing references the plan amended on September 10, 2021, and the 2023 filing introduces the plan as amended and restated effective January 1, 2024, with a filing date of December 8, 2023. The LLM correctly identifies both the prior and updated plan effective dates. (2) Quantitative accuracy is perfect—dates (September 10, 2021; January 1, 2024; December 8, 2023) are all correctly reported. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings to show evolution in the plan. (4) The only minor shortcoming is that the LLM does not explicitly mention the December 8, 2023 filing date of the new amendment, which is included in the ground truth and adds context about when the 2024-effective amendment was formally disclosed. However, stating the plan is 'effective January 1, 2024, as disclosed in the 2023 filing' is semantically close and does not detract significantly from accuracy. Overall, the answer is concise, correct, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 320,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "From 2022 to 2024, Lowe's amended and restated its Benefit Restoration Plan as of January 1, 2025, indicating a structured update to the plan's terms. This evolution suggests that Lowe's is proactively aligning its retirement benefits with changing regulatory or internal compensation strategies, emphasizing continued support for employees whose benefits are limited under the 401(k) Plan due to IRS provisions. This reflects a commitment to maintaining competitive retirement benefits for eligible employees.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately identifies the key evolution: Lowe's amended and restated its Benefit Restoration Plan effective January 1, 2025, reflecting a structured update from its prior form in 2022. The date (January 1, 2025) and the nature of the change (amended and restated) match the original answer. While the LLM does not explicitly mention the 2024 10-K filing or exhibit 10.3, it correctly infers the plan update occurred by 2024 in preparation for the 2025 effective date, which is consistent with SEC filing timelines. The explanation that this reflects proactive alignment with regulatory or internal strategies is logically sound and semantically equivalent to the ground truth's interpretation of a 'strategic and forward-looking approach.' The LLM correctly identifies the plan’s purpose—supporting employees affected by IRS limits on 401(k) contributions—and maintains accurate entity references (Lowe's, Benefit Restoration Plan, 401(k), IRS). However, it omits specific structural details mentioned in the original answer, such as the inclusion of both employee salary deferrals and employer match components in the plan design, which represents a minor gap in completeness. There are no numerical inaccuracies (quantitative accuracy is high, hence 9), and reasoning is sound across the multi-hop elements (tracking plan structure over time and inferring strategic intent). Contextual relevance is perfect—the response directly addresses the evolution and implications. Thus, the answer is strong but slightly less detailed than the ground truth, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 451,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "The financial obligations related to NVDA's 0.584% Notes Due 2024 decreased between fiscal years 2023 and 2024. As of January 29, 2023, the fair value of these notes was $1,185 million, and by January 28, 2024, it had increased slightly to $1,228 million. However, in fiscal year 2025 (as of January 26, 2025), the notes were fully repaid, with their value listed as $0, indicating the obligation was settled.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, NVDA's liability for the 0.584% Notes Due 2024 was $1,185 million in fiscal year 2023 and was fully repaid by fiscal year 2024. However, the LLM claims the fair value increased to $1,228 million by January 28, 2024 (end of fiscal 2024), which contradicts the ground truth that the obligation was fully repaid. It further states repayment occurred in fiscal year 2025 (as of January 26, 2025), which is incorrect—the repayment was reported in the 2024 10-K, meaning it occurred by the end of fiscal 2024. (2) Quantitative accuracy is low: while $1,185 million is correct for 2023, the $1,228 million value in 2024 is unsupported and incorrect; the correct value should be $0 by end of 2024. The dates (January 29, 2023, January 28, 2024) may align with NVDA’s fiscal year-ends, but associating repayment with fiscal 2025 is factually wrong. (3) Multi-hop reasoning failed: the model incorrectly synthesized the timeline and status of debt repayment. It misinterprets when the obligation was settled, introducing a future repayment date not in the original data. (4) Contextual relevance is moderate—the answer addresses the right instrument and company and attempts to track changes over time, but the core conclusion (obligation decreased) is misleading since it implies a gradual decline when in fact it was fully resolved by 2024. The answer introduces false intermediate values and delays repayment to 2025, undermining correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 423,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Between 2022 and 2023, Mavyret's global revenue decreased by 7.2% (from $1,541 million in 2022 to $1,430 million in 2023). In the United States, revenue for Mavyret declined by 12.7% (from $755 million in 2022 to $659 million in 2023), while international revenue saw a smaller decline of 1.9% (from $786 million in 2022 to $771 million in 2023).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: 2022 global revenue ($1,541 million), 2023 global revenue ($1,430 million), U.S. revenue in 2022 ($755 million) and 2023 ($659 million), international revenue in 2022 ($786 million) and 2023 ($771 million). (2) Percentages are correctly calculated: the 12.7% U.S. decline ((755-659)/755 ≈ 12.7%) and 1.9% international decline ((786-771)/786 ≈ 1.9%) match the ground truth. The overall global decline is accurately implied as ~7.2% ((1541-1430)/1541 ≈ 7.2%). (3) The multi-hop reasoning is sound—information is synthesized across both years and both regions to describe the trend in global, U.S., and international performance. (4) The answer addresses all parts of the question: global revenue evolution, U.S. trends, and international trends. While the LLM answer is more concise than the original, it maintains full semantic equivalence without omitting critical context. All entities (Mavyret, U.S., international, 2022, 2023) are correctly identified and used. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 321,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "Between 2022 and 2024, Netflix remained in compliance with the covenant limitations related to its Senior Notes, with no violations reported in any of the periods. The covenants primarily restricted the Company's ability to incur additional debt, create liens, and engage in certain corporate actions such as mergers or asset sales. In 2024, Netflix entered into a new $3 billion five-year Revolving Credit Agreement, which included a financial covenant requiring the maintenance of a minimum consolidated EBITDA to interest expense ratio of 3.0 to 1.0, a more specific metric compared to prior years. The Company was in compliance with all covenants as of December 31, 2024, and no material changes in the scope of restrictions were noted during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Netflix remained in compliance with covenants in both 2022 and 2024, it introduces a $3 billion five-year Revolving Credit Agreement with a financial covenant (minimum EBITDA to interest ratio of 3.0 to 1.0) that is not present in the ground truth and is not mentioned in the original answer. This is a major fabrication or misattribution not supported by the provided data. Additionally, the LLM claims 'no material changes in the scope of restrictions were noted,' which directly contradicts the ground truth stating that by 2024, certain Senior Notes no longer included restrictions on sale and lease-back transactions—a narrowing of covenant scope. The repayment of $400 million of 5.750% Senior Notes in 2024 is completely omitted from the LLM answer, which is a key factual event related to debt management and evolution of repayment obligations. (2) Quantitatively, the $3 billion revolving credit facility is incorrect and unsupported. The ground truth mentions €5,170 million in euro-denominated Senior Notes in 2022 and a $400 million repayment in 2024, none of which are accurately reflected in the LLM response. The $400 million repayment is entirely missing, and the €5,170 million total is not referenced. (3) The multi-hop reasoning is flawed: the question asks about the evolution of covenant limitations and repayment obligations between 2022 and 2024. The LLM fails to compare changes in covenant scope (e.g., removal of sale and lease-back restrictions) and instead asserts no material changes, which is incorrect. It also conflates Senior Notes covenants with a new credit agreement not mentioned in the ground truth, indicating poor synthesis. (4) Despite these issues, the answer is contextually relevant—addressing compliance, covenants, and debt management—and correctly notes ongoing compliance, which aligns with the ground truth. However, the introduction of false financial instruments and omission of key repayment and covenant changes severely undermine factual accuracy, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 574,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "Between 2022 and 2023, Honeywell's approach to the Safety and Retail product line evolved through a structural realignment. In July 2022, the Safety and Retail business unit was combined with the Advanced Sensing Technologies business unit to form the Sensing and Safety Technologies business unit. This realignment reflects a shift toward integrating safety technologies with sensing capabilities to enhance product offerings and operational efficiency. The change was implemented within the Safety and Productivity Solutions segment, streamlining operations and focusing on broader safety and productivity solutions for customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the Safety and Retail unit was merged with Advanced Sensing Technologies to form Sensing and Safety Technologies; the change occurred in July 2022 and was reflected in the 2023 reporting cycle; the strategic rationale of integrating sensing and safety technologies is correctly explained. (2) Quantitative accuracy is perfect: while the LLM does not explicitly mention the $2,387 million revenue figure from 2022, this omission does not detract significantly from the core of the question, which focuses on the structural evolution and change. No incorrect numbers or dates are presented. (3) Multi-hop reasoning is sound—the model correctly synthesizes the timing (July 2022 action, reported in 2023), the entities involved (Safety and Retail + Advanced Sensing Technologies), and the strategic intent. (4) The answer is contextually relevant and directly addresses both parts of the question: the evolution of approach and the structural change. The only minor shortcoming is the omission of the specific 2022 revenue figure, which was included in the original answer and could have strengthened completeness. However, since the question does not explicitly ask for financial performance, this is not a critical error. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 394,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "Between 2023 and 2024, the status of Class B-2 Common Stock evolved significantly, primarily due to its convertibility into Class A Common Stock. In 2023, Class B-2 Common Stock had no outstanding shares and no earnings per share, as noted in the 2023 10-K. However, by 2024, 49 shares of Class B-2 Common Stock were outstanding, and it had a basic and diluted earnings per share of $15.45 and $15.43, respectively. This change indicates that the Class B-2 Common Stock became active and tradable during this period, likely as a result of the Class B-1 Common Stock exchange offer. The impact on corporate governance is evident in the increased voting power and influence of Class B-2 Common Stockholders, as their shares now contribute to the overall governance structure of the company.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) Quantitatively, the LLM claims that in 2023 there were no outstanding shares of Class B-2 Common Stock and in 2024 there were 49 shares outstanding with earnings per share of $15.45 and $15.43. However, the ground truth states that by 2024, no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer, meaning the stock was being phased out, not activated. The specific numbers (49 shares, EPS values) are fabricated and not supported by the original answer. (2) The LLM incorrectly asserts that Class B-2 became active and tradable in 2024, while the original answer indicates the opposite: Class B-2 was no longer outstanding, signaling its elimination. (3) The reasoning is fundamentally flawed: the LLM suggests increased governance influence due to new activity, but the ground truth describes a reduction in influence because the shares were no longer outstanding. (4) The answer fails on multi-hop synthesis—instead of recognizing the discontinuation of Class B-2, it invents a narrative of activation and financial performance. While the mention of convertibility into Class A stock aligns loosely with the 2023 description, the overall trajectory is reversed. The contextual relevance is low because the answer describes the opposite evolution of the stock. Only minimal credit is given for mentioning convertibility and governance, but factual and directional errors dominate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 407,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "Between 2023 and 2024, The Home Depot enhanced the ease of shopping experience by expanding both digital and in-store capabilities. In 2024, the company continued to invest in store infrastructure, such as wayfinding signage, self-service lockers, curbside service, electronic shelf labels, and redesigned checkout areas, while also empowering customers with mobile app-enabled store navigation. Additionally, they opened 12 new stores in 2024 as part of a five-year plan to address market voids and improve customer access. Digitally, they focused on improving their platforms by enhancing search capabilities, site functionality, product content, and fulfillment options, aiming to deliver a seamless, interconnected experience across all channels.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies The Home Depot's continued investment in digital and in-store capabilities between 2023 and 2024, and includes accurate elements such as mobile app-enabled navigation, electronic shelf labels, and checkout improvements. It also correctly notes digital enhancements like product content and site functionality. However, it introduces details not present in the ground truth, such as 'wayfinding signage,' 'self-service lockers,' 'curbside service,' and the opening of 12 new stores in 2024, which were not mentioned in the original answer and cannot be verified from the provided knowledge. These additions, while plausible, represent unverified expansions. Additionally, the LLM answer omits key 2024-specific advancements highlighted in the ground truth, particularly the use of customer data for personalized experiences, customer review summaries, and the strategic shift toward data-driven personalization. (2) There are no numeric values, dates, or calculations in the original or LLM answer that conflict—any numbers (e.g., '12 new stores') introduced are not contradicted by the ground truth but are unsupported, hence not penalized in quantitative accuracy since they don’t directly conflict. (3) The multi-hop reasoning is partially sound—the model connects in-store and digital improvements across years, but fails to fully synthesize the evolution from infrastructure-focused (2023) to data-personalization-focused (2024) strategy, which is the core of the ground truth’s narrative. (4) The correctness score is 7 because the answer captures the general direction of improvement and includes many accurate elements, but misses the key strategic shift toward personalization and adds unverified initiatives. Quantitative accuracy is 10 because no incorrect numbers are presented. Qualitative accuracy is 7 due to partial reasoning and missing conceptual evolution. Contextual relevance is 9 as the response stays on-topic and addresses the question’s scope with high relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 548,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "From 2022 to 2024, the Target Corporation Long-Term Incentive Plan evolved by introducing more specific and varied forms of equity awards. In 2022, the plan included forms such as Restricted Stock Units (RSUs), Performance-Based RSUs, and Performance Share Units. By 2024, the plan expanded further, incorporating additional award structures such as Cliff-Vested RSUs and Performance Award Performance Share Units, indicating a more nuanced approach to long-term incentives for employees.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Target Corporation's Long-Term Incentive Plan from 2022 to 2024. It accurately identifies the core equity award types present in 2022, including Restricted Stock Units (RSUs), Performance-Based RSUs, and Performance Share Units, which are subsets of the more comprehensive list in the ground truth (which also includes Non-Qualified Stock Options, Price-Vested Options, and Non-Employee Director awards). While the LLM omits these additional forms, it correctly highlights the introduction of Cliff-Vested RSUs and Performance Award Performance Share Units in 2024, aligning with the ground truth's indication of expanded award types. The dates (2022 and 204) are correct, and there are no numerical inaccuracies (no calculations required). The reasoning is sound in showing an expansion and increased nuance in equity compensation. The omission of some 2022 award types reduces completeness slightly, but the core multi-hop synthesis—comparing plan structures across years and identifying new award forms—is accurate and contextually relevant. Semantic equivalence is maintained for the key developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 329,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Qulipta's commercial performance saw significant growth from its FDA approval in 2021 through 2023. In 2021, Qulipta generated $0 in net revenues, as it was newly approved. By 2022, its net revenues reached $158 million, and in 2023, they surged to $405 million in the United States alone, with international revenues also showing strong growth. This growth was driven by continued market share uptake and favorable regulatory approvals, including for the preventive treatment of chronic migraine in adults.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Qulipta generated $0 in 2021, $158 million in 2022, and $405 million in U.S. revenue in 2023, which matches the ground truth. It omits the $3 million in international revenue in 2023, which slightly reduces completeness but does not invalidate the core financial narrative. (2) All numeric values—$0 in 2021, $158M in 2022, $405M U.S. in 2023—are accurate and correctly attributed to the right years and geographies. The total revenue of $408M in 2023 is implied by stating $405M in the U.S. and 'strong international growth,' though the exact $3M figure is missing. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly traces Qulipta’s performance from approval (2021) through 2023 using financial disclosures, synthesizing year-over-year growth. It appropriately infers strong market adoption, though it adds a detail about approval for chronic migraine not present in the ground truth, which may be factually accurate but not supported by the provided context. (4) The answer is highly relevant, directly addressing the evolution of commercial performance. The omission of the exact international revenue and the slight overstatement about chronic migraine approval prevent a perfect score, but overall, the answer is factually strong, well-reasoned, and semantically aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 384,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "Netflix's 2020 Stock Plan is described in both the 2022 and 2024 SEC filings as a stockholder-approved plan allowing for the issuance of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock, and restricted stock units to employees, directors, and consultants. In 2022, the plan's activities included the granting of RSUs and PSUs with vesting over three-year periods and performance-based vesting. By 2024, the plan continued to focus on RSUs and PSUs, but no new stock options or RSUs were granted in 2023 and 2022, respectively. Additionally, the 2024 filing notes that the total fair value of RSUs that vested in 2024 was $15 million, showing a significant decline from prior years' stock-based compensation expenses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, the 2020 Stock Plan was only referenced in the exhibit list (Def 14A, filed April 22, 2020) with no detailed description or disclosure of equity compensation activities. However, the LLM claims that in 2022, the plan included granting RSUs and PSUs with three-year vesting and performance-based criteria—this is incorrect and contradicts the ground truth. The ground truth states that detailed disclosure only began in 2024, but the LLM implies such details were already present in 2022. (2) The LLM introduces specific numbers not present in the ground truth, such as 'the total fair value of RSUs that vested in 2024 was $15 million' and comparisons to prior years’ stock-based compensation. These figures are unsupported by the original answer and likely fabricated. There is no mention of $15 million or any quantitative financial data in the ground truth. (3) The multi-hop reasoning is flawed. The question asks for a comparison of how the *treatment and disclosure* of the plan evolved. The ground truth emphasizes a shift from passive documentation (2022) to active, detailed disclosure (2024). The LLM instead focuses on operational equity activities (e.g., grants, vesting) that are not supported for 2022 and misrepresents the evolution. It fails to identify the core shift from mere exhibit inclusion to substantive description. (4) While the LLM correctly identifies the types of awards (RSUs, options, etc.) as part of the plan, this generic description does not reflect the actual evolution in *disclosure practices*. The contextual relevance is moderate because it addresses the plan and equity compensation, but the qualitative and quantitative inaccuracies severely undermine correctness. Hence, low scores in quantitative (2) and qualitative accuracy (3), and a correctness score of 3 for being mostly incorrect with only minor factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 533,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "Between 2022 and 2023, Boeing's approach to aluminum purchase agreements remained consistent in their classification as derivative instruments for accounting purposes due to their pricing at prevailing market rates and offsetting quantities. However, there was a strategic shift in the notional amounts of these agreements, with the notional value of commodity contracts under non-hedge accounting treatment decreasing from $412 million in 2022 to $115 million in 2023. This suggests a potential reduction in the volume of unhedged aluminum contracts or a shift in sourcing strategy. Additionally, the company continued to use commodity swaps and fixed-price purchase commitments as cash flow hedges, with commodity contracts hedging forecasted transactions through 2028 in 2023, compared to 2029 in 2022, indicating a slight shortening of the hedging horizon.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) The company in question is not Boeing—this entity is not mentioned in the original answer, making the identification incorrect. (2) The quantitative figures—$412 million in 2022 and $115 million in 2023—are not present in the ground truth and cannot be verified; these numbers are likely fabricated or misattributed. (3) The claim about hedging horizons extending to 2028 in 2023 versus 2029 in 2022 is unsupported by the original answer, which does not mention hedging durations or changes in hedging periods. (4) While the LLM correctly identifies that aluminum purchase agreements are classified as derivative instruments and involve offsetting quantities and market pricing, this is only partially aligned with the ground truth, which emphasizes a refinement in strategic clarity around market pricing and offsetting positions—not changes in notional amounts or hedging timelines. (5) The reasoning is flawed due to reliance on incorrect data and entities, undermining the multi-hop synthesis. Although the answer addresses the general theme of classification and strategy evolution, it fails on core factual accuracy, especially regarding numbers, company identity, and specific strategic developments. The contextual relevance is moderate because the topic and conceptual framework (derivatives, hedging, market pricing) are relevant, but the specifics are largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 411,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "Between 2023 and 2024, the Directors' Code of Conduct remained accessible on the company's website, with no changes to its availability. In both years, the code was posted at a dedicated URL under investor relations, and the company committed to disclosing amendments or waivers on its website. However, the 2024 filing added a separate section titled \"Insider Trading Policies and Procedures,\" which was not explicitly mentioned in 2023, indicating an expanded focus on governance-related disclosures. The scope of the Directors' Code of Conduct itself was not explicitly modified in the provided pages.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the addition of the 'Insider Trading Policies and Procedures' section in 2024, which was not present in 2023, reflecting an expanded scope in governance disclosures—this aligns with the ground truth and supports partial credit for qualitative accuracy. However, the LLM incorrectly states that there was 'no change' in the URL or accessibility of the Directors' Code of Conduct. The ground truth explicitly notes a URL change from 2023 (https://www.bnymellon.com/...) to 2024 (https://www.bny.com/...), reflecting a rebranding and structural shift in document categorization (e.g., domain change from 'bnymellon.com' to 'bny.com', path updates like 'inv relations' to 'investor-relations'). This error undermines the correctness of the accessibility analysis, which is a core part of the question. While the LLM acknowledges continued web accessibility and disclosure practices, it fails to report the actual URL change, leading to a significant factual omission. The entity names and years are correct, and the reasoning around expanded disclosure scope is sound, but the failure to detect and report the URL change—a key evolution in accessibility—results in a moderate correctness score. Quantitative accuracy is high because no numerical data is misstated (the issue is missing textual details, not numbers), and contextual relevance remains strong as the response addresses both accessibility and scope as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 399,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "In 2023, HD issued $750 million of 4.95% Senior Notes due September 30, 2026. In 2024, HD further increased its issuance of 4.95% Senior Notes by $1.75 billion, with a maturity date of June 25, 2034. This indicates a strategic move to extend the maturity profile of HD's long-term debt, potentially to lock in favorable interest rates for a longer period and manage refinancing risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that HD issued $750 million of 4.95% Senior Notes due September 30, 2026, in 2023, it incorrectly claims that in 2024 HD issued an additional $1.75 billion of 4.95% Senior Notes due June 25, 2034. The ground truth states that in 2024, HD reported $980 million in 4.95% senior notes due September 2052—not June 2034, and not as part of a $1.75 billion issuance. There is no mention of a June 2034 maturity or a $1.75 billion issuance in the original data. Additionally, the LLM omits the $1.6 million discount and the 2024 carrying amount of $747 million as of February 2, 2025, for the 2026 notes, which are key quantitative details. (2) The quantitative inaccuracies are severe: the maturity date (2034 vs. 2052), the amount ($1.75 billion vs. $980 million), and the absence of the discount and carrying value reduce numerical precision. The LLM also fails to note that the 2052 notes are a separate issuance with the same coupon but different maturity, not an extension of the 2026 notes. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that extending maturities suggests a strategy to lock in rates and manage refinancing risk, which aligns with the ground truth’s interpretation. However, because the underlying data is incorrect, the reasoning is based on false premises. (4) The contextual relevance is fair, as the answer addresses the evolution of HD's debt structure and attempts to interpret strategy, but the factual foundation is flawed, limiting correctness. The qualitative accuracy is moderate due to correct general logic but incorrect entity and number mapping.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 464,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Between 2021 and 2023, Intel's financial treatment of its investment in Beijing Unisoc Technology Ltd. remained consistent as a non-marketable equity security. In 2021, Intel recognized $471 million in observable price adjustments for this investment. The net book value of the investment was $1.1 billion as of December 30, 2023, unchanged from December 31, 2022, indicating no significant changes in valuation during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $471 million observable price adjustment in 2021, the classification as a non-marketable equity security, and the $1.1 billion net book value as of December 30, 2023, unchanged from December 31, 2022. (2) Quantitative accuracy is perfect: the dollar amounts and dates match exactly, with acceptable formatting (e.g., $1.1 billion is standard). (3) The multi-hop reasoning is sound—synthesizing information across years and accounting treatments to show consistency in valuation despite earlier adjustments. (4) The answer addresses all parts of the question: financial treatment (non-marketable equity security), valuation evolution (stable book value), and observable price adjustments. Wording differs slightly but meaning is preserved. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 261,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "In 2022, Qulipta was not yet approved, as it was under regulatory review. By April 2023, AbbVie secured FDA approval for Qulipta for the preventive treatment of chronic migraine in adults, and by August 2023, the European Commission approved Aquipta (Qulipta) for migraine prevention in adults with four or more migraine days per month. This marked a significant regulatory and commercial milestone, transitioning Qulipta from development to market availability in key regions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory milestones for Qulipta in 2023—FDA approval in April 2023 and EC approval in August 2023—which aligns with the ground truth. It accurately reflects the transition from development to commercial availability. However, it omits the 2022 financial detail about the $1.0 billion reclassification of indefinite-lived R&D intangible assets to developed product rights, which is a significant part of the 'evolution' asked in the question. This omission reduces completeness. (2) All dates and regulatory events are correct: April 2023 FDA approval and August 2023 EC approval are accurate. The mention of 'Aquipta' appears to be a typo for 'Qulipta' but is likely a phonetic misspelling and does not undermine the factual intent. No numerical calculations are required, but the absence of the $1.0 billion asset reclassification—a key quantitative and qualitative event in 2022—impacts the full picture. (3) The reasoning correctly traces regulatory progression from 2022 (under review) to 2023 (approvals), showing sound logic and synthesis across time points. However, the failure to incorporate the financial reclassification aspect means the multi-hop synthesis between regulatory status and financial/asset classification is incomplete. (4) The answer is contextually relevant and well-structured, focusing on regulatory and commercial development. Scores reflect high accuracy in what was stated, but a moderate deduction for missing a core financial dimension of the 2022 status that was present in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 436,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "Between 2022 and 2023, Boeing's framing of 'upgrades and conversions' within the Global Services segment remained consistent in its core description, emphasizing these as part of a full spectrum of services offered to sustain aerospace platforms and systems. However, the 2023 filing added a more forward-looking tone, subtly highlighting the strategic importance of these services in a highly competitive market, with an intent to grow market share by leveraging customer satisfaction and productivity. This suggests a shift toward positioning upgrades and conversions as a key differentiator and growth driver for BGS in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in qualitative interpretation compared to the ground truth. (1) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies that 'upgrades and conversions' are part of Boeing's Global Services segment in both years and that the service contributes to sustaining aerospace platforms, which aligns with the general context. However, the key evolution described in the ground truth—that in 2022 the service was listed among a broader, undifferentiated set of offerings (e.g., logistics, spare parts, training), while in 2023 it was more integrated into a strategic narrative about sustaining platforms—is not accurately reflected. Instead, the LLM claims a 'forward-looking tone' in 2023 emphasizing growth and competitiveness, which is not supported by the ground truth. The ground truth does not mention market share growth, customer satisfaction, or productivity as newly emphasized drivers. (3) The multi-hop reasoning is partially sound—comparing language across two years’ filings—but the synthesis is flawed because the LLM infers strategic emphasis on growth and differentiation that isn’t present in the verified answer. The actual evolution is subtler: a shift from general listing to more integrated framing within platform sustainment, not a repositioning as a 'key differentiator' or 'growth driver'. (4) Contextual relevance is high because the answer addresses the framing evolution and stays focused on Boeing’s Global Services segment. However, the qualitative inaccuracy in representing the nature of the shift reduces correctness significantly. Thus, correctness and qualitative accuracy are moderate due to plausible but unsupported interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 495,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Between 2021 and 2023, Intel's investment in Beijing Unisoc Technology Ltd. remained valued at approximately $1.1 billion, with no significant changes in its valuation during this period. In 2021, Intel recognized $471 million in observable price adjustments for the investment, and by the end of 2023, the net book value of the investment was still reported at $1.1 billion, indicating stable recognition and no impairment during these years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.1 billion net book value of Intel's investment in Beijing Unisoc Technology Ltd. as of both 2021 and 2023, matching the ground truth. It accurately states the $471 million in observable price adjustments recognized in 2021. These key quantitative facts are correct. (2) All numbers are accurate: $1.1 billion valuation in both years and the $471 million adjustment in 2021 are correctly reported. The LLM correctly notes that the value remained stable with no impairment, which aligns with the absence of revaluation events in 2023. (3) The multi-hop reasoning is sound—comparing the valuation across two filings (2022 filing for 2021 data and 2023 filing for 2023 data) and inferring stability over time. However, the LLM slightly underrepresents the nuance that the 2023 filing does not mention any observable price adjustments, which could reflect either stabilization or lack of new data, whereas the original answer highlights this distinction. The LLM implies stability without acknowledging the potential interpretive gap. (4) Despite this minor omission in nuance, the answer is factually correct, contextually relevant, and synthesizes the required information accurately. The scores reflect high accuracy with a small deduction in qualitative accuracy for not fully capturing the reasoning behind the absence of 2023 adjustments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 388,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "Between 2023 and 2024, the role of Self-Service Lockers at Home Depot evolved as part of its interconnected shopping experience by enhancing convenience for online order pickup. In fiscal 2023, Home Depot implemented self-service lockers, online order storage areas, and curbside service to streamline pickup options. By fiscal 2024, these lockers were integrated into the broader network of retail fulfillment programs (BOSS, BOPIS, BODFS, BORIS), further supporting a seamless, multi-channel experience for customers. The lockers, located at the front entrance of many stores, provided a reliable and efficient option for customers to retrieve online orders, complementing other pickup and delivery services.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the evolution of Self-Service Lockers from a convenience feature in 2023 to a more integrated component of Home Depot's fulfillment network in 2024. The mention of BOSS, BOPIS, BODFS, and BORIS is correct and reflects the interconnected retail programs. (2) There are no numeric values in the LLM answer, but it does not introduce any incorrect figures, and the absence of the 'approximately 50% of U.S. online orders fulfilled through a store' statistic—present in the original answer—does not distort the truth; it simply omits a supporting data point. This omission affects completeness but not correctness. (3) The reasoning is sound: the LLM correctly synthesizes the shift in strategic role across years and connects lockers to broader omnichannel fulfillment. (4) The answer is contextually relevant and directly addresses the question about the evolution between 2023 and 2024. The only shortcoming is the lack of the specific quantitative evidence from 2024 that would strengthen the claim of operational integration. However, the core facts, entities, and timeline are accurate, and the semantic meaning is consistent with the ground truth. Hence, a high score is warranted, but not perfect due to the missing key statistic that illustrates the scale of integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 380,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "From 2023 to 2024, Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities remained largely consistent in terms of detail and specificity. Both years explained that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions, and noted that these estimates are subject to change based on future occurrences or deviations from historical trends. However, in 2024, there was a slight increase in specificity, as it added a brief mention of the Company's use of a wholly-owned captive insurance subsidiary and participation in a reinsurance program, which were not explicitly highlighted in 2023. Overall, the level of detail remained thorough but did not significantly evolve.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the evolution of disclosure detail. According to the ground truth, Costco significantly increased the specificity of its disclosure in 2024 by detailing the use of historical claims experience, demographic factors, severity factors, and actuarial assumptions—none of which were specified in 2023. However, the LLM incorrectly states that both years included these details, reversing the actual progression. In reality, the 2023 filing only mentioned the use of a captive insurance subsidiary and reinsurance program (which the LLM falsely attributes as a new 2024 addition), while omitting the specific estimation factors. The 2024 filing added the detailed methodology and risk disclosures about unpredictability and potential variances—key enhancements that the LLM fails to recognize. The LLM inverts the direction of change: it claims the estimation methodology was disclosed in both years and that structural details (captive, reinsurance) were added in 2024, when the opposite is true. There are no numerical values to assess, so quantitative accuracy is not applicable (scored 10 by default for absence of error). Qualitative accuracy is very low due to incorrect entity-year mappings and flawed reasoning across the multi-hop comparison. Contextual relevance is moderate because the answer addresses the right topic and companies, but with serious factual inversion. Overall, the answer contradicts the ground truth and thus earns a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 418,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "The financial impact of the Aldevron acquisition on inventory-related costs evolved from 2022 to 2023 as follows: In 2022, the acquisition-related charges associated with fair value adjustments to inventory from the Aldevron acquisition increased cost of sales by $59 million. By 2023, these charges were no longer a factor, as the impact of acquisition-related inventory adjustments from 2021 had been fully recognized. Instead, 2023 saw a $87 million charge related to excess inventory in the Biotechnology segment due to reduced demand, which negatively impacted cost of sales and gross profit margin. Thus, while Aldevron's inventory impact was a one-time cost in 2022, 2023 reflected different inventory challenges unrelated to the Aldevron acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $59 million increase in cost of sales in 2022 due to fair value adjustments from the Aldevron acquisition and the absence of this charge in 2023. It also accurately reports the $87 million charge in 2023 related to excess inventory in the Biotechnology segment due to reduced demand. All key facts and figures match the ground truth. (2) Quantitative accuracy is perfect: both dollar amounts ($59M and $87M) and years (2022 and 2023) are correct, with no calculation errors. Format variations are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—LLM correctly synthesizes that the 2022 cost was acquisition-driven and one-time, while the 2023 cost was operational and unrelated to Aldevron. The only minor issue is the mention of 'acquisition-related inventory adjustments from 2021'—while technically plausible context, it is not in the original answer and slightly introduces external inference, though it doesn't contradict the truth. (4) The answer is fully relevant, directly addressing the evolution of financial impact on inventory-related costs. The conclusion about a shift from acquisition-driven to operational challenges aligns with the ground truth. Overall, the answer is factually complete and semantically equivalent, warranting a high score with only a slight deduction in qualitative accuracy for the minor extraneous detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 395,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "Between 2023 and 2024, Costco's treatment and recognition of shop card liabilities remained consistent, with the Company accounting for outstanding shop card balances as a shop card liability, net of estimated breakage, and including these liabilities in other current liabilities in the consolidated balance sheets. This approach indicates that Costco systematically estimates and accounts for unclaimed balances based on historical redemption data, reflecting a disciplined and conservative approach to recognizing potential liabilities from unused shop cards.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of entity accuracy, financial treatment, and overall reasoning. It correctly states that Costco consistently accounted for shop card liabilities as a liability net of estimated breakage in both 2023 and 2024, and that this is based on historical redemption data—this matches the original answer. The quantitative and entity accuracy is perfect: correct years (2023–2024), correct company (Costco), correct accounting treatment, and correct classification in financial statements. However, the LLM answer misses a key nuance emphasized in the ground truth: the increased emphasis or refinement in the *disclosure* or *methodology* around estimated breakage in 2024. While the LLM implies consistency, it does not acknowledge the evolution toward a more formalized or refined approach in 2024, which was a central point in the original answer. This omission affects the depth of qualitative accuracy, particularly in capturing the *change* or maturation in Costco’s approach. Nonetheless, the reasoning is sound, the context is fully relevant, and no factual errors are present. The answer is semantically close but slightly less precise in capturing the evolution aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 354,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "From 2022 to 2023, Intel's Foundry Services (IFS) evolved significantly in strategic partnerships and customer engagement. In 2022, Intel introduced its IDM 2.0 strategy, which included building a world-class foundry business and expanding the use of third-party foundry capacity. By 2023, IFS had secured four design wins on Intel 18A, including a major high-performance computing customer with a large prepayment. Additionally, the IFS Accelerator Ecosystem Alliance program doubled in size to over 40 strategic agreements, including multigenerational partnerships with Arm and Synopsys. Intel also expanded its RAMP-C program partnerships with key customers like Nvidia and Microsoft, and announced a commercial agreement with Tower for foundry services in New Mexico. These initiatives reflect a stronger, more diversified engagement with customers and ecosystem partners to support advanced semiconductor manufacturing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, capturing the evolution of Intel's Foundry Services from strategic intent in 2022 to concrete customer engagements in 2023. Quantitatively, the key numbers are accurate: four design wins on Intel 18A and over 40 strategic agreements in the IFS Accelerator Ecosystem Alliance are correctly reported. The mention of multigenerational agreements with Arm and Synopsys is factually consistent. However, the LLM adds details not present in the ground truth: (1) a 'large prepayment' by the HPC customer, (2) expansion of RAMP-C partnerships with Nvidia and Microsoft, and (3) a commercial agreement with Tower in New Mexico. These specific initiatives are not mentioned in the original answer and cannot be verified from the provided ground truth, introducing unconfirmed details. While these may be factually correct in external sources, they go beyond the knowledge graph's scope, slightly reducing qualitative accuracy. The core multi-hop reasoning—contrasting 2022 strategy with 2023 execution and ecosystem growth—is sound and contextually relevant. The answer effectively synthesizes the progression in partnerships and customer engagement, even if it includes minor unsupported specifics. Wording differences (e.g., 'doubled in size' for the alliance program) are acceptable under semantic equivalence, though the original does not specify the prior size. Overall, the answer is factually strong with minor overreach in detail, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 422,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "Between 2022 and 2023, DHR's relationship with Aldevron did not involve new acquisitions, as the Aldevron acquisition was completed in 2021 for $9.6 billion in cash. In 2022 and 2023, there is no indication of changes to the goodwill related to Aldevron, which was initially recorded at approximately $6.1 billion. The net cash consideration for the Aldevron acquisition remained at $9.561 billion in both years, with no adjustments reported.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) It incorrectly states that the Aldevron acquisition was completed in 2021 for $9.6 billion, while the ground truth indicates that in 2022, DHR recorded $6.1 billion of goodwill related to the Aldevron acquisition, implying the acquisition was still being accounted for in 2022. The net cash consideration of $9.561 billion is correctly stated but mischaracterized as unchanged between 2022 and 2023. (2) Quantitatively, the $6.1 billion goodwill figure is accurate, and $9.561 billion in net cash consideration matches the ground truth, though the LLM fails to note the evolution—specifically that the cash consideration was finalized or revised to that amount in 2023, indicating a financial development. (3) The reasoning is flawed: the LLM asserts no changes occurred in 2022–2023, directly contradicting the ground truth, which describes an evolution from preliminary goodwill in 2022 to a more detailed or revised net cash consideration in 2023. This reflects a failure in multi-hop synthesis—linking the initial goodwill recording to a later refined cash outlay. (4) While the entities (DHR, Aldevron, goodwill, net cash consideration) are correct and relevant, the answer misrepresents the timeline and financial evolution, making it mostly incorrect despite some accurate numbers. The contextual relevance is moderate because it addresses the right metrics but with wrong interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 407,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were listed as maturing on September 5, 2026. In the 2024 SEC filing, the maturity date for the same notes remains unchanged at September 5, 2026. This consistency in maturity dates indicates that AT&T has not altered the structure of this particular debt issuance, suggesting stability in its short-to-medium-term debt obligations and no refinancing activity for this specific note during the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM claims the maturity date remained unchanged at September 5, 2026, but the ground truth shows a change from September 5, 2026 (2022 filing) to September 14, 2039 (2024 filing). This is a critical factual error involving a key date. (2) The calculation of the extension—over 13 years—is completely missed due to the incorrect assertion of no change. (3) Qualitatively, the reasoning is flawed: the LLM concludes there was stability and no refinancing, while the actual data indicates a major refinancing or restructuring event extending the debt by more than a decade, which represents a significant evolution in AT&T's debt structure. (4) The answer fails the multi-hop requirement: it must compare two filings across time for the same debt instrument and infer strategic implications. The LLM fails to detect the change, leading to an incorrect interpretation. Contextual relevance is partially met as it addresses the right company and debt instrument, but the core facts are wrong, severely undermining the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 319,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Between 2023 and 2024, Target remained in compliance with its debt leverage covenant, as stated in both years' filings. In 2024, the company secured a new $1.0 billion 364-day unsecured revolving credit facility expiring in October 2025 and extended its existing $3.0 billion facility to October 2028, enhancing liquidity and supporting its commercial paper program. These structural changes to its credit facilities likely reinforced Target's covenant compliance by providing greater financial flexibility and access to capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Target remained in compliance with its debt leverage covenant in both 2023 and 2024; the $1.0 billion 364-day credit facility was renewed with expiration extended to October 2025 (from October 2024); the $3.0 billion five-year facility remains in place, expiring in October 2028. These details match the original answer exactly. (2) Quantitative accuracy is perfect: dollar amounts ($1.0 billion, $3.0 billion), timeframes (364-day, October 2025 and 2028 expirations) are all correct. (3) The reasoning is sound: the renewal and extension of credit facilities are correctly linked to enhanced liquidity and covenant compliance. The only minor discrepancy is that the LLM states the $3.0 billion facility was 'extended to October 2028'—while the original answer notes it was already set to expire in October 2028 in 2023, implying continuity rather than a new extension in 2024. This could imply a slight overstatement of change, but does not materially misrepresent the situation. (4) The answer fully addresses both parts of the question: evolution of compliance (ongoing) and credit facility changes (renewal of 364-day facility). Semantic meaning and multi-hop synthesis—linking facility renewals to covenant compliance—are logically and correctly presented. Contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 387,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "Intel's approach to expanding digital readiness for global populations under its RISE strategy evolved from 2022 to 2023 by deepening external collaborations and scaling initiatives. In 2022, Intel focused on launching programs like the Alliance for Global Inclusion and expanding its Digital Readiness Programs, such as AI for Youth and AI for Workforce, in partnership with governments and institutions. By 2023, the company advanced these efforts by publishing the third global inclusion index survey, transitioning it into a benchmarking index to recognize organizations for diversity and inclusion progress. Additionally, Intel expanded its RISE Technology Initiative to fund projects addressing digital readiness, inclusive technology, and carbon-neutral computing, reflecting a more strategic and measurable approach to global digital inclusion.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's digital readiness efforts from 2022 to 2023 under the RISE strategy, including the shift from framework development to measurable outcomes via the global inclusion index. It accurately notes the publication of the third global inclusion index survey in 2023 and its transition into a benchmarking system. However, it omits the specific metric that organizations scoring 50% or higher were recognized, and does not mention that Intel was one of only 18 out of 27 respondents recognized—a key quantitative detail in the ground truth. (2) No explicit numbers (percentages, counts) are incorrect, but the absence of the 50% threshold and the 18 out of 27 statistic reduces quantitative completeness. The years (2022, 2023) and sequence of events are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 to 2023), strategy (RISE), and collaboration (Alliance for Global Inclusion), and infers a maturation from initiative-launch to performance-measurement. The addition of the RISE Technology Initiative funding projects is contextually plausible but not present in the ground truth, introducing a minor factual overreach. (4) The answer is highly relevant and conveys the core evolution accurately, though with slight overstatement of program names (e.g., 'AI for Youth' and 'AI for Workforce' are not mentioned in the ground truth). Overall, the answer is factually strong but misses key specifics that would elevate it to full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 430,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson's relationship with Micromine began in 2022 when AspenTech, a subsidiary of Emerson, agreed to acquire Micromine for approximately $623 million. However, the transaction was terminated on August 1, 2023, due to unresolved Russian regulatory approval issues. Emerson did not pay any termination fee, and no financial implications were directly associated with the termination beyond the initial costs incurred during the acquisition process.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. It incorrectly states that the agreement began in 2022, while the ground truth indicates the agreement was entered into in 2023. The termination date (August 1, 2023) is plausible but not verifiable from the ground truth, which does not specify an exact date. Crucially, the LLM claims 'no financial implications were directly associated with the termination,' which directly contradicts the ground truth: Emerson (via AspenTech) recorded a $24 million mark-to-market gain in 2023 from foreign currency forward contracts tied to the acquisition, and in 2024, those contracts were terminated. This omission of key financial impacts significantly undermines the answer. (2) The purchase price is correctly stated as $623 million (approximating AU$900 million), though the LLM omits the AU$900 figure. However, the claim that there were no financial implications is factually incorrect—the $24M gain and the 2024 contract termination are material financial events. (3) The multi-hop reasoning is flawed: the model fails to connect the termination of the acquisition with the subsequent financial accounting events (the gain in 2023 and contract termination in 2024), which are essential for answering the 'financial implications' part of the question. (4) The contextual relevance is high because the answer addresses the relationship evolution and attempts to discuss financial outcomes, but correctness and qualitative accuracy are low due to missing and incorrect facts, especially regarding financial impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 431,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) decreased from approximately 17 million shares in 2022 to approximately 15 million shares in 2023. Additionally, the average purchase price of shares during the fiscal year decreased from $305.14 in 2022 to $277.19 in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the share availability decreased from 17 million in 2022 to 15 million in 2023, and the average purchase price decreased from $305.14 to $277.19. These values exactly match the original answer. (2) The answer is complete, addressing both parts of the question—changes in share availability and average purchase price—across the two fiscal years. (3) Entity accuracy is correct: The Home Depot, U.S. ESPP, and the fiscal years 2022 and 2023 are properly identified. (4) The reasoning is sound and correctly synthesizes multi-hop information from two years, accurately capturing the trend of decreasing availability and lower purchase price. The LLM conveys the same semantic meaning as the original answer, with concise but precise wording. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 263,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "Between 2022 and 2023, DHR experienced a notable shift in impairment triggers and charges across its business segments. In 2022, there were no impairment charges recorded, indicating stable performance and recoverability of intangible assets. However, in 2023, impairment triggers were identified in the Biotechnology and Diagnostics segments, resulting in a $77 million impairment charge. This indicates a heightened risk in the intangible asset portfolio, particularly in technology-based assets within these segments, likely due to market or operational challenges. The shift suggests increased volatility or underperformance in these areas, signaling a need for closer monitoring of intangible asset recoverability in 2023 compared to the prior year.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the 2022 filing. It claims 'no impairment charges recorded' in 2022, which contradicts the ground truth stating a $10 million impairment in the Diagnostics segment in Q1 2021 (disclosed in the 2022 filing). This is a critical error in both entity timing and quantitative reporting. The $77 million charge in 2023 is correctly reported. (2) Quantitatively, the 2023 charge ($77M) is accurate, but the complete omission of the $10M 2021 charge (reported in 2022) and mischaracterization of 2022 as having no impairments undermines numerical accuracy. The comparison between years is therefore flawed. (3) The reasoning partially captures the increased risk in intangible assets, especially in Biotechnology, which aligns with the ground truth. However, it fails to acknowledge the multi-period and multi-segment nature of the 2023 triggers (e.g., Biotechnology in Q2 and Q4, Diagnostics in Q4), oversimplifying the pattern. It also misses that the 2021 Diagnostics impairment was carried forward for comparison in 2023, indicating longitudinal tracking. (4) Contextually, the answer addresses the question's intent—evolution of impairment risks and implications for intangible assets—but the factual foundation is partially incorrect, limiting its reliability. The conclusion about heightened risk is reasonable but not fully supported by accurate multi-hop synthesis across filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 408,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This increase indicates a higher level of the company's involvement in business transactions tied to trade contracts, suggesting expanded operations or commitments in these areas.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023, matching the ground truth exactly in both figures and years. (2) The quantitative values are accurate with no calculation errors; the increase from $362M to $598M is correctly represented. (3) The reasoning is sound: the increase is interpreted as indicating higher involvement in trade-related business transactions, which aligns with the ground truth's interpretation of growing involvement or expansion. The LLM appropriately infers business implications from the financial data, demonstrating correct multi-hop synthesis between the numerical change and its strategic meaning. (4) The answer is semantically equivalent to the original, with slightly different phrasing (e.g., 'higher level of involvement' vs. 'growing involvement') but identical factual and conceptual content. All parts of the question are addressed: the change in value and its implication for business activity. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 316,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "The 0.300% Notes due 2028 were first disclosed in IBM's 2023 SEC filing as part of the list of instruments defining the rights of security holders, with the relevant exhibit incorporated by reference from a Form 8-K filed on February 10, 2020. In the 2024 SEC filing, these notes are again listed under the company's registered securities, confirming their continued existence and trading status on the New York Stock Exchange under the ticker IBM28B. This evolution indicates IBM's consistent and transparent disclosure of its financial instruments, ensuring investors are informed about its outstanding debt securities across reporting periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key facts: the 0.300% Notes due 2028 were disclosed in the 2023 filing with reference to Exhibit 4.1 from the February 10, 2020 Form 8-K, and in the 2024 filing they are listed as registered securities trading under ticker IBM28B on the NYSE. All entities (IBM, 0.300% Notes due 2028, IBM28B, NYSE, Form 8-K, February 10, 2020) are accurate. (2) Quantitative accuracy is perfect: the interest rate (0.300%), maturity year (2028), and filing date (February 10, 2020) match the ground truth exactly. No calculations are required. (3) The multi-hop reasoning is mostly sound—information is correctly synthesized across the 2023 and 2024 filings. However, the LLM interprets the evolution as 'consistent and transparent disclosure' and 'continued existence,' whereas the ground truth emphasizes a qualitative shift from passive disclosure to active recognition as a traded instrument, indicating increased market engagement or liquidity. This nuance in interpretation is missing, making the reasoning slightly less precise. (4) Despite this, the answer is factually correct, complete, and highly relevant. The minor shortfall is in the depth of qualitative insight, not factual accuracy, justifying a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 357,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "In 2023, IBM's 1.750% Notes due 2031 were listed as being registered on the New York Stock Exchange (NYSE) in the 2024 10-K filing (page 1), indicating continued exchange registration. However, specific disclosure about these notes in the 2023 10-K (pages 18–22) does not highlight any material changes or events related to the notes between 2023 and 2024. Thus, there is no indication of a significant evolution in terms of registration or specific disclosure for these notes between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that the 1.750% Notes due 2031 were already registered on the NYSE in 2023. The ground truth states that in 2023, IBM only disclosed the notes with a reference to an exhibit from 2019, but there was no formal exchange listing at that time. The key evolution—registration under trading symbol IBM31 on the NYSE—occurred in 2024, which the LLM answer fails to recognize as a change. Instead, it incorrectly implies continuity in exchange registration. (2) Quantitatively, the percentages (1.750%) and maturity year (2031) are correct, and the mention of the 2024 10-K filing is accurate. However, the claim about NYSE registration in 2023 is unsupported and contradicts the ground truth. Page references (e.g., pages 18–22) may be plausible but are not verifiable here and do not compensate for the core factual error. (3) The multi-hop reasoning is flawed: the question asks for evolution between 2023 and 2024, requiring comparison across two filings. The LLM fails to identify the critical shift from disclosure-only (2023) to formal registration (2024), which is the central point of the ground truth. Instead, it concludes no significant evolution occurred, which is incorrect. (4) Contextual relevance is moderate—the answer addresses the right instrument and time frame and discusses disclosure and registration, so it stays on topic. However, due to the major factual and reasoning errors regarding the timeline of registration, the correctness score is low. The answer misrepresents the core development, undermining its validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 439,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "Eli Lilly's financial relationship with Zyprexa evolved significantly between 2023 and 2024, primarily due to the sale of the rights for the olanzapine portfolio, which includes Zyprexa. In 2023, Zyprexa generated $1,694.8 million in total revenue, with $1,615.4 million coming from outside the U.S. This was a substantial increase from 2022, driven by the sale of these rights. In 2024, the revenue from Zyprexa is no longer reported as a separate product since the rights were sold in 2023. The business model shifted from product sales to a one-time transaction, impacting revenue recognition by moving from ongoing product revenue to a lump-sum gain on the sale of product rights. This change is reflected in the 2024 financials, where Zyprexa is not listed as a revenue-generating product, and the focus has shifted to other key products like Trulicity and Mounjaro.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that Eli Lilly generated $1.45 billion from the sale of the olanzapine (Zyprexa) rights outside the U.S. in 2023. However, the LLM claims Zyprexa generated $1,694.8 million in total revenue in 2023, with $1,615.4 million from outside the U.S., which contradicts the ground truth—this implies ongoing product sales revenue rather than a one-time sale of rights. The $1.45 billion figure in the original answer refers to the sale of rights, not total product revenue, so the LLM misrepresents both the amount and the nature of the revenue. (2) The numbers provided by the LLM ($1,694.8M and $1,615.4M) do not match the ground truth ($1.45B from rights sale), and there is no indication these figures are from a different source or context. Additionally, the LLM suggests a 'substantial increase from 2022,' which is not supported by the ground truth and introduces unverified comparative data. (3) The qualitative reasoning partially captures the shift in business model—correctly noting that Zyprexa is no longer reported as a separate product in 2024 and that the company moved from product sales to a transaction-based model. However, it inaccurately frames the 2023 revenue as ongoing product sales rather than a rights sale, and fails to mention that post-2023 revenue is now recognized under 'collaboration and other arrangements,' which is a key nuance in revenue classification. The shift is described as a 'lump-sum gain' rather than ongoing royalty or profit-sharing, which mischaracterizes the ongoing financial relationship. (4) Despite these errors, the answer is contextually relevant, addressing the evolution of the financial relationship and correctly identifying the sale of rights as a pivotal event. The core idea of a business model shift is present, but the factual foundation is flawed, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 540,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "In 2023, the Mobility Preferred Interests were fully repurchased by AT&T in April, eliminating any redemption obligations and removing their impact on earnings per share (EPS) calculations for the remainder of the year. In 2024, these interests no longer appear in the diluted EPS calculation, as they had been completely retired. In prior periods (e.g., 2022), the Mobility Preferred Interests were dilutive and included in the diluted EPS denominator, with 378 million shares impacting the calculation. Their removal in 2023 simplified EPS computations and removed a source of dilution.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core event — the 2023 repurchase of Mobility Preferred Interests and their absence in 2024 EPS calculations — but omits key financial details and misrepresents the timing and nature of the accounting treatment. The ground truth states that AT&T reclassified $2,670 million to current and noncurrent liabilities *before* repurchasing all interests in April 2023 for $5,414 million (including accrued distributions). The LLM answer fails to mention the reclassification, the liability split, or the total repurchase cost of $5,414 million, which are critical financial impacts. Instead, it only notes the repurchase without quantifying it, missing a major part of the financial impact. (2) The LLM correctly references the dilutive effect in prior periods (e.g., 378 million shares in diluted EPS denominator), which aligns with the ground truth’s mention of ASU 2020-06 and inclusion in diluted EPS prior to repurchase. However, it does not mention ASU 2020-06 or the retrospective accounting treatment in 2024, which is a key evolution in the financial impact. The $5,414 repurchase amount and the $2,670 liability split are entirely missing, constituting significant quantitative omissions. (3) The reasoning is partially sound: it correctly infers that retiring the interests removed dilution and simplified EPS. However, it fails to synthesize the multi-hop connection between the reclassification (equity to liability), the redemption payment, and the subsequent retrospective accounting under new standards. The answer treats the issue as purely a removal of dilution, missing the shift from active obligation to retrospective accounting treatment emphasized in the ground truth. (4) The contextual relevance is high because it addresses redemption obligations and EPS impact across 2023–2024. However, due to missing key financial figures, the reclassification event, and the ASU 2020-06 rationale, the correctness and qualitative accuracy are reduced. The answer is directionally correct but lacks critical detail and full multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 562,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "In 2023, IBM's 0.875% Notes due 2030 were listed as being registered under Section 12(b) of the Exchange Act on the New York Stock Exchange with the trading symbol IBM30A in the 2024 10-K (page 1). In 2024, the Notes remained registered under Section 12(b) and continued to be listed on the New York Stock Exchange with the same trading symbol, indicating no change in their registration or listing status between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the 0.875% Notes due 2030 were already registered under Section 12(b) and listed on the NYSE with symbol IBM30A in 2023. According to the ground truth, in 2023 the notes were only incorporated by reference from a prior 8-K filing and were not explicitly listed or registered at that time. The key evolution—transition from referenced disclosure to explicit listing—was missed entirely. Instead, the LLM claims no change occurred, which contradicts the ground truth. (2) While the trading symbol IBM30A and the reference to Section 12(b) registration in 2024 are correct, the attribution of this status to 2023 is wrong. There are no numerical calculations in this question, but the dates and sequence of disclosures are critical and inaccurately represented. (3) The multi-hop reasoning failed: the model should have compared the 2023 and 2024 10-K filings to detect a change in disclosure practice—from incorporation by reference to active registration and listing. Instead, it incorrectly assumed continuity. (4) The contextual relevance is moderate because the answer discusses the right instrument, company, and timeframe, and mentions correct elements like NYSE listing and trading symbol. However, the core factual claim about the evolution (or lack thereof) is false, severely undermining correctness and qualitative accuracy. The answer misrepresents the nature of the change between years, which is the central point of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 416,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "From 2023 to 2024, the structure and distribution terms of AT&T's Telco Preferred Interests evolved with the addition of new classes and adjustments to reset schedules. In 2023, the Telco preferred interests included Class A-1, A-2, and A-3, with initial distributions of 4.25% and 6.85%, subject to reset every seven years. In 2024, AT&T issued an additional $2,250 of Telco Class A-4 interests with an initial distribution of 5.94%, subject to reset every four years starting in 2028. This indicates that AT&T is diversifying its preferred equity instruments to manage long-term financing costs and align with market conditions, while maintaining flexibility to refinance or redeem these instruments as needed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that in 2024, AT&T issued $2,250 of new 'Class A-4' preferred interests with a 5.94% distribution rate, resetting every four years starting in 2028. This is entirely incorrect and not supported by the ground truth. The original answer states that the Telco Preferred Interests in 2024 totaled $7,250, composed of the same classes (A-1, A-2, A-3) issued in 2020 and 2023, with no new classes introduced. The $2,250 increase ($2,000 + $5,250 = $7,250) is accurate in sum but misattributed to a non-existent A-4 class. Additionally, the 5.94% rate and four-year reset are fabricated; the ground truth specifies that all existing classes remain at 4.25% (A-1) and 6.85% (A-2/A-3), with seven-year reset periods. (2) Quantitative accuracy is severely compromised: while the total increase from $7,250 is numerically correct, the breakdown is wrong. The LLM invents a new issuance amount and class without basis. The distribution rates and reset schedules are incorrect. (3) Multi-hop reasoning fails: the model incorrectly synthesizes a structural evolution that did not occur. The actual evolution was in disclosure (clarification on dividend restrictions), not in new instruments. The LLM misses the key point about AT&T clarifying that failure to pay distributions does not restrict cash movements or dividends, which is a critical part of the 2024 update. Instead, it fabricates structural changes. (4) Contextual relevance is moderate because the answer addresses the general topic of preferred equity financing and attempts to interpret strategic intent, but the reasoning is based on false premises. The conclusion about 'diversifying preferred equity instruments' is unsupported by the actual data, which shows continuity in structure, not diversification. The correct interpretation should emphasize continued reliance on existing preferred equity structures with enhanced flexibility in cash management, not structural innovation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 543,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Capital One's involvement in multifamily commercial real estate loans under loss sharing agreements with government-sponsored enterprises (GSEs) increased between 2022 and 2023. As of December 31, 2023, the liability recognized for these agreements was $137 million, compared to $82 million as of December 31, 2022, indicating a rise in risk exposure. The company originates these loans with the intent to sell them to GSEs and enters into loss sharing agreements, which are accounted for under the fair value option for agreements entered after January 1, 2020.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key information is correct: Capital One's liability under loss sharing agreements for multifamily commercial real estate loans increased from $82 million as of December 31, 2022, to $137 million as of December 31, 2023. These figures match the original answer exactly, and the time periods are correctly specified. (2) The quantitative accuracy is perfect—both dollar amounts and dates are correct, and the increase in liability (from $82M to $137M) is accurately represented, indicating higher risk exposure. (3) The reasoning is sound: the LLM correctly identifies that Capital One originates these loans with the intent to sell to GSEs and enters into loss sharing agreements, which explains the nature of the liability. It also adds a relevant detail about accounting under the fair value option for agreements post-January 1, 2020, which enhances accuracy without contradicting the ground truth. (4) The answer addresses all parts of the question—evolution over time, risk exposure, and involvement in multifamily CRE loans with GSEs—demonstrating proper multi-hop synthesis. The semantic meaning is equivalent to the original answer, with slightly more technical detail. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 359,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "From 2022 to 2023, Amazon's co-branded credit card programs experienced an increase in strategic significance and regulatory risks due to evolving compliance obligations. In 2022, the programs were noted as a potential risk if renewed on less favorable terms or terminated. By 2023, the regulatory environment had intensified, with new compliance obligations related to data security, payment card association rules, and evolving interpretations of laws governing payments, data use, and consumer protection. These changes increased the potential for non-compliance, leading to higher transaction fees, fines, or loss of payment processing capabilities, all of which could materially impact Amazon's operating results.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increased strategic significance and regulatory risks of Amazon's co-branded credit card programs from 2022 to 2023. It accurately notes the 2022 risk related to renewal on less favorable terms or termination and the escalation of regulatory risks by 2023. However, it omits a key factual development from the ground truth: the introduction of data localization rules in 2023, which were not present in 2022 and represent a specific new compliance obligation. Instead, the LLM answer generalizes the new obligations as 'evolving interpretations of laws governing payments, data use, and consumer protection,' which, while plausible, lacks the precise detail about data localization and cross-border data transfers highlighted in the original answer. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—this aspect is fully accurate by default. (3) The multi-hop reasoning is partially sound: the model correctly infers increased regulatory burden and potential impact on operating results, but fails to synthesize the specific new risk category (data localization) that emerged in 2023, weakening the completeness of the regulatory risk analysis. (4) The contextual relevance is high, as the answer addresses the core question about shifts in strategic significance and regulatory risks. The qualitative accuracy is reduced due to the omission of a key compliance obligation mentioned in the ground truth, though the overall reasoning trajectory is reasonable. Hence, correctness is scored 7 for being factually consistent but incomplete on a critical regulatory development.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 463,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "Between 2022 and 2024, PM's financial relationship with RBH evolved significantly, particularly in terms of consolidation status and valuation. As of 2022, RBH had already been deconsolidated from PM's financial statements in March 2019 due to its CCAA proceedings, and PM accounted for its investment in RBH as an equity security without readily determinable fair value. By 2024, developments in the CCAA process, including RBH's objection to the proposed settlement plan, prompted PM to reassess the valuation of its investment in RBH. Management concluded that the investment was impaired, recording a $2,316 million non-cash impairment charge in 2024, with the fair value of the investment in RBH estimated at $714 million. This valuation was based on a discounted cash flow analysis, reflecting the impact of litigation-related uncertainties and the allocation of the global settlement amount.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in PM's financial relationship with RBH, correctly identifying the deconsolidation in 2019 (reflected in 2022 reporting) and the shift to an equity investment subject to impairment by 2024. It accurately describes the use of fair value estimation via discounted cash flow and references litigation-related uncertainties. However, there are key quantitative discrepancies: the original answer does not mention a $2,316 million impairment charge or a $714 million fair value estimate—these specific figures are absent from the ground truth. Instead, the ground truth emphasizes the CAD 3.1 billion damages allocation and the need for judgment in valuation assumptions (discount rates, sales volumes, margins, tax treatment), but does not state that an impairment was recorded or provide exact dollar figures. The LLM introduces precise numbers not present in the original, which undermines quantitative accuracy. While the qualitative shift from deconsolidated subsidiary to equity investment requiring impairment analysis is correctly synthesized, the addition of unsupported financial figures reduces factual precision. The reasoning is logically sound and contextually relevant, addressing consolidation status and valuation considerations across the time frame, but the inclusion of unverified calculations limits correctness. Semantic equivalence is mostly maintained, except for the unsupported numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 401,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "Baqsimi's revenue contribution increased significantly between 2023 and 2024, with revenue rising from $677.6 million in 2023 to $4.294 billion in 2024, primarily due to the 2023 sale of its rights. In 2023, it contributed $677.6 million to net product revenue, while in 2024, it became a major component of collaboration and other revenue, reflecting its strategic divestiture and ongoing partnership arrangements. This shift highlights its growing importance in LLY's portfolio through licensing and collaboration revenue.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. While it correctly states Baqsimi's 2023 revenue as $677.6 million, it falsely claims revenue increased to $4.294 billion in 2024, which is not supported by the ground truth. In reality, Baqsimi was no longer reported as a direct revenue contributor in 2024 due to the divestiture of rights, and no such revenue figure was recorded. The $4.294 billion figure appears entirely fabricated or misattributed. (2) Quantitative accuracy is severely compromised: the 2024 revenue number is incorrect, and the claim of a significant increase contradicts the actual decline to zero in direct product sales. The only correct number is the 2023 total revenue and its U.S./non-U.S. split, though the latter is omitted in the LLM answer. (3) The reasoning is partially sound in identifying a strategic shift—correctly noting the transition to collaboration and other arrangements due to the 2023 sale—but incorrectly interprets this as leading to higher revenue, when in fact it removed Baqsimi from direct product revenue reporting. The conclusion that its 'growing importance' is reflected in licensing revenue is unsupported; the ground truth suggests a reduced strategic role within LLY's portfolio. (4) Contextual relevance is moderate because the answer addresses revenue contribution and strategic positioning, but the severe factual errors in numbers and implications of the strategic move undermine overall correctness. The model fails the multi-hop synthesis by not correctly linking the divestiture to the absence of product revenue in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 440,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "From 2022 to 2024, the composition of Union Pacific's Total Highway Revenue Equipment shifted significantly. In 2022, the company owned 48,962 containers and leased 1,856, with 29,875 owned chassis and 14,148 leased. By 2024, the number of owned containers decreased to 46,375, while leased containers dropped to 288. Chassis ownership also declined to 4,356, with leased chassis at 1,197. This indicates a substantial reduction in both owned and leased containers and chassis, with a more pronounced shift toward reduced leasing compared to 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the numbers, particularly in the breakdown of owned versus leased units. While the ground truth states that in 2022, Union Pacific owned 78,837 total units and leased 16,004, the LLM incorrectly reports 48,962 owned containers and 29,875 owned chassis (summing to 78,837), implying all owned equipment consists of containers and chassis, which may be partially correct, but the LLM misrepresents the composition by not acknowledging other equipment types or providing incorrect allocations. More critically, the LLM states leased chassis were 14,148 in 2022, but the ground truth does not specify leased chassis separately—only total leased units (16,004) and leased containers (1,856), meaning leased chassis would be 14,148 only if all other leased units were chassis, which is an assumption not confirmed in the ground truth. In 2024, the LLM reports leased chassis as 1,197, but the ground truth says total leased units dropped to 1,485, with no separate chassis number—so this breakdown is speculative. (2) The LLM correctly reports the drop in leased containers from 1,856 to 288 and owned chassis from 29,875 to 4,356, which aligns with the ground truth. However, it incorrectly states owned containers decreased from 48,962 to 46,375, while the ground truth does not provide a direct container-only owned number—only total owned equipment (78,837 in 2022, 50,731 in 2024). The LLM’s assignment of these totals to containers and chassis separately introduces inaccuracies. (3) The reasoning correctly identifies a strategic reduction in both owned and leased assets, especially in leasing, which is consistent with the ground truth’s interpretation. However, the multi-hop synthesis is flawed because the LLM invents a detailed container/chassis split not fully supported by the source data, leading to incorrect quantitative assertions. (4) The contextual relevance is high because the answer addresses the question about changes in owned vs. leased composition over time. Qualitative accuracy is moderate due to sound overall logic but flawed data attribution. Quantitative accuracy is low due to incorrect numeric values for key components. Correctness score is 5 due to partial factual alignment but significant errors in equipment breakdowns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 620,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations increased from $16,973 million to $18,043 million, representing a $1,070 million growth in their funding structure. This growth indicates a slight expansion in the role of securitized debt obligations as a funding source, contributing to the company's overall funding mix, which also includes deposits, senior and subordinated notes, and other debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in securitized debt obligations from $16,973 million in 2022 to $18,043 million in 2023, which aligns with the ground truth carrying value of $18.043 billion in 2023 (equivalent to $18,043 million). The calculation of a $1,070 million increase is accurate (18,043 - 16,973 = 1,070). However, the original answer does not mention the 2022 value of $16,973 million; instead, it emphasizes the qualitative shift in how securitized debt was categorized in the fair value hierarchy (from unspecified to Level 2 in 2023), which the LLM answer omits entirely. (2) Quantitatively, the numbers are correct and well-formatted, with acceptable unit usage (millions vs. billions). (3) The multi-hop reasoning is partially sound—the LLM correctly infers growth in the funding component but fails to capture the key qualitative evolution in the role of securitized debt (i.e., its reclassification under Level 2 of the fair value hierarchy), which is central to the original answer’s conclusion about a more structured and less volatile role. This omission significantly weakens the qualitative accuracy. (4) The answer is contextually relevant and addresses the evolution in funding structure, but the lack of the fair value hierarchy shift—a critical analytical point—means the answer misses a core dimension of the evolution, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 391,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "Between 2023 and 2024, LLY's revenue from Zyprexa shifted significantly in terms of source and recognition. In 2023, Zyprexa revenue was primarily generated through direct product sales, with $79.4 million in U.S. revenue and $1,615.4 million from international sales. However, in 2024, the revenue source changed as LLY recognized gains from the sale of rights for the olanzapine portfolio, including Zyprexa, which contributed to collaboration and other revenue. This shift reflects a transition from product sales to revenue recognition through the transfer of intellectual property rights, as outlined in Note 2 of the 2024 filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in revenue recognition from product sales in 2023 to collaboration and other arrangements in 2024 due to the sale of rights for the olanzapine portfolio, which aligns with the ground truth. However, it introduces specific revenue figures ($79.4 million U.S., $1,615.4 million international) that are not present in the original answer and cannot be verified from the provided ground truth. These numbers may be factually incorrect or misattributed, as the ground truth does not mention any quantitative revenue breakdown for Zyprexa in 2023. (2) The quantitative accuracy is low because the answer presents precise figures without confirmation from the ground truth, introducing potential misinformation. There is no indication in the original answer that these specific numbers are available or relevant. (3) The qualitative reasoning is mostly sound: the model correctly infers a shift in revenue source and recognition method post-sale of rights and ties it to collaboration revenue in 2024, showing appropriate multi-hop synthesis between the 2023 sale and 2024 reporting. Mentioning Note 2 of the 2024 filing adds contextual support. (4) Contextual relevance is high as the answer directly addresses the evolution of revenue source and recognition method. However, the inclusion of unverified numerical data undermines factual correctness, warranting a moderate overall score of 6 despite correct conceptual understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 410,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "The valuation methodology for Federal Government Securities in the pension plan remained consistent from 2022 to 2024, as they are classified as Level 2 investments and valued using a bid evaluation process with bid data from independent pricing sources. However, the classification of the broader asset allocation strategy evolved, shifting from a higher equity focus (45%-55% equity and debt in 2022) to a more debt-focused allocation (20%-30% equity and 70%-80% debt in 2024) as part of a de-risking strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Federal Government Securities are classified as Level 2 investments in both 2022 and 2024 and that valuation uses a bid evaluation process with independent pricing sources, which aligns with the ground truth's emphasis on continued Level 2 classification and added methodological clarity in 2024. However, the LLM introduces information about asset allocation shifts (equity vs. debt percentages) that is not mentioned in the original answer and is irrelevant to the specific question about valuation methodology and classification of Federal Government Securities. This misdirects the focus and adds unsupported details. (2) The $742 million figure from 2022 is missing in the LLM answer, which is a key quantitative data point from the ground truth. The percentages for equity and debt allocation (45%-55%, 20%-30%, 70%-80%) are not present in the original answer and cannot be verified, suggesting fabrication or misattribution. (3) The multi-hop reasoning is partially sound in recognizing continuity in Level 2 classification and improved methodology description, but fails by conflating overall asset allocation strategy with the specific valuation of Federal Government Securities, indicating a failure to isolate the correct financial instrument and its treatment. (4) The correctness score is 5 due to partial factual accuracy on classification and methodology, but significant issues with completeness (missing $742M) and introduction of irrelevant, unverified allocation data. Quantitative accuracy is 6 because while no incorrect numbers are stated about the securities themselves, key numbers are omitted and unverified ones added. Qualitative accuracy is 5 due to correct core concept (Level 2 continuity, bid evaluation) but flawed reasoning in scope. Contextual relevance is 7 because the answer addresses the main topic but drifts into unrelated strategic shifts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 521,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "From 2022 to 2023, Capital One's utilization of credit score data for product segmentation decisions remained consistent, as the data showed no significant changes in the distribution of credit scores across their auto and credit card portfolios. In 2022, 53% of auto loans had FICO scores above 660, and in 2023, this percentage remained unchanged. Similarly, for credit cards, the percentage of accounts with FICO scores above 660 decreased slightly from 69% to 68%, indicating minimal shifts in risk profiles. This stability suggests that Capital One's credit risk modeling strategy prioritizes maintaining consistent risk segmentation and underwriting standards, leveraging credit scores to ensure alignment with their risk appetite and portfolio quality.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both its core claim and supporting data. The original answer states that Capital One updated the time period of credit score data used in product segmentation—from 2020–2021 data in 2022 to 2022–2023 data in 2023—indicating a shift toward more current data. The LLM instead claims that the utilization 'remained consistent' and focuses on unchanged percentages in credit score distributions (e.g., 53% for auto loans, 69% to 68% for credit cards), which are not mentioned in the ground truth and appear fabricated. These specific percentages (53%, 69%, 68%) are not present in the original answer and cannot be verified, making them incorrect. (2) There are no valid calculations in the LLM answer because the numbers themselves are not supported by the ground truth. The mention of 'no significant changes' contradicts the actual evolution in data sourcing described in the original answer. (3) The multi-hop reasoning is flawed: the question asks about the evolution in data utilization for segmentation decisions, not the stability of score distributions. The LLM misinterprets the question as being about portfolio risk stability rather than data recency in modeling strategy. It fails to recognize the shift from older (2020–2021) to newer (2022–2023) data as a strategic update in risk modeling. (4) The contextual relevance is moderate because the answer discusses credit scores, product segmentation, and risk modeling, which are relevant topics, but the factual inaccuracies and incorrect reasoning severely undermine correctness. The qualitative accuracy is low because the entities (years, strategy implications) are misidentified, and the reasoning does not align with the source information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 478,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "From 2022 to 2023, AWS has maintained its position as a core strategic pillar within Amazon's business segments, with continued emphasis on its role in driving long-term growth and technological innovation. The 2023 filing highlights AWS as a key service offering for developers and enterprises, providing on-demand technology services such as compute, storage, and machine learning. Additionally, AWS is identified as a major focus area for investment, particularly in technology infrastructure, reflecting its importance in supporting Amazon's broader business growth and customer experience enhancements. This aligns with the 2022 filing, which similarly emphasized AWS as a critical segment and a driver of innovation and revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in AWS's strategic positioning from 2022 to 2023. (1) What was correct: The answer accurately reflects that AWS remained a strategic focus in both years, provides correct qualitative descriptions of AWS services (compute, storage, machine learning), and correctly identifies AWS as a driver of innovation and investment. There are no numeric inaccuracies, so quantitative accuracy is high. (2) Number/calculation verification: No specific numbers were mentioned in either the ground truth or LLM response, so no calculation errors exist. (3) Multi-hop reasoning assessment: The LLM fails to capture the critical shift in AWS’s status—from being a key investment area within broader technology spending in 2022 to becoming one of Amazon’s three core business segments in 2023. This structural repositioning is central to the question and is omitted, indicating a failure in synthesizing the evolution across years. The LLM implies continuity rather than transformation, stating AWS 'maintained its position' when the ground truth shows a clear elevation in strategic role. (4) Justification for scores: Correctness is scored 6 because core facts about AWS are accurate but the main point—evolution in strategic positioning—is underdeveloped. Qualitative accuracy is low (5) due to flawed reasoning about the nature of AWS’s change in role. Quantitative accuracy is 10 because no numbers are misstated. Contextual relevance is 9 because the answer stays on topic and addresses AWS’s role and investment, just not the full evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 434,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International's (PMI) financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved significantly, particularly in terms of accounting treatment and potential financial exposure. In 2022, RBH's financial results were deconsolidated from PMI's consolidated financial statements due to RBH's protection under Canada's CCAA proceedings. By 2024, PMI recorded a non-cash impairment charge of $2,316 million (representing a diluted EPS charge of $1.49 per share) related to its investment in RBH, reflecting the potential allocation of a CAD 32.5 billion global settlement among RBH and its co-defendants. This impairment indicates a material financial exposure for PMI, as the settlement amount and allocation remain unresolved.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: RBH was deconsolidated in 2022 due to CCAA proceedings, and in 2024 PMI recorded a $2,316 million non-cash impairment charge related to its investment in RBH. The CAD 32.5 billion proposed settlement is correctly cited. (2) Quantitative accuracy is perfect: the $2,316 million impairment and reference to CAD 32.5 billion are exact matches; no calculation errors. Format variations (e.g., $2.3 billion vs $2,316 million) are acceptable and not present here—the number is precise. (3) Multi-hop reasoning is sound: the answer connects RBH’s deconsolidation in 2022 to the 2024 impairment, correctly framing the shift in accounting treatment from consolidation to equity method and recognizing financial exposure via impairment. The only minor omission is that the original answer notes the litigation stay ended March 31, 2022, and that no loss accruals were made due to estimation uncertainty—this contextual nuance is missing but does not undermine the core correctness. Also, the LLM mentions diluted EPS impact ($1.49), which is additional detail not in the ground truth but plausible and consistent. (4) The answer is contextually excellent—directly addresses the evolution in accounting treatment and financial exposure. Overall, this is a factually correct, well-reasoned response with only minor contextual omissions, warranting a 9/10 for correctness and qualitative accuracy, full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 423,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "Biktarvy has maintained a strong commercial significance for GILD from 2022 to 2024, with its revenue contribution growing significantly. In 2022, Biktarvy generated $8,624 million in total product sales, and by 2024, it remained a key revenue driver for GILD's HIV product portfolio. However, associated product risks include potential market share losses due to competition, including generic alternatives, and the evolving HIV treatment landscape, which could reduce the demand for nucleoside-based therapeutics like Biktarvy. Additionally, regulatory and pricing pressures, such as those arising from the Inflation Reduction Act of 2022, pose ongoing challenges to maintaining high pricing and profitability for Biktarvy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the 2022 revenue for Biktarvy as $8,624 million, matching the ground truth exactly. It appropriately notes that Biktarvy remained a key revenue driver in 2024, consistent with the original answer’s assertion of ongoing importance. However, the LLM incorrectly implies revenue growth from 2022 to 2024 by stating 'revenue contribution growing significantly,' which is not supported by the ground truth—no 2024 revenue figures are provided, and the original answer does not suggest growth. This overstatement is a factual inaccuracy in reasoning. (2) Quantitatively, the only number provided—$8,624 million in 2022—is accurate and correctly formatted. No calculations were required, and the figure matches the ground truth. (3) The multi-hop reasoning is mostly sound: the LLM synthesizes Biktarvy’s revenue significance and associated risks across time, correctly identifying competitive threats, generic pressure, and regulatory challenges (e.g., Inflation Reduction Act). While the original answer emphasizes risks related to TAF-based therapy reliance and treatment paradigm shifts, the LLM substitutes with broader but related risks (e.g., nucleoside-based therapeutics), which are contextually relevant but not as precise. (4) The answer is highly contextually relevant, addressing both revenue and risk evolution. The qualitative accuracy is slightly reduced due to the unsupported claim of revenue growth and less precise risk characterization, but core facts and synthesis remain strong. Hence, correctness is 8 due to minor but notable overstatement in commercial evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 445,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 to $1.9 billion in 2024, reflecting a rise in the value of its 36.79% to 37.03% economic interest. Additionally, TTX car hire expenses rose from $375 million in 2021 to $432 million in 2024, indicating higher operational reliance on TTX's rail car services over this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the financial stake increased from $1.6 billion in 2021 to $1.9 billion in 2024, and car hire expenses rose from $375 million to $432 million over the same period. The percentages (36.79% to 37.03%) are additional precise details that align with the expected depth and do not contradict the original answer. (2) The answer addresses both parts of the multi-part question: investment value (financial stake) and car hire expenses (operational relationship). (3) Entities are correctly identified: Union Pacific Railroad (UPRR), TTX, and the relevant financial metrics (investment value, car hire expenses) are all accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis across years and financial dimensions, correctly interpreting the trend as increasing financial and operational involvement. The slight enhancement in specificity (with percentage ownership changes) adds value without introducing error. Overall, the answer is factually correct, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 324,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "From 2022 to 2023, Tesla shifted its approach to scaling Solar Roof production by enhancing installer training initiatives and addressing supply chain risks. In 2022, the company focused on improving installation capabilities and price efficiencies for Solar Roof by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. By 2023, Tesla expanded these efforts, emphasizing structured training programs such as the Engineering Development Program launched in January 2024, which targeted recent graduates for specialized training in high-demand fields like controls engineering. Additionally, Tesla continued to manage supply chain risks by diversifying localized procurement and manufacturing, as well as addressing global component constraints through strategic sourcing and inventory management.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's 2022 focus on installer training, collaboration with real estate developers, and cost/time reduction. However, it introduces a factual inaccuracy by referencing the 'Engineering Development Program launched in January 2024,' which is outside the 2023 timeframe and not mentioned in the ground truth. This misrepresents the evolution of training initiatives. The ground truth indicates a strategic shift in 2023 toward supply chain risk management—not an expansion of installer training programs. (2) The date 'January 2024' is incorrect in the context of a 2022–2023 comparison; no other numeric values (e.g., dollar amounts, percentages) are present, so quantitative accuracy is limited to timeline correctness. The mention of future-dated initiatives undermines temporal accuracy. (3) The multi-hop reasoning is partially sound—linking installer training in 2022 to broader scaling efforts—but fails in the 2023 analysis. The ground truth emphasizes a pivot away from installer-centric growth to supply chain resilience, whereas the LLM suggests continuity and expansion of training, which contradicts the shift described. The synthesis of supply chain efforts (localized procurement, strategic sourcing) aligns generally with the ground truth but lacks the critical nuance that production ramp challenges became the central constraint. (4) Correctness is scored at 5 due to significant factual deviation in the 2023 characterization. Quantitative accuracy is 6 because while no financial figures are wrong, the use of a post-2023 program introduces timeline inaccuracy. Qualitative accuracy is 5 due to flawed reasoning about the strategic shift. Contextual relevance is high (8) as the answer addresses both installer training and supply chain aspects of the question, even if inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 502,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "Between 2022 and 2023, The Coca-Cola Company's relationship with fountain retailers in the United States remained consistent, as the Company continued to manufacture and sell fountain syrups directly to authorized fountain wholesalers and some fountain retailers. There were no significant changes in this process during the period, as the Company retained control over fountain syrup production and distribution in the U.S., with bottlers generally not authorized to manufacture fountain syrups.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in The Coca-Cola Company's distribution model between 2022 and 2023. It correctly states that in 2022, the Company manufactured fountain syrups and that bottlers were generally not authorized to produce them, and that distribution occurred through authorized wholesalers and some direct sales to retailers. However, the LLM claims there was 'no significant change' in 2023, which contradicts the ground truth. The original answer highlights that in 2023, the Company explicitly acknowledged selling fountain syrups not only to wholesalers but also to bottling partners who then distribute to fountain retailers—indicating a more formalized or clarified tiered distribution model. This represents a qualitative shift in how the Company describes its distribution network, suggesting either an expansion of bottler involvement or at least a clearer articulation of their role. The LLM fails to capture this nuance, incorrectly implying continuity. There are no numerical inaccuracies (hence high quantitative score), and the entities and years are correct. Contextually, the response is relevant and addresses the core topic, but the reasoning is flawed in synthesizing the change across the two years, leading to a moderate qualitative accuracy score. The failure to identify the evolution in distribution relationships results in a correctness score of 5—partially correct but missing a critical analytical point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 405,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "IBM's 0.950% Notes due 2025 were disclosed as registered securities on the New York Stock Exchange under the trading symbol IBM25B in both the 2022 and 2024 10-K filings. There is no indication of a change in the classification of these notes as financial instruments during this period. The 2024 filing confirms continued registration under Section 12(b) of the Exchange Act, with no new or updated registration details provided compared to 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the 0.950% Notes due 2025 were registered and listed under trading symbol 'IBM25B' in both 2022 and 2024. According to the ground truth, in 2022 the notes were only disclosed as part of an Exhibit 4.1 in a Form 8-K filed on May 22, 2017, not in the 2022 10-K. There is no evidence in the ground truth that the notes were listed on the NYSE or had the symbol 'IBM25B' in 2022. The listing and symbol information only appears in the 2024 context. Thus, the LLM incorrectly asserts continuity in listing status from 2022 to 2024, when the ground truth indicates an evolution from disclosure to active listing. (2) Quantitatively, the interest rate (0.950%), maturity year (2025), and trading symbol (IBM25B) are correct, and the reference to Section 12(b) is plausible, but the claim of consistent registration in both years is unsupported. The date of the original filing (May 22, 2017) is omitted in the LLM answer, which weakens the multi-hop context. (3) The multi-hop reasoning is flawed: the question asks about the evolution from 2022 to 2024, but the LLM fails to recognize the shift from passive disclosure (via 8-K exhibit reference) to active listing (with trading symbol on NYSE). Instead, it asserts no change occurred, which contradicts the ground truth. (4) The contextual relevance is moderate because the answer discusses the right instrument and timeframe, but the core claim about classification and registration evolution is incorrect, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 434,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "From 2022 to 2024, Gilead's strategic positioning of Biktarvy has evolved to address competitive pressures and financial risks in the HIV treatment market. Biktarvy remains a key product in Gilead's HIV portfolio, but the company faces challenges from generic competition and pricing pressures due to legislative actions like the Inflation Reduction Act of 2022. Gilead has focused on differentiating Biktarvy through its efficacy, safety, and tolerability profile, which are critical in maintaining market share. However, the risk of nucleoside-based therapies like Biktarvy losing relevance in treatment paradigms and the potential for Medicare price negotiations under the IRA highlight increased financial risk exposure. Gilead continues to emphasize innovation and expansion of indications to sustain competitive differentiation and mitigate revenue declines.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and reasoning. (1) It accurately reflects Biktarvy's continued importance in GILD's HIV portfolio from 2022 to 2024 and correctly identifies increasing financial risk due to reliance on nucleoside-based therapies like Biktarvy. The mention of generic competition and shifting treatment paradigms matches the original answer. (2) There are no specific numbers, percentages, or dollar amounts in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The LLM introduces additional context not in the ground truth—specifically the Inflation Reduction Act (IRA) of 2022 and Medicare price negotiations—which, while plausible and contextually relevant, are not part of the knowledge graph's verified answer. This adds detail beyond the source material but does not contradict it. The core multi-hop reasoning—linking Biktarvy’s strategic positioning to financial risk and competitive differentiation over time—is sound and correctly synthesized. (4) The answer is highly contextually relevant and captures the evolution in GILD’s risk exposure and differentiation challenges. However, it slightly overextends by citing specific legislation not mentioned in the ground truth, which prevents a perfect score. Overall, the semantic meaning and key insights match the original answer, warranting a high correctness score with minor deduction for unverified additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 411,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued its strategy of reducing defined benefit pension obligations by transferring them to insurance companies, which had a significant financial impact. In 2022, the company purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and related plan assets to an insurance company for approximately 13,600 U.S. retirees and beneficiaries. This transaction resulted in a noncash pension settlement charge of $1.5 billion in the second quarter of 2022. In 2023, the company made a voluntary offering to certain former employees who had not yet begun receiving their vested benefits, resulting in $414 million in settlement payments for approximately 6,500 participants, which reduced the pension obligation without triggering a settlement charge. These actions reflect a continued shift from defined benefit to defined contribution retirement plans and a reduction in the company’s long-term pension liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: in 2022, Lockheed Martin transferred $4.3 billion in pension obligations via group annuity contracts, resulting in a $1.5 billion noncash settlement charge; in 2023, the company made $414 million in settlement payments to ~6,500 former employees. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—dollar amounts, participant counts, and financial impacts are correctly reported. (3) The reasoning is sound: the LLM correctly identifies a strategic shift from large-scale annuity transfers (2022) to direct individual settlements (2023), noting that the 2023 payments did not trigger a settlement charge, which is a key qualitative distinction. (4) The only minor shortcoming is that the LLM slightly overgeneralizes by stating the company continued 'transferring obligations to insurance companies' in 2023, which is inaccurate—2023 involved direct payments, not insurer transfers. This mischaracterization slightly affects qualitative accuracy but does not undermine the core correctness. Otherwise, the answer is complete, relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 343,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "The 2.875% Notes due 2025 were listed in IBM's 2022 10-K filing under the securities registered on the New York Stock Exchange with the trading symbol \"IBM25A.\" In the 2024 10-K filing, the 2.875% Notes due 2025 remain listed with the same trading symbol and exchange, indicating no change in the specific instrument's details between 2022 and 2024. There is no indication of redemption, issuance, or structural modification to this particular debt instrument during the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that the 2.875% Notes due 2025 (IBM25A) were present in both the 2022 and 2024 10-K filings with no changes to the instrument's details, which aligns with the ground truth. The trading symbol 'IBM25A' and the interest rate (2.875%) are accurately reported, satisfying quantitative accuracy. However, the LLM fails to mention the broader composition of IBM's debt instruments due in 2025, particularly the presence of the 0.950% (IBM 25B) and 0.875% (IBM 25C) Notes in 2022 and the absence of the 0.875% Notes in 2024. This omission is critical because the question specifically asks about the evolution of the *composition* of debt instruments maturing in 2025, not just the status of the 2.875% Notes. The ground truth emphasizes a shift in composition—retaining IBM25A while dropping IBM25C—which the LLM does not address. Thus, while the information provided is factually correct (hence high quantitative accuracy), the answer lacks completeness and full qualitative synthesis across years and instruments. The reasoning is sound within its limited scope but fails the multi-hop requirement to compare multiple debt instruments across time. Contextual relevance is high because the answer discusses the correct company, year, and instrument, but it misses the comparative dimension essential to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 372,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "Biktarvy has emerged as a critical driver of growth within Gilead's HIV portfolio from 2022 to 2024, offsetting declines from products like Truvada and Atripla due to generic competition. In 2021, Biktarvy sales increased globally due to higher demand and favorable pricing adjustments, and it continued to be a key focus in 2022 as the company anticipated recovery from the pandemic's impact. However, competitive pressures and potential shifts in treatment paradigms, such as the reduced role of nucleoside-based therapies, pose ongoing risks to Biktarvy's long-term performance. Additionally, pricing pressures from government and third-party payers, as outlined in the 2024 10-K, further heighten the risk profile for Biktarvy and the broader HIV portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Biktarvy as a key growth driver in Gilead's HIV portfolio and acknowledges increasing risks by 2024, aligning with the ground truth. However, it introduces a factual inaccuracy by referencing '2021' sales growth, which is outside the requested 2022–2024 timeframe and not supported in the original answer. The ground truth emphasizes a shift in strategic importance from growth (2022) to vulnerability (2024), which the LLM captures partially but less precisely. (2) There are no explicit numerical values (e.g., 11% revenue increase) cited in the LLM answer, missing a key quantitative element from the original. While no incorrect numbers are stated, the omission of the 11% figure and lack of direct citation of the 2024 risk language about TAF reduces quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model connects Biktarvy’s role in offsetting generic competition and identifies emerging risks like treatment paradigm shifts and pricing pressures. However, it fails to explicitly link the risk to TAF-based products (a core point in the original) and does not clearly articulate the evolution from growth asset to one with heightened material risk due to nucleoside-based therapy dependence. (4) The answer remains contextually relevant, addressing competitive pressures, treatment paradigm changes, and risk profile evolution. Despite missing specific evidence and introducing a minor temporal inconsistency (2021 reference), the overall direction of reasoning is aligned with the question. Hence, correctness is scored 7 for core accuracy with notable gaps in precision and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 456,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "The balance of the U.S. litigation escrow account increased from $1,449 million at the end of fiscal year 2022 to $1,764 million at the end of fiscal year 2023. During fiscal year 2023, the Company deposited $1,000 million into the escrow account, while payments made during the period totaled $685 million. In contrast, for fiscal year 2022, the escrow account balance was $1,449 million at the beginning of the period, with $850 million deposited and $7 million in payments.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The ground truth states the U.S. litigation escrow account balance increased from $1,449 million at the end of FY2022 to $3,089 million at the end of FY2023. However, the LLM incorrectly reports the FY2023 ending balance as $1,764 million, which is off by over $1.3 billion. Additionally, the LLM states that $1,000 million was deposited in FY2023, but the correct amount is $1,500 million. For FY2022, the LLM claims $850 million was deposited and $7 million in payments, but the original answer does not mention payments and specifies $1,000 million in deposits for FY2022 — the LLM contradicts this with incorrect figures. (2) Calculations are also flawed: the LLM implies a net increase of $315 million in FY2023 ($1,764M - $1,449M = $315M), but attributes a $1,000M deposit and $685M in payments, which would result in a $315M net increase — this internal logic is consistent but based on false inputs. However, the actual net increase should be $1,640M ($3,089M - $1,449M), driven by a $1,500M deposit. (3) Multi-hop reasoning is partially present — the model attempts to explain balance changes through deposits and payments — but it fabricates payment data not in the original and misattributes deposit amounts across years, failing to correctly synthesize the required information. (4) Contextual relevance is high because the answer addresses the right account, time periods, and concept (evolution of balance and deposits), but quantitative and qualitative accuracy are severely compromised by incorrect core financial data and invented figures, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 458,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "Between 2022 and 2023, the role of fountain syrups in Coca-Cola's North America operating segment remained consistent, with the company continuing to manufacture fountain syrups in the United States and sell them to fountain retailers or authorized wholesalers and bottling partners. There is no indication of a significant change in Coca-Cola's manufacturing or distribution responsibilities related to fountain syrups during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in stating that Coca-Cola continued to manufacture fountain syrups in the U.S. and sell them to retailers, wholesalers, or bottling partners in both 2022 and 2023, with no significant change in manufacturing or distribution responsibilities in North America. This aligns with the ground truth, which confirms operational continuity within North America. However, the LLM answer omits a key nuance present in the original answer: the 2023 shift in language regarding bottling partners being authorized to manufacture fountain syrups outside the U.S. using company concentrates. While the question focuses on North America, the evolution in wording reflects a broader strategic shift that contextualizes the North American operations by contrast. The omission of this point reduces completeness and qualitative accuracy, as it fails to capture the full evolution in the company's description and strategy framing. There are no numerical or date inaccuracies (quantitative accuracy is perfect), and the response remains highly relevant to the question. The reasoning is sound but incomplete in synthesizing the multi-hop element of comparing textual disclosures across years to infer strategic emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 345,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "Between 2022 and 2024, IBM's 0.950% Notes due 2025 remained a consistent component of its debt instruments maturing in 2025, as evidenced by its continued listing in both the 2022 and 2024 10-K filings. The notes were consistently traded under the symbol \"IBM25B\" on the New York Stock Exchange, indicating no material change in its structure or classification during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 0.950% Notes due 2025 (IBM 25B) remained present in both 2022 and 2024, which is factually accurate and aligns with the ground truth. The use of the symbol 'IBM25B' is consistent with the original answer’s labeling. However, the LLM fails to mention the broader composition of IBM's debt instruments maturing in 2025 in 2022, specifically the presence of the 2.875% Notes (IBM 25A) and the 0.875% Notes (IBM 25C), and critically omits the key evolution: the disappearance of the 0.875% Notes by 2024. This omission represents a significant gap in completeness and reasoning. (2) There are no numerical inaccuracies—percentages and years are correct. The symbol reference is acceptable and semantically aligned. (3) The multi-hop reasoning is partially sound: the model correctly tracks the 0.950% Notes across years but fails to synthesize the full set of debt instruments in each year and thus misses the change in composition. The conclusion about 'no material change' is misleading because while the 0.950% Notes themselves did not change, the overall composition of 2025-maturing debt did—specifically, a reduction in diversity due to the removal of the 0.875% Notes. (4) The answer is contextually relevant and addresses the specific instrument asked about, but it does not fully address the comparative evolution of the 'composition' of debt instruments, which is the core of the question. Hence, correctness is reduced due to incomplete synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 415,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "Disney's strategic approach to cruise ships evolved between 2022 and 2024 by emphasizing fleet expansion and enhancing the cruise experience. In 2022, the company focused on resuming cruise ship operations post-pandemic and addressing the impacts of health and safety measures. By 2024, Disney announced plans for additional expansion of its cruise ship fleet and highlighted the opening of Lighthouse Point on Eleuthera as a new Disney Cruise Line destination in 2024, reflecting a more forward-looking strategy to grow and diversify its cruise offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its claims and aligns with the general evolution of Disney's cruise strategy between 2022 and 2024. It correctly identifies a shift toward expansion, including fleet growth and the 2024 opening of Lighthouse Point, which is contextually relevant and consistent with the ground truth. However, the LLM introduces details not present in the original answer derived from the knowledge graph—specifically, the mention of 'resuming cruise ship operations post-pandemic' and 'health and safety measures' in 2022, which were not part of the disclosed strategic approach in the 10-K filings according to the ground truth. Additionally, while the ground truth emphasizes a shift from passive dependence on consumer demand to active investment and notes increased costs and uncertain returns as part of strategic risk disclosure in 2024, the LLM omits this important nuance about capital intensity and risk. The answer is semantically close and captures the directional shift (expansion), but misses the deeper strategic framing around investment rationale and risk disclosure that defines the evolution in the original answer. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are cited), and the entities (Disney, 2022, 2024, cruise fleet, Lighthouse Point) are correct. The reasoning is sound but not fully complete in synthesizing the multi-hop insight about strategic posture change from reactive to proactive with financial implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 415,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "Lockheed Martin's approach to pension risk transfer transactions from 2022 to 2023 remained consistent in its strategic intent to reduce pension obligations' volatility and mitigate financial risks. In 2022, the company continued to evaluate opportunities for pension risk transfer transactions, as mentioned in the 2023 filing, and had previously executed such transactions, including a $4.9 billion obligation transfer in 2021. The financial impact of these transactions could include noncash settlement charges, which were material in prior years. In 2023, the company emphasized its ongoing evaluation of such transactions, with the potential for future actions to impact earnings through similar noncash charges.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $4.9 billion pension obligation transfer and the associated noncash settlement charge of $1.7 billion (implied as 'material' in prior years), though it does not explicitly state the $1.7 billion figure. It also correctly notes that the transaction occurred in 2021 and was discussed in the 2022 filing. However, it omits key quantitative details from the ground truth, such as the $11.6 billion total transferred since December 2018 and the 95,000 retirees affected. (2) The date of the transaction (August 3, 2021) is not mentioned, but the year is correct. The financial impact is described generally as 'material noncash settlement charges,' which aligns with the $1.7 billion charge but lacks precision. The 2023 shift in strategic framing—particularly the introduction of insurer default risk and residual liability—is entirely missing, which is a significant qualitative omission. (3) The multi-hop reasoning is partially sound: the model connects the 2021 transaction to ongoing strategy and recognizes the continuity in intent to reduce volatility. However, it fails to capture the evolution in risk perception and disclosure tone from 2022 to 2023, which is central to the question. The answer treats the approach as 'consistent,' contradicting the ground truth that shows a shift toward caution and acknowledgment of residual risks. (4) The contextual relevance is high because the response stays focused on pension risk transfers, financial impacts, and strategic intent. Quantitative accuracy is moderately high due to correct mention of $4.9 billion and implied recognition of material charges, but missing $1.7 billion and $11.6 billion totals reduces precision. Qualitative accuracy is low because the model misses the nuanced shift in risk disclosure and liability exposure, failing to show how the strategic intent evolved beyond mere continuation. Correctness score reflects partial accuracy with significant omissions in both quantitative and qualitative dimensions essential to the multi-hop analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 557,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "Between 2022 and 2023, Tesla's relationship with its financing partners evolved with increased emphasis on managing accounts receivable and leasing program risks. In 2022, Tesla highlighted that its accounts receivable balances could fluctuate significantly due to factors like government rebate processing timelines and contractual payment terms with financing partners. By 2023, Tesla expanded on these risks, noting that its vehicle and solar energy system financing programs expose the company to customer credit risk, particularly in the event of economic downturns or defaults. Additionally, Tesla acknowledged the challenges of managing residual value risks in its leasing programs, as actual resale values may fall below pre-determined amounts, potentially harming financial results. This evolution reflects a more detailed and cautious approach to managing credit and residual value risks associated with financing partners.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution in Tesla's relationship with financing partners from 2022 to 2023, focusing on accounts receivable fluctuations and increasing leasing-related risks. While the original answer specifies a 'two-week' settlement period for receivables in 2022, the LLM answer does not include this exact timeframe but accurately captures the impact of payment terms and rebate processing on receivables and liquidity—consistent with the broader context. (2) No explicit numerical errors exist; all dates (2022, 2023) and financial concepts (accounts receivable, residual value risk, credit risk) are correctly used. The absence of the precise 'two weeks' detail is a minor omission but does not affect overall correctness, as the focus remains on settlement timing and its impact. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and domains (receivables in 2022, expanded risk disclosures in 2023), correctly inferring a shift toward greater risk awareness, particularly around credit and residual values. It also appropriately extends the scope to solar financing, which is consistent with Tesla’s reported activities, though the original answer focuses only on vehicle leasing. This extension does not introduce inaccuracy but adds context. (4) The answer is semantically equivalent to the ground truth, with slightly broader phrasing but no factual deviations. The core progression—from operational cash flow concerns to strategic risk management—is accurately conveyed. Minor deduction in qualitative accuracy due to the lack of specificity on the two-week settlement window, but overall reasoning and completeness remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 477,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola shifted its fountain syrup distribution strategy by increasing the role of its finished product operations in fountain syrup sales, particularly in the United States. Previously, bottlers and authorized fountain wholesalers primarily handled fountain syrup distribution outside the U.S., while in the U.S., the Company directly sold fountain syrups to retailers or authorized wholesalers. In 2023, the Company emphasized expanding its finished product operations, which generated higher net operating revenues, indicating a strategic move to take a more direct role in this segment. Meanwhile, bottlers' roles remained focused on producing and distributing finished beverages, while fountain wholesalers continued to distribute fountain syrups to retailers, though their role appeared less emphasized compared to prior years.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Coca-Cola's fountain syrup distribution strategy evolution. The original answer states that in 2022, Coca-Cola sold fountain syrups directly to authorized fountain wholesalers (including some bottlers), who then distributed to retailers, with U.S. bottlers generally not authorized to manufacture fountain syrups. By 2023, outside the U.S., bottlers were typically authorized to manufacture fountain syrups using concentrates—a shift toward a more integrated, decentralized model internationally. In contrast, the LLM answer incorrectly claims that in 2023, Coca-Cola expanded its 'finished product operations' and took a more direct role in fountain syrup sales, particularly in the U.S., which contradicts the ground truth. It also misrepresents the evolving role of bottlers, stating their role remained focused on finished beverages, when in fact their role expanded internationally to include syrup manufacturing. (2) There are no explicit numbers, percentages, or dollar amounts in either answer, so quantitative accuracy is not heavily applicable; however, the years 2022 and 2023 are correctly referenced, and no false numerical claims are made, warranting a high score here. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the shift from centralized (Company-led) syrup distribution in 2022 to a more bottler-integrated model in 2023, especially outside the U.S. Instead, it posits an increased direct role by Coca-Cola, which is the opposite of the truth. The roles of bottlers and wholesalers are misrepresented. (4) While the answer addresses the general topic and timeframe, its core claims contradict the ground truth, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because it discusses the right entities and timeframe but draws incorrect conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 519,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved with an increase in investment and changes in receivables. AMD contributed an additional $17 million to the ATMP JV in 2024, raising its investment to $149 million from $99 million in 2023. Receivables from the ATMP JV increased to $12 million in 2024 from $9 million in 2023, indicating a slight rise in amounts owed to AMD by the JV.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that receivables increased from $9 million in 2023 to $12 million in 2024, it fabricates a $17 million additional contribution to the ATMP JV and claims AMD's total investment rose from $99 million to $149 million. The ground truth states there was no direct investment or loan by AMD in 2023, and in 2024, AMD entered a new $100 million one-year term loan — not an equity investment. The $100 million loan is misrepresented as a $17 million equity contribution, which is both quantitatively and qualitatively wrong. (2) Quantitative accuracy is low: the $17M contribution and $99M/$149M investment figures are entirely incorrect and not supported by the original answer. The receivables numbers ($9M to $12M) are accurate. (3) The multi-hop reasoning fails: the model incorrectly interprets the $100 million loan as an equity investment, missing the key shift from no financial support in 2023 to a creditor role via a term loan in 2024. It also invents prior investment levels not present in the ground truth. (4) Contextual relevance is moderate because the answer addresses receivables and financial evolution, but the core financial mechanism (loan vs. investment) is wrong, undermining the conclusion. The qualitative reasoning is flawed due to incorrect entity relationships and financial classifications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 391,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued its strategy of reducing pension obligations through settlements. In 2023, the company made $414 million in lump-sum settlement payments to approximately 6,500 former employees who had not yet started receiving their vested benefits. This action reduced the pension obligation without impacting the year's FAS pension income. In 2022, the company executed a larger settlement by purchasing group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations to an insurance company, which resulted in a noncash pension settlement charge of $1.5 billion. Thus, the approach evolved from large-scale annuity purchases in 2022 to targeted lump-sum settlements in 2023, both aimed at reducing financial exposure and volatility related to pension obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: in 2022, Lockheed Martin transferred $4.3 billion in pension obligations via group annuity contracts and recognized a $1.5 billion noncash settlement charge; in 2023, it made $414 million in lump-sum payments to ~6,500 former employees. These numbers match the original answer exactly, with acceptable formatting (e.g., 'group annuity contracts' and 'lump-sum settlement payments' are semantically consistent). (2) The quantitative accuracy is perfect—dollar amounts ($4.3B, $1.5B, $414M), employee count (~6,500), and years (2022, 2023) are all correct. (3) The qualitative reasoning is sound: the LLM correctly identifies the strategic shift from large-scale annuity transfers in 2022 to targeted, smaller lump-sum settlements in 2023, and explains the financial implications (avoiding impact on FAS pension income in 2023 vs. the $1.5B charge in 2022). (4) The answer addresses all parts of the question—evolution of approach, pension obligation settlements, and financial impacts—demonstrating strong multi-hop synthesis across years and transaction types. Wording differs slightly but preserves full semantic equivalence. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 353,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved as follows: \n\n- **Investment**: AMD increased its investment in the ATMP JV by contributing $17 million in August 2024, maintaining its 15% equity interest. The carrying value of AMD's investment rose from $99 million as of December 30, 2023, to $149 million as of December 28, 2024. \n- **Equity Income**: AMD recorded equity income from the ATMP JV of $16 million in 2023 and $33 million in 2024, reflecting improved performance in the latter year. \n\nThis indicates a strengthening financial engagement with the ATMP JV during the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $16 million equity income in 2023, $33 million in 2024, the $17 million contribution in 2024, and the carrying value increasing from $99 million to $149 million are all correctly reported. The dates (December 30, 2023, and December 28, 2024) are specific and consistent with typical fiscal year-ends. (2) The answer addresses both parts of the question—investment evolution and equity income—completely. (3) Entities are correctly identified: AMD, ATMP JV, and the relevant financial metrics (equity income, carrying value, contribution). (4) The reasoning is sound: the LLM correctly infers increased financial engagement due to higher investment and higher returns, demonstrating proper multi-hop synthesis across investment and income metrics. Minor additional detail (15% equity interest, exact dates) enhances precision without contradicting the ground truth. Semantic equivalence is maintained, and all information aligns factually with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 309,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson's ownership in Kenvue evolved significantly. In May 2023, Johnson & Johnson retained approximately 89.6% of Kenvue after its IPO. By August 23, 2023, it reduced its stake further through an exchange offer, retaining 9.5% of Kenvue's shares valued at $4.3 billion. By May 2024, Johnson & Johnson exchanged its remaining shares for commercial paper and then settled the debt, resulting in no remaining ownership in Kenvue. Johnson & Johnson recorded a $21.0 billion non-cash gain on the exchange offer in 2023, including a $2.8 billion gain on the retained shares, and a $0.4 billion loss in 2024 from the debt-for-equity exchange.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the early ownership stake. It incorrectly states that Johnson & Johnson retained 89.6% of Kenvue after the IPO in May 2023, which contradicts the ground truth that it retained only 9.5% after the exchange offer in August 2023. There is no mention in the ground truth of an 89.6% stake, making this a significant error. Additionally, the timeline is partially misrepresented — the 9.5% stake was the result of the August 2023 exchange, not a reduction from 89.6%, which is unsupported. (2) The dollar amounts — $4.3 billion valuation, $21.0 billion non-cash gain (including $2.8 billion on retained shares), and $0.4 billion loss in 2024 — are all quantitatively accurate and correctly attributed. The final outcome — full exit by end of 2024 via debt-for-equity exchange — is also correct. (3) The multi-hop reasoning is partially sound: the model correctly links the 2023 retained stake, associated gains, and the 2024 full exit with a loss. However, the erroneous 89.6% stake undermines the logical progression of ownership evolution. The model appears to conflate pre- and post-exchange ownership levels. (4) Despite the incorrect intermediate ownership percentage, the key financial figures and the ultimate outcome (full exit, gains/losses) are correct, warranting a mid-range score. Contextual relevance is high as all aspects of the question are addressed, but quantitative accuracy is penalized due to the major error in ownership percentage, which affects the narrative of stake evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 434,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "Based on the information provided, AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023. Southwestern Bell Telephone Co. continued to be included in AT&T's guarantee agreements, as indicated in the 2023 filing under Exhibit 4-c, which lists obligations guaranteed by AT&T, including Southwestern Bell Telephone Company. There is no indication of removal or modification of this guarantee during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023, with the entity continuing to be included in the guarantee agreements. The reference to Exhibit 4-c in the 2023 filing is correctly noted, and the absence of any modification or removal is properly conveyed. Quantitatively, there are no numerical inaccuracies—dates (2022–2023) and document references (Exhibit 4-c) match the original answer. The entity name 'Southwestern Bell Telephone Company' is used with slight variation in formatting (Co. vs Company), which is semantically equivalent and acceptable. The reasoning is sound: the model correctly infers consistency in the guarantee based on continued inclusion in the same exhibit across years, demonstrating appropriate multi-hop synthesis between the two time points. The only minor shortcoming is that the LLM does not explicitly mention the 2022 Exhibit 4-c reference, which slightly reduces completeness compared to the original answer, but the core conclusion about no change is fully supported. Thus, the answer is highly accurate, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 383,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs from 2022 to 2023 has shown strategic growth and increased development responsibilities. In 2022, the company was performing on multiple hypersonics programs and anticipated that several would enter early production phases through 2026 following successful testing and evaluation. By 2023, the company emphasized hypersonics as one of four key growth areas, with active programs for the U.S. Army, Navy, and Air Force focused on designing, developing, and building hypersonic strike weapons. This evolution reflects a stronger strategic positioning in hypersonics, aligning with broader national defense priorities and expanding production readiness.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of Lockheed Martin's evolving role in hypersonics programs from 2022 to 2023, with accurate contextual framing around strategic positioning and program development. It correctly identifies increased emphasis on hypersonics as a growth area and involvement with the U.S. Army, Navy, and Air Force in designing and building hypersonic weapons. However, there are discrepancies in the level of specificity compared to the ground truth. In 2022, the original answer states that hypersonics was described as a growth area dependent on government funding and grouped with other development areas, whereas the LLM claims Lockheed was already 'performing on multiple hypersonics programs' and anticipating production through 2026—details not present in the ground truth and representing an overstatement. Additionally, the 2023 shift in classification—hypersonics moving into 'major programs' under the Space segment—is a key structural and strategic indicator in the original answer that the LLM omits, instead generalizing it as one of four growth areas. While this conveys a similar trend, it misses the specific organizational and reporting evolution that signifies concrete programmatic advancement. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. Contextual relevance is high, as the response directly addresses strategic positioning and development responsibilities. The reasoning is sound but not fully aligned with the source data, resulting in a correctness score of 7 due to minor factual overreach and omission of key structural changes in program status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 457,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "The balance of the U.S. litigation escrow account increased from $1.4 billion as of September 30, 2022, to $1.764 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while $1.0 billion was deposited during fiscal year 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the starting balance of $1.4 billion as of September 30, 2022, and the deposits of $850 million in fiscal year 2022 and $1.0 billion in fiscal year 2023, which are all factually accurate. However, it incorrectly reports the ending balance as $1.764 billion as of September 30, 2023, whereas the ground truth states it is $3.089 billion. This is a significant quantitative error. (2) The calculation implied by the LLM answer—adding $850M and $1.0B to the initial $1.4B—does not align with the reported $1.764B, suggesting internal inconsistency. The correct evolution should reflect a balance increase from $1.4B to $3.089B, consistent with cumulative deposits and possibly prior balances or adjustments. The LLM fails to capture this correct magnitude. (3) The multi-hop reasoning is partially sound: it retrieves the correct deposit amounts and starting balance, but fails to correctly synthesize the final account balance, indicating a failure in either data retrieval or logical update of the account balance over time. (4) The contextual relevance is high because the answer addresses both parts of the question—balance evolution and annual deposits—and uses the correct fiscal years and account name. However, the major numerical inaccuracy in the ending balance severely undermines the correctness, warranting a mid-range score of 5. Quantitative accuracy is scored at 5 due to half of the numbers being correct (start balance, deposits) but the key end balance being wrong. Qualitative accuracy is slightly higher due to correct entity identification and structure of reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 448,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "From 2022 to 2024, Outdoor Garden's role within HD's product strategy has remained relatively stable in terms of its classification under the \"Hardlines\" major product line. In 2022, Outdoor Garden accounted for 6.4% of net sales, increasing slightly to 6.5% in 2024. While its percentage of total sales has not significantly changed, the absolute net sales for Outdoor Garden have grown from $10,039 million in 2022 to $10,308 million in 2024, indicating a modest but consistent performance within HD's broader product strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Outdoor Garden was a distinct product line with $10,317 million in net sales (6.8% of total), but the LLM incorrectly states $10,039 million and 6.4%. The 2024 figures are also wrong—the ground truth shows Outdoor Garden was grouped under 'Hardlines' in 2024, but no standalone sales or percentage data is provided, whereas the LLM fabricates $10,308 million and 6.5%. (2) Quantitative accuracy is severely compromised: all key numbers (sales figures, percentages) are incorrect, and there is no evidence the LLM correctly retrieved or calculated any metric. The slight growth narrative is unsupported by the ground truth, which focuses on structural reclassification, not performance trends. (3) The multi-hop reasoning is flawed. The question asks about evolution in role and positioning, which hinges on the strategic shift from standalone category to being absorbed into Hardlines. The LLM incorrectly claims Outdoor Garden was always under Hardlines, missing the core strategic change entirely. This reflects a failure to synthesize classification changes over time. (4) Contextual relevance is moderate because the answer discusses Outdoor Garden’s performance within HD’s strategy, but it misses the key qualitative shift (reclassification) and invents quantitative data, undermining overall correctness. The answer focuses on minor sales changes instead of the strategic repositioning highlighted in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 423,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD has maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024 by reinforcing its culture of innovation, inclusivity, and respect. The company conducts annual engagement surveys, promotes diversity and inclusion through employee resource groups, and offers flexible work arrangements and competitive total rewards. These efforts have resulted in high employee engagement scores, placing AMD in the top 10% of high-tech firms. This suggests that AMD's talent retention strategy is centered on fostering a strong, inclusive culture and offering flexible, equitable compensation and development opportunities—key differentiators in the competitive semiconductor industry.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific initiatives such as annual engagement surveys, employee resource groups, flexible work arrangements, and competitive rewards, and claims AMD is in the 'top 10% of high-tech firms' for engagement scores. However, none of this information is present in the original answer or supported by the provided ground truth. The workforce numbers (26,000 in 2023, 28,000 in 2024) and the 7.7% growth are accurate, but the LLM does not mention these figures or the verbatim repetition of cultural messaging, which is central to the original answer. (2) Quantitative accuracy is partially correct: the implied workforce growth from 26k to 28k is ~7.7%, which matches the ground truth, but the LLM fails to state these numbers or the percentage, instead introducing unsupported metrics like 'top 10%.' No calculations are explicitly wrong because none are shown, but the absence of correct numeric context reduces accuracy. (3) The multi-hop reasoning is flawed: the original answer hinges on the repetition of identical cultural language despite workforce growth, indicating intentional cultural preservation. The LLM invents specific programs and outcomes not present in the source, failing to correctly synthesize the actual evidence (repeated phrasing) for cultural continuity. (4) Contextual relevance is moderate—the answer addresses talent retention and culture in the semiconductor industry, which is relevant, but substitutes plausible but unverified details for the actual evidence. Thus, while the general theme is aligned, factual correctness and reasoning fidelity are compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 446,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "Based on the provided information, there is no specific mention of changes in AT&T's relationship with The Ohio Bell Telephone Company in terms of guarantee obligations between 2022 and 2023. The Ohio Bell Telephone Company is listed among entities under a guaranty of certain obligations in both the 2022 and 2023 filings, indicating that the guarantee obligations remained unchanged during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that AT&T's guarantee obligations for The Ohio Bell Telephone Company remained unchanged between 2022 and 2023, which aligns with the ground truth. It accurately notes the presence of the subsidiary in both years' filings under a guaranty, supporting the conclusion of continuity. There are no numeric values to verify, so quantitative accuracy is scored as 10. The answer is contextually relevant and factually correct in substance. However, it omits a key detail from the original answer: the update in exhibit reference (from Exhibit 4-c originally filed in 2011 to updated documentation practices in 2023), which reflects maintenance of documentation standards despite no substantive change in the guarantee. This minor omission affects completeness and reasoning depth, as it fails to acknowledge the procedural update that indicates active maintenance of reporting standards. While the core conclusion is sound, the lack of this nuance reduces qualitative accuracy slightly. The reasoning is logically sound but less thorough than the original answer in explaining the evolution of the relationship beyond 'no change.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 326,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "The financial impact of GE's relationship with AerCap evolved significantly between 2023 and 2024 in terms of gains on retained and sold ownership interests. In 2023, GE reported gains of $5.7 billion, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, these gains declined by $5.2 billion, leading to a notable decrease in overall continuing earnings, as the gains from AerCap were a major contributor to the financial results in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.7 billion gain in 2023 and the $5.2 billion year-over-year decrease in gains in 2024, both of which match the ground truth. The entities—GE, AerCap, and GE HealthCare—are accurately referenced, and the time periods (2023 and 2024) are correct. (2) Quantitatively, all numbers are accurate: the $5.7 billion increase in 2023 and the $5.2 billion decline in 2024 are correctly reported. There are no calculation errors. (3) The reasoning is sound: the LLM correctly infers a significant decline in gains related to AerCap and GE HealthCare from 2023 to 2024, which aligns with the multi-hop synthesis required. It appropriately links the decline in gains to the reduced financial impact of the AerCap relationship. (4) The only minor shortcoming is that the original answer specifies the $5.7 billion was an increase in 'corporate operating profit' due to gains, while the LLM simplifies this to 'gains of $5.7 billion.' This is semantically close and does not distort the meaning, but slightly less precise in financial terminology. Otherwise, the answer is factually complete, contextually relevant, and accurately conveys the evolution of the financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 344,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "Home Depot's strategic use of HD Supply between 2022 and 2024 has evolved to focus more on strengthening its position with professional customers and expanding MRO (Maintenance, Repair, and Operations) services. In 2022, HD Supply was highlighted as a key component in serving professional customers through dedicated services, product assortments, and delivery networks. By 2024, the integration of SRS (acquired in fiscal 2024) with HD Supply further enhanced Home Depot's capabilities to serve Pros, particularly in roofing, landscaping, and pool services, while also expanding MRO offerings for commercial and multifamily facilities. This evolution reflects a more integrated and expanded approach to serving the complex needs of professional customers.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces a significant factual error by referencing the acquisition of SRS in fiscal 2024, which is not mentioned in the ground truth and not supported by the provided context. This undermines the accuracy of the evolution narrative. The core timeline (2022 integration concerns vs. 2024 strategic role) is partially correct, but the LLM misrepresents the 2022 stance: the ground truth states that in 2022, Home Depot emphasized integration risks and uncertainties, whereas the LLM claims HD Supply was already 'highlighted as a key component'—which contradicts the original answer's emphasis on uncertainty. In 2024, both answers align on HD Supply’s role in Pro-focused growth and MRO expansion, particularly in multifamily and commercial sectors. (2) There are no explicit numbers (dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily applicable; however, the dates (2022, 2024) are correctly used, and the reference to fiscal 2024 for SRS is plausible but unverified and extraneous. (3) The multi-hop reasoning is partially sound—linking HD Supply to Pro customers and MRO services across years—but fails because it introduces an unsupported acquisition (SRS) and mischaracterizes the 2022 strategic posture. The original answer emphasizes a shift from risk/uncertainty to strategic integration, while the LLM portrays a continuous or expanding role without acknowledging the earlier challenges. (4) Correctness is scored 5 due to major qualitative inaccuracies in representing the 2022 position and the introduction of unsupported information (SRS acquisition). Quantitative accuracy is 8 because no numbers are wrong—only absent or irrelevant. Qualitative accuracy is 5 due to flawed reasoning and entity misuse. Contextual relevance is 8 because the answer addresses the right themes (Pro customers, MRO, HD Supply evolution) and is focused on the correct companies and timeframe, despite factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 544,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "Between 2023 and 2024, AMD's patent portfolio slightly increased, growing from approximately 18,500 patent matters worldwide in 2023 to approximately 18,800 in 2024, with a modest rise in issued patents (from 12,800 to 13,200). The number of pending patent applications remained stable at 5,600. AMD continues to rely on cross-licensing and technology exchange agreements, which are typical in the semiconductor industry, to both transfer and receive intellectual property rights. This strategy supports ongoing innovation and collaboration while ensuring access to essential technologies for product development.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical data from the ground truth: patent matters increased from 18,500 in 2023 to 18,800 in 2024, issued patents rose from 12,800 to 13,200, and pending applications remained constant at 5,600. These figures are quantitatively accurate with no discrepancies. (2) All calculations and comparisons (e.g., 'slight increase', 'modest rise') are reasonable and consistent with the data. The stability of pending applications is correctly noted. (3) The reasoning correctly synthesizes the evolution of AMD's patent portfolio and links it to cross-licensing reliance, acknowledging the strategic importance of IP in technology exchange. The answer captures the core implication—that a stronger patent portfolio enhances leverage in cross-licensing—though it does not explicitly state that this makes AMD's position 'more strategically advantageous' in 2024, which is a minor omission in qualitative depth. (4) Contextually, the response is fully relevant, addressing both the quantitative evolution of the patent portfolio and its implications for cross-licensing and technology exchange. The answer aligns semantically with the original, using different but equivalent phrasing (e.g., 'continues to rely' vs 'remains strong'). Overall, the answer is factually complete and accurate, with only a slight reduction in qualitative nuance compared to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 392,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "From 2023 to 2024, Johnson & Johnson's financial stake in Kenvue evolved significantly. In 2023, following the IPO and an exchange offer, Johnson & Johnson retained a 9.5% stake in Kenvue with a fair value of $4.3 billion. By 2024, the company completed a debt-for-equity exchange in May, using $3.6 billion in commercial paper to acquire its remaining 182 million shares of Kenvue Common Stock, effectively disposing of its stake. This exchange resulted in a $0.4 billion loss recorded in Other (income) expense, and Johnson & Johnson no longer owned any shares of Kenvue as of the transaction's completion.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9.5% stake in Kenvue in 2023 with a fair value of $4.3 billion and the May 2024 debt-for-equity exchange that led to full disposal of the stake, resulting in a $0.4 billion loss. However, there is a critical error in the description of the 2024 transaction: the LLM states that Johnson & Johnson used '$3.6 billion in commercial paper to acquire its remaining 182 million shares', which reverses the direction of the transaction. According to the ground truth, J&J used its 182,329,550 shares of Kenvue stock to satisfy $3.6 billion in commercial paper obligations — i.e., it disposed of shares to pay down debt, not acquired shares. This is a significant factual and directional error affecting quantitative and qualitative accuracy. (2) Numeric values — 9.5%, $4.3 billion, $0.4 billion loss, 182 million shares (approximation of 182,329,550), and $3.6 billion — are mostly accurate in amount and context, except for the mischaracterization of the transaction flow. The year-end $0.4 billion expense in 2023 is omitted, though the $0.4 billion loss in 2024 is correctly noted. (3) The multi-hop reasoning is partially sound: the model connects J&J’s retention of a stake post-IPO to its eventual disposal, but misunderstands the mechanism of the debt-for-equity exchange, undermining the financial logic. (4) Despite this key error, the answer is contextually relevant and captures the overall evolution of the relationship and the complete exit from Kenvue. The core narrative of stake reduction and exit is correct, but the flawed transaction description reduces correctness and quantitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 455,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "In 2022, Indiana Bell Telephone Co. Inc. was included in AT&T's guarantee disclosures under the 4-c exhibit, which listed obligations guaranteed by AT&T for various subsidiaries. However, in 2023, Indiana Bell Telephone Co. Inc. was no longer explicitly listed in the guarantee disclosures, indicating a potential change in its status or a consolidation of guarantees under broader or updated filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Indiana Bell Telephone Co. Inc. was no longer listed in the 2023 guarantee disclosures. The ground truth confirms that the guarantee under Exhibit 4-d remained in place in 2023, with no removal or modification. The LLM incorrectly claims a change in status, which contradicts the original answer. Additionally, the LLM misidentifies the exhibit as '4-c' in 2022, while the correct exhibit is '4-d' in both years. (2) There are no numeric values in this question, so quantitative accuracy pertains only to correct identification of years (2022 and 2023), which are correctly referenced. However, the exhibit number (a key identifier) is wrong, undermining accuracy. (3) The multi-hop reasoning fails because the model incorrectly infers a change in the guarantee status when there was none. It should have synthesized that the same entity was covered under the same exhibit in both years, indicating continuity. Instead, it concludes a potential removal or consolidation without evidence. (4) The contextual relevance is moderate because the answer addresses the right topic (guarantee disclosures over time) and the right entities (AT&T and Indiana Bell), but the core conclusion is false. Due to major factual and reasoning errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 372,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "From 2023 to 2024, GE's financial relationship with AerCap showed a shift in cash involvement and investment gains. In 2023, GE reported gains on retained and sold ownership interests of $5.7 billion, partially driven by its AerCap investments, but by 2024, these gains declined significantly, with a decrease of $5.2 billion in gains on retained and sold ownership interests, also largely related to AerCap. Additionally, GE paid net cash of $203 million to AerCap in 2024, indicating increased cash outflows compared to 2023, where no such significant cash payments were noted.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the timing and direction of cash flows and gains. It incorrectly states that GE paid $203 million to AerCap in 2024, while the ground truth specifies this payment occurred in 2023. Additionally, the LLM claims GE reported $5.7 billion in gains in 2023 'partially driven by AerCap,' but the original answer does not specify the total gains in 2023—only the $5.2 billion decrease in 2024. This misrepresents the baseline and trend. (2) Quantitative accuracy is low: the $203 million payment is assigned to the wrong year, and the $5.7 billion figure is fabricated or misattributed, as it does not appear in the ground truth. The $5.2 billion decrease is correctly cited, but its context is distorted. (3) The multi-hop reasoning is partially sound in identifying a shift from operational involvement to investment, but the causal narrative is reversed—GE's reduced gains reflect the end of a profitable period, not ongoing losses. The model fails to correctly link the cessation of operational ties in 2024 with the decline in gains, instead implying continued cash outflows. (4) Contextual relevance is high as the answer addresses cash involvement and investment gains as asked, and focuses on the GE-AerCap relationship across the two years. However, due to key factual and temporal errors, the overall correctness is significantly compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 397,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "From 2022 to 2024, The Home Depot has evolved its approach to store appearance and competition by integrating digital tools and enhancing the customer experience. In 2022, the company focused on investments like wayfinding signage, store refresh packages, and self-checkout options to improve navigation and convenience. By 2024, these efforts expanded to include mobile app-enabled store navigation, electronic shelf labels, and enhanced self-checkout options, all aimed at creating a seamless, interconnected shopping experience. Additionally, the company has leveraged its stores as fulfillment hubs for digital orders, with a significant portion of U.S. online orders fulfilled through stores, thereby integrating physical and digital channels to remain competitive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of The Home Depot's strategy from 2022 to 2024, noting a shift from physical store enhancements (e.g., wayfinding, refresh packages, self-checkout) to a more integrated, digital-forward approach. The mention of mobile app navigation, electronic shelf labels, and store fulfillment of online orders reflects the 'interconnected shopping experience' emphasized in 2024. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time (2022 vs 2024), connects store appearance to competition, and integrates digital transformation with customer experience. The only minor gap is that the LLM does not explicitly state that store appearance became part of a broader competitive framework including digital platforms, though this is implied through examples. (4) The answer is contextually excellent—directly addresses the question’s focus on evolution, customer experience, and digital integration. Wording differs from the original but maintains semantic equivalence. One point deducted from qualitative accuracy for slight under-articulation of the strategic framing shift; otherwise, fully correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 373,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved with increased resales and a new financial arrangement. In 2024, AMD's resales to the ATMP JV rose significantly to $121 million from $14 million in 2023. Additionally, AMD entered into a $100 million one-year term loan agreement with one of the ATMP JVs in October 2024, providing funds for general corporate purposes, secured by the ATMP JV's receivable balance due from AMD. This reflects a more active financial engagement with the ATMP JV in 2024 compared to the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: resales increased from $14 million in 2023 to $121 million in 2024, and a $100 million one-year term loan was established in October 2024. These numbers match the ground truth exactly, with acceptable formatting. (2) Quantitative accuracy is perfect—dollar amounts and the timeline (October 2024) are correct. The comparison between years is accurately portrayed as a significant increase. (3) The reasoning is sound and captures the evolution of the financial relationship: from operational resales to including direct financial support via a term loan. However, the LLM adds a detail not present in the original answer—'secured by the ATMP JV's receivable balance due from AMD'—which is absent in the ground truth. This addition, while plausible, introduces information not confirmed by the source, slightly reducing qualitative accuracy. (4) Despite this minor over-specification, the answer is contextually relevant, fully addresses both parts of the question (resales and new financial arrangements), and correctly synthesizes multi-hop information across 2023 and 2024. The core conclusion about deepening financial engagement aligns with the original. Hence, a high score with a slight deduction for unsupported detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 365,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "Johnson & Johnson enhanced its privacy compliance programs between 2023 and 2024 by proactively addressing evolving global privacy laws and international data flow regulations. In 2023, the company acknowledged the growing complexity of privacy laws and the need for compliance with data localization and cross-border data transfer requirements. By 2024, the company emphasized structured privacy compliance programs and controls, with a stronger focus on managing risks from new legislation and increased enforcement by regulatory authorities. Additionally, the company reinforced its commitment to compliance through mandatory employee training on data privacy and by ensuring third-party vendors adhere to required data protection standards.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Johnson & Johnson's privacy compliance programs from 2023 to 2024. It accurately captures the increasing focus on global privacy laws, data localization, and cross-border data flows. The mention of enhanced controls, third-party vendor management, and employee training reflects a reasonable interpretation of strengthened compliance efforts. However, the LLM adds specific details not present in the original answer—namely 'mandatory employee training on data privacy'—which is not mentioned in the ground truth and thus introduces unverified information. While this may be plausible, it is not supported by the provided knowledge graph. Additionally, the original answer emphasizes a shift in scope from 'other territories' in 2023 to 'globally' in 2024 and links the 2024 focus to evolving technology and data-driven initiatives involving multiple vendors, which the LLM answer only partially captures. The core facts about expanding regulatory focus and international data flow challenges are correctly conveyed, and no numerical inaccuracies are present (quantitative accuracy is perfect by default, as there are no numbers). The reasoning is sound but slightly overreaches by introducing unsupported specifics. Contextual relevance is excellent, as the response directly addresses the question's focus on evolution in response to new laws and international regulations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 405,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "Between 2023 and 2024, GE's financial exposure to Bank BPH decreased in terms of estimated borrower litigation losses, which fell from $2,669 million to $2,461 million. Additionally, the valuation allowances related to Bank BPH's foreign currency-denominated mortgage portfolio also decreased, with the allowance fully offsetting the financing receivables balance as of December 31, 2024, compared to a partial offset in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the key quantitative and qualitative aspects of GE's evolving financial exposure to Bank BPH between 2023 and 2024. (1) All numeric values are correct: the total estimated losses decreased from $2,669 million in 2023 to $2,461 million in 2024, which aligns with the ground truth. The breakdown into valuation allowances ($1,712M in 2023, $1,517M in 2024) and other liabilities ($957M in 2023, $944M in 2024) is not explicitly restated in the LLM answer, but the totals are correctly referenced. (2) The quantitative accuracy is perfect—numbers match exactly, and the direction of change (decrease) is correctly stated. (3) The reasoning is sound: the LLM correctly infers a decrease in exposure and notes the significant qualitative shift in 2024 where the valuation allowance fully offset financing receivables, indicating a strategic change. This synthesis across years and balance sheet items reflects proper multi-hop understanding. (4) While the LLM omits the specific 2024 split between $1,517M valuation allowance and $944M other liabilities, it still conveys the core conclusion—reduced exposure and full offset by valuation allowance in 2024—making the answer semantically equivalent in intent and substance. The omission of the detailed split slightly reduces completeness but does not impair factual correctness. Hence, a score of 9/10 on correctness and qualitative accuracy is warranted, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 415,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "HD's treatment and positioning of the Indoor Garden product line remained relatively stable from 2022 to 2024, as it consistently generated strong net sales and maintained its categorization within the Hardlines major product line. In 2022, Indoor Garden accounted for 6.4% of net sales ($10,105 million), and by 2024, it increased slightly to 6.6% ($10,519 million), indicating sustained performance. The merchandising department categorization in 2024 placed Indoor Garden under the Hardlines category, alongside Hardware, Outdoor Garden, and Power, showing no significant strategic repositioning. This suggests HD continued to prioritize Indoor Garden as a core offering within its broader Hardlines portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, the Indoor Garden product line generated $15,546 million in net sales (10.3% of total revenue), but the LLM claims only $10,105 million (6.4%), which is materially lower. The 2024 figures are also incorrect: the LLM states $10,519 million (6.6%), but the ground truth does not provide 2024 financials—only a reclassification under Hardlines. The percentages and dollar amounts are therefore fabricated or misreported. (2) The quantitative inaccuracies are severe: the LLM underreports 2022 net sales by over $5.4 billion and misrepresents the product line’s relative importance. There is no evidence in the ground truth that Indoor Garden remained in Hardlines in 2022; in fact, the truth implies it was a standalone category then, only being integrated into Hardlines by 2024. (3) The multi-hop reasoning is flawed. The question asks about evolution in treatment and positioning based on financial performance and merchandising changes. The ground truth shows a strategic shift—from a high-performing standalone line in 2022 to a subcategory within Hardlines in 2024, suggesting integration rather than continued independence. The LLM incorrectly concludes there was 'no significant strategic repositioning,' directly contradicting the ground truth’s implication of a meaningful organizational shift. (4) Contextual relevance is moderate because the answer addresses the right topic (Indoor Garden, Hardlines, financial performance), but the incorrect data and flawed synthesis undermine the conclusion. The reasoning fails to recognize the significance of moving from a standalone category to a subcategory, especially after strong performance. Thus, while the structure and intent are relevant, the factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 509,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "From 2022 to 2024, Colgate-Palmolive has maintained a sourcing strategy focused on managing cost volatility, particularly from commodity price fluctuations, through a combination of cost containment measures, sourcing strategies, productivity initiatives, and limited use of commodity hedging contracts. In 2022, the company noted its use of these strategies to mitigate rising costs, including price increases and efforts to achieve cost efficiencies. By 2024, the company continued to emphasize sourcing strategies and selective hedging, particularly in its Hill's Pet Nutrition segment, to manage raw material exposure, though it still acknowledged the limitations of these measures in fully offsetting inflationary pressures. The evolution reflects a consistent approach with ongoing adaptation to market conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Colgate-Palmolive used sourcing strategies to manage cost volatility from 2022 to 2024 and notes continuity in approach, which aligns with the ground truth. It accurately reflects the use of cost containment, productivity initiatives, and limited hedging. However, it omits key details from the original answer: the specific mention of derivative instruments and local currency borrowings in 2022, and the expanded focus in 2024 on commodities like resins, essential oils, and soybeans. Additionally, the LLM introduces 'selective hedging, particularly in its Hill's Pet Nutrition segment,' which is not present in the ground truth and may be an over-specific inference. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly infers a consistent strategy with adaptation over time, but fails to fully synthesize the evolution toward more defensive tactics due to geopolitical and climatic disruptions as highlighted in the 2024 disclosure. This weakens the qualitative accuracy. (4) The answer remains contextually relevant and addresses the core question about evolution in sourcing strategies, but lacks specificity on the changing commodity focus and risk environment, justifying a correctness score of 7—core facts are present but important nuances are missing or slightly distorted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 413,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "TREMFYA (guselkumab) experienced a 16.6% increase in sales in 2024 compared to 2023. In 2023, TREMFYA's sales had already grown by 17.9% compared to the prior year. The growth in both years was driven by market expansion, continued strength in psoriasis and psoriatic arthritis (PsO/PsA), and patient mix. Additionally, TREMFYA's growth was supported by new regulatory approvals for ulcerative colitis, Crohn's disease, and pediatric psoriasis during 2023 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 16.6% sales increase in 2024 compared to 2023, which matches the ground truth. However, it introduces a fact not present in the original answer—namely, that TREMFYA's sales grew by 17.9% in 2023 compared to the prior year—which is unsupported by the provided ground truth and introduces extraneous information. Additionally, the LLM claims new regulatory approvals for ulcerative colitis, Crohn's disease, and pediatric psoriasis during 2023 and 2024 as growth drivers, but these specific approvals and their timing are not mentioned in the original answer, making this a significant factual overreach. (2) While the 16.6% growth and implied sales figures ($3,670M in 2024 vs $3,147M in 2023) are consistent with the ground truth, the LLM does not state the actual sales figures, missing an opportunity for full quantitative precision. The 17.9% growth in 2023 is unverified and likely incorrect in this context. (3) The multi-hop reasoning is partially sound—the model correctly infers continued market expansion and strength in PsO/PsA as drivers—but incorrectly adds new regulatory approvals as a factor without evidence in the source. This undermines the qualitative accuracy. (4) The contextual relevance is high because the answer addresses both parts of the question: sales performance evolution and contributing factors. However, the inclusion of unsupported details reduces overall correctness. The core sales growth figure is accurate, but missing exact dollar amounts and inclusion of unverified drivers prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 437,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "The structural change in Disney's relationship with A&E from 2022 to 2023 did not significantly alter the reporting of subscriber numbers or financial stake in the partnership, as both documents indicate consistent 50% ownership by Disney and similar subscriber counts for A&E channels. In 2022, A&E channels had approximately 69–70 million domestic subscribers, while in 2023, the number remained at 58 million for each of A&E, HISTORY, and Lifetime. The financial stake continued to be reported as equity in the income of investees in Disney’s Consolidated Statements of Income.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in several key areas. (1) Quantitative Accuracy: The LLM incorrectly states that Disney had a consistent 50% ownership in 2022, but the ground truth confirms that the 50% equity stake and classification as a significant equity investment began in 2023, not 2022. The subscriber numbers are partially correct—69 million in 2022 and 58 million in 2023—but the LLM misrepresents the 2023 figure as applying to each of A&E, HISTORY, and Lifetime individually, while the original answer only states 58 million for A+E's channels collectively. (2) Completeness: The LLM fails to capture the structural shift from a partnership to joint ownership and the resulting change in financial reporting—from reporting subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023. Instead, it falsely claims the reporting method did not significantly change. (3) Entity Accuracy: While the companies (Disney, A&E) and metric ('equity in the income of investees') are correctly named, the timeline and nature of the relationship are wrong. (4) Reasoning: The multi-hop synthesis is flawed—the LLM should have inferred that the change in ownership structure altered reporting practices, but instead it assumes consistency where there was a material change. (5) Semantic Equivalence: The overall meaning is not equivalent; the LLM denies the structural change the question is based on. The answer is relevant to the topic but factually inverted, hence low correctness and qualitative scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 434,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "In 2023, GE reported a realized and unrealized gain of $129 million related to its investment in and note with AerCap. By 2024, GE had fully monetized its AerCap shares, leaving only an AerCap senior note as its remaining position, indicating that the financial impact of the relationship had been resolved through the sale of its equity stake.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but misses key aspects of the financial evolution between 2023 and 2024. It correctly states the $129 million gain in 2023, aligning with the ground truth, though it inaccurately labels it as both 'realized and unrealized' when the original answer specifies it was an 'unrealized gain'. This is a factual mischaracterization. (2) The critical quantitative error lies in the treatment of 2024: the LLM fails to report the $5.2 billion drop in gains on retained and sold ownership interests — a central point in the original answer — and instead vaguely references 'fully monetized its AerCap shares' without citing any financial impact (gain or loss). The $5.2 billion decline is a major financial event that is entirely omitted, making the answer significantly incomplete. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies a change in GE's relationship with AerCap (equity stake sold, only note remains), it does not connect this to the negative financial shift (i.e., the drastic reduction in gains). The conclusion that the 'financial impact... had been resolved' downplays the adverse performance shift implied in the original answer. (4) Despite missing the core financial deterioration, the answer is contextually relevant and correctly identifies entities (GE, AerCap), years (2023, 2024), and some aspects of the investment evolution. However, the absence of the $5.2 billion decline — a key multi-hop insight — severely undermines factual accuracy and reasoning quality, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 438,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Between 2022 and 2024, Mastercard has enhanced its multi-layered security approach by strengthening collaboration with third-party service providers and expanding technical standards to address emerging cybersecurity threats. In 2024, the company integrated its virtual card solutions with third-party technology platforms, launched the Alias-Based Remittances and Payouts platform to reduce cross-border payment risks, and continued to develop real-time account-based payment capabilities to improve transaction security. These developments indicate a strategic shift toward proactive ecosystem-wide security, emphasizing innovation and partnerships to mitigate risks in an increasingly complex digital payments landscape.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies regarding Mastercard's security evolution. While it correctly identifies a strategic shift toward ecosystem-wide security and increased focus on third-party collaboration, it fabricates specific initiatives not mentioned in the ground truth, such as integrating virtual card solutions with third-party platforms, launching the 'Alias-Based Remittances and Payouts' platform, and developing real-time account-based payments as part of its 2024 security enhancements. These programs are not referenced in the original answer and cannot be verified from the provided knowledge. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is partially sound in that the LLM infers a strategic trend toward broader ecosystem security, which aligns with the ground truth’s conclusion. However, it fails to accurately represent the nature of the evolution: the key development was the explicit integration of third-party provider risk management into the security framework by 2024, not the launch of specific payment platforms. The original answer emphasizes risk monitoring through internal experts and public-private partnerships, which the LLM omits entirely. (4) Contextual relevance is moderate—the response addresses the general theme of security evolution and third-party involvement, but introduces irrelevant innovations that shift focus away from risk management toward product development, misrepresenting the core of Mastercard's strategic response. Thus, while the direction of the conclusion is plausible, the supporting facts are incorrect, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 492,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Target Corporation remained in compliance with its debt leverage covenant in both 2022 and 2023. In 2023, the company updated its credit facilities, including obtaining a new $1.0 billion 364-day unsecured revolving credit facility and extending its existing $3.0 billion five-year facility to October 2028. Despite these changes, Target confirmed it was in compliance with its debt leverage and secured debt covenants as of February 3, 2024, and expects to remain so. No covenant violations were reported during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Target remained in compliance with its debt leverage covenant in both 2022 and 2023, which aligns with the ground truth. It accurately reports the $1.0 billion 364-day unsecured revolving credit facility (expiring October 2024) and the extension of the $3.0 billion five-year facility to October 2028. The original answer notes the prior expiration of the $3.0 billion facility was October 2026, extended to 2028—this detail is omitted in the LLM answer but does not distort the factual evolution. (2) All numeric values—$1.0 billion, $3.0 billion, October 2028—are correct and match the ground truth. The mention of compliance as of February 3, 2024, is consistent with Target’s fiscal year-end and adds timely context without contradicting the 2023 compliance assertion. (3) The multi-hop reasoning is sound: the model synthesizes information about covenant compliance across two years and links it to changes in credit facilities. The only minor gap is not explicitly stating that compliance was already affirmed in 2022 under the pre-extension terms, though this is implied by stating compliance in both years. (4) The answer is contextually complete and relevant, directly addressing the evolution of compliance and credit facility changes. The addition of 'secured debt covenants' slightly extends beyond the original focus on 'debt leverage covenant' but does not introduce inaccuracy, as it is plausible within the context. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth with only minor omissions in background detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 448,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "From 2023 to 2024, the risks associated with Salesforce's AI offerings, including generative AI like Agentforce, have evolved in several key ways. In 2023, the focus was primarily on the nascent and uncertain markets for AI offerings, with risks related to pricing strategies for consumption-based models and the potential for lower customer consumption than anticipated. By 2024, the risks had expanded to include increased regulatory scrutiny, particularly around data privacy, ethical use of AI, and the potential for reputational harm due to AI-generated content inaccuracies, biases, or misuse. Additionally, the complexity and cost of compliance with evolving AI-specific laws, such as the EU AI Act and state-level regulations, became more prominent as a growing concern.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies a shift in risk focus from 2023 to 2024 and captures the general evolution toward increased regulatory, ethical, and reputational risks tied to AI, which aligns with the ground truth. It accurately notes emerging concerns such as data privacy, AI bias, inaccuracies, and evolving regulations like the EU AI Act—elements consistent with the expanded risk profile in 2024. However, the characterization of 2023 risks is incorrect: the ground truth states that AI-specific risks were not yet prominent, and the main concern was third-party integration liabilities and warranty expectations, not 'nascent markets' or 'pricing strategies for consumption-based models.' The LLM introduces risks (e.g., pricing, customer consumption) not present in the original 2023 disclosures, indicating a factual misrepresentation of the earlier risk landscape. While the 2024 risks are largely accurate and contextually relevant, the failure to correctly represent the 2023 baseline undermines the multi-hop comparison. No numeric data is present, so quantitative accuracy is scored as 10 by default. The reasoning is partially sound but based on incorrect premises for 2023, reducing qualitative accuracy. Contextual relevance remains high as the answer addresses the evolution of AI-related risks as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 367,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "Between fiscal years 2023 and 2024, Lowe's significantly improved its delivery capabilities for parcel-eligible items. In 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By 2024, this was enhanced to deliver most parcel-eligible items within two business days or less at standard shipping rates, and Lowe's expanded its gig provider network to enable same-day delivery for certain products. Additionally, the company achieved next-day delivery for major appliances in nearly every U.S. zip code.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all timeframes and delivery speeds are correct: 'within two business days' in 2023 and 'two business days or less' in 2024 are accurately reported. The expansion to next-day delivery for major appliances in nearly every U.S. zip code is correctly stated. (2) The only minor discrepancy is the mention of 'expanded its gig provider network to enable same-day delivery for certain products,' which adds detail not present in the original answer. While this may be a plausible inference or additional context, it is not explicitly supported by the ground truth and introduces information beyond what was verified. However, it does not contradict the original answer. (3) The multi-hop reasoning is sound—LLM correctly compares delivery capabilities across fiscal years and synthesizes improvements in speed and coverage. (4) All entities (Lowe's, fiscal years 2023 and 2024, parcel-eligible items, major appliances, U.S. zip codes) are accurate. The answer is contextually relevant and fully addresses both parts of the question: evolution over time and specific improvements. Due to the minor addition of same-day delivery via gig providers not present in the ground truth, a full 10 is not warranted, but the answer is otherwise factually correct and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 376,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The financial impact of the Dermstore LLC sale on Target's consolidated revenues and operating income is minimal in both 2022 and 2023. Dermstore represented less than 1% of consolidated revenues, operating income, and net assets in both years. In 2021, when the sale occurred, it contributed a $335 million pretax gain, but no specific impact on 2022 or 2023 is detailed, indicating that its effect on consolidated results remained negligible in the subsequent years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Dermstore represented less than 1% of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023, and accurately notes the $335 million pretax gain from the February 2021 sale. It correctly emphasizes the minimal financial impact in both years. (2) All numeric values—'less than 1%', '$335 million', and '2021'—are factually correct and match the ground truth. No calculations were required, but the temporal reference to the 2021 sale is accurate. (3) The multi-hop reasoning is sound: the model correctly infers that because the sale occurred in 2021 and Dermstore's contribution was negligible in 2022 and 2023, there was no material change in financial impact across those years. The only minor shortcoming is that the LLM answer says 'no specific impact... is detailed' rather than explicitly stating that no significant post-sale financial contribution occurred, which slightly weakens the assertiveness of the conclusion compared to the original. (4) The answer is contextually fully relevant, directly addressing the evolution of financial impact on revenues and operating income. Scores reflect high accuracy with a minor deduction in qualitative accuracy due to slightly less definitive phrasing on the absence of post-sale impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 369,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "Between 2023 and 2024, the strategic positioning of Data Cloud has evolved to become a more central component of Salesforce's broader service offerings, particularly as a foundational element of its AI-powered Customer 360 platform. In 2023, Data Cloud was described as a hyperscale, trusted data engine that unifies disconnected enterprise data to deliver a 360-degree view of customers. By 2024, it was further integrated into the Einstein 1 Platform, emphasizing its role in enabling AI-driven automation and analytics across multiple service offerings. This evolution reflects Salesforce's broader strategy to leverage Data Cloud as a key enabler of AI and data unification, enhancing customer personalization and operational efficiency across sales, service, marketing, and other business functions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Data Cloud's role within Salesforce's service offerings, accurately describing its 2023 positioning as a 'hyperscale, trusted data engine' that enables a 360-degree customer view. It also correctly notes increased integration with AI platforms like Einstein 1 in 2024, reflecting deeper embedding into Salesforce's architecture. However, the LLM omits key strategic shifts highlighted in the ground truth, particularly around competitive landscape and monetization risks. The original answer emphasizes that by 2024, Salesforce explicitly acknowledged the 'relatively new and uncertain' market for Data Cloud, increasing competition from AI and data platforms, and limited experience with consumption-based pricing—critical elements of strategic positioning related to risk and business model challenges. These omissions represent a significant gap in qualitative accuracy, as the LLM focuses only on technological integration and value proposition while missing the strategic caution and external pressures noted in the 2024 filing. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains contextually relevant to the question about strategic positioning, though it leans more toward technical integration than competitive and business model evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 373,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, LOW's treatment and accounting of forward interest rate swap contracts remained consistent in terms of hedge designation, with all such contracts designated as cash flow hedges. However, the financial impact changed, as the notional amounts of forward interest rate swap agreements dropped significantly from $1,290 million in 2023 to $0 in 2024, indicating that all such contracts were settled by the end of 2024. In 2023, the Company received $247 million from settling these contracts in connection with the issuance of its March 2023 Notes, while no such forward contracts were outstanding in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that LOW received $247 million from settling forward interest rate swaps in 2023 related to the March 2023 Notes, it incorrectly claims the notional amount was $1,290 million, whereas the ground truth specifies $2.0 billion. More critically, the LLM asserts that the hedge designation remained as cash flow hedges in both years, which directly contradicts the ground truth: in 2024, LOW shifted to accounting for its fixed-to-floating interest rate swaps as fair value hedges using the shortcut method, not cash flow hedges. The claim that notional amounts dropped to $0 in 2024 due to settlement is unsupported and incorrect—while the forward swaps from 2023 were settled, new swap agreements were entered into and accounted for under a different hedge designation. (2) Quantitative inaccuracies include the wrong notional amount ($1,290M vs $2.0B) and the false implication that no swaps existed in 2024, when in fact swaps were still present but under a different accounting treatment. The $247 million settlement amount is correct. (3) The multi-hop reasoning is flawed: the model fails to recognize the shift in accounting policy between years and misinterprets the absence of forward-starting swaps in 2024 as an absence of all swap activity, rather than a change in hedge type and accounting method. It does not synthesize the key evolution—change from cash flow to fair value hedging with shortcut method and its impact on earnings. (4) Scores are low due to major factual and conceptual errors in both quantitative and qualitative dimensions. Contextual relevance is moderate because the answer addresses the general topic and timeframe, but it misses the core evolution in accounting treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 489,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "From 2022 to 2023, Target's strategy around its owned brands has evolved with a stronger emphasis on differentiation and affordability. In 2022, the focus was on strengthening the owned brands portfolio and curating national brands to deliver newness, style, and value. By 2023, the strategy expanded to include delivering affordability, differentiating through owned brands and curated national brands, and leveraging size and scale for sustainability. This shift reflects a more integrated approach, aligning brand strategy with broader goals of guest value and market relevance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a strategic evolution in Target's owned brands from 2022 to 2023 and captures the general direction of increased strategic emphasis. However, it introduces elements not present in the ground truth, such as 'affordability' and 'sustainability' as new 2023 priorities, which are not mentioned in the original answer. The ground truth emphasizes that in 2023, Target elevated owned brands as a core element to 'delight with newness, style, and value'—a direct quote—and positioned them as a strategic differentiator to drive traffic, sales, and market share. The LLM answer inaccurately states that 'delivering affordability' and 'leveraging size and scale for sustainability' were part of the 2023 shift, which is not supported by the original. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift over time and references portfolio strengthening and value delivery. However, it adds unverified strategic objectives (affordability, sustainability) that were not in the source, indicating a failure to precisely synthesize the actual evolution. (4) The contextual relevance is high because the answer addresses the evolution of Target's owned brand strategy across the correct time frame and discusses portfolio emphasis and strategic objectives. The qualitative accuracy is reduced due to the inclusion of unsupported strategic goals, though the core idea of increased strategic integration is correct. Thus, the correctness score is 7—core facts are directionally accurate but with notable factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 481,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "From 2022 to 2023, GM's approach to software-enabled services has evolved significantly, with a stronger emphasis on expanding service offerings and deploying scalable digital platforms. In 2023, GM highlighted its end-to-end software platform, which enables over-the-air delivery of software-defined features, apps, and services, enhancing the ownership experience with updates to vehicle performance and driver assistance features like Super Cruise. Additionally, OnStar has become a central enabler of active safety, infotainment, and connectivity features across a broader set of digital offerings. This evolution reflects GM's increased investment in scalable digital solutions, as evidenced by the rollout of the software platform across most products and the integration of advanced driver assistance systems.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in GM's approach to software-enabled services from 2022 to 2023. It accurately reflects the shift from general descriptions in 2022 to a more mature, platform-driven strategy in 2023, including the deployment of an end-to-end software platform enabling over-the-air updates for features like Super Cruise, infotainment, and driver assistance. The mention of OnStar's expanded role aligns with the broader digital offering context. However, the LLM answer omits specific vehicle models cited in the ground truth—namely the Cadillac LYRIQ and Chevrolet Silverado EV—as early adopters of the platform in select 2024 models, which is a notable detail demonstrating concrete deployment. While it states the platform is rolling out across 'most products,' this is slightly more expansive than the ground truth, which specifies 'select 2024 models,' potentially overstating the scale. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), as no incorrect figures or dates are presented. The reasoning is sound and reflects multi-hop synthesis between 2022 and 2023 disclosures, though the lack of specific model examples slightly weakens the qualitative accuracy. Contextual relevance is strong, directly addressing service offerings, platform deployment, and implications for investment in scalable digital solutions. Overall, the answer is factually consistent with minor omissions affecting completeness, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 419,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category increased from $581 million in fiscal 2022 to $661 million in fiscal 2023, representing a 14% growth. In fiscal 2024, this contribution further rose to $837 million, marking a 27% increase compared to fiscal 2023. Thus, between fiscal years 2022 and 2023, the revenue contribution from ThousandEyes grew by $80 million, or 14%.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not provide absolute revenue figures for ThousandEyes (e.g., $581M or $661M); instead, it reports that the broader product category grew by $75M (11%) in FY2022 and $80M (14%) in FY2023, with ThousandEyes being a contributing factor. The LLM incorrectly presents ThousandEyes' standalone revenue and growth, which is not supported by the original answer. Additionally, the mention of fiscal year 2024 is irrelevant as the question only asks about 2022 and 2023. (2) The calculation of $80M growth at 14% aligns with the FY2023 category growth in the ground truth, but this is misattributed solely to ThousandEyes rather than being part of a broader category including monitoring and analytics. The $581M to $661M increase implies an $80M rise, which matches numerically but lacks sourcing and context. (3) The multi-hop reasoning is flawed: the model fails to recognize that ThousandEyes' contribution is embedded within a larger product category and instead treats it as a standalone revenue line. It also introduces data (absolute revenues, FY2024) not present in the original answer, indicating incorrect synthesis. (4) While the 14% growth figure for FY2023 is mentioned in both answers, its application is incorrect in the LLM response. The contextual relevance is moderate because it addresses the general trend of growth, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 413,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "In the 2023 10-K, Amendment No. 4 to the Executive Severance Plan was listed as Exhibit 10.34, incorporated by reference from a 2022 10-Q. In the 2024 10-K, it was renumbered to Exhibit 10.36 and incorporated by reference from the same 2022 10-Q. This renumbering, along with the inclusion of Amendment No. 5 as Exhibit 10.37, indicates a more systematic and updated disclosure strategy, reflecting the company's ongoing amendments and ensuring clarity in the sequence of plan revisions.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Amendment No. 4 was disclosed in both the 2023 and 2024 10-K filings and incorporated by reference from the September 2022 10-Q, which aligns with the ground truth. However, it introduces a significant factual error by stating that Amendment No. 4 was 'renumbered to Exhibit 10.36' in the 2024 10-K. The ground truth indicates that Amendment No. 4 was not listed as a standalone exhibit at all in the 2024 filing but was instead included as part of a sequence of amendments (Nos. 2, 3, 4, and 5) within a consolidated disclosure. There is no evidence of renumbering to Exhibit 10.36; rather, the treatment shifted from individual highlighting to integration. This misrepresentation affects both quantitative accuracy (incorrect exhibit number) and qualitative reasoning (misinterpreting structural change as simple renumbering). The conclusion about a 'more systematic and updated disclosure strategy' is plausible but mischaracterizes the nature of the change: the shift reflects consolidation and retrospective integration, not systematic renumbering. The answer addresses the evolution and strategic implication, satisfying contextual relevance, but fails in precise factual synthesis across filings, undermining the multi-hop reasoning. Thus, while some core facts are correct, the key detail about exhibit treatment is wrong, leading to a partially correct assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 389,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "JPMorgan's Tier 1 leverage ratio remained stable at 7.2% for both 2024 and 2023, exceeding the regulatory minimum requirement of 4.0%. The Standardized CET1 capital ratio increased from 15.0% in 2023 to 15.7% in 2024, reflecting higher CET1 capital and consistent risk-weighted assets, and comfortably surpassing the minimum requirement of 11.4%.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states JPMorgan's 2023 Standardized CET1 ratio as 15.0% and the 2024 Tier 1 leverage ratio as 7.2%, it incorrectly claims the CET1 ratio increased to 15.7% in 2024 — this figure is not present in the ground truth, which does not provide a 2024 CET1 ratio. Additionally, the LLM falsely asserts the Tier 1 leverage ratio was 7.2% in both 2023 and 2024, but the ground truth only reports the 2024 value (7.2%) and does not mention the 2023 value at all. (2) Quantitative accuracy is compromised: two invented numbers (7.2% for 2023 Tier 1 leverage and 15.7% CET1 in 2024) are introduced without support. The regulatory requirements (11.4% and 4.0%) are correctly cited. (3) The reasoning is partially sound in structure — it attempts to assess compliance over time and references capital strength — but fails on multi-hop synthesis because it fabricates data points instead of accurately reporting only what is known. The original answer does not support a year-over-year comparison of CET1 or leverage ratios due to missing 2023 leverage data and 2024 CET1 data. (4) Contextual relevance is high as the response addresses the right metrics and time frame, and interprets regulatory compliance appropriately. However, correctness and quantitative accuracy are severely impacted by unsupported numerical claims, warranting a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 396,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "Between 2022 and 2023, GM Financial remained a distinct reportable segment within General Motors' consolidated financial statements, with its performance evaluated through EBT-adjusted (Earnings Before Taxes-adjusted). The integration of GM Financial continued to be reflected in the consolidated financial statements, where its interest income and interest expense were included in operating results. In terms of financial presentation, GM Financial's results were adjusted to reflect the impact of being included in the consolidated tax return, eliminating intercompany transaction effects. No significant changes in its role or integration were observed in the provided data.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entities, years, and the general role of GM Financial as a reportable segment with tax and intercompany adjustments. It correctly identifies that GM Financial remained part of the consolidated financial statements and that its results were adjusted for consolidated tax return impacts and intercompany eliminations. However, it states 'No significant changes in its role or integration were observed,' which contradicts the original answer's emphasis on an evolution in disclosure—specifically, a more detailed and explicit focus in 2023 on deferred tax positions and the difference from stand-alone reporting. This omission downplays the qualitative shift in financial presentation, which is central to the question. While no numeric data is incorrect (hence a 10 in quantitative accuracy), the answer lacks the nuance regarding increased disclosure detail in 2023, affecting qualitative accuracy. The reasoning is sound but incomplete in synthesizing the change over time. Contextual relevance is high as it directly addresses the integration and financial presentation within consolidated statements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 330,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "Between 2022 and 2024, the treatment and disclosure of step-rent provisions in lease accounting remained consistent, with periodic rent increases based on price indices or sales volume recognized as variable lease payments. In both years, the Company accounted for such provisions by recognizing them on a straight-line basis over the original lease term and any extension options reasonably certain to be exercised. The disclosures in both years also confirm that these variable lease payments are included in the calculation of right-of-use (ROU) assets and lease obligations, with no material residual value guarantees or restrictive covenants impacting the treatment.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the evolution of accounting treatment. According to the ground truth, there was a clear shift between 2022 and 2024: in 2022, step-rent provisions based on price indices or sales volume were accounted for on a straight-line basis, but by 2024, these were reclassified as variable lease payments and no longer straight-lined. The LLM incorrectly states that the treatment 'remained consistent' and that both years used the straight-line method, which directly contradicts the ground truth. This is a critical factual and conceptual error in both reasoning and entity accuracy. While the LLM correctly identifies relevant concepts like ROU assets and lease obligations, and the general context of lease accounting disclosures, it fails to capture the key change in treatment. There are no numeric values to verify, so quantitative accuracy is minimally penalized, but qualitative accuracy is severely impacted due to incorrect synthesis across years. Contextual relevance is moderate because the answer discusses the right topic and related accounting concepts, but it misrepresents the evolution. The multi-hop reasoning fails because the model did not detect the change over time, which is the central point of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 358,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "From 2023 to 2024, the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans show that no contributions were expected in 2025. For 2025, the expected benefit payment is $1.8 billion. Over the long-term period from 2029 to 2033, the total estimated payments are projected to be $9.99 billion.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct numbers but has significant inaccuracies. It correctly states the $1.8 billion (i.e., $1,800 million) expected benefit payment for 2025, which aligns closely with the ground truth of $1,860 million (minor rounding acceptable). However, it incorrectly reports the long-term projection from 2029 to 2033 as $9.99 billion ($9,990 million), while the original answer specifies $10,020 million for that period in 2023 and a decrease to $9,990 million for 2030–2034 in 2024—not 2029–2033. The LLM conflates two different time periods and fails to reflect the correct long-term window. (2) Quantitative accuracy is compromised: while $1.8 billion is a reasonable approximation of $1,860 million, the long-term figure is misattributed to the wrong five-year span. Additionally, the LLM omits the fact that the 2025 projection remained unchanged from 2023 to 2024 and fails to mention the shift in the long-term period from 2029–2033 to 2030–2034. (3) The multi-hop reasoning is flawed—the question asks for evolution from 2023 to 2024, requiring comparison across filings and time periods. The LLM does not address how projections evolved year-over-year or note the period shift in long-term forecasts. (4) Contextual relevance is high because the answer addresses pension obligations and timeframes, but correctness and qualitative reasoning are limited by factual and temporal inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 399,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "Between 2023 and 2024, JPMorgan Chase expanded its disclosures on resolution plan obligations, particularly emphasizing liquidity risk management strategies and funding cost considerations. In 2023, the focus was on maintaining capital adequacy, regulatory capital requirements, and the potential impact of Basel III reforms on its capital distribution strategy. By 2024, the disclosures highlighted more detailed strategies for managing liquidity under stress scenarios, including the need to address obligations under its resolution plan, pre-positioning liquidity in subsidiaries, and the potential for higher funding costs due to regulatory requirements. Additionally, JPMorgan Chase emphasized the impact of market stress on collateral valuation and liquidity, reflecting a more proactive approach to managing resolution-related liquidity risks.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that JPMorgan Chase expanded its disclosures between 2023 and 2024 regarding resolution plan obligations, liquidity risk management, and funding costs, which aligns with the ground truth. It accurately notes the 2024 emphasis on pre-positioning liquidity in subsidiaries and potential higher funding costs due to regulatory requirements. However, it mischaracterizes the 2023 focus: the original answer states that in 2023, JPMorgan emphasized resolution plan impacts on liquidity coverage and net stable funding ratios, funding costs, and reliance on alternative funding sources, whereas the LLM incorrectly frames 2023 disclosures around 'capital adequacy' and 'Basel III reforms on capital distribution strategy,' which are not mentioned in the ground truth for that year. This is a significant factual misalignment. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are involved. (3) The multi-hop reasoning is partially sound: the model correctly infers an evolution in disclosures over time and connects resolution plans to liquidity and funding considerations. However, it fails to accurately represent the 2023 content, undermining the synthesis. The shift toward regulatory evolution and systemic events in 2024 is partially captured but not fully articulated—the LLM mentions 'market stress' and 'collateral valuation,' which are related but not equivalent to the ground truth's focus on 'dynamic regulatory expectations' and 'systemic events affecting laws and regulations.' (4) The correctness score is 6 due to partial factual accuracy: core themes are present (liquidity pre-positioning, funding costs), but key details—especially the misrepresentation of 2023 disclosures—are significant. Qualitative accuracy is 6 due to reasoning flaws and incorrect emphasis. Contextual relevance is high (8) because the answer stays on topic and addresses the evolution of disclosures, even if with inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 559,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Between 2022 and 2023, the financial structure of Optum Rx's pharmacy care services showed notable changes in revenue recognition and accounts receivable. Revenue recognition for Optum Rx primarily stems from products sold through retail pharmacies, home delivery, and specialty pharmacies, with product revenues recognized when prescriptions are dispensed. In 2023, accounts receivable related to products and services increased to $8.6 billion from $7.1 billion in 2022, indicating a rise in outstanding receivables. This growth may reflect higher prescription volumes or timing differences in billing and payment cycles. Additionally, the company continues to accrue rebates from pharmaceutical manufacturers, which are recognized as a reduction in cost of products sold, impacting both revenue and accounts receivable dynamics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: accounts receivable increased from $7.1 billion in 2022 to $8.6 billion in 2023, and these values match the original answer exactly. (2) The answer correctly identifies that revenue is recognized at the point of prescription dispensing, consistent with the gross revenue model implied in the original answer. (3) The reasoning about increased receivables reflecting higher volume or timing differences is logically sound and consistent with the original interpretation. (4) The only minor deviation is the mention of rebates reducing cost of products sold, which, while factually plausible and contextually relevant, was not part of the original answer’s focus on revenue recognition and accounts receivable evolution. This addition does not introduce error but adds a detail outside the scope of the ground truth. Otherwise, the multi-hop synthesis across years and financial metrics is accurate and complete. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness due to slight over-elaboration without factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 331,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps remained relatively stable between 2022 and 2024. In 2022, UPS reported a $5 million loss reclassified from AOCI related to interest rate contracts, while in 2023, this increased to a $10 million loss. By 2024, the loss had decreased to $5 million again. Additionally, in 2024, $0 gains were recognized in AOCI for interest rate contracts, compared to a $1 million loss in 2023. This suggests that UPS continued to use interest rate swaps to hedge against forecasted payment obligations, maintaining a consistent strategy to manage its interest rate risk exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative exposure and strategic evolution. The ground truth states that in 2022, UPS had a $28 million notional amount for Floating to Fixed Interest Rate Swaps. The LLM instead cites AOCI reclassifications of losses ($5M in 2022, $10M in 2023, $5M in 2024) and gains/losses on contracts, which are unrelated to notional exposure and not mentioned in the original answer. These figures do not reflect the quantitative exposure (i.e., notional amount of swaps) and are therefore factually misaligned. (2) There is no mention of the $28 million notional amount in 2022 or any notional amount in 2024 in the LLM response, missing the core quantitative metric. Additionally, the LLM introduces data for 2023, which is outside the 2022–2024 comparison scope but not inherently wrong—however, it distracts from the actual trend. (3) The reasoning is flawed: the LLM infers a 'stable' strategy based on P&L impacts in AOCI, while the ground truth identifies a strategic shift from limited use in 2022 to a broader, intentional approach in 2024 focused on managing the fixed/floating debt mix. The LLM fails to capture this evolution in strategic intent. (4) The contextual relevance is moderate because it discusses interest rate swaps and risk management, but it focuses on irrelevant financial effects (AOCI reclassifications) rather than notional exposure or strategic framing. The multi-hop synthesis fails: it does not connect the quantitative exposure (notional amount) to the strategic narrative across years. Thus, the answer is factually incorrect and misses the core evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 457,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "Between 2022 and 2023, GM's financial relationship with LG Energy Solution (LGES) evolved primarily through joint venture activities related to battery production and recall-related costs. In 2021, GM expanded a recall for Chevrolet Bolt EVs due to battery defects traced to LGES. By 2023, GM had accrued a total of $2.6 billion for these recall costs, with $1.6 billion recognized as receivables from LGES, reflecting agreements to reimburse GM for certain expenses. Additionally, commercial negotiations with LGES resolved other matters tied to their Ultium Cells joint venture. By December 31, 2023, GM's remaining accrual for these matters was $0.6 billion. This indicates a significant financial impact from the joint venture and recall, though some costs were mitigated through reimbursement agreements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in GM's financial relationship with LG Energy Solution (LGES) from joint venture collaboration to recall-related financial liabilities. All quantitative figures are accurate: $2.6 billion total recall accrual, $1.6 billion receivable from LGES, and $0.6 billion remaining accrual by end of 2023 (which is consistent with $2.6B - $1.6B = $1.0B potentially reimbursed, though $0.6B reflects updated accrual after adjustments—this nuance is acceptable and aligns with financial reporting practices). (2) Quantitative accuracy is perfect: all dollar amounts and their relationships are correct. The $0.6 billion remaining accrual is not in the original answer but is factually consistent and adds precision without contradicting the ground truth. (3) The multi-hop reasoning is sound—LLM connects the Ultium Cells joint venture (strategic collaboration) with the recall cost liabilities and reimbursement agreements, showing a shift in relationship dynamics. The mention of 'commercial negotiations' adds context not in the original but plausibly explains resolution mechanisms. (4) The only minor shortcoming is that the original emphasizes the 'transition from strategic collaboration to transactional dynamic' more explicitly, which the LLM implies but doesn't state as clearly. However, the factual and numerical core is fully accurate, and the added detail about the $0.6B accrual enhances completeness. Thus, the answer is highly correct with excellent reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 426,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Observability product category increased by 15% in fiscal 2024 compared to fiscal 2023, excluding the contribution from Splunk. Additionally, when including the contribution from Splunk, the total revenue for the Observability category grew by 27% in fiscal 2024 compared to fiscal 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It discusses fiscal 2024 compared to fiscal 2023, but the question asks about the evolution from fiscal 2022 to fiscal 2023. This is a critical error in time period alignment. The ground truth does not mention any data for fiscal 2024, so the LLM has fabricated information. (2) Quantitatively, the 27% growth figure is correct but misattributed to the wrong year comparison. In the ground truth, the 27% increase ($176M) occurred in fiscal 2023 (vs 2022), not fiscal 2024. The 15% organic growth (excluding Splunk) is also from fiscal 2023 vs 2022, not 2024 vs 2023. The $80M increase in fiscal 2022 is completely omitted. (3) The multi-hop reasoning is flawed: the model fails to trace revenue evolution across the correct two-year window (2022–2023) and incorrectly introduces Splunk’s impact in a future period not supported by the data. It also fails to note that Splunk was newly included in fiscal 2023, not 2024. (4) Contextual relevance is moderate because the answer discusses the right product category (Observability), mentions ThousandEyes and Splunk as contributors, and references organic vs total growth—but all within an incorrect fiscal framework, undermining factual utility. The core evolution from 2022 to 2023 is entirely misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 373,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS's 7.620% Debentures, with a principal amount of $276 million and a maturity of April 1, 2030, remained unchanged in terms of their redemption terms and interest payment structure between 2022 and 2024. The debentures are redeemable at UPS's option at any time, with the redemption price being the greater of the principal amount plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Interest is payable semi-annually in April and October, and no sinking fund requirements apply. The interest rate of 7.620% has been in effect since April 1, 2020, and no changes to the terms were noted in the 2024 filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the principal amount ($276 million), maturity date (April 1, 2030), interest rate (7.620%), and semi-annual interest payment schedule (April and October), which aligns with the ground truth. The redemption terms are also accurately described, including the redemption price formula based on the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. These quantitative details are factually correct and consistent with the 2024 disclosure. (2) However, the key error lies in the reasoning and interpretation of how the relationship evolved. The ground truth emphasizes that in 2022, only basic details (principal, maturity, carrying value) were reported, while in 2024, UPS provided a more detailed explanation of redemption flexibility and interest payment structure. The LLM incorrectly states that 'no changes to the terms were noted' and that the terms 'remained unchanged', which contradicts the original answer’s emphasis on increased disclosure and clarification — an evolution in transparency, not necessarily in contractual terms. This misrepresents the nature of the evolution, which is about disclosure depth, not static terms. (3) The multi-hop reasoning is partially flawed: while the model synthesizes correct data points from both years, it fails to recognize that the evolution refers to the level of detail disclosed, not a change in contractual terms. The original answer highlights a shift from general to detailed description; the LLM interprets this as no change, missing the nuance of informational evolution. (4) Quantitative accuracy is high due to correct numbers and dates. Qualitative accuracy is lower because of incorrect reasoning about the nature of change. Contextual relevance is strong as the answer addresses redemption and interest structure. Correctness score is 6 due to significant conceptual error despite factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 540,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "From 2022 to 2023, the total fair value of Fixed Maturity Securities AFS held by MET decreased slightly from $6,802 million in 2022 to $6,714 million in 2023. U.S. government bonds saw a decrease in fair value from $1,507 million in 2022 to $1,575 million in 2023, while corporate securities increased from $3,001 million in 2022 to $3,083 million in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and trends. According to the ground truth, the total fair value of Fixed Maturity Securities AFS increased dramatically from $2,164 million (as of Dec 31, 2021, reported in 2022) to $6,714 million in 2023. However, the LLM incorrectly states that the value decreased from $6,802 million in 2022 to $6,714 million in 2023 — both the prior-year figure and the trend are wrong. The ground truth does not provide a 2022 fair value directly, but the $2,164 million is explicitly tied to December 31, 2021, meaning it is not the 2022 year-end value. The LLM misattributes this and fabricates a $6,802 million figure for 2022. (2) The LLM correctly reports the 2023 fair values for corporate securities ($3,083 million) and U.S. government bonds ($1,575 million), which match the ground truth. However, it falsely claims U.S. government bonds increased from $1,507 million in 2022 to $1,575 million in 2023 — the $1,507 million figure is not in the ground truth. Similarly, the $3,001 million for corporate securities in 2022 is unsupported. (3) The multi-hop reasoning is flawed: the model fails to correctly interpret the timeline and misaligns the data points across years. It assumes the $2,164 million from 2021 is the 2022 value and invents a near-$6.8B 2022 total, which distorts the entire analysis. The ground truth describes a major expansion in holdings, but the LLM portrays a slight decline — the opposite of the correct narrative. (4) Despite incorrect numbers and trends, the answer is contextually relevant and addresses the right entities (MET, Fixed Maturity Securities AFS, U.S. government bonds, corporate securities) and time frame. The qualitative structure is sound, but the factual foundation is weak, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 505,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "General Motors' relationship with Ultium Cells LLC in 2023 shows increased regulatory scrutiny compared to 2022. In 2022, GM's financial involvement with Ultium Cells LLC was noted as an investment of $0.5 billion. By 2023, there were no further financial investments reported, but regulatory implications emerged. In February 2023, GM self-disclosed potential violations of TSCA requirements at Ultium Cells LLC, which were settled in November 2023 via a consent agreement with the EPA. The settlement includes civil penalties estimated at approximately $5.1 million, jointly and severally assessed to GM and Ultium Cells LLC. This indicates a shift from financial investment to regulatory compliance challenges in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $0.5 billion investment in 2022, the February 2023 self-disclosure of TSCA violations, the November 2023 EPA settlement, and the $5.1 million joint civil penalty are all accurately reported. Number formats and dates match or are semantically equivalent. (2) Quantitative accuracy is perfect—no calculation errors, and all dollar amounts and timeframes are correct. (3) The multi-hop reasoning is sound: the answer synthesizes financial data from 2022 and regulatory events in 2023, correctly inferring a shift in the nature of GM's relationship with Ultium Cells LLC. The only minor shortcoming is that the LLM frames the shift primarily as a move to 'regulatory compliance challenges,' whereas the original emphasizes a broader evolution to 'operationally integrated partnership'—a nuance slightly underdeveloped in the LLM response. However, the core qualitative progression from investment to operational entanglement is implied through the regulatory accountability. (4) Contextual relevance is excellent, as the answer directly addresses both financial involvement and regulatory implications across both years, fully satisfying the multi-part, multi-hop nature of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 360,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "Between 2022 and 2024, the company's use of variable-priced contracts for natural gas and fuel purchases remained consistent, with the company entering into such contracts on an index basis for some purchases of natural gas and fuel for its gas stations. These contracts meet the characteristics of derivative instruments but generally qualify for the \"normal purchases and normal sales\" exception, requiring no mark-to-market adjustment. There is no indication of a significant change in the company's strategy or volume related to these variable-priced contracts during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in describing the company's use of variable-priced contracts as being on an index basis and qualifying for the 'normal purchases and normal sales' exception with no mark-to-market adjustment. All entities (contract types, accounting treatment, commodities) and years (2022, 2024) are correctly referenced, and there are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10). However, the key discrepancy lies in the interpretation of evolution: the original answer identifies a meaningful shift by 2024 toward a more formalized or strategic use of these contracts, particularly in how they are aligned with derivative accounting frameworks, suggesting increased sophistication or intentional management. The LLM answer incorrectly concludes there was 'no significant change' in strategy, which contradicts the ground truth's implication of a shift in accounting alignment and strategic handling. This misrepresents the qualitative evolution the question asks about, leading to a moderate drop in qualitative accuracy (6) and overall correctness (6). Contextual relevance is high as the response stays focused on the topic and timeframe, but fails to capture the nuanced progression in contract management strategy between the years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 358,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco's financial reporting approach for the APJC segment remained consistent between fiscal 2022 and fiscal 2023 in terms of the expense categories excluded from segment performance measurement. Both years excluded research and development, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements and other contingencies, charges related to asset impairments and restructurings, and certain other charges from the gross margin calculations for the APJC segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. It correctly identifies that Cisco's financial reporting approach for the APJC segment remained consistent between fiscal 2022 and 2023, with no change in the expense categories excluded from segment performance measurement. The excluded expenses listed—research and development, sales and marketing, general and administrative, amortization and impairment of acquisition-related intangible assets, share-based compensation, significant litigation settlements, asset impairments, restructurings, and certain other charges—are fully aligned with the original answer, including all key categories. The only minor difference is that the LLM groups 'other contingencies' and 'certain other charges' slightly more broadly than the original, which specifies 'significant litigation settlements and other contingencies'—a nuance in phrasing but not a factual deviation. There are no numeric inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes the multi-hop requirement by comparing two fiscal years and identifying consistency in reporting policy. The answer is highly relevant and complete, warranting a 9/10 for correctness and qualitative accuracy due to slight imprecision in phrasing of one exclusion category, but not enough to affect overall factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 385,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "UNH's approach to managing medical cost trends in 2023 evolved to include a stronger focus on addressing rising outpatient procedure costs for seniors by engaging physicians and consumers with information to help them make clinically sound choices. This strategy aims to achieve high-quality, affordable care while mitigating the impact of increased care patterns observed in seniors. Additionally, UNH emphasized the transition to value-based care delivery models to improve outcomes and reduce overall health system costs over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core evolution in UNH's approach from 2022 to 2023, particularly the shift toward targeted strategies for managing rising outpatient procedure costs for seniors. It correctly identifies the 2023 focus on engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care, aligning with the ground truth. It also appropriately references value-based care models, which is consistent with UNH's risk-based and outcome-focused strategy. However, the LLM omits explicit mention of the 2022 context—specifically, UNH's concern over deferred care during the pandemic and its impact on medical cost trends—which is a key part of the multi-hop comparison asked in the question. While the 2023 response is well-articulated, the absence of a direct contrast with 2022's more general concern slightly weakens the completeness of the evolution narrative. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and all entities (UNH, seniors, outpatient costs, value-based care) are correctly identified. The reasoning is sound but slightly incomplete in synthesizing both years fully. Contextual relevance is strong as the answer directly addresses the question's focus on strategy evolution and senior outpatient costs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 379,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "Between 2022 and 2024, UPS has expanded the scope of its time-definite delivery services by enhancing its integrated global air and ground network, enabling more efficient and reliable delivery options. The company has also improved service scope through technological advancements, such as RFID-enabled Smart Package Smart Facilities, and by insourcing UPS SurePost final delivery to maintain greater control over service quality. Additionally, UPS has optimized its network design to reduce environmental impact and improve operational efficiency, supporting faster and more consistent delivery times globally.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key developments in UPS's time-definite delivery evolution, including the insourcing of UPS SurePost final delivery and the use of an integrated global air and ground network. It also mentions network optimization and technological enhancements like RFID-enabled Smart Package Smart Facilities, which align with UPS's broader efficiency goals. However, it omits specific 2024 service expansions mentioned in the ground truth: same-day pickup seven days a week and expanded returns services in approximately 150 countries. These are important elements of the expanded customer-centric service scope and their absence reduces completeness. (2) There are no numeric values, dates, or calculations in either answer that conflict; the LLM correctly references 2022–2024 evolution without introducing incorrect figures. Thus, quantitative accuracy is fully preserved. (3) The multi-hop reasoning is partially sound—LLM correctly synthesizes network integration and control improvements via SurePost insourcing, but fails to incorporate the full scope of service expansions (same-day pickup frequency, returns reach) that demonstrate the evolution in customer-centric offerings. (4) The answer is contextually relevant and well-structured, but the missing details prevent a higher score. While the core facts about network integration and SurePost are correct, the absence of key 2024 service scope expansions limits qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 413,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "In the 2022 filing, Lowe's Companies, Inc. recognized its 2.50% Notes maturing in April 2026 under the Thirteenth Supplemental Indenture dated April 20, 2016. In the 2023 filing, there was no direct change in the treatment of these specific notes, as they were not referenced in new supplemental indentures. However, the 2023 filing included a new issuance of 4.800% Notes due April 1, 2026, indicating a new debt obligation in 2023 with a different interest rate and maturity date close to the 2026 2.50% Notes.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual accuracy but fundamentally misrepresents the evolution in disclosure treatment of the 2.50% Notes maturing in April 2026. While it correctly identifies the Thirteenth Supplemental Indenture dated April 20, 2016, in the 2022 filing, it incorrectly states there was 'no direct change' in treatment in 2023. The ground truth shows a clear shift from historical/reference treatment in 2022 to explicit recognition as issued instruments in 2023, which the LLM fails to capture. Instead, the LLM incorrectly introduces a new issuance of '4.800% Notes due April 1, 2026'—a fact not present in the ground truth and which confuses the response. (2) Quantitatively, the interest rate (2.50%), maturity year (2026), and indenture date (April 20, 2016) are correct, earning moderate quantitative accuracy. However, the introduction of a fictional 4.800% note with a similar maturity date introduces false data, undermining numerical reliability. (3) The multi-hop reasoning is flawed: the question asks for evolution in treatment of a specific instrument across two filings, requiring synthesis of disclosure changes. The LLM fails this by not identifying the procedural shift and instead conflating it with unrelated debt issuance. (4) Contextual relevance is moderate because the response discusses the correct company and general topic (debt notes), but the introduction of irrelevant securities and failure to address the actual disclosure evolution significantly reduces usefulness. Correctness score is low due to core factual and reasoning errors despite some accurate details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 445,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "The impact of sovereign debt crises on Costco's merchandise sourcing and cost structure from 2022 to 2024 remained a concern but did not significantly escalate. In 2022, the 10-K noted that sovereign debt crises, along with tariffs and trade actions, could affect merchandise costs and sourcing. By 2024, while the risk remained, the focus shifted slightly toward broader economic factors such as inflation, foreign exchange fluctuations, and geopolitical tensions, which had a more immediate impact on sourcing and cost structures. The company continued to manage these risks through merchandising and pricing strategies, though no major new developments in sovereign debt crises were highlighted as directly affecting Costco's operations during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in characterizing the evolution of sovereign debt crisis impacts. The ground truth states that in 2022, sovereign debt crises were part of broader macroeconomic risks that could 'adversely affect' demand, inventory costs, and product mix. By 2024, the language escalated to explicitly state that such crises would 'negatively impact' Costco's business, financial condition, and results of operations—indicating a clear escalation in risk assessment. However, the LLM incorrectly claims the impact 'did not significantly escalate,' which contradicts the documented shift in tone and severity. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in dates or formats, hence a score of 10. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the change in risk language from conditional/potential (2022) to definitive/negative (2024), missing the heightened concern in 2024 filings regarding supply chain risks, supplier standards, and geopolitical instability as cascading effects of sovereign debt crises. Instead, it downplays the risk and shifts focus to inflation and FX, which, while mentioned, do not diminish the explicit worsening of sovereign debt crisis implications. (4) Contextual relevance is moderate—the answer addresses sourcing and cost structure and references correct years and general risk factors, but misrepresents the core evolution of risk perception, leading to a low correctness and qualitative accuracy score despite appropriate structure and terminology use.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 449,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "The number of shares available for future grants under the 2020 Stock Incentive Plan decreased from 64 million in 2021 to 53 million in 2023. This reduction indicates that UnitedHealth Group has issued a significant number of share-based awards during this period, which may suggest active use of its equity compensation programs to incentivize employees, though it also implies a reduced capacity for issuing new share-based awards without additional shareholder approvals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the number of shares available for future grants in 2021 (64 million) and 2023 (53 million), matching the ground truth exactly. The change of -11 million shares is accurately implied. (2) All numeric values and years are correct, with no calculation or formatting errors. (3) The multi-hop reasoning is sound: the model correctly infers that the decrease in available shares indicates issuance of share-based awards, which reflects active use of equity compensation. It also correctly concludes that the reduced balance implies lower capacity for future awards, aligning with the ground truth. The addition of 'without additional shareholder approvals' is a reasonable inference, though not explicitly stated in the original answer. (4) The answer is factually complete and semantically equivalent to the ground truth, with only minor additional interpretation that does not detract from accuracy. Full points for quantitative accuracy and contextual relevance. One point deducted in qualitative accuracy for slight over-interpretation, though it remains within reasonable bounds.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 321,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "Between 2022 and 2024, the expiration date of the collective bargaining agreement associated with the IAM National Pension Fund / National Pension Plan was extended from July 31, 2024 (as of 2022) to July 31, 2029 (as of 2024). During this period, UPS continued to be a significant contributor to the plan, providing more than 5% of total contributions each year. In 2024, UPS also reached an agreement to withdraw from the IAM Fund and transfer impacted employees to the UPS Pension Plan, indicating a shift in the relationship with the multiemployer plan.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the extension of the expiration date from July 31, 2024, to July 31, 2029, and accurately states that UPS contributed more than 5% of total plan contributions annually, which aligns with the ground truth for both 2022 and 2024. These quantitative elements—dates and contribution thresholds—are factually correct. (2) However, the LLM introduces new information not present in the original answer: that UPS 'reached an agreement to withdraw from the IAM Fund and transfer impacted employees to the UPS Pension Plan.' This claim is not supported by the ground truth and introduces a significant factual discrepancy, undermining the qualitative accuracy. The original answer emphasizes continuity and sustained contribution significance, not withdrawal or transition. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the evolution of the expiration date and contribution significance over time—but the addition of unsupported strategic shifts reflects a failure in accurately representing the source data. (4) The correctness score is 7 because core facts (dates, contribution levels) are accurate, but the added narrative about withdrawal introduces a material error. Quantitative accuracy is high (9) due to correct dates and percentages. Qualitative accuracy is reduced (7) due to the unsupported claim about withdrawal. Contextual relevance remains high (9) as the response directly addresses the evolution of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 414,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "Between fiscal years 2022 and 2023, the terms and availability under LOW's 2020 Credit Agreement evolved as follows: In September 2023, the Company entered into an amended and restated $2.0 billion five-year unsecured revolving credit agreement (2023 Credit Agreement), which extended the term of the original 2020 Credit Agreement from March 2025 to September 2028. Additionally, the combined availability under the 2023 Credit Agreement and the December 2021 Third Amended and Restated Credit Agreement remained at $4.0 billion, with the potential to increase by an additional $1.0 billion if certain conditions were met. The Company was in compliance with all financial covenants as of February 2, 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution of LOW's 2020 Credit Agreement: in September 2023, it was amended and restated into the 2023 Credit Agreement with a maturity extended from March 2025 to September 2028, and the $2.0 billion availability was maintained. The combined availability under the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, matching the ground truth. All numeric values—$2.0 billion, $4.0 billion, March 2025, September 2028—are factually correct. (2) Quantitative accuracy is perfect: dates and dollar amounts align exactly with the original answer, including the unchanged total availability of $4.0 billion between years. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across fiscal years 2022 and 2023, identifies the amendment event, and links the continuity of credit availability. The only minor shortcoming is that the LLM adds information not present in the ground truth—specifically, the potential to increase availability by $1.0 billion and compliance with covenants as of February 2, 2024—which, while possibly true, are not part of the original answer and slightly exceed the scope. However, this does not introduce inaccuracy. (4) The answer is highly contextually relevant, directly addressing the evolution of terms and availability. The qualitative accuracy is slightly reduced due to the extra details, but core reasoning and entity identification (LOW, 2020 vs. 2023 Credit Agreement, correct fiscal years) are accurate. Overall, the answer is factually correct and semantically equivalent to the ground truth with minor elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 461,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "MDLZ's notional amounts for Net Investment Hedge Derivative Contracts increased significantly between 2022 and 2024. As of December 31, 2022, the notional value was $3.9 billion, rising to $7.5 billion as of December 31, 2023, and reaching $8.6 billion as of December 31, 2024. This reflects an expansion in MDLZ's hedging activities to manage exchange rate risks related to its non-U.S. operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend correctly—MDLZ increased its use of Net Investment Hedge Derivative Contracts from 2022 to 2024. However, there are significant quantitative inaccuracies. The original answer states that the $3,915 million notional amount was reported in the 2022 filing but refers to December 31, 2021 (not December 31, 2022), and $4,551 million was as of December 31, 2020. The LLM incorrectly assigns $3.9 billion to December 31, 2022, which is not supported by the ground truth. Similarly, the LLM states $7.5 billion as of December 31, 2023, which aligns approximately with the correct value of $7,456 million, and $8.6 billion as of December 31, 2024, close to the correct $8,647 million. While the direction and magnitude of growth are reasonably captured, the misattribution of dates and values reduces quantitative accuracy. (2) The numbers are off in both value and timing: the 2022 filing does not report a value for December 31, 2022, but rather retrospectively reports prior years (2020 and 2021). The LLM assumes a forward-looking reporting pattern that contradicts the disclosed data. (3) The multi-hop reasoning is partially sound—the model identifies the increasing trend and infers growing hedging activity, which is consistent with the conclusion in the original answer. However, it fails to correctly interpret the lag in reporting (i.e., 2022 filing contains 2021 data), leading to incorrect year mappings. (4) Correctness is scored 7 because the core insight (growing reliance) is preserved despite date/number mismatches. Quantitative accuracy is 6 due to incorrect year assignments and approximate figures. Qualitative accuracy is 8 because reasoning is logical and entities are correct. Contextual relevance is 10—answer directly addresses the question's focus on evolution and notional amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 504,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "Between 2022 and 2024, Microsoft 365's integration with AI technologies evolved significantly, with a focus on enhancing productivity and collaboration. In 2024, Microsoft introduced **Copilot for Microsoft 365**, which combines AI with business data in the Microsoft Graph and Microsoft 365 applications to provide role-specific insights and workflow assistance. Additionally, **Copilot Studio** was introduced, allowing customers to customize Copilot for Microsoft 365 or build their own Copilot solutions. These capabilities, along with **Copilot Pro**, a consumer subscription service offering enhanced AI assistance, reflect Microsoft's commitment to leveraging AI to streamline business processes and improve user efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of Microsoft 365's AI integration from 2022 to 2024, noting the shift to an 'AI-first platform' and the introduction of Copilot for Microsoft 365 in 2024. The mention of Copilot combining AI with Microsoft Graph and M365 apps is factually correct. The LLM adds specific capabilities introduced in 2024: Copilot for Microsoft 365, Copilot Studio, and Copilot Pro. While the ground truth highlights role-specific extensions like Copilot for Sales, Service, and Finance, the LLM captures the essence of role-specific and customizable AI assistance through Copilot Studio and implies personalization. The only minor omission is not explicitly naming the role-specific Copilots (Sales, Service, Finance), but the concept is conveyed through 'role-specific insights and workflow assistance' and customization capabilities. All dates (2022, 2024) are correct, and no numerical inaccuracies exist. The reasoning is sound, showing multi-hop understanding of AI evolution and new features. Semantic equivalence is strong, with slightly different phrasing but same core meaning. Contextual relevance is excellent, directly addressing both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 351,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "Between 2022 and 2024, 3M's approach to PFAS discharge characterization in its wastewater permits at the Decatur, Alabama facility evolved through increased regulatory engagement and remediation efforts. In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit and had submitted an application to add additional PFAS compounds, while also implementing wastewater treatment controls. By 2024, the company had entered into an interim Consent Order with ADEM in July 2020, which expanded obligations to include future analytical studies, capital improvements, and ongoing remediation activities. Additionally, 3M continued to optimize wastewater treatment systems and cooperate with EPA and ADEM investigations, reflecting a more structured and proactive approach to compliance and remediation.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. Most notably, it incorrectly states that 3M entered into an interim Consent Order with ADEM in July 2020, which is outside the 2022–2024 timeframe and not mentioned in the ground truth. This date and event are factually incorrect in the context of the question. Additionally, the ground truth does not mention implementation of wastewater treatment controls in 2022—only that an application was submitted to ADEM to add PFAS to the permit and that characterization was incomplete. The LLM incorrectly implies controls were already being implemented in 2022. In 2024, the LLM correctly notes optimization of treatment systems and cooperation with regulators, but adds unverified details about the Consent Order and expanded obligations not present in the original. (2) The date 'July 2020' is a clear quantitative error, as the question focuses on developments between 2022 and 2024. No other numbers are present, but the inclusion of an incorrect date undermines timeline accuracy. (3) The multi-hop reasoning is partially sound—LLM attempts to show evolution from disclosure to action—but fails in synthesis by introducing a false regulatory milestone (the 2020 Consent Order) that distorts the progression. The actual evolution is from incomplete characterization and a permit modification request (2022) to installation/upgrading of treatment controls pending regulatory action (2024), which the LLM only partially captures. (4) The contextual relevance is high because the answer addresses PFAS characterization, regulatory engagement, and treatment efforts at the Decatur facility. However, factual errors—especially the incorrect date and unverified Consent Order—reduce correctness. Core elements like permit modification delays and treatment optimization are present but mixed with inaccuracies, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 512,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "Lowe's Companies, Inc. issued the 4.550% Notes as part of the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049. There is no indication of any material change or evolution in these specific 4.550% Notes between 2022 and 2023 based on the provided documents.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the 4.550% Notes were issued under the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049. There is no indication of changes between 2022 and 2023, which aligns with the original answer stating no modifications occurred in 2023. (2) Quantitative elements—dates and interest rate (4.550%)—are correct and match the ground truth exactly. (3) The reasoning is sound: the model correctly infers that no evolution occurred due to absence of changes, synthesizing information across years as required by the multi-hop nature of the question. (4) The only minor shortcoming is that the LLM does not explicitly mention that the notes were 'first introduced' in the 2019 indenture and continued to be referenced in 2023, slightly reducing completeness in narrative detail, but the core conclusion about lack of evolution is correctly conveyed. Thus, the answer is highly accurate, contextually appropriate, and well-reasoned with only negligible omission in phrasing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 314,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ's financial relationship with KDP evolved as follows in terms of gains recognized from changes in accounting for the investment:\n\n- In 2022, MDLZ recorded a pre-tax gain of $71 million (or $54 million after-tax) from the sale of KDP shares, reducing its ownership interest.\n- In 2023, MDLZ's ownership in KDP fell below 5%, prompting a change in accounting from the equity method to marketable securities. MDLZ recorded a pre-tax gain of $493 million ($368 million after-tax) on equity method transactions related to this change and subsequently sold the remainder of its KDP shares, receiving $2.4 billion in proceeds.\n- In 2024, MDLZ had fully exited its investment in KDP, and no further gains or losses were recorded related to KDP.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $71 million pre-tax ($54 million after-tax) gain in 2022 and the $493 million pre-tax ($368 million after-tax) gain, aligning with the ground truth. However, the original answer attributes the $493 million gain to 2024, while the LLM assigns it to 2023 due to the accounting change when ownership fell below 5%. The ground truth states the gain was recorded in 2024, so the LLM's placement in 2023 is factually incorrect. Additionally, the LLM introduces new information—proceeds of $2.4 billion from selling the remainder of shares and full exit in 2024—which is not present in the original answer and cannot be verified against the ground truth. (2) All numeric values mentioned in the original answer are accurately reported by the LLM, but their temporal assignment differs. The $493 million gain should be attributed to 2024 per the ground truth, not 2023. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that a change in accounting method (from equity to marketable securities) triggers a gain, and that ownership reduction drives this change. However, the timeline is misaligned, and the addition of unverified details (e.g., $2.4B proceeds, full exit) introduces unsupported claims. (4) The contextual relevance is high as the response directly addresses the evolution of MDLZ's financial relationship with KDP and focuses on gains from accounting changes. Quantitative accuracy is high due to correct dollar amounts, but qualitative accuracy is reduced due to incorrect timing and extraneous details. Correctness score is 7 because core financial figures are accurate and the overall narrative of increasing gains due to accounting changes is supported, but the misattribution of the $493M gain to 2023 instead of 2024 is a significant factual deviation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 498,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "Between 2022 and 2024, the scale and positioning of Xbox Game Pass evolved significantly. In 2022, Xbox Game Pass offered access to over 100 first- and third-party titles, but by 2024, the library expanded to over 400 titles, reflecting Microsoft's strategic emphasis on growing its gaming ecosystem. Additionally, Microsoft positioned Xbox Game Pass as a central pillar of its gaming platform, leveraging exclusive content, cloud gaming, and cross-device accessibility to attract and retain a broader user base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Xbox Game Pass had over 100 titles in 2022 and expanded to over 400 by 2024, matching the ground truth exactly in both scale and direction of growth. The strategic emphasis is accurately reflected, with Microsoft positioning the service as a 'central pillar'—semantically equivalent to 'cornerstone' in the original answer. (2) All numeric values (100+, 400+) and years (2022, 2024) are correct and consistent with the ground truth. No calculations were required, but the comparison in scale (over 100 to over 400) is accurately conveyed. (3) The multi-hop reasoning is sound: the model synthesizes information about library size and strategic positioning across two time points, correctly inferring increased strategic importance. The only minor shortcoming is that the original answer explicitly mentions 'content, community, and cloud services' as the 2022 strategy, while the LLM answer generalizes to 'growing its gaming ecosystem'—slightly less specific but still accurate in essence. (4) The answer is fully contextually relevant, directly addressing both the scale (number of titles) and strategic positioning over time. The use of 'central pillar' effectively captures the heightened strategic emphasis. Overall, the answer is factually correct and semantically equivalent to the ground truth, warranting a high correctness score with only a minor deduction in qualitative accuracy for slightly less precise phrasing of the 2022 strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 414,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "The structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan has not shown any notable evolution from 2022 to 2024. In both filings, the relevant form is referenced as \"Form of Deferred Stock Unit Award Agreement for deferred stock units granted on or after January 1, 2019 to Non-Employee Directors under the 3M Company 2016 Long-Term Incentive Plan,\" and it is consistently incorporated by reference from the 2018 10-K filing. There is no indication of amendments or changes to this form in the 2022 or 2024 filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error regarding the incorporation by reference. The ground truth states that the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, specifically noting amendments as of May 8, 2023. However, the LLM incorrectly claims that the agreement is 'consistently incorporated by reference from the 2018 10-K filing' in both 2022 and 2024, which contradicts the ground truth. This misrepresents the evolution of disclosure practices over time and omits the key update in 2024. While the LLM correctly identifies that the effective date for grants (January 1, 2019) remained unchanged and that the structure appears consistent, it fails to acknowledge the procedural update in disclosure linkage to the 2023 filing. This is a significant omission in the multi-hop synthesis required to assess evolution in disclosure practices. Quantitatively, dates (January 1, 2019) are accurate, but the incorrect citation of the 2018 10-K as the ongoing source undermines factual precision. The reasoning is sound in structure but based on incorrect data, and the answer remains contextually relevant to the question about evolution in disclosure. Thus, the answer is mostly accurate in intent but flawed in a key detail necessary for full correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 368,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Between 2023 and 2024, the total First Mortgages and HELOCs portfolio of Charles Schwab Bank increased from $26,153 million to $27,389 million. In terms of origination costs, the unamortized premiums, discounts, and direct origination costs rose from $100 million in 2023 to $112 million in 2024. Regarding geographic concentration, the portfolio remained stable, with 42% in 2024 and 43% in 2023 concentrated in California, with no significant performance issues observed in either year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts from the ground truth: unamortized premiums, discounts, and direct origination costs increased from $100 million in 2023 to $112 million in 2024, and California concentration decreased from 43% to 42%. These numbers match the original answer exactly, with acceptable formatting. The LLM also adds the total portfolio size ($26,153M to $27,389M), which is not in the ground truth but is factually accurate and adds context without contradicting anything. (2) Quantitative accuracy is perfect: all reported figures (100M, 112M, 43%, 42%) are correct and consistent with the ground truth. The additional portfolio totals do not introduce errors. (3) The reasoning is sound and reflects proper multi-hop synthesis across years and metrics. The LLM correctly infers stability in geographic concentration despite a 1-point drop, aligning with the original answer’s implication of a 'slight shift'. It omits the explicit interpretation about 'geographic risk exposure' and 'increase in loan origination activity', but the factual basis for such an inference is still present. (4) The answer is fully contextually relevant, addressing origination costs and geographic concentration as asked. The extra detail on total portfolio size enhances relevance without straying off-topic. Only a minor deduction in qualitative accuracy due to lack of interpretive synthesis present in the original answer, but core reasoning remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 410,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Based on the language in the product research and development sections of Nike's 10-K filings, Nike's strategic emphasis on Dri-FIT technology between fiscal 2023 and fiscal 2024 remained consistent, with a continued focus on leveraging such technologies to respond to consumer preferences and enhance product performance. In both years, Nike emphasized the integration of technologies like Dri-FIT into various product categories to improve functionality and meet market demands. There is no indication of a shift in strategic emphasis on Dri-FIT during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that Nike's strategic emphasis on Dri-FIT technology remained consistent between fiscal 2023 and 2024, which aligns with the ground truth. It accurately reflects that Dri-FIT was part of a list of key technologies and that the language in the 10-K filings showed no shift in emphasis. While the LLM does not explicitly state that the 'exact same language was used' in both years—a detail present in the original answer—it captures the semantic equivalent by indicating there was 'no indication of a shift in strategic emphasis.' This omission slightly affects completeness but does not undermine factual correctness. There are no numerical values in this question, so quantitative accuracy is scored as 10 by default. The reasoning is sound, correctly synthesizing information from the R&D sections across two fiscal years. Contextual relevance is strong, as the response directly addresses the evolution (or lack thereof) in strategic emphasis. Minor deduction in qualitative accuracy due to missing the precise detail about verbatim repetition of language, but overall the answer is factually and semantically aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 330,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "Mondelez International has significantly enhanced its investment in backup and disaster recovery from 2022 to 2024 in response to increasing cybersecurity threats. In 2022, the company acknowledged rising global cybersecurity risks and outlined efforts to strengthen network security, backup and disaster recovery, and workforce training. By 2024, Mondelez had expanded these efforts, emphasizing advanced threat protection, 24/7 security operations, and improved monitoring and detection capabilities across its environment, including manufacturing and operational technologies. The company also highlighted the need for ongoing investment to address increasingly complex and sophisticated cyber threats.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Mondelez increased investment in backup and disaster recovery from 2022 to 2024 in response to rising cybersecurity threats. In 2022, the company was actively addressing global cybersecurity risks, including through backup and disaster recovery improvements. By 2024, it had expanded efforts, explicitly continuing to invest in cybersecurity with enhanced solutions. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes Mondelez’s evolving cybersecurity posture across two time points, linking increased threats to expanded investments. The LLM adds contextual details not in the original (e.g., 24/7 security operations, manufacturing tech monitoring), which are plausible and consistent with the trajectory described, though not explicitly stated in the ground truth. (4) The only minor gap is that the original emphasizes 'state-sponsored actors' and 'artificial intelligence' as emerging threat drivers, which the LLM omits. However, the core message—increased sophistication of threats driving investment—is preserved. Thus, the answer is semantically equivalent with high completeness and accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 381,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "Microsoft's financial commitment and engagement with Black and African American-owned suppliers significantly increased from fiscal year 2022 to 2024. In fiscal year 2022, Microsoft committed $20 million through Microsoft Philanthropies to support underserved communities, including Black and African American communities, by providing access to digital skills and education. By fiscal year 2024, the company exceeded its goals, achieving over 90% of its target to spend $500 million with double the number of Black- and African American-owned suppliers. Additionally, Microsoft committed $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses, demonstrating a substantial escalation in both financial investment and supplier engagement.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that in fiscal year 2022, Microsoft committed $20 million through Microsoft Philanthropies for digital skills and education, which is not mentioned in the ground truth and misrepresents the nature of the financial commitment. The correct information is that in FY2022, Microsoft had reached over 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. The LLM reverses this timeline, claiming the goal was 'exceeded' in FY2024 as 'over 90%', which misstates both the achievement level and the year. The ground truth confirms the $500M goal was fully achieved by FY2024, not just over 90%. However, the $150 million commitment to Minority Depository Institutions and funds supporting Black-owned small businesses in FY2024 is correctly reported. (2) Quantitative accuracy is partially correct: $500 million and $150 million figures are accurate, but the $20 million figure is fabricated and not in the original. The misuse of 'over 90%' in the wrong year undermines calculation and timeline accuracy. (3) Multi-hop reasoning is partially sound—the model attempts to compare FY2022 and FY2024 commitments and recognizes the expansion of financial engagement. However, it fails to correctly synthesize the evolution: it misattributes the nature of spending (supplier contracts vs. philanthropy) and misrepresents progress toward the $500M goal. (4) Contextual relevance is high—the answer addresses the evolution of Microsoft's supplier engagement and includes relevant initiatives. However, due to key factual and quantitative errors, especially the incorrect $20M figure and misstated progress timeline, the overall correctness is significantly reduced. The core message of increased commitment is directionally correct, but the specifics are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 512,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "The availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees decreased from 10,638,639 in 2021 (as reported in 2022's 10-K) to 8,565,087 in 2023. This reduction indicates that shares were issued during the purchase cycles in 2022 and 2023, reflecting active participation in the plan. It suggests that Abbott continues to utilize its stock-based incentive strategy to engage and retain non-U.S. employees through discounted share purchases.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the two key figures: 10,638,639 shares available as of December 31, 2021 (referenced in the 2022 10-K) and 8,565,087 shares as of December 31, 2023 (reported in the 2023 filing), which matches the ground truth exactly. The quantitative accuracy is perfect. (2) However, the LLM mischaracterizes the implication of the reduction. While the ground truth states the decrease 'suggests a potential tightening or adjustment' in Abbott's stock-based incentive strategy, the LLM interprets the reduction as evidence of 'active participation' and continued utilization of the strategy to 'engage and retain' employees. This is a reasonable inference but contradicts the more cautious interpretation in the original answer, which frames the reduction as possibly indicating a strategic tightening. The LLM overlooks the possibility that a declining share reserve could signal a more constrained or conservative approach. (3) The multi-hop reasoning is partially sound—correctly linking the two data points across years and identifying the trend—but the qualitative synthesis misaligns with the intended inference. (4) Therefore, while numbers are accurate and context is relevant, the qualitative interpretation diverges from the ground truth, warranting a 7 in correctness and qualitative accuracy. Quantitative accuracy is 10 due to exact number matching, and contextual relevance is high as the answer directly addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 409,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike has continued to integrate and expand the use of Nike Air technology across its product development strategy. The technology remains a core component of its innovation efforts, as highlighted by its inclusion in the proliferation of technologies like Air-Sole cushioning components used in footwear. In fiscal 2024, Nike Air-Sole components were supplied by Air Manufacturing Innovation, a wholly-owned subsidiary, as well as contract manufacturers in China and Vietnam, indicating a continued strategic emphasis on in-house and controlled production of this key technology. This reflects Nike's ongoing commitment to leveraging Nike Air technology to enhance performance and differentiate its product offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually plausible and includes accurate entities (e.g., Air Manufacturing Innovation, contract manufacturers in China and Vietnam) and correct fiscal years (2023–2024), with no incorrect numbers or dates—hence a quantitative accuracy of 10. However, the core of the question asks about the *evolution* in Nike's *strategic treatment* of Nike Air technology, which the ground truth identifies as a shift from promoting Nike Air as an innovative, distinct technology in 2023 to treating it as a mature, integrated component alongside Zoom, Free, and React in 2024. The LLM answer misses this strategic evolution entirely. Instead, it emphasizes continued expansion and production logistics (e.g., manufacturing locations), which, while relevant, do not capture the conceptual shift from 'innovative differentiator' to 'foundational platform.' The answer is contextually relevant and correctly identifies Nike Air as a core technology, but fails to synthesize the multi-hop insight about changing strategic positioning. Thus, qualitative accuracy is moderate (5) due to correct entities but flawed reasoning, and overall correctness is 5—partially correct but missing the key strategic nuance central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 344,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "Between 2022 and 2023, Abbott has maintained Osmolite as a key component of its enteral feeding portfolio within the Nutritional Products segment, with no significant strategic repositioning indicated. Osmolite is consistently listed among the primary nutritional products used in enteral feeding in healthcare institutions, alongside items like Jevity, Glucerna, and Oxepa, suggesting a stable product line strategy focused on institutional healthcare markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that Abbott maintained Osmolite as a stable part of its enteral feeding portfolio between 2022 and 2023, with no significant repositioning, which aligns with the ground truth. All entities—Osmolite, Jevity, Glucerna, Oxepa—are accurately named and correctly categorized as enteral feeding products used in healthcare institutions. The time frame (2022 to 2023) is properly referenced, and there are no numerical inaccuracies, earning a perfect score on quantitative accuracy. The reasoning is sound: the model correctly infers stable strategic positioning from consistent product listing, demonstrating appropriate multi-hop synthesis across the two years. The only minor limitation is that the LLM does not explicitly mention the absence of changes such as discontinuation or new introduction, which is included in the original answer, slightly reducing completeness in qualitative accuracy. However, the core message of strategic stability is preserved. The response is fully contextually relevant, directly addressing Abbott's positioning of Osmolite within its Nutritional Products segment and its enteral feeding strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 326,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "Between 2022 and 2024, 3M's regulatory engagement and remediation obligations related to PFAS discharge in Minnesota and Alabama have evolved significantly. In Minnesota, 3M continued to address PFAS discharges at its Cottage Grove facility, including implementing a new wastewater treatment system and working with the MPCA under a Settlement Agreement and Consent Order (SACO) to remediate PFAS contamination at multiple sites. In 2024, the Minnesota Department of Health issued more stringent health-based values for PFOA and PFOS, prompting 3M to evaluate potential impacts on its obligations. Additionally, MPCA issued a revised draft Clean Water Act permit with significantly reduced effluent limits for PFAS, which 3M is actively engaging with.\n\nIn Alabama, 3M entered into an interim Consent Order with ADEM in 2020 to address PFAS-related discharges and emissions at its Decatur facility. The company completed a multilayer cap on former sludge incorporation areas and implemented wastewater treatment controls. However, regulatory scrutiny continued, including a grand jury subpoena related to compliance with the 2009 TSCA consent order and unpermitted discharges to the Tennessee River. These developments reflect increased regulatory pressure and evolving compliance requirements for 3M in both states.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key developments in 3M's regulatory engagement and remediation obligations related to PFAS in Minnesota and Alabama between 2022 and 2024. It correctly identifies the ongoing implementation of the 2007 SACO in Minnesota, the completion of remediation at Cottage Grove with continued operational activities, and the 2020 Interim Consent Order with ADEM in Alabama, including the multilayer cap at Decatur. The answer accurately notes the issuance of a revised draft Clean Water Act permit by MPCA in 2024 with stricter effluent limits and 3M's public engagement, as well as the more stringent health-based values (HBVs) issued by MDH in January 2024. It also correctly references ongoing regulatory scrutiny in Alabama, including the grand jury subpoena related to TSCA and unpermitted discharges. However, the LLM omits specific details about the August 2024 public comment submission and the December 2024 revised draft permit update from MPCA, which are important timeline markers in the escalation of regulatory pressure. Additionally, while it mentions increased scrutiny, it does not explicitly state that the 2020 Interim Consent Order remained in effect through 2024 or that future remediation would involve multi-year capital and operating costs. These omissions reduce completeness slightly but do not undermine the core factual accuracy. All dates, entities (MPCA, ADEM, MDH), and regulatory instruments are correctly named and contextualized. The reasoning is sound, synthesizing multi-hop information across time and jurisdictions, and the answer remains highly relevant to the question. Minor formatting variations (e.g., 'revised draft permit' vs 'draft permit') are acceptable under semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1704,
        "completion_tokens": 478,
        "total_tokens": 2183
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "Between 2022 and 2024, The Coca-Cola Company maintained its equity method investment in Coca-Cola HBC AG, with its stake percentage remaining at 22% as of December 31, 2024. The carrying value of the investment in Coca-Cola HBC AG decreased from $1,197 million in 2022 to $1,087 million in 2024, primarily due to foreign currency translation adjustments and impairment charges. The investment is classified as an equity method investment, and its fair value exceeded the carrying value by $1,528 million as of December 31, 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Coca-Cola HBC AG remained an equity method investee through 2024, it incorrectly claims a 22% stake was maintained throughout, including in 2022. The ground truth explicitly states that the ownership percentage was not disclosed in 2022 — thus, asserting a 22% stake in 2022 is factually wrong. Additionally, the LLM introduces specific carrying values ($1,197M in 2022 and $1,087M in 2024) and attributes changes to foreign currency adjustments and impairments, none of which are supported by the provided evidence. The fair value exceeding carrying value by $1,528 million as of 2024 is also not mentioned in the original answer and cannot be verified from the ground truth. (2) Quantitative accuracy is low because the numbers cited (carrying values, fair value difference) are either fabricated or not present in the ground truth. The 22% stake is correct for 2024 but incorrectly projected back to 2022. (3) The reasoning partially captures the continuity of equity method accounting but fails the multi-hop synthesis by not recognizing the key evolution: the shift from undisclosed stake (2022) to explicit 22% disclosure (2024). Instead, it assumes continuity of ownership percentage, missing the nuance of formalization and quantification over time. (4) Contextual relevance is high because the answer addresses investment classification and stake percentage as asked, and stays focused on the financial relationship. However, the inclusion of unsupported financial figures and incorrect historical stake data undermines correctness. The core insight about evolving transparency in disclosure is missed, leading to a partially correct but misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 481,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle's strategic emphasis on hybrid deployments has evolved between fiscal 2022 and fiscal 2024 by increasing investment in product development to enhance integration across deployment models and by expanding offerings to support customer flexibility. In fiscal 2022, Oracle highlighted its commitment to hybrid deployments, including Oracle Cloud@Customer, and invested $7.2 billion in research and development to improve interoperability and migration capabilities. By fiscal 2024, Oracle further emphasized hybrid deployment integration as a core element of its strategy, with continued investment in technologies enabling seamless transitions between on-premise, cloud-based, and hybrid environments. This is reflected in the company's focus on Oracle Cloud Services and the expansion of programs to help customers migrate existing workloads to the Oracle Cloud.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's strategic evolution in hybrid deployments from fiscal 2022 to 2024, accurately stating the $7.2 billion R&D investment in 2022 and the continued focus on hybrid integration by 2024. The key product Oracle Cloud@Customer is correctly mentioned, and the emphasis on interoperability, migration, and deployment flexibility aligns with the ground truth. (2) Quantitative accuracy is perfect: the $7.2 billion R&D figure is correctly cited with no calculation required. (3) The multi-hop reasoning is sound—information is synthesized across fiscal years and strategic focus areas. The LLM captures the shift from development-focused (2022) to integrated deployment model (2024), though it does not explicitly state that hybrid became a 'standard deployment choice' alongside on-premise and cloud, which is a minor omission in phrasing but not in substance. (4) The answer is highly relevant, complete, and semantically equivalent to the original, with only slight softening in the strength of the conclusion about integration maturity. No factual errors; minor deduction from 10 due to slightly less precise framing of hybrid deployment's strategic positioning in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 345,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "The filing status of the Mandatory Clawback Policy for Wells Fargo & Company evolved between the 2023 and 2024 SEC 10-K disclosures. In the 2023 filing, the policy was not explicitly listed as an exhibit. However, in the 2024 filing, the Mandatory Clawback Policy is included as Exhibit 97, titled \"Wells Fargo & Company Mandatory Clawback Policy, effective as of October 2, 2023,\" and is incorporated by reference to the Company's Annual Report on Form 10-K for the year ended December 31, 2023. This indicates that the policy was formally filed and disclosed in the 2024 10-K.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It falsely claims that in 2023, the Mandatory Clawback Policy was 'not explicitly listed as an exhibit,' when the original answer states it was filed directly as Exhibit 97 in the 2023 10-K. Conversely, the LLM claims the policy was 'included as Exhibit 97' in the 2024 filing, which misrepresents the situation: in 2024, it was not filed directly but incorporated by reference from the 2023 filing. (2) The date 'October 2, 2023' is mentioned in the LLM answer, which may be factually accurate about the policy's effective date, but this detail is not in the ground truth and does not compensate for the core inaccuracies about filing status. (3) The multi-hop reasoning is flawed: the key distinction between direct filing (2023) vs. incorporation by reference (2024) is reversed, indicating a failure to correctly synthesize the procedural change. (4) The conclusion that the policy was 'formally filed and disclosed in the 2024 10-K' is misleading—the policy was first filed in 2023; 2024 merely referenced it. Thus, the answer fails on factual accuracy, reasoning, and completeness, warranting a low correctness score despite addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 344,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher Scientific acquired CorEvitas, LLC on August 14, 2023, within the Laboratory Products and Biopharma Services segment, to enhance its real-world evidence solutions for drug development. The acquisition added $0.91 billion to Thermo Fisher's 2023 investing activities cash outflows and contributed to a 2% increase in the segment's revenues for 2023. Financially, the acquisition led to the recognition of definite-lived intangible assets, including customer relationships, product technology, and goodwill, with a weighted-average amortization period of 17 years for the intangible assets acquired.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the acquisition of CorEvitas, LLC by Thermo Fisher in 2023 for $0.91 billion and its integration into the Laboratory Products and Biopharma Services segment, which aligns with the ground truth. It accurately notes the financial impact on investing activities and mentions the recognition of definite-lived intangible assets. However, there are two discrepancies: the amortization period is stated as 17 years, while the ground truth specifies 18 years, which is a minor but notable quantitative inaccuracy. Additionally, the LLM introduces a 2% revenue increase for the segment in 2023, which is not present in the original answer and cannot be verified from the provided ground truth, making it an unsupported addition. (2) The dollar amount ($0.91 billion) and date (August 14, 2023) are accurate and consistent with expectations, though the exact date was not in the ground truth—this could be correct but is not verifiable from the provided data. The amortization period (17 vs 18 years) is off by one year, likely due to rounding or data source variation, but still close. The 2% revenue increase is unverified and not mentioned in the original, reducing quantitative accuracy slightly. (3) The multi-hop reasoning is sound: the model connects the acquisition to financial outflows, segment integration, and subsequent accounting treatment (amortization of intangibles), demonstrating proper synthesis across events and financial implications. However, the unsupported revenue impact weakens the reasoning chain. (4) The answer is highly contextually relevant, addressing both the evolution of the relationship and financial implications. The core facts are correct, but the minor error in amortization period and the unverified revenue impact prevent a top score. Thus, correctness is rated 8 due to high accuracy with minor factual deviations and one unsupported claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 520,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "Between 2022 and 2023, RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce remained contingent on the flight hours of V2500-powered aircraft in service as of the acquisition date, with payments due through June 2027. These payments are included in \"Other commercial aerospace commitments\" and are capitalized as collaboration intangible assets as payments are made. The timing of these payments is aligned with the expected flight hour usage, with no material changes in the capitalization treatment observed between the two periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the payment obligations are contingent on flight hours of V2500-powered aircraft as of the acquisition date, extend through June 2027, are reported under 'Other commercial aerospace commitments', and are capitalized as collaboration intangible assets. There is no indication of changes between 2022 and 2023 in either timing or treatment. (2) Quantitative elements—specifically the June 2027 end date—are correctly stated, and no numerical inaccuracies are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across the two years and maintains consistency in the structure and treatment of obligations. (4) The only minor shortcoming is that the LLM does not explicitly state that there was 'no indication of a change in the magnitude or timing'—instead phrasing it as 'no material changes...observed'—which is semantically very close but slightly less precise in reflecting the original's emphasis on stability due to lack of disclosed change. However, this does not affect factual correctness. Overall, the answer is factually complete, contextually relevant, and accurately captures the continuity between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 351,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "The Coca-Cola Company's financial relationship with fairlife has evolved from 2022 to 2024 through contingent payments tied to performance milestones. As of December 31, 2024, the contingent consideration liability related to the 2020 acquisition of fairlife was $6,126 million, contingent on fairlife achieving certain financial targets through 2024, with the payment due in 2025. This liability is based on agreed-upon formulas tied to fairlife's operating results and is remeasured quarterly at fair value, with changes recorded in income. In 2023, a milestone payment of $275 million was made.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies, particularly in quantitative details. The contingent consideration liability of $6,126 million ($6.126 billion) is grossly exaggerated and not supported by the ground truth; no such figure appears in the original answer. Additionally, the claim that a $275 million milestone payment was made in 2023 is not mentioned or implied in the original answer, which only states that a payment is expected in 2025 based on performance through 2024. These invented figures severely undermine factual correctness. (2) Quantitative accuracy is very low: the original answer does not specify any dollar amount for the contingent payment, only its existence and timing (due in 2025 based on 2024 performance). By fabricating precise numbers like $6,126 million and $275 million, the LLM introduces false precision and incorrect data. Even allowing for format variation, these numbers are orders of magnitude off and not plausible in context. (3) Qualitatively, the LLM correctly identifies the evolution of the financial relationship—acknowledging the 2020 acquisition and the presence of a future contingent payment tied to performance through 2024, due in 2025—which aligns with the multi-hop reasoning in the original answer. It also correctly frames the contingent consideration as tied to financial targets and remeasured quarterly, which may reflect standard accounting practice, though not explicitly stated in the ground truth. However, the inclusion of unverified details reduces reliability. (4) Contextual relevance is high because the response addresses the core question about the evolution of the financial relationship and contingent payments, focusing on the correct companies and timeline. Despite incorrect numbers, the structure and intent of the answer are aligned with the question. Overall, the answer fails on factual accuracy due to fabricated figures, warranting a low correctness score despite some conceptual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 538,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "Between 2022 and 2024, Oracle has further enhanced the strategic positioning of Oracle Cloud Services by emphasizing deeper integration with enterprise applications and infrastructure technologies. Oracle has focused on delivering comprehensive, interoperable, and flexible cloud-based solutions, such as Oracle SaaS and Oracle Cloud Infrastructure (OCI), which enable customers to seamlessly transition from on-premise to cloud environments. The company has also introduced programs to facilitate migration and expansion to Oracle Cloud for existing workloads, leveraging its Next-Generation Cloud Infrastructure to support advanced technologies like AI, machine learning, and IoT. This evolution reflects Oracle's commitment to providing a unified, secure, and scalable platform that meets diverse enterprise IT needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of overall strategic evolution and correctly identifies Oracle's focus on integration, interoperability, and flexibility in cloud services between 2022 and 2024. It accurately references Oracle SaaS and OCI, migration support, and the role of advanced technologies like AI and machine learning, which aligns with the Autonomous Database emphasis in 2022. However, the LLM answer lacks the specific evolution in strategic messaging: it does not mention the shift from promoting individual innovations (e.g., Autonomous Database) in 2022 to positioning Oracle Cloud as a holistic, integrated platform by 2024. Additionally, the 2024 emphasis on 'customer choice' and 'comprehensive and integrated offerings' as stated in the original answer is not explicitly captured. While the LLM conveys a similar theme of integration and enterprise transformation, it misses the nuanced shift in strategic narrative that is central to the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are present), and the entities (Oracle, OCI, SaaS, cloud infrastructure) are correct. The reasoning is sound but not fully precise in capturing the multi-hop evolution across years. Contextual relevance is high as the response directly addresses Oracle's strategic positioning and integration with enterprise systems.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 391,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "The Key/Specified Employee Policy was incorporated by reference in the 2023 SEC filing (page 18 of WFC_10k_2023.pdf) as Exhibit 10(r), referencing its inclusion in the Company's Annual Report on Form 10-K for the year ended December 31, 2018. In the 2024 SEC filing (page 20 of WFC_10k_2024.pdf), the policy remains referenced under the same exhibit number and description, with no indication of amendments or updates to the policy's documentation or incorporation by reference. Thus, there is no evidence of change in the treatment or status of the Key/Specified Employee Policy between the 2023 and 2024 filings.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Key/Specified Employee Policy was referenced in both the 2023 and 2024 filings with no amendments, which aligns with the ground truth. However, there is a discrepancy in the exhibit number: the LLM states Exhibit 10(r) in both years, while the ground truth specifies Exhibit 10(v). This is a factual error affecting entity accuracy. Additionally, the LLM cites specific page numbers (18 and 20) not present in the original answer, which may be accurate to the document but are not verifiable from the ground truth and introduce unconfirmed details. (2) There are no numerical values, dates, or calculations in the question or answers beyond the year 2018, which both answers correctly reference. Thus, quantitative accuracy is high, though the exhibit number is a critical identifier and its inaccuracy reduces confidence. (3) The reasoning is sound—LLM correctly infers that no changes occurred between years due to consistent referencing and lack of amendment notices. It performs the necessary multi-hop comparison across two filings and draws a valid conclusion about continuity. However, the incorrect exhibit number suggests a potential misidentification of the document source, weakening the synthesis. (4) The answer is highly contextually relevant, addressing documentation, incorporation by reference, and evolution (or lack thereof) between years. Despite the exhibit number error, the core conclusion—that the policy remained unchanged in status and documentation—is consistent with the ground truth. Hence, correctness is reduced to 7 due to the exhibit discrepancy but not lower because the central claim about policy continuity remains valid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 468,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The aggregate principal balance of the 6.700% notes due 2028 remained unchanged at $285 million between 2022 and 2023. This stability suggests that RTX did not refinance or retire these notes during the period, indicating a strategy of maintaining existing long-term debt obligations without immediate restructuring. This could reflect a focus on preserving liquidity or a decision to hold higher-yielding debt if it aligns with their broader capital structure goals.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the aggregate principal balance remained unchanged at $285 million. According to the ground truth, the balance was $115 million in 2022 and increased to $285 million in 2023 — a significant change, not stability. This misstatement undermines the entire response. (2) Quantitatively, the LLM reports only one value ($285 million) and omits the 2022 figure entirely, failing to capture the correct evolution. The increase from $115M to $285M represents a $170M rise, which the model completely misses. Even allowing for format variations, the numbers are factually wrong. (3) The reasoning is flawed because it assumes no change and draws conclusions about debt management strategy based on that false premise. The correct inference — that RTX expanded its exposure to this fixed-rate debt — is not made. The model fails the multi-hop requirement to compare two years of data across the same instrument. (4) While the answer addresses the structure of the question (evolution and strategy), its factual foundation is incorrect, leading to a low correctness and quantitative accuracy score. Qualitative accuracy is slightly higher because the type of reasoning (linking debt stability to strategy) is conceptually valid, albeit applied to wrong data. Contextual relevance is moderate as the answer stays on topic but draws incorrect conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 391,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "The carrying value of TMO's 1.95% 12-Year Senior Notes increased from $749 million at the end of 2023 to $773 million at the end of 2024. Additionally, the effective interest rate for these notes rose slightly from 2.08% in 2023 to 2.07% in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both carrying value and effective interest rate trends. According to the ground truth, the carrying value decreased from $773 million in 2023 to $725 million in 2024, but the LLM incorrectly states it increased from $749 million to $773 million. The initial 2023 value is wrong ($749M vs $773M), and the direction of change is incorrect (increase vs actual decrease). Additionally, the LLM misstates the effective interest rate movement: it claims the rate rose from 2.08% to 2.07%, which is logically inconsistent (a rise cannot result in a lower number), and contradicts the ground truth where the rate declined slightly from 2.08% to 2.07%. (2) Quantitative accuracy is severely compromised: all key figures are either incorrect or misapplied. The carrying values are wrong for both years, and the rate change is inaccurately described despite the numbers being close. (3) The multi-hop reasoning is flawed—the model fails to correctly track the evolution of both metrics over time and misrepresents the direction of change for both carrying value and interest rate. It also introduces a non-existent value ($749M) not present in the ground truth. (4) Contextual relevance is high because the answer addresses the right company (TMO), the correct financial instrument, and the appropriate metrics (carrying value and effective interest rate) over the correct time frame. However, due to major factual and directional inaccuracies, the overall correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 425,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "The change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings reflects a shift in transparency and accessibility. In 2022, the Code of Conduct and Directors' Code of Conduct were mentioned with specific website links, but in 2024, the Directors' Code of Conduct is more prominently integrated into the document's corporate governance section and also linked on the website. This suggests a stronger emphasis on corporate governance disclosure and accountability, aligning with best practices for board transparency and stakeholder trust.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its characterization of the change in presentation. The ground truth states that in 2022, BNY Mellon provided a direct URL link to the Directors' Code of Conduct and explicitly discussed it in the context of ethics and governance, whereas in 2024, the Code was listed among other governance documents without a direct link or specific mention of updates—indicating reduced visibility. In contrast, the LLM claims the 2024 filing 'more prominently integrates' the Code and maintains a website link, which contradicts the original answer. This misrepresents the direction and nature of the change. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the shift from explicit, accessible disclosure to a more consolidated, less transparent format. Instead, it infers increased prominence and integration, which is the opposite of the documented trend. The conclusion about 'stronger emphasis on corporate governance' and 'best practices' is unsupported and contradicts the implication of reduced transparency in the ground truth. (4) While the answer addresses corporate governance implications and is framed around transparency and accountability, its core factual premise is inverted, severely undermining correctness. Contextual relevance is moderate because it engages with the right topic and level of analysis, but the incorrect facts limit usefulness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 435,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon established a new $5.0 billion Short-Term Credit Agreement in October 2024, replacing the prior agreement from November 2023. The facility matures in October 2025 and can be extended for an additional 364 days with lender approval. The facility size remained unchanged at $5.0 billion, with no borrowings outstanding as of December 31, 2023, and 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.0 billion facility size in both years, the October 2025 maturity date for the 2024 agreement, and the replacement of the November 2023 agreement. However, it incorrectly states that the new agreement was established in October 2024, while the ground truth indicates Amazon entered into the 2024 agreement in October 2024 (which is correct), but the prior agreement was established in November 2023 — this timing is accurate. The LLM omits that the 2023 agreement was established in November 2023 and matured in October 2024, which is relevant context for the evolution. (2) All numeric values — $5.0 billion, October 2025 maturity — are correct. The statement about no borrowings outstanding as of December 31, 2023 and 2024 is not in the ground truth and cannot be verified from the provided information; this is an addition not supported by the original answer, but does not contradict it directly. (3) The multi-hop reasoning is mostly sound: the LLM correctly infers continuity in facility size and tracks the replacement of agreements. However, it misses the shift in establishment timing from November (2023) to October (2024), which was a key point in the original answer about procedural evolution. (4) The answer is contextually relevant and captures the core evolution, but lacks full completeness regarding the 2023 agreement's establishment and maturity dates, and adds unverified detail about borrowings. Thus, high scores for accuracy and relevance, minor deduction for completeness and unsupported detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 433,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "AMD's APU strategy evolved significantly from 2022 to 2024, particularly in terms of product integration and target markets. In 2022, AMD focused on integrating CPUs and GPUs for mainstream PCs, emphasizing performance and efficiency for consumer and commercial notebooks. By 2024, the strategy shifted toward embedding dedicated neural processing units (NPUs) directly into APUs, such as the Ryzen AI 300 Series, to power next-generation AI PCs. This integration enables enhanced AI capabilities at the edge, targeting both consumer and enterprise markets. The shift positions AMD to capture a larger share of the AI PC segment by offering differentiated, high-performance solutions that combine traditional computing with AI acceleration, thereby increasing its revenue potential in this emerging market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the strategic evolution of AMD's APU strategy from 2022 to 2024: starting with CPU-GPU integration for mainstream devices in 2022 and shifting toward NPU-integrated APUs for AI PCs by 2024. The mention of the Ryzen AI 300 Series as an example of this shift is factually consistent with AMD's 2024 product direction. (2) There are no numeric values (e.g., revenue figures, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across time periods and strategic focus areas (from external GPU reliance in data centers to on-die NPU integration in client devices), correctly inferring the implications for revenue potential in the AI PC market. (4) The only minor gap is that the LLM omits the specific reference to AMD being 'the first company to include a dedicated NPU on the same SoC as an x86 CPU,' which is a key differentiator highlighted in the ground truth. However, the core facts—integration of NPUs, targeting AI PCs, enhanced revenue potential—are all present and correctly reasoned. Wording differs slightly but maintains semantic equivalence. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 388,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "The treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic remained consistent between 2023 and 2024. In both years, dividends paid to U.S. residents were generally exempt from Irish dividend withholding tax (25% rate) if the shareholders met specific documentation requirements, such as providing a U.S. Certification of Residence (Form 6166) or having their U.S. address recorded through the DTC. Additionally, if withholding tax applied, the payment satisfied any Irish income tax liability, provided the shareholder submitted the required documentation to Irish Revenue authorities. No material changes to this framework were noted in the 2024 filing compared to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 25% Irish dividend withholding tax rate, the availability of exemptions for U.S. residents via Form 6166 or equivalent documentation, and the principle that withholding tax payment discharges any Irish income tax liability upon submission of required documentation. (2) Quantitative accuracy is perfect: the 25% rate is correctly cited, and no incorrect numbers or dates are present. (3) The reasoning is sound and reflects proper multi-hop synthesis across the 2023 and 2024 tax treatments, correctly concluding no material changes occurred. (4) Minor omission: the ground truth mentions the Irish Non-Resident Form V2 as an alternative to Form 6166, while the LLM mentions DTC address recording as a proxy for documentation—this is contextually acceptable but slightly less precise. However, DTC practices often align with exemption procedures, so this does not constitute a factual error. Overall, the answer is semantically equivalent, with only slight variation in specificity regarding documentation forms. Thus, high scores across all dimensions are warranted, with a 9 in correctness due to the minor detail omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 349,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "The risk disclosure around new products and services evolved between 2022 and 2024 to include more specific mention of the platforms operating model initiative. In 2022, the risk related to new products and services was mentioned generally as a potential source of new or additional risks. By 2024, the disclosure explicitly highlighted the risk that the company \"may not realize some or all of the expected benefits of our transition to a platforms operating model,\" indicating a more detailed and focused risk assessment of this strategic initiative.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in risk disclosure between 2022 and 2024 as described in the ground truth. (1) All factual elements are correct: the 2022 general risk statement about new products and services introducing new risks is accurately summarized, and the 2024 addition—specifically citing the 'transition to a platforms operating model' and the risk of not realizing expected benefits—is correctly quoted and contextualized. (2) There are no numeric values, percentages, or financial figures in the question or ground truth, so quantitative accuracy is not applicable beyond correct handling of years (2022 and 2024), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes how the risk disclosure evolved over time and attributes the more specific language to the platforms operating model initiative in 2024. (4) The LLM answer is semantically equivalent to the original answer, though it omits the explicit mention of BNY Mellon by name (referring instead to 'the company'), which is a minor contextual omission but does not impair understanding since the subject is clear from context. Otherwise, the reasoning, entity identification (implied), and synthesis are strong. The answer is fully relevant to the question and conveys the key shift from general to specific risk disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 377,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "Amazon's 3.600% Note due 2032 was disclosed in both the 2023 and 2024 10-K filings under the Supplemental Indenture dated April 13, 2022 (Exhibit 4.2). In both years, the note was included as part of Amazon's long-term debt instruments, with no new amendments or changes to its terms disclosed between 2023 and 2024. The note remains outstanding, with the maturity date unchanged at 2032.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3.600% Note due 2032, the Supplemental Indenture dated April 13, 2022, and its inclusion in both 2023 and 2024 10-K filings as part of long-term debt. These factual elements—interest rate, maturity year, indenture date, and exhibit number—are quantitatively accurate and match the ground truth. (2) All numbers, dates, and percentages are correct: 3.600%, 2032 maturity, April 13, 2022 indenture date. No calculation errors. (3) However, the LLM fails to capture the key qualitative evolution in the trustee relationship—a core part of the question. The ground truth highlights that in 2023, both Wells Fargo Bank (prior trustee) and Computershare (successor trustee) were named, but in 2024, only Computershare is referenced, indicating a formal transition. This procedural shift in administration is entirely missing from the LLM response, which states 'no new amendments or changes' without acknowledging the trustee update. This omission represents a failure in multi-hop reasoning: the model must compare trustee disclosures across two years and infer administrative evolution, even if terms are unchanged. (4) While the answer is factually sound on surface-level disclosures and contextually relevant to Amazon's debt instruments, it lacks the deeper synthesis required to explain how the relationship evolved administratively. Hence, correctness is partially compromised despite strong quantitative accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 410,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "From 2023 to 2024, MDLZ's net investment hedge (NIH) derivative contracts showed a significant increase in asset value and a decrease in liability value. In 2024, NIH derivative contracts had an asset value of $305 million and a liability value of $50 million, compared to $163 million in assets and $382 million in liabilities in 2023. This shift indicates a more favorable financial position for MDLZ in terms of these hedges. Additionally, the fair value of NIH contracts moved from a net liability of $219 million in 2023 to a net asset of $255 million in 2024, reflecting improved market conditions or effective hedging strategies. The presentation in the financial statements remained consistent, with these contracts categorized under Level 2 fair value measurements based on observable inputs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The numbers provided for 2023 and 2024 asset and liability values ($305M assets and $50M liabilities in 2024; $163M assets and $382M liabilities in 2023) are not supported by the ground truth. The original answer states that in 2023, MDLZ reported $1,347 million in other current assets and $250 million in other assets related to derivative assets, with corresponding liabilities of $377 million and $413 million in prior years, but does not provide a full 2024 balance sheet breakout. The LLM invents specific asset/liability figures for 2024 that are not in the ground truth. (2) The calculation of net liability of $219 million in 2023 (from $163M - $382M) and net asset of $255 million in 2024 is based on fabricated inputs and is therefore incorrect. The ground truth does not provide a net position comparison between years. (3) The qualitative shift described in the original answer — from balance sheet disclosure of fair values in 2023 to emphasis on income statement impact in 2024, particularly within 'Other income, net' — is completely missed by the LLM. Instead, the LLM incorrectly claims the presentation remained consistent, which contradicts the core point about evolving disclosure focus. (4) The LLM introduces irrelevant details about Level 2 fair value measurements not mentioned in the ground truth. While the question involves multi-hop reasoning across years and disclosures, the LLM fails to synthesize the correct evolution and instead fabricates numerical data and draws incorrect conclusions. The contextual relevance is moderate because it addresses NIH derivatives and financial statement presentation, but the factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 481,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "From 2023 to 2024, the Abrams Main Battle Tank's modernization strategy has evolved with a focus on next-generation upgrades and increased international demand. In 2023, the U.S. Army announced the development of the M1E3 Abrams, a significant engineering change aimed at improving capability and reducing sustainment needs. By 2024, the emphasis shifted to delivering the system enhancement package version 3 (SEPv3), which includes advancements in communications, power generation, fuel efficiency, optics, and armor. International demand for Abrams tanks and upgrades remains strong, with continued procurement and modernization efforts by NATO members and partners in Europe, the Middle East, and other regions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the development of the M1E3 Abrams in 2023 and the features of the SEPv3 upgrade (communications, power generation, fuel efficiency, optics, armor). It also correctly notes strong international demand and procurement by NATO and partners in Europe, the Middle East, and other regions. However, there is a critical factual reversal in the timeline: the original answer states that in 2023, General Dynamics was focused on delivering SEPv3 *and* announced the M1E3, while in 2024 the emphasis was on continued capability enhancement and global strategic relevance. The LLM incorrectly states that the M1E3 was announced in 2023 by the U.S. Army (not General Dynamics) and then claims that by 2024 the focus shifted to delivering SEPv3—this reverses the actual progression, as SEPv3 was already in delivery in 2023. (2) There are no explicit numbers (e.g., dollar amounts, percentages, unit counts) in either answer, so quantitative accuracy is not compromised beyond timeline accuracy, which is treated as a qualitative error. (3) The multi-hop reasoning is partially sound—linking technological development with international demand across years—but fails in synthesizing the correct sequence of events and responsible entities (General Dynamics vs. U.S. Army). (4) The contextual relevance is high because the answer addresses both technological development and international demand as asked. However, the reversal of the modernization timeline and misattribution of announcements significantly reduce factual correctness, warranting a score of 6—partially correct but with major errors in event sequencing and actor identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 465,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "Between 2022 and 2024, AMD's role in the development and positioning of APUs has evolved significantly, with a strategic emphasis on integrating CPU and GPU capabilities to serve diverse market segments. In 2022, APUs were primarily highlighted for value and mainstream PCs, offering visual processing on a single chip. By 2024, APUs were positioned more broadly across client, embedded, and semi-custom markets, with a stronger focus on heterogeneous computing and performance optimization for gaming, professional workloads, and cloud applications. This evolution reflects AMD's strategic shift to leverage APUs as a core component in delivering balanced, power-efficient computing solutions across a wider range of use cases.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key factual developments from the ground truth. It correctly identifies a strategic evolution in AMD's APU positioning between 2022 and 2024 and notes broader use cases. However, it inaccurately characterizes the 2022 positioning as focused on 'value and mainstream PCs,' which is not supported by the original answer—APUs were instead grouped under a general Enterprise, Embedded and Semi-Custom portfolio without specific segmentation. The 2024 shift is also misrepresented: the original answer specifies that APUs were formally integrated into two reportable segments—Data Center and Client—with explicit mention of AI accelerators, CPUs, GPUs, and DPUs in Data Center. The LLM answer omits this structural reporting change and incorrectly emphasizes 'cloud applications' and 'professional workloads' without evidence from the source. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—scored as 10 by default due to absence of numerical claims. (3) The multi-hop reasoning is partially sound—there is an attempt to compare 2022 and 2024 strategies—but fails to synthesize the correct organizational and segment-level changes reported in the filings. The evolution described is plausible but not factually aligned with the ground truth. (4) Correctness is scored at 5 due to partial factual alignment but significant omissions and misrepresentations of AMD's actual segment reporting structure. Qualitative accuracy is low for the same reasons. Contextual relevance is high because the answer addresses the question's intent and timeframe, even if details are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 459,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries remained consistent from 2023 to 2024. In both years, the company noted that the Irish Minister for Finance has the authority to restrict financial transfers between Ireland and third countries, with the list of restricted countries subject to ongoing change. Additionally, transfers involving countries under United Nations or EU sanctions may also face restrictions under Irish law. There were no material changes in the language or scope of this disclosure between the two periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in describing the Financial Transfers Act 1992 and the Irish Minister for Finance's authority, which aligns with the ground truth. However, it incorrectly states that there were 'no material changes' in disclosure between 2023 and 2024, directly contradicting the Original Answer, which notes a clear evolution: in 2023, Medtronic emphasized the dynamic nature of the list of restricted countries, but by 2024, this emphasis was dropped, suggesting a shift in focus or stabilization. The LLM fails to capture this nuanced but important change in tone and emphasis, instead asserting consistency where there was a subtle but meaningful evolution. While all entities (Medtronic, Ireland, Financial Transfers Act 1992) and years are correct, and no numerical inaccuracies are present (hence high quantitative accuracy), the qualitative reasoning is flawed due to incorrect synthesis of the change in disclosure over time. The answer is contextually relevant and addresses the right topic, but misses the core of the question—how the disclosure evolved—by asserting no change when the ground truth identifies a shift in emphasis. This constitutes a significant error in multi-hop reasoning and interpretation, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 357,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "In 2023, GD disclosed that the G700, an ultra-long-range, ultra-large-cabin aircraft, was expected to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating successful certification and the start of production and delivery operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: in 2023, the G700 was expected to enter service after FAA certification in early 2024; by 2024, deliveries began in Q2, indicating successful certification and transition to production. (2) There are no numeric or date inaccuracies—'early 2024' for certification and 'second quarter' for deliveries match the timeline in the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesized information across two years and linked certification to delivery, showing progression from development to active production. (4) The only minor omission is that the original answer explicitly frames the evolution as a shift 'from a future product to a realized and delivered aircraft,' which adds slight contextual emphasis on the milestone achieved; however, this nuance does not affect factual correctness. Wording differences are acceptable under semantic equivalence. All entities (G700, GD, FAA, 2023, 2024) are accurate. The answer is fully relevant and responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 314,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "The nature of PMI's relationship with KT&G from 2023 to 2024 has remained stable in terms of strategic dependency and product commercialization. In 2023, PMI renewed and extended its long-term collaboration with KT&G, securing exclusive global rights (excluding South Korea) to commercialize KT&G's smoke-free devices and consumables for 15 years, through 2038. This agreement provided PMI with access to KT&G's innovation pipeline, including products for low- and middle-income markets. In 2024, there is no indication of material changes to this arrangement, and PMI continued to include KT&G-licensed heat-not-burn products (Fiit and Miix) in its smoke-free product portfolio. Thus, the strategic dependency and commercialization framework with KT&G remained consistent between the two periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains accurate quantitative details—correct dates (15-year agreement through 2038), correct geographic exclusion (South Korea), and correct identification of product types (smoke-free devices, heat-not-burn products like Fiit and Miix). These match the ground truth exactly, warranting a perfect quantitative accuracy score. (2) However, the core qualitative assessment is incorrect: the LLM claims the relationship 'remained stable' and that 'there is no indication of material changes,' which contradicts the ground truth that the relationship evolved into a more integrated dependency by 2024, shifting from exclusive distribution to inclusion within PMI's broader smoke-free strategy. This evolution reflects deeper strategic alignment, which the LLM fails to recognize. Instead, it interprets continued commercialization as stability, missing the nuance of operational integration. (3) The multi-hop reasoning is flawed—the question asks how the relationship evolved, requiring a comparison across time to detect change. The LLM acknowledges both years but concludes no change occurred, contradicting the ground truth's assertion of a strategic shift. It fails to synthesize the implication that inclusion in PMI's product portfolio signifies deeper integration beyond mere distribution. (4) Contextual relevance is high because the answer discusses the right companies, timeframes, and products, and addresses both strategic dependency and commercialization. However, the incorrect conclusion about the nature of the evolution significantly undermines factual correctness, justifying a mid-range score of 5 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 460,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "From 2022 to 2024, AMD has evolved its approach to semi-custom SoC products by integrating them more strategically into broader product ecosystems and emphasizing AI capabilities. In 2022, the focus was on delivering semi-custom SoC products as part of gaming and embedded solutions, with revenue dependent on customer product success. By 2024, AMD positioned semi-custom SoCs as a core component of its AI and high-performance computing strategy, leveraging them in data center AI accelerators and co-engineering solutions for gaming consoles and handheld devices. Additionally, AMD expanded its AI ecosystem through acquisitions like Silo AI and the planned acquisition of ZT Systems, aiming to enhance deployment speed and integration across cloud, edge, and end devices.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in AMD's semi-custom SoC strategy from 2022 to 2024. It correctly identifies the shift from a dependency model (tied to customer product success) to a more strategic, integrated role within broader ecosystems, particularly in AI and high-performance computing. The mention of revenue dependence on customer success in 2022 aligns with the ground truth, as does the 2024 emphasis on integration with AI, data centers, gaming, and embedded systems. However, the LLM introduces specific acquisitions—Silo AI and the planned acquisition of ZT Systems—that are not mentioned in the original ground truth answer derived from the knowledge graph. While these may be real-world developments, they are not part of the verified filing-based evidence and thus represent unverified additions that slightly undermine factual accuracy. Additionally, the ground truth emphasizes the architectural integration of components like NPUs with x86 CPUs in AI PCs, which the LLM omits. The LLM does correctly highlight co-engineering for gaming consoles and handhelds and the expanded ecosystem role. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. Contextual relevance is perfect—the answer directly addresses strategic positioning and ecosystem integration over the specified time frame. The reasoning is sound and reflects multi-hop synthesis across years and strategic themes, though minor overreach via unverified acquisitions prevents a top score in qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 432,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax on dividends paid to U.S. residents remained largely consistent, with dividends generally subject to a 25% Irish dividend withholding tax unless exemptions applied. U.S. residents holding shares through the Depository Trust Company (DTC) with U.S. addresses were exempt from withholding tax. Additionally, U.S. residents who met exemption criteria and did not hold shares through an Irish branch or agency generally had no Irish income tax liability. The 2024 filing reiterated these exemptions and emphasized that withholding tax payments satisfied any Irish income tax obligations for affected shareholders. No significant changes to exemptions or obligations were noted in the 2024 filing compared to 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 25% Irish withholding tax rate and the general exemption for U.S. residents, which aligns with the ground truth. It also correctly notes that the rate remained unchanged between 2023 and 2024. However, it introduces specific details not present in the original answer—namely, the mention of the Depository Trust Company (DTC) and U.S. addresses as a basis for exemption—which are absent from the ground truth and not supported by the provided knowledge. The original answer focuses on tax residency and connection to Ireland (e.g., not holding through an Irish branch), not DTC or address-based criteria. Additionally, the LLM claims that 'no significant changes' occurred, which contradicts the ground truth stating that 2024 brought more structured exemption conditions and clarified post-withholding procedures. (2) Quantitatively, the 25% withholding tax rate is accurately reported, and no incorrect numbers or miscalculations are present—hence a high quantitative accuracy score. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information across years and identifies continuity in tax treatment, but it fails to capture the evolution in disclosure clarity and procedural details in 2024, misrepresenting the nature of changes. The introduction of unverified mechanisms (DTC) undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses Irish tax treatment of dividends for U.S. residents, covers both years, and discusses exemptions and tax liability—core elements of the question—despite inaccuracies in specifics and missed nuances.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 455,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "General Dynamics' Marine Systems segment experienced cost pressures in 2023 due to supply chain impacts on the Virginia-class submarine schedule and cost growth on the DDG-51 program, which contributed to a 110-basis-point decline in operating margin. In 2024, the segment's revenue is expected to increase to approximately $12.8–12.9 billion, with an improved operating margin of around 7.6%. Additionally, the Columbia-class submarine initiative drove significant revenue growth in 2023, and its ongoing production is expected to remain a key revenue driver in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: the 110-basis-point decline in operating margin in 2023 due to supply chain issues on the Virginia-class and cost overruns on the DDG-51 program, the projected 2024 revenue range of $12.8–12.9 billion, and the expected operating margin of approximately 7.6%. It also accurately notes the revenue growth from the Columbia-class submarine program in 2023 and its continued importance in 2024. (2) All numeric values are correct and match the original answer exactly—no calculation errors or misstatements. Format variations (e.g., '110-basis-point' vs '110 basis point') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes financial performance (margin decline, revenue outlook) with strategic focus (Columbia-class as a growth driver) across two years and multiple programs. The only minor omission is that the original answer explicitly frames the shift from 2023 cost pressures to 2024 stabilization as a 'strategic effort,' which the LLM implies but does not directly state. This slight lack of emphasis on strategic intent prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, addressing every component of the question—financial performance changes, cost pressures, and revenue outlook—across the specified programs and time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 393,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Based on the provided information, BKNG's financial dependency on Booking.com, as measured by the proportion of revenue derived from accommodation reservations, remained relatively stable between 2022 and 2023. In 2023, approximately 89% of the Company's revenues were from online accommodation reservation services, while in 2022, the proportion was also approximately 89%. This indicates that the majority of BKNG's revenue continued to be driven by accommodation reservations, primarily through Booking.com, with no significant change in dependency between the two years.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that 89% of BKNG's revenues came from accommodation reservations in both 2022 and 2023, which matches the ground truth exactly. All numeric values and years are accurate, satisfying quantitative accuracy. (2) The quantitative accuracy is perfect—percentages (89%) and years (2022, 2023) are correctly cited, with no calculation errors. (3) However, the qualitative reasoning differs slightly: the ground truth states that dependency 'slightly increased' and 'remained unchanged' in percentage terms, which appears contradictory but may reflect nuance in underlying data or phrasing. The LLM correctly interprets the flat 89% as 'no significant change,' which is factually supported by the numbers. Yet, it fails to acknowledge the ground truth's claim of a slight increase in dependency despite unchanged percentages—possibly due to other factors like total revenue growth or segment performance. This omission affects completeness and reasoning in the multi-hop synthesis. (4) Contextual relevance is full—the answer directly addresses the question about evolution of dependency over time. The correctness score is 7 because core facts are right, but the answer misses the nuanced interpretation present in the ground truth regarding dependency trends beyond the percentage figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 369,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "The company's Swiss Franc note, which had a value of $299 million at the end of 2023, was fully repaid by 2024 and no longer appears in the 2024 financial statements. This indicates that the company successfully settled its Swiss Franc currency obligation between 2023 and 2024, reducing its exposure to foreign currency debt during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $299 million Swiss Franc note obligation in 2023 and its complete removal by 2024, matching the ground truth. The statement that it 'no longer appears in the 2024 financial statements' aligns with the original answer's claim that the obligation was 'completely removed.' The interpretation about reduced foreign currency exposure is consistent and reasonable. (2) Quantitatively, the $299 million figure is accurate, years (2023 and 2024) are correct, and there are no calculations required beyond correct temporal comparison. Format ($299 million) matches ground truth. (3) The multi-hop reasoning is sound: the model correctly infers from the disappearance of the liability that it was likely repaid or settled, and draws a logical conclusion about foreign currency risk management. The only minor gap is that the original answer mentions 'repaid or restructured,' while the LLM assumes 'repaid'—a slight narrowing of possibilities, but repayment is a plausible and likely scenario. (4) All parts of the question are addressed: evolution of the Swiss Franc note (from $299M to zero) and its implication (reduced foreign currency exposure). The answer is semantically equivalent to the ground truth with only slight variation in wording and emphasis. Thus, the answer is highly accurate with only a minor deduction in qualitative accuracy for not acknowledging restructuring as an alternative to repayment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 404,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "Goldman Sachs introduced new Non-Employee Director RSU Award Agreements in the 2024 10-K, specifically the \"Form of Non-Employee Director RSU Award Agreement\" and the \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled),\" which were not present in the 2023 10-K. These agreements reflect modifications or additions to the treatment of non-employee director compensation, offering more structured and potentially diversified award mechanisms.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content. According to the ground truth, Goldman Sachs did not introduce new 'Form of Non-Employee Director RSU Award Agreement' or 'Cash-Settled' versions in the 2024 10-K. Instead, the 2024 filing retained the existing 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8 and added a new Exhibit 10.18 titled 'Amendments to Certain Non-Employee Director Equity Award Agreements', which was not present in 2023. The LLM incorrectly claims two new forms were introduced, which is not supported by the original data. This misrepresents the nature of the change — it was an amendment to existing agreements, not the introduction of new award structures. The reasoning is flawed as it fails to recognize the continuity of the pre-2015 agreement and misidentifies the new exhibit. While the general direction (evolution in treatment of RSU agreements) is relevant, the specific entities, exhibits, and nature of changes are wrong. No numerical data is present, so quantitative accuracy is neutral but not penalized. The answer lacks semantic equivalence with the ground truth due to significant factual inaccuracies in the description of the agreements and exhibits introduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 349,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "Between 2023 and 2024, PMI's long-term debt obligations related to the acquisition of Swedish Match AB significantly decreased. In 2023, the Euro credit facility borrowings tied to the acquisition were €6,121 million, but by 2024, this amount was reduced to €2,610 million. This reduction was primarily due to PMI prepaying approximately €3 billion (about $3.2 billion) under the 3-year tranche of the senior unsecured term loan facility on November 21, 2024. As of December 31, 2024, only the 5-year tranche of €2.5 billion (approximately $2.6 billion) remained outstanding.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the direction and magnitude of the debt reduction from 2023 to 2024, aligning with the ground truth's core claim of a significant decrease in long-term debt obligations. However, there are critical quantitative discrepancies. The original answer reports debt in USD ($6,121 million and $2,610 million), while the LLM answer uses EUR (€6,121 million and €2,610 million), which is factually incorrect unless conversion is properly addressed. The knowledge graph ground truth specifies USD, so reporting in EUR without conversion or clarification is a material error. Additionally, the LLM introduces a prepayment of €3 billion on November 21, 2024, and references a 5-year tranche of €2.5 billion, details not present in the original answer and potentially speculative or sourced from outside the provided truth. (2) The numbers themselves (6,121 and 2,610) match in magnitude but are misrepresented in currency. The $3.2 billion and $2.6 billion conversions from euros are approximate but not directly relevant since the original data is in USD. The calculation of the reduction (~$3.5 billion) is consistent with the ground truth difference of $3,511 million, but the attribution to a specific prepayment event and date is not supported in the original answer. (3) The multi-hop reasoning is sound in interpreting a decrease in debt as evidence of repayment and reduced financial exposure, which is logically valid and consistent with the original conclusion. However, the addition of specific tranches and prepayment timing goes beyond the provided information, suggesting over-inference or external data use. (4) The contextual relevance is high, as the answer directly addresses the evolution of PM's debt obligations tied to the Swedish Match acquisition. The qualitative reasoning is strong, but the quantitative inaccuracies—especially the currency mismatch—reduce confidence in factual correctness. Thus, while the overall trend and interpretation are correct, the specific financial figures are not accurately represented, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 569,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "BMY's strategic positioning around KRAS inhibition evolved significantly from 2023 to 2024, primarily through the acquisition of Mirati in January 2024. This acquisition provided BMY with commercial rights to Krazati, a KRAS inhibitor approved for second-line NSCLC and in development for first-line NSCLC in combination with a PD-1 inhibitor, as well as for KRAS-mutated colorectal cancer. Additionally, BMY gained access to Mirati’s clinical assets, including MRTX1719, a potential first-in-class PRMT5 inhibitor in Phase I development. This move solidified BMY’s position in KRAS inhibition by expanding its portfolio of targeted oncology therapies and enhancing its ability to address multiple indications with innovative mechanisms of action.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of BMY's strategic positioning around KRAS inhibition from 2023 to 2024. It correctly identifies the acquisition of Mirati in January 2024 (specific timing not in ground truth but not contradicted), which gave BMY full rights to Krazati, a KRAS G12C inhibitor. The answer accurately notes Krazati’s FDA approval in second-line NSCLC and its development in first-line NSCLC with a PD-1 inhibitor, as well as its expansion into KRAS-mutated colorectal cancer—though it omits the detail that this approval was specifically in combination with cetuximab, a minor omission. The mention of MRTX1719, a PRMT5 inhibitor, is factually correct and adds value by highlighting additional assets from Mirati, even though it's not directly KRAS-related. The $4.8 billion acquisition cost is missing from the LLM answer, which is a quantitative gap, hence the deduction in quantitative accuracy. However, no incorrect numbers are stated—only one omitted. The reasoning is sound, with correct multi-hop synthesis between BMY’s pre-acquisition position, the Mirati deal, and the resulting enhancement in KRAS-focused oncology. The answer is contextually fully relevant and conveys semantic equivalence to the ground truth with only minor completeness gaps. Thus, the correctness score is 9 due to the omission of the acquisition price and the cetuximab combination detail, but all other facts are accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 404,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan between 2023 and 2024 remained largely consistent, with the plan being referenced in both years as part of the company's historical compensation structures. However, in 2024, the firm emphasized the introduction of the Amended and Restated The Goldman Sachs Group, Inc. Clawback Policy, effective December 1, 2023, which may have influenced the broader governance framework for compensation. While no major changes were explicitly detailed for the Restricted Partner Compensation Plan itself, the updated clawback policy suggests a heightened focus on accountability and alignment with newer governance standards during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in substance but misses a key detail regarding the exhibit numbering and positioning shift of the Restricted Partner Compensation Plan, which is central to the question. Quantitatively, the answer correctly references the December 1, 2023 effective date of the Clawback Policy (Exhibit 10.1 in 2024), aligning with ground truth. The entity names (Goldman Sachs, Restricted Partner Compensation Plan, Clawback Policy) and years (2023–2024) are accurate. However, the LLM incorrectly states the plan was 'referenced in both years' without noting the exhibit number change (10.3 in 2023 → 10.4 in 2024) and the significant repositioning later in the exhibit list, which the original answer highlights as a strategic disclosure shift. While the LLM captures the broader governance trend with the clawback policy, it fails to synthesize the multi-hop insight that the plan's diminished prominence in disclosure order reflects a strategic repositioning alongside newer governance policies. This omission reduces qualitative accuracy. The reasoning is sound on the clawback policy’s implications but incomplete on the plan’s evolving disclosure treatment. Wording is semantically close and contextually relevant, hence high scores in contextual relevance and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 362,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) significantly advanced its approach to heat-not-burn (HTU) products by integrating them more prominently into its business strategy and product categorization. In 2023, HTU shipment volumes increased by 14.7%, reflecting strong growth across all regions, and HTUs were explicitly categorized under smoke-free products in financial reporting. Additionally, PMI expanded its smoke-free portfolio through the acquisition of Swedish Match, which contributed to a 100% increase in oral product shipments, further emphasizing the company's shift toward diversified, reduced-risk product offerings. This integration highlights PMI's strategic focus on transitioning from combustible products to smoke-free alternatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces information not present in the ground truth. While it correctly identifies the shift in categorization of heat-not-burn products under 'smoke-free products' in 2023, it fabricates key quantitative data: the 14.7% HTU shipment growth and 100% increase in oral product shipments due to Swedish Match acquisition are not mentioned in the original answer and cannot be verified from the provided ground truth. These specific numbers and the emphasis on Swedish Match are unsupported, making the quantitative claims incorrect. (2) The original answer highlights that in 2023, PMI began including licensed KT&G heat-not-burn products as part of its portfolio, indicating broader integration through licensing—not acquisition of Swedish Match, which primarily relates to oral nicotine products but is overstated here as central to HTU strategy. The LLM incorrectly positions the Swedish Match acquisition as a driver of HTU integration, conflating oral products with heat-not-burn products. (3) The multi-hop reasoning is partially sound—PMI did shift toward smoke-free products—but the synthesis is flawed by introducing unrelated or unverified data points and misattributing strategic developments. The core evolution in product categorization (from RRPs to smoke-free) is correctly identified, showing some qualitative understanding. (4) The contextual relevance is high because the answer addresses the evolution in categorization and business integration, but correctness is significantly undermined by fabricated metrics and misaligned examples. Thus, the correctness score is moderate due to partial factual alignment but major quantitative and entity-level inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 475,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "Between 2023 and 2024, Bristol-Myers Squibb maintained its compliance with the SEC Consent Order by continuing to strengthen its business risk governance framework, particularly through the role of the business risk and disclosure group. The group remained integral to ensuring adherence to the Consent by overseeing procedures to monitor and limit sales to direct customers based on expected demand, as well as by providing oversight in financial reporting and disclosures. The company also continued to rely on data from distributor agreements and external sources to estimate inventory levels and ensure transparency in its sales practices, reinforcing its commitment to compliance with the Consent Order.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no numeric values, dates, or calculations, so quantitative accuracy is not applicable—scored 10 by default as no incorrect numbers were introduced. However, the answer misses key factual developments from the ground truth: in 2023, the business risk and disclosure group was newly established specifically to comply with the SEC Consent Order, involving a formal review process, hiring an outside consultant, and implementing a governance mechanism for escalation. The LLM incorrectly implies continuity and strengthening of an existing framework rather than reporting the creation of the group in 2023. (2) The LLM introduces details not present in the ground truth—such as monitoring sales to direct customers based on demand and using distributor data to estimate inventory—which are unrelated to the actual role of the business risk and disclosure group as described in the original answer. These additions reflect a misalignment with the documented compliance activities. (3) The multi-hop reasoning is flawed: the question asks for evolution between 2023 and 2024, requiring synthesis of the group’s creation in 2023 and its sustained role in 2024. The LLM fails to mention the group’s formation in 2023 and instead suggests ongoing enhancements without noting the foundational changes. It also does not confirm the integration into ongoing compliance or lack of scope reduction, which is central to the 2024 status. (4) While the LLM correctly identifies the group’s continued importance and general role in financial reporting and disclosures, it omits the key establishment event in 2023 and adds unverified operational details, leading to a partial but materially incomplete and somewhat misleading response. Hence, correctness and qualitative accuracy are moderate, contextual relevance is fair due to focus on compliance theme, and quantitative accuracy is unaffected by absence of numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 524,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "Between 2023 and 2024, UNP maintained a consistent expected long-term rate of return of 5.25% on pension plan assets, aligned with its asset allocation strategy of 20% to 30% in equity securities and 70% to 80% in debt securities. The treatment of the relationship between the expected return and asset allocation mix remained stable, with no changes to the target allocation ranges or the expected return assumption. The portfolio continued to be rebalanced quarterly to maintain diversification and achieve the long-term return objective.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that in 2023, UNP reported an actual return of 6% and based expected returns on asset allocation, historical returns, and market conditions. In 2024, the language changed to say expected return 'depends on' asset allocation mix only, with no mention of historical returns or market conditions and no disclosure of actual return. The LLM instead claims UNP maintained a consistent expected return of 5.25% and stable asset allocation strategy, which contradicts the ground truth. There is no mention in the ground truth of a 5.25% expected return or specific equity/debt ranges (20%-30%/70%-80%), nor any discussion of quarterly rebalancing—these details are fabricated or misattributed. (2) Quantitatively, the 6% actual return in 2023 is ignored, and the 5.25% figure is unsupported. The asset allocation percentages are not mentioned in the ground truth, making them factually inaccurate. (3) The multi-hop reasoning fails completely: the question asks about evolution in *treatment of the relationship* between expected return and asset allocation—i.e., qualitative disclosure changes—not stability of assumptions or portfolio management practices. The LLM misinterprets the question as being about numerical consistency rather than narrative/disclosure evolution. (4) The answer is contextually relevant in topic (pension plan, asset allocation, expected return) but fails on correctness and qualitative accuracy due to invented data and mischaracterization of the evolution. Hence, low scores across correctness and accuracy dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 453,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon enhanced the accessibility and integration of its Directors' Code of Conduct by explicitly listing it among the corporate governance materials available on its website, as noted in the 2023 filing. In the 2022 filing, the Directors' Code of Conduct was mentioned in the context of general corporate governance disclosures but was not specifically highlighted as publicly accessible. In contrast, the 2023 filing directly provided URLs to access both the Directors' Code of Conduct and the Code of Conduct for employees, indicating a more transparent and integrated approach within its corporate governance reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies the evolution in BNY Mellon's disclosure approach between 2022 and 2023: in 2022, the Directors' Code of Conduct was mentioned within broader governance disclosures but not explicitly highlighted as accessible; in 2023, it was specifically listed among governance materials available online, indicating improved accessibility and integration. The LLM correctly captures the enhanced transparency and structured presentation in 2023, including the mention of URLs for both the Directors' Code and the employee Code of Conduct. While the original answer emphasizes the 'centralized approach' and 'integration with Corporate Governance Guidelines and committee charters,' the LLM answer omits this specific contextual linkage but still conveys the core progression in disclosure practice. There are no numerical or date inaccuracies (quantitative accuracy is perfect), and all entities (BNY Mellon, Directors' Code of Conduct, years 2022 and 2023) are correct. The reasoning is sound and reflects proper multi-hop synthesis across the two years’ disclosures. The slight deduction in qualitative accuracy is due to the absence of explicit mention of the co-listing with other key governance documents (e.g., charters, guidelines), which strengthens the integration narrative. Overall, the answer is semantically equivalent and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 397,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with engineered systems. The company has expanded deployment options to include on-premise, cloud (OCI), and hybrid models such as Oracle Exadata Cloud@Customer and OCI Dedicated Region, enabling customers to run Oracle Database in diverse IT environments. This evolution reflects Oracle's commitment to supporting cloud migration and hybrid IT environments by offering seamless integration with Oracle Engineered Systems and OCI services, allowing customers to optimize performance, scalability, and security while maintaining flexibility in their cloud strategies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately captures Oracle's strategic emphasis on deployment flexibility (on-premise, OCI, hybrid) and integration with engineered systems between 2023 and 2024. Key offerings like Oracle Exadata Cloud@Customer are correctly mentioned, and the general evolution toward integrated systems is acknowledged. (2) There are no numeric values, dates, or financial figures in the response, so quantitative accuracy is not applicable—no errors in this regard. (3) The multi-hop reasoning is sound: the answer synthesizes Oracle's deployment models and engineered systems to infer a strategic focus on hybrid IT and cloud migration. However, it misses the specific 2024 shift toward deeper integration with Oracle Exadata Database Machine as a unified engineered system, and does not mention Oracle Roving Edge Infrastructure or OCI Dedicated Region (though the latter is partially covered). The answer generalizes the evolution without highlighting the strategic maturation from flexible deployment to performance-optimized, holistic infrastructure packages as clearly as the ground truth. (4) Despite these minor omissions, the answer remains contextually accurate and relevant, correctly identifying Oracle's broader strategic direction. Wording differences are acceptable under semantic equivalence, but the absence of specific engineered system integration details in 2024 prevents a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 415,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "Between 2023 and 2024, the formal review and certification process of annual and quarterly SEC reports has evolved by reinforcing compliance monitoring and governance procedures. Specifically, the company has established a business risk and disclosure group, retained an outside consultant to re-engineer financial reporting processes, and ensured that its budget process incorporates bottom-up inputs with thorough documentation. These measures reflect a heightened focus on transparency and internal controls to ensure adherence to SEC requirements and prevent prior issues related to accounting and sales practices.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. While it mentions a formal review and certification process evolving between 2023 and 2024, it introduces entities and initiatives not present in the ground truth—such as a 'business risk and disclosure group,' an 'outside consultant to re-engineer financial reporting processes,' and 'bottom-up inputs in the budget process'—which are not mentioned in the original answer and cannot be verified from the provided knowledge. These details appear fabricated or hallucinated. (2) There are no numeric values, dates, or calculations in either the original or LLM answer, so quantitative accuracy is not applicable; however, the absence of incorrect numbers allows a score of 10 by default. (3) The multi-hop reasoning is flawed: the original answer emphasizes the evolution from initial implementation in 2023 (under a Consent agreement) to integration into broader operational policies (e.g., sales and inventory) in 2024. The LLM fails to mention the Consent agreement, compliance escalation procedures, or integration into sales policies—key elements of the actual evolution. Instead, it invents new governance structures without grounding in the source. (4) Contextual relevance is moderate because the answer addresses the general topic of SEC report review processes and governance evolution, but it fails to reflect the actual progression described in the ground truth, making it misleading despite being on-topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 413,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) significantly advanced its market positioning and product categorization for heat-not-burn (HNB) products. In 2023, PMI reported a 14.7% increase in heated tobacco unit (HTU) shipment volume compared to 2022, driven by strong growth across all regions, particularly in Europe and Japan. This growth reflects PMI's strategic focus on expanding its smoke-free product portfolio as part of its transition away from combustible tobacco. Additionally, PMI categorized its HNB products under \"smoke-free products,\" which saw a significant revenue increase from $10.2 billion in 2022 to $12.8 billion in 2023, emphasizing their role in PMI's broader reduced-risk product (RRP) strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer includes several specific quantitative claims—such as a 14.7% increase in heated tobacco unit (HTU) shipment volume and smoke-free product revenue rising from $10.2 billion in 2022 to $12.8 billion in 2023—that are not present in the original ground truth answer and cannot be verified from the provided knowledge graph. Since the ground truth does not mention any numerical data, these figures appear to be hallucinated or sourced from external data not in the reference, making them factually unsupported in this evaluation context. This significantly undermines quantitative accuracy. On qualitative aspects, the LLM correctly identifies the strategic shift of categorizing heat-not-burn (HNB) products under 'smoke-free products' in 2023 and acknowledges PMI's broader transition from combustible tobacco, which aligns with the ground truth's description of refined product categorization. However, it omits key details such as the inclusion of licensed KT&G products in 2023 and the evolution from internal development focus to a more integrated, commercialized approach. It also fails to mention Platform 1 or the progression through development, assessment, and commercialization stages in 2022. While the reasoning reflects a plausible interpretation of strategic evolution, it lacks full multi-hop synthesis present in the original answer—particularly the shift in portfolio structure and partnership expansion. The answer is contextually relevant and addresses market positioning and categorization, but with partial factual inaccuracies and omissions. Thus, the correctness score is moderate due to unsupported numbers and incomplete alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 459,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with other Oracle technologies. In 2024, Oracle has expanded deployment options to include on-premise, cloud-based, hybrid, and multicloud environments, with offerings such as Oracle Exadata Cloud@Customer, OCI Dedicated Region, and Oracle Roving Edge Infrastructure. These options allow customers to run Oracle Database in their own data centers, in Oracle Cloud, or at the edge of networks. Additionally, Oracle Database is more tightly integrated with Oracle Cloud Infrastructure (OCI), Oracle Autonomous Database, and Oracle Middleware, enabling seamless data management, real-time analytics, and application development across diverse IT environments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's strategic emphasis on deployment flexibility and integration with Oracle technologies between 2023 and 2024. It accurately notes expanded deployment models including on-premise, cloud, hybrid, and edge (via Oracle Roving Edge), which aligns with the direction indicated in the ground truth. However, it omits the specific 2023 focus on perpetual licensing and customer choice, which is a key part of the evolution. Instead of contrasting 2023's standalone flexibility with 2024's integration into engineered systems, the LLM presents 2024 enhancements without clearly differentiating the shift from 2023. The mention of Oracle Exadata Cloud@Customer and OCI Dedicated Region is consistent with Oracle's engineered systems strategy but does not explicitly link Oracle Database's evolving role as a 'foundational component' of Oracle Exadata Database Machine as stated in the ground truth. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—scored 10 by default for absence of errors. (3) The multi-hop reasoning is partially sound: the LLM synthesizes deployment models and integration points correctly but fails to fully capture the strategic evolution from standalone product (2023) to integrated engineered system component (2024). This weakens the qualitative accuracy. (4) Contextual relevance is high because the answer addresses deployment flexibility and integration thoroughly, even if the comparative evolution across years is underdeveloped. Correctness score is 7 due to accurate core facts but missing key strategic nuance in the year-over-year shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 462,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "BMY's strategic relationship with Krazati evolved significantly in 2024 through the acquisition of Mirati, which granted BMY the rights to commercialize Krazati (a KRAS inhibitor) for lung cancer and further develop related assets. In 2024, BMY made a major financial commitment by acquiring Mirati in an all-cash transaction valued at $4.8 billion, or $4.1 billion net of cash acquired, along with contingent value rights potentially worth up to $1.0 billion tied to future regulatory milestones. This acquisition reflects BMY's strategic focus on expanding its oncology portfolio and enhancing its position in targeted therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY acquired Mirati in 2024 for $4.8 billion (stated as $4.1 billion net of cash acquired, which is consistent with public filings), and committed up to $1.0 billion in contingent value rights (CVRs) tied to regulatory milestones, specifically for the PRMT5 inhibitor development. The mention of Krazati as a KRAS inhibitor approved for second-line NSCLC and in development for first-line is implied through context, though slightly less explicit than the original. (2) Quantitative accuracy is perfect: $4.8 billion total value and $1.0 billion CVR are correctly reported; the net $4.1 billion reflects standard adjustment for cash acquired and does not contradict the original. (3) Multi-hop reasoning is sound—correctly linking BMY’s 2023 strategic interest in Krazati to the 2024 acquisition of Mirati, and interpreting the financial commitments as signals of strategic evolution. (4) The only minor shortcoming is that the LLM does not explicitly state that Krazati received FDA and EMA approvals in 2024 or that the CVR is specifically tied to the PRMT5 inhibitor (it says 'future regulatory milestones,' which is accurate but less specific). However, this does not detract significantly from the overall correctness. The answer is contextually excellent, directly addressing both the evolution of the relationship and the financial commitments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 401,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "Based on the provided SEC filings, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV, traded under the symbol BK/P and fully guaranteed by The Bank of New York Mellon Corporation, remained registered and listed on the New York Stock Exchange in both 2022 and 2023. There is no indication of material changes in their status or treatment during this period, as they are consistently referenced in the filings as outstanding securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) All key facts are accurate: the securities are 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV, traded under BK/P, guaranteed by The Bank of New York Mellon Corporation, and listed on the NYSE in both 2022 and 2023. There is no change in status, which matches the original answer. (2) Quantitative accuracy is perfect: the percentage (6.244%), trading symbol (BK/P), and years (2022–2023) are correctly stated. No calculations are required, but all numeric and symbolic references are precise. (3) The multi-hop reasoning is sound—information about registration under Section 12(b), listing status, and guarantee structure is correctly synthesized across years, even though the LLM answer does not explicitly mention Section 12(b). This is a minor omission but does not affect the correctness of the conclusion about unchanged status. (4) The answer is contextually relevant and directly addresses the evolution (or lack thereof) between 2022 and 2023. The phrasing 'no indication of material changes' and 'consistently referenced' effectively communicates the stability in treatment and status. The only reason for not scoring a 10 is the omission of the specific regulatory detail (Section 12(b)), which is present in the ground truth and adds completeness, though it does not undermine the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 399,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "From 2022 to 2023, PMI's short-term credit arrangements increased from approximately $1.9 billion to $2.7 billion, indicating an expansion in available liquidity. Additionally, borrowings under these arrangements remained relatively stable, decreasing slightly from $295 million in 2022 to $283 million in 2023. This suggests that PMI has maintained a strong near-term liquidity posture by increasing its credit availability while prudently managing its actual borrowing levels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: the increase in short-term credit capacity from $1.9 billion to $2.7 billion and the slight decrease in utilization from $295 million to $283 million. These figures match the ground truth exactly, with acceptable rounding ('approximately' used for $1.9B is reasonable). (2) Quantitative accuracy is perfect—no calculation errors, and all dollar amounts and years are correct. The comparison across 2022 and 2023 is accurate. (3) The reasoning is sound: the model correctly infers that increased capacity with stable/declining utilization reflects a strong and prudent liquidity posture, which aligns with the ground truth's conclusion about conservative financing and working capital management. The term 'prudently managing' is slightly less specific than 'more conservative approach to short-term financing and working capital management,' but the semantic meaning is equivalent. (4) The answer is fully relevant, addressing both the quantitative changes and their implication for PMI's near-term liquidity. The only minor gap is a slightly less explicit mention of 'working capital management,' but the core insight is preserved. Thus, the answer is factually complete and logically sound, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 359,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "Between 2023 and 2024, Oracle has enhanced the positioning of its Autonomous Database by emphasizing deeper integration with other Oracle Cloud services and expanding automation capabilities. In 2024, the Autonomous Database is highlighted as a self-driving platform that integrates with services like Java Cloud and Oracle APEX, enabling developers to build cloud-native applications on a modern, open platform. Additionally, automation features have been expanded to include policy- and machine learning-driven optimization, automatic threat detection and remediation, and on-demand scaling with consumption-based pricing. These improvements aim to reduce labor costs, human error, and administrative overhead while enabling organizations to deploy data marts, data warehouses, and data lake houses more efficiently.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Oracle's 2024 positioning emphasizes deeper integration with Java Cloud and Oracle APEX, which is explicitly mentioned in both the original and LLM answers. Automation capabilities powered by machine learning, including threat detection, diagnostics, and optimization, are correctly highlighted. The focus on cloud-native development, data lake houses, and reduced administrative overhead is consistent with the 2024 evolution. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2023 and 2024), which are accurate. (3) The multi-hop reasoning is sound—LLM correctly synthesizes changes in positioning over time, comparing 2023's focus on automation and hybrid deployment with 2024's expanded integration and machine learning-driven features. The LLM infers the strategic intent (reducing labor costs, enabling efficient data deployment) from the enhanced capabilities, which is logically supported. (4) The only minor omission is that the LLM does not explicitly mention 'open interfaces' or 'native machine learning capabilities' as standalone features, though these are partially covered under 'machine learning-driven optimization' and 'open platform.' Also, 'real-time analysis of transactional data' from the original is implied in 'data marts, data warehouses, and data lake houses' but not explicitly stated. These are minor gaps that prevent a perfect 10 on qualitative accuracy. Overall, the answer is contextually excellent, factually correct, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 467,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "Between 2023 and 2024, GM's financial relationship with Ultium Cells Holdings LLC remained consistent in terms of capital involvement, with committed capital contributions of $0.8 billion at December 31, 2023, and $1.4 billion at December 31, 2022. In 2024, GM continued its strategic positioning by maintaining its investment in Ultium Cells Holdings LLC, as evidenced by a $0.7 billion investment in 2024, aligning with its long-term strategy in battery cell production and electrification. However, GM did not consolidate Ultium Cells Holdings LLC, as it lacked the power to direct the activities that most significantly affect its economic performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that GM had a $0.8 billion commitment at December 31, 2023, and a $1.4 billion commitment at December 31, 2022 — the latter date and amount are irrelevant to the question and not supported by the ground truth. The ground truth indicates a shift from a $0.8 billion *contingent* commitment in 2023 to a $0.7 billion *realized* investment in 2024. The LLM misrepresents this evolution as consistent capital involvement, which contradicts the actual transformation from contingent liability to direct investment. (2) Quantitative accuracy is poor: the $1.4 billion figure for 2022 is incorrect and distracts from the 2023–2024 comparison; no such figure appears in the ground truth. The $0.7 billion investment in 2024 is correctly mentioned, but it is framed as a continuation rather than a strategic shift. (3) The multi-hop reasoning is flawed: the model fails to recognize the qualitative change from a VIE with no voting control and contingent commitment (2023) to a direct investment (2024), which is central to the question. It incorrectly concludes that the relationship 'remained consistent,' directly contradicting the ground truth's emphasis on strategic evolution. (4) Contextual relevance is moderate — the answer discusses GM and Ultium Cells in the correct timeframe and touches on strategic positioning, but the core message is factually incorrect. Due to major errors in numbers, timeline, and interpretation of strategic shift, the correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 431,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "Between 2022 and 2024, the financial impact of the Litigation Management Deed evolved as follows: \n\n- In 2022, during the sixth anniversary release, Visa released $3.5 billion of as-converted value from its Series B and C preferred stock and issued 176,655 shares of Series A preferred stock. \n- In 2024, during the eighth anniversary release, Visa released $2.7 billion of as-converted value from its Series B and C preferred stock and issued 99,264 shares of Series A preferred stock. \n\nThus, the amount of as-converted value released decreased from $3.5 billion in 2022 to $2.7 billion in 2024, and the number of Series A preferred shares issued also decreased from 176,655 in 2022 to 99,264 in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: $3.5 billion and 176,655 shares in 2022, and $2.7 billion and 99,264 shares in 2024. These match the ground truth exactly in value, share count, and year. (2) Quantitative accuracy is perfect—dollar amounts and share numbers are correct, and the directional decrease is accurately described. (3) The only minor discrepancy is that the LLM mentions 'Series B and C preferred stock' as the source of as-converted value, which is not mentioned in the original answer. While this detail may be contextually accurate based on external knowledge, it was not present in the ground truth and introduces unverified information, slightly affecting qualitative accuracy. However, it does not contradict the truth and may reflect deeper context. (4) The reasoning is sound: the model correctly identifies the two anniversary events, associates them with the correct years (sixth in 2022, eighth in 2024), and draws the correct conclusion about decreasing financial impact. The answer is fully relevant, addressing both parts of the question—value released and shares issued—over the specified time frame. The minor addition of Series B and C does not detract from overall correctness but prevents a perfect 10 due to introduction of unconfirmed detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 365,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "Between 2023 and 2024, the financial and strategic relationship between 3M and the Aearo Entities evolved significantly, particularly in terms of litigation impact and business segment adjustments. In 2023, 3M reconsolidated the Aearo Entities after the dismissal of their bankruptcy filing, which led to the CAE Settlement to resolve Combat Arms Earplugs litigation, resulting in a $4.2 billion pre-tax charge. This settlement shifted litigation costs from the Safety and Industrial segment to Corporate and Unallocated, impacting financial reporting. By 2024, the Aearo Entities remained consolidated, and the litigation-related costs were largely resolved, contributing to a decrease in corporate special item net costs year-over-year. Additionally, the reconsolidation and settlement influenced business segment adjustments, particularly in how litigation expenses were allocated and managed across segments.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding financial figures and segment impacts. The ground truth states that the reconsolidation had an immaterial income statement impact, but the LLM claims a $4.2 billion pre-tax charge, which is not supported by the original answer and introduces a major quantitative error. There is no mention of this specific dollar amount in the ground truth, making this a critical factual deviation. (2) Quantitative accuracy is low because the $4.2 billion figure is entirely fabricated in context; no numerical values were present in the original answer to support such a charge. Additionally, the claim about shifting litigation costs to Corporate and Unallocated and the year-over-year decrease in corporate special item net costs in 2024 are not mentioned or implied in the ground truth. (3) Qualitatively, the LLM correctly identifies the reconsolidation in 2023 following dismissal of bankruptcy and the resolution of litigation via the CAE Settlement. It also correctly notes ongoing consolidation into 2024 and connects the Aearo Entities to financial reporting adjustments. However, it misrepresents the nature of the financial impact and fails to mention the key point from the ground truth: that in 2024, the Aearo Entities were referenced specifically in the context of divestiture and acquisition effects in the Transportation and Electronics segment due to prior deconsolidation and reconsolidation. This is a crucial multi-hop element missing from the LLM response. (4) Contextual relevance is high because the answer addresses litigation impact and business segment adjustments as asked, and maintains focus on the evolution between 2023 and 2024. However, due to the introduction of unsupported financial data and omission of the strategic financial treatment in 2024 related to segment reporting, the overall correctness score is moderate at 5—partially correct but with significant errors in key facts and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 542,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "Between 2022 and 2024, the financial treatment and structure of Class C Common Stock evolved primarily through changes in its relationship with other stock classes and its earnings per share (EPS) performance. In 2022, Class C Common Stock had a basic EPS of $28.03 and a diluted EPS of $28.00, with only 10 million weighted-average shares outstanding. By 2024, the basic EPS for Class C Common Stock increased to $38.97, and the diluted EPS rose to $38.92, with 16 million weighted-average shares outstanding. This increase in EPS reflects a higher earnings allocation to Class C shares, despite a relatively modest increase in share count, indicating improved performance relative to other classes like Class A and B-1. Additionally, Class C Common Stock remained free of transfer restrictions, distinguishing it from other classes like Class B-1 and B-2, which were subject to conversion and exchange mechanisms tied to litigation resolutions and conversion rate adjustments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Class C Common Stock was discussed in terms of voting rights and influence on corporate actions, with no mention of EPS figures. However, the LLM incorrectly assigns EPS values of $28.03 (basic) and $28.00 (diluted) to Class C in 2022, which contradicts the original answer. Similarly, for 2024, the LLM reports Class C EPS as $38.97 (basic) and $38.92 (diluted), but the ground truth states $33.17 (basic) and $33.13 (diluted). These numbers are materially off, indicating major quantitative errors. Additionally, the LLM introduces 'Class B-1' and 'Class B-2' with details about transfer restrictions and litigation-related conversion mechanisms—information not present in the original answer and irrelevant to the question. The original answer makes no mention of share counts (10M or 16M), so those are fabricated. (2) All numeric values provided by the LLM are incorrect. There is no support in the ground truth for any of the EPS figures or share counts cited. The correct 2024 EPS for Class C is $33.17 (basic), not $38.97, and for Class A it is $8.29 (basic), which the LLM fails to mention at all. The comparison between classes is therefore based on false data. (3) The multi-hop reasoning is flawed. The LLM invents financial data and structural details not present in the source, failing to correctly synthesize the evolution from governance focus in 2022 to financial performance in 2024. It misses the key point that while governance role remained unchanged, financial performance (EPS) diverged significantly in favor of Class C. Instead, it fabricates a narrative around share count and transfer restrictions. (4) The contextual relevance is moderate because the LLM attempts to address the evolution of Class C stock in terms of EPS and relationship to other classes, which aligns with the question. However, due to severe factual and quantitative inaccuracies, the qualitative reasoning is undermined. Correctness and quantitative accuracy are very low due to invented numbers and entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 569,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "Qualcomm's involvement in ADAS/AD technology evolved significantly from fiscal 2022 to 2024. In fiscal 2022, ADAS/AD development was primarily driven through research and development investments and strategic acquisitions, such as the $4.7 billion acquisition of Veoneer’s Arriver business, which bolstered Qualcomm’s autonomous driving capabilities. By fiscal 2024, ADAS/AD became a more prominent revenue stream under the QCT segment, with $2.91 billion in automotive revenues, including connectivity, digital cockpit, and ADAS/AD products, reflecting increased commercialization and integration of these technologies into the automotive industry.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Qualcomm's ADAS/AD involvement from development in 2022 to commercialization in 2024, aligning with the ground truth. It appropriately references strategic investments and the Veoneer Arriver acquisition ($4.7 billion), which is factually accurate and relevant to the development phase. However, the LLM introduces a specific revenue figure of $2.91 billion in automotive revenues under QCT in fiscal 2024, which is not present in the original answer and cannot be verified from the provided ground truth. While automotive revenues did include ADAS/AD by 2024, the exact dollar amount and its attribution to QCT (rather than the broader automotive segment) are not confirmed in the ground truth, making this a significant quantitative overreach. (2) The $4.7 billion acquisition amount is correct and well-placed. However, the $2.91 billion revenue figure lacks corroboration in the original answer and risks misrepresenting the data. The ground truth only confirms that ADAS/AD was included in automotive revenue streams by 2024, not the total amount or segment classification. (3) The multi-hop reasoning is sound: the model connects early-stage development (via acquisition and R&D) in 2022 to commercialization in 2024, correctly inferring a strategic shift. It synthesizes the idea that inclusion in revenue categorization indicates commercialization, which matches the ground truth logic. (4) The correctness score is 7 because the core narrative and qualitative evolution are accurate, but the unsupported revenue number reduces confidence in quantitative precision. Qualitative accuracy is high due to correct entity identification (Qualcomm, Veoneer Arriver, ADAS/AD, fiscal years) and logical progression. Contextual relevance is strong as all information directly addresses the question’s focus on strategic and revenue evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 515,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's U.S. Retrospective Responsibility Plan evolved by increasing the U.S. litigation escrow account balance from $1.4 billion to $3.089 billion, with deposits rising from $850 million in 2022 to $1.5 billion in 2024. The plan's mechanisms, including the escrow account, conversion features of class B common stock, and indemnification obligations, remained consistent in structure but were expanded in scale to address growing litigation liabilities. This evolution suggests a proactive approach to managing litigation risk by maintaining robust financial safeguards and ensuring sufficient liquidity to cover potential settlements or judgments, reflecting a strategic emphasis on risk mitigation and financial preparedness.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth does not mention specific dollar amounts such as a $1.4 billion escrow balance in 2022 or $3.089 billion in 2024, nor does it state that deposits increased from $850 million to $1.5 billion. These figures are fabricated or incorrectly sourced, severely undermining the answer's factual basis. (2) There is no verification of these numbers in the original answer, which focuses on structural evolution rather than financial scale. The original answer emphasizes the addition of new mechanisms (e.g., conversion features, makewhole agreements, interchange judgment sharing, loss sharing, omnibus agreement), but the LLM incorrectly frames the evolution as primarily quantitative (i.e., increased funding) rather than qualitative (i.e., structural complexity). (3) The reasoning is partially sound in identifying that the plan evolved to address litigation risk more proactively, but it fails the multi-hop synthesis by not recognizing the shift from a simpler escrow-based mechanism to a comprehensive network of interrelated legal and financial agreements. The LLM mentions some correct elements (conversion features, indemnification) but misrepresents their role as unchanged in structure rather than newly integrated into a broader framework. (4) While the answer is contextually relevant and addresses the question's intent regarding risk management, the severe quantitative inaccuracies and incomplete qualitative analysis limit its correctness. The core insight about a more proactive approach is aligned with the original answer, but the lack of structural detail and invented numbers result in a partially correct but misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 482,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck's financial stake in Lynparza, as part of its collaboration with AstraZeneca, grew in 2024, with alliance revenue increasing by 9% compared to 2023, driven by higher demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for adjuvant treatment for germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating increased strategic importance and potential for expanded market reach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% growth in alliance revenue in 2024 compared to 2023, which matches the ground truth. It also accurately reports the January 2025 China approval for Lynparza in adjuvant treatment of early breast cancer, including the correct indication (germline BRCA-mutated, HER2-negative high-risk early breast cancer) and reference to the OlympiA trial, which adds specificity and accuracy. However, the LLM omits the explicit $1.5 billion net intangible asset reported by Merck in 2023, which is a key part of the financial stake evolution. While the revenue growth implies continued strategic importance, the absence of the initial asset value reduces completeness in tracing the full evolution of the financial stake. (2) All numbers and dates are correct: 9% revenue growth and January 2025 approval are accurately stated. No calculations are required, and the percentage is correctly attributed. (3) The multi-hop reasoning is sound—linking revenue growth and regulatory approval to increased strategic importance is logically supported by the ground truth. The synthesis between financial performance (revenue increase) and regulatory milestone (China approval) correctly infers growing strategic value. The only gap is the missing reference to the 2023 asset value, which weakens the full 'evolution' narrative slightly. (4) Despite the omission, the answer remains highly accurate, relevant, and semantically aligned with the core developments in 2024 and beyond. The strategic importance is well-supported, and all presented facts are correct. Hence, a score of 9 is justified—excellent but not fully complete on the financial stake's starting point in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 467,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "Between 2022 and 2024, Skoal's market position within Altria's oral tobacco products segment declined. Shipment volume for Skoal decreased from 163.1 million units in 2023 to 147.0 million units in 2024, and its retail share dropped from 9.3% to 7.6%. This decline was driven by retail share losses and competition from oral nicotine pouches, particularly the on! brand, which saw growth in market share despite a slight decline in its own share of the nicotine pouch category. Skoal faced challenges from shifting consumer preferences toward newer product formats like nicotine pouches, which contributed to the overall transformation of the oral tobacco market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Skoal's declining market position, with accurate retail share dropping from 9.3% in 2022 to 7.6% in 2024, matching the ground truth. It also correctly references shipment volume decline from 163.1 million units in 2023 to 147.0 million in 2024, which aligns with data not in the original answer but does not contradict it. However, the original answer emphasizes comparative performance against Copenhagen and on!, which the LLM only partially captures—while it mentions on! gaining traction, it does not explicitly state on!'s market share rise from 6.8% to 8.3%, nor Copenhagen’s drop from 23.5% to 19.1%. (2) All provided numbers (9.3%, 7.6%, 163.1M, 147.0M) are quantitatively accurate and correctly attributed. The years 2022–2024 are used appropriately. (3) The reasoning is sound in attributing Skoal’s decline to competition from nicotine pouches and shifting consumer preferences, especially toward on!. However, the multi-hop synthesis is incomplete—it fails to directly compare Skoal’s performance with Copenhagen’s and on!’s in terms of market share trends, which is central to the original answer’s conclusion about relative underperformance. (4) Despite missing some comparative data, the LLM answer remains contextually relevant, focused on Skoal’s performance and competitive dynamics. The omission of key comparative metrics prevents a top score, but core facts and directionality are correct, warranting a high but not perfect correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 415,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "The revenue contribution from Dynamics 365 within Microsoft Cloud increased between fiscal years 2022 and 2023. In fiscal year 2022, Dynamics products and cloud services revenue was $4,687 million, and it grew to $5,437 million in fiscal year 2023, representing a 16% increase. This growth is attributed to the performance of Dynamics 365.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific numerical values ($4,687 million in FY2022 and $5,437 million in FY2023) and claims a 16% growth for Dynamics 365, but these figures are not supported by the ground truth. The original answer states that Dynamics 365 revenue grew 39% in FY2022 as part of Dynamics products and cloud services, but does not provide exact dollar amounts or a specific growth rate for FY2023. The LLM invents precise figures and a 16% growth rate that are not present in the source, making the quantitative claims factually incorrect. (2) There is no mention in the ground truth of Dynamics 365 generating $4.7B or $5.4B in revenue in those years; the only revenue figure provided is the total Microsoft Cloud revenue ($91.2B in FY2022 and $111.6B in FY2023), with Dynamics 365 being a component but not broken out into exact dollar amounts. The 16% growth rate is fabricated. (3) The reasoning is flawed because the LLM fails to correctly synthesize the multi-hop information: it incorrectly assumes that a specific dollar amount and growth rate can be extracted when the original text only provides percentage growth for FY2022 (39% increase in Dynamics 365) and implies continued contribution without explicit FY2023 growth metrics. (4) While the general direction of growth is consistent with the original answer (i.e., Dynamics 365 is growing and contributing to Microsoft Cloud), the invention of unsupported numbers severely undermines factual accuracy. The contextual relevance is moderate because the answer addresses the evolution of Dynamics 365 revenue, but the reliance on false precision renders it largely incorrect. Correctness and quantitative accuracy are low due to fabricated data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 471,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program in 2024 shows a continued focus on using forward exchange contracts and foreign currency debt, with some notable changes compared to 2023. In 2024, the company expanded its use of forward exchange contracts designated as hedges of net investment in foreign operations, as evidenced by the inclusion of euro-denominated notes as economic hedges of net investment in foreign operations. Additionally, Merck increased the scale of its hedging activities, as reflected in the higher notional amounts and more extensive use of derivatives, particularly forward contracts, compared to 2023. The scope of hedging also broadened, with a more significant emphasis on mitigating exposure through a combination of financial instruments and operational strategies.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant factual inaccuracies and misses key aspects of the evolution in Merck's foreign exchange risk management approach from 2023 to 2024. (1) Correctly identifies that forward exchange contracts remain a core instrument in 2024, and notes an expansion in hedging activities, which aligns with the broader scope mentioned in the ground truth. However, it incorrectly states that forward contracts were 'designated as hedges of net investment in foreign operations' in 2024—this contradicts the ground truth, which specifies that in 2023, contracts were *not* designated as hedges and were marked to market through earnings. The introduction of such designations is not supported in the original answer. (2) The mention of 'foreign currency debt' and 'euro-denominated notes as economic hedges' is not present in the original answer and appears to be fabricated or misattributed information; the ground truth does not reference debt instruments at all. (3) The LLM fails to mention the key 2024 innovations: the use of *purchased local currency put options* and *collar options*, which are central to the evolution described in the original answer. (4) The concept of 'strategic layering of hedges over time' and increasing hedge coverage as forecast dates approach based on cost-benefit analysis—a critical qualitative shift in 2024—is entirely omitted. (5) While the LLM notes a broader scope and increased scale, it lacks specific instruments and structural changes that define the program’s evolution. Quantitative accuracy is scored moderately because no specific numbers (e.g., notional amounts) are provided in either answer, but the LLM's reference to 'higher notional amounts' is speculative and unsupported in the ground truth. Contextual relevance is fair because the response stays on topic and discusses instruments and scope, but the reasoning is flawed due to incorrect synthesis and introduction of non-existent elements. Overall, the answer is partially correct in direction but fails on key factual and qualitative dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 561,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "PayPal's involvement with merchant receivables between 2022 and 2024 shows growth in direct investment, with purchases of $1.8 billion and $1.7 billion in 2024 and 2023, respectively. The outstanding merchant loans and advances increased from $1.2 billion in 2023 to $1.5 billion in 2024. Credit loss provisions for merchant receivables decreased from $160 million in 2023 to $113 million in 2024, attributed to improved credit quality in the PPBL portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly notes that PayPal purchased $1.8 billion in merchant receivables in 2024 (matching the ground truth), it incorrectly states that $1.7 billion was purchased in 2023—this figure is not present in the original answer, which only mentions an outstanding balance of $1.2 billion in 2023. Additionally, the LLM introduces credit loss provisions of $160 million in 2023 and $113 million in 2024, which are entirely absent from the ground truth and thus factually unsupported. The original answer discusses a coverage ratio of 9% as of December 31, 2021 (down from 23% in 2020), but this is not mentioned in the LLM response, representing a significant omission. (2) The outstanding balance increase from $1.2 billion to $1.5 billion is correctly reported, aligning with the ground truth. However, the introduction of fabricated credit loss provision figures undermines quantitative accuracy. The $1.8 billion purchase in 2024 is correct, but the $1.7 billion in 2023 is not corroborated. (3) The reasoning partially captures the evolution toward greater direct investment, correctly identifying increased purchasing and outstanding balances. However, it fails to reflect the shift from risk disclosure in 2022 to active investment by 2024, missing the key multi-hop insight about strategic evolution in PayPal’s role. The mention of PPBL is consistent with the original, but the absence of context about methodology changes in 2022 weakens the synthesis. (4) The contextual relevance is high because the answer addresses both credit loss provisions and direct investment as asked. However, due to significant factual errors in numbers and missing key elements like the 2022 risk disclosure framework and coverage ratios, the correctness score is limited to 5. The qualitative accuracy is moderate because the direction of evolution is roughly correct, but the reasoning lacks full grounding in the source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 547,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "From 2022 to 2024, the financial significance of smokeable products to MO (Altria) has shown mixed trends. In terms of operating income, smokeable products generated $10,821 million in 2024 compared to $10,670 million in 2023, indicating a slight increase. However, net revenues for smokeable products decreased from $21,756 million in 2023 to $21,204 million in 2024, reflecting a decline. Regarding goodwill allocation, the smokeable products segment had a consistent goodwill value of $99 million in both 2021 and 2020, with no impairment charges reported in 2024. Thus, while operating income for smokeable products slightly improved, their net revenue contribution declined, and goodwill remained stable without impairment.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. Correct elements include the 2024 operating income of $10,821 million and 2023 operating income of $10,670 million, which match the ground truth and correctly show a slight increase. It also correctly states that goodwill for smokeable products was $99 million in 2022 (though it incorrectly cites 2020 and 2021 instead of 2022). However, the LLM introduces net revenues of $21,756 million in 2023 and $21,204 million in 2024, which are not present in the original answer or implied by the ground truth, making this a significant factual addition not supported by the provided data. Additionally, the claim that goodwill was $99 million in 2020 and 2021 is irrelevant to the question’s 2022–2024 scope and distracts from the lack of 2024 goodwill disclosure. (2) Quantitative accuracy is partially correct: the operating income figures are accurate, and the goodwill amount is correct for 2022 (though misattributed to earlier years). However, the net revenue figures are unverified and not part of the ground truth, introducing inaccuracies. (3) The multi-hop reasoning is flawed: the model fails to emphasize the key contrast between stable/undisclosed goodwill and rising operating income, instead introducing unsupported revenue data and misrepresenting the timeline of goodwill disclosures. It does not infer the potential shift in reporting focus as noted in the original answer. (4) Contextual relevance is high because the answer addresses both goodwill and operating income over the requested timeframe, but correctness is undermined by hallucinated revenue numbers and incorrect temporal referencing of goodwill, leading to a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 472,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "The revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud increased from $13.6 billion in fiscal year 2022 to $14.9 billion in fiscal year 2023, representing a growth of $1.3 billion or approximately 9.6%.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative claims. The original answer (ground truth) states that Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was $91.2 billion in FY2022 and $111.6 billion in FY2023. However, the LLM incorrectly reports the commercial portion of LinkedIn alone as $13.6B and $14.9B for those years—figures not present in the ground truth. There is no breakdown in the original answer isolating LinkedIn's specific revenue contribution within Microsoft Cloud; thus, the LLM fabricated precise numbers unsupported by the source. The calculation of $1.3B growth and 9.6% increase is internally consistent but based on false inputs. Entity accuracy is partially correct—Microsoft Cloud, LinkedIn, and fiscal years 2022–2023 are relevant—but the reasoning fails multi-hop synthesis because it invents granular data rather than correctly inferring or reporting aggregate figures. While the direction of growth (increase) aligns with the original, the core financial data is entirely inaccurate. Hence, the correctness and quantitative accuracy scores are very low. Contextual relevance is moderate because the answer addresses the right topic and timeframe but misrepresents the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 347,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "Between 2023 and 2024, the commercialization and market expansion of Lynparza saw growth in geographic approvals and alliance revenue. In 2023, Lynparza received FDA and Japan's MHLW approvals for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone/prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, China's NMPA approved Lynparza as adjuvant treatment for adult patients with germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, further expanding its geographic footprint.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: 2023 approvals by the FDA and Japan's MHLW for BRCA-mutated mCRPC based on the PROpel trial, 9% alliance revenue growth in 2024 due to international demand, and January 2025 NMPA approval in China for adjuvant treatment of gBRCA-mutated, HER2-negative high-risk early breast cancer based on the OlympiA trial. (2) Quantitative elements—specifically the 9% revenue growth and the correct years (2023, 2024, and January 2025)—are accurately reported with no calculation errors. (3) The multi-hop reasoning is sound: the answer synthesizes information across time, geography (U.S., Japan, China, international markets), therapeutic indications, and regulatory bodies, correctly linking approvals to clinical trials and commercial impact. (4) The answer is semantically equivalent to the original, with only minor rephrasing (e.g., 'higher demand in most international markets' vs. 'largely due to higher demand...') and includes all required elements of the question—geographic approvals and revenue growth—making it contextually complete and precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 326,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "Between 2023 and 2024, the Powder Metal Matter's financial treatment by RTX resulted in a reduction in future income tax benefits. Specifically, the deferred tax asset related to the Powder Metal Matter decreased from $644 million in 2023 to $455 million in 2024, indicating a decline in the anticipated future tax benefits associated with this matter.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, all numbers are correct: the deferred tax asset decreased from $644 million in 2023 to $455 million in 2024, a difference of $189 million. The LLM correctly reports these values without error. (2) The answer accurately reflects the shift in financial treatment—though it does not explicitly mention the 2023 classification as a 'reduction in sales,' it correctly identifies the 2024 treatment as a reduction in future income tax benefits, which aligns with the core of the question about evolution in tax benefit impact. (3) The reasoning is sound: the decrease in the deferred tax asset implies a reduced future tax benefit, which is a valid interpretation. However, the answer omits the explicit contrast in accounting treatment (from sales reduction to tax benefit recognition), which is a minor gap in completeness. (4) Despite this, the LLM focuses precisely on the tax benefit evolution, which is the central thrust of the question, making it contextually excellent. Minor deduction in qualitative accuracy for not fully capturing the nature of the treatment shift, but numbers and core logic are flawless.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 343,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "The borrowing capacity and terms of the Paidy Credit Agreement evolved significantly from 2022 to 2024. In 2022, the Paidy Credit Agreement initially provided for an unsecured revolving credit facility of ¥60.0 billion, which was later increased by ¥30.0 billion in September 2022, bringing the total borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024). By 2024, the full ¥90.0 billion was drawn down, leaving no available borrowing capacity. The interest rate terms remained based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60%, and the agreement was set to terminate in February 2027.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the 2022 Paidy Credit Agreement was an unsecured facility, while the ground truth specifies it was a secured revolving credit facility of $198 million. The LLM also misrepresents the timeline and structure of the increase, claiming a ¥60.0 billion facility increased by ¥30.0 billion in September 2022, which is not supported by the original answer. The original does not mention incremental increases or unsecured status in 2022. (2) The LLM correctly identifies the 2024 borrowing capacity as ¥90.0 billion (~$574 million) and the interest rate as TIBOR plus 0.40%-0.60%, aligning with the ground truth. However, it incorrectly states that the full amount was drawn down in 2024, which is not mentioned in the original. The maturity date (February 2027) is correctly noted. (3) The multi-hop reasoning is partially sound in connecting 2022 and 2024 terms, but fails in synthesizing the correct evolution: it omits the shift from secured to unsecured (which occurred in 2024, not in 2022), and misses the introduction of the consolidated leverage ratio covenant. Instead, it fabricates details about drawdown status and early unsecured status. (4) The contextual relevance is high as the answer addresses the evolution of borrowing capacity and terms, but the correctness score is low due to key factual errors in security status, facility structure, and covenant information. Quantitative accuracy is moderate due to correct final amounts and rates but incorrect intermediate figures. Qualitative accuracy suffers from flawed reasoning and entity misattribution across time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 460,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Altria's reliance on long-term senior unsecured notes as part of its capital resources remained significant between 2022 and 2024, with the company accessing credit markets for general corporate purposes. In 2024, Altria issued $1.0 billion in new long-term senior unsecured notes (comprising $0.5 billion at 4.875% due 2028 and $0.5 billion at 5.625% due 2035) to refinance maturing debt and manage its capital structure. Total long-term debt was $24.9 billion at December 31, 2024, compared to $26.2 billion at December 31, 2023, indicating a slight reduction in overall debt levels, while continued access to long-term senior unsecured notes remained a key component of its capital resources strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Altria continued to rely on long-term senior unsecured notes as a key capital resource in both 2022 and 2024, which aligns with the ground truth. However, it introduces specific details not present in the original answer—such as the issuance of $1.0 billion in new notes in 2024 with specific tranches and interest rates, and total long-term debt figures of $24.9 billion (2024) and $26.2 billion (2023)—that are absent from the ground truth and cannot be verified against it. These additions may be factually accurate but are not supported by the provided knowledge graph, raising concerns about hallucination or unsupported specificity. (2) The ground truth emphasizes a decline in cash and cash equivalents from $4.5 billion in 2022 to $3.1 billion in 2024 as a signal of potentially increased reliance on external financing, including unsecured notes. This key comparative insight is missing in the LLM answer, which fails to mention cash levels at all—representing a significant omission in the evolution of capital structure. (3) While the LLM demonstrates sound reasoning in linking note issuance to debt refinancing and capital structure management, it does not perform the multi-hop synthesis required to infer increased reliance due to declining cash reserves. Instead, it focuses on debt reduction, which is a different analytical point. (4) The contextual relevance is high because the answer addresses the core topic—Altria’s use of long-term senior unsecured notes. Qualitative accuracy is moderate due to correct entity and metric identification (Altria, long-term senior unsecured notes, capital resources), but quantitative accuracy is lower because the introduced numbers, while plausible, are not corroborated by the ground truth and may misrepresent the available data. The absence of cash balance trends, a critical component of the original answer, reduces overall correctness despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 535,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "RTX's financial treatment of the Powder Metal Matter shifted from a $2.9 billion charge in 2023 to a $2.5 billion reduction in cost of sales in 2024, primarily reflecting the partners' share of the matter. This evolution indicates a decrease in the negative impact on future income tax benefits, as the charge in 2023 significantly lowered pretax income and provided an approximate 4% benefit to the effective tax rate for that year. The reduced impact in 2024 suggests a lessened drag on future tax benefits compared to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that the Powder Metal Matter contributed $644 million to RTX's future income tax benefits in 2023 and $455 million in 2024, indicating a reduction in tax benefits. However, the LLM claims a $2.9 billion charge in 2023 and a $2.5 billion reduction in cost of sales in 2024, which are entirely different figures and financial treatments not mentioned in the ground truth. These numbers do not match any aspect of the correct financial impact related to income tax benefits. (2) The quantitative inaccuracies are severe: $2.9B and $2.5B are not only wrong in magnitude but also mischaracterize the nature of the item (as a charge or cost reduction rather than a contributor to tax benefits). The 4% benefit to the effective tax rate is an unsupported detail not present in the original answer and cannot be verified. (3) The reasoning is flawed: instead of recognizing that the Powder Metal Matter positively contributes to future tax benefits (via e.g., deductions or credits), the LLM frames it as a negative charge reducing pretax income, which contradicts the concept of a 'benefit.' The evolution described does not align with the actual decline in a positive tax attribute. (4) Contextual relevance is moderate because the answer addresses RTX, the Powder Metal Matter, and changes between 2023 and 2024, but the substance is factually incorrect. The core financial treatment and its implications are misrepresented, failing the multi-hop synthesis required. Thus, the correctness score is low due to fundamental factual and conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 455,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "PayPal's utilization of the Paidy Credit Agreement evolved significantly between 2022 and 2024. In 2022, the Paidy Credit Agreement had a borrowing capacity of approximately $198 million, with $98 million outstanding and $100 million available. By 2024, the borrowing capacity had increased to ¥90.0 billion (approximately $574 million), and the full amount was drawn down, leaving no available borrowing capacity. This indicates a substantial increase in both the borrowing capacity and the actual drawdown under the Paidy Credit Agreement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $198 million borrowing capacity in 2022, $98 million outstanding (implying $100 million available), and an increase to ¥90.0 billion (~$574 million) in 2024 with full drawdown. The conversion from yen to dollars is consistent with the original answer. (2) The answer addresses both parts of the question—borrowing capacity and actual drawdown—across the specified time frame (2022 to 2024), demonstrating completeness. (3) Entities are correctly identified: PayPal, the Paidy Credit Agreement, and the relevant years. (4) The reasoning is sound: it correctly infers increased reliance on the facility due to both expanded capacity and full utilization by 2024, reflecting proper multi-hop synthesis of capacity changes and drawdown behavior. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 281,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "From 2023 to 2024, the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. remained largely consistent, with noncontrolling interests held by current and former members of Accenture Leadership being less than 1% as of August 31, 2024. Holders of Accenture Canada Holdings Inc. exchangeable shares retain the right to exchange their shares for Accenture plc Class A ordinary shares on a one-for-one basis, and Accenture plc maintains the option to redeem these shares for cash at market price. No significant changes were reported in the terms or mechanics of these exchangeable shares or noncontrolling interests during the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the quantitative fact that noncontrolling interests were less than 1% as of August 31, 2024, which aligns with the ground truth. However, it incorrectly frames the evolution from 2023 to 2024 as 'largely consistent' and states 'no significant changes were reported,' which contradicts the ground truth that the equity relationship became more formalized in 2024 with new structural provisions. (2) Quantitatively, the date (August 31, 2024) and percentage (<1%) are accurate, and the one-for-one exchange and cash redemption terms are correctly stated. There are no calculation errors. (3) The multi-hop reasoning is flawed: the ground truth emphasizes an evolution in structure—specifically the introduction of Class X shares tied to exchangeable shares and a formal restriction ensuring parity between them—which the LLM omits entirely. This is a critical omission in the qualitative evolution of the equity relationship. (4) While the LLM captures the basic mechanics of exchangeable shares and noncontrolling interests, it fails to reflect the key 2024 structural development involving Accenture plc Class X shares and the formal linkage to exchangeable shares, making the answer incomplete and misleading about the nature of the evolution. Hence, correctness and qualitative accuracy are penalized, though quantitative accuracy remains high due to correct numbers and dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 395,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "Merck's approach to managing balance sheet risk through forward exchange contracts between 2022 and 2024 has seen an expansion in the currencies hedged and a more nuanced cost-benefit analysis. In 2022, the company primarily focused on major developed market currencies like the euro, Japanese yen, and Chinese renminbi, hedging based on exposure magnitude and volatility. By 2024, Merck extended its hedging to include additional developed currencies such as the British pound and Canadian dollar, while continuing to selectively hedge developing market currencies like the Chinese renminbi when cost-benefit analyses justified it. The company also increased its use of forward contracts for net investment hedges, with gains and losses recorded in OCI, reflecting a more strategic and comprehensive approach to managing foreign exchange risks.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect and contradicts the ground truth. The original answer states that Merck's 2024 disclosure omitted specific details about cost-benefit analysis and the mention of the Chinese renminbi, suggesting a simplification or shift away from detailed justification for hedging developing market currencies. In contrast, the LLM claims that by 2024, Merck 'extended its hedging' to more currencies and continued selective hedging of developing markets like the renminbi based on cost-benefit analysis—implying increased sophistication, which is the opposite of the documented trend. (2) There are no numeric values to verify, but the temporal claims (2022 vs 2024) are factually wrong. The LLM incorrectly asserts expansion and increased nuance in 2024, while the ground truth indicates a reduction in disclosed detail and specificity, especially regarding developing countries and the renminbi. (3) The multi-hop reasoning is flawed: the model fails to synthesize the correct evolution—reduced disclosure and likely simplification—instead inventing an expansionary narrative with new currencies (British pound, Canadian dollar) and increased strategic use, none of which are supported by the original answer. (4) The contextual relevance is moderate because the answer addresses balance sheet risk, forward contracts, currencies, and cost-benefit considerations, but the factual inaccuracies and reversed direction of change severely undermine correctness. Thus, the correctness, quantitative, and qualitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 432,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggests a reduction in its financial impact, particularly on future income tax benefits. In 2023, the Powder Metal Matter had a deferred tax asset of $644 million, while in 2024, this amount decreased to $455 million. This decline indicates that the anticipated future tax benefits associated with the matter have diminished, likely due to a reassessment of the related tax positions or a reduction in the expected tax-deductible amounts.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets the core numbers correct—$644 million in 2023 and $455 million in 2024—but mischaracterizes the nature of these amounts. According to the ground truth, these values are listed under 'future income tax benefits,' not as a 'deferred tax asset' per se, though they may represent such an asset. The LLM incorrectly frames the $644 million and $455 million as deferred tax assets in both years, while the original answer emphasizes a shift in disclosure category—from an operational loss (net sales charge of $5.3 billion) in 2023 to being reported under future income tax benefits in 2024. This key multi-hop insight (a change in accounting treatment and disclosure location) is missed entirely by the LLM. (2) Quantitatively, the dollar amounts and years are accurate, and the direction of change (decrease from $644M to $455M) is correctly noted. However, the LLM omits the $5.3 billion net sales charge in 2023, which is a major component of the original answer and essential context for understanding the shift. (3) The reasoning is partially sound—recognizing that a decline in future tax benefits suggests reduced expectations—but fails to capture the broader narrative shift: the Powder Metal Matter moved from negatively impacting revenue to being treated as a tax-related item, indicating resolution progress. This synthesis across years and reporting categories is missing. (4) Scores reflect that while numbers are correct and the answer is relevant, the qualitative misrepresentation of the financial treatment and omission of key context (the $5.3B operational impact) limits correctness. The answer is plausible but lacks the full multi-hop insight required for high accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 469,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "PayPal's involvement in the merchant receivables space between 2022 and 2024 has shown growth in scale and continued partnership with WebBank in the U.S. The total outstanding balance in merchant receivables increased from $1.2 billion in 2023 to $1.5 billion in 2024, with $1.8 billion and $1.7 billion in merchant receivables purchased in 2024 and 2023, respectively. PayPal continues to work with WebBank, purchasing receivables extended to U.S. merchants and servicing the portfolio, while sharing risks pro rata with WebBank's participation interests. The credit quality of the merchant receivables improved in 2024, as reflected in a decrease in the allowance for credit losses from $160 million in 2023 to $113 million in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's merchant receivables activities from 2022 to 2024. Quantitatively, the key figures are accurate: the $1.2 billion to $1.5 billion increase in outstanding balance (as of Dec 31, 2023 and 2024), the $1.7 billion and $1.8 billion in receivables purchased in 2023 and 2024, and the continued partnership with WebBank are all factually correct. The mention of pro rata risk sharing aligns with the original description of selling participation interests. However, the LLM introduces a detail not present in the ground truth: the allowance for credit losses decreasing from $160M to $113M. While plausible, this specific figure is not in the original answer and cannot be verified from the provided truth, making it an unsupported addition. Additionally, the original answer specifies that the participation interest sold to the partner institution increased from $44M (2023) to $53M (2024), which the LLM omits despite referencing risk sharing. This is a minor but notable omission in completeness. The reasoning is sound—correctly identifying the growth trend and ongoing partnership—and the context fully addresses the question’s focus on scale and institutional relationships. Wording differences are acceptable and semantically equivalent where aligned. The answer is highly relevant and mostly accurate, but the unverified credit loss detail and missing participation interest figures prevent a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 407,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck's alliance revenue from Lynparza increased by 9% in 2024 compared to 2023, primarily driven by higher demand in most international markets. This growth was supported by the expansion of Lynparza's indications and approvals in various regions. In January 2025, Lynparza received additional approval in China for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, further contributing to its potential growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 9% growth in alliance revenue for Lynparza and attributes it to increased international demand and expanded indications, which aligns with the ground truth. However, it incorrectly states that the 9% increase is from 2024 compared to 2023, while the original answer specifies the growth is from 2022 to 2024. This misrepresents the time frame and undermines the quantitative accuracy. The 2022 revenue figure of $989 million is omitted entirely, which is a key data point required by the question. (2) The approval in China in January 2025 is accurately mentioned, including the indication (adjuvant treatment in early breast cancer), though the LLM adds specificity around 'germline BRCA-mutated, HER2-negative' which is plausible but not in the original answer. The core issue is the missing 2022 revenue number and incorrect year comparison. (3) The reasoning is logically sound in linking approvals and demand to revenue growth, and the multi-hop synthesis between clinical approvals and commercial performance is appropriate. However, the failure to correctly compare 2022 and 2024 revenue as stated in the ground truth indicates a flaw in temporal reasoning. (4) The contextual relevance is high because the answer addresses revenue evolution and contributing factors. Qualitative accuracy is strong due to correct causal factors and approval details. Quantitative accuracy is reduced due to the missing $989M figure and incorrect base year for the 9% growth. Correctness score is 7 because the core growth driver and approval information are correct, but the answer lacks full quantitative precision and completeness on the revenue timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 462,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "PayPal's involvement in merchant receivables between 2022 and 2024 has shown growth in financial exposure, with the total outstanding balance increasing from $1.2 billion in 2023 to $1.5 billion in 2024. Operationally, PayPal continues to expand its merchant finance offerings through products like PPWC and PPBL, purchasing approximately $1.8 billion in merchant receivables in 2024. The company also maintains an active role in credit risk management, using internal risk models and adjusting underwriting criteria to manage exposure, particularly in response to macroeconomic conditions. The allowance for credit losses on merchant receivables decreased from $160 million in 2023 to $113 million in 2024, reflecting improved credit quality in the PPBL portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in outstanding balance from $1.2 billion to $1.5 billion and the $1.8 billion in receivables purchased in 2024, which aligns with the ground truth. However, it incorrectly states the $1.2 billion balance was in 2023, while the original answer implies the $1.2 billion was the prior year to 2024 (i.e., 2023), but does not specify the year for the $1.2 billion—this is a minor ambiguity. More critically, the LLM introduces a new figure—allowance for credit losses decreasing from $160M in 2023 to $113M in 2024—which is not present in the ground truth and cannot be verified, making it an unsupported addition. (2) The $1.8 billion in 2024 and $1.5 billion outstanding are accurate. The $1.7 billion in 2023 (purchases) from the original answer is missing in the LLM response, weakening the year-over-year comparison. The allowance figures are extraneous and not in the ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM correctly infers increased financial exposure via growing balances and purchases, and identifies operational expansion through PPWC and PPBL. It also correctly notes active risk management, though this is framed more in 2022 in the original answer. The evolution from risk-focused (2022) to active purchasing and servicing (2024) is partially captured, but the shift from CECL-based accounting to direct purchases is underemphasized. (4) The correctness score is 8 due to accurate core financial figures and correct identification of operational expansion, but docked for the unverified allowance numbers and missing 2023 purchase volume. Quantitative accuracy is 7 due to the unsupported loss allowance data. Qualitative accuracy is 9—reasoning is strong and entities (PPWC, PPBL, years, balances) are correct. Contextual relevance is 10—response directly addresses the evolution in financial exposure and operational role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 526,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "Merck's involvement in the development and commercialization of Lynparza from 2022 to 2024 shows notable regulatory progress and revenue growth. In 2022, Lynparza was under regulatory review for additional indications, including adjuvant treatment for early-stage breast cancer based on the OlympiA trial. By 2024, Lynparza achieved regulatory approvals in new indications and markets, including China's NMPA approval in January 2025 for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer. Additionally, alliance revenue related to Lynparza grew 9% in 2024, driven by higher demand in international markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Merck's involvement in Lynparza from 2022 to 2024, including regulatory progress and revenue growth. It accurately notes the 2022 regulatory review for adjuvant treatment of early-stage breast cancer based on the OlympiA trial and the January 2025 China NMPA approval. The 9% alliance revenue growth in 2024 is correctly reported. (2) Quantitatively, all numbers and dates align with the ground truth: the 9% revenue growth is exact, and while the approval is dated January 2025 (slightly beyond 2024), this is consistent with the original answer and reflects forward-looking regulatory momentum. The PDUFA date in Q1 2022 is implied as 'under review' in 2022, which is acceptable. (3) The multi-hop reasoning is sound—linking 2022 regulatory status to 2024 commercial and regulatory outcomes, synthesizing information across time and geography. The mention of international demand driving revenue ties back to alliance revenue correctly. (4) Minor deduction in quantitative and qualitative accuracy due to slightly less specificity on the 2022 PDUFA timeline (original specifies Q1 2022 decision pending), but overall semantic equivalence is strong. Contextual relevance is perfect as all parts of the question are addressed with accurate, focused information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 370,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "Between 2022 and 2024, Boeing's strategy with commodity purchase contracts has shown a shift in risk management horizon and financial exposure. In 2022, the company had significant losses related to commodity contracts, with $31 million in costs and expenses, and reclassified $50 million in losses from AOCI due to forecasted transactions not occurring. By 2024, while the costs and expenses related to commodity contracts remained at $7 million, the company expects to reclassify $64 million in losses from AOCI into earnings in the next 12 months. Additionally, Boeing's commodity contracts now hedge forecasted transactions through 2028, indicating an extended risk management horizon. Financial exposure has also increased, with the fair value of contracts in a net liability position at $22 million by 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, a 10% change in commodity prices would impact unrealized losses by $46 million, but the LLM incorrectly reports $31 million in costs and $50 million reclassified from AOCI—figures not present in the original answer and unsupported by the provided context. In 2024, the LLM claims $7 million in costs and $64 million expected to be reclassified from AOCI, which are not mentioned in the ground truth. The only partially correct element is the extension of the hedging horizon, but the LLM states 'through 2028' while the ground truth specifies 'through 2031', a material discrepancy. (2) The quantitative inaccuracies are severe: none of the dollar amounts in the LLM answer ($31M, $50M, $7M, $64M, $22M) appear in the original answer. The ground truth does not mention AOCI reclassifications, net liability positions, or specific expense figures for commodity contracts in either year. The correct financial exposure metric in 2022 was sensitivity to a 10% price change ($46M impact), which the LLM omits entirely. (3) The multi-hop reasoning is flawed. The LLM fails to correctly synthesize the evolution from a general hedging approach in 2022 to a long-term strategy through 2031. Instead, it fabricates AOCI reclassification dynamics and cost figures that shift focus away from the actual strategic evolution—extending hedging duration for production stability. The core insight about aligning risk management with extended production cycles is missing. (4) While the LLM attempts to address risk management horizon and financial exposure, it does so with incorrect data and reasoning, leading to a low correctness score. Contextual relevance is moderate because it discusses related concepts (hedging, AOCI, liability), but the substance is factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 507,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "Schwab's exposure to Pledged Asset Lines (PALs) remained fully collateralized by securities with fair values exceeding the borrowings as of December 31, 2021, and no allowance for credit losses was required for PALs during that period. By December 31, 2024, the document does not explicitly mention changes in the collateralization status of PALs, but it is implied that Schwab continued to maintain strong collateral coverage, given the consistent risk management practices described in prior years. Additionally, the allowance for credit losses on bank loans, including PALs, remained low, reflecting strong credit quality and effective collateral management.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that in 2021, PALs were fully collateralized with fair values exceeding borrowings and no allowance for credit losses was required, which matches the ground truth. However, the 2024 portion is less accurate: while the ground truth specifies that PALs saw slight growth and the allowance for credit losses decreased due to lower projected loss rates and improved credit quality (indicating a strategic shift in risk assessment), the LLM does not mention the decrease in allowance or its reasons. Instead, it vaguely states the allowance 'remained low' without acknowledging the change from 2021 to 2024. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is high based on correct qualitative descriptions of conditions in 2021 and general trends in 2024. (3) The multi-hop reasoning is partially sound—the model connects collateralization and credit risk across years—but fails to fully synthesize the evolution in risk management approach (from full collateralization as the sole mitigant to a broader credit quality assessment). (4) The answer is contextually relevant and uses correct entities (PALs, allowance for credit losses, Schwab, 2021, 2024), but omits key qualitative shifts in risk philosophy and the directional change in allowance, which are central to the question. Thus, while factually consistent where stated, it lacks completeness and depth in capturing the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 418,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "Between 2022 and 2024, Boeing's financial treatment and strategic positioning of the 777X program evolved significantly due to increasing cost impacts and rising research & development (R&D) investments. In 2022, R&D expenses for the 777X were $1,510 million, but by 2023, these expenses had increased to $2,036 million, and further rose to $2,386 million in 2024, reflecting heightened investment in the program. Additionally, the 777X contributed to a reach-forward loss of $1,770 million in 2024, which significantly increased the cost of sales as a percentage of revenue to 103.0%, compared to 90.1% in 2023. This indicates that the program's financial burden grew over the period, impacting Boeing's profitability and necessitating strategic cost management and operational adjustments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Boeing increased R&D spending on the 777X by $525 million from 2022 to 2023 and by $435 million from 2023 to 2024, but the LLM fabricates absolute R&D figures ($1,510M, $2,036M, $2,386M) that are not in the original answer and cannot be verified from the provided truth. Additionally, the claim of a $1,770 million 'reach-forward loss' in 2024 and cost of sales rising to 103.0% of revenue in 2024 (vs 90.1% in 2023) is not supported by the ground truth, which only mentions a reach-forward loss in 2022, not 2024. These fabricated numbers severely undermine factual correctness. (2) The quantitative inaccuracies are extensive: no dollar amounts or percentages in the LLM answer match or can be derived from the original answer. The original does not provide absolute R&D figures or cost-of-sales percentages, nor does it mention a 2024 reach-forward loss. The increases cited in the ground truth ($525M, then $435M) are misrepresented as part of a fabricated time series. (3) The multi-hop reasoning is flawed. The original answer describes a strategic shift: from 2022 (cost burden due to losses) to 2024 (strategic investment via rising R&D). The LLM incorrectly frames the program as an increasing financial burden through 2024, contradicting the ground truth's narrative of strategic prioritization. This misrepresents the evolution and direction of Boeing's strategy. (4) While the LLM attempts to address the question’s scope—financial treatment and strategic positioning over time—the use of false data and incorrect interpretation of trends results in a factually incorrect conclusion. Contextual relevance is moderate because the structure and intent align with the question, but correctness is severely compromised by hallucinated metrics and inverted logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 506,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Between 2022 and 2024, Schwab's exposure and risk management of Portfolio Against Loans (PALs) remained relatively stable, with limited credit risk due to over-collateralization by marketable securities and daily monitoring of collateral levels. The credit loss allowance methodology for PALs continued to rely on the practical expedient based on collateral maintenance provisions, as the inherent credit loss risk in this portfolio is considered minimal. While the 2024 disclosures did not highlight significant changes in methodology, the PALs portfolio grew in size, as evidenced by the increase in total average balances from $17,024 million in 2022 to $45,236 million in 2024, reflecting expanded lending activity under Schwab's conservative risk management framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Schwab uses over-collateralization and daily monitoring for PALs risk management and applies the practical expedient due to minimal inherent credit risk, which aligns with the 2022 ground truth. It also correctly notes that the methodology did not significantly change by 2024 and that portfolio growth occurred. However, it introduces specific dollar amounts—$17,024 million in 2022 and $45,236 million in 2024—that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually incorrect or taken from external data not in the knowledge graph, making them unsupported. (2) The quantitative accuracy is low because the original answer does not provide any specific numerical values for the PALs portfolio size in 2022 or 2024. The LLM fabricates precise figures without grounding, which violates factual correctness. Additionally, the original answer mentions a 'slight decrease in 2023' before growth in 2024, but the LLM implies a direct increase from 2022 to 2024, missing this nuance. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the stability of methodology and the idea of portfolio growth. However, it fails to incorporate the key point that the allowance ratio decreased in 2024 due to improved credit quality and lower projected loss rates, which is central to the evolution of risk management. This omission weakens the qualitative accuracy. (4) Contextual relevance is high because the response stays focused on PALs, risk management, allowance methodology, and portfolio trends. Despite missing key qualitative insights and introducing unverified numbers, the overall structure and intent match the question's requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 486,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "MDLZ's value of British pound sterling notes shifted from a $45 million after-tax gain in 2022 to no gain or loss in 2023. This shift suggests that the company may have adjusted its hedging strategy or reduced exposure to British pound sterling-related risks in 2023, reflecting a proactive approach to managing foreign exchange risk by potentially offsetting or minimizing exposure to currency fluctuations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the change. The ground truth states that MDLZ's value of British pound sterling notes increased from $3 million in 2022 to $45 million in 2023. However, the LLM claims a $45 million after-tax gain in 2022 and no gain in 2023, which misrepresents both the base values and the nature of the metric (value of notes vs. after-tax gain). This is a critical error in quantitative reporting. (2) The numbers are entirely inaccurate: the $45 million figure is incorrectly placed in 2022 instead of 2023, and the $3 million value from 2022 is omitted entirely. Furthermore, the LLM introduces 'after-tax gain'—a concept not present in the original answer or supported by the question—which distorts the financial interpretation. There are no correct calculations because the inputs are wrong. (3) The multi-hop reasoning is flawed. The original answer infers increased exposure to GBP as part of FX risk strategy due to a significant increase in note value. The LLM incorrectly infers reduced exposure or hedging adjustments due to absence of gains, which contradicts the actual increase in value. The reasoning is based on a misinterpretation of the data and introduces an unsupported causal narrative. (4) The contextual relevance is moderate because the LLM attempts to address FX risk management strategy, which is relevant. However, due to severe factual and quantitative errors, the qualitative analysis is built on false premises. Correctness and quantitative accuracy are very low because the core financial data is wrong in both amount and year. Qualitative accuracy is low due to incorrect entity interpretation (confusing value with gain) and flawed logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 475,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "In the 2022 filing, Amgen's 3.125% 2025 Notes were hedged using an interest rate swap with an effective rate of LIBOR + 1.8%, while in the 2024 filing, the effective rate for the same notes remained LIBOR + 1.8% (now referenced as SOFR + 1.8%). This consistency in the hedging rate suggests that Amgen has maintained a stable approach to managing interest rate risk for this debt instrument, likely aiming to preserve predictable interest expenses despite broader market changes. The shift from LIBOR to SOFR reflects a transition in benchmark rates rather than a change in the company's hedging strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and interpretation. The ground truth states that in the 2022 filing, the 3.125% 2025 Notes had a fixed rate of 3.125% with no variable rate mention, while in 2024, the rate was disclosed as SOFR + 2.1%. The LLM incorrectly claims the notes were 'hedged' using an interest rate swap with an effective rate of LIBOR + 1.8% in 2022 and SOFR + 1.8% in 2024. There is no mention of hedging or swaps in the ground truth, nor is there any reference to LIBOR or a +1.8% spread. The shift from LIBOR to SOFR is correctly contextualized as a benchmark transition, but the core financial terms are fabricated. (2) Quantitatively, all key numbers are wrong: the 1.8% spread does not appear in the ground truth (correct spread is 2.1%), and the use of LIBOR is incorrect (not mentioned in original). The years and note details (3.125% 2025 Notes) are correctly identified, but their associated terms are not. (3) The multi-hop reasoning fails: instead of recognizing a shift from fixed to floating rate structure as evidence of refinancing or repricing, the LLM invents a hedging narrative that contradicts the ground truth. This misrepresents Amgen’s debt financing approach entirely. (4) Scores are low due to major factual errors in numbers, entities, and reasoning. Contextual relevance is moderate because the answer addresses the right instrument and time frame and attempts to interpret strategic intent, albeit based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 415,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "Schwab's reliance on its Commercial Paper Issuance Program increased between 2022 and 2024 in response to market disruptions and rising interest rates. In 2022 and 2023, rapid increases in short-term interest rates led to significant client reallocation of cash away from sweep features and into higher-yielding alternatives, necessitating the use of higher-cost supplemental funding sources, including commercial paper. By 2024, Schwab continued to maintain its commercial paper issuance program as part of its diversified liquidity strategy to meet short-term funding needs amid ongoing market volatility and liquidity demands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly states that Schwab's reliance on the Commercial Paper Issuance Program increased between 2022 and 2024 in response to market disruptions and rising interest rates. The key drivers—rising short-term interest rates in 2022 and 2023 leading to client cash outflows—are accurately described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly links rising rates → client behavior (reallocation from sweep accounts) → increased funding needs → greater reliance on commercial paper. It also correctly positions the program as part of a diversified liquidity strategy, consistent with the original mention of FHLB advances and repurchase agreements. (4) The only minor omission is that the LLM does not explicitly mention Schwab’s initial introduction of the program in 2022 as a potential (rather than actively relied upon) source, nor does it reference constraints like credit rating risks. However, the evolution of increased reliance by 2024 is clearly conveyed. Overall, the answer captures the core factual and causal trajectory accurately, with only slight loss of nuance. Hence, correctness is high at 9/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 386,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "The 3.625% Notes due 2024 were initially issued in 2022 with a fixed coupon rate of 3.625%, and the company entered into interest rate swap contracts to hedge a portion of this debt, effectively converting the fixed-rate coupon to a floating rate of SOFR + 3.4% in 2023. By 2024, these swaps matured in connection with the repayment of the 3.625% 2024 Notes. This evolution reflects a strategic approach to managing interest rate risk by leveraging hedging instruments to align with market conditions and optimize the cost of debt. The repayment of the 3.625% 2024 Notes and the use of interest rate swaps indicate a proactive debt management strategy focused on mitigating exposure to interest rate fluctuations and maintaining financial flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly identifies the 3.625% fixed interest rate and the 2024 maturity of the notes, it introduces information not present in the original answer—specifically, the use of interest rate swaps converting the rate to SOFR + 3.4% in 2023. The ground truth does not mention any swaps or hedging activity, only that the notes were paid off by 2024 and replaced with floating-rate debt. This is a significant factual addition unsupported by the source. Additionally, the original answer states the carrying value was $1,400 million in 2022, which the LLM omits entirely, failing a key quantitative benchmark. (2) The numbers mentioned in the LLM answer (e.g., SOFR + 3.4%) are not in the ground truth and cannot be verified; the only correct numeric is the 3.625% rate and 2024 maturity. The $1,400 million carrying value and $0 notional in 2024 are missing, undermining quantitative accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift in debt management and connects repayment with broader strategy—but it fabricates a mechanism (interest rate swaps) not present in the source data, which undermines the reasoning chain. The conclusion about proactive debt management aligns semantically with the original, but the path to it is flawed. (4) The contextual relevance is high because the answer addresses the evolution of the notes and interprets strategic implications. However, the correctness score is reduced due to unsupported details and missing key figures. The answer is plausible but not factually aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 458,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "Between 2022 and 2024, Schwab's approach to providing financial or other support to variable interest entities (VIEs) remained consistent in terms of intent, as the company did not provide or intend to provide any financial or other support to VIEs that it was not contractually required to provide. However, the conditions for funding commitments evolved, with Schwab expecting to pay substantially all of these commitments between 2022 and 2025, as noted in the 2022 filing. The 2024 filing does not provide specific updates on these conditions or funding timelines, suggesting that the original conditions and timeline remained in place.",
      "correctness_score": 2,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim about Schwab's evolving approach to VIE support. The ground truth states that there was a clear shift between 2022 and 2024: in 2022, Schwab explicitly stated it did not provide and did not intend to provide support beyond contractual obligations; by 2024, it acknowledged it may choose to provide support (e.g., credit or liquidity) to its proprietary funds under stress conditions like valuation declines or redemptions, even without contractual obligation. This reflects a meaningful change in intent and policy. The LLM incorrectly claims the 'intent' remained consistent, which contradicts the ground truth. Instead, the LLM focuses on funding commitment timelines (e.g., 'expecting to pay substantially all of these commitments between 2022 and 2025'), a detail not mentioned in the original answer and irrelevant to the question about intent and conditions for support. This suggests confusion in multi-hop reasoning—failing to synthesize the shift in qualitative disclosure between years. While the LLM correctly references Schwab and VIEs and the years 2022 and 2024 (entity accuracy), and does not fabricate numeric data (quantitative accuracy is acceptable due to lack of incorrect numbers), the absence of the key 2024 policy shift renders the answer factually wrong. The contextual relevance is moderate because it addresses the topic and timeframe but misses the central evolution in Schwab’s stance. The qualitative reasoning is flawed due to incorrect interpretation of intent continuity and introduction of irrelevant funding timelines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 437,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023 primarily through the sale of shares, which positively impacted liquidity. In 2023, proceeds from the sale of JDE Peet's shares contributed to higher net cash provided by investing activities, as noted in the cash flow section. Additionally, the investment in JDE Peet's provided MDLZ with financial flexibility, as mentioned in the 2023 10-K. The impact on the capital structure was minimal, as the debt-to-capitalization ratio decreased slightly from 0.46 in 2022 to 0.41 in 2023, indicating a reduced reliance on debt financing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that MDLZ's relationship with JDE Peet's changed from 'Has_Stake_In' to 'Invests_In' in 2023, reflecting a reclassification in accounting treatment and strategic posture. However, the LLM incorrectly claims that MDLZ sold shares of JDE Peet's in 2023, which is not supported by the original answer and contradicts the narrative of increased strategic alignment. There is no mention of a sale in the ground truth. (2) The quantitative elements introduced in the LLM answer—such as the debt-to-capitalization ratio decreasing from 0.46 to 0.41—are not present in the original answer and cannot be verified against the provided ground truth. These numbers may be factually incorrect or taken from external data not referenced in the knowledge graph. Since the original answer does not include any financial ratios or cash flow figures, their inclusion here represents fabrication or misattribution. (3) The multi-hop reasoning is flawed. While the LLM attempts to connect JDE Peet's investment to liquidity and capital structure, it does so through unsupported claims of share sales and ratio changes rather than the actual evolution in investment classification and its implications for financial flexibility. The correct reasoning should focus on the change in relationship type and its impact on reporting and strategic integration, not on divestment. (4) Despite the factual errors, the LLM does address the core question about the evolution of the financial relationship and its impact on liquidity and capital structure, showing some contextual understanding. It correctly identifies that the investment contributed to financial flexibility in 2023, which aligns with the original answer. However, the incorrect mechanism (sale vs. reclassification) undermines the overall correctness. Hence, the correctness score is low due to major factual and reasoning errors, though not entirely irrelevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 537,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "The interest rate hedging strategy for the 3.125% 2025 Notes remained consistent between 2022 and 2024, with the interest rate under the swap agreements being SOFR (or LIBOR in earlier years) plus 1.8%. In 2022, the rate was LIBOR + 1.8%, and by 2024, it transitioned to SOFR + 1.8%, reflecting the shift from LIBOR to SOFR as the reference rate.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM states that the spread under the swap was consistently 1.8% (LIBOR + 1.8% in 2022, SOFR + 1.8% in 2024), but the ground truth indicates that while the 2022 rate was not disclosed, the 2024 rate was explicitly SOFR + 2.1%, not 1.8%. Additionally, the LLM incorrectly implies continuity in the hedging strategy, whereas the original answer states that swaps were terminated and reentered in 2022, indicating a change in strategy. (2) The notional amount of $1,000 million is omitted entirely in the LLM response, which is a key quantitative detail provided in the ground truth for both 2023 and 2024. (3) Qualitatively, the reasoning is flawed: the LLM assumes a smooth transition from LIBOR to SOFR with a constant spread, but the ground truth shows a strategic reset of swaps in 2022 with undisclosed rates, and only in 2024 is the SOFR + 2.1% rate specified. There is no mention of LIBOR in the original answer, so asserting LIBOR + 1.8% in 2022 is unsupported. (4) Contextually, the answer addresses the evolution of the hedging strategy and the shift in reference rates, which is relevant, but the factual inaccuracies severely undermine correctness. The synthesis across years is attempted but based on incorrect data, failing the multi-hop requirement. Minor credit is given for recognizing the SOFR transition context and focusing on the correct debt instrument.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 405,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,570 million in fiscal year 2022 to $4,414 million in fiscal year 2023, representing a decline of $1,156 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, Walmart's fair value of equity investments using Level 2 inputs was $5,819 million in fiscal year 2022 and decreased to $5,570 million in fiscal year 2023, a decline of $249 million. The LLM incorrectly states the 2022 value as $5,570 million and the 2023 value as $4,414 million, implying a decline of $1,156 million—both values and the change are wrong. (2) The calculation in the LLM answer ($5,570M - $4,414M = $1,156M) is mathematically correct but based on incorrect input figures, so quantitative accuracy fails at the data level. The correct change is $5,819M - $5,570M = $249M. (3) While the LLM attempts the required multi-hop reasoning—comparing two fiscal years and computing the change—it uses incorrect data points, indicating a failure in retrieving or synthesizing the correct values from the source documents. (4) Contextual relevance is high because the answer addresses the right metric, company, and time frame, and correctly interprets the need to report a year-over-year change. However, due to severe quantitative inaccuracies and resulting flawed conclusions, the overall correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 344,
        "total_tokens": 1458
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "Between its 2023 and 2024 10-K filings, Apple's characterization of its reliance on marketing abilities remained consistent, emphasizing that the company relies primarily on the innovative skills, technical competence, and marketing abilities of its personnel to differentiate its business. There was no notable evolution in the description of marketing's role in Apple's competitive strategy in the provided pages.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Apple's characterization of its reliance on marketing abilities 'remained consistent' between the 2023 and 2024 10-K filings. The ground truth shows a clear evolution in language: from 'relies primarily' in 2023 to 'depends heavily' in 2024, with added strategic context about ensuring a 'continual and timely flow' of competitive offerings. The LLM incorrectly asserts there was 'no notable evolution,' which contradicts the documented shift in emphasis. While there are no numeric values to assess (so quantitative accuracy is high by default), the qualitative accuracy is very low because the model failed to detect and report the change in tone and strategic framing. The answer is contextually relevant to the question but fundamentally wrong in its conclusion, reflecting a failure in multi-hop reasoning—specifically, comparing the two filings to identify changes in language and implication. The original answer highlights a stronger strategic emphasis on marketing due to competitive pressures, a nuance entirely missed by the LLM.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 311,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "The notional amount for the 3.625% 2024 Notes was $1,400 million in 2022 and was fully repaid by 2024, as the notional amount for these notes was $0 by 2024. The interest rate structure for these notes was hedged using interest rate swap contracts at SOFR + 3.4% in 2022, but the swaps matured in 2024 in connection with the repayment of the notes. This indicates that Amgen's hedging strategy involved using interest rate swaps to convert the fixed-rate debt to floating-rate SOFR-based debt, and the termination of these swaps in 2024 reflects the completion of the hedging activity as the underlying debt was repaid.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative details. According to the ground truth, in 2022 Amgen terminated interest rate swaps on a total notional amount of $5.2 billion covering multiple notes, not specifically $1,400 million for the 3.625% 2024 Notes alone. The $1,400 million figure corresponds to the notional amount for these specific notes as of December 2023, not 2022. The LLM incorrectly states the 2022 notional amount as $1,400 million, which is factually wrong. Additionally, the interest rate hedge (SOFR+3.4%) applied in 2023, not 2022 as implied. The LLM also misrepresents the timing and nature of the swap termination — the ground truth states that the swaps were terminated in 2022 and then reentered, not that they matured in 2024. The notional amount dropped to $0 by end of 2024 due to unwinding, not necessarily full repayment. (2) Calculation-wise, the LLM gets the $1,400 million to $0 change correct in direction but misattributes timing. However, it fails to mention the reentering of swaps at current rates in 2022, a key strategic move. (3) The multi-hop reasoning is partially sound — the LLM correctly infers that terminating swaps upon debt repayment reflects a completed hedging strategy. However, it misses the nuance that Amgen actively restructured its hedges in 2022 rather than simply letting them mature, indicating a dynamic hedging strategy. (4) Contextual relevance is high as the answer addresses both parts of the question — changes in notional and rate structure, and implications for hedging. But due to major quantitative errors and incomplete/misrepresented facts, the correctness score is moderate. The qualitative reasoning is reasonable but based on incorrect premises, limiting its accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 486,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "Schwab integrated TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, into its offerings for independent advisor clients by 2023, building on its 2022 efforts to combine Schwab and TD Ameritrade platforms. This evolution indicates Schwab's competitive positioning in the RIA market by enhancing its service capabilities and leveraging acquired technologies to provide more tailored solutions for RIAs, thereby strengthening its value proposition and market leadership.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution of Schwab's integration of iRebal from 2022 to 2023. It correctly identifies that iRebal was part of TD Ameritrade Institutional and was integrated into Schwab's offerings for independent advisors by 2023, building on platform integration efforts that began in 2022. The answer accurately reflects the strategic significance of this integration for Schwab's competitive positioning in the RIA market. However, it omits specific details present in the ground truth, such as Schwab's initial decision in 2022 to merely retain iRebal (without full integration), and the deeper 2023 shift to making it a core offering. Additionally, the ground truth includes concrete evidence of integration scale—over $1.6 trillion in assets and 15 million accounts transitioned by 2023—which strengthens the argument but is missing in the LLM response. There are no numerical inaccuracies (quantitative accuracy is perfect, hence 10), and the entities (Schwab, TD Ameritrade, iRebal, RIAs) and years (2022, 2023) are correct. The reasoning is sound but slightly less detailed in multi-hop synthesis—while it connects integration to competitive advantage, it doesn't explicitly link iRebal's elevation to Schwab's broader credibility and brand strength as a differentiator. Contextual relevance is excellent, directly addressing both parts of the question. The answer is semantically aligned but slightly less comprehensive than the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 408,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "Based on the disclosures in its 10-K filings, Apple introduced a new iMac in the first quarter of 2024 as part of its product announcements, indicating a continued focus on updating its desktop product line. There is no specific mention of prior iMac-related updates in the 2023 filing, suggesting that the 2024 introduction marked a notable evolution in the iMac product line during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but lacks the full depth of the ground truth. (1) It correctly identifies that Apple introduced a new iMac in Q1 2024 and notes the absence of specific iMac updates in the 2023 10-K, which aligns with the original answer's implication of increased strategic focus in 2024. However, it misses the key qualitative shift described in the ground truth: the elevation of iMac to a 'significant product announcement' status in the MD&A section of the 2024 10-K, alongside products like the MacBook Pro and iPad Pro. This omission reduces completeness and reasoning accuracy. (2) There are no numerical values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is partially sound—correctly inferring evolution from absence in 2023 and presence in 2024—but fails to synthesize the strategic context provided in the 2024 filing about the iMac’s elevated status. (4) Contextual relevance is high because the answer addresses the evolution of the iMac line between 2023 and 2024 using 10-K disclosures, though it does not fully capture the nuance of how Apple framed the product strategically.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 320,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "RTX's 2.820% Notes Due 2051 had an aggregate principal balance of $1,000 million in both 2024 and 2023, indicating no change in the outstanding amount during this period. This suggests that the notes remain part of RTX's long-term debt structure, contributing to its extended maturity profile. The stability of this debt instrument reflects a strategic approach to maintaining long-term financing, with no repayments or issuances affecting it between 2022 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 2.820% Notes Due 2051 had a principal balance of $1,000 million in 2024, and implies consistency with 2022 by stating no change between 2023 and 2024. However, it omits explicit confirmation for 2022, instead referencing 2023 which is not mentioned in the ground truth, introducing a minor factual misalignment. The core quantitative fact—$1,000 million principal unchanged—is correct. (2) The dollar amount ($1,000 million) and interest rate (2.820%) are accurate, and the conclusion that no repayment or issuance occurred is logically sound. However, the LLM fails to mention the broader context of total long-term debt increasing from $40,078 million to $41,146 million, a key part of the original answer that explains the evolution of RTX's overall debt structure. This omission limits completeness. (3) The reasoning correctly infers stability in this specific debt instrument but does not perform the full multi-hop synthesis required—linking the unchanged 2051 notes to the expansion in total long-term debt. This weakens the qualitative accuracy, as the conclusion about long-term debt structure is partially supported but lacks the comparative analysis that defines the ground truth. (4) Despite missing the broader debt trend, the answer remains contextually relevant, addressing the core relationship and strategic implication. The score reflects high factual accuracy on the specific note, but partial credit due to missing multi-hop context and reference to an unverified year (2023).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 426,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "Between 2022 and 2023, Schwab transitioned its Investment Deposit Account (IDA) agreement from referencing LIBOR to alternative benchmark rates, as LIBOR ceased publication on June 30, 2023. This change was part of a broader effort to update financial models, systems, and agreements tied to LIBOR. Specifically, the IDA agreement and related intercompany lending agreements were amended to use appropriate reference rates in place of LIBOR. No specific service fee changes were mentioned, but the transition to new reference rates reflects an adjustment in how interest rates are determined under the agreement.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 transition from LIBOR to alternative benchmark rates in Schwab's IDA agreement, including the context of LIBOR's cessation on June 30, 2023, which aligns with the ground truth. However, it omits the key 2022 change in service fees—specifically the reduction from 25 to 15 basis points—which is a central part of the question about the evolution of terms between 2022 and 2023. This omission significantly affects completeness and factual accuracy. (2) Quantitatively, the LLM does not include any incorrect numbers; it avoids stating false figures and correctly references the 2023 LIBOR phase-out date. Since it fails to mention the 25 to 15 basis point fee reduction, those specific percentages are missing, but no numerical inaccuracies are present. (3) The reasoning around the LIBOR transition is sound and reflects proper synthesis of financial regulatory trends and Schwab’s contractual updates. However, the model fails in multi-hop reasoning by not connecting both years’ changes—fee structure in 2022 and reference rate shift in 2023—as complementary evolutions of the same agreement. The absence of the 2022 fee adjustment breaks the full narrative of how terms evolved across both years. (4) Contextual relevance is high because the answer addresses the core topic (IDA agreement changes) and provides relevant background on LIBOR. However, the lack of service fee details reduces completeness. The qualitative accuracy is moderate due to correct logic but incomplete entity-event linkage. Correctness score is 6 due to significant omission of a key factual component (fee change), despite accurate treatment of the LIBOR transition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 465,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "The change in Filorga's financial treatment from 2023 to 2024 suggests a shift in its strategic importance and valuation approach by Colgate-Palmolive. In 2023, Filorga was recognized as a standalone reporting unit with $221 million in goodwill, indicating it was viewed as a distinct and valuable business segment. By 2024, Filorga was listed among other trademarks within broader segments, implying a reclassification likely due to a realignment of reporting structures. This change reflects a more integrated approach to valuing intangible assets, treating Filorga as part of a larger portfolio of brands rather than a separate entity, and may indicate a reduced emphasis on its standalone strategic significance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: in 2023, Filorga was a standalone reporting unit with $221 million in goodwill, and in 2024, it was grouped with other trademarks without separate disclosure. These facts match the ground truth exactly. The interpretation — that this reflects a shift in strategic importance and valuation approach — is consistent with the original answer. (2) Quantitative accuracy is perfect: the $221 million goodwill figure and the years 2023 and 2024 are correctly cited. No calculations are required, and all numbers are accurate. (3) The multi-hop reasoning is sound: the model synthesizes changes in financial reporting treatment over time and infers implications for strategic importance and valuation methodology. It correctly interprets the move from standalone to aggregated reporting as indicative of integration into a broader brand portfolio. The only minor shortcoming is that it does not explicitly mention the impact on impairment analysis or future strategic decisions like divestiture or investment, which are included in the ground truth and add depth to the implications. (4) Contextual relevance is excellent — the answer directly addresses the question about strategic importance and valuation approach. Overall, the answer is factually correct, well-reasoned, and only slightly less comprehensive than the ground truth in discussing downstream strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 399,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "The 2024 10-K filing reflects a more detailed and forward-looking disclosure about the iPhone 16 Pro compared to the 2023 filing, indicating Apple's strategic shift toward emphasizing innovation and differentiation in its product development. The 2024 filing explicitly mentions the iPhone 16 Pro in the context of new product launches and technological advancements, such as Apple Intelligence™ and updated operating systems, highlighting a focus on integrating AI and enhancing user experience. This evolution in reporting suggests Apple is aligning its disclosures with its broader strategy to underscore product leadership and long-term competitive advantages.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents the core facts from the ground truth. (1) It claims the 2024 10-K contains 'more detailed and forward-looking disclosure' about the iPhone 16 Pro, which contradicts the ground truth: the 2023 filing was forward-looking (announcing the iPhone 16 Pro as part of the upcoming Q4 2024 lineup), while the 2024 filing treats it as an existing product, indicating a retrospective, not forward-looking, posture. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable in terms of calculations, but the temporal facts (2023 vs 2024 filing content) are factually wrong—this is a critical error in factual reporting. (3) The multi-hop reasoning fails: the model should have recognized the shift from planning/launch phase (2023) to established product (2024), but instead asserts increased forward-looking detail in 2024, which is the opposite of the truth. (4) The mention of 'Apple Intelligence™', 'new product launches', and 'updated operating systems' in the 2024 context is speculative and not supported by the ground truth, introducing fabricated context. While the answer is relevant to Apple's reporting strategy, its factual foundation is inverted, leading to a low correctness score. Contextual relevance is moderate because it addresses product development and reporting strategy, but with incorrect evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 388,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "Between 2022 and 2023, the company enhanced its Economic Value of Equity (EVE) simulations by incorporating updated modeling assumptions, particularly in response to rising interest rates and evolving balance sheet dynamics. In 2023, the company updated deposit beta assumptions in a declining market interest rate environment for its EVE and net interest revenue simulation models, reflecting more current client behaviors and market conditions. Additionally, the liability duration shortened significantly due to rising interest rates, becoming shorter than asset duration, which increased EVE sensitivity. The company also began utilizing interest rate swap derivative instruments in 2023 to assist with managing interest rate risk, with these effects incorporated into EVE analyses. These changes reflect a more dynamic and responsive approach to modeling interest rate risk in 2023 compared to 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that in 2023, the company updated deposit beta assumptions in a declining interest rate environment and incorporated these into net interest revenue and EVE models, which aligns with the ground truth. However, it incorrectly states that these updates were made in response to 'rising interest rates' and that liability duration shortened due to rising rates—this contradicts the ground truth, which specifies a 'declining interest rate environment.' This mischaracterization of the rate environment undermines the reasoning. Additionally, the LLM introduces new information not present in the ground truth: the use of interest rate swaps in 2023 and their incorporation into EVE analyses, which is unsupported. It also mentions changes in liability and asset duration comparisons, which were not part of the original answer. (2) There are no specific numerical values (e.g., percentages, dollar amounts) in either the ground truth or LLM answer, so quantitative accuracy is not heavily penalized, but the directional error (rising vs. declining rates) affects factual precision. (3) The multi-hop reasoning is partially sound—the LLM attempts to connect modeling updates to balance sheet dynamics and client behavior—but it fabricates causal mechanisms (duration shifts, derivatives use) and misaligns the economic context. The core evolution—enhanced modeling of client cash allocation in 2023—is missing entirely, which is a key point in the ground truth. Instead, the LLM invents 'client behaviors' as a rationale for beta updates without mentioning the specific addition of client cash allocation effects. (4) The contextual relevance is high because the answer stays focused on EVE simulation evolution and interest rate risk modeling. However, the correctness score is moderate due to significant factual inaccuracies and hallucinated details, despite capturing the deposit beta update correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 541,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 enhanced its competitive positioning by expanding its product portfolio into edge networking, including mobile broadband and wireless access points. This move allowed Qualcomm to leverage its foundational technologies in 5G, Wi-Fi, and RF front-end components to offer end-to-end solutions, strengthening its presence in the broader networking market and differentiating itself from competitors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately captures Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 (correct years and entity actions). The answer correctly identifies the impact on competitive positioning and product portfolio breadth, noting the expansion into end-to-end solutions and stronger presence in edge networking. It references relevant technologies (5G, Wi-Fi, RF) and implies broader market competition, though it does not explicitly name competitors like Broadcom and Intel as in the original answer—this is a minor omission but does not detract from the core factual accuracy. There are no numerical values requiring verification, so quantitative accuracy is 10. The reasoning is sound, demonstrating multi-hop synthesis between years, strategic changes, and implications for market positioning. The answer is semantically equivalent to the ground truth, with slightly less detail on specific product categories (e.g., routers, network processors) but still conveys the essential expansion of the product suite. Contextual relevance is perfect—directly addresses the question’s focus on competitive positioning and portfolio breadth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 353,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "In 2022, approximately 28% of Schwab's adjustable-rate mortgages had interest-only payment terms, with about 89% of these not scheduled to reset for three or more years. By 2023, the percentage of adjustable-rate mortgages with interest-only terms slightly decreased to 27%, while the portion not scheduled to reset for three or more years increased to 86%. This indicates a marginal decline in the prevalence of interest-only terms and a slight reduction in the proportion of such loans with extended reset periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor error in the interpretation of the second metric. Quantitatively, the percentages are accurate: 28% to 27% for interest-only adjustable-rate mortgages (correct), and 89% to 86% for those not scheduled to reset for three or more years (also correct). However, the LLM incorrectly states that the portion not scheduled to reset 'increased to 86%', when in fact it decreased from 89% to 86%. This misstatement affects the qualitative reasoning, as the conclusion about a 'slight reduction in the proportion of such loans with extended reset periods' is correct, but the supporting explanation incorrectly frames the 86% as an increase rather than a decrease. Despite this, the overall trend interpretation aligns with the ground truth—both metrics declined slightly. The entities (Schwab, HELOC, adjustable-rate mortgages, years 2022–2023) and timeframes are accurate, and the answer addresses all parts of the multi-hop question. Semantic equivalence is largely preserved, and contextual relevance is strong. The error is limited to a single mischaracterization of directionality, not magnitude or data origin.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 326,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "Qualcomm's involvement in the XR (Extended Reality) market evolved from 2022 to 2023 through strategic investments and product development. In 2022, Qualcomm highlighted its focus on XR as part of its QSI segment, making strategic investments in early-stage companies across various industries, including XR. By 2023, the company expanded its QCT segment's product offerings, with QCT revenues including XR as part of the IoT category, indicating increased product integration and market engagement in XR technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies Qualcomm's 2022 focus on XR through strategic investments, particularly via early-stage funding, and notes the evolution in 2023 to direct product integration and revenue generation under the QCT segment, specifically within IoT. While the original answer emphasizes a shift from investment (Qualcomm Ventures) to commercialization (product sales), the LLM captures this transition by referencing QCT revenues including XR, which is semantically equivalent. The mention of QSI in 2022 is slightly less precise—the ground truth emphasizes Qualcomm Ventures rather than QSI—but this does not materially misrepresent the strategic investment angle. No numeric inaccuracies are present; dates and entities (Qualcomm, XR, 2022–2023 timeline) are correct. The reasoning is sound, showing a logical progression from investment to product integration. The answer is highly contextually relevant, directly addressing the evolution in strategy and revenue disclosure. The only minor gap is the lack of explicit mention that XR was 'explicitly listed' as a revenue-generating area in filings, but the inference from QCT/IoT inclusion is valid. Thus, the answer is highly accurate with only slight room for added precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 364,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained at $1,100 million between 2022 and 2024, as shown in the long-term debt tables for both periods. This stability indicates that RTX has not issued new notes of this type or repaid any existing ones during this period, suggesting a consistent long-term debt structure for this specific obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the aggregate principal balance of the 3.030% Notes Due 2052 remained at $1,100 million in both 2022 and 2024, matching the ground truth exactly. All numeric values, including the interest rate (3.030%), maturity year (2052), dollar amount ($1,100 million), and time frame (2022 to 2024), are accurate. (2) Quantitative accuracy is perfect—no calculation errors or misstatements; format variation ($1,100 million) is acceptable and standard. (3) The reasoning is sound: the stability in principal balance implies no new issuances or repayments, which aligns with the ground truth’s interpretation. The LLM correctly infers strategic consistency in RTX’s long-term debt management for this instrument. However, it omits a minor but relevant point from the original answer: that this stability occurred despite changes in other long-term debt components, which adds context about RTX’s broader capital structure management. This omission slightly reduces completeness and qualitative accuracy but does not undermine the core correctness. (4) The answer is fully contextually relevant, directly addressing both parts of the question—evolution of the balance and its implication for RTX’s debt structure. Overall, the response is factually correct, well-reasoned, and only slightly less comprehensive than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 382,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "Between 2023 and 2024, AXP has further emphasized innovation and differentiation in its Corporate Card solutions, evolving its value propositions and expanding features such as financing and payment solutions for business customers. This shift underscores a broader commercial payments strategy focused on enhancing the capabilities of its integrated payments platform, strengthening its position in the commercial market, and delivering tailored solutions to meet the needs of business clients.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All entities—AXP, Corporate Card solutions, 2023–2024 timeframe, commercial payments strategy—are correctly identified. There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years, which are accurate. (2) The answer addresses both parts of the question: the evolution between 2023 and 2024 and what it suggests about AXP’s broader strategy. It correctly captures the shift from differentiating corporate card and expense management solutions in 2023 to offering more integrated financing, banking, and payment solutions in 2024. (3) The multi-hop reasoning is sound: it synthesizes AXP’s strategic emphasis across two years and infers a broader strategic intent toward integrated business financial services. The only minor shortcoming is that the LLM answer does not explicitly mention 'accounts payable expense management' or 'solution-oriented approach' from the original, slightly reducing qualitative precision. However, the core meaning—that AXP is moving beyond product differentiation to a more holistic suite—is clearly conveyed. (4) Contextual relevance is perfect: the response directly addresses the evolution and strategic implication without extraneous information. Overall, this is a highly accurate, well-reasoned answer with only negligible omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 397,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "Between 2023 and 2024, PCA SKIN's strategic positioning within Colgate-Palmolive's Oral, Personal, and Home Care segment has evolved to include a broader distribution strategy. In 2023, PCA SKIN products were primarily sold to skin health professionals, while by 2024, the brand expanded its reach to include traditional and e-commerce retailers, wholesalers, and distributors. This shift reflects an effort to increase market accessibility and broaden the brand's customer base.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly reverses the evolution of distribution channels for PCA SKIN. According to the ground truth, in 2023 PCA SKIN was sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists — not primarily to skin health professionals. The expansion occurred in 2024, when distribution was broadened to include sales to skin health professionals in some geographies, not the other way around. The LLM falsely claims that in 2023 the brand was focused on skin health professionals and then expanded into retail and wholesale channels in 2024, which is factually inverted. (2) There are no numeric values, percentages, or financial figures in the question or answers, so quantitative accuracy is not applicable — no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is fundamentally flawed: the model fails to correctly synthesize the directional change in distribution strategy across the two years. It misidentifies the sequence and nature of channel expansion, indicating a failure in logical inference from the source data. (4) While the answer addresses the topic of distribution channel evolution and is framed around the correct segment and brand, its core factual claim is reversed, making it largely incorrect. Contextual relevance is moderate because it discusses the right brand, company, and type of strategic change, but the substance is inaccurate. Correctness and qualitative accuracy are low due to the inversion of key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 419,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "Between 2022 and 2023, Opdivo's strategic focus and commercial positioning evolved through expanded tumor indications and combination therapies. In 2023, Opdivo received approvals for new indications such as adjuvant treatment for melanoma and neoadjuvant treatment for resectable non-small cell lung cancer (NSCLC), both in combination with other therapies. These developments, along with ongoing studies for additional tumor types and combinations, position Opdivo for broader use in earlier lines of therapy, potentially enhancing its revenue growth trajectory by expanding its market reach and therapeutic utility.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Opdivo's strategic focus toward new indications and combination therapies between 2022 and 2023, and accurately highlights expansion into earlier lines of therapy such as adjuvant melanoma and neoadjuvant NSCLC. However, it omits key details present in the ground truth, including the full list of indications approved in 2022 (e.g., bladder, blood, CRC, HCC, MPM, stomach cancers) and the specific commercial success in U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. The mention of 2023 approvals is partially accurate but lacks specificity about regulatory breadth across multiple markets and the continued role of the Opdivo + Yervoy regimen. Additionally, the LLM fails to mention the subcutaneous formulation, a key strategic element in the original answer that impacts long-term adoption and patient benefits. (2) There are no numerical values, dates, or calculations in either answer that conflict; the use of '2022' and '2023' is consistent and accurate. Thus, quantitative accuracy is high. (3) The reasoning is sound in connecting expanded indications and earlier-line use to revenue growth, demonstrating correct multi-hop synthesis between clinical development and commercial implications. However, the answer is less comprehensive in synthesizing the full scope of 2022 positioning and the breadth of combination approvals, weakening the qualitative accuracy. (4) The answer is contextually relevant and addresses the core of the question—evolution in strategy and implications for revenue—but misses critical components of the full strategic picture, particularly around Yervoy combinations and delivery innovation, warranting a moderate score on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 493,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "American Express's investment in foreign government bonds and obligations remained stable in fair value between 2023 and 2024, with $770 million in 2023 and $765 million in 2024. In terms of maturity distribution, in both years, all of these investments were due within one year, indicating a short-term focus for these holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, American Express held $549 million in foreign government bonds in 2023, not $770 million as stated. The 2024 value of $765 million is correct. The LLM incorrectly claims the fair value remained stable, when in fact it increased substantially from $549M to $765M. (2) Maturity distribution is completely misrepresented: in 2023, all $549 million matured in 12 months or more (i.e., long-term), not within one year as the LLM claims. In 2024, $764 million matured within one year and $1 million after one year, so the 2024 maturity description is partially correct but still misaligned with the full picture. The LLM falsely states that in both years all investments were due within one year, which contradicts the 2023 data. (3) Multi-hop reasoning failed: the model did not correctly synthesize the change in both fair value and maturity structure over time. It missed the key shift from long-term maturities in 2023 to predominantly short-term in 2024, which is central to the question. (4) Contextual relevance is moderate because the answer addresses the right topic (fair value and maturity evolution), but with incorrect data and reasoning, undermining the overall correctness. The conclusion about a 'short-term focus in both years' is false given the 2023 long-term positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 386,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "Between 2022 and 2024, the amount of Walmart's cash not freely transferable to the U.S. decreased from $4.3 billion as of January 31, 2022, to $3.3 billion as of January 31, 2025. The cash not freely transferable is primarily due to local laws or other restrictions in the jurisdictions where it is held, and in some cases, requires approval from noncontrolling interest shareholders, particularly in relation to Flipkart. Walmart utilizes intercompany financing arrangements to ensure cash can be made available in the country where it is needed at the minimum cost possible. These arrangements allow the company to manage liquidity across its global operations while adhering to legal and regulatory constraints.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in cash not freely transferable from $4.3 billion in 2022 to $3.3 billion in 2024, aligning with the ground truth. However, it incorrectly states the 2024 figure as of January 31, 2025, rather than January 31, 2024 (fiscal year 2024), which is a minor date misalignment but still within acceptable reporting period interpretation given Walmart's fiscal calendar (ends January 31). (2) The numeric values are accurate: $4.3 billion in 2022 and $3.3 billion in 2024 are correctly reported. The ground truth specifies that in 2022, $2.2 billion of the restricted cash was tied to Flipkart shareholder approval; this specific breakdown is missing in the LLM answer, representing a minor omission. (3) The qualitative reasoning is sound: the LLM correctly notes that restrictions arise from local laws and noncontrolling interest approvals, and it broadly captures the shift toward a more generalized reference to noncontrolling shareholders rather than specifically Flipkart, though it still mentions Flipkart as a key example. This reflects partial synthesis of the evolving conditionality, but does not fully emphasize the shift in framing from Flipkart-specific to broader noncontrolling interest language as highlighted in the original answer. (4) Contextual relevance is strong—the response directly addresses both parts of the question: the change in amount and the conditions for transfer. It also accurately describes Walmart’s use of intercompany financing for global liquidity management. The slight deduction in correctness and qualitative accuracy is due to the missing Flipkart-specific detail in 2022 and the soft date mismatch, but overall, the answer is factually solid and semantically close to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 484,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "Between 2023 and 2024, the composition of Texas Instruments' U.S. Retiree Health Care Plan assets showed a slight shift in allocation. In 2023, fixed income securities and cash equivalents accounted for 80% of the total plan assets, while equity securities made up 20%. In 2024, the allocation remained largely consistent, with fixed income securities and cash equivalents at 80% and equity securities at 20%. Thus, the allocation between fixed income and equity securities remained stable from 2023 to 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the asset allocation between fixed income and equity securities remained stable from 2023 to 2024, which aligns with the ground truth that there was no change in composition. However, it inaccurately rounds the percentages: the ground truth specifies fixed income at approximately 79.5% and equity at 20.5% in both years, not 80% and 20% as stated. While this is a minor rounding difference, it affects quantitative accuracy because the exact figures are available and should be reflected precisely. (2) The LLM fails to report the actual dollar amounts ($210 million in fixed income and cash equivalents, $54 million in equity securities, totaling $264 million), which are key components of the original answer and necessary for full completeness. The omission of these figures means the answer lacks critical quantitative detail. (3) The reasoning is partially sound—the conclusion of stability in allocation is correct—but the answer does not demonstrate multi-hop verification across the 2023 and 2024 filings by citing the identical dollar values, which is central to the ground truth's conclusion of no evolution. (4) Contextual relevance is high because the response addresses the core question about allocation changes and correctly concludes no significant shift. However, due to missing dollar amounts and imprecise percentages, the correctness score is reduced to 6, reflecting partial accuracy with notable omissions in quantitative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 415,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "Between 2022 and 2024, Honeywell's 2006 Stock Plan for Non-Employee Directors evolved by introducing more specific and updated forms of award agreements, such as the \"Form of Stock Option Award Agreement\" and \"Form of Restricted Stock Unit Agreement\" under the 2016 Stock Plan for Non-Employee Directors. These amendments suggest a shift toward more structured and performance-based compensation mechanisms for non-employee directors, reflecting a broader trend in aligning director incentives with long-term shareholder value and corporate governance best practices.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual and entity errors. (1) It incorrectly states that the changes occurred under the '2016 Stock Plan for Non-Employee Directors', while the question and ground truth are specifically about the '2006 Stock Plan'. This is a critical entity error. (2) The LLM claims new forms were 'introduced', but the ground truth indicates that the 'Form of Restricted Unit Agreement' was dropped between 2022 and 2024, not that new forms under a different plan were added. (3) There is no mention in the LLM answer of the specific exhibit numbers (e.g., Exhibit 10.30, 10.32 in 2022; 10.29 in 2024), which are key to verifying the evolution of award agreements. (4) The reasoning about a shift toward 'performance-based compensation' and 'structured mechanisms' is speculative and not supported by the ground truth, which only notes a potential shift from restricted units to stock options based on exhibit removal. (5) The answer fails the multi-hop requirement: it does not correctly track the change in award forms under the 2006 plan over time. While the general topic of director compensation evolution is relevant, the specific facts, entities, and timeline are wrong, leading to a low correctness score. Minor credit is given for addressing the theme of compensation structure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 371,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "Between 2022 and 2024, Walmart's strategic position regarding its ownership stake in Flipkart evolved as it faced regulatory scrutiny in India. In 2022, Walmart's ownership in Flipkart was reduced from approximately 83% to 75% following a new equity funding round. By 2024, Flipkart was under investigation by the Directorate of Enforcement in India for alleged violations of Foreign Direct Investment rules from 2009 to 2015, prior to Walmart's majority acquisition in 2018. This regulatory exposure could result in monetary penalties or share ownership restrictions, though the outcome remains uncertain. Financially, Walmart's reduced stake and potential regulatory liabilities could impact its financial position and cash flows from Flipkart.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Walmart's ownership stake decreased from 83% to 75% in 2022 due to an equity funding round, and regulatory scrutiny by India's Directorate of Enforcement relates to FDI violations from 2009–2015, prior to Walmart's 2018 acquisition. The $3.2 billion funding amount is implied (though not explicitly stated) as the cause of the stake reduction, which is consistent with known events. (2) Quantitative accuracy is excellent: percentages (83% to 75%), years (2009–2015, 2018 acquisition, 2022 stake change) are all correct. The only minor omission is the explicit mention of the $3.2 billion figure, which was present in the original answer and adds financial specificity. (3) Reasoning is sound: the LLM correctly synthesizes the evolution from financial de-risking (reduced stake) to ongoing regulatory exposure, recognizing that risks stem from pre-acquisition conduct. It appropriately notes uncertainty in outcomes and potential impacts on financials. (4) Contextual relevance is strong—directly addresses strategic position, financial implications, and regulatory risks. The answer could have slightly improved by mentioning the July 2021 show cause notice and Walmart’s disclosure about inability to estimate losses or indemnification, which are important nuances in risk exposure. However, the core multi-hop synthesis across time, ownership, and regulation is accurate and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 412,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "Between 2022 and 2024, HON's U.S. cash balances decreased from $11.5 billion in 2022 to $11.0 billion in 2024, while total cash holdings declined from $11.5 billion in 2022 to $8.1 billion in 2023 before slightly increasing to $11.0 billion in 2024. The geographic distribution of funds showed that as of December 31, 2024, $8.0 billion of cash, cash equivalents, and short-term investments were held in non-U.S. subsidiaries, indicating a strategic shift toward international liquidity. This shift likely reflects efforts to optimize global capital allocation and manage tax efficiency, particularly in light of evolving regulatory frameworks like the OECD's Pillar Two global minimum tax.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that HON's U.S. cash balances decreased from $11.5 billion in 2022 to $11.0 billion in 2024. However, the original answer clarifies that the $11.5 billion figure was as of December 31, 2021 (reported in 2022), and the $11.0 billion was as of December 31, 2024 (reported in 2024). The LLM misattributes the timing of these figures, implying a direct year-over-year decline in U.S. cash, which is not supported. Additionally, the LLM introduces a $8.1 billion total cash figure for 2023 that is not present in the ground truth and cannot be verified. (2) The only correct quantitative data points are the $11.0 billion total cash in 2024 and the $8.0 billion held in non-U.S. subsidiaries as of that date. However, the claim that $8.0 billion includes 'short-term investments' is an overreach—the original answer specifies 'cash and cash equivalents,' not short-term investments. (3) The reasoning partially captures the geographic shift in cash distribution but incorrectly frames it as a reduction in U.S. cash holdings, when the original answer does not specify U.S. cash in 2022—only total cash. The strategic emphasis on safety and diversification is omitted in the LLM answer, replaced with speculative commentary on OECD Pillar Two and tax efficiency, which are not mentioned in the ground truth. (4) Despite these issues, the answer correctly identifies the key trend of increased non-U.S. cash holdings and maintains contextual relevance by addressing both total cash and geographic distribution. The qualitative reasoning is plausible but includes unsupported inferences. Hence, the correctness score is 5 due to partial factual accuracy with significant errors in data attribution and missing core elements of the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 498,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "From 2023 to 2024, the financial treatment and liability estimation methodology for the Membership Rewards program remained largely consistent, with continued use of the Ultimate Redemption Rate (URR) and weighted average cost (WAC) per point to estimate the liability. However, in 2024, additional sensitivity metrics were provided, indicating that a 25 basis point increase in URR would raise the liability by approximately $197 million, and a 1 basis point increase in WAC per point would increase it by approximately $220 million. This highlights a more explicit quantification of the impact of changes in assumptions in 2024 compared to 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in terms of quantitative accuracy, correctly reporting the sensitivity figures: a 25 basis point increase in URR increases liability by $197 million and a 1 basis point increase in WAC per point increases it by $220 million. These numbers match the ground truth exactly, earning full marks for quantitative accuracy. However, the qualitative reasoning is significantly flawed. The LLM incorrectly states that the Ultimate Redemption Rate (URR) and weighted average cost (WAC) per point were 'continued' from 2023, implying these modeling assumptions were already in use in 2023. In contrast, the ground truth explicitly states that in 2023, only deferred fees were mentioned—there was no disclosure of URR or WAC methodology. The shift in 2024 was from a simpler deferral approach to a more sophisticated, model-driven methodology using URR and WAC. By asserting continuity rather than evolution, the LLM misrepresents the core change in financial treatment. This is a critical error in multi-hop reasoning, as it fails to recognize the progression from basic revenue deferral in 2023 to detailed liability modeling in 2024. Contextual relevance is high because the answer addresses the question's focus on methodology evolution and includes relevant metrics, but the incorrect characterization of the 2023 methodology undermines the overall correctness. Hence, the correctness score is moderate (5/10), reflecting accurate numbers but flawed conceptual and comparative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 415,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "Adobe acquired Frame.io in October 2021 for approximately $1.18 billion and began integrating it into its Digital Media segment. By 2024, Frame.io's integration has advanced, with the platform being directly connected to key Adobe video tools such as Adobe Premiere Pro, After Effects, Photoshop, and Lightroom, enabling seamless frame-specific feedback and collaboration. Additionally, Frame.io is part of Adobe GenStudio, which supports large-scale content production. This integration aligns Frame.io with Adobe's broader product ecosystem by enhancing cross-product workflows and reinforcing Adobe's position in creative collaboration and video production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of Frame.io's integration into Adobe's ecosystem between 2022 and 2024. (1) Quantitatively, all numbers and dates are correct: the $1.18 billion acquisition price is accurate, and while the acquisition closed in October 2021 (slightly before the 2022 focus of the question), this is a minor contextual detail that does not undermine the answer. The mention of integration into Premiere Pro, After Effects, Photoshop, and Lightroom aligns with ground truth, though the original answer specifies Workfront instead of Lightroom. This is a minor discrepancy—both are part of Adobe’s ecosystem, but Workfront was explicitly named in the ground truth as a key integration point by 2024. (2) The inclusion of Frame.io in Adobe GenStudio is correctly noted, which is a key strategic signal of deeper ecosystem alignment. (3) The reasoning is sound: the answer captures the multi-hop progression from acquisition and initial integration (2022 context) to deep product integration and strategic positioning by 2024. (4) The answer addresses all core aspects of the question—strategic positioning, integration timeline, and alignment with Adobe’s broader ecosystem—making it contextually excellent. The only reason for not scoring a 10 is the substitution of Lightroom for Workfront, which slightly affects qualitative accuracy in entity precision, though the overall meaning remains largely intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 401,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "The composition of private alternative investments, specifically equity-like funds, in terms of fair value measurements using significant unobservable inputs (Level 3), slightly increased between 2022 and 2023. In 2022, equity-like funds had $25.4 million in Level 3 fair value measurements, while in 2023, this amount rose to $25.1 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It states that in 2022, equity-like funds had $25.4 million in Level 3 fair value, and in 2023 it was $25.1 million, implying a slight decrease. However, the ground truth shows the opposite: $5.5 million in 2022 and $25.4 million in 2023 — a significant increase, not a slight change. The LLM swapped the years and misrepresented the trend. (2) Quantitative accuracy is critically flawed: the values are either reversed or inaccurately reported. The 2022 figure is off by a factor of nearly 5x (reports $25.4M vs. correct $5.5M), and 2023 is slightly wrong ($25.1M vs. correct $25.4M). These are not minor rounding differences but fundamental errors. (3) The reasoning is unsound: the conclusion of a 'slight increase' contradicts the actual fivefold growth. The model failed to correctly synthesize the multi-hop information across years and misrepresents the evolution. (4) Contextual relevance is partially met — the answer addresses fair value measurements of equity-like funds using Level 3 inputs and the time frame — but with completely incorrect data, rendering the response misleading. Due to severe factual and quantitative errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 354,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "Adobe acquired Frame.io in October 2021 for approximately $1.18 billion and began integrating it into its Digital Media segment. By 2024, Frame.io is positioned as a cloud-native creative collaboration platform, directly integrated with key Adobe Apps like Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. It enables real-time upload, review, and approval workflows for video, still images, design files, and PDFs, with features such as Camera to Cloud functionality for automatic footage upload. Frame.io is also part of Adobe GenStudio, enabling scalable content production. This integration reflects Adobe's strategy to enhance cross-product collaboration and streamline creative workflows within its Digital Media offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe acquired Frame.io in October 2021 (not 2022, but the answer correctly states the 2021 acquisition), and integration into the Digital Media segment began post-acquisition, with deeper embedding by 2024. The mention of integration with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, and inclusion in Adobe GenStudio matches the original answer. (2) Quantitative accuracy is perfect: the $1.18 billion acquisition figure, while not in the original answer, is a correct external fact and does not contradict the ground truth; no incorrect numbers, dates, or financials are present. (3) Multi-hop reasoning is sound—the answer synthesizes Frame.io’s acquisition, initial integration, and evolution into a core collaboration platform by 2024, correctly inferring strategic intent. (4) The only minor gap is that the original emphasizes the evolution *between 2022 and 2024*, and while the LLM references the 2021 acquisition, it still accurately describes the 2024 state and implies the progression. The added detail about Camera to Cloud and file type support enhances context without introducing error. Semantic equivalence is maintained, with slightly richer detail in the LLM response. Thus, the answer earns a 9 for correctness and qualitative accuracy due to excellent fidelity with one small nuance in temporal framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 398,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "Between 2022 and 2024, CVS expanded its Medication Management approach by enhancing clinical programs and digital tools to improve medication adherence and cost efficiency. Key developments include the launch of the **CVS Weight Management program**, which optimizes GLP-1 medication use with lifestyle support, and the **Pharmacy Advisor** program, which uses digital, phone, and provider outreach to help members with chronic diseases adhere to prescriptions. Additionally, the **Drug Savings Review** tool provides visibility into lower-cost alternatives through advanced analytics and data sharing. CVS also integrated **Canopy**, a proprietary AI-driven platform, to support value-based care by enabling personalized care plans and predictive insights, further enhancing medication management and patient outcomes.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of CVS's evolution in Medication Management between 2022 and 2024, correctly identifying a shift toward enhanced clinical programs and digital tools for adherence and cost efficiency. It accurately mentions the CVS Weight Management program with GLP-1 optimization and lifestyle support, which aligns with the 2024 developments in the ground truth. The contextual relevance is high, as the response addresses medication adherence, cost efficiency, digital tools, and clinical programs. However, there are significant qualitative inaccuracies: (1) The 'Pharmacy Advisor' program is not mentioned in the ground truth and appears to be fabricated or misattributed; (2) The 'Drug Savings Review' tool is not present in the original answer—instead, the ground truth specifies 'NovoLogix preauthorization platform' and enhanced analytics for lower-cost alternatives, which the LLM omits; (3) 'Canopy' as an AI-driven platform is not referenced in the ground truth—instead, the correct 2024 expansion includes integration through Oak Street Health, operating 239 primary care centers in 27 states, which the LLM fails to mention entirely. These omissions and substitutions represent a failure in entity accuracy and multi-hop synthesis, particularly around key 2024 initiatives. While no numeric values are incorrect (hence a 10 in quantitative accuracy), the LLM invents tools and omits major factual components (e.g., Oak Street Health, NovoLogix), undermining the factual integrity of the response. The core idea of digital and clinical expansion is correct, but the specific supporting evidence is partially inaccurate or fabricated, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 466,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved significantly from 2022 to 2024 by deepening its collaboration workflows and expanding its capabilities. In 2022, Adobe acquired Frame.io and began integrating it into Creative Cloud to enhance collaborative video workflows, particularly in Premiere Pro and After Effects. By 2024, Frame.io was further embedded as a core component of Adobe GenStudio, enabling scalable content production, and its review and approval features were enhanced to provide a seamless, cloud-native experience. Specific enhancements to collaboration features included frame-accurate commenting, real-time upload and review, and Camera to Cloud functionality, which allows footage to be automatically uploaded from set for immediate review. Additionally, Frame.io now supports a broader range of file types, including still images, design files, and PDFs, and integrates with Adobe Workfront for streamlined project management.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of timeline, key developments, and feature enhancements. It accurately notes the 2022 acquisition and integration into Creative Cloud with initial focus on Premiere Pro and After Effects. The description of 2024 enhancements—real-time upload, review, Camera to Cloud, support for still images, design files, and PDFs, and integration with Workfront—is factually consistent with the original answer. However, the LLM introduces 'Adobe GenStudio,' which is not mentioned in the ground truth and appears to be incorrect or speculative; there is no evidence in the provided data that Frame.io is embedded in a product called GenStudio. This is a notable entity error affecting qualitative accuracy. All dates (2022, 2024) and feature descriptions (frame-accurate commenting, Camera to Cloud) are accurate, and no numerical data is incorrect (quantitative accuracy is perfect). The reasoning correctly synthesizes the evolution from video-specific to broader creative collaboration, showing sound multi-hop logic. The answer is highly contextually relevant, addressing both the evolution and specific collaboration enhancements. The one fabricated entity prevents a higher score, but core facts and timeline are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 360,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "The use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024 by becoming more integrated into fair value determination, particularly for corporate loans and lending commitments. In 2024, the valuation techniques for corporate loans increasingly relied on recently executed transactions, market price quotations, and implied yields from comparable debt, adjusted for basis differences between cash and derivative instruments. Additionally, for nonrecurring fair value measurements, the valuation of loans and lending commitments incorporated recently executed transactions and market price quotations more prominently, especially when position-specific external price data were not observable. This evolution reflects a shift toward leveraging observable market data to enhance the accuracy and reliability of fair value assessments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in the use of recently executed transactions from 2023 to 2024 as described in the ground truth. (1) What was correct: The answer correctly identifies that recently executed transactions were used in 2023 and continued to be important in 2024 for valuing corporate loans and lending commitments, and that they were used alongside market price quotations and implied yields. It also correctly notes increased reliance on observable market data, which aligns with the trend toward more reliable fair value measurements. (2) Quantitative accuracy: There are no specific numbers, percentages, or dollar amounts in either the original or LLM answer, so this dimension is neutral; no inaccuracies present. (3) Multi-hop reasoning assessment: The LLM fails to capture the key shift in 2024—namely, that the use of recently executed transactions became more specifically targeted to the held-for-sale category of loans and lending commitments, and was extended to other assets like 'other investments' where it was combined with discounted cash flow models and comparable company multiples. This represents a more focused and broader application, respectively, which the LLM does not mention. Instead, it generalizes increased integration without specifying the change in scope or category focus. (4) Justification for scores: The correctness score is 6 due to partial factual accuracy—core elements (continued use of transaction data) are right, but the nuanced evolution (targeted use in held-for-sale, extension to other assets) is missing. Qualitative accuracy is 6 because while reasoning is logical, it lacks the precise entity and conceptual linkages required for full accuracy. Quantitative accuracy is 10 by default (no numbers involved). Contextual relevance is 9 because the response stays on topic and addresses fair value determination, though it misses specific developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 525,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "Adobe's approach to Substance 3D Stager evolved between 2022 and 2024 by positioning it more clearly within the broader Substance 3D ecosystem as a specialized tool for building and assembling 3D scenes. In 2022, Substance 3D Stager was mentioned as part of the Substance 3D Collection, highlighting its role alongside other tools like Painter and Modeler. By 2024, the product was explicitly described as part of a cohesive ecosystem that includes tools for texturing, modeling, and digitizing assets, emphasizing integration and workflow efficiency. This shift reflects Adobe's strategy to enhance the Substance 3D ecosystem's value by emphasizing seamless, end-to-end 3D creation capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Adobe's evolving positioning of Substance 3D Stager from 2022 to 2024 is accurately described, with correct emphasis on its role in building and assembling 3D scenes. The integration into a broader ecosystem including Painter, Modeler, and other tools is correctly noted. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—dates (2022, 2024) are consistent with the original answer and used appropriately. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2024) and across product positioning (from standalone mention to integrated ecosystem role). The evolution in strategic framing—from trademark listing to functional integration—is logically inferred and well-articulated. (4) Semantic equivalence is strong: while the LLM answer uses slightly different phrasing (e.g., 'Substance 3D Collection' in 2022 vs 'listed among trademarks' in ground truth), it does not contradict and reasonably interprets early-stage inclusion. The only minor gap is that the original specifies Stager’s 2022 status was known primarily via trademark records (implying limited public detail), whereas the LLM suggests it was already mentioned in the Collection, which may slightly overstate early integration. However, this does not materially misrepresent the evolution. Overall, the answer is factually correct, contextually precise, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 426,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "From 2022 to 2023, GE's strategic positioning regarding grid-scale batteries evolved as part of its broader energy transition strategy, particularly within the context of its planned separation into independent companies. In 2022, GE emphasized the importance of grid-scale batteries as a future enabler of deep decarbonization in the power sector, acknowledging their potential role in modernizing power grids to support higher penetration of renewable energy sources. However, it also noted the uncertainties around the pace of adoption and the need for significant investment in infrastructure and technology development.\n\nBy 2023, GE's focus on grid-scale batteries became more integrated into its strategic priorities, particularly under the umbrella of GE Vernova, the planned spin-off encompassing its energy businesses. The company recognized grid-scale batteries as part of a broader suite of technologies—such as hydrogen, carbon capture, and advanced nuclear—that would be critical for achieving long-term decarbonization goals. GE's strategic reliance on grid-scale batteries increased as it positioned them as a key solution for balancing renewable energy supply and demand, thereby enhancing grid reliability and supporting its energy transition ambitions. However, the company also highlighted the inherent risks and uncertainties in this space, including technological, regulatory, and market challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: in 2022, GE viewed grid-scale batteries as a potential future investment among emerging technologies for decarbonization; by 2023, they were elevated to a more strategic role, explicitly integrated into GE's energy transition strategy as a dependency for decarbonization goals. The mention of GE Vernova as the spin-off housing energy businesses is contextually accurate and adds relevant detail not in the original answer but consistent with public knowledge. (2) There are no numeric values to verify, so quantitative accuracy is unaffected. (3) The multi-hop reasoning is sound—correctly synthesizing GE’s evolving stance across two years and linking it to broader strategic shifts like the company’s separation. The LLM correctly infers increased strategic reliance without overstating it as absolute dependence. (4) The only minor gap is that the original answer emphasizes a specific linguistic shift—from 'may become more important' to 'depend in part'—which the LLM captures in spirit but does not quote directly. However, the semantic meaning and strategic implication are preserved. Overall, the answer is complete, factually correct, and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 356,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "CVS's disclosure regarding the use of broker-quoted debt securities in its fair value measurements indicates no presence of such securities in 2024, similar to 2023, as explicitly stated in both years' filings. This represents a continuation of the prior trend, as the 2022 filing also noted no broker-quoted debt securities. While there is no direct impact on financial reporting due to their absence, the continued absence suggests a reliance on observable market data (Level 2) and internal analyses (Level 3) for valuing debt securities, maintaining consistency in valuation methodologies over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key fact that CVS disclosed no broker-quoted debt securities in both 2022 and 2024 filings, accurately reflecting the absence of such securities for the relevant years (2020–2024). The dates and entities (CVS, broker-quoted debt securities, fair value measurements) are correct, and there are no numerical inaccuracies, earning a perfect quantitative accuracy score. However, the LLM misses a critical qualitative evolution highlighted in the ground truth: the 2024 disclosure no longer mentions any negative impact or specific review process related to broker-quoted debt securities, indicating a reduced emphasis over time. This change in disclosure tone and content is a key part of the evolution in reporting and was not addressed in the LLM response. While the LLM correctly infers continued reliance on Level 2 and Level 3 inputs, it does not capture the shift in narrative focus or reduced disclosure detail, which is central to the question about evolution in disclosure practices. Thus, while factually sound on the presence/absence of securities, it falls short on fully characterizing the evolution in disclosure depth and emphasis, leading to a moderate deduction in qualitative accuracy. The answer remains contextually relevant and addresses the core trend, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 373,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "Between 2023 and 2024, BlackRock's Equity Securities at FVTNI increased from $1,585 million to $1,950 million, primarily driven by growth in equity securities/mutual funds, which rose from $1,585 million to $1,950 million. Equity method investments also increased, with higher values in private equity funds ($1,060 million vs. $1,264 million) and real assets funds ($520 million vs. $417 million), partially offset by a decrease in hedge funds.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, equity securities/mutual funds were $1,211 million, not $1,585 million as stated by the LLM. The LLM incorrectly states that the total Equity Securities at FVTNI increased from $1,585 million to $1,950 million, but the ground truth reports separate values for two components: equity securities/mutual funds ($1,211M in 2023, $1,950M in 2024) and equity method investments ($1,895M in 2023, $2,783M in 2024). The LLM conflates these and misrepresents the composition. (2) The LLM introduces subcategories—private equity funds, real assets funds, and hedge funds—not mentioned in the original answer and assigns them values that do not align with the ground truth. There is no mention in the ground truth of a decrease in hedge funds or a split between fund types, making this detail fabricated. (3) The multi-hop reasoning is flawed: the model fails to correctly identify and separate the two main components of Equity Securities at FVTNI and instead merges them into a single incorrect total. It also invents a breakdown not present in the source data, indicating a failure in accurate synthesis. (4) While the $1,950 million figure for equity securities/mutual funds in 2024 is correct, the rest of the quantitative data is wrong or made up. The contextual relevance is moderate because the answer addresses the general topic and direction of change (increases), but the specifics are largely incorrect. Thus, the correctness score is low due to major factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 438,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities from 2022 to 2024 remained consistent in methodology, with the Company assessing impairments by considering the present value of expected cash flows relative to amortized cost, issuer financial condition, and other factors. In 2022, the Company reported $274 million in gross unrealized losses on available-for-sale debt securities, with no material allowance for credit losses. By 2024, while specific numbers for unrealized losses were not provided, the Company continued to emphasize that unrealized losses were primarily due to interest rate changes rather than credit quality deterioration, and the allowance for credit losses remained immaterial, reflecting ongoing confidence in the collectability of principal and interest.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but misses key qualitative evolution described in the ground truth. It correctly states that in 2022, unrealized losses were not due to credit deterioration and that the allowance for credit losses was immaterial. However, it inaccurately claims the allowance remained 'immaterial' in 2024, while the ground truth indicates a structural change — the allowance is now explicitly recorded through a separate allowance account, with credit impairments affecting investment income, signaling a more formalized framework. This key evolution is entirely omitted. (2) The $274 million unrealized loss figure in 2022 is not present in the original answer (ground truth), making this a hallucinated number. The ground truth does not provide any specific dollar amount for unrealized losses, so this quantitative claim is incorrect. No other numbers are provided in the LLM answer for 2024, which aligns with the lack of specific figures in the ground truth for that year. (3) The multi-hop reasoning is partially sound — the model correctly identifies consistent factors in impairment evaluation (cash flows, issuer condition). However, it fails to synthesize the critical shift from a qualitative, low-risk stance to a more structured accounting treatment by 2024, which is the core of the evolution. This represents a failure in qualitative synthesis across years. (4) The contextual relevance is high because the answer addresses the right topic, time frame, and securities type. However, the correctness score is reduced to 5 due to the hallucinated number and the omission of the key conceptual shift in accounting treatment, which undermines the accuracy of the evolution narrative. Quantitative accuracy is scored at 6 because while one number is fabricated, the absence of 2024 figures is acceptable. Qualitative accuracy is 5 due to correct baseline methodology description but failure to capture the material change in impairment recognition framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 541,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "Between 2022 and 2023, AMD's investment in the ATMP JV increased from $69 million to $99 million, reflecting a rise in the joint venture's value. Additionally, AMD's equity income from the ATMP JV grew from $6 million in 2022 to $16 million in 2023, indicating improved performance and returns from its 15% equity stake in the venture.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, AMD's carrying value of its investment in the ATMP JV was $83 million in 2022, but the LLM incorrectly states it as $69 million. Similarly, the equity income in 2022 was $14 million (LLM says $6 million), while both correctly report 2023 values as $99 million and $16 million respectively. These errors affect the core quantitative accuracy. (2) Number verification: 2022 investment value is off by $14M ($83M vs $69M), and 2022 equity income is off by $8M ($14M vs $6M). The 2023 numbers are correct. Calculations of growth are therefore based on incorrect baselines, undermining the analysis. (3) Multi-hop reasoning is partially sound—the model correctly identifies the need to compare investment value and equity income across two years and draws a logical conclusion about improved performance. It also correctly references AMD’s 15% stake, which aligns with known public information, though not explicitly in the original answer. However, the reasoning is built on incorrect data, weakening the validity. (4) Contextual relevance is high—the answer addresses both parts of the question (investment value and equity income) and interprets the trend correctly (growth in value and returns). Despite incorrect inputs, the direction of change (increase) is accurate. Scores reflect major quantitative errors but acceptable structure and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 407,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth Group's exposure to tort claims, particularly those related to the delivery of health care services such as medical malpractice, has remained a consistent risk between 2022 and 2024. The nature of the claims has not changed significantly, as they continue to involve allegations against affiliated physicians, health care practitioners, or providers serving managed care networks, often stemming from failures to meet clinical or patient safety standards. The potential financial impact remains substantial, as the company is largely self-insured for these claims, and actual losses could exceed recorded liabilities. Additionally, the increasing complexity of legal theories and the potential for large claims continue to pose risks of significant defense costs, monetary damages, and reputational harm.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects but misses a critical evolution in the nature of tort claims between 2022 and 2024. (1) Correct elements: The answer accurately identifies that UnitedHealth Group faces ongoing tort exposure related to medical malpractice and clinical quality failures, that affiliated physicians and providers are central to these claims, and that the company is largely self-insured—leading to potential financial impact exceeding recorded liabilities. It also correctly notes the risks of high defense costs, monetary damages, and reputational harm. (2) Quantitative accuracy: There are no numerical values in the question or answers, so this dimension is not applicable; however, the use of years (2022–2024) is correct and consistent with the original answer. (3) Multi-hop reasoning: The LLM fails to fully capture the shift in focus from 2022 to 2024. In 2022, the emphasis was on medical malpractice and new legal theories circumventing damage caps. By 2024, the risk profile broadened to include systemic issues like clinical quality and patient safety standards, with explicit mention of reputational harm and impacts on business relationships as part of a more expansive risk framework. The LLM treats the nature of claims as largely unchanged, which underrepresents the strategic shift in risk disclosure. (4) This results in a correctness score of 7: core facts and financial exposure are well-represented, but the qualitative evolution in risk nature and scope is underdeveloped, leading to a partial rather than complete synthesis of the multi-year progression.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 445,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "Between 2023 and 2024, Boeing's three-year revolving credit agreement remained unchanged at $3.0 billion, expiring in August 2025. However, in 2024, Boeing terminated its $0.8 billion 364-day credit facility and $3.2 billion five-year credit facility expiring in October 2024, replacing them with a new $4.0 billion five-year credit agreement expiring in May 2029. This evolution indicates a shift toward longer-term liquidity solutions, enhancing flexibility and reducing the need for short-term refinancing. The unchanged three-year facility suggests Boeing continues to maintain backup liquidity, reflecting a balanced approach to managing its debt structure and ensuring financial stability amid ongoing operational demands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Boeing's three-year $3.0 billion revolving credit agreement remained unchanged from 2023 to 2024, expiring in August 2025, which matches the ground truth. It accurately states that in 2024, Boeing replaced two other facilities — a $0.8 billion 364-day facility and a $3.2 billion five-year facility expiring October 2024 — with a new $4.0 billion five-year agreement expiring May 2029. The total of the terminated facilities ($0.8B + $3.2B = $4.0B) aligns with the size of the new facility, indicating correct synthesis. (2) All numbers, dates, and dollar amounts are factually accurate and consistent with the ground truth. The only minor discrepancy is the explicit naming of the terminated facilities' amounts, which were not specified in the original answer but are logically and factually consistent with the knowledge graph data (since terminating $3.2B and $0.8B adds to $4.0B, matching the new facility). These details go beyond the ground truth but do not contradict it. (3) The multi-hop reasoning is sound: the model correctly infers that maintaining the existing $3.0B facility while replacing expiring facilities with a larger, longer-dated $4.0B facility indicates a strategic shift toward enhanced liquidity and extended maturities. The conclusion about Boeing’s liquidity strategy — emphasizing longer-term financing, reduced refinancing risk, and financial flexibility — is logically supported and semantically equivalent to the original. (4) The answer is fully contextually relevant, addressing both the structural evolution and strategic implications. The only reason for not scoring a perfect 10 is that the original answer emphasizes the strategic intent ('reinforcing financial flexibility and commitment to managing corporate borrowing'), while the LLM elaborates with plausible interpretation (e.g., 'balanced approach', 'backup liquidity') that, while reasonable, slightly extends beyond the documented inference. However, this does not compromise factual correctness. Overall, the answer is quantitatively precise, contextually complete, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 574,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "The financial impact of the 2017 Performance-based Options evolved between 2023 and 2024 as follows: the fair value of options vested was $56 million in 2023 and $52 million in 2024. The intrinsic value of options exercised was $44 million in 2023 and increased to $373 million in 2024, reflecting the rising stock price and the final tranche of vesting in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $56 million and $52 million for the fair value of options vested in 2023 and 2024, respectively, and $44 million and $373 million for the intrinsic value of options exercised in those years. These match the original answer exactly, with acceptable formatting. (2) The answer is complete, addressing both parts of the question—the evolution of fair value of vested options and intrinsic value of exercised options—across both years. (3) Entity accuracy is correct: the options are correctly identified as the 2017 Performance-based Options, and the years 2023 and 2024 are properly referenced. (4) The reasoning is sound and adds contextual insight—mentioning the rising stock price and final tranche of vesting in 2024—which aligns with the implied financial dynamics without contradicting the ground truth. While the original answer emphasizes the contrast between slight decline in vesting value and large increase in exercise value, the LLM captures this evolution accurately and even enhances it with plausible explanation. All multi-hop elements (tracking same option grant across two years, two different financial metrics) are correctly synthesized. The semantic meaning and factual content are equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 376,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "Between 2022 and 2023, AMD's approach to estimating adjustments for product return rights remained largely consistent, with no significant changes in the overall methodology. In both years, AMD estimated adjustments based on actual historical product return rates, adjusted for known events or current economic conditions. However, in 2023, there was a slight refinement in the description of how adjustments were made for OEM and distributor price incentives, emphasizing the use of internal and external market data analysis to better align estimates with market dynamics. Additionally, in 2023, AMD explicitly highlighted the inclusion of adjustments for known events in its estimates, reinforcing the judgmental nature of these provisions and their potential impact on future revenue and operating results.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in noting that AMD used historical return rates adjusted for known events in both years, which aligns with the ground truth. However, it fails to accurately capture the key evolution in AMD's methodology between 2022 and 2023. The ground truth states that in 2023, AMD adopted a more structured approach under ASC 606-10-32-8 through 14, explicitly using the 'most likely amount' method for variable consideration, including returns, rebates, and price protection. This represents a significant methodological shift toward codified accounting standards, which the LLM answer completely misses. Instead, the LLM claims only a 'slight refinement' focused on OEM/distributor incentives and market data analysis—details not present in the original answer and which misrepresent the nature of the change. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. Qualitative accuracy is low because the model fails to identify the correct multi-hop reasoning—linking the change to ASC 606 and the shift to 'most likely amount' as part of variable consideration. Contextual relevance is moderate since the answer discusses related concepts (historical rates, adjustments for events) but mischaracterizes the core change. Overall, the answer contains plausible-sounding but factually incorrect information about the evolution of AMD's methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 389,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The number of shares under option for the 2017 Performance-based Options decreased from 1,549,080 at the end of 2023 to 625,825 at the end of 2024. This reduction was primarily due to exercises of 905,219 shares and forfeitures of 18,036 shares during 2024. The significant exercise activity indicates that employees were actively exercising their vested options, while the relatively small number of forfeitures suggests that employee retention remained strong for this tranche of options.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the starting number of shares (1,549,080 in 2023), ending number (625,825 in 2024), exercises (905,219), and forfeitures (18,036) are exactly correct. The implied calculation (1,549,080 - 625,825 = 923,255 total reduction; 905,219 + 18,036 = 923,255) is mathematically sound. (2) The answer is complete, addressing both parts of the question: the evolution of shares from 2023 to 2024 and the interpretation regarding exercise and forfeiture trends. (3) Entity accuracy is perfect: the option type (2017 Performance-based Options) and time periods (end of 2023 to end of 2024) are correctly identified. (4) The reasoning is sound and adds value by interpreting the high exercise volume as active employee participation and low forfeitures as strong retention—logical inferences consistent with the data. The answer demonstrates proper multi-hop synthesis by connecting changes in share counts to underlying employee behavior. (5) Semantic equivalence is achieved: while the LLM adds slight interpretive nuance (e.g., 'employee retention remained strong'), it does not contradict or distort the ground truth and remains factually aligned. All scoring dimensions warrant full marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 362,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "Between 2022 and 2024, Optum Rx's role and strategic positioning within UnitedHealth Group's ecosystem have expanded significantly. In 2022, Optum Rx managed $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceuticals, offering services like utilization management, medication management, and adherence programs. By 2024, Optum Rx managed $178 billion in pharmaceutical spending, with $74 billion in specialty pharmaceuticals, reflecting growth in both scale and scope. Additionally, Optum Rx expanded its service offerings to include rare disease and gene therapy support services, direct-to-consumer solutions, and in-home infusion services. The strategic positioning of Optum Rx has evolved to emphasize integration with medical and behavioral care, embedding pharmacists as key members of patient care teams, and leveraging data and analytics to improve health outcomes and reduce costs across UnitedHealth Group's broader health care ecosystem.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative data. According to the ground truth, in 2022, Optum Rx managed $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceuticals. The LLM claims that by 2024, spending increased to $178 billion with $74 billion in specialty pharmaceuticals. However, the original answer explicitly states that 'specific spending figures were not provided in 2024,' making the LLM's precise 2024 figures fabricated and factually incorrect. This is a critical error in a financial context. (2) The calculation of growth from $112B to $178B and $45B to $74B is unsupported by the source material and represents a failure in quantitative accuracy. No such figures appear in the 2024 data within the knowledge graph. (3) Qualitatively, the LLM captures some correct directional trends—such as expanded integration with care teams, use of data analytics, and broader strategic positioning within UnitedHealth Group’s ecosystem. Mentions of in-home infusion, medication management, and care team integration align partially with the 2022 services and the 2024 strategic vision. However, specific new offerings like 'rare disease and gene therapy support services' and 'direct-to-consumer solutions' are not mentioned in the ground truth and appear to be speculative. (4) Contextually, the answer addresses the evolution of Optum Rx’s role and strategic positioning, which matches the question’s intent. It attempts multi-hop reasoning by comparing 2022 and 2024 states, but fails due to hallucinated data. While the narrative of deeper integration and expanded scope is plausible and thematically consistent, the reliance on invented metrics undermines the entire response. The correctness score is low due to the severity of the numerical inaccuracies, which are central to financial analysis in SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 517,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "The composition and valuation of BlackRock's Equity Securities at FVTNI increased between 2023 and 2024. In 2023, Equity Securities at FVTNI were valued at $1,585 million, while in 2024, they rose to $1,950 million. Additionally, investments related to deferred cash compensation plans, which are included within Equity Securities at FVTNI, were valued at $241 million in 2023 and $173 million in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, in 2023, BlackRock reported only $9 million in Equity Securities at FVTNI related to deferred cash compensation plans, not $241 million as stated by the LLM. Furthermore, by 2024, this category was reclassified and no longer appeared under Equity Securities at FVTNI, but the LLM incorrectly claims it was still included with a value of $173 million. The LLM also fabricates total Equity Securities at FVTNI values of $1,585 million in 2023 and $1,950 million in 2024, which are not present in the ground truth and contradict the core point about reclassification. (2) The numbers provided by the LLM are entirely inaccurate: $241M and $173M for deferred compensation investments are wrong in context, as the $173M in 2024 was moved out of FVTNI into the Equity Method section. The LLM fails to recognize the reclassification, which is the central point of the original answer. (3) The multi-hop reasoning is flawed: instead of identifying a reclassification (a key structural change in financial reporting), the LLM assumes continuity and even calculates a false trend (decline from $241M to $173M), missing the fact that the 2024 amount is no longer in the same category. It does not synthesize the change in composition due to reporting realignment. (4) The contextual relevance is moderate because it discusses the right topic (Equity Securities at FVTNI and deferred compensation), but the factual inaccuracies and missed reclassification severely undermine correctness. Quantitative accuracy is very low due to fabricated numbers. Qualitative accuracy is poor because the reasoning misrepresents the nature of the change. Correctness score is low because the answer conveys the opposite of the truth—implying the investments remained in FVTNI when they were actually reclassified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 517,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $6,129,296 as of August 31, 2022, to $2,694,281 as of August 31, 2024, before increasing to $6,694,281 following an additional $4,000,000 repurchase authority approved in September 2024. This indicates a strategic reduction in available repurchase capacity during 2023–2024, followed by a significant replenishment, reflecting a balanced capital allocation approach that prioritizes flexibility and responsiveness to market conditions and shareholder returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The starting authorization amount is incorrect: the ground truth states $3,129,296 in 2022, but the LLM claims $6,129,296 as of August 31, 2022—overstating the figure by $3 million. This error undermines the entire quantitative analysis. Additionally, the LLM introduces a $4,000,000 repurchase authority approved in September 2024 and claims the authorization increased to $6,694,281, which is not supported by the original answer or implied time frame of the question (which focuses on changes between 2022 and 2024). These figures and events are not present in the ground truth and appear fabricated. (2) The only correct number is the 2024 available authorization of $2,694,281, which matches the original answer. However, the claimed increase to $6,694,281 is unsupported. The calculation of a $4M addition is speculative and not verifiable from the provided data. (3) The multi-hop reasoning is flawed. While the question asks about the change between 2022 and 2024 and its implication, the LLM extrapolates beyond the data by introducing a post-2024 event (September 2024 approval), which is outside the scope. The original answer draws a straightforward conclusion about reduced capital allocation, while the LLM infers a 'replenishment' and 'balanced approach' that is not grounded in the evidence provided. (4) The contextual relevance is moderate—the answer addresses share repurchase programs and capital allocation strategy appropriately—but the qualitative and quantitative inaccuracies severely reduce its correctness. The reasoning is plausible-sounding but based on incorrect data, leading to a misleading interpretation. Hence, the correctness score is low at 3, with similarly low quantitative accuracy due to major number errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 494,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "Between 2022 and 2024, the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares show a few notable developments. In 2022, the focus was on the structure and rights of the exchangeable shares, including their one-for-one exchangeability for Accenture plc Class A ordinary shares and the company's repurchase intentions. By 2024, the disclosures included more detailed share repurchase activity, with $15,254 in purchases of exchangeable shares and an updated $6,694,281 total share repurchase authorization. Additionally, shareholder rights remained consistent, with exchangeable share holders retaining the right to exchange their shares for Class A ordinary shares and receive equivalent distributions. However, no significant changes in rights or redemption terms were disclosed during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly identifies the one-for-one exchangeability of Accenture Canada Holdings Inc. exchangeable shares for Accenture plc Class A ordinary shares and the continuity of shareholder rights, it misstates key financial figures. The ground truth states that as of August 31, 2024, the remaining share repurchase authorization was $2,694,281, but the LLM claims a total authorization of $6,694,281 — a significant overstatement. Additionally, the LLM mentions $15,254 in purchases of exchangeable shares in 2024, which is not present in the original answer and appears to be fabricated or misattributed. (2) The calculation and reporting of repurchase authorizations are incorrect. The original answer does not specify the amount spent on exchangeable share purchases in 2024, only the remaining authorization, so the $15,254 figure lacks support. The increase from $2.7M to $6.7M in authorization is not corroborated and contradicts the ground truth. (3) The multi-hop reasoning is partially sound — the model correctly infers that disclosures evolved from general intentions in 2022 to more structured disclosures in 2024, and it accurately notes the consistency in shareholder rights. However, it fails to mention the key structural commitment to align Class X ordinary shares with outstanding exchangeable shares, which is a critical part of the 2024 disclosure evolution. (4) Contextual relevance is high because the answer addresses both share repurchase activity and shareholder rights across the two years, but the quantitative inaccuracies severely undermine factual correctness, warranting a low overall score despite reasonable structure and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 483,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "The global revenue from Electrophysiology Devices increased from $2,195 million in 2023 to $2,467 million in 2024. Excluding the impact of foreign exchange fluctuations, the percentage change in this revenue was 14.4%.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the global revenue from Electrophysiology Devices was $2,195 million in 2023 and $2,467 million in 2024, and the percentage change excluding foreign exchange fluctuations was 14.4%. (2) Quantitative accuracy is perfect: the dollar amounts are correctly stated, and although the LLM did not explicitly calculate the nominal percentage change (12.3%), the question primarily asks for the change excluding FX impact, which is correctly reported as 14.4%. The omission of the 12.3% figure does not detract from the core request, which emphasizes the FX-excluded change. (3) The reasoning is sound—revenue evolution is correctly presented with accurate year-over-year figures, and the key metric requested (percentage change excluding FX) is correctly identified and reported. (4) The answer is contextually relevant, directly addressing both parts of the question: revenue evolution and the adjusted percentage change. Semantic equivalence is maintained with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 306,
        "total_tokens": 1434
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Accenture's investment in Duck Creek Technologies remained a significant equity method investment, with its carrying amount decreasing slightly from $138,902 as of August 31, 2022, to an unspecified amount in 2024. However, in fiscal 2023, Accenture recorded a $253 million investment gain related to Duck Creek Technologies, which positively impacted its adjusted operating margin and diluted earnings per share. No specific valuation changes for fiscal 2024 are disclosed, but the investment's influence on financial performance appears to have diminished compared to fiscal 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Accenture's investment in Duck Creek Technologies was valued at $223,166 in fiscal 2022, but the LLM claims it was $138,902 as of August 31, 2022—this is a major discrepancy. Additionally, the LLM incorrectly states that the carrying amount decreased slightly and that the 2024 valuation is unspecified, while the ground truth confirms a $253 million gain in fiscal 2024 (not fiscal 2023). The LLM misattributes the timing of the gain, stating it occurred in fiscal 2023, whereas the original answer clearly places the $253 million gain in fiscal 2024. (2) The $253 million gain is correctly cited in magnitude but wrong in timing—this is a critical error affecting financial period attribution. The fiscal years are central to the question, so misplacing the gain undermines the quantitative and temporal accuracy. (3) The multi-hop reasoning is partially sound—the LLM recognizes the equity method and attempts to link the investment gain to financial performance (e.g., adjusted operating margin and EPS). However, it fails to correctly synthesize the evolution from 2022 valuation to 2024 gain, and incorrectly infers a diminished impact in 2024 when the ground truth indicates a significant positive impact. The conclusion that the investment's influence 'diminished' contradicts the original answer's emphasis on a 'significant increase in value.' (4) Scores reflect major quantitative and temporal errors (hence low quantitative accuracy), partial but flawed reasoning (moderate qualitative accuracy), and good relevance to the question's focus on investment evolution and financial impact (high contextual relevance). The correctness score is low due to incorrect numbers and misattributed fiscal events, despite some correct elements like the gain amount and recognition of equity method accounting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 517,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Between 2022 and 2023, Union Pacific's retention share and unit awards show a shift in scale and structure, with an increased emphasis on long-term performance-based incentives. In 2022, the company granted performance stock units tied to return on invested capital (ROIC) and operating income growth (OIG) relative to industry benchmarks, with vesting over a 37-month period. By 2023, the company continued this trend, as evidenced by the February 2024 performance stock unit grants and the inclusion of new retention units in the equity compensation plans. This indicates a strategic focus on aligning executive compensation with long-term financial performance and shareholder value creation.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding quantitative disclosures. The ground truth states that 389,207 retention shares were outstanding as of December 31, 2021 (disclosed in 2022), and by 2023, 954,405 retention shares and 366,046 retention units were outstanding. The LLM answer does not mention these specific numbers at all, failing the core requirement of reporting the scale and composition change. Instead, it references performance stock units (PSUs) tied to ROIC and OIG with a 37-month vesting period, which are not mentioned in the ground truth and appear to conflate different types of equity awards. (2) There are no correct numerical values cited from the ground truth—missing both the exact share/unit counts and the year-over-year increase. The introduction of retention units in 2023 is a key factual point in the original answer, but the LLM only vaguely references 'new retention units' without quantifying them or correctly situating their introduction. (3) The reasoning is partially sound in interpreting the trend toward long-term incentives, and the answer correctly infers a strategic focus on alignment with shareholder value. However, it fails the multi-hop synthesis because it does not connect the specific disclosed numbers from 2022 to 2023 to support this conclusion. The LLM appears to rely on general knowledge about executive compensation trends rather than the specific data points from Union Pacific's filings. (4) The contextual relevance is moderate—it addresses executive compensation strategy and changes over time, which is relevant. However, due to the absence of correct quantitative data and mischaracterization of award types, the qualitative accuracy is limited, and the quantitative accuracy is very low. A correct answer must include the actual figures and note the introduction of retention units as a structural change, which this response lacks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 523,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "Between 2023 and 2024, MetLife's application of GAAP guidance for adjusted earnings remained consistent in terms of exclusions related to market volatility and asymmetrical accounting adjustments. Adjusted earnings continued to exclude the impact of market volatility, such as net investment gains/losses, net derivative gains/losses, and changes in fair value associated with market risk benefits (MRBs). Additionally, asymmetrical and non-economic accounting adjustments, such as those related to in-force reinsurance, were still excluded from adjusted earnings in 2024, aligning with the methodology described in 2023. No material changes to these exclusions were noted in the 2024 disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that there were no material changes between 2023 and 2024 in MetLife's application of GAAP guidance for adjusted earnings. The ground truth explicitly states that MetLife made notable refinements in 2024, including expanding the exclusion of policyholder liability remeasurement gains (losses) related to asymmetrical accounting from in-force reinsurance and adding exclusions for joint venture adjustments under the equity method in net investment income—changes not present in 2023. The LLM incorrectly claims continuity and absence of material changes, which contradicts the original answer. (2) While there are no explicit numerical values (e.g., dollar amounts, percentages) to verify, the dates (2023 and 2024) are correctly referenced, and terms like MRBs, in-force reinsurance, and asymmetrical accounting are accurately mentioned, supporting a moderate quantitative accuracy score. (3) The multi-hop reasoning is flawed: the model fails to synthesize the evolution over time, missing the key progression from 2023 (adoption of LDTI and initial exclusions) to 2024 (expanded exclusions). This represents a failure in qualitative reasoning, particularly in tracking changes across years. (4) The answer is contextually relevant—it addresses MetLife, GAAP, adjusted earnings, market volatility, and asymmetrical accounting—but the core conclusion is incorrect, leading to a low correctness and qualitative accuracy score despite appropriate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 419,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "From 2022 to 2024, Accenture's approach to achieving compressed transformations has evolved by expanding its focus on advanced technologies and broadening the scope of its transformation services. In 2022, the company emphasized technologies such as cloud, AI, and IoT, while in 2024, it has integrated generative AI, digital twins, and the metaverse continuum more prominently into its offerings. Additionally, the scope of transformation services has expanded to include more comprehensive, enterprise-wide reinvention, with a stronger emphasis on intelligent operations, sustainability, and hyper-personalized customer experiences. This evolution reflects a deeper integration of technology and innovation to help clients achieve faster, more scalable transformations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Accenture and the 2022–2024 timeframe, and generally captures the evolution toward more advanced technologies and broader transformation scope. However, there are key factual discrepancies in the technologies cited. The original answer specifies that in 2022, Accenture leveraged digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse — all of which are partially reflected in the LLM answer (mentions cloud, AI, IoT, digital twins, metaverse), but omits 5G and Edge computing and incorrectly implies digital twins and metaverse were more prominent in 2024 rather than already being part of the 2022 toolkit. Additionally, the LLM introduces 'metaverse continuum' — a term not in the original — and fails to mention Accenture’s development of automation equipment and commercial hardware by 2024, which is a significant addition in the ground truth. The expansion into capital projects (plant construction, infrastructure, power grids, data centers) is entirely missing and replaced with vague concepts like 'enterprise-wide reinvention', 'sustainability', and 'hyper-personalized customer experiences' — which are not supported in the original. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable but assumed correct by default. (3) The multi-hop reasoning is partially sound — the model infers an evolution in tech and scope — but fails to accurately synthesize the specific technological additions (generative AI, AR/VR, advanced robotics) and the concrete expansion into capital project transformation. Instead, it substitutes with plausible but unverified themes. (4) Correctness is scored 6 due to partial factual alignment but significant omissions and misrepresentations in key details; qualitative accuracy is 6 for incomplete entity and technological representation despite logical flow; quantitative accuracy is 10 as no numbers are involved; contextual relevance is 9 because the answer stays on topic and addresses the evolution question appropriately, even if with inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 570,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Between 2023 and 2024, Abbott reduced its use of interest rate hedge contracts to manage exposure to changes in the fair value of fixed-rate debt. In 2023, the notional value of these contracts was $2.2 billion, down from $2.9 billion in 2022 due to the maturity of $700 million of contracts in 2023. By 2024, the notional value remained at $2.2 billion, indicating no significant increase in new hedges during this period. This suggests a stable but reduced reliance on interest rate hedges as some existing hedges matured without being replaced.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Abbott had $2.2 billion in interest rate hedge contracts at the end of 2023 and that the notional amount remained at $2.2 billion in 2024, it incorrectly claims that Abbott 'reduced its use' of hedges and that the amount declined from $2.9 billion in 2022 due to $700 million maturing in 2023. This information is not present in the original answer and contradicts the ground truth, which describes a consistent hedging strategy with stable notional amounts. The LLM introduces unsupported claims about prior-year reductions and lack of replacement, which misrepresent the evolution as a reduction rather than stability. (2) Quantitatively, the $2.2 billion figure for 2023 and 2024 is correct, but the $2.9 billion and $700 million figures are fabricated, leading to major quantitative inaccuracies. The average interest rate increase from 3.6% to 3.8%—a key point in the original answer—is entirely omitted. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a reduction in hedging activity based on assumed prior-year data not in the ground truth, fails to recognize that stable notional amounts indicate consistency, and misses the nuanced point that despite stable hedges, the average debt rate increased, suggesting changes in debt composition or market conditions. (4) Contextual relevance is moderate because the answer addresses interest rate hedges and notional values, but the incorrect narrative about reduction and missing rate increase undermine accuracy. The conclusion of 'stable but reduced reliance' is unsupported and misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 455,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "MetLife's treatment and definition of Adjusted Earnings remained largely consistent between 2023 and 2024, with Adjusted Earnings continuing to serve as the primary measure of segment performance aligned with GAAP guidance. However, in 2024, the adoption of ASU 2023-07 led to enhanced disclosures about significant segment expenses and other segment items, improving transparency. Additionally, the 2024 filing reflects continued adjustments to exclude market volatility, asymmetrical accounting, and non-economic items, consistent with prior periods, while also incorporating the impact of the proportional amortization method for tax equity investments under ASU 2023-02. These updates refined the presentation and clarity of Adjusted Earnings without altering its fundamental purpose or methodology.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but misses key factual developments in MetLife's Adjusted Earnings definition between 2023 and 2024, particularly the specific changes due to LDTI adoption and the evolution of exclusions. (1) What was correct: The answer correctly notes that Adjusted Earnings remained the primary measure of segment performance and that it aligns with GAAP guidance. It also correctly identifies that ASU 2023-07 enhanced segment disclosures, improving transparency, which is contextually relevant. The mention of excluding market volatility, asymmetrical accounting, and non-economic items is consistent with the general direction of the 2023–2024 evolution. (2) Quantitative accuracy: There are no explicit numerical errors (e.g., dollar amounts, percentages), but the answer introduces ASU 2023-02 (proportional amortization for tax equity investments), which is not mentioned in the ground truth and appears irrelevant to the core evolution of Adjusted Earnings in this context—this is a factual overreach. (3) Multi-hop reasoning assessment: The LLM fails to accurately trace the multi-hop evolution: in 2023, the key change was due to LDTI (Long-Duration Targeted Improvements), which eliminated DAC/VOBA amortization adjustments and instead introduced adjustments for measurement of guarantees. The 2024 refinements built on this with more structured exclusions (e.g., inflation-indexed benefits, non-economic losses from single premium annuities, MRB remeasurements). The LLM answer does not mention LDTI, MRBs, annuitization guarantees, or goodwill impairments—key exclusions highlighted in the ground truth. Instead, it substitutes with ASU 2023-02, which is not supported by the original answer. (4) Justification for scores: Correctness is scored 5 because the answer gets the general direction right (continued use of Adjusted Earnings, exclusion of non-economic items) but misses the core LDTI-driven changes and introduces potentially incorrect ASUs. Quantitative accuracy is 8 because no numbers are wrong, but the answer fabricates regulatory context. Qualitative accuracy is 5 due to flawed reasoning and incorrect synthesis of accounting standards. Contextual relevance is 8 because the response stays on topic and discusses segment performance and GAAP alignment appropriately, even if details are inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 626,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "From 2022 to 2024, Accenture's available authorization for its share purchase program decreased from $6,129,296 as of August 31, 2022, to $2,694,281 as of August 31, 2024, before being increased by $4,000,000 in September 2024, bringing the total available authorization to $6,694,281. Share acquisitions primarily occurred through open-market purchases, with 9,635,751 shares in 2022 and 11,753,807 shares in 2024, while additional purchases were made via employee equity plans for tax obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The original answer states that in 2022, Accenture had an aggregate available authorization of $3,129,296, but the LLM claims $6,129,296 — a significant overstatement of over $3 million. The 2024 figure of $2,694,281 and a subsequent $4M increase in September 2024 are not supported by the ground truth, which does not mention any specific remaining authorization or replenishment in 2024. These numbers appear fabricated. (2) The share purchase volumes (9.6M in 2022, 11.7M in 2024) are not present in the original answer and are therefore unverified and likely incorrect. The original emphasizes a shift in acquisition method — specifically share withholding for tax obligations in 2024 — but the LLM incorrectly states that open-market purchases were primary in both years. (3) The multi-hop reasoning is flawed: the original answer distinguishes between the public share purchase program (for Accenture plc Class A shares) and other methods like share withholding and exchangeable share acquisitions. The LLM fails to recognize this distinction and incorrectly implies open-market purchases were the main method throughout, missing the key evolution in acquisition strategy. (4) While the LLM attempts to address funding (authorization amounts) and acquisition methods, it gets the core numbers wrong and misrepresents the shift in utilization, particularly the non-impact of employee-related purchases on the authorization. Contextual relevance is moderate as it addresses the general topic, but factual and reasoning errors severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 445,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "From 2023 to 2024, MetLife's treatment and valuation methodology for Unit-linked Securities remained consistent in terms of cost basis, as these securities are primarily equity securities and fixed maturity securities valued at amortized cost or original cost, adjusted for amortization or depreciation. However, the fair value sensitivity for Unit-linked Securities increased in 2024, as reflected in the higher estimated fair value of these securities and the impact of changes in significant unobservable inputs, such as long-term equity volatilities and nonperformance risk spreads, on their valuation.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant inaccuracies regarding the evolution of MetLife's valuation methodology. It incorrectly states that the cost basis treatment 'remained consistent' from 2023 to 2024, which contradicts the ground truth: in 2024, Unit-linked securities were moved into Level 3 fair value measurements using significant unobservable inputs, marking a shift away from the prior cost-based approach. This is a fundamental error in capturing the change in methodology. (2) While there are no explicit numerical values (e.g., dollar amounts, percentages) to verify, the qualitative descriptions of valuation techniques are factually incorrect. The mention of 'nonperformance risk spreads' and 'long-term equity volatilities' as unobservable inputs in 2024 is partially aligned with the ground truth, but the failure to note the inclusion in Level 3 and the use of mortality and lapse rates — key new elements — undermines accuracy. (3) The multi-hop reasoning is flawed: the model fails to recognize the shift from a cost-based (amortized/original cost) methodology in 2023 to a dynamic, assumption-driven fair value model in 2024. Instead, it asserts consistency in cost basis, missing the core evolution. (4) Contextual relevance is high because the answer addresses both cost basis and fair value sensitivity as asked, and references appropriate concepts like unobservable inputs. However, the qualitative inaccuracy — particularly the incorrect claim of consistency — severely limits correctness. The answer captures increased sensitivity in 2024 correctly but misattributes the broader methodological shift, resulting in a partially correct but fundamentally misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 466,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "Between fiscal years 2022 and 2023, the structure and vesting timeline of market-based RSUs evolved in the following ways:\n\n1. **Vesting Periods**: In fiscal year 2022, market-based RSUs generally vested over four years, subject to market conditions. In fiscal year 2023, in addition to the four-year vesting RSUs, Broadcom also granted market-based RSUs with a five-year vesting period, subject to stock price performance milestones.\n\n2. **Performance Metrics**: In 2022, market-based RSUs were tied to total shareholder return (TSR) on an absolute basis and relative to an index group of companies. In 2023, while TSR remained a key metric, the company introduced stock price performance milestones as an additional condition for vesting.\n\nThese changes reflect a more diversified approach to aligning executive and employee compensation with both relative and absolute stock performance over extended periods.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that in fiscal year 2022, market-based RSUs generally vested over four years with payout ranging from 0% to 300% based on TSR relative to an index group. In 2023, the company maintained four-year vesting but also introduced five-year market-based RSUs tied to stock price performance milestones—this structural expansion is correctly captured. (2) All quantitative and temporal details are accurate: the four-year vesting in 2022, the addition of five-year vesting in 2023, and the use of TSR (with implied 0–300% range, though not explicitly repeated in the LLM answer) are factually correct. The mention of stock price performance milestones as a new condition aligns with the ground truth. (3) The multi-hop reasoning is sound—information is synthesized correctly across fiscal years and compensation structures, showing evolution over time. (4) The LLM adds slight elaboration (e.g., 'absolute and relative TSR') not in the original but consistent with typical market-based RSU design and does not contradict the ground truth. The core facts, entities (Broadcom implied, fiscal years 2022–2023), metrics (TSR, stock price milestones), and timeline are all accurate. Semantic equivalence is maintained, with no factual errors or omissions affecting correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 378,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "Between 2023 and 2024, the phase-in treatment of the CECL standard's ongoing impact on regulatory capital progressed as follows: In 2023, 50% of the cumulative \"day 2\" ongoing impact of CECL was phased in, while the remaining 50% was scheduled to be phased in over 2024 and 2025. By 2024, 75% of this impact had been phased in, with the final 25% to be fully phased in by 2025. During the phase-in period, the CECL Transition Rule allowed for a gradual inclusion of the after-tax \"day 1\" CECL adoption impact and the cumulative \"day 2\" ongoing impact at 25% per year from 2022 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the phase-in schedule. According to the ground truth, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased in at 25% per year from 2022 through 2024, meaning 25% in 2022, 50% by end of 2023, and 75% by end of 2024, with full phase-in completed by December 31, 2024. However, the LLM incorrectly states that in 2023 only 50% was phased in (should be cumulative 50% by end of 2023, not during 2023 alone), and further claims that phase-in continues into 2025, which contradicts the ground truth stating completion by end of 2024. (2) The quantitative inaccuracies are critical: the annual phase-in rate is correctly cited as 25%, but the cumulative progression and end date are wrong. The LLM implies a four-year phase-in from 2022–2025, while the truth is a three-year phase-in (2022–2024) at 25% per year. (3) The multi-hop reasoning is partially sound—the model identifies the correct regulatory framework (CECL Transition Rule) and the concept of phasing in the 'day 2' impact—but fails to correctly synthesize the timeline and completion date. It also incorrectly references 'day 1' after-tax impact, which is not part of the 'ongoing' impact described in the question. (4) Despite these errors, the answer is contextually relevant and captures the general idea of a phased approach. The qualitative accuracy is moderate because core concepts are present but misapplied. The correctness score is low due to major factual and timeline errors that affect regulatory interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 439,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "Between 2022 and 2023, Broadcom continued its relationship with Wilmington Trust, National Association as trustee for its senior notes under various indentures. In 2022, the company issued senior notes with maturities in 2027, 2029, 2031, 2028, 2030, and 2034 under indentures dated April 18, 2022, and October 2, 2024. The terms of these notes included varying interest rates (e.g., 5.050%, 4.150%, 4.350%, etc.) and maturity dates extending through 2034. The relationship remained consistent in 2023, with no new indentures introduced in the 2023 filing, but the terms of the existing indentures continued to govern the senior notes issued under them.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that senior notes were issued under an indenture dated October 2, 2024, which is in the future relative to 2023 and contradicts the ground truth that mentions a July 12, 2024 indenture. The ground truth indicates that in 2022, notes from the January 2021 indenture were still governed by Wilmington Trust, not new issuances in 2022 under April 18, 2022 (which is correct), but the LLM misrepresents the timing and scope. The LLM claims notes were issued with maturities in 2027, 2029, 2031, etc., but the ground truth specifies maturities such as 2028 and 2051 in 2022, and later 2037 and 2034 in 2023–2024. The interest rates cited in the LLM answer (e.g., 5.050%, 4.350%) do not appear in the ground truth; instead, the correct rates are 1.950% to 3.750% in 2022 and 4.150% to 4.926% in later issuances. (2) Quantitative accuracy is very low: multiple incorrect dates (October 2, 2024 instead of July 12, 2024), wrong interest rates, and incorrect maturity years. The LLM also claims no new indentures in 2023, but the ground truth states that the April 18, 2022 indenture was active and a new one was set for July 12, 2024—so the evolution includes forward-dated agreements documented in the 2023 filing period. (3) The multi-hop reasoning is flawed: the LLM fails to show the evolution from lower-rate, long-term notes in 2022 to higher-rate notes in 2023–2024. Instead, it suggests continuity without change, missing the key shift toward higher yields and longer maturities. It also fabricates issuance dates and rates not present in the original. (4) Contextual relevance is moderate because the answer discusses the trustee relationship and indentures, which is on-topic, but the incorrect details undermine usefulness. The answer does not reflect the actual evolution described in the ground truth, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 523,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One's regulatory capital add-back under the CECL Transition Rule evolved from 2023 to 2024 as part of a five-year phase-in period. In 2023, 50% of the cumulative \"day 2\" ongoing impact of CECL was phased in, while in 2024, 75% was phased in. This progression reflects the annual 25% incremental phase-in of the after-tax \"day 1\" CECL adoption impact and the cumulative \"day 2\" ongoing impact, as outlined in the CECL Transition Rule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the 50% phase-in in 2023 and 75% in 2024 are accurately reported, reflecting the correct 25 percentage point annual increase. The dollar amount ($2.4 billion) is not explicitly mentioned in the LLM answer, which is a minor omission, but the phase-in percentages — the core of the question — are correct. (2) The explanation of the five-year phase-in with 25% annual increments is factually sound and consistent with the CECL Transition Rule. (3) The reasoning is strong: the LLM correctly synthesizes the progression from 2023 to 2024 and references both 'day 1' and 'day 2' impacts, showing understanding of the regulatory mechanism, even if the original answer focused more on the 'cumulative impact' without distinguishing day 1 vs day 2. (4) Contextual relevance is excellent — the response directly addresses the evolution and phase-in progression. The only reason for not scoring a 10 is the omission of the $2.4 billion figure, which was present in the original answer and adds concrete financial context, though the question emphasizes the 'phase-in progression' more than the dollar amount. Overall, the answer is semantically equivalent in intent and accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 359,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "Following the Broadcom acquisition of VMware in November 2023, the treatment of VMware stock options for non-employee directors evolved such that all outstanding in-the-money VMware stock options held by non-employee directors were accelerated and converted into the right to receive cash and shares of Broadcom common stock in equal parts. This marked a shift from the 2022 disclosure, where no such conversion had occurred as the acquisition was still pending.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the essential evolution in the treatment of VMware stock options for non-employee directors between 2022 and 2023. It correctly states that in 2022, the conversion had not yet occurred because the acquisition was pending, and by 2023, the outstanding in-the-money options were accelerated and converted into equal parts cash and Broadcom shares. The date of the acquisition (November 2023) is accurately included, which aligns with external knowledge and enhances precision. All entities—VMware, Broadcom, non-employee directors, stock options, RSUs (implied), and the nature of the conversion—are correctly identified. The reasoning correctly reflects the multi-hop synthesis: from planned treatment in 2022 to actualized outcome in 2023. The only minor omission is that the original answer specifically mentions RSUs in addition to stock options, while the LLM answer only references stock options. This slightly reduces completeness in qualitative accuracy, but since the core mechanism and evolution are correctly described, the impact is minimal. Quantitative elements (timing, equal cash/share split) are correct. The answer is fully contextually relevant and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 351,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "Based on AbbVie's disclosures, the therapeutic positioning of Vraylar evolved from 2022 to 2024 by expanding its use as an adjunctive treatment for major depressive disorder (MDD). In 2022, AbbVie reported positive top-line results from two Phase 3 trials evaluating Vraylar for this indication, with one trial meeting its primary endpoint. By 2024, while specific trial outcomes for MDD are not reiterated, Vraylar's broader role in neuroscience therapies is highlighted, indicating its continued development and integration into AbbVie's portfolio for complex neurological and psychiatric conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but lacks key details that limit its completeness and accuracy in reflecting the full evolution of Vraylar's therapeutic positioning. (1) It correctly identifies that in 2022, Vraylar was in Phase 3 trials for adjunctive treatment of MDD, with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement—this aligns with the ground truth. However, the LLM omits the specific outcome of the second trial, which weakens the precision of the response. (2) Quantitatively, no explicit numbers (e.g., p-values, effect sizes) are mentioned in either answer, so the absence is consistent; dates (2022 and 2024) are accurate. (3) The major shortcoming is in qualitative accuracy and reasoning: the LLM fails to convey the full breadth of Vraylar’s expanded indications by 2024. The ground truth specifies clear regulatory approvals for schizophrenia, bipolar I and II episodes (manic, mixed, and depressive), and adjunctive MDD—representing a significant broadening of labeling. The LLM only vaguely references a 'broader role in neuroscience therapies' without specifying these approved indications, missing the core of the therapeutic evolution. (4) Contextual relevance is high because the answer stays focused on Vraylar’s development trajectory and AbbVie’s disclosures. However, the failure to report the specific 2024 indications—despite their availability in the ground truth—means the answer does not fully capture the multi-hop synthesis required: from investigational use in 2022 to approved, diversified use in 2024. Thus, while the direction of evolution is correctly implied, the factual richness and specificity of the therapeutic expansion are inadequately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 477,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "GE's accounting policy for long-term services agreements has remained consistent from 2022 to 2024 in terms of revenue recognition method, as it continues to use the percentage of completion method based on costs incurred to date relative to total expected costs. In both periods, revenue recognition is tied to performance under the agreements, with adjustments made for changes in estimates. Regarding contract billing estimates, the company still bases billings on asset utilization or maintenance events, and differences between revenue recognition timing and billing terms result in contract asset or liability adjustments. There is no indication of a material change in the approach to estimating utilization or costs during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in stating that GE's revenue recognition method remained consistent from 2022 to 2024. According to the ground truth, GE changed its method from straight-line in 2022 to percentage of completion in 2024, particularly within the CES segment. This major shift is completely missed by the LLM, which incorrectly asserts continuity. Additionally, the LLM fails to mention the $6.6 billion net liability balance in 2024 and the total estimated life of contract billings of $162 billion, which are key quantitative indicators of GE's evolved estimation process. (2) Quantitatively, the LLM omits all specific numbers: $6.6 billion liability, $162 billion total billings, and the 4.1% ratio. These are critical data points that demonstrate the scale and sophistication of the updated billing estimates. Their absence renders the answer factually incomplete and misleading. (3) The multi-hop reasoning is flawed—the question requires comparing accounting policies across two years and identifying changes in both revenue recognition and billing estimates. The LLM fails to detect the change in method and incorrectly concludes no material change occurred, contradicting the ground truth. It also does not link the new percentage-of-completion method to the CES segment or note the enhanced forward-looking estimation process involving asset utilization and cost improvements that was not explicitly used in 2022. (4) While the answer is contextually relevant—discussing revenue recognition and billing estimates—it is factually inaccurate on the core evolution of policy. The qualitative reasoning is weak due to incorrect synthesis, and quantitative accuracy is very low due to missing key figures. Hence, the correctness score is low at 2, with similarly low scores for quantitative and qualitative accuracy. Contextual relevance is moderate because the topic and domain are correctly addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 525,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "In the 2022 10-K filing, IBM's disclosure of the 1.250% Notes due 2027 appears in the \"Securities registered pursuant to Section 12(b) of the Act\" table on page 28, listing the notes with the trading symbol \"IBM 27B\" and noting the New York Stock Exchange as the exchange. In the 2023 10-K filing, the same 1.250% Notes due 2027 are similarly listed on page 1 under the same table, with identical details including the trading symbol \"IBM 27B\" and the New York Stock Exchange. There is no substantive change in the disclosure between the two filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) According to the original answer, in the 2022 10-K, the 1.250% Notes due 2027 were disclosed by referencing Exhibit 4.3 to Form 8-K filed on January 30, 2019, as part of the instruments defining the rights of holders—not listed in a 'Securities registered pursuant to Section 12(b)' table with trading symbol IBM 27B. However, the LLM claims the note was listed with symbol 'IBM 27B' on page 28 of the 2022 10-K, which directly conflicts with the ground truth. (2) The LLM states there was 'no substantive change' between 2022 and 2023 filings, but the ground truth indicates a clear evolution: from a reference to an exhibit defining rights (2022) to being explicitly listed as a registered security with a trading symbol (2023). This shift represents a meaningful change in disclosure practice, which the LLM completely misses. (3) The multi-hop reasoning fails—the question asks how the disclosure *evolved*, requiring comparison across years and understanding of disclosure types (instrument reference vs. registered security listing). The LLM incorrectly asserts consistency where there is a documented evolution. (4) While the trading symbol 'IBM 27B' and the New York Stock Exchange are correctly mentioned for 2023, attributing the same level of registration detail to the 2022 filing is factually wrong. The LLM fabricates specific document locations (page 28 in 2022, page 1 in 2023) not present in the ground truth. Overall, the answer is factually inaccurate in both quantitative placement (pages, tables) and qualitative interpretation (nature of disclosure change), leading to a low correctness score despite minor alignment on the symbol and exchange in the 2023 context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 476,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "Between 2022 and 2024, the structure and performance criteria of AbbVie's performance-vested RSUs have evolved in terms of vesting increments and performance metrics. In 2022, performance-vested RSUs had the potential to vest in one-third increments during a three-year performance period, based on AbbVie's return on invested capital (ROIC) performance relative to a defined peer group. By 2024, the vesting structure remained similar, with performance-vested RSUs and performance shares vesting in one-third increments over a three-year performance period. However, the performance metric shifted to focus on AbbVie's EPS achievement and total stockholder return (TSR) relative to the same peer group, incorporating a market condition. This change reflects a broader emphasis on stock price performance and profitability metrics.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the performance metrics evolution, which undermines the core of the multi-hop comparison. (1) Correctness: The original answer states that performance metrics remained focused on ROIC relative to a peer group through 2024, with only a streamlining of language. However, the LLM incorrectly claims a shift in 2024 to EPS achievement and total stockholder return (TSR), which contradicts the ground truth. This is a major factual error affecting the conclusion about the evolution of performance criteria. (2) Quantitative Accuracy: While the vesting increments (one-third over three years) are correctly reported for both years, the introduction of EPS and TSR as new metrics in 2024 is unsupported by the original data and introduces false quantitative constructs (e.g., implied new performance conditions). No actual numbers are misstated, but the metrics themselves are wrong. (3) Reasoning: The multi-hop reasoning fails because the model incorrectly infers a change in performance metrics based on non-existent data. It synthesizes a narrative of broadening metrics (from ROIC to include TSR and EPS) that is not present in the ground truth, which instead indicates continuity and simplification of ROIC-based measurement. (4) Contextual Relevance: The structure of the response is relevant and addresses vesting increments and performance metrics over time, but the incorrect substitution of key financial metrics reduces its accuracy. The mention of 'market condition' related to TSR is speculative and not in the original. Overall, while the vesting structure is accurately described, the critical error in performance metrics leads to a low correctness score despite some structural alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 476,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "From 2022 to 2024, GE's financial relationship with AerCap, as reflected in realized and unrealized gains or losses, showed a significant improvement. In 2022, GE reported a realized and unrealized loss of $865 million related to its investment in and note with AerCap. This loss decreased to $129 million in 2023 and further improved to a gain of $38 million in 2024, indicating a positive shift in the valuation of its investment in AerCap over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, GE reported an *unrealized loss* of $865 million, but the LLM incorrectly describes it as a 'realized and unrealized loss', which misrepresents the nature of the financial impact. Furthermore, the LLM introduces a figure of a $129 million loss in 2023, which is not present in the original answer or ground truth data—this number is entirely fabricated. The 2024 gain of $38 million is correctly stated as a 'realized and unrealized gain', aligning with the original answer. (2) Quantitative accuracy is low because the $865 million figure is mischaracterized in terms of realization status, and the $129 million 2023 loss has no basis in the provided truth. Only the 2024 $38 million gain is accurate. (3) The multi-hop reasoning is partially sound in that the model identifies a trend of improvement from loss to gain, but the inclusion of an unsupported intermediate value (2023) undermines the validity of the synthesis. The model fails to accurately reflect the two-point comparison (2022 vs 2024) without introducing unverified data. (4) Contextual relevance is high because the answer addresses the evolution of GE's financial relationship with AerCap through gains/losses and attempts to show a trend. However, due to the incorrect characterization of the 2022 loss and the invention of a 2023 figure, the overall correctness score is significantly reduced to 4, reflecting partial accuracy with major factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 422,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "In the 2022 SEC filing, the 0.300% Notes due 2026 (IBM 26B) are listed among other debt instruments but are not highlighted or discussed in detail in the provided pages. In contrast, the 2023 SEC filing explicitly includes the 0.300% Notes due 2026 in the table of securities registered under Section 12(b) of the Exchange Act, indicating a formalized and visible inclusion in IBM's disclosure of financial instruments. This suggests an increased visibility and formal recognition of the 0.300% Notes due 2026 in IBM's 2023 filing compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in disclosure status of the 0.300% Notes due 2026 from 2022 to 2023. While the original answer specifies that in 2022 the notes were referenced in Exhibit 4 to Form 8-K filed November 1, 2016, the LLM states they were 'listed among other debt instruments but not highlighted or discussed in detail,' which is consistent in substance, though slightly less specific. The key point—that the 2023 filing shows increased visibility by being formally listed under Section 12(b) of the Exchange Act with trading symbol IBM 26B—is accurately captured and aligns with the ground truth. (2) All quantitative elements (interest rate: 0.300%, maturity year: 2026, symbol: IBM 26B) are correct. No calculations are required, and all dates and percentages match. (3) The multi-hop reasoning is sound: the model correctly infers a progression in disclosure formality from being a background exhibit reference in 2022 to a formally registered security in 2023. It synthesizes across years and disclosure contexts appropriately. (4) The answer is contextually fully relevant, directly addressing the question about evolution in disclosure status and visibility. The only minor shortcoming is the lack of explicit mention of the 'Exhibit 4 to Form 8-K filed November 1, 2016' detail in the 2022 context, which slightly reduces qualitative accuracy, but the semantic meaning and conclusion remain correct. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 411,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "Between 2022 and 2024, GE's approach to the RISE Program has evolved to place a stronger strategic emphasis on sustainable aviation technologies and advanced engine development. In 2022, the RISE program was highlighted as a technology development initiative targeting more than 20% lower fuel consumption and CO2 emissions compared to current engines, with a focus on innovations like Open Fan, compact core, and hybrid electric systems. By 2024, the RISE program had progressed to include over 250 tests on a full-scale Open Fan engine, reflecting a more mature and investment-intensive phase aimed at enabling a more sustainable future of flight. This shift demonstrates an increased focus on scaling and refining sustainable technologies to meet future regulatory and market demands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 2022 RISE Program announcement targeting over 20% reduction in fuel consumption and CO2 emissions is accurately reported, and the strategic focus on Open Fan, compact core, and hybrid electric systems is consistent with known program elements. By 2024, the shift to active testing and investment is correctly conveyed, including the detail about over 250 full-scale Open Fan engine tests, which reflects a concrete advancement in R&D—consistent with the 'significant investments' mentioned in the original answer. (2) Quantitative accuracy is perfect: the 20% reduction figure is correctly cited, and the 250+ tests are a valid and specific metric of progress. No calculations were required, but the use of numbers is precise and contextually appropriate. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 to 2024), correctly identifying the evolution from conceptual announcement to active development and testing. While the original answer emphasizes 'significant investments' and the LLM emphasizes 'over 250 tests,' these are complementary indicators of the same strategic shift. (4) The only minor gap is that the LLM does not explicitly mention Safran as the collaborator in the 2022 phase, which is a small but relevant entity omission. However, the focus on GE’s internal strategic evolution is well articulated, and the omission does not undermine the core correctness. Overall, the answer is factually robust, contextually relevant, and semantically equivalent to the ground truth with only a slight reduction in completeness due to the missing partner reference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 466,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "From 2022 to 2023, American Express maintained a consistent emphasis on asset securitizations as a cost-effective funding strategy, particularly for its U.S. card business. In both years, the company securitized Card Member loans and receivables by transferring them to trusts that issued asset-backed securities to third-party investors. The 2023 10-K reaffirmed this strategy, noting that securitizations continue to provide cost-effective funding, with the 2023 debt issuances including $3.5 billion in Fixed Rate Class A Certificates under the American Express Credit Account Master Trust. While specific volume comparisons between 2022 and 2023 are not provided in the excerpts, the continued inclusion of securitization programs in the funding strategy and the substantial 2023 issuance indicate that the role of asset securitizations remained integral in 2023, consistent with 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but misrepresents the core evolution of American Express's funding strategy regarding asset securitizations. While it correctly notes that securitizations were used in both years and describes the mechanics (transferring loans to trusts, issuance of asset-backed securities), it incorrectly asserts that the emphasis was 'consistent' between 2022 and 2023. The ground truth shows a significant shift—from a definitional, glossary-level mention in 2022 to a strategic, explicitly highlighted component of diversified funding in 2023. The LLM fails to capture this evolution, instead implying continuity, which contradicts the original answer. (2) The $3.5 billion in Fixed Rate Class A Certificates issued in 2023 is a specific detail not present in the ground truth; while plausible, it cannot be verified against the provided original answer and may be hallucinated or misattributed. No quantitative data about issuance volumes was included in the ground truth, so introducing this figure undermines quantitative accuracy. (3) The multi-hop reasoning is flawed: the model should have contrasted the nature of disclosure (glossary definition vs. strategic funding source) across the two years but instead focused on operational continuity. It missed the key qualitative shift in emphasis and strategic positioning. (4) Contextual relevance is moderate—the response addresses funding strategy and securitizations, uses correct entities (American Express, asset securitizations, 10-K filings), and refers to the right time frame, but fails the central task of identifying the evolution in role and emphasis. Thus, correctness and qualitative accuracy are significantly penalized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 474,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "Emerson's financial and strategic relationship with AspenTech evolved significantly from 2022 to 2023. In 2022, Emerson completed the acquisition of Heritage AspenTech, creating a new AspenTech segment, which contributed $656 million in sales and $12 million in earnings. By 2023, Emerson further solidified its control by proposing to acquire the remaining shares of AspenTech not already owned, valuing the company at $15.3 billion. This strategic move aimed to integrate AspenTech's advanced analytics and optimization capabilities more deeply into Emerson's automation solutions, enhancing operational synergy and expanding Emerson's digital ecosystem offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Emerson completed the acquisition of Heritage AspenTech in 2022, while the ground truth indicates that the minority investment was in 2022 and the controlling 55% acquisition occurred in 2023. The LLM also fabricates a $15.3 billion valuation and a proposal to acquire remaining shares in 2023, which is not supported by the original answer. (2) Quantitative inaccuracies include the misrepresentation of the $656 and $12 figures as 'million'—the original answer does not specify units, but given the context of $14,484 in total assets, these are likely in millions; however, the LLM incorrectly inflates the significance by implying recent acquisition in 2022 when it was not. More critically, the $15.3 billion figure is entirely absent from the ground truth. (3) The multi-hop reasoning is flawed: the LLM reverses the timeline—portraying the 2023 controlling stake move as a follow-up to a 2022 full acquisition, when in fact 2022 was a passive investment and 2023 marked the shift to control. It fails to mention the 55% ownership stake or the 0.6 percentage point gross margin improvement, both key strategic impacts. (4) Contextual relevance is moderate—the answer addresses financial and strategic evolution and mentions integration goals, but the incorrect timeline and fabricated details severely undermine factual reliability. Core transformation from passive to active ownership is misunderstood, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 424,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly. In 2022, Emerson completed an acquisition of Heritage AspenTech, creating \"New AspenTech,\" and owned 55% of the outstanding shares (on a fully diluted basis). The transaction was accounted for using the acquisition method, with Emerson as the accounting acquirer, and a noncontrolling interest of $5.9 billion was recorded for the 45% ownership held by former Heritage AspenTech stockholders. By 2023, Emerson increased its ownership to 57% of AspenTech. The impact of the Heritage AspenTech acquisition on Emerson's financials included higher intangible assets and amortization expenses, which contributed to increased Other deductions, net. Additionally, the acquisition positively affected sales and gross margins in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also key inaccuracies. It correctly identifies the 2022 creation of New AspenTech, Emerson's 55% ownership, the $5.9 billion noncontrolling interest, and the use of acquisition accounting. However, it incorrectly states that Emerson increased ownership to 57% in 2023—this is not supported by the ground truth, which does not mention any change in ownership percentage. This is a significant factual error. (2) Quantitative accuracy is partially correct: the $5.9 billion noncontrolling interest matches, but the ground truth mentions a $550 million decrease to additional paid-in capital in 2022, which the LLM omits. Also, the LLM fails to include the specific $572 million increase in SG&A expenses in 2023, instead vaguely referencing 'higher' expenses. While it mentions positive gross margin impact (0.6 percentage points in ground truth), the LLM does not quantify this. (3) The reasoning is logically structured and addresses the evolution over time, correctly framing the shift from initial accounting (2022) to operational impacts (2023). However, it introduces an unsupported claim about ownership increase and misses key financial metrics, weakening the multi-hop synthesis. (4) Contextual relevance is high—the answer stays focused on the financial relationship, noncontrolling interest, and acquisition impacts. The qualitative accuracy is moderate due to correct conceptual framing but flawed specifics. Overall, the answer is partially correct but misses or distorts key quantitative details and introduces an unsupported claim, warranting a score of 6 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 452,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "Between the 2022 and 2023 SEC filings, IBM's treatment and disclosure of the 6.22% Debentures due 2027 remained consistent in terms of listing and exchange information. In both filings, the debentures are disclosed as being traded on the New York Stock Exchange under the ticker symbol IBM 27. There is no indication of any substantive changes in the terms or accounting treatment of these debentures between the two years based on the provided pages.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that IBM's disclosure was consistent between 2022 and 2023. The ground truth states that in 2022, IBM only referenced the debentures via a historical Exhibit 3 to Form 8-K from 1997, while in 2023, it introduced a more structured disclosure by listing the debentures with the trading symbol IBM 27 and identifying them among NYSE-registered securities. The LLM incorrectly claims this listing information was present in both years, which contradicts the ground truth. (2) Quantitatively, the percentage (6.22%), maturity year (2027), and ticker symbol (IBM 27) are correctly stated, hence a moderate score for quantitative accuracy. However, the key evolution in disclosure format — the core of the question — is misrepresented. (3) The multi-hop reasoning fails: the model should have contrasted the nature of disclosure (historical reference vs. current market-oriented presentation) across the two years but instead asserts consistency where there is none. It misses the shift in transparency and presentation entirely. (4) Contextual relevance is moderate because the answer discusses the right instrument and exchange listing, but it fails to capture the evolution asked in the question, rendering it substantially misleading despite some correct surface-level details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 373,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers has remained a significant aspect of its operations, with continued emphasis on managing these risks to ensure cost estimation accuracy and service delivery. From 2023 to 2024, the company has maintained risk-based arrangements to limit exposure to rising medical costs, but these arrangements expose it to risks related to the financial stability and performance of healthcare providers. If providers face financial difficulties or fail to meet obligations, UnitedHealth Group could be held responsible for unpaid claims, which could impact its cost estimation and service delivery responsibilities. This highlights the importance of robust provider oversight and risk management strategies to ensure financial stability and uninterrupted service delivery for members.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that UnitedHealth Group maintains risk-based arrangements and faces financial risk if providers fail to meet obligations, including responsibility for unpaid claims. It also correctly notes the implications for cost estimation and service delivery. However, it fails to explicitly mention the evolution from 2023 to 2024 as detailed in the ground truth—specifically, the expansion of exposure in 2024 and the increased operational and financial risks tied to provider solvency and data reporting. The 2023 context about premium recognition (estimated premiums earned, net of rebates, and per-patient-per-month models) is omitted, weakening the multi-hop comparison. (2) There are no numeric values, percentages, or dollar amounts in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The reasoning is logically sound and contextually appropriate, but it lacks the specific comparative analysis across years required for full qualitative accuracy. The LLM generalizes the risk without clearly differentiating the increased complexity and broader exposure in 2024 versus 2023. (4) The answer is highly relevant and captures the core risk dynamics, but misses key nuances in the temporal evolution and specific revenue recognition practices, warranting a correctness score of 7—core facts are correct, but important contextual details from the ground truth are missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 407,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly in terms of investment magnitude and strategic involvement. In 2022, Emerson completed the acquisition of Heritage AspenTech, increasing its ownership stake and integrating AspenTech's modeling, simulation, and optimization capabilities into its digital ecosystem. By 2023, Emerson further solidified its strategic control by proposing to acquire the remaining shares of AspenTech not already owned, signaling a move toward full ownership. This evolution reflects a shift from a partial ownership and collaboration model to a more dominant, vertically integrated position, enhancing Emerson's digital offerings and strengthening its industrial automation leadership.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Emerson 'completed the acquisition of Heritage AspenTech' in 2022, which contradicts the ground truth: in 2022, Emerson only reported a $362 million investment in AspenTech, not an acquisition. The ground truth confirms that the major transaction occurred in 2023, when Emerson contributed its Industrial Software Business and $6.0 billion in cash to create 'New AspenTech,' gaining 55% ownership. The LLM misrepresents the timeline and nature of the transactions. Additionally, the LLM claims Emerson proposed to acquire 'remaining shares' in 2023, implying a move toward full ownership, but the ground truth states Emerson gained 55% control through a strategic transaction involving asset and cash contribution—not a share-by-share acquisition. (2) Quantitatively, the LLM omits the correct $362 million 2022 investment figure and completely misses the $6.0 billion cash contribution in 2023. It also fails to mention the 55% ownership stake, a key metric. Instead, it fabricates a narrative of 'acquisition of remaining shares' without supporting numbers. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution from a minority financial investment in 2022 to a controlling strategic stake in 2023 via a complex transaction. It misidentifies the nature of the 2023 event and incorrectly frames it as a continuation of an acquisition that never occurred in 2022. (4) Contextual relevance is moderate—the answer addresses the general theme of increasing strategic involvement and investment magnitude, but the factual backbone is incorrect, undermining the qualitative and quantitative accuracy. Due to major errors in entities, numbers, and reasoning, the correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 495,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023 by becoming a more integrated and AI-driven personalization engine, working closely with other Adobe Experience Cloud solutions such as Adobe Journey Optimizer and Real-Time Customer Data Platform. This evolution indicates Adobe's strategic direction of leveraging AI and machine learning to deliver hyper-personalized, real-time customer experiences across all touchpoints, emphasizing automation and intelligent decision-making throughout the customer journey.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Adobe Target from a general personalization tool to a more prominent AI-driven engine, aligning with Adobe's strategic focus on AI-powered personalization. (1) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies the shift in Adobe Target’s role and its integration with Adobe Experience Cloud tools like Journey Optimizer and Real-Time CDP, which reflects accurate entity and contextual understanding. (3) The multi-hop reasoning is sound: it infers strategic direction from product evolution across fiscal years. However, the LLM omits specific details from the ground truth, such as the explicit 2022 description of Adobe Target being grouped with Marketo Engage and Adobe Campaign, and the precise 2023 characterization as an 'AI- and machine learning-driven personalization engine' with A/B and multivariate testing capabilities. These omissions reduce completeness and precision in qualitative accuracy. (4) Despite missing some specifics, the LLM conveys the correct strategic implication—Adobe’s increased emphasis on AI-driven, real-time personalization—making the answer contextually relevant and semantically aligned with the ground truth. Minor lack of detail prevents a perfect score, but core facts and reasoning are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 391,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "Emerson completed the acquisition of Heritage AspenTech in the third quarter of 2022, as noted in the 2023 filings. By 2023, Emerson's financial stake in AspenTech was reflected in the goodwill and intangible assets, with the AspenTech segment showing a goodwill balance of $8,326 million as of September 30, 2022, which carried over into 2023. Post-acquisition integration activities included converting Heritage AspenTech's share-based payment awards into AspenTech awards, maintaining the same terms and conditions, and allocating the fair value of these awards between pre- and post-combination service periods. Additionally, Emerson assumed responsibility for ongoing stock-based compensation expenses related to post-combination service periods, which were recognized in the consolidated financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $8,326 million goodwill balance is correctly reported and matches the original answer, with the correct time reference (as of September 30, 2022, carried into 2023). The acquisition timing in Q3 2022 is consistent with the knowledge graph. (2) The LLM accurately describes post-acquisition integration activities, including the conversion of share-based awards, maintenance of terms, and allocation of fair value between pre- and post-combination periods—details that reflect proper synthesis from SEC filings. It also correctly notes Emerson's recognition of stock-based compensation expenses for post-combination service, which aligns with operational integration. (3) The qualitative reasoning is sound and demonstrates multi-hop understanding: linking the 2022 acquisition to 2023 financial reporting, connecting equity award treatment to integration efforts, and interpreting goodwill as part of the financial stake. (4) The only minor gap is that the LLM does not explicitly mention AspenTech operating as a 'separate publicly traded company' post-acquisition or the performance stock units tied to metrics like annual contract value and free cash flow—details present in the original answer. However, the core financial stake and integration activities are correctly conveyed. Wording differs but meaning is semantically equivalent on key points. No factual errors; minor omission prevents a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 413,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "Adobe Experience Platform's role within Adobe's customer journey solutions evolved significantly from 2022 to 2023, particularly in its integration with AI-powered tools and cross-channel campaign orchestration. In 2022, the platform was described as a foundational infrastructure for collecting, connecting, and activating customer data in real time, enabling robust customer profiles and AI-driven insights. By 2023, Adobe Experience Platform had further strengthened its role by enhancing cross-channel campaign orchestration through tools like Adobe Journey Optimizer, which allows brands to deliver personalized, connected customer journeys across any app, surface, or channel. Additionally, AI-powered tools such as Adobe Sensei were more deeply integrated to provide real-time insights and intelligent decision-making, further enabling hyper-personalized experiences at scale.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Adobe Experience Platform from 2022 to 2023. It accurately describes the platform's foundational role in 2022 involving real-time data integration and AI-driven insights via Adobe Sensei, aligning with the ground truth. In 2023, it correctly identifies the enhanced role in cross-channel orchestration through Adobe Journey Optimizer and deeper AI integration for personalized customer journeys. However, the LLM omits specific mention of Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, which leveraged cross-channel data in the Platform for marketing investment optimization—a key addition in the ground truth. While the answer conveys the shift toward actionable campaign orchestration, this omission reduces completeness. There are no quantitative inaccuracies (dates are correct, no numbers misstated), so quantitative accuracy is perfect. The reasoning is sound and contextually relevant, synthesizing the platform’s evolving role, but the missing detail about Mix Modeler prevents a top qualitative score. Overall, the answer is semantically close and correctly interprets the multi-hop evolution, but lacks one critical 2023 enhancement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 344,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "In response to Medicare Advantage funding pressures from 2023 to 2024, UnitedHealth Group intensified its focus on value-based care delivery models, accelerating the transition from fee-for-service to fully accountable, high-quality, and affordable care. The company invested in integrated care coordination technology, physician training, and clinical engagement to improve health outcomes and reduce long-term costs. Additionally, UnitedHealthcare adjusted member benefits, increased premiums, and selectively ceased offering plans in certain counties to manage the financial impact of reduced Medicare Advantage benchmarks and risk adjustment model revisions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures UnitedHealth Group's 2023 emphasis on value-based care, investment in clinical engagement, care coordination technology, and new delivery models (in-home and virtual care), which matches the original answer. It also correctly identifies the 2024 shift due to Medicare Advantage funding pressures, including reduced benchmarks and risk adjustment changes. (2) There are no specific numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The reasoning is sound and reflects multi-hop synthesis: connecting 2023 strategic investments to 2024 operational retrenchment in response to external financial pressures. However, the LLM answer states UnitedHealth 'intensified its focus' in 2024, which slightly mischaracterizes the shift as continued expansion rather than strategic pullback. The original answer emphasizes a move from 'expansion-focused investment to cost containment and strategic retrenchment,' whereas the LLM implies continued acceleration. Also, the LLM mentions 'increased premiums,' which is not mentioned in the ground truth; instead, the original cites changes to provider networks, benefit structures, and county-level plan offerings. This is a minor factual overreach. (4) Despite these nuances, the answer remains contextually relevant and factually strong overall, capturing the core evolution and drivers. Hence, correctness is 8 due to minor inaccuracies in tone and one unsupported detail (premium increases), but qualitative accuracy is also 8 due to otherwise solid reasoning and entity alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 462,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "The composition of TMO's debt instruments remained consistent between 2022 and 2023 regarding the 1.950% Notes due 2029. In both years, the notes were listed as securities registered pursuant to Section 12(b) of the Exchange Act, with the trading symbol \"TMO 29\" and listed on the New York Stock Exchange. There were no changes in the coupon rate, maturity date, or exchange listing for these notes during the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the 1.950% Notes due 2029 remained unchanged between 2022 and 2023, with the same trading symbol TMO 29 and listing on the NYSE under Section 12(b). This aligns with the ground truth, which confirms continuity in this specific instrument. All quantitative details—coupon rate (1.950%), maturity year (2029), and trading symbol (TMO 29)—are factually accurate. (2) There are no calculations in this question, but all numeric elements (percentages, years, symbols) match the original answer exactly and correctly. (3) However, the LLM answer is incomplete in terms of multi-hop reasoning and overall composition analysis. The ground truth highlights that TMO introduced *new* debt instruments in 2023—specifically the 3.200% Notes due 2026 and 3.650% Notes due 2034—indicating a broader evolution in debt strategy. The LLM fails to mention these new instruments, thus missing a key part of the 'evolution' in composition. This omission limits the qualitative accuracy, as the answer focuses only on the stability of one instrument without addressing the expansion of the overall debt portfolio. (4) Despite this, the answer is contextually relevant and factually correct where it does respond, earning high marks for quantitative accuracy and contextual relevance. The correctness score is reduced to 7 due to the missing synthesis of new debt issuances, which is central to the question about 'evolution' in composition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 405,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Between 2022 and 2023, TMO's debt instruments remained largely consistent, with the 0.500% Notes due 2028 (TMO 28A) continuing to be listed in both years. However, in 2023, a new 3.200% Notes due 2026 (TMO 26B) was introduced, indicating a diversification in the maturity and coupon rate structure of TMO's debt offerings. No other new note categories were added during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the continued presence of the 0.500% Notes due 2028 and the introduction of the 3.200% Notes due 2026 in 2023, which aligns with the ground truth. However, it fails to mention the introduction of the 3.650% Notes due 2034, a key new debt category highlighted in the original answer. This omission affects completeness and qualitative accuracy. (2) All numeric values—interest rates (0.500%, 3.200%) and maturity years (2028, 2026)—are accurate and correctly attributed. No calculation errors are present. (3) The reasoning correctly infers a diversification strategy based on new maturities and coupon rates, but the multi-hop synthesis is incomplete because it does not incorporate all new note categories introduced in 2023, particularly the 3.650% Notes due 2034. (4) The answer is contextually relevant and well-structured, but the missing note category reduces the correctness and qualitative accuracy scores despite strong quantitative performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 288,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "The range of excess fair value over carrying value for DHR's reporting units decreased between the 2023 and 2024 annual goodwill impairment analyses. In 2023, the excess ranged from approximately 140% to 495%, while in 2024, the range was approximately 70% to 450%. This indicates a reduction in the lowest end of the excess range, with the upper end remaining relatively stable.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages for both years are accurate: 140% to 495% in 2023 and 70% to 450% in 2024. These values are reported correctly with appropriate approximations (e.g., 'approximately'). (2) The answer is complete, addressing the change in range between the two years and correctly identifying the direction and nature of the change—specifically noting the reduction in the lower bound from 140% to 70%, while the upper bound decreased slightly but is described as 'relatively stable,' which is a reasonable interpretation given the small drop from 495% to 450%. (3) Entity accuracy is correct: DHR refers to Danaher Corporation, and the years 2023 and 2024 are properly aligned with the respective goodwill impairment analyses. (4) The reasoning is sound and reflects proper multi-hop synthesis—comparing the ranges across two reporting periods and drawing a logical conclusion about the declining cushion at the lower end. (5) The semantic meaning is equivalent to the original answer, with only minor rephrasing (e.g., 'upper end remaining relatively stable' vs. 'decline in the lowest excess fair value percentage'), which does not affect factual accuracy. All components of the question are addressed with precision and clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 368,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "From 2022 to 2023, the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan increased the available share pool by a factor of two times the number of canceled RSUs or shares withheld. In 2022, 14,739 thousand RSUs were canceled, and 41 million shares were withheld for taxes, while in 2023, 8,144 thousand RSUs were canceled, and 37 million shares were withheld. This means that the share pool increased by 29.48 million shares (2 × 14.739 million) from canceled RSUs and 82 million shares (2 × 41 million) from tax-withheld shares in 2022, and by 16.29 million shares (2 × 8.144 million) from canceled RSUs and 74 million shares (2 × 37 million) from tax-withheld shares in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the treatment of canceled RSUs and tax-withheld shares from 2022 to 2023. According to the ground truth, in 2022, canceled RSUs and tax-withheld shares were returned to the share pool at a 2x multiplier, but in 2023, this 2x factor was explicitly omitted. The LLM incorrectly assumes that the 2x multiplier remained in effect in 2023, which contradicts the key factual evolution described in the original answer. While the numerical data (e.g., 14,739 thousand RSUs canceled in 2022, 8,144 thousand in 2023, 41 million and 37 million shares withheld) may be factually accurate, the application of the 2x multiplier in 2023 is wrong. This leads to incorrect calculations of the share pool increase for 2023 (16.29 million and 74 million), which should not have used a 2x factor. The reasoning fails the multi-hop requirement by not recognizing the policy change between years. The answer is contextually relevant to the topic and includes appropriate entities and timeframes, but the qualitative and quantitative inaccuracies due to the incorrect application of plan rules severely undermine the response. Thus, the correctness score is low despite some accurate input data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 345,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "Between 2023 and 2024, Aldevron remained integrated into Danaher's Life Sciences segment, as highlighted in the 2024 10-K. Acquired in 2021 for $9.6 billion, Aldevron is described as a leading manufacturer of high-quality plasmid DNA, mRNA, and proteins, supporting genomic medicine. There is no indication of a change in Danaher's financial stake in Aldevron during this period, and it continues to operate as part of the Life Sciences segment, contributing to product offerings in genomic medicines.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but misses the key evolution in Danaher's relationship with Aldevron between 2023 and 2024 as described in the ground truth. While it correctly identifies Aldevron's integration into the Life Sciences segment in 2024, it fails to note the change in financial stake — specifically, that Aldevron was a separately accounted stake in 2023 with $9,561 million in net cash consideration, but was no longer listed as a standalone stake in 2024 due to full integration. Instead, the LLM claims there was 'no indication of a change,' which contradicts the ground truth. (2) The dollar amount is approximately correct ($9.6 billion vs. $9,561 million), with acceptable rounding. However, the acquisition date is inaccurately stated as 2021, which is not supported by the provided data — the 2023 filing implies the acquisition occurred around that time. (3) The multi-hop reasoning is flawed: the model should have inferred from the absence of Aldevron in the 2024 acquisition table and its incorporation into the Life Sciences segment that a strategic shift from financial stake to full integration occurred. The LLM instead assumes continuity without recognizing the structural change indicated in the financial disclosures. (4) Despite missing the core dynamic of stake evolution, the answer is contextually relevant and correctly places Aldevron within the Life Sciences segment and describes its business focus accurately, warranting moderate scores in quantitative and qualitative accuracy. However, the failure to capture the key transition results in a mid-range correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 451,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "Between 2023 and 2024, Microsoft 365's strategic positioning evolved significantly by deepening its integration with AI technologies, particularly through the Copilot suite. In 2024, Microsoft 365 became an \"AI-first platform,\" combining Office, Windows, Copilot, and Enterprise Mobility + Security to enhance productivity and collaboration. The introduction of role-based Copilot extensions (e.g., Copilot for Sales, Service, and Finance) and Copilot Pro for consumers further solidified its AI-driven value proposition. Commercial business metrics reflected this shift, with Microsoft Cloud revenue increasing by 23% to $137.4 billion in 2024, driven by strong growth in Office 365 Commercial (16%) and Dynamics 365 (24%), showcasing Microsoft 365's central role in driving enterprise productivity and AI adoption.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. While it correctly identifies the strategic shift toward AI integration in Microsoft 365, especially through Copilot, it fabricates or misrepresents key financial metrics. The claim that 'Microsoft Cloud revenue increased by 23% to $137.4 billion in 2024' is not supported by the ground truth and introduces specific numbers absent from the original answer. Similarly, the 16% growth in Office 365 Commercial and 24% growth in Dynamics 365 are not mentioned in the ground truth and appear to be hallucinated. (2) The ground truth does not provide any revenue figures or percentage growth rates, so these numerical claims cannot be verified and are likely incorrect. The only metric mentioned is the expansion of the Microsoft 365 Consumer subscribers to include Basic subscribers in 2024, which the LLM answer omits entirely. (3) The qualitative reasoning is partially sound: the LLM correctly identifies the 'AI-first platform' positioning and mentions relevant components like Copilot, Office, and Enterprise Mobility + Security. It also correctly infers a strategic emphasis on AI and productivity in the commercial segment. However, it fails to capture the specific evolution in business metrics—namely the change in subscriber definition—which is a core part of the ground truth. The introduction of 'role-based Copilot extensions' and 'Copilot Pro' adds detail not present in the original and may reflect general knowledge but isn't supported by the provided truth. (4) The contextual relevance is high because the answer addresses AI integration and commercial impact, aligning with the question's focus. However, due to significant quantitative inaccuracies and omission of the key metric change, the correctness score is limited to 5. The qualitative accuracy is moderate due to correct conceptual framing, while quantitative accuracy is low due to unsupported numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 535,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "Between 2023 and 2024, Microsoft has elevated Copilot Pro's role within Microsoft 365 apps and web-based AI assistance by positioning it as a consumer subscription service that delivers faster and more powerful AI assistance. In 2023, Copilot Pro was introduced as a service to enhance productivity and streamline workflows, while by 2024, it had become more deeply integrated into Microsoft 365 applications and web experiences, emphasizing its role in improving user productivity and enabling seamless AI-driven interactions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. It correctly identifies that Copilot Pro was introduced in 2023 as a consumer subscription service offering faster and more powerful AI assistance in Microsoft 365 apps and on the web. It also accurately reflects the 2024 evolution, noting deeper integration and an enhanced emphasis on productivity and AI-driven workflows. The answer captures the key elements of positioning and evolution, though it omits the specific nuance from the original answer about Copilot Pro being embedded in a 'broader narrative of AI-driven transformation across Microsoft's ecosystem' and its strategic role beyond a standalone offering. This missing layer of strategic context slightly weakens the qualitative depth, but the essential facts, entities (Microsoft, Copilot Pro, Microsoft 365, 2023–2024 timeline), and reasoning are correct. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is fully relevant to the question. Minor deduction in qualitative accuracy due to less comprehensive synthesis of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 321,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan had approximately 50 million shares available for issuance as of December 31, 2023, and this decreased to approximately 47 million shares available for issuance as of December 31, 2024. This reduction reflects the issuance of shares related to stock-based compensation awards during 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that approximately 50 million shares were available as of December 31, 2023, which contradicts the ground truth stating that no specific figure was provided for 2023. This is a major factual error. The 2024 figure of 47 million shares available is correct and matches the ground truth. (2) The quantitative accuracy is low because the 50 million share number for 2023 is fabricated; there is no support for this in the original answer. The reduction from 50M to 47M implies a calculation (3M shares issued) that cannot be validated due to the incorrect starting point. (3) The reasoning is partially sound in that it infers a decrease due to stock-based compensation, which is plausible, but it fails the multi-hop requirement by not acknowledging the shift in disclosure transparency between years — a key qualitative point in the ground truth. The model assumes numerical continuity where none was reported. (4) Contextual relevance is high because the answer addresses share availability and evolution over time, but correctness is significantly undermined by the invented 2023 number, leading to a low overall score despite capturing the 2024 figure correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 342,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Microsoft maintained its updated accounting policy for the estimated useful lives of server and network equipment, which was changed from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. There is no indication of a further change in this policy in fiscal year 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitative accuracy: The key numbers—change from 4 to 6 years, effective beginning fiscal year 2023—are accurately reported. No calculations are required, and all dates and durations match the original. (2) Completeness: The answer addresses both parts of the question—how the policy evolved between FY2023 and FY2024, and the factors influencing the change. It correctly notes the change occurred at the start of FY2023 and remained unchanged in FY2024. (3) Entity accuracy: Microsoft, server and network equipment, fiscal years 2023 and 2024, and the relevant policy are all correctly identified. (4) Reasoning: The multi-hop synthesis is sound—linking the policy change to its drivers (software investments, tech advances) and correctly inferring no further change in FY2024. (5) Semantic equivalence: While the LLM omits the explicit mention of 'cloud and AI infrastructure investments' as a sustaining factor in FY2024, it does state the policy remained consistent and cites the initial rationale, which captures the core of the original answer. The omission is minor and does not undermine the overall correctness. Hence, a score of 9 is warranted—very close to full accuracy with only slight loss in qualitative completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 364,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "MDT's exposure to auction rate securities remained consistent in fair value from 2022 to 2023, at $33 million for both periods. In both years, auction rate securities were classified within \"Other Assets\" on the balance sheet, as they were part of Level 3 available-for-sale debt securities. There were no changes in the classification or significant shifts in fair value during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that MDT's auction rate securities had a fair value of $33 million in both 2022 and 2023, which matches the ground truth. However, it incorrectly claims that the securities were classified under 'Other Assets' in both years. According to the original answer, in 2022 they were included under 'Total' in the investment portfolio without a separate classification, and only in 2023 were they explicitly moved to 'Other Assets'. This is a critical factual error in classification evolution. (2) Quantitative accuracy is perfect—$33 million in both years is correctly reported with no calculation issues. (3) The multi-hop reasoning fails because the model does not recognize the change in balance sheet classification over time, which is central to the question. Instead, it asserts no change occurred, contradicting the ground truth. (4) While the answer is relevant and addresses fair value and classification, the incorrect portrayal of consistency in classification significantly undermines the qualitative accuracy. The correctness score is low due to this major misrepresentation of how the accounting treatment evolved, despite correct numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 336,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "The net losses from Cisco's available-for-sale debt investments increased from a loss of $21 million in fiscal 2023 to a loss of $67 million in fiscal 2024. This indicates a decline in the performance of this investment category, likely influenced by factors such as interest rate fluctuations and market conditions affecting the fair value of these investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net losses for both fiscal years—$21 million in 2023 and $67 million in 2024—matching the ground truth exactly. The increase in losses is accurately described, and the conclusion that performance declined is consistent with the original answer. (2) All numeric values are correct and properly attributed to the right fiscal years. The comparison between the two years is accurate, and no calculations are required beyond the stated values, which are factually sound. (3) The multi-hop reasoning is solid: the model correctly synthesizes data across two fiscal periods for Cisco’s available-for-sale debt investments and draws a valid conclusion about performance trends. The addition of potential explanatory factors (interest rate fluctuations, market conditions) is reasonable and adds context without contradicting the ground truth; however, these factors are not present in the original answer, slightly extending beyond the provided information. (4) The answer is fully relevant to the question, addressing both the change in net gains/losses and the implication for investment performance. The slight elaboration on causes is contextually appropriate but not required, hence not penalized heavily. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 371,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Between 2023 and 2024, Cisco's approach to the APJC region evolved by maintaining a geographic operational structure but shifting financial investment priorities to align with its strategy of integrating AI and modernizing infrastructure. The company emphasized cloud-based solutions, cybersecurity, and AI-driven insights to meet customer needs in the region. This shift suggests a move toward a revenue model increasingly reliant on subscription-based services and software solutions, as opposed to traditional hardware sales, to drive sustainable growth in APJC.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. While it correctly identifies Cisco and the APJC region and references the 2023–2024 timeframe, it fabricates a shift in financial investment priorities toward AI and infrastructure modernization, which is not supported by the ground truth. The original answer states that Cisco evolved from direct operational presence in 2023 to including financial investments (marketable/non-marketable equity and equity method investments) in 2024—information entirely absent from the LLM response. Instead, the LLM introduces subscription-based revenue and software shifts, which are not mentioned in the ground truth and represent a different strategic narrative. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the absence of specific financial instruments and investment categories from the LLM answer undermines factual precision. (3) The multi-hop reasoning is flawed: the question requires synthesis of changes in operational structure versus financial investment across two years, but the LLM fails to recognize the key shift from operational to investment-based engagement. It does not mention equity investments or the coexistence of operational and investment strategies, missing the core of the multi-hop analysis. (4) Contextual relevance is moderate because the answer discusses Cisco’s regional strategy and revenue model, which are relevant themes, but the specific evolution described is factually incorrect. The LLM invents a technology-driven strategic pivot rather than reporting the actual structural and financial changes documented in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 462,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Between 2022 and 2024, Apple has modified its App Store commission policies and regulatory compliance strategies in response to legal and market pressures. In 2022, Apple acknowledged litigation and market conditions as factors influencing App Store changes, particularly regarding how developers communicate with consumers about alternative purchasing methods. By 2024, Apple had implemented more significant adjustments, including adapting to the EU's Digital Markets Act (DMA), which required new business terms, alternative fee structures, and alternative app distribution and payment methods. These changes reflect Apple's evolving approach to balancing regulatory compliance with maintaining its business model, while also addressing legal challenges and competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: Apple acknowledged legal and market pressures in 2022, particularly around developer communication, and by 2024 had implemented concrete changes in response to the EU's Digital Markets Act (DMA). The mention of new business terms, alternative fee structures, and alternative distribution and payment methods matches the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is unaffected and scores perfectly. (3) The multi-hop reasoning is sound—correctly linking Apple’s 2022 risk acknowledgment to its 2024 regulatory adaptations across jurisdictions (U.S. and EU), though the LLM omits explicit mention of U.S.-specific changes noted in the original answer. This is a minor omission, not an error. (4) Semantic equivalence is strong: the LLM captures the evolution from general risk disclosure to specific compliance actions affecting App Store revenue and commission models. The only slight gap is less emphasis on the financial impact (e.g., reduced sales volume affecting commissions), but the core reasoning and entity accuracy (Apple, App Store, DMA, 2022–2024 timeline) are fully correct. Contextual relevance is excellent as it directly addresses the evolution in response to legal and market pressures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 388,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "Between 2022 and 2024, Texas Instruments' U.S. Retiree Health Care Plan shifted its allocation strategy slightly toward fixed income securities and away from equity securities. In 2022, the weighted average asset allocation was 64% fixed income securities and 36% equity securities. By 2024, the allocation had changed to 80% fixed income securities and 20% equity securities. This shift aligns with the plan's target allocation range of 75%-85% for fixed income and 15%-25% for equity securities, indicating a more conservative investment approach over this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift toward fixed income securities from 2022 to 2024 and accurately reports the 2024 allocation (80% fixed income, 20% equity), which aligns with the ground truth. However, the 2022 allocation is incorrect: the LLM states 64% fixed income and 36% equity, while the ground truth reports $248 million in fixed income and cash equivalents and $137 million in equity securities. Calculating from these figures: total assets = $248M + $137M = $385M; fixed income percentage = $248M / $385M ≈ 64.4%, which is close to the LLM's 64%. Despite this numerical proximity, the ground truth does not state that 64% was the 'weighted average asset allocation'—it provides dollar amounts, not percentages. The LLM invents a percentage not explicitly confirmed in the original answer, introducing a potential misrepresentation. (2) The 2024 figures (80%/20%) are correct and match the ground truth. The mention of the target allocation range (75%-85% fixed income, 15%-25% equity) is plausible but not present in the original answer, adding context not supported by the ground truth. (3) The reasoning is sound in identifying a strategic shift toward conservatism and capital preservation, which is consistent with the original answer. The multi-hop synthesis across years is logical and correctly interprets the trend. (4) The answer is contextually relevant and captures the core evolution in allocation strategy. However, the use of inferred percentages for 2022 without explicit confirmation, and the addition of external-sounding details (target ranges), reduce quantitative accuracy. The core facts are mostly correct, but the presentation includes unverified precision and minor fabrication, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 481,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "Texas Instruments' strategic emphasis on Embedded Processing Products from 2022 to 2024 shows a decline in revenue contribution, with revenue decreasing from $3,261 million in 2022 to $2,533 million in 2024. Despite this, Embedded Processing has maintained a competitive advantage through its role as the digital 'brains' of electronic equipment, optimized for performance, power, and cost. However, its operating profit has significantly declined from $1,253 million in 2022 to $352 million in 2024, indicating challenges in sustaining profitability within this segment. The segment remains part of the two reportable segments (Analog and Embedded Processing), but its relative importance appears to have diminished compared to the Analog segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and interpretation. The Original Answer (ground truth) states that Embedded Processing was elevated to a reportable segment in 2024, indicating increased strategic importance. In contrast, the LLM claims declining revenue and profitability (e.g., revenue dropping from $3,261M to $2,533M and operating profit from $1,253M to $352M), which contradicts the strategic elevation and is unsupported by the ground truth. These specific financial figures are not present in the ground truth and appear fabricated. (2) There are no verifiable calculations or accurate numbers in the LLM response—no dollar amounts, percentages, or financial trends were correctly reported. The ground truth does not provide any financial metrics for the Embedded Processing segment, so asserting such precise figures constitutes a serious factual error. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers that declining financials imply reduced strategic importance, while the ground truth shows the opposite: structural changes (elevating to a reportable segment) signal increased focus. The model fails to recognize that organizational reporting changes reflect strategic prioritization, regardless of short-term financial trends. (4) Contextual relevance is moderate because the answer addresses the right topic—strategic emphasis on Embedded Processing—and mentions correct elements like performance, power, cost, and the two-segment structure. However, the incorrect data and reversed conclusion severely undermine accuracy. The qualitative reasoning fails on entity synthesis and logical inference, warranting low scores in correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 472,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "TMO issued its 2.00% 10-Year Senior Notes in 2022, with a maturity date of October 15, 2031, and a carrying value of $1,200 million. By 2024, the 2.00% 10-Year Senior Notes remained outstanding, with no changes in issuance, and were still valued at $1,200 million, with an effective interest rate of 2.23%. There is no indication of redemption or modification of these notes between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same essential information as the ground truth. (1) All key facts are correct: the issuance in 2022, maturity date (October 15, 2031), principal amount ($1,200 million), and effective interest rate (2.23%) are correctly reported. The 2024 status accurately reflects no change in principal or interest rate. (2) Quantitative elements are fully accurate—dollar amounts, percentages, and dates match the original answer exactly, with acceptable phrasing variations (e.g., 'carrying value' vs. 'reported'). (3) The reasoning is sound: the model correctly infers no new issuance or repayment occurred based on the unchanged figures, demonstrating proper multi-hop synthesis across 2022 and 2024 filings. (4) The only minor shortcoming is that the LLM does not explicitly state that the effective interest rate remained unchanged in 2024 (though it implies it by stating the rate without qualification), whereas the original answer explicitly confirms the rate stability. This slight omission in completeness prevents a perfect 10, but the answer remains factually aligned and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 323,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "REMICADE's sales declined from $1.839 billion in 2023 to $1.605 billion in 2024, representing a 12.8% decrease, primarily due to continued biosimilar competition. This decline highlights the increasing pressure on REMICADE's market position within Johnson & Johnson's Pharmaceutical segment, indicating a diminishing role as biosimilars erode its sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the sales figures for REMICADE in 2023 ($1.839 billion) and 2024 ($1.605 billion), matching the ground truth in both absolute values and format (allowing $1.839 billion = $1,839 million). The calculated 12.8% decrease is accurate: (1,839 - 1,605) / 1,839 ≈ 0.1272, which rounds to 12.7%–12.8%, so this is correct. (2) The answer addresses the evolution of financial performance between 2022 and 2024, though it omits explicit mention of REMICADE's status in 2022 as a key product in the Immunology therapeutic area. However, it does imply a historical role by referencing declining sales and market position. (3) The reasoning is sound: the decline is attributed to biosimilar competition, which aligns with industry context and plausibly explains the drop. While the original answer cites 'market saturation, increased competition, or emergence of newer biologics', the LLM narrows it to 'biosimilar competition'—a specific and valid form of increased competition—so this is a reasonable and focused interpretation, not an error. (4) All entities (REMICADE, Johnson & Johnson's Pharmaceutical segment) are correctly identified, and the temporal scope (2023 to 2024) appropriately reflects the performance trend. The omission of the 2022 context is minor and does not undermine the core factual accuracy. Thus, the answer is highly accurate, complete in key aspects, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 430,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "REMICADE's sales declined from $3.19 billion in 2022 to $1.605 billion in 2024, representing a significant drop of 12.8% in 2024 compared to the prior year. This decline was primarily driven by continued biosimilar competition in the United States and other markets. This performance indicates that REMICADE is losing market share within JNJ's Immunology portfolio, highlighting the growing impact of biosimilars on its position as a key product in the segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports REMICADE's sales of $3.19 billion in 2022 and $1.605 billion in 2024, which align with the ground truth ($3,190 million and $1,605 million). However, the LLM states a 12.8% drop in 2024 compared to the prior year, which is accurate per the original answer, but omits the 2022-to-2020 comparison (14.9% decline) mentioned in the ground truth. This omission reduces completeness. (2) The numbers themselves are quantitatively accurate, with acceptable format variations (e.g., $3.19 billion = $3,190 million). The 12.8% decline from 2023 to 2024 is correctly cited, though the lack of 2023 sales data in the response makes the calculation less transparent. (3) The reasoning is sound: the LLM correctly infers that declining sales indicate a weakening market position and attributes this to biosimilar competition, which is a plausible and contextually supported explanation, even if not explicitly stated in the ground truth. This shows good qualitative synthesis. (4) The answer is highly contextually relevant, addressing both the sales trend and market position within JNJ's Immunology portfolio. However, the absence of the earlier 2020 comparison and the lack of explicit mention of the multi-year decline trend (from 2020 onward) result in a slightly lower correctness and quantitative accuracy score. Overall, the core facts and interpretation are correct, but minor omissions prevent a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 400,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "Between 2021 and 2024, REMICADE's sales declined significantly, from $3.19 billion in 2021 to $1.605 billion in 2024. The primary factor contributing to this decline was continued biosimilar competition in the United States and other markets, which led to a reduction in market share and sales volume. This trend is consistent with the company's acknowledgment that biosimilar versions of REMICADE have been introduced and that additional competitors have entered the market, further pressuring sales.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The ground truth states that REMICADE's sales were $16.8 billion in 2021 as part of total Immunology sales, not $3.19 billion for REMICADE alone. The 2024 figure of $1.605 billion is correct and matches the ground truth (expressed as $1,605 million). However, the 2021 figure is severely understated, leading to an incorrect portrayal of the magnitude of decline. Additionally, the LLM fails to mention the 12.8% year-over-year decrease from 2023 to 2024, which is a key detail in the original answer. (2) The calculation of decline is therefore incorrect: from $3.19B to $1.605B implies roughly a 50% drop, whereas the actual decline from a much higher base (within $16.8B Immunology segment) is more complex and was not properly isolated to REMICADE’s standalone performance over the full period. The LLM does not clarify that the $16.8B was total Immunology sales, not REMICADE-specific, but incorrectly assigns a much lower figure to REMICADE itself without sourcing. (3) The qualitative reasoning about biosimilar competition in the U.S. and global markets is accurate and aligns with the ground truth; the explanation of market share erosion due to biosimilars is logically sound and reflects correct multi-hop understanding of competitive dynamics. (4) Contextually, the answer addresses both parts of the question—sales evolution and contributing factors—and does so with relevant terminology and structure. However, the severe numerical inaccuracy in the starting sales figure undermines the correctness score, as it misrepresents the scale of the business and the trajectory. While the directionality (decline due to biosimilars) is correct, the magnitude is not, warranting a low quantitative accuracy score and a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 501,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "Between 2022 and 2024, STELARA (ustekinumab) experienced a decline in sales, decreasing by 4.6% from $10.858 billion in 2022 to $10.361 billion in 2024. The decline was primarily driven by share loss due to European biosimilar entrants and the anticipation of biosimilar competition in the U.S. in 2025. Despite this, STELARA continued to perform well in the U.S., with sales of approximately $6.7 billion in 2024. The product also saw regulatory progress, with a new indication for pediatric Crohn's disease filed in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it misstates the timeline of sales figures: it claims STELARA had $10.858 billion in sales in 2022 and $10.361 billion in 2024, implying a direct two-year decline. However, the ground truth states that the $10.858 billion was in 2023, not 2022, and the $10.361 billion was in 2024. This misassignment of years leads to an incorrect temporal narrative. The 4.6% decline is accurate but incorrectly framed as occurring between 2022 and 2024, when it actually occurred between 2023 and 2024. (2) The dollar amounts themselves ($10.858B and $10.361B) are numerically correct but assigned to the wrong years, which undermines quantitative accuracy. The $6.7B U.S. sales figure and the mention of pediatric Crohn’s disease filing in 2024 are not present in the ground truth and cannot be verified; thus, they introduce unconfirmed details. (3) The reasoning partially captures the commercial trend (declining sales due to biosimilar pressure), which aligns with plausible market dynamics, but fails to reflect the correct multi-hop evolution: from regulatory activity in 2022 (pediatric psoriatic arthritis filing) to commercial performance in 2024. The LLM mentions a 2024 filing for pediatric Crohn’s, which is a different indication and not in the original answer, suggesting potential confusion or hallucination. (4) Despite the incorrect year assignments and unsupported specifics, the answer remains contextually relevant by addressing both regulatory and commercial aspects of STELARA’s evolution and correctly identifying the overall sales trend direction and magnitude (albeit over the wrong period). The core idea of a mature drug facing biosimilar-driven decline is consistent with the ground truth. However, the quantitative inaccuracies significantly reduce the correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 507,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The total net revenue from Restasis in the United States decreased from $382 million in 2023 to $172 million in 2024, representing a 55.2% decrease in 2024. In 2023, the revenue decreased by 38.5% compared to 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts are accurate: $382 million in 2023 and $172 million in 2024. The percentage decreases are correctly stated: 38.5% decrease in 2023 (vs. 2022) and 55.2% decrease in 2024 (vs. 2023). (2) The calculations are sound: a drop from $382M to $172M is indeed a (382-172)/382 ≈ 55.2% decrease, and the 38.5% decline in 2023 is consistent with prior-year data. (3) The multi-hop reasoning is accurate—the model correctly synthesizes two years of year-over-year percentage changes and associates them with the correct time periods and revenue figures. (4) All entities (Restasis, United States net revenue, years 2023 and 2024) are correctly identified and contextualized. The answer is semantically equivalent to the original, with clear, concise phrasing that captures all required information without omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 269,
        "total_tokens": 1378
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "Between 2022 and 2023, Master Lease Agreements (MLAs) have become more strategically important for AMT in supporting international growth and tenant relationships. These agreements provide consistent, long-term revenue and reduce non-contractual churn, which is critical as AMT expands in diverse markets with varying stages of network development. For instance, the T-Mobile MLA from 2020 has continued to influence churn rates in the U.S. & Canada segment, while in international markets, MLAs help AMT build strong strategic partnerships with carriers, streamline colocation processes, and support rapid deployment of equipment as wireless networks evolve. This strategic use of MLAs has enhanced AMT's ability to meet growing demand for communications infrastructure and maintain stable revenue streams across its global portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic importance of Master Lease Agreements (MLAs) in supporting AMT's international growth and tenant relationships, highlighting consistent long-term revenue, reduced churn, streamlined colocation, and rapid deployment—key points from the ground truth. However, it omits specific quantitative data from both years: the international portfolio size of approximately 177,000 sites in 2022 and 182,000 in 2023, which are central to the evolution of MLAs' role. Instead, it references the T-Mobile MLA from 2020, which is not mentioned in the ground truth and introduces an unsupported example. (2) Quantitative accuracy is compromised because the LLM fails to report the exact portfolio sizes for 2022 and 2023, which are critical metrics in the original answer showing growth and scale. While no incorrect numbers are stated, the absence of these figures—especially since they demonstrate tangible expansion—reduces factual completeness. (3) The multi-hop reasoning is partially sound: the model correctly infers that MLAs support international growth and tenant retention, and links them to operational efficiencies. However, it does not explicitly connect the portfolio growth (177k to 182k sites) with the enhanced strategic role of MLAs over time, missing a key synthesis point. The mention of 'customer consolidation and regulatory changes' as risks mitigated by MLAs in the original is also omitted. (4) Despite missing key numbers and one risk dimension, the LLM answer captures the core qualitative evolution—increased strategic focus on MLAs for growth and stability—and remains contextually relevant and well-reasoned. Wording differences are acceptable, but omission of specific site counts lowers quantitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 490,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "Between 2023 and 2024, the Google Marketing Platform continued to serve as a key channel for advertising revenue generation, with revenues recognized primarily on a gross basis for ads placed on Google Network properties. This means that the amounts billed to customers are recorded as revenues, while payments to Google Network partners are classified as cost of revenues. There is no indication of a significant change in the role or structure of how advertising revenues are recognized or managed across Google Network properties during this period. The platform remains central to facilitating advertising inventory sales through tools like Google Ads, Google Ad Manager, and Google Display & Video 360.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually accurate in describing the gross revenue recognition model and the classification of partner payments as cost of revenue, which aligns with the ground truth. However, it incorrectly states that there was 'no significant change' in the role or structure of revenue recognition and management between 2023 and 2024, which directly contradicts the original answer. The ground truth specifies a clear evolution in 2024 involving a more nuanced evaluation of principal versus agent status and greater emphasis on control over inventory—key developments that the LLM answer omits. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable beyond correct use of terms like 'gross basis,' which the model handles correctly. (3) The multi-hop reasoning fails because the model does not synthesize the change over time—specifically, the shift in 2024 toward a more detailed assessment of control and principal status—which is central to the question. The answer treats the two years as static, missing the evolution entirely. (4) While the response is contextually relevant and uses correct terminology, the absence of the key 2024 developments results in a partially correct answer, warranting a moderate correctness score of 4. The qualitative accuracy is low due to flawed reasoning about change over time, but contextual relevance remains high as the content is on-topic and plausibly framed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 407,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "Based on the information provided in the document pages, the volume and fair value of Federal Funds Purchased & Securities Loaned increased between 2023 and 2024. In 2023, the fair value was $133,053 million, and in 2024, it rose to $144,501 million. This increase suggests that Bank of America (BAC) is utilizing more short-term funding through these instruments in 2024 compared to 2023. This could indicate a strategic shift or adjustment in BAC's short-term funding approach, potentially to take advantage of favorable market conditions or to meet increased liquidity needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numbers. According to the ground truth, in 2023, the volume (net change) was $16,466 million, not a fair value of $133,053 million as stated by the LLM. Furthermore, the 2024 fair value in the ground truth is $192,859 million, not $144,501 million. These discrepancies indicate incorrect data retrieval or synthesis. (2) The quantitative inaccuracies are severe: the LLM reports fair values for both years that do not match the ground truth, and it fails to report the 2023 net volume change of $16,466 million, instead inventing a fair value figure not present in the original answer. The increase from $133,053M to $144,501M implies a $11,448M rise, which does not align with the ground truth trajectory or magnitude. (3) The reasoning is partially sound—increasing Federal Funds Purchased & Sec Loaned does suggest greater reliance on short-term funding—but the conclusion is based on incorrect data. The multi-hop synthesis is flawed because the model did not correctly identify or link the 2023 volume change and 2024 fair value from distinct data points. (4) Contextual relevance is moderate because the answer addresses the question's structure and infers plausible implications about BAC's funding strategy, but the incorrect numbers undermine the validity of the analysis. Thus, correctness is low due to major factual errors, despite appropriate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 399,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations became more detailed and specific. In 2022, the discussion was limited to general references in the risk management framework and market risks sections. By 2024, the 10-K explicitly highlighted increased pension and retiree medical benefits expense due to higher settlement charges from lump sum distributions and the purchase of a group annuity contract, directly linking these changes to market and financial conditions. This evolution reflects a more transparent and granular explanation of how market fluctuations impact these liabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative description of PepsiCo's disclosure evolution. (1) What was correct: The general direction of increased disclosure detail between 2022 and 2024 is accurate, and the years (2022, 2024) and entity (PepsiCo) are correct. There are no numeric values in either answer, so quantitative accuracy is not compromised. (2) However, the LLM introduces specific events—'higher settlement charges from lump sum distributions' and 'purchase of a group annuity contract'—that are not present in the original ground truth and misrepresent the nature of the disclosure change. The original answer emphasizes a broadening of risk context to include inflationary, deflationary, and recessionary conditions, not specific accounting events or transactions. (3) The multi-hop reasoning is flawed: while the model correctly identifies a trend toward more detailed disclosure, it fabricates operational details rather than accurately synthesizing the shift in risk characterization (from market fluctuations alone to broader macroeconomic conditions). This indicates a failure to correctly interpret or retrieve the actual content of the disclosures. (4) The contextual relevance is high because the answer addresses the evolution of sensitivity disclosures over time and remains focused on pension and retiree medical plan liabilities. However, the incorrect qualitative details reduce factual accuracy, warranting a mid-range correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 416,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "Adobe Scan has been increasingly integrated into Adobe's broader document management ecosystem between 2023 and 2024. In 2023, Adobe Scan was primarily highlighted as a standalone mobile app for converting paper documents into PDFs. By 2024, it is positioned more strategically within Adobe Document Cloud, emphasizing seamless integration with Adobe Acrobat, Acrobat Sign, and other document workflows. This evolution reflects Adobe's focus on unifying document capture, management, and collaboration tools to enhance productivity across devices and platforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Adobe Scan's positioning between 2023 and 2024. It accurately captures the shift from a standalone mobile scanning tool in 2023 to a more integrated component of Adobe Document Cloud in 2024, with emphasis on integration with Acrobat, Acrobat Sign, and broader document workflows. The answer correctly identifies the strategic move toward unifying document capture, management, and collaboration tools, which reflects Adobe's broader ecosystem goals. However, it omits specific 2024 advancements mentioned in the original answer, such as AI-driven features like Content Credentials and Firefly-powered generative AI workflows, which are key indicators of the enhanced focus on digital trust and enterprise integration. These omissions reduce completeness and slightly weaken the qualitative accuracy, though the core reasoning and entity identification (Adobe Scan, Adobe Document Cloud, Acrobat, time periods) are correct. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is highly relevant to the question. Semantic equivalence is mostly preserved, but the lack of AI-specific enhancements limits it to a score of 8 rather than 9–10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 355,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini's role and integration across Google's products evolved significantly from its initial launch in 2023 to 2024. In 2023, Gemini was introduced as a natively multimodal AI model capable of understanding and combining different types of information, such as text, code, audio, image, and video. By 2024, Gemini 2.0 was launched, enhancing its capabilities and expanding its integration to all seven of Google's two-billion-user products: Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube. Specific advancements in its multimodal capabilities included the ability to perform complex tasks such as generating images, coding support, and app integration, as well as improving AI-driven features like AI Overviews and YouTube recommendations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Gemini was introduced in 2023 as a multimodal model capable of handling text, code, audio, image, and video; in 2024, Gemini 2.0 launched and was integrated into all seven of Google's two-billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube. These entities and timeframes are correctly identified. (2) Quantitative accuracy is perfect: the reference to 'seven' products and 'two-billion-user' products matches the ground truth exactly. No numerical calculations were required, but the numbers used are factually correct. (3) Multi-hop reasoning is sound—the model synthesizes information about evolution over time (2023 to 2024), product integration, and capability advancements. The only minor shortcoming is that the LLM mentions 'generating images, coding support, and app integration' as specific multimodal advancements, which, while plausible, are not explicitly detailed in the ground truth. Instead, the original answer highlights experimental prototypes like Project Astra and Project Mariner as evidence of broader applications. This omission of specific research projects slightly reduces qualitative accuracy, but the overall meaning and scope remain semantically equivalent. (4) The answer is fully contextually relevant, directly addressing both the evolution of Gemini's integration and its multimodal advancements. Wording differences do not affect factual correctness. A score of 9 is justified due to high accuracy with a minor omission in experimental use cases.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 441,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "Between 2022 and 2024, Linde's global helium wholesale operations, which are included in the \"Other\" segment, experienced a decline in sales and mixed impacts on operating profit. In 2024, sales for the Other segment decreased by 2% compared to 2023, primarily due to lower volumes in global helium. However, operating profit increased by 44% in 2024 versus 2023, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher helium-related costs. This suggests that while helium volumes negatively impacted sales, cost management and insurance recoveries helped improve profitability in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key developments in Linde's relationship with helium between 2022 and 2024. It accurately states that in 2024, lower global helium volumes led to a 2% decrease in sales for the 'Other' segment, which aligns with the ground truth. It also correctly notes the 44% increase in operating profit for the 'Other' segment and the role of insurance recovery in Linde Advanced Materials Technology (LAMT), partially offset by higher helium-related costs. However, the LLM answer does not explicitly mention the shift in relationship from neutral/positive in 2022 (helium as a supply) to negative in 2024, which is a key qualitative evolution highlighted in the original answer. This omission slightly reduces completeness and qualitative accuracy. (2) Quantitatively, all numbers are accurate: the 2% sales decrease and 44% operating profit increase are correctly reported. The comparison between 2024 and 2023 is appropriate given the data available, though the original answer does not specify the comparison year for the 44% increase—assuming 2023 is reasonable. (3) The multi-hop reasoning is sound: the model synthesizes information about helium’s impact on sales and operating profit across segments and factors in both volume declines and cost pressures. However, it misses the explicit contrast between 2022 and 2024 in terms of the nature of the relationship (from supply/input to a negative factor), which requires connecting two temporal data points. (4) The answer is highly contextually relevant, directly addressing the evolution in Linde's helium relationship and its financial impacts. The scores reflect high accuracy with minor gaps in completeness and reasoning depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 472,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net value of acquired franchise rights decreased from $1,891 million in 2022 to $1,858 million in 2024, representing a decline of $33 million over the two-year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers. The ground truth states that the net value of acquired franchise rights was $789 million in 2022 and $598 million in 2024, whereas the LLM claims $1,891 million in 2022 and $1,858 million in 2024. These values are not only incorrect but also vastly overstated. The calculated decline of $33 million ($1,891M - $1,858M) is therefore also wrong; the actual decline is $191 million ($789M - $598M). (2) Quantitative accuracy is extremely low because both the starting and ending values are incorrect, and the resulting change is off by more than 80%. Even allowing for format variations (e.g., $1.891B vs $1,891M), the numbers do not match the ground truth. (3) The qualitative reasoning structure is sound—identifying a decrease over time and calculating the magnitude—but it fails on multi-hop synthesis because the model did not retrieve or use the correct data points from the knowledge base. The entities (metric: 'acquired franchise rights', time frame: 2022–2024) are correctly identified, but the values associated with them are not. (4) Contextual relevance is high because the answer addresses the right metric and time period and attempts to compute the change, fulfilling the question's structure. However, due to severe factual inaccuracies, the correctness and quantitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1082,
        "completion_tokens": 385,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "Chevron's natural gas delivery commitments related to Tengizchevroil (TCO) in Kazakhstan remained relatively stable from 2023 to 2024, with no specific changes mentioned in the provided documents. In 2023, Chevron's production in Kazakhstan averaged 114 million cubic feet of natural gas per day, and in 2024, it averaged 113 million cubic feet per day. These figures suggest consistent production levels, indicating that Chevron's commitments tied to TCO were likely maintained without significant fluctuations during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Chevron's total natural gas volumes in 2023 were 596 million cubic feet per day (mmcf/d) consumed in operations and 7,148 mmcf/d sold, including its share from Tengizchevroil. In 2024, these increased to 609 mmcf/d consumed and 7,569 mmcf/d sold. The LLM instead reports production in Kazakhstan as 114 mmcf/d in 2023 and 113 mmcf/d in 2024, which contradicts the ground truth and misrepresents the scale and nature of the data. These numbers appear to refer only to direct production in Kazakhstan, not the total volumes including TCO's contribution as reported in the original answer. (2) The quantitative discrepancy is severe: the correct sold volumes are over 7,000 mmcf/d, not 114 mmcf/d. The LLM underreports by an order of magnitude and fails to reflect the actual growth trend. There are no accurate calculations or comparisons in the LLM response because the input numbers are wrong. (3) The multi-hop reasoning is flawed. The question asks about how delivery commitments and production volumes related to Tengizchevroil evolved, which requires synthesizing Chevron’s overall gas volumes with its TCO-related contributions across years. The LLM fails this synthesis, instead implying stability based on incorrect, narrow production figures. It does not acknowledge the significant increase in total sold volumes tied to TCO. (4) Contextual relevance is moderate because the answer addresses Chevron and Tengizchevroil in the correct timeframe and attempts to discuss production trends. However, due to factual inaccuracy and failure to reflect the correct data scope and direction of change, the answer is mostly incorrect. Correctness and quantitative accuracy are therefore very low; qualitative accuracy is slightly higher only because the structure and intent align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 519,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "Between 2023 and 2024, the description of payments to Google Network partners remained largely consistent, with no significant changes in the way these payments are accounted for in the financial statements. Payments to Google Network partners are still primarily reported as a cost of revenues, as Google generally acts as the principal in these arrangements and reports advertising revenues on a gross basis. However, the 2024 filing provides more detailed context on the nature of these payments, emphasizing that they are primarily for ads displayed on partners' properties and are part of the broader TAC (traffic acquisition costs) category. This suggests a slight increase in transparency or specificity in the 2024 disclosure, but the overall accounting treatment and role of these partners in the advertising revenue model remain unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable in a traditional sense, but since there are no incorrect numbers or miscalculations, it scores highly on that dimension. However, the core factual claim in the LLM answer—that there was no significant change in the description of payments—directly contradicts the ground truth, which states a clear evolution from a general operating expense in 2023 to a more strategic categorization under Traffic Acquisition Costs (TAC) in 2024. The LLM acknowledges that the 2024 filing provides more detail and mentions TAC, but incorrectly concludes that the accounting treatment and role remain unchanged, when the ground truth emphasizes a shift in classification and strategic framing. This misrepresents the evolution in the financial narrative. While the LLM correctly identifies that payments relate to ads on partner properties and are part of cost of revenues/TAC, it fails to recognize the significance of the re-categorization as a strategic shift. The answer shows partial understanding but misses the key inference about evolving financial reporting logic and the deeper integration of partners into revenue-generating activities. Thus, while contextually relevant and factually plausible in parts, it is not fully accurate in its conclusion, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 375,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "From 2023 to 2024, Bank of America has noted an increasing regulatory focus on climate-related matters, with new or heightened requirements emerging across jurisdictions, including state, federal, and non-U.S. levels. This has led to greater legal, compliance, and public disclosure risks and costs, particularly due to jurisdictional divergence in climate policies. In 2024, the bank emphasized the growing complexity of managing climate-related regulatory expectations, which are expected to intensify over time, amplifying compliance risks as global regulatory frameworks evolve with varying standards and disclosure mandates.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the increasing regulatory focus on climate-related matters for Bank of America from 2023 to 2024, accurately noting jurisdictional divergence across state, federal, and non-U.S. levels as a key challenge. It correctly states that this divergence increases legal, compliance, and public disclosure risks and costs, which aligns with the original answer. However, the LLM answer falls short in capturing a critical evolution in tone and reality between the two years: in 2023, Bank of America anticipated increased risks due to regulatory divergence, but by 2024, it reported that these requirements were already actively impacting risks and costs. The LLM answer uses forward-looking language (e.g., 'expected to intensify') rather than reflecting the shift to current, tangible impacts as stated in the ground truth. This misrepresents the progression from anticipation to actual impact, which is central to the question about how public policy impact evolved. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and all entities (Bank of America, climate regulations, jurisdictions) are correct. The reasoning is mostly sound but misses the key multi-hop insight—the transition from expected future risk to present operational impact—which reduces qualitative accuracy. Contextual relevance is high as the response stays focused on the question and provides relevant regulatory and risk context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 408,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "General Motors has increased its strategic emphasis on full-size pickup trucks from 2022 to 2024, as evidenced by the significant contribution of these vehicles to GM North America's (GMNA) sales and profitability. In 2024, GMNA's total net sales and revenue increased by 11.4%, driven by higher net wholesale volumes, particularly for full-size pickup trucks, mid-size pickup trucks, and other vehicles. The EBIT-adjusted for GMNA rose by 18.1% in 2024, with favorable cost adjustments and increased sales of full-size pickup trucks contributing to stronger profitability. These quantitative indicators suggest a clear shift toward stronger performance and market positioning for the full-size pickup truck segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of GM's strategic emphasis on full-size pickup trucks from 2022 to 2024 and links it to improved performance and market positioning. It accurately notes increased net wholesale volumes and contribution to EBIT-adjusted results. However, it introduces mid-size pickup trucks as a contributing factor, which is not mentioned in the ground truth and dilutes the focus on full-size trucks specifically. (2) Quantitative inaccuracies exist: the ground truth does not provide percentage increases in net sales (11.4%) or EBIT-adjusted (18.1%) for GMNA, nor does it attribute these changes directly to full-size trucks using those exact figures. Instead, the ground truth emphasizes a 'variable profit of approximately 160% for trucks on a weighted-average basis,' which is a key profitability metric entirely missing from the LLM answer. This omission significantly affects quantitative accuracy. (3) The multi-hop reasoning is partially sound—connecting strategic emphasis to financial outcomes—but fails to incorporate the critical 160% variable profit metric that demonstrates the depth of profitability improvement. The synthesis across years (2022 risk → 2024 strength) is well-reasoned and contextually appropriate. (4) Scores reflect that core qualitative narrative and contextual relevance are strong, but quantitative accuracy is reduced due to unsupported percentages and missing key metrics. The answer is relevant and logically structured but lacks precise data from the source, impacting overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 434,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "From 2022 to 2024, the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts increased significantly. In 2022 (as reflected in the 2021 data), the allocation was $21 million for Alabama Power and $293 million for Georgia Power, totaling $314 million. By 2024, the allocation had risen to $9 million for Southern Company Gas and $369 million for Southern Company, totaling $378 million. This shift indicates a strategic move toward safer, more stable investments, likely to preserve capital and ensure liquidity for long-term decommissioning obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Alabama Power's allocation decreased slightly from $21M to $20M, while Georgia Power's increased from $293M to $349M. However, the LLM incorrectly reports allocations for Southern Company Gas ($9M) and Southern Company ($369M), which are not mentioned in the original answer and do not align with the entities discussed. These figures appear fabricated or misattributed. (2) The total calculation in 2022 is correct at $314M ($21M + $293M), but the 2024 total of $378M is incorrect because it uses wrong component values. The actual combined total should be $20M + $349M = $369M, not $378M. Additionally, the claim that 2022 data reflects '2021 data' is unsupported and misleading. (3) The multi-hop reasoning is flawed: the original answer highlights a shift toward Georgia Power’s portfolio within the same corporate structure, indicating internal reallocation. The LLM instead infers a general strategic move toward safer investments based on incorrect data and entities, missing the nuanced subsidiary-level reallocation. (4) Despite incorrect numbers and entities, the answer attempts to address both parts of the question—evolution of allocation and strategic implication—and maintains relevance in topic and intent, hence a moderate contextual relevance score. However, due to major quantitative and qualitative errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 403,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "From 2022 to 2024, PepsiCo's relationship with independent bottlers has evolved through increased financial incentives and a strategic shift toward a trademark licensing and flavor sales model. The company has expanded bottler funding programs, which are negotiated annually to support trade and consumer initiatives, such as advertising, new product launches, and equipment placement. Additionally, PepsiCo has transitioned certain beverage brands to a licensing model, granting bottlers rights to manufacture and distribute products under PepsiCo's trademarks, thereby enhancing strategic dependency on bottlers for localized market execution.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PepsiCo's relationship with independent bottlers from 2022 to 2024, noting increased structure in financial incentives and strategic dependency. It accurately describes annual negotiations for bottler funding and allocation across trade and consumer programs such as advertising, new product launches, and equipment placement—consistent with the ground truth. However, it introduces a detail not present in the original answer: the 'trademark licensing and flavor sales model' and the transition of brands to a licensing model. While plausible, this specific strategic shift is not mentioned in the ground truth and represents an addition not supported by the provided data. Additionally, the LLM omits the key quantitative insight that Walmart accounted for approximately 14% of consolidated net revenue in 2024, which is a critical piece of evidence for increased strategic dependency. (2) There are no numeric inaccuracies in the LLM answer because it does not include specific numbers—thus, no incorrect figures are stated. However, the omission of the 14% Walmart revenue contribution, which is central to the ground truth’s argument about strategic dependency, reduces completeness and factual equivalence. (3) The multi-hop reasoning is partially sound: the model correctly infers a deepening strategic and financial relationship over time based on structured funding and program allocation. However, it fails to connect the revenue dependency data point (Walmart’s 14%) that grounds the claim in financial reality, weakening the synthesis. The introduction of the licensing model goes beyond the source material, indicating potential over-inference or hallucination. (4) The correctness score is 7 because core financial and structural changes are accurately described, but a major factual omission (the 14% revenue figure) and an unsupported addition (licensing model) prevent a higher score. Quantitative accuracy is 10 because no incorrect numbers are given. Qualitative accuracy is 7 due to the hallucinated licensing model and missing synthesis of revenue dependency. Contextual relevance is 9 because the answer stays focused and relevant, only slightly diverging with the licensing detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 606,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "Adobe Firefly's role within Adobe's product innovation strategy has evolved from being a newly introduced generative AI product in 2023 to a more central and emphasized part of Adobe's AI integration efforts in 2024. In 2023, Firefly was mentioned as one of Adobe's new generative AI offerings, with the company focusing on incorporating AI capabilities across its products. By 2024, Firefly is highlighted as a key example of Adobe's responsible AI development approach, with increased attention to its positioning amid evolving AI regulations and competitive pressures. This suggests a strategic shift toward leveraging Firefly as a flagship AI innovation to drive differentiation and meet market demands.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its interpretation of Adobe Firefly's evolving strategic role from 2023 to 2024, with accurate dates and no numerical inaccuracies (quantitative accuracy is perfect as there are no numbers to verify and no errors in time periods). The answer correctly identifies Firefly as a generative AI product introduced in 2023 and gaining strategic prominence in 2024. However, it diverges from the ground truth in key factual details: the original answer specifies that Firefly's evolution is evidenced by its movement from trademark listings in 2023 to being explicitly mentioned in the 2024 risk factors section of disclosures — a critical multi-hop signal that the LLM answer omits. Instead, the LLM claims Firefly was already a 'new generative AI offering' in 2023 and emphasizes 'responsible AI' and regulatory positioning, which are not mentioned in the ground truth. While the overall direction of reasoning (increasing strategic importance) is sound and contextually relevant, the qualitative accuracy is reduced because the evidence cited (responsible AI, regulatory focus) is not supported by the provided truth. The answer synthesizes a plausible narrative but does not accurately reflect the specific evidence (trademark listing → risk factor disclosure) that defines the evolution in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 372,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "The role of contractual rent escalations in driving tenant billing growth decreased between 2022 and 2023 due to increased churn and lease cancellations in 2023. In 2022, contractual rent escalations were a significant contributor to tenant billing growth, with escalations averaging approximately 3% in the U.S. and inflationary indices in international markets. However, in 2023, churn rose to 3% of tenant billings, primarily driven by lease cancellations in the U.S. & Canada segment, particularly from T-Mobile's actions under the Sprint merger agreement. This elevated churn reduced the effectiveness of contractual rent escalations as a growth driver, as cancellations and non-renewals offset the incremental revenue from escalations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that contractual rent escalations were a key growth driver in 2022 and remained a stated driver in 2023, but faced headwinds due to increased churn. The 3% churn rate in 2023 is accurately cited and correctly attributed to the U.S. & Canada segment, with T-Mobile's lease cancellations under the Sprint merger agreement as the cause—this matches the knowledge graph. (2) Quantitatively, the 3% escalations in the U.S. and inflation-linked escalations internationally are consistent with typical disclosures, though the original answer does not specify the 3% escalation rate—this is a minor addition not contradicted by the ground truth. The 3% churn figure is correctly used. (3) The multi-hop reasoning is sound: the model synthesizes the continued presence of escalations as a growth driver with the countervailing effect of churn, concluding that escalations became less effective—this reflects the nuanced shift described in the original answer. (4) The answer is contextually excellent, directly addressing how the role of escalations changed due to churn and lease cancellations. The only reason for not scoring a 10 is that the original answer emphasizes that escalations 'remained a stated driver' without implying a formal downgrade in disclosure, whereas 'decreased' in role, while reasonable, slightly overstates the shift. However, this is a subtle distinction and the overall factual and logical alignment is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 419,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "Chevron's relationship with Tengizchevroil (TCO) in 2024 shows an increased capital expenditure commitment compared to 2023, with nearly half of the $3 billion Affiliate Capex in 2024 allocated to TCO's FGP/WPMP Project in Kazakhstan. This reflects a continued focus on major development projects in Kazakhstan, maintaining TCO as a significant operational and investment priority for Chevron. Production involvement remains consistent, as TCO contributes to Chevron's net proved reserves and production in Kazakhstan.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding the timing of the $3 billion Affiliate Capex. The original answer states that the $3 billion was *expected in 2024*, with nearly half allocated to Tengizchevroil's FGP/WPMP project — but it does not state that this $3 billion was actually spent in 2024 or that the allocation represented an *increase* from 2023. The LLM incorrectly implies a year-over-year increase in capital expenditure commitment, which is not supported by the ground truth. The original answer emphasizes a *shift in focus* from capital investment in 2023 to production involvement in 2024, a key evolution that the LLM fails to capture. (2) Quantitatively, the $3 billion figure and the 'nearly half' allocation to TCO are correctly cited, so numeric values are accurate, but their temporal attribution is flawed. There are no calculation errors, but the misplacement of the Capex commitment (as if it were realized in 2024 rather than planned) undermines quantitative precision. (3) The multi-hop reasoning is partially sound — the model correctly links Chevron to Tengizchevroil, identifies the FGP/WPMP project, and associates Capex with production — but it misses the critical transition from investment phase (2023) to operational phase (2024), which is the core of the relationship's evolution. This weakens the qualitative accuracy. (4) Contextual relevance is high because the answer addresses both capital expenditure and production involvement, uses correct entities (Chevron, Tengizchevroil, FGP/WPMP, Kazakhstan), and discusses reserves and production. However, the failure to accurately represent the shift in phases between years reduces correctness. Overall, the answer is factually partially correct but misrepresents the evolution of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 494,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "Between 2023 and 2024, the specificity of UPS's bond matching approach for determining the discount rate for U.S. pension and postretirement benefit plans remained consistent in methodology but showed changes in the resulting discount rates. In both years, UPS used a bond matching approach to select specific bonds that align with projected benefit payments. However, the discount rate for U.S. pension benefits decreased from 5.42% in 2023 to 5.88% in 2024, while the rate for U.S. postretirement medical benefits decreased from 5.80% in 2023 to 6.18% in 2024, reflecting updated market conditions and bond yields.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in addressing the question. The question asks about the evolution in the *specificity* and *description* of UPS's bond matching approach in determining the discount rate, not changes in the discount rates themselves. The original answer focuses on a shift in language from 2023 to 2024—specifically, that the approach evolved from describing the method as reflecting settlement intentions to framing it as a 'guide' for bond selection—without any material change in mechanics. The LLM instead introduces numerical discount rates (5.42% to 5.88% for pensions, 5.80% to 6.18% for postretirement) that are not present in the ground truth and are factually unsupported in the provided context. These numbers are entirely fabricated or misattributed, making the quantitative claims false. (2) There are no valid calculations or correct numbers in the LLM response because the percentages cited do not appear in the ground truth and contradict the non-quantitative nature of the actual evolution described. (3) The multi-hop reasoning fails because the model misinterprets the core concept: it confuses a qualitative disclosure change in accounting policy description with a quantitative change in discount rates. It does not synthesize the correct evolution in narrative tone or operational framing, which is the essence of the ground truth. (4) The contextual relevance is low because the answer discusses discount rate movements instead of methodological specificity. While it correctly identifies UPS and the use of a bond matching approach in both years, it misses the key nuance about how the *description* of the method became more precise in 2024 by stating it 'guides' selection. Thus, despite some entity accuracy, the answer fails on correctness due to factual inaccuracies and misdirection.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 500,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "From 2022 to 2024, Linde's global helium operations experienced a decline in volumes, contributing to a 2% decrease in underlying sales for the \"Other\" segment in 2024 compared to 2023. Despite this, operating profit in the \"Other\" segment increased by 44%, primarily due to insurance recovery for Linde Advanced Materials Technology (LAMT), which offset higher helium-related costs. Thus, while helium volumes negatively impacted sales, the segment's operating profit improved significantly in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in helium volumes negatively impacting sales in the 'Other' segment by 2% in 2024 and attributes it to global helium and LAMT, which aligns with the ground truth. It also correctly notes that operating profit increased due to an insurance recovery offsetting helium-related costs. However, the LLM states that operating profit increased by 44%, a specific figure not present in the original answer and unsupported by the provided ground truth, which only mentions downward pressure on operating profit partially offset by insurance recovery—without quantifying the net increase. This introduces a significant quantitative inaccuracy. (2) The $32 million sales decrease (2%) is accurately reflected in the LLM answer as a 2% decrease, though the dollar amount is omitted. The 44% operating profit increase is incorrect or at least unverifiable from the ground truth, which does not provide any percentage change in operating profit. (3) The multi-hop reasoning is mostly sound: the model connects helium volume declines to sales impact and links insurance recovery to profit resilience. However, it overreaches by asserting a 44% profit increase, which requires data not confirmed in the ground truth. (4) The contextual relevance is high—the answer directly addresses the evolution of Linde's relationship with helium and its financial impact. Qualitative accuracy is strong in reasoning but docked slightly for overprecision. Quantitative accuracy is reduced due to the unsupported 44% figure. Correctness score is 7 because core facts about sales impact and insurance offset are correct, but the erroneous operating profit figure undermines full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 469,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Bank of America's unfunded capital contributions for renewable energy investments decreased from $6.2 billion in 2023 to $4.6 billion in 2024. Correspondingly, the recognized tax credits related to these investments slightly decreased from $4.0 billion in 2023 to $3.9 billion in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and years are accurate: unfunded capital contributions decreased from $6.2 billion in 2023 to $4.6 billion in 2024, and recognized tax credits declined from $4.0 billion to $3.9 billion. These values exactly match the original answer, with no calculation or formatting issues. (2) The answer is complete, addressing both parts of the question: the evolution of unfunded capital contributions and the corresponding change in tax credits. (3) Entity accuracy is perfect—Bank of America is correctly identified, and the financial metrics and years are precise. (4) The reasoning is sound and reflects proper multi-hop synthesis across the two years and two financial metrics. While the LLM omits the interpretive sentence about reduced near-term commitments and stable tax benefits, this does not affect factual correctness, as the question only asks for the evolution and corresponding change, which are fully and accurately reported. The answer is semantically equivalent to the ground truth in all key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 316,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "General Motors' approach to fleet sales involving commercial fleet customers from 2022 to 2024 has seen a decline in the proportion of fleet sales relative to total vehicle sales. In 2021, fleet sales accounted for 11.3% of total vehicle sales, decreasing to 8.7% in 2024, indicating a strategic shift toward more profitable retail sales. Additionally, GM has focused on optimizing its dealer network and enhancing profitability by managing the balance between fleet and retail sales, recognizing that fleet transactions, particularly with daily rental companies, are generally less profitable. This evolution reflects a broader emphasis on profitability and market demand dynamics.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the timeline and specific evolution of GM's fleet sales approach. The ground truth states that in 2022, GM sold fleet vehicles either directly or through dealers, and by 2024 used both dealer networks and direct sales—indicating a refinement in channel strategy. However, the LLM introduces a trend from 2021 to 2024 (11.3% to 8.7%) that is not mentioned in the original answer and is unsupported by the provided context. This quantitative claim misrepresents the evidence and shifts focus to a percentage decline not present in the ground truth. (2) The numbers cited (11.3% in 2021, 8.7% in 2024) are not found in the original answer and cannot be verified from the given information. There is no mention of 2021 in the question or ground truth, making this a factual overreach. Additionally, the original answer does not provide any percentages on fleet sales volume over time, so this data appears fabricated or misattributed. (3) The reasoning partially captures the idea that fleet sales are less profitable than retail, which aligns with the original answer’s mention of lower profitability for rental fleet sales. It also correctly identifies GM’s focus on profitability and channel optimization. However, it fails to accurately describe the evolution in sales channels—specifically the shift toward a more structured use of both dealer and direct channels by 2024—as the core of the strategic change. Instead, it substitutes this with an unverified volume-based narrative. (4) The contextual relevance is moderate because the answer addresses fleet sales, profitability, and strategic shifts, which are relevant themes. However, due to the introduction of unsupported statistics and the omission of the actual channel evolution described in the ground truth, the qualitative and quantitative accuracy scores are low. The correctness score is 4 because while some conceptual elements are right (profitability concerns, strategic balancing), key facts and the central multi-hop insight about channel structure evolution are missing or incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 575,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's relationship with Sabra evolved from retaining a noncontrolling interest in a joint venture to fully divesting its stake. In 2022, PepsiCo sold its Tropicana, Naked, and other juice brands to PAI Partners while retaining a 39% noncontrolling interest in the newly formed joint venture. By 2024, PepsiCo recognized a pre-tax gain of $122 million ($92 million after-tax or $0.07 per share) in its FLNA division related to the remeasurement of its previously held 50% equity ownership in Sabra at fair value, indicating a complete divestiture. This change had financial implications, including a gain on the transaction and the removal of Sabra-related assets and liabilities from PepsiCo's consolidated financial statements.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states a $122 million pre-tax gain in 2024 related to Sabra, it incorrectly claims PepsiCo fully divested its stake and that the gain was from a complete divestiture. The ground truth indicates PepsiCo retained a 50% equity stake after remeasuring its previously held ownership, not a full divestiture. Additionally, the LLM conflates the Sabra transaction with the unrelated 2022 sale of Tropicana and Naked brands to PAI Partners, incorrectly linking a 39% noncontrolling interest (from the juice brands deal) to Sabra, which is factually wrong. (2) Quantitatively, the $122 million pre-tax gain is correct, and the after-tax amount of $92 million and $0.07 per share are plausible elaborations not contradicted by the ground truth. However, the 39% interest is misattributed to Sabra when it pertains to a different joint venture. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution of PepsiCo's stake in Sabra, instead merging details from two separate transactions (Sabra and the juice brands). It does not accurately reflect that PepsiCo moved from full ownership to 50% ownership via remeasurement, not full divestiture. (4) Due to major factual errors in entity mapping, ownership changes, and transaction nature, the correctness score is low. The quantitative accuracy is partially preserved due to the correct mention of the $122M gain, but qualitative accuracy suffers from incorrect reasoning and conflation of events. Contextual relevance is moderate as the answer discusses Sabra and financial implications but distracts with irrelevant details about Tropicana.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 465,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "Between 2023 and 2024, Adobe has positioned Adobe Scan more prominently within its Document Cloud ecosystem, emphasizing its role as a mobile-first tool for converting physical documents into editable PDFs. In 2023, Adobe Scan was described as a free mobile app that transforms paper documents into PDFs via Adobe Document Cloud. By 2024, it was highlighted as an integral part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other integrated tools, suggesting a stronger integration and strategic emphasis on Adobe Scan as a key entry point for digital document workflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All entities—Adobe Scan, Adobe Document Cloud, Acrobat, Acrobat Sign—are correctly identified, and the timeframes (2023 vs 2024) are accurately referenced. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years, which are accurate. (3) The multi-hop reasoning is sound: the model correctly infers a strategic evolution from trademarked product in 2023 to an integrated component of Document Cloud in 2024, based on positioning shifts. The LLM adds contextual detail (e.g., 'mobile-first tool', 'free mobile app') that is plausible and consistent with Adobe's ecosystem, though not explicitly in the ground truth. (4) The core claim—that Adobe Scan became more strategically emphasized and integrated into Document Cloud—is fully supported. The only minor gap is that the original answer highlights the 2023 status as a trademark as evidence of recognition, while the LLM focuses on functionality; this nuance is omitted but does not distort the overall correctness. Hence, the answer earns a 9 for correctness and qualitative accuracy due to slight difference in emphasis, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 369,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "General Motors' financial exposure and nature of obligations to Stellantis from 2022 to 2024 regarding indemnifications and historical liabilities have remained largely consistent, with no significant changes in materiality. In both periods, GM indemnifies Stellantis for certain losses arising from inaccuracies in representations, warranties, or breaches of covenants related to the 2017 sale of the Opel/Vauxhall business. These obligations include emissions claims, product liabilities, and recalls. However, GM has been unable to estimate reasonably possible losses or ranges for these indemnifications, and no material accruals have been recorded in either year. Additionally, in 2024, GM provided an immaterial indemnification for Takata-related recalls, but such obligations are considered remote. Overall, the nature of these obligations remains contingent and subject to thresholds or caps.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies in reasoning and completeness, particularly regarding the evolution of GM's obligations from 2022 to 2024. (1) Correctly identifies that GM has indemnification obligations tied to the Opel/Vauxhall sale and mentions emissions claims, product liabilities, and recalls. It also correctly states that no material accruals were recorded and that the exposure is immaterial—consistent with the ground truth noting an 'immaterial amount accrued' as of 2024. (2) Quantitatively, there are no explicit numerical errors; the use of 'immaterial' aligns with the original answer’s characterization. However, the LLM fails to specify that the nature of the relationship evolved from supply-related transactions in 2022 to indemnification-based exposure in 2024—a key multi-hop insight. Instead, it claims obligations 'have remained largely consistent,' which contradicts the ground truth. (3) The qualitative reasoning is flawed: the original answer emphasizes a transformation in the nature of exposure—from operational (supply) to passive (indemnifications)—but the LLM misses this shift entirely. It also incorrectly implies continuity rather than evolution. Additionally, while the LLM mentions Takata-related recalls in 2024, it downplays them as 'remote,' whereas the ground truth presents them as active indemnifications. (4) Contextual relevance is strong—the response addresses indemnifications, historical liabilities, and time periods—but fails to synthesize the change over time, which is central to the question. Thus, despite correct entity identification (GM, Stellantis, Opel/Vauxhall, 2017 sale) and accurate use of terms like 'immaterial,' the answer misses the core dynamic of change between 2022 and 2024, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 492,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "PepsiCo's relationship with co-packers between 2022 and 2024 has remained relatively consistent, with the company continuing to rely on a network of contract manufacturers, co-packers, strategic alliances, and joint ventures to support its production and distribution operations. There is no indication of a significant shift in operational dependency or strategic involvement during this period, as PepsiCo still utilizes these third-party resources to supplement its owned or leased facilities. The company emphasizes that its properties and third-party arrangements are adequate for current operations, suggesting a stable and ongoing reliance on co-packers rather than a marked change in strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that PepsiCo's relationship with co-packers remained 'relatively consistent' between 2022 and 2024. The ground truth shows a clear evolution in language and strategy—from describing co-packers as part of a 'highly distributed network' of third-party facilities in 2022 (indicating operational dependency) to framing them as part of 'strategic alliances or joint ventures in which we have an equity interest' in 2024 (indicating deeper strategic involvement). The LLM fails to detect or report this shift, instead claiming there is 'no indication of a significant shift,' which directly contradicts the evidence. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning requirement—comparing PepsiCo's evolving language and strategic posture across two time points using its SEC filings—is not fulfilled. The LLM does not synthesize the change in wording or interpret its strategic implications, missing the core of the question. (4) While the answer is contextually relevant (it discusses co-packers and third-party arrangements), it is factually inaccurate in its conclusion, leading to a low correctness and qualitative accuracy score. The answer would be appropriate if no change had occurred, but it contradicts the documented shift in corporate language and strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 403,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "Between 2023 and 2024, SPG's financial relationship with ABG evolved significantly. In 2023, SPG recognized a pre-tax gain of $157.1 million from the sale of a portion of its interest in ABG and a non-cash pre-tax gain of $59.1 million from deemed disposals due to ABG's capital transactions. By 2024, SPG fully exited its remaining interest in ABG, selling it for $1.2 billion and recognizing a substantial pre-tax gain of $414.8 million. These transactions reflect a strategic shift, with SPG divesting its stake in ABG and reallocating capital elsewhere.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $157.1 million gain from the sale of a portion of SPG's ABG interest and the $59.1 million non-cash gain in 2023, it fabricates a $414.8 million pre-tax gain from a $1.2 billion sale of SPG's 'remaining' interest in ABG in 2024, which is not supported by the ground truth. The original answer states that in 2024, SPG disclosed an $18.8 million gain from the sale of a portion of its ABG interest that occurred in December 2021 (not 2024), not a new divestment. Additionally, the LLM omits the $145.8 million gain from dilution in SPARC Group in 2023 and fails to mention the strategic partnership with ABG for Reebok in the U.S., which represents the actual strategic evolution in 2024. (2) Quantitative accuracy is severely compromised: the $414.8 million gain and $1.2 billion sale are entirely incorrect and not present in the ground truth. The only correct numbers are the $157.1 million and $59.1 million gains in 2023. The $18.8 million gain in 2024 is mischaracterized as part of a full exit rather than a delayed disclosure of a 2021 transaction. (3) The multi-hop reasoning is flawed: the model incorrectly infers a full exit and large gain in 2024, missing the shift from financial gains to operational collaboration via the Reebok partnership. It fails to synthesize the correct timeline and nature of the relationship evolution. (4) Correctness is low due to major factual and numerical errors. Quantitative accuracy is poor due to fabricated figures. Qualitative accuracy is low because of incorrect entity relationships and reasoning. Contextual relevance is moderate as the answer addresses the general theme of financial evolution but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 484,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "Lockheed Martin's involvement in Sikorsky helicopter programs, as part of its Rotary and Mission Systems (RMS) segment, shows increased production volume from 2022 to 2024. In 2022, higher production volume on Sikorsky helicopter programs contributed to increased product costs and sales within RMS. By 2024, Sikorsky programs remain a key focus for RMS, with continued emphasis on military and commercial helicopters such as the Black Hawk, Seahawk, and CH-53K King Stallion. The program scope has expanded to include sustainment and support for these platforms, reflecting sustained demand and strategic importance in Lockheed Martin's portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the LLM correctly identifies the 2022 increase in production volume linked to higher product costs, though it does not explicitly state the $560 million figure from the original answer. However, this omission does not distort the meaning, as the focus is on the causal relationship between production volume and cost increases. All years (2022, 2024) and program names (Black Hawk, Seahawk, CH-53K King Stallion) are correct. (2) The qualitative reasoning is sound: the LLM correctly infers an evolution in strategic focus, noting sustained emphasis and expansion into sustainment and support, which is consistent with the original answer’s implication of a shift toward a defined strategic product line. (3) Multi-hop synthesis is effectively demonstrated—linking 2022 cost drivers to 2024 strategic portfolio emphasis across Sikorsky programs. (4) Contextual relevance is excellent, directly addressing both production volume and program scope evolution. The only minor shortcoming is the absence of the specific $560M cost increase, which slightly reduces completeness but does not affect overall correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 368,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "Walmart acquired Alert Innovation in fiscal 2023 for $0.4 billion, increasing its ownership to 100%. There is no indication in the provided documents that Walmart's ownership stake or financial investment in Alert Innovation changed between fiscal 2023 and fiscal 2024. Additionally, it is noted that Alert Innovation was subsequently sold and deconsolidated in fiscal 2025.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Walmart acquired Alert Innovation in fiscal 2023 for $0.4 billion and increased ownership to 100%, which matches the ground truth. However, it contradicts the ground truth by stating there was no change in ownership between fiscal 2023 and 2024, when the original answer indicates Walmart had exited its stake by fiscal 2024. The LLM introduces new information—'Alert Innovation was subsequently sold and deconsolidated in fiscal 2025'—which is not present in the ground truth and shifts the timeline of divestiture to a later period, thus misrepresenting the evolution of ownership during the specified timeframe. (2) All numeric values ($0.4 billion, 100%) are accurate and correctly formatted. (3) The multi-hop reasoning is partially sound—while the acquisition is correctly identified, the synthesis of ownership changes between fiscal 2023 and 2024 fails because the model does not recognize or report the exit in fiscal 2024 as indicated in the ground truth. Instead, it claims no change occurred and pushes the divestiture to fiscal 2025, breaking the logical chain required by the question. (4) The correctness score is 5 due to significant factual inaccuracy regarding the timing of the divestiture, despite correct numbers and partial context. Quantitative accuracy is 10 because all numbers are correct. Qualitative accuracy is 5 due to flawed reasoning and incorrect inference about ownership continuity. Contextual relevance is 8 because the answer addresses the right entities and topic but misaligns on key temporal dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 435,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "Between 2023 and 2024, SPG's utilization of the Supplemental Facility showed a shift in borrowing and repayment strategy. In 2023, SPG issued €750.0 million in senior unsecured bonds to repay €750.0 million outstanding under the Supplemental Facility, reflecting a focus on refinancing and reducing variable-rate debt exposure. By 2024, the Supplemental Facility had an available borrowing capacity of $3.5 to $4.5 billion, with SPG leveraging it for long-term liquidity needs, including fixed-rate debt issuances such as the $1.0 billion senior unsecured notes in September 2024. This evolution highlights a strategic shift toward fixed-rate financing and optimizing debt maturity profiles to manage interest rate risk and enhance financial flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that €750.0 million was repaid in 2023, it incorrectly claims that SPG issued €750.0 million in bonds to repay the facility—ground truth states the repayment occurred *after* the bond issuance, not that the bond proceeds were necessarily used for repayment. More critically, the LLM falsely claims that in 2024, SPG continued to use the Supplemental Facility with $3.5 to $4.5 billion in available capacity and leveraged it for long-term liquidity and the $1.0 billion note issuance. This is incorrect: the ground truth explicitly states there was *no outstanding balance* under the Supplemental Facility in 2024, and the $1.0 billion note issuance was a separate refinancing move, not tied to drawing on the Supplemental Facility. (2) Quantitative accuracy fails on key points: the $3.5–$4.5 billion capacity figure is fabricated and not in the original; the linkage of the $1.0 billion September 2024 issuance to the Supplemental Facility is false. Only the €750.0 million figure is correct. (3) Multi-hop reasoning is flawed: the model incorrectly infers continued use and strategic leveraging of the facility in 2024, when the actual evolution was a *complete drawdown and repayment* in 2023 followed by *zero usage* in 2024. The conclusion about 'strategic shift toward fixed-rate financing' is plausible but misattributed to ongoing use of the facility rather than a move *away* from it. (4) Scores reflect major factual errors in both numbers and synthesis: correctness is low due to core misinformation; quantitative and qualitative accuracy are poor; contextual relevance is moderate because the answer addresses the general topic of debt strategy but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 484,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "Between 2023 and 2024, Linde has maintained helium as a key process gas within its industrial gases business, but there is no indication of a significant shift in its positioning as a primary product. Helium is consistently listed among process gases (e.g., hydrogen, carbon dioxide, specialty gases) sold through the three distribution methods—on-site, merchant, and packaged gases. In 2024, there is no new emphasis on helium as a standalone strategic focus, though its supply through merchant channels (which allows for longer-distance shipping) remains notable. Linde’s supply strategies for helium appear to align with broader process gas distribution practices, with no specific changes highlighted in the 2024 filing compared to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that in 2023, helium was explicitly listed as a primary product alongside oxygen, nitrogen, and hydrogen, but by 2024 it was no longer specifically named and was instead subsumed under general gas descriptions—indicating a strategic repositioning. The LLM incorrectly asserts there is 'no indication of a significant shift' and that helium remains consistently listed, which contradicts the documented change in disclosure and emphasis. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2023, 2024), which are accurate. (3) The multi-hop reasoning is flawed: the question requires synthesis of how helium’s treatment changed across two filings (2023 vs 2024), particularly in product positioning and supply strategy. The LLM fails to identify the key change—helium’s removal as a named primary product in 2024—thus missing the central evolution. Instead, it assumes consistency without evidence, leading to an incorrect conclusion. (4) While the answer discusses relevant distribution methods (merchant, on-site, packaged), it misrepresents the strategic shift and omits the critical detail that helium was demoted from explicit mention, reducing its standalone status. This undermines both qualitative accuracy and overall correctness, warranting a low score despite correct contextual framing of gas distribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 412,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "Between 2022 and 2023, the U.S. Retiree Health Care Plan's asset allocation shifted slightly toward fixed income securities and away from equity securities. In 2022, the allocation was 65% fixed income and 35% equity, while in 2023, it adjusted to 80% fixed income and 20% equity. This change aligns with the plan's target allocation range of 75%–85% for fixed income and 15%–25% for equity, indicating a deliberate move to increase the proportion of fixed income securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both dollar amounts and percentages. According to the ground truth, in 2022, fixed income and cash equivalents were $248 and equity securities were $137 (total $385), while in 2023, they were $210 and $54 respectively (total $264). The LLM incorrectly reports allocations in percentages (65%/35% in 2022 and 80%/20% in 2023), which do not match the actual dollar values. For example, $248/$385 is approximately 64.4% (close to 65%), but $210/$264 is about 79.5% (close to 80%), so the percentages are approximately correct but presented without reference to declining total assets, misleading the interpretation. However, the core error is that the LLM implies a strategic shift toward fixed income within a target range, which is not supported by the data — both asset classes decreased, especially equities, from $137 to $54 (a 60.6% drop), suggesting a reduction in total plan assets rather than a reallocation strategy. (2) The dollar amounts are entirely missing in the LLM answer, and instead, unverified percentages and a 'target allocation range' are introduced that are not in the original answer. There is no mention of total asset decline from $385 to $264, which is a key part of the evolution. (3) The multi-hop reasoning is flawed: the model fails to recognize that the question asks for how the allocation evolved in terms of actual asset values, not just proportions. It incorrectly infers intent (‘deliberate move’) without evidence from the ground truth, which only states the factual change. (4) The correctness score is low (2) due to major factual inaccuracies in quantitative data and unsupported qualitative claims. Quantitative accuracy is 2 because the percentages are roughly derivable but presented without proper context or total amounts, and the actual dollar figures — central to the ground truth — are omitted. Qualitative accuracy is 3 because while the direction of change (decrease in equity share) is partially reflected, the reasoning about target ranges and strategic intent is fabricated. Contextual relevance is 6 because the answer addresses the general topic and time frame but misrepresents the nature of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 592,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's financial performance and strategic positioning showed significant growth and regulatory progress. Revenue from Trodelvy increased by 56% in 2023 compared to 2022, driven by higher demand in new and existing geographies. Strategically, Trodelvy received FDA approval for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. Additionally, it received EC approval for monotherapy in similar patient populations, expanding its market reach and therapeutic applications.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the quantitative claim of a '56% increase in revenue in 2023 compared to 2022.' The ground truth states that Trodelvy generated $380 million in 2022 but explicitly notes that 'specific revenue figures for 2023 are not provided.' Therefore, the 56% growth figure is fabricated and not supported by the source data. This severely undermines factual correctness. (2) No calculation can be verified because the 56% figure is unsupported; the only confirmed number is the $380 million in 2022 sales, which the LLM omits in favor of an unverified percentage increase. (3) The qualitative aspects of the answer—regarding FDA and EC approvals for HR+/HER2- metastatic breast cancer—are accurate and reflect correct multi-hop synthesis of regulatory milestones, showing strong understanding of strategic positioning evolution. The description of the indications is semantically aligned with the ground truth. (4) While the reasoning around regulatory progress is sound and contextually relevant, the inclusion of a precise but false revenue growth figure results in a low quantitative accuracy score. The correctness score is partially mitigated by accurate entity identification (Trodelvy, FDA, EC, correct indication) and proper framing of strategic expansion, but the unsupported number makes the answer misleading overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 385,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "Chevron's downstream-related earnings from GS Caltex increased from $874 million in 2022 to $58 million in 2024, indicating a significant decline. Meanwhile, Chevron's investment in GS Caltex slightly decreased from $4,309 million in 2023 to $4,144 million in 2024. This suggests that while Chevron maintains a strategic presence in the joint venture, the downstream performance of GS Caltex has weakened in recent years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The claim that Chevron's downstream-related earnings from GS Caltex increased from $874 million in 2022 to $58 million in 2024 is incorrect—this represents a sharp decline, not an increase, and these specific figures do not appear in the ground truth. The ground truth does not provide earnings figures for 2024 or 2022 broken down specifically from GS Caltex, only that downstream earnings from GS Caltex contributed to improved income in 2022. The investment figures ($4,309M in 2023 and $4,144M in 2024) are not mentioned in the ground truth at all, making them fabricated or misattributed. (2) The ground truth reports Chevron's total sales and other operating revenues with affiliated companies (including GS Caltex) as $16,286 million in 2022 and $13,850 million in 2024, which shows a decrease, but this is not earnings from GS Caltex alone. The LLM incorrectly interprets or invents granular data. There are no calculations in the LLM answer, but the use of false numbers undermines any quantitative reasoning. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the relationship between Chevron’s equity stake, downstream earnings, and overall affiliated revenues. It incorrectly infers declining performance of the joint venture based on invented figures, while the ground truth emphasizes continued strategic importance despite a slight revenue decrease. (4) The contextual relevance is moderate—the answer addresses the evolution of the relationship and strategic importance, but due to severe factual and quantitative errors, the conclusion about weakening performance is unsupported. Correctness and quantitative accuracy are very low due to invented numbers; qualitative accuracy is low due to flawed reasoning; contextual relevance is acceptable as the structure and intent align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 515,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "From 2022 to 2024, the CH-53K program, part of the Sikorsky helicopter programs under the Rotary and Mission Systems (RMS) segment, experienced notable improvements in production volume and risk retirements. In 2021 (as referenced in the 2022 filing), production volume for the CH-53K increased, contributing to higher net sales. By 2024, production volume on the CH-53K program continued to rise, partially offsetting lower volume on the VH-92A program. Additionally, the 2024 results indicated that risk retirements positively impacted operating profit for Sikorsky helicopter programs, including the CH-53K, although specific figures for the CH-53K were not disclosed. Overall, the CH-53K program showed progress in both production scale and risk mitigation during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. It incorrectly references 2021 data 'as referenced in the 2022 filing' when the original answer clearly states that in 2022, the CH-53K program drove approximately $140 million in increased profit due to higher risk retirements and production volume. The LLM fails to mention this key $140 million figure, which is a significant omission in quantitative terms. Additionally, while the LLM correctly notes rising production volume in 2024, it does not acknowledge the 73% decline in RMS operating profit that contextualizes the CH-53K's performance, nor does it explain that the earlier gains from risk retirements likely diminished as the program matured—both key points in the original answer. (2) The LLM introduces a claim about 2021 data not present in the ground truth and does not provide or reference the $140 million profit increase in 2022, making its quantitative accuracy low. There are no explicit calculation errors, but critical numbers are missing. (3) The reasoning is partially sound—LLM correctly identifies that production volume and risk retirements improved for CH-53K and that it is part of Sikorsky/RMS. However, it fails to synthesize the multi-hop insight that while CH-53K performed well in 2022, the broader RMS profit decline in 2024 suggests reduced incremental gains from risk retirements despite ongoing production increases. This weakens the qualitative accuracy. (4) The answer remains contextually relevant, addressing production volume, risk retirements, and program status across the 2022–2024 timeframe, but lacks the critical financial context and figures that define the evolution of the program’s financial performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 479,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "Between 2022 and 2023, PayPal's approach to seller protection programs evolved with a stronger strategic emphasis on expanding risk management solutions and enhancing merchant confidence. In 2022, the focus was on mitigating transaction and credit losses through customer protection programs, fraud prevention, and historical loss rate monitoring. By 2023, PayPal reorganized its operations to align more closely with customer needs, emphasizing seamless and differentiated experiences for merchants, including proprietary protection programs to reduce losses and improve trust. This shift reflects a more proactive and integrated approach to managing risk exposure while reinforcing seller protection as a key differentiator in the competitive payments landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in PayPal's approach from 2022 to 2023, noting a shift from risk mitigation to a more strategic, merchant-centric emphasis on trust and differentiation. However, it omits the specific quantitative detail from the ground truth—historical transaction loss rates between 0.09% and 0.15% of TPV—which is a factual element present in the original answer. While the LLM mentions monitoring loss rates, it does not specify the range, representing a minor but notable omission. (2) There are no incorrect numbers or dates; the LLM does not introduce any false quantitative claims, so quantitative accuracy is full. The absence of the percentage range is a completeness issue, not an inaccuracy. (3) The multi-hop reasoning is sound: the model synthesizes changes in strategic emphasis across years, correctly identifying the shift from risk management (2022) to competitive differentiation and merchant trust (2023). It appropriately links seller protection to broader platform goals, aligning with the ground truth’s theme of integration with analytics and merchant services, though this integration is less explicitly detailed. (4) The answer is contextually relevant and semantically close to the original, with accurate entity identification (PayPal, seller protection, 2022–2023 timeframe) and correct qualitative interpretation of strategic evolution. The correctness score is 8 due to the omission of the key quantitative benchmark, but the reasoning and framing remain substantially accurate and well-aligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 432,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "Between 2023 and 2024, Starbucks' approach to its ready-to-drink beverages remained consistent in terms of revenue recognition, as these products are included in \"Other Revenues\" and recognized upon shipment to customers. Additionally, Starbucks continues to source ready-to-drink beverages from several specialty suppliers under long-term contracts, indicating stable supplier dependency. There is no indication of significant changes in either revenue recognition practices or supplier relationships for ready-to-drink beverages during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. While it correctly states that ready-to-drink beverages are included in 'Other Revenues' and recognized upon shipment (consistent with 2023 practices), it claims there was no significant change between 2023 and 2024. This directly contradicts the ground truth, which identifies a clear strategic shift from revenue-centric reporting in 2023 to a focus on supply chain resilience and supplier dependency in 2024. The LLM fails to capture this evolution, instead asserting stability where there was a notable strategic pivot. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable beyond correct use of years (2023 and 2024), which the LLM gets right. (3) The multi-hop reasoning is flawed: the question requires synthesizing changes in two dimensions—revenue recognition and supplier dependency—across two years. The LLM acknowledges both aspects but incorrectly concludes no change occurred, missing the shift in emphasis from revenue reporting to risk management in 2024. (4) The contextual relevance is moderate because the answer discusses the correct topic and uses appropriate terminology, but it fails to address the key evolution highlighted in the original answer, resulting in a misleading response. Correctness and qualitative accuracy are low due to the failure to identify a strategic shift explicitly stated in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 402,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's geographic reach and regulatory approvals expanded significantly. In 2022, Trodelvy was approved in several countries, including the United States, Europe, and Canada, under the Project Orbis initiative. By 2023, Trodelvy received additional regulatory approvals, including EC approval for monotherapy in HR+/HER2- breast cancer and FDA approval for the same indication. Sales of Trodelvy increased by 56% in 2023 compared to 2022, reflecting higher demand in new and existing geographies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 FDA and EC approvals for HR+/HER2- metastatic breast cancer, which aligns with the ground truth and shows accurate understanding of regulatory developments. However, it introduces unverified information not present in the original answer: specifically, the claim that Trodelvy was approved in Canada and under 'Project Orbis' in 2022 is not supported by the ground truth, which only confirms U.S. and European sales (with no mention of Canada or Project Orbis). Additionally, the LLM states that sales increased by 56% in 2023 compared to 2022, but the original answer does not provide a percentage increase or global sales totals—only $370M (U.S.) and $10M (Europe) in 2022, with no 2023 sales figures. This 56% figure is therefore unsupported and likely incorrect. (2) Quantitative accuracy is compromised due to the fabricated percentage increase. While the 2022 sales figures ($370M U.S., $10M Europe) are consistent with the ground truth, they are not explicitly repeated in the LLM answer, and the 56% growth claim cannot be verified and appears inaccurate. (3) The multi-hop reasoning is partially sound—the model connects regulatory approvals to expanded market access, which is logical and contextually appropriate. However, it fails to mention the limited geographic reach in 2022 (only U.S. and Europe with no other international sales), which is a key part of the original answer’s assessment of geographic reach. Instead, it overstates early availability by referencing Canada and Project Orbis without evidence. (4) Despite these issues, the answer remains contextually relevant and captures the core idea of regulatory and geographic expansion. The qualitative reasoning is mostly sound, but the inclusion of unsupported details reduces factual reliability. Correctness score is 6 due to partial factual accuracy with significant omissions and one major quantitative error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 525,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's ownership stake in ABG decreased significantly. As of late 2023, Simon held approximately 9.6% of ABG following several dilutive capital transactions during the year. In 2024, Simon sold all of its remaining interest in ABG for cash proceeds of $1.2 billion, resulting in a pretax gain of $414.8 million. This transaction marked the complete divestiture of Simon's stake in ABG.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect factually. According to the ground truth, Simon Property Group (SPG) reduced its ownership stake in ABG gradually in 2023 from 12.3% to 11.8%, 11.7%, and finally 9.6% through dilutive capital transactions, not a single sale. The LLM falsely claims that in 2024, SPG sold all of its remaining interest for $1.2 billion and recognized a pretax gain of $414.8 million. This is not supported by the original answer, which states that SPG did not report any new transactions in 2024 and only referenced a prior 2021 transaction involving an $18.8 million gain and a $100 million acquisition. (2) Quantitative inaccuracies are severe: the $1.2 billion cash proceeds and $414.8 million gain are completely fabricated. The actual 2023 gains were $36.4M, $12.4M, and $10.3M—summing to $59.1M, not $414.8M. No 2024 transaction occurred. (3) The multi-hop reasoning failed: instead of recognizing the shift from active stake reduction in 2023 to passive disclosure in 2024, the model invented a major divestiture event. It missed the nuance of dilution vs. direct sale and misrepresented the timeline and nature of transactions. (4) Scores are low because the core facts—ownership changes, financial gains, and year-by-year evolution—are all wrong. Contextual relevance is slightly above zero because the answer addresses SPG’s stake in ABG and financial gains, but the substance is false.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 398,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "Between 2023 and 2024, the 2012 Equity Incentive Plan was amended with the addition of a Fourth Amendment in 2024 (10.2(C)+ filed August 1, 2024). Additionally, the 2024 filing includes more forms of award agreements under the plan, with 2024 disclosing additional forms up to 10.2(K)+, compared to 10.2(D)+ in 2023, indicating an expansion in the variety and number of award agreements provided.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the Fourth Amendment dated August 1, 2024, matching the original answer's key factual point. The reference to exhibit numbers (10.2(C)+ and 10.2(K)+ vs 10.2(D)+) reflects internal document labeling, which is consistent with SEC filing conventions and indicates an increase in award agreement forms. (2) All dates and amendment numbers are correct: 'Fourth Amendment' and 'August 1, 2024' are factually accurate. The progression from 10.2(D)+ in 2023 to 10.2(K)+ in 2024 logically implies the addition of new forms, which matches the ground truth's claim of 'additional forms of award agreements from April 2024'. While the LLM does not explicitly mention the April 2024 date for the new forms, it correctly infers expansion. (3) The multi-hop reasoning is sound—comparing amendments and forms across two years—and the conclusion about plan expansion is valid. (4) Minor omission of the specific April 2024 date for new award forms prevents a perfect 10, but the overall meaning and factual core are preserved. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 330,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "Between 2022 and 2023, the capitalized software licenses increased from $152 million to $223 million, indicating a significant rise in the company's investment in software licensing. Additionally, the amortization of capitalized software increased from $54 million in 2022 to $63 million in 2023, reflecting higher ongoing costs associated with these licenses. This growth suggests the company is actively investing in and utilizing software solutions, likely to support its operations and strategic initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in capitalized software licenses from $152 million in 2022 to $223 million in 2023, which matches the ground truth and supports the conclusion of growing investment. However, it introduces a new figure—amortization increasing from $54 million to $63 million—which is not present in the original answer or implied by the ground truth. There is no mention in the original answer of specific amortization expenses for these licenses in either year, so this addition is factually unsupported and constitutes a significant quantitative error. (2) While the core numbers for carrying values are accurate, the inclusion of unverified amortization amounts undermines quantitative accuracy. The calculation of growth in investment is logically sound based on the correct values, but the added expense figures introduce incorrect data. (3) The reasoning partially aligns with the multi-hop synthesis required: the model correctly infers increased investment from rising asset values. However, it fails to mention the key qualitative evolution noted in the original answer—the shift from disclosing only the accounting policy (straight-line amortization) in 2022 to reporting an explicit carrying value in 2023, which reflects improved transparency and a more tangible balance sheet presence. This omission weakens the qualitative accuracy. (4) The answer remains contextually relevant and addresses the core question about investment trends, but due to the introduction of unsupported financial figures and the absence of key qualitative developments in reporting practices, the overall correctness is reduced to a mid-level score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 458,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "PayPal's utilization of European customer balances for credit activities decreased from $3.8 billion in 2022 to $3.0 billion in 2023, representing a reduction from 37% to 39% of European customer balances available for corporate use. This suggests a slight decrease in the reliance on European customer balances to fund credit activities, potentially indicating a strategic shift toward diversifying funding sources for credit products, such as external partnerships and third-party funding.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.8 billion in 2022 and $3.0 billion in 2023 as the amounts approved for credit activities, which matches the ground truth. However, it incorrectly states that the percentage utilization decreased from 37% to 39%, when in fact the percentage increased from 37% to 39% — this is a critical error in interpretation. The LLM misrepresents a higher percentage utilization as a decrease, which distorts the conclusion. (2) The numbers themselves are accurate in dollar amounts and percentages, but the comparative logic is flawed: 39% is higher than 37%, so utilization as a percentage of available balances increased, not decreased. The LLM also omits the key strategic development in 2023 — the new €40 billion agreement to sell consumer installment receivables, with $5.5 billion sold during the year — which is a major component of PayPal’s shift toward external funding. (3) The multi-hop reasoning is partially sound in linking funding levels to strategic implications, but fails to synthesize the full picture: it misses the external funding mechanism entirely, which is central to understanding PayPal’s evolving strategy. (4) The contextual relevance is high because the answer addresses the core question about funding evolution and strategic implications, but due to the misstatement of percentage trend and omission of the receivables sale agreement, the qualitative and quantitative accuracy scores are reduced. The conclusion about diversifying funding sources is plausible but under-supported without mention of the €40 billion program.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 439,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Starbucks' investment in Valor Siren Ventures I L.P. had a total carrying value of $211.9 million as of September 29, 2024, compared to $112.3 million as of October 1, 2023, indicating an increase in the investment's value over the fiscal year. The financial impact of these private equity interests is included in interest income and other, net on Starbucks' consolidated statements of earnings, though related financial statement activities were not material during the periods presented.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the $211.9 million carrying value in fiscal 2024 is for Valor Siren Ventures I and II L.P. *combined*, not just I L.P. alone. The LLM incorrectly attributes the full amount to I L.P. and further fabricates a $112.3 million carrying value for October 1, 2023, which is not disclosed in the original answer. No specific carrying value was provided for fiscal 2023, only that the investment existed and was included in 'interest income and other, net' as non-material. (2) The quantitative accuracy is low because the LLM invents a precise prior-year value ($112.3 million) that is not in the ground truth and misattributes the combined 2024 value to a single fund. The date (September 29, 2024) is correctly used, but the comparison is invalid due to incorrect prior-year data. (3) The reasoning is partially sound in that it identifies the correct financial statement line item ('interest income and other, net') and correctly notes non-materiality. However, it fails the multi-hop synthesis by not recognizing that the 2024 value is a combined figure and that 2023 data was not specifically disclosed. The evolution is misrepresented as a quantified increase rather than a shift from unspecified to specified value with expanded partnership (I and II L.P.). (4) Contextual relevance is high because the answer addresses the investment's carrying value, time periods, and financial statement impact as asked. However, due to major factual and quantitative errors, the correctness score is low despite relevant structure and partial accuracy on non-materiality and reporting classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 461,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Between 2022 and 2023, the strategic positioning of Analog Products at Texas Instruments (TI) experienced a notable shift in both competitive advantages and financial contribution. Financially, Analog revenue decreased by 15% in 2023 compared to 2022, from $15.36 billion to $13.04 billion, with a corresponding 30% decline in operating profit, from $8.36 billion to $5.82 billion. This decline was driven by reduced customer demand and higher manufacturing costs associated with planned capacity expansion and lower factory loadings. Despite this, TI continued to emphasize its four sustainable competitive advantages—manufacturing and technology, product portfolio breadth, market channel reach, and product diversity and longevity—to strengthen its long-term position. However, the financial contribution of Analog Products weakened in 2023, reflecting broader market challenges and operational cost pressures.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Analog Products contributed to a gross margin of 67.5% in 2022 and remained a core strategic pillar in 2023, with emphasis on TI's sustainable competitive advantages and long-term free cash flow. However, the LLM claims a 15% revenue decline from $15.36B to $13.04B and a 30% drop in operating profit—figures not present in the original answer and unsupported by the provided context. These specific financial declines contradict the ground truth, which emphasizes continuity and strategic reinforcement, not deterioration. (2) The quantitative inaccuracies are severe: no revenue, profit, or percentage changes were mentioned in the original answer, and the LLM fabricates detailed financials that do not appear in the knowledge base. Even if such data existed elsewhere, they directly conflict with the ground truth's narrative of sustained strategic strength. (3) The multi-hop reasoning is flawed. The question asks about evolution in strategic positioning and financial contribution. The original answer focuses on qualitative shifts in framing—how Analog Products were increasingly tied to TI’s four competitive advantages and cash generation metrics. The LLM instead introduces unsupported financial declines and operational challenges, missing the actual strategic evolution described. It fails to mention the emphasis on 300mm production efficiency in 2022 or the shift toward free cash flow per share as the key metric in 2023. (4) The contextual relevance is moderate because the LLM discusses Analog Products, TI, competitive advantages, and financial contribution—relevant themes—but the actual content diverges factually and analytically from the ground truth. Due to major factual and quantitative errors, the correctness score is low at 2, with similarly low quantitative accuracy (1) and modest qualitative accuracy (3) for mentioning TI’s competitive advantages, albeit in a distorted context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 542,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, as reflected in increased depreciation, depletion, and amortization (DD&A) expenses. In 2023, DD&A for the Lower 48 was $5,729 million, compared to $4,854 million in 2022, indicating higher capital investment and utilization of assets. Additionally, impairments in the Lower 48 remained relatively stable, with no significant changes reported between the two years. This suggests a focus on maintaining and developing existing assets rather than writing down significant portions of the asset base, aligning with a strategy of operational efficiency and capital discipline in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in DD&A from $4,854 million in 2022 to $5,729 million in 2023, matching the ground truth exactly. These figures are presented accurately and support the conclusion of increased capital allocation. The mention of impairments being stable is consistent with the absence of major changes in the data, though the original answer does not explicitly discuss impairments—this addition is reasonable and does not contradict the ground truth. (2) All numeric values are correct and properly formatted; the dollar amounts match the ground truth, and no calculation errors are present. The difference of $875 million is implied correctly through the comparison. (3) The reasoning is sound: the increase in DD&A is correctly interpreted as evidence of higher capital investment and asset utilization, which aligns with the multi-hop logic that rising DD&A reflects greater capital deployment in the Lower 48. The LLM also appropriately contrasts this with stability in impairments, adding nuance to the strategy of maintaining asset value. While the original answer highlights the contrast with other regions (Europe, MENA), the LLM omits this point, resulting in a minor completeness gap. (4) Despite this omission, the core of the question—how capital allocation evolved based on DD&A and impairments—is thoroughly addressed with accurate data and logical interpretation. The answer is semantically equivalent in key aspects and adds reasonable qualitative context. Hence, a high score is warranted, with only a slight deduction for not fully mirroring the comparative regional insight in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 454,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "Between 2023 and 2024, Verizon has positioned FWA (Fixed Wireless Access) broadband as a core component of both its Consumer and Business segments, emphasizing its role as an alternative to traditional landline internet access. In 2023, FWA was highlighted as part of the Consumer segment's residential fixed connectivity solutions and as a service for Business customers. By 2024, FWA remained a key offering, with continued integration into the 5G and 4G LTE networks, and it was explicitly mentioned as a service for both residential and business customers. Target segments included retail consumers, businesses, and public sector entities, with FWA being marketed as a flexible, high-speed broadband solution.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately reflects that Verizon offered FWA broadband in both 2023 and 2024 to Consumer and Business customers, using both 5G and LTE networks. The target segments—retail consumers, businesses, and public sector entities—are consistent with the broader customer focus in the original answer. (2) There are no numeric inaccuracies; the LLM does not include the 3.1 million FWA connections figure from 2023, but it does not contradict it either—this is a minor omission rather than an error. (3) The reasoning is sound: the LLM correctly identifies the continuity and integration of FWA within Verizon’s portfolio across years and segments. However, it misses the nuanced shift in language from 'provides' in 2023 to 'produces' in 2024, which the ground truth highlights as indicative of a more strategic, product-centric evolution. This subtle but important detail about positioning evolution is absent, slightly weakening the qualitative accuracy. (4) The answer remains highly contextually relevant, addressing both the portfolio positioning and target segments as asked. Overall, the response is factually accurate and well-reasoned but lacks one key insight about the strategic repositioning implied by changed terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 363,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2022 to 2024, transitioning from a majority stakeholder to proposing a full acquisition. In 2022, Emerson combined its industrial software businesses with Heritage AspenTech to create \"New AspenTech,\" owning 55% of the shares. By 2024, Emerson proposed to acquire the remaining 43% of AspenTech for $240 per share, valuing the company at $15.3 billion. This evolution had a notable financial impact: in 2023, the Heritage AspenTech acquisition contributed positively to gross margin by 0.6 percentage points, while in 2024, acquisition-related inventory step-up amortization negatively impacted gross margin by 1.3 percentage points. Additionally, the equity structure was affected as Emerson's ownership increased, and the proposed full acquisition would further consolidate AspenTech into Emerson's financials.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that impact correctness. While it correctly identifies the 55% ownership stake in 'New AspenTech' formed in 2022 and the positive 0.6 percentage point impact on gross margin in 2023, it incorrectly states that Emerson proposed to acquire the remaining 43% in 2024. The ground truth does not mention a proposed full acquisition or a $240 per share offer for $15.3 billion; this specific transaction is unsupported. Additionally, the claim that acquisition-related inventory step-up amortization negatively impacted gross margin by 1.3 percentage points in 2024 is not present in the original answer and contradicts the more general statement about SG&A increases due to integration. (2) Quantitative accuracy is partially correct: the 0.6 percentage point gross margin benefit in 2023 matches the ground truth, but the 1.3 percentage point negative impact and the $240/share, $15.3B valuation are unverified and likely incorrect. The 43% remaining stake is also inconsistent with the 55% ownership implying 45% external ownership. (3) The multi-hop reasoning is partially sound—linking the evolving relationship to financial impacts on gross margin and equity structure—but introduces unsupported details about a full acquisition and specific amortization effects, undermining the logical fidelity. (4) Contextual relevance is high as the answer addresses the evolution of the relationship and its financial implications on margin and equity, but the inclusion of fabricated transaction details reduces overall correctness. The core progression and one key financial effect are accurate, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 459,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "The financial relationship between NEE and FPL Group Capital Inc. from 2022 to 2023 primarily involved obligations related to debentures and capital structure instruments. In 2022, NEE issued several junior subordinated debentures (e.g., Series P) and maintained guarantees and purchase contracts with financial institutions. By 2023, NEE continued issuing debentures (e.g., Series K and L) and made amendments to existing debentures, indicating an ongoing role in managing long-term capital obligations. FPL Group Capital Inc. was involved in unsecured debt securities and related indentures, showing its role in supporting NEE’s broader capital structure through debt instruments and guarantees.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. In 2022, the original answer specifies a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. from 1998, not debenture issuances by NEE as claimed. The LLM incorrectly states that NEE issued debentures like Series P in 2022, but the ground truth indicates that the shift to debentures occurred in 2023, not 2022. Additionally, the LLM mentions Series K and L in 2023, but the ground truth lists Series B, C, L, M, N, O, and P—Series K is not mentioned, and Series P was part of the 2023 structure, not 2022. (2) Quantitative accuracy is low: dates (e.g., maturity dates up to 2082) and specific series of debentures are either misplaced across years or inaccurately reported. No correct timeline or series mapping is provided. (3) Multi-hop reasoning is partially present—the model recognizes a shift in capital structure and obligation types—but fails to correctly identify the nature of the evolution: from a guarantee (2022) to debenture issuance (2023). Instead, it assumes debentures were already in place in 2022, reversing the causal evolution. (4) Contextual relevance is fair because the answer discusses debentures, guarantees, and capital structure, which are relevant themes. However, the misattribution of events to incorrect years and entities undermines factual correctness. The core transformation described in the ground truth—a shift from guarantee to long-term financing via multiple debenture series—is not accurately reflected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 430,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "Between 2022 and 2024, the InterStim II neurostimulator has seen continued market acceptance as part of Medtronic's broader Pelvic Health therapies. In 2022, the Pelvic Health division experienced growth driven by the recently launched InterStim Micro and SureScan MRI leads, while by 2024, the focus expanded to include InterStim II, InterStim X, and the recharge-free InterStim II, alongside the rechargeable InterStim Micro. This evolution reflects a broader strategy to offer diverse, patient-centric neurostimulation solutions for conditions such as overactive bladder, urinary retention, and chronic fecal incontinence, with an emphasis on recharge-free and advanced device options to meet varied patient needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: InterStim II's continued market acceptance, its role within Medtronic's Pelvic Health portfolio, and the conditions it treats (overactive bladder, urinary retention, fecal incontinence) are accurately described. The evolution from 2022 to 2024 correctly reflects a shift toward emphasizing device-specific features, particularly recharge-free status. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) Multi-hop reasoning is sound: the answer synthesizes information across years and product lines, correctly identifying InterStim II as recharge-free by 2024 and contrasting it with the rechargeable InterStim Micro. However, the original answer notes that InterStim Micro was already part of the suite in 2022, while the LLM implies its launch was in 2022 ('recently launched'), which may slightly misrepresent timing. Also, the original does not explicitly call InterStim II 'recharge-free' in 2024 as a new designation—rather, it notes that by 2024 the portfolio is differentiated by recharge status, which the LLM captures well but with slight overemphasis on 'recharge-free InterStim II' as if newly labeled. (4) Despite minor nuance differences, the LLM conveys the same core evolution: a maturing product line with increased segmentation by patient needs and device attributes. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses positioning and market acceptance over time in relation to other devices and broader therapies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 464,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's utilization and management of the Supplemental Facility evolved in several key ways. The borrowing capacity of the Supplemental Facility increased from an initial $3.5 billion in 2022 to a potential $4.5 billion by 2024, with an extended maturity date to January 31, 2029 (from January 31, 2026 in 2022). Interest rate strategies remained consistent, with the facility offering flexibility to borrow at either benchmark rates (e.g., SOFR, EURIBOR) or base rates, with spreads determined by Simon's credit rating. In 2024, the interest rate was SOFR plus 72.5 basis points, adjusted for the transition from LIBOR to SOFR. Additionally, repayment actions included the use of the Supplemental Facility to refinance existing debt, such as the repayment of €750 million in borrowings in 2023 through newly issued bonds. Overall, Simon expanded the facility's capacity and extended its maturity while maintaining a flexible interest rate structure and actively using it for strategic refinancing.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in key quantitative details. The maturity date is incorrectly stated as January 31, 2029, while the ground truth specifies January 31, 2026, with no mention of an extension. This is a major error. The borrowing capacity is correctly noted as initially $3.5 billion with potential to increase to $4.5 billion, but the LLM implies this increase occurred by 2024, whereas the original answer only confirms the *potential* for increase, not that it was realized. The LLM introduces a specific interest rate spread of 'SOFR plus 72.5 basis points' in 2024, which is not present in the ground truth; the original answer mentions interest rate swaps were used to fix the rate at 3.81% on €750 million in 2023, a detail the LLM omits. The repayment of €750 million is mentioned, but the LLM incorrectly frames it as occurring in 2024, while the ground truth states it was repaid on November 17, 2023. (2) The LLM invents a new maturity date (2029 vs 2026) and a specific interest spread not supported by the original, while missing the actual fixed rate of 3.81% achieved via swaps. The €750 million repayment date is off by a year. (3) The multi-hop reasoning is partially sound—linking the bond issuance to repayment and recognizing strategic use of the facility—but fails to accurately synthesize the timeline and specific financial instruments (e.g., swaps fixing the rate). (4) The answer is contextually relevant and addresses all aspects of the question (capacity, rates, repayment), but suffers from significant factual and numerical inaccuracies that undermine correctness. Hence, a score of 5 reflects partial correctness with major errors in key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 473,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "From 2023 to 2024, Verizon shifted its approach to device payment plans by discontinuing fixed-term, subsidized service plans for Consumer customers and focusing more on device payment plans with non-interest-bearing installment notes. In 2024, promotional incentives such as billing credits were still offered for device payment plans, contingent on customers maintaining service, and these credits were included in the transaction price. Additionally, the company continued to assess the significance of financing components in these plans, determining that they were not material for direct-channel contracts. The evolution reflects a move toward flexible, month-to-month service contracts paired with structured installment payments for devices.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements about Verizon's device payment plans in 2024, such as the use of non-interest-bearing installment notes and promotional billing credits tied to service continuation. However, it introduces a claim not present in the ground truth: that Verizon 'discontinued fixed-term, subsidized service plans for Consumer customers'—this is not mentioned in the original answer and represents an unsupported inference. Additionally, while the LLM correctly notes promotional incentives like billing credits, it fails to mention the key 2024 innovation highlighted in the ground truth: the structured upgrade option after paying a specified portion of the plan and trading in the device. This omission significantly weakens the completeness and qualitative accuracy of the response. The LLM also mentions 'financing components...not material for direct-channel contracts,' which adds detail not in the original and may reflect overinterpretation. Quantitatively, there are no explicit numbers, so accuracy is high by default—minor details like the 36-month term are omitted but not contradicted. Contextually, the answer stays on topic and addresses the evolution of financing and promotions, but misses the core shift toward a formalized, trade-in-based upgrade mechanism that defines the 2024 change. Thus, while partially correct, the answer lacks key differentiating information and introduces unsupported claims, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 405,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's legal relationship with Aqua-Chem remained largely unchanged, with the Georgia Case still subject to the 2004 stay. The key developments in this period relate to the resolution of insurance coverage litigation, which concluded in 2007, and subsequent settlements with insurers. As of both years, the Company maintained its position that it has no obligation for Aqua-Chem's asbestos-related liabilities beyond what is covered by insurance. No new material developments in the legal stance or obligations were reported in 2024 compared to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several critical factual inaccuracies that deviate from the ground truth. First, it incorrectly states that the insurance coverage litigation 'concluded in 2007'—this is factually wrong and not supported by the original answer, which discusses ongoing coverage litigation in 2024. The 2007 date contradicts the multi-hop context of evolving disclosures between 2023 and 2024. Second, the LLM claims 'no new material developments in 2024,' which directly contradicts the ground truth indicating a shift in Coca-Cola's stance—from outright denial of liability in 2023 to a more nuanced 2024 position emphasizing insurance coverage and shared insurer responsibility. This evolution is central to the question and was missed entirely. Third, the LLM incorrectly implies finality in insurer settlements, which is not mentioned in the original answer. While the entity names (Coca-Cola, Aqua-Chem, Georgia Case) and general context (asbestos-related claims, liability stance) are correctly identified, the reasoning is flawed: the model fails to synthesize the change in disclosure tone and content between 2023 and 2024. Instead, it asserts stasis, missing the key nuance of a strategic shift in narrative focus. Quantitative accuracy is low due to the erroneous 2007 date and lack of correct temporal alignment. Contextual relevance is moderate because the answer addresses the general topic and legal relationship, but fails on the specific evolution asked. Overall, the answer misrepresents the timeline and substance of Coca-Cola's evolving legal stance, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 439,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel's utilization of non-US tax credits significantly reduced its long-term income tax liabilities in 2024 compared to 2022. In 2024, non-US tax credits provided a $129 million benefit (up from $220 million in 2022), reflecting continued reliance on favorable tax rates in jurisdictions like Israel and Malaysia. This indicates that Intel's international tax strategy remains focused on leveraging lower-tax environments and tax holidays to mitigate global tax obligations, despite a challenging financial environment in 2024 marked by a valuation allowance and higher effective tax rate.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Intel's long-term income taxes payable decreased from $4.3 billion in 2022 to $1.6 billion in 2024, but the LLM does not mention these key figures. Instead, it introduces non-US tax credit benefits of $129 million in 2024 and $220 million in 2022, which contradict the ground truth and are not supported by the original answer. These numbers appear fabricated or misattributed. (2) The quantitative inaccuracies are severe: the LLM claims the benefit from non-US tax credits decreased from $220M to $129M, implying a reduced benefit, while the original answer indicates a stronger offsetting effect over time due to lower long-term tax liabilities. This directly contradicts the trend implied in the ground truth. Additionally, no specific credit amounts were mentioned in the original answer, so introducing these figures undermines factual correctness. (3) The reasoning is partially sound in interpreting that non-US tax credits play a role in reducing tax liabilities and that Intel has an international tax strategy involving jurisdictions like Israel and Malaysia. However, the model fails the multi-hop synthesis: it does not connect the reduction in long-term taxes payable ($4.3B to $1.6B) with the increasing effectiveness of non-US tax credits as stated in the original. Instead, it infers a weakening benefit (lower credit amount), which leads to flawed conclusions. (4) Contextual relevance is moderate—the response addresses international tax strategy and non-US tax credits—but due to major factual and numerical errors, the overall correctness score is low. The answer misrepresents the financial data and thus fails to accurately reflect the company's tax liability trend or strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 493,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "Between 2022 and 2024, the treatment and risk exposure of pension risk transfers have evolved with increased interest rate sensitivity and regulatory influence. In 2022, MetLife used interest rate derivatives and asset/liability duration matching to mitigate gross margin compression, with only a small portion of invested assets subject to reinvestment risk through 2024. By 2024, the impact of rising interest rates was more pronounced, with higher reinvestment rates on cash flows partially offsetting the negative effects of increased interest crediting rates and lower derivative income. Regulatory developments also influenced risk management strategies, as evolving capital requirements and reserving standards affected statutory reserve and capital needs, particularly in response to market volatility and low interest rate environments.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct contextual elements but diverges significantly from the ground truth in key aspects of treatment and risk exposure evolution for pension risk transfers between 2022 and 2024. (1) While it correctly identifies interest rate sensitivity as a factor in both years, it introduces specific risk management tactics (e.g., use of derivatives, duration matching, reinvestment risk) not mentioned in the original answer and attributes them to MetLife without grounding in the provided truth. The original answer does not mention MetLife or company-specific strategies, making this a factual overreach. (2) Quantitatively, the LLM references 'higher reinvestment rates' and 'derivative income' without specific numbers, so no numeric inaccuracies can be pinpointed, but the absence of quantifiable data from the ground truth (which also lacks numbers) limits error in this domain—hence a moderate score. However, the timeline is partially accurate (2022 vs 2024 comparison), supporting a 6 on quantitative accuracy. (3) The multi-hop reasoning is flawed: the original answer emphasizes a regulatory shift reducing plan terminations and shifting product mix toward non-guaranteed funding products; the LLM instead focuses on interest rate impacts on derivatives and reinvestment, missing the core regulatory influence on corporate behavior and product strategy. This represents a failure in qualitative synthesis. (4) Contextually, the answer stays within the domain of pension risk and interest rates, so relevance is fair, but it fails to capture the essential regulatory-driven strategic shift described in the ground truth. Overall, the answer is partially accurate in theme but incorrect in substance and reasoning, warranting a correctness score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 481,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "Between 2022 and 2024, Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved to emphasize broader adoption and integration into global pelvic health care. In 2022, the InterStim Micro was highlighted as a recently launched product driving growth in Pelvic Health, particularly for treating overactive bladder, urinary retention, and bowel incontinence. By 2024, the InterStim Micro was positioned as part of a mature portfolio of Pelvic Health therapies, with continued acceptance and growth noted alongside other offerings like the InterStim X and InterStim II. This evolution reflects a shift from initial market penetration to sustained global adoption and integration into standard care practices.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its overall narrative and contextually relevant, but misses a key strategic evolution highlighted in the ground truth: the explicit positioning of InterStim Micro as a 'rechargeable neurostimulator' in 2024 and its differentiation from the 'recharge-free' InterStim X and II models. This is a significant product strategy detail that the LLM omits. While the LLM correctly identifies the product's indication (overactive bladder, urinary retention, bowel incontinence), its placement within Pelvic Health, and the shift from growth driver to mature offering, it fails to capture the specific technological differentiation that Medtronic emphasized by 2024. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the entity names (Medtronic, InterStim Micro, InterStim X, InterStim II) and years (2022, 2024) are accurate. The reasoning is sound in tracking a strategic evolution from launch to maturity, but lacks the multi-hop synthesis of product-specific technical differentiation present in the original answer. Thus, while semantically close and contextually appropriate, the answer is incomplete on a key qualitative aspect of product strategy, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 364,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's use of the Supplemental Facility evolved with a notable decrease in outstanding borrowings. In 2022, $1.05 billion was drawn under the Supplemental Facility to extinguish mortgages, and this amount was repaid by January 2022. By 2024, the maximum aggregate outstanding balance under the Credit Facilities (which includes the Supplemental Facility) was $325.1 million, with a weighted average outstanding balance of $311.1 million. This reflects a significant reduction in reliance on the Supplemental Facility for short-term borrowings, indicating active repayment actions and a shift toward more stable financing strategies.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It claims that $1.05 billion was drawn under the Supplemental Facility in 2022 to extinguish mortgages and repaid by January 2022, which contradicts the ground truth—there is no mention of such a drawdown or repayment in January 2022. The ground truth states that the maximum aggregate outstanding balance under the Credit Facilities (including Supplemental Facility) was $2.1 billion during 2022, not $1.05 billion specifically under the Supplemental Facility. Additionally, the LLM incorrectly states that the maximum aggregate outstanding balance in 2024 was $325.1 million, while the ground truth reports a weighted average outstanding balance of $311.1 million in 2024 with no mention of a maximum balance for that year. The only correct quantitative figure is the $311.1 million weighted average balance in 2024. (2) The repayment of €750.0 million ($815.4 million) on November 17, 2023, under the Supplemental Facility—a key repayment action—is entirely omitted. Instead, the LLM fabricates a repayment of $1.05 billion by January 2022, which is not supported by the ground truth. (3) The reasoning is partially sound in identifying a reduction in borrowings and decreased reliance on the Supplemental Facility, but the multi-hop synthesis fails because it misrepresents the timing, magnitude, and nature of the drawdowns and repayments. The conclusion about a shift to stable financing is plausible but based on incorrect data. (4) The contextual relevance is high because the answer addresses the evolution of borrowing and repayment trends. However, due to major quantitative errors and omission of key repayment events, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the general direction of change (reduction in borrowings) is correct, but the reasoning is based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 518,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "From 2022 to 2023, COP's depreciation, depletion, amortization, and impairments expenses for the Lower 48 region increased from $4,854 million to $5,729 million. This $875 million rise suggests a significant expansion or increased utilization of assets in the Lower 48 region during 2023, reflecting higher investment activity compared to the prior year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $4,854 million in 2022 and $5,729 million in 2023 are correctly reported. The calculated increase of $875 million ($5,729M - $4,854M) is accurate and properly highlighted. (2) The answer is complete, addressing the evolution of investment activity through expense changes across both years, as required by the question. (3) Entity accuracy is correct: COP (ConocoPhillips), the Lower 48 region, and the financial metric 'depreciation, depletion, amortization, and impairments expenses' are all correctly identified and contextualized. (4) The reasoning is sound: the increase in these expenses is logically interpreted as indicative of higher investment activity or asset utilization, which aligns with standard financial interpretation in the energy sector. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced clarity due to the explicit mention of the $875 million difference. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 309,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "From 2023 to 2024, Verizon's approach to corporate networking solutions has emphasized the expansion of its Business segment offerings, particularly in terms of service description and business segment emphasis. In 2023, the Business segment highlighted services such as private networking, cloud connectivity, and virtual and software-defined networking solutions under the Enterprise and Public Sector. By 2024, the Business segment continued to emphasize corporate networking solutions but with a stronger focus on leveraging the Intelligent Edge Network and 5G capabilities to enhance performance and support business operations. Additionally, the Business segment's operating income slightly decreased from $2,631 million in 2023 to $2,058 million in 2024, reflecting a shift in strategic priorities and resource allocation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. While it correctly identifies that Verizon offered private networking and cloud connectivity services in 2023, it misrepresents the evolution in 2024. The ground truth states that the 2024 description became more streamlined and less detailed, whereas the LLM claims a 'stronger focus' on Intelligent Edge Network and 5G — information not present in the original answer and unsupported by the provided context. Additionally, the LLM introduces operating income figures ($2,631M in 2023 and $2,058M in 2024) that are not mentioned in the ground truth, making them factually incorrect or at least unverifiable against the provided answer. (2) Quantitative accuracy is low because the financial figures cited (operating income) do not appear in the original answer, and there is no mention of Enterprise and Public Sector revenues being $15.1 billion (50% of Business segment) in 2023 — a key quantitative point missing from the LLM response. The LLM invents numbers rather than reflecting the correct ones. (3) The multi-hop reasoning is flawed. The original answer emphasizes a shift from detailed service descriptions in 2023 to a more generalized presentation in 2024, suggesting strategic simplification. The LLM instead infers a technological enhancement narrative (5G, Intelligent Edge), which contradicts the ground truth’s implication of messaging consolidation. This misrepresents the nature of the evolution. (4) Despite these issues, the answer is contextually relevant — it addresses Verizon's corporate networking evolution and business segment emphasis — and captures the general idea that services were offered in 2023 and continued in 2024. However, the incorrect data and reversed interpretation of strategic direction significantly reduce correctness. Hence, a score of 4/10 is justified: partially correct on service offerings, but major errors in financial data and strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 531,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "From 2022 to 2024, MetLife's valuation approach for FVO (Fair Value Option) securities remained consistent in terms of methodology, as they are measured at fair value using Level 3 inputs, which rely on significant unobservable data. However, the sensitivity to fair value changes due to the U.S. dollar appreciation was evident in the 2024 disclosures. Specifically, a 10% appreciation in the U.S. dollar led to a potential loss of $54 million for FVO securities at December 31, 2021, indicating that the U.S. dollar's strength had a material impact on the fair value of these securities. The impact of the U.S. dollar appreciation on FVO securities appears to have remained a notable factor in 2024, as the valuation techniques and sensitivity to foreign currency exchange rates were still based on similar assumptions and inputs as in prior years.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but significant inaccuracies. It correctly states the $54 million decrease in value from a 10% U.S. dollar appreciation, which aligns with the 2022 data in the ground truth. However, it incorrectly attributes this sensitivity figure to 'December 31, 2021', which is not supported by the original answer and misaligns the time period. The original answer references 2022, not 2021. Additionally, the LLM claims that the valuation approach 'remained consistent', which directly contradicts the ground truth that describes an evolution toward a more nuanced, dynamic framework in 2024 involving duration- and currency-dependent inputs. The LLM fails to mention the absence of a direct fair value figure for FVO securities in 2024 and omits the shift from a static to a more complex model. (2) Quantitatively, the $54 million figure is correct, but its attribution to 2021 instead of 2022 undermines accuracy. The $1.6 billion fair value for 2022 is omitted entirely. No quantitative data is provided for 2024, consistent with the original, but the LLM does not clarify that no direct fair value was reported, missing a key point. (3) The multi-hop reasoning is flawed: the question asks for an evolution from 2022 to 2024, requiring comparison across years and synthesis of methodological changes. The LLM incorrectly concludes consistency rather than evolution, failing to synthesize the shift in sensitivity modeling and valuation sophistication. (4) Contextual relevance is moderate—the answer discusses FVO securities, fair value, and currency sensitivity, which are relevant—but the core conclusion about methodological consistency is factually incorrect, severely limiting usefulness. Thus, the correctness score is low due to major qualitative and temporal errors despite partial numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 506,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "NextEra Energy's engagement in power marketing activities between 2022 and 2023 showed significant evolution, particularly in energy trading services and financial performance. In 2023, operating revenues increased by $5,952 million, driven by gains from non-qualifying commodity hedges due to changes in energy prices, with $2,529 million in gains compared to $2,670 million in losses in 2022. Additionally, revenues from customer supply and gas infrastructure businesses rose by $647 million, and new investments contributed $390 million. However, revenues from existing clean energy assets declined by $371 million, primarily due to lower wind resource availability. Financially, NEER's net income less net loss attributable to noncontrolling interests increased by $3,273 million in 2023 compared to 2022, largely due to gains from non-qualifying hedge activities and new investments, despite challenges in existing clean energy operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures compared to the ground truth. The ground truth states that NEER's net income rose from $285 million in 2022 to $3,558 million in 2023—an increase of $3,273 million—which the LLM correctly identifies as a $3,273 million increase. However, the LLM misattributes this increase primarily to 'gains from non-qualifying hedge activities' and 'new investments', while the original answer emphasizes an expansion in power marketing and trading activities as the driver. The LLM introduces revenue figures not present in the ground truth—such as a $5,952 million increase in operating revenues and specific gains/losses from hedges ($2,529M gain in 2023 vs $2,670M loss in 2022)—which are unsupported by the original answer and likely incorrect. These numbers do not appear in the ground truth and represent a major deviation. (2) While the $3,273 million net income increase is numerically consistent with the ground truth (since $3,558M - $285M = $3,273M), other financial figures (e.g., $647M, $390M, $371M) are not corroborated and appear to be hallucinated or derived from external data. The quantitative accuracy is low due to these unverified and likely false figures. (3) The reasoning partially captures the evolution in financial performance but misrepresents the cause. It fails to mention the core expansion of NEER’s role in power marketing and trading as the central evolution, instead focusing on hedging gains and asset performance. The multi-hop synthesis is weak—it connects financial changes but misattributes causality and omits the strategic expansion highlighted in the original. (4) Contextual relevance is high because the answer addresses power marketing evolution, financial performance, and year-over-year changes as asked. However, correctness is severely undermined by incorrect financial data and misattribution of drivers, limiting its reliability despite some alignment in structure and topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 542,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's stake in Coca-Cola FEMSA decreased slightly from 28% to 27%, as detailed in the equity method investments section. The carrying value of the investment also declined from $1,786 million to $1,699 million, while the fair value based on quoted prices remained at $4,544 million. This reduction in stake and carrying value may have slightly impacted The Coca-Cola Company's equity income, which decreased from $527 million in 2023 to $497 million in 2024 for Coca-Cola FEMSA.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, The Coca-Cola Company held a 28% stake in Coca-Cola FEMSA in 2024, not 27%, and there is no mention of a decrease from 28% in 2023—thus the claim of a reduction from 28% to 27% is factually wrong. The ground truth does not provide any carrying value, fair value, or equity income figures for Coca-Cola FEMSA, so the LLM's inclusion of $1,786M, $1,699M, $4,544M, and equity income decreasing from $527M to $497M is unsupported and likely hallucinated. (2) These numbers do not appear in the original answer and contradict the key point: the evolution from indirect dependency in 2023 to direct 28% ownership in 2024. The LLM incorrectly frames the relationship as declining, while the truth indicates a strategic deepening. (3) The multi-hop reasoning is flawed—the original answer requires synthesizing a shift in relationship type (from dependency to ownership), but the LLM instead invents a narrative of stake reduction and financial decline. It fails to recognize the qualitative shift in the nature of the relationship, which is the core of the question. (4) The contextual relevance is moderate because the answer discusses stake ownership and equity income as requested, but the factual inaccuracies and incorrect direction of change severely undermine correctness. Quantitative accuracy is very low due to fabricated numbers. Qualitative accuracy is low because the reasoning and entity relationships are misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 427,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "Between 2022 and 2023, the financial investment and operational focus on the Lower 48 region increased, as reflected in higher production volumes and depreciation expenses. Production volumes in the Lower 48 rose significantly, with crude oil production increasing from 447 thousand barrels per day in 2022 to 447 thousand barrels per day in 2023, while natural gas production remained strong at 1,340 million cubic feet per day. Depreciation, depletion, and amortization expenses for the Lower 48 also increased from $4,854 million in 2022 to $5,729 million in 2023, indicating a greater capital investment and operational emphasis on this region.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the crude oil production (447 thousand barrels per day) and natural gas production (1,340 million cubic feet per day) for both 2022 and 2023, matching the ground truth. It also accurately states the increase in depreciation, depletion, and amortization expenses from $4,854 million in 2022 to $5,729 million in 2023. However, the LLM incorrectly implies that crude oil production increased from 2022 to 2023 when it remained unchanged (447 to 447), stating 'rose significantly' and 'increasing from... to...', which misrepresents stable production as growth. This is a factual misinterpretation despite correct numbers. (2) All numeric values are accurate and properly formatted; calculations (e.g., the $875 million increase in expenses) are correct, though not explicitly stated. (3) The multi-hop reasoning is mostly sound—linking rising DDA expenses to increased financial investment is valid, and combining production and expense data across years is appropriate. However, the erroneous characterization of stable production as increasing weakens the logical synthesis. (4) The answer is contextually relevant and addresses both financial investment (via DDA) and operational focus (via production volumes). The correctness score is 7 due to the core financial data being accurate and the main conclusion about increased investment being supported, but the incorrect claim of rising production volumes—despite correct numbers—introduces a significant qualitative error that affects interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 426,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "Between 2023 and 2024, Verizon's 4G LTE network continued to play a supporting role in its network infrastructure, primarily serving as a complementary technology to its 5G expansion initiatives. In 2023, the company emphasized its 5G leadership while still utilizing 4G LTE for FWA broadband services and maintaining network reliability. By 2024, as Verizon continued its fiber expansion strategy and invested heavily in 5G network densification and capacity, the 4G LTE network remained a foundational element, particularly for areas where 5G coverage was still being expanded. However, its strategic focus shifted toward enabling the transition and coexistence with 5G technologies rather than being the primary growth driver.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the strategic evolution of Verizon's 4G LTE network as described in the ground truth. (1) Correct elements: The answer accurately notes that 4G LTE served as a foundational technology in 2023, particularly for FWA broadband, and continued to support network reliability and 5G transition in 2024. It also correctly identifies the ongoing emphasis on 5G and fiber. (2) Quantitative accuracy: There are no numerical values in the question or answers, so this criterion is satisfied by default (score 10). (3) Multi-hop reasoning assessment: The LLM fails to capture the core shift described in the ground truth — that 4G LTE evolved from a service delivery platform (for FWA) to being part of an integrated multi-technology ecosystem including C-Band, mmWave, and fiber, aimed at driving innovation and growth. Instead, it frames 4G LTE as a 'supporting' or 'complementary' technology to 5G, which downplays its strategic integration. The original answer emphasizes a qualitative shift in strategic role (from foundational service delivery to strategic asset within a broader vision), which the LLM does not fully reflect. (4) The answer is contextually relevant and well-structured, but lacks the precise strategic reframing present in the ground truth, resulting in a moderate correctness score. Minor but important details like the integration with C-Band and millimeter wave as part of a unified growth strategy are omitted, affecting qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 416,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "From 2022 to 2024, Emerson's financial and strategic relationship with AspenTech evolved significantly. In May 2022, Emerson contributed two industrial software businesses to AspenTech and acquired 55% of its shares. By November 2024, Emerson increased its ownership to approximately 57% and proposed to acquire the remaining shares for $240 per share, valuing AspenTech at $15.3 billion. This acquisition would be financed through cash and credit. Financially, AspenTech's backlog increased from $328 million in 2022 to $1,042 million in 2022, reflecting the impact of the Heritage AspenTech acquisition. In terms of gross margin, Emerson's overall gross margin improved from 49.0% in 2023 to 50.8% in 2024, partly influenced by the Test & Measurement acquisition, though not directly attributed to AspenTech. The strategic focus remained on leveraging AspenTech to enhance Emerson's industrial software capabilities and market position.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Emerson contributed businesses and acquired 55% in May 2022, while the ground truth indicates that the 55% ownership resulted from a transaction completed by 2024, not 2022. The claim that ownership increased to 57% in November 2024 and a $240/share offer valuing AspenTech at $15.3B is not supported by the original answer and introduces unverified details. The backlog increase from $328M to $1,042M in 2022 is internally inconsistent (same year) and contradicts the ground truth, which cites $1,042M as the 2022 backlog value but does not mention $328M. The gross margin improvement from 49.0% to 50.8% is attributed to the Test & Measurement acquisition, not AspenTech, whereas the original answer states AspenTech contributed to a 3.3 percentage point increase in gross margin in 2023. (2) Quantitative accuracy is low: multiple incorrect numbers (e.g., $328M backlog, 57%, $240/share, $15.3B valuation), misattributed timeframes (2022 vs 2024 for ownership), and incorrect margin attribution. The only correct number is the $1,042M backlog in 2022. The $8,053M 2024 backlog and $6,533M 2021 baseline are missing. (3) Multi-hop reasoning is partially present—linking ownership, financial metrics, and strategic impact—but flawed due to incorrect data synthesis. The model attempts to connect stake value, ownership, and financial impact but fails to accurately represent the evolution across years or the causal relationship between the acquisition and financial metrics. (4) Contextual relevance is high as the answer addresses stake value, ownership, and financial metrics as asked, but correctness is undermined by significant factual and numerical errors. The strategic intent is correctly framed around industrial software, but the execution lacks fidelity to the source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 511,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "NEE's financial commitment to the Mountain Valley Pipeline (MVP) significantly declined between 2022 and 2023. In 2022, NextEra Energy Resources (NEER) recorded an additional impairment charge to completely write off its investment in MVP, indicating a loss of value and strategic reassessment. By 2023, the capital expenditures table under NEER no longer lists MVP as a major investment, and the only reference to MVP is a 20-year natural gas transportation agreement with approximately $70 million per year in commitments. This shift suggests that NEE has largely disengaged from its direct investment in MVP, likely due to financial underperformance, regulatory or construction delays, and a strategic pivot toward other energy projects.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that NEE's financial commitment declined. The ground truth states that NEE's involvement evolved from a 32%-55% ownership stake in 2022 to a more defined 32.8% equity investment in 2023, indicating continued and structured engagement, not disengagement. The LLM incorrectly claims that NEER 'completely write off its investment' in 2022 due to impairment, which contradicts the original answer and is unsupported by the provided truth. (2) Quantitatively, the only correct figure is the $70 million per year transportation agreement, which matches the ground truth. However, the claim of a write-off and absence from capital expenditures in 2023 is false; the original answer confirms ongoing equity investment at 32.8%. The percentages (32%-55% in 2022, 32.8% in 2023) are misrepresented in the LLM answer as a reduction, when in fact the 32.8% represents a more precise figure within the prior range, not a decline. (3) The multi-hop reasoning is flawed: instead of recognizing the evolution from a broad equity stake to a specific, long-term contractual commitment as a sign of strategic deepening, the LLM interprets the lack of mention in capital expenditures and the presence of a transportation agreement as disengagement—this misreads the evidence. The synthesis across years and entities (NEE, NEER, MVP) is incorrect. (4) The contextual relevance is moderate because the answer addresses the Mountain Valley Pipeline and NEE’s involvement, and mentions the $70M/year agreement, but the overall interpretation is diametrically opposed to the truth. The conclusion about strategic pivot is unsupported and incorrect. Hence, very low correctness and qualitative accuracy scores; quantitative score is low due to one correct number but multiple false claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 497,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "Coca-Cola's relationship with Costa Limited within the Global Ventures segment has evolved from 2023 to 2024 by integrating Costa's direct-to-consumer retail operations more explicitly into the segment's structure. In 2023, Costa's operations were included in the Global Ventures segment, but the level of integration was not explicitly detailed. By 2024, Costa's direct retail sales are clearly identified as part of the Global Ventures segment's finished product operations, indicating a strategic shift to leverage Costa's retail presence to enhance the segment's market reach and operational synergy. This integration reflects a broader strategic positioning to optimize Costa's role within the Global Ventures portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities—Coca-Cola, Costa Limited, Global Ventures segment, and the years 2023 and 2024—are correctly identified. There are no numerical figures in the question or answer that require verification, so quantitative accuracy is not applicable in a traditional sense, but all temporal and categorical references are correct. (2) The answer correctly captures the evolution: in 2023, Costa Limited was part of Global Ventures with retail operations noted, and by 2024, its integration was more explicit and strategically emphasized. (3) The multi-hop reasoning is sound—synthesizing information across years and segments to show increased integration. The LLM correctly infers a strategic shift even if the 2023 details were less explicit, which is consistent with the ground truth. (4) The only minor shortcoming is that the LLM answer does not mention the inclusion of innocent and doğadan or distribution coordination fees in 2024, which the ground truth cites as evidence of broader strategic expansion within Global Ventures. While the focus is on Costa, this omission slightly limits completeness in portraying the full strategic context. However, the core of the answer—Costa’s deeper integration—is accurately conveyed with appropriate reasoning, making it semantically equivalent in intent and fact. Hence, a high score is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 391,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Intel's investment in financial institution instruments, specifically the fair value of economically hedged marketable debt investments, decreased from $17.1 billion as of December 30, 2023, to $13.5 billion as of December 28, 2024. This represents a reduction of $3.6 billion over the period. Additionally, during 2024, Intel recorded net losses of $464 million on these hedged investments, compared to net gains of $534 million in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the fair value of economically hedged marketable debt investments decreasing from $17.1 billion in 2023 to $13.5 billion in 2024, and the $464 million net losses recorded in 2024. However, it incorrectly states that Intel recorded net gains of $534 million in 2023, which contradicts the ground truth that focuses on 2022 losses of $748 million and does not mention 2023 gains. This introduces a significant factual error. Additionally, the original answer emphasizes the evolution from 2022 to 2024, but the LLM skips 2022 data entirely and misrepresents 2023 performance. (2) The dollar amounts for 2023 and 2024 fair values are accurate ($17.1B and $13.5B), and the $3.6B difference is correctly calculated. However, the claim about $534 million net gains in 2023 is unsupported by the ground truth and conflicts with the documented trend. The 2022 loss of $748 million is omitted, breaking the multi-year comparison requested. (3) The reasoning partially captures the portfolio size reduction but fails the full multi-hop synthesis by neglecting the 2022 data point and introducing an incorrect 2023 gain figure. The comparison should have been between 2022 and 2024, with 2023 as intermediate context, but instead shifts focus incorrectly. (4) Despite the factual inaccuracies, the answer remains contextually relevant by addressing Intel's hedged investments and their fair value changes. The structure follows the question's intent, but the quantitative and qualitative errors—especially the fabrication of 2023 gains—reduce overall correctness. Hence, a score of 6 reflects partial accuracy with significant gaps in data fidelity and multi-year synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 473,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "From 2023 to 2024, AMT's financial focus regarding communications sites evolved with a continued emphasis on recurring revenue generation, as the majority of its tenant leases have multiyear terms and include rent escalations. In 2024, AMT highlighted the importance of maintaining these recurring revenues to sustain operating cash flows and achieve operating efficiencies. Additionally, AMT addressed asset retirement obligations, noting an estimated $4.5 billion in undiscounted future cash outlay for site remediation as of December 31, 2024, reflecting an ongoing commitment to managing long-term liabilities associated with its communications infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key elements from the ground truth: recurring revenue generation as a continued focus and the $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. The quantitative values (dollar amount and date) are accurate and match the original answer exactly. (2) The $4.5 billion figure and the December 31, 2024 date are correctly reported, with no calculation errors. Format is consistent and precise. (3) The multi-hop reasoning is sound—synthesizing AMT’s shift from emphasizing revenue in 2023 to also addressing long-term liabilities in 2024. While the LLM does not explicitly restate the 99% of revenues from property operations mentioned in the original answer, it captures the essence of recurring revenue through references to multiyear leases and rent escalations, which supports the same conclusion. (4) The answer is contextually fully relevant and conveys the evolution in financial focus. The only minor shortcoming is the absence of the specific 99% revenue figure from property operations in 2023, which slightly reduces completeness but does not undermine the overall correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 373,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "Between 2023 and 2024, XOM's strategic positioning in Guyana evolved under the legal framework established by the Petroleum Activities Act 2023, which provides for an exploration period of up to 10 years and a production period of 20 years for oil fields, each with a renewal period of up to 10 years. This legal operating framework likely supported XOM's continued growth emphasis in Guyana, as the country remains a key asset in its advantaged volume growth strategy, particularly in the context of high-value oil production. The stability and clarity of the regulatory environment in Guyana would have facilitated XOM's long-term investment and operational planning in the region.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the Petroleum Activities Act 2023 and accurately describes its provisions — exploration up to 10 years, production period of 20 years, and renewal up to 10 years — which matches the ground truth exactly. All legal framework details are factually correct. However, the LLM answer misses a key strategic evolution stated in the original answer: that by 2024, Guyana was explicitly classified as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver. While the LLM mentions Guyana being part of an 'advantaged volume growth strategy,' it does not clearly convey the formal categorization shift in XOM's strategic portfolio, which is central to the question. (2) Quantitative accuracy is perfect: all dates (2023), time periods (10, 20, 10 years), and legal terms are correct and match the ground truth. No calculations were required. (3) The multi-hop reasoning is partially sound — the model connects the legal framework to business stability and growth, but fails to explicitly synthesize the shift from a regulatory environment to a formal strategic repositioning within XOM’s asset hierarchy. The evolution from 'jurisdiction with defined terms' to 'core growth asset' is underdeveloped. (4) Correctness is scored 7 due to accurate facts but missing key strategic nuance; qualitative accuracy is 7 due to incomplete reasoning synthesis; quantitative accuracy is 10 as all numbers/dates are correct; contextual relevance is 9 as the response is highly relevant but omits a critical strategic update from 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 435,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Caterpillar's involvement in the diesel-electric locomotives business remained a core part of its Energy & Transportation segment in both 2023 and 2024, with responsibilities including manufacturing, remanufacturing, and providing related rail services. In 2024, the segment reported a 3% increase in total sales compared to 2023, driven by favorable price realization, with transportation sales rising due to growth in marine and rail services. This indicates a strategic focus on expanding service offerings and maintaining a strong market position in rail-related solutions.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key aspects of Caterpillar's strategic evolution in the diesel-electric locomotives business. While it correctly identifies Caterpillar's involvement in rail services and manufacturing/remanufacturing, it fails to capture the shift described in the ground truth from a broader ME&T segment focus in 2023 to a more targeted integration with electrified powertrains and zero-emission technologies in 2024. The answer introduces a 3% sales increase in the Energy & Transportation segment with growth in marine and rail services, which is not present in the original answer and cannot be verified from the provided ground truth. (2) Quantitatively, the 3% sales increase and claim about transportation sales growth are unsupported by the original answer, which contains no financial figures or performance metrics. This introduces unverified data, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound in linking Caterpillar to rail services across years, but it fails to synthesize the strategic pivot toward integrated systems and environmentally focused technologies, which is central to the question about strategic positioning and operational responsibilities. The LLM focuses on financial performance not mentioned in the ground truth instead of the qualitative strategic shift. (4) Despite the introduction of unsupported numbers, the answer remains contextually relevant by addressing Caterpillar’s locomotive involvement and service offerings. However, the omission of the key strategic shift toward electrification and zero-emission power sources—highlighted in the original answer—results in a significant gap in qualitative and overall correctness, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 484,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "The company's reliance on securitized debt obligations as a funding source increased from $12.4 billion in 2022 to $14.3 billion in 2024. This indicates a growing emphasis on securitization programs as part of its funding strategy, likely to diversify funding sources and manage liquidity needs alongside deposit growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its quantitative claims. The ground truth states that in 2022, the company did not disclose an exact amount raised through securitized debt obligations, but the LLM incorrectly asserts a specific figure of $12.4 billion. This number is not supported by the original data and represents a fabrication. In 2024, the correct carrying value is $14,264 million ($14.264 billion), which the LLM approximates as $14.3 billion—this is reasonably close and acceptable under format variation. However, the false precision in 2022 undermines the quantitative integrity. (2) The calculation of change from 2022 to 2024 is therefore invalid, as it compares a made-up number to a real one. No actual year-over-year comparison can be made due to lack of 2022 data. (3) The reasoning partially captures the strategic implication—increased reliance on securitized debt and structured financing—but draws this conclusion from incorrect data. The multi-hop synthesis fails because it assumes a numeric trend that cannot be verified from the source. (4) While the general direction of the conclusion (growing emphasis on securitization) aligns with the ground truth’s interpretation of increased definition and potential reliance, the faulty foundation reduces qualitative accuracy. Contextual relevance is high as the answer addresses both parts of the question—evolution over time and strategic implication—using appropriate financial terminology and framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 417,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "Between 2023 and 2024, McDonald's treatment of developmental licensees remained largely consistent in financial reporting, with royalties and initial fees continuing to be recognized based on a percentage of sales and performance obligations, respectively. However, the adoption of ASU 2023-07 in 2024 introduced enhanced segment disclosures, which likely improved transparency around developmental licensee contributions. Relationship management also showed continuity, with McDonald's maintaining its focus on supporting developmental licensees through strategic growth initiatives, as evidenced by increased capital expenditures and the refinement of lease renewal assumptions to reflect expected growth under the Restaurant Development pillar.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but introduces significant inaccuracies. It correctly notes continuity in royalty and initial fee structures between 2023 and 2024, which aligns with the ground truth. However, it incorrectly attributes changes to 'ASU 2023-07' and 'enhanced segment disclosures,' which are not mentioned or supported in the original answer. There is no mention in the ground truth about capital expenditures, lease renewal assumptions, or strategic growth initiatives related to developmental licensees. Instead, the actual evolution involves McDonald's evaluation of variable interest entities and a change in rounding presentation to the nearest whole number in 2024—details entirely missing from the LLM response. (2) No specific numbers (e.g., percentages, dollar amounts) are provided in either the question or ground truth, so quantitative accuracy is not heavily penalized, but the introduction of unverified standards (ASU 2023-07) undermines factual precision. (3) The multi-hop reasoning is flawed: the LLM fabricates accounting standard updates and operational changes not present in the source, failing to correctly synthesize the actual evolution in financial reporting (rounding changes, VIE assessment). It also misses the key point about allocation of consideration using historical methods in 2023 and the conclusion that consolidation was not appropriate in 2024. (4) While the answer stays relevant to the topic of developmental licensee treatment and attempts to compare years, it substitutes real developments with plausible-sounding but incorrect information, leading to a moderate score for contextual relevance but low scores for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 472,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "Between 2023 and 2024, Southern Company's Equity and Incentive Compensation Plan saw a slight decrease in share availability, from 26.9 million shares reserved at the end of 2023 to 26.8 million shares in 2024. Additionally, the 2024 disclosures indicate updates to executive award structures, including amendments to deferred compensation agreements and new provisions for named executive officers under the 2021 plan, reflecting ongoing adjustments to align with evolving regulatory and internal governance standards.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2024, Southern Company increased transparency by disclosing specific terms for Named Executive Officer awards under the 2021 plan, but it does not mention a decrease in share availability to 26.8 million. In fact, the original answer highlights 26.9 million shares available in 2023 and implies continued availability in 2024 without stating a reduction. The claim of a drop to 26.8 million is unsupported and contradicts the ground truth. Additionally, the LLM introduces 'amendments to deferred compensation agreements' and 'new provisions' not present in the original answer, adding speculative details. (2) Quantitatively, the 26.9 million figure is correct for 2023, but the 26.8 million figure for 2024 is incorrect—no such number appears in the ground truth. There is no indication of a decrease, so this represents a clear numerical error. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the 2021 plan and attempts to discuss executive award disclosures, it misrepresents the evolution as a quantitative reduction in shares and structural amendments rather than a shift from internal reserve planning to enhanced transparency. The core evolution described in the original—increased disclosure and formalized governance—is missed. (4) Despite the factual errors, the response is contextually relevant, addressing share availability and executive award disclosures as asked. However, the incorrect numbers and invented details severely undermine correctness, warranting a low score. The qualitative reasoning shows some understanding of compensation plan dynamics but fails to accurately synthesize the actual progression.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 478,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Between 2022 and 2023, Inlyta's revenue increased by 3% globally, with a 5% rise in the U.S. and a 7% operational increase in international markets. The growth in the U.S. was driven by the adoption of combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced RCC, while international growth was attributed to continued expansion in emerging markets. However, this growth was partially offset by lower volumes and reduced net pricing in certain European markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details. According to the ground truth, Inlyta's global revenue grew by 3% in total with a 5% operational growth in 2023—however, the LLM incorrectly states a 5% rise in the U.S. and a 7% operational increase internationally, which are not supported by the original answer. The original does not break down U.S. and international growth percentages in this way, nor does it mention '7% operational increase in international markets.' Additionally, the LLM invents a 7% figure not present in the source. (2) The only correct quantitative element is the 3% total global revenue increase and the $1,036 million revenue figure (implied by context, though not explicitly restated). However, the breakdown into U.S. and international components is fabricated. (3) Qualitatively, the reasoning is mostly sound: the LLM correctly identifies the key driver of growth—the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S.—and acknowledges offsetting pressures from lower volumes and net pricing in Europe. It also correctly frames the growth as ongoing but moderated. The mention of 'emerging markets' as a driver for international growth is plausible but not specified in the original, representing an unsupported addition. (4) Contextual relevance is high, as the answer addresses both parts of the question—revenue evolution and contributing factors—and maintains focus on Inlyta’s performance across 2022–2023. However, the incorrect numerical breakdowns significantly undermine factual reliability, warranting a moderate correctness score of 6 due to partial accuracy with key errors in multi-hop quantitative synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 478,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "From 2023 to 2024, McDonald's relationship with its franchisees evolved in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms. The Company recognizes revenue from franchisees for technology platforms on a gross basis, as it is the principal in these arrangements, with related expenses recognized as incurred. Additionally, franchisees pay fees to recover a portion of the costs incurred by the Company for these platforms, indicating a shared financial responsibility. This structure reflects a continued emphasis on collaboration and cost-sharing between McDonald's and its franchisees for technological advancements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments from 2023 to 2024. It accurately identifies the shift in revenue recognition for technology platforms to a gross basis and notes the cost-sharing mechanism where franchisees pay fees to recover company-incurred costs, which reflects the increased financial interdependence. The answer correctly states that McDonald's acts as the principal in these arrangements, justifying gross revenue recognition, and links this to shared financial responsibility—consistent with the 2024 evolution described in the original answer. However, the LLM omits the explicit contrast between 2023 and 2024: while it mentions the 2024 structure, it does not clearly articulate how the 2023 model was more traditionally based on rent, royalties, and fees without the integrated cost-sharing for technology. Additionally, the LLM does not mention that related expenses are recorded in 'Other restaurant expenses,' a specific financial detail that reinforces the operational integration. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect figures are presented), and the reasoning is sound, though slightly less comprehensive in comparative analysis. The response remains contextually relevant and semantically aligned with the core facts, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 385,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives held by Southern Company's subsidiaries decreased from $199 million (assets) and $210 million (liabilities) in 2022 to $55 million (assets) and $358 million (liabilities) in 2023. This indicates an increase in the company's net exposure to energy market fluctuations, as the liabilities grew significantly relative to the assets, suggesting a higher potential financial impact from changes in energy prices.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. In 2022, the total assets and liabilities reported in the ground truth are not $199M and $210M as claimed. Correct calculation from ground truth: 2022 total assets = $59M (Mississippi Power) + $8M (Southern Power) + $28M (Southern Company Gas) = $95M; total liabilities = $32M + $12M + $65M = $109M. Thus, net liability = $109M - $95M = $14M, not the $54M stated in the original answer — however, the original answer states a net liability of $54M, which appears to be an internal inconsistency. But the LLM’s $199M assets and $210M liabilities are completely unsupported by the data. For 2023, the LLM claims $55M in assets and $358M in liabilities. Ground truth: Alabama Power ($15 assets, $110 liabilities), Georgia Power ($13 assets, $124 liabilities). Total assets = $28M, total liabilities = $234M. The LLM’s figures are therefore incorrect — it overstates both assets and liabilities. (2) Calculations are flawed: the LLM implies a net liability increase from $11M ($210M - $199M) to $303M ($358M - $55M), but correct net liability evolution is from $14M to $206M. While the direction (increase in net liability) is correct, the magnitude is wrong. (3) Multi-hop reasoning is partially sound — the LLM recognizes the need to aggregate across subsidiaries and years and draws a reasonable qualitative conclusion about increased exposure. However, it uses incorrect entity data: it omits Mississippi Power, Southern Power, and Southern Company Gas in 2023, and incorrectly includes Alabama and Georgia Power in the 2022 calculation (which were not mentioned for that year in the original). Also, the subsidiaries reported in 2022 vs 2023 are different, suggesting a change in reporting entities, which the LLM fails to acknowledge. (4) Despite incorrect numbers, the answer captures the directional trend (increasing net liability) and correctly infers greater exposure to energy market fluctuations, which saves it from a lower score. Contextual relevance is high as it directly addresses both parts of the question. However, quantitative accuracy is low due to fabricated totals, and qualitative accuracy is reduced by incorrect entity mapping and incomplete synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 608,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "The Procter & Gamble 2019 Stock and Incentive Compensation Plan's significance and treatment evolved from 2022 to 2024 as reflected in the 10-K filings. In 2022, the plan had 119 million shares available for future issuance, with full value awards (like RSUs and PSUs) counted as five shares for each share awarded. By 2024, the available shares had decreased to 77 million, indicating that a significant portion of the plan's share capacity had been utilized over the two-year period. This reduction highlights increased usage of the plan for granting equity-based incentives to employees and executives during that time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative data—119 million shares available in 2022 and 77 million in 2024—that are not present in the original answer (ground truth). These numbers, while plausible, cannot be verified against the provided ground truth, which contains no such figures. Therefore, the quantitative claims are ungrounded and likely hallucinated. (2) There is no mention in the ground truth of share counts, full value awards, or share utilization calculations, so the core of the LLM's argument (reduction from 119M to 77M shares showing increased usage) is unsupported. This severely undermines quantitative accuracy. (3) The qualitative reasoning attempts multi-hop synthesis by inferring increased significance due to share usage, but the actual evolution described in the ground truth is about disclosure context—transition from a newly introduced plan with detailed shareholder approval notes to being listed among standard equity plans. The LLM misses this narrative shift entirely and instead fabricates a usage-based evolution. (4) Contextually, the LLM stays on topic—discussing the plan’s treatment over time in 10-Ks—and correctly identifies it as part of equity compensation, so relevance is moderate. However, it fails to capture the actual evolution in disclosure significance and formal integration into PG's compensation framework as described in the ground truth. Thus, while the answer is structurally coherent, it is factually misaligned with the source truth, resulting in a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 427,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "From 2023 to 2024, Southern Company's approach to managing the risk of large losses in its pension plan assets remained focused on diversification and formal rebalancing programs but showed a slight shift in emphasis toward alternative investments. In 2023, the asset allocation emphasized equities (41%) and fixed income (30%), with alternative investments such as real estate, private equity, and private credit comprising 24% of the portfolio. By 2024, the allocation to equities slightly decreased to 40%, while fixed income remained stable at 31%. However, the share of alternative investments increased to 27% (real estate 13%, private equity 12%, and private credit 1%). This shift suggests a growing emphasis on diversifying into non-traditional, lower-correlation assets to further mitigate risk and enhance long-term returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of the actual evolution of Southern Company's risk management approach. The original answer states that the key change from 2023 to 2024 was a reduced emphasis on external investment manager oversight and a greater focus on market-driven risks like volatility and interest rates. However, the LLM answer fabricates a narrative about a shift toward alternative investments, which is not supported by the ground truth. The specific allocation percentages (e.g., equities 41% in 2023, 40% in 2024; alternatives increasing from 24% to 27%) are not present in the original answer and are therefore factually inaccurate. (2) Quantitative accuracy is low because the numbers cited (asset allocations by category) do not appear in the ground truth and cannot be verified. There are no calculations in the original answer to validate, but the LLM invents precise figures without basis, which constitutes a serious factual error. (3) The multi-hop reasoning is flawed. The question asks about changes in risk management emphasis, particularly regarding large losses. The correct reasoning should compare risk governance mechanisms (e.g., oversight, rebalancing, market risk linkage) across years. Instead, the LLM incorrectly infers that portfolio allocation shifts reflect risk management evolution, missing the actual qualitative shift in emphasis described in the original answer. (4) Contextual relevance is moderate because the LLM stays within the domain of pension risk management and discusses related concepts like diversification and rebalancing. However, it fails to address the actual shift in risk management philosophy, focusing instead on fabricated asset allocation data. As a result, the core of the answer is misaligned with the ground truth, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 500,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "NVIDIA's role in the development and supply of the CUDA platform between 2022 and 2023 has evolved from being a foundational component of its GPU-based computing solutions to becoming a central pillar of its broader full-stack computing infrastructure strategy. In 2022, CUDA was highlighted as a key enabler for parallel processing in applications like AI, data analytics, and scientific computing. By 2023, CUDA's role expanded to support not only GPUs but also new processor classes like DPUs and CPUs, emphasizing NVIDIA's push toward data-center-scale solutions. This shift indicates a strategic focus on unifying hardware and software ecosystems to dominate AI, HPC, and enterprise markets, leveraging CUDA as a core differentiator across diverse industries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of NVIDIA's role in CUDA from 2022 to 2023: in 2022, CUDA was a foundational component (supplier/enabler role), and by 2023, it became central to a full-stack strategy (developer/integrator role). The strategic focus on unifying hardware and software ecosystems matches the ground truth's emphasis on strengthening a full-stack computing platform. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only years (2022, 2023), which are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes CUDA’s expanded role across new processor types (DPUs, CPUs) and links it to NVIDIA’s broader strategic goals in AI, HPC, and enterprise markets, which reflects an accurate understanding of the platform’s integration into domain-specific frameworks and data center-scale solutions. (4) While the LLM uses slightly different phrasing (e.g., 'central pillar' vs. 'developer'), the semantic meaning is equivalent and captures the core shift from supply to strategic development. The only minor gap is that the LLM does not explicitly mention 'CUDA-X libraries, APIs, and domain-specific frameworks' as in the original, but it does refer to 'broader full-stack computing infrastructure' and 'unifying hardware and software ecosystems,' which encompass those elements. Thus, the answer is complete and contextually precise, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 418,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "Between 2022 and 2023, Pfizer's financial relationship with Viatris remained structured through supply agreements and transitional services, with no material financial impact on Pfizer's operations. As of December 31, 2023, the net amounts due to Viatris under these agreements were $33 million, compared to $94 million as of December 31, 2022, indicating a significant reduction in outstanding balances. These agreements primarily involved manufacturing, supply, and transitional services, with most services under transitional service agreements (TSAs) completed by the end of 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the reduction in net amounts due to Viatris from $94 million as of December 31, 2022, to $33 million as of December 31, 2023, which matches the ground truth exactly. It also accurately notes that most transitional services under the TSAs were completed by the end of 2023, indicating reduced operational ties. However, the LLM omits the key 2022 revenue growth figure of $780 million from PC1 related to manufacturing legacy Upjohn products for Viatris, which is a significant part of the financial relationship evolution. This omission affects completeness and qualitative accuracy. (2) All numeric values and dates are correct and properly formatted; no calculation errors. (3) The reasoning is sound in interpreting the declining balance and TSA completion as signs of reduced interdependence, but fails to incorporate the earlier revenue contribution from the supply agreement, weakening the multi-hop synthesis between 2022 revenue and 2023 balance trends. (4) Despite the omission, the answer remains factually accurate where it speaks, addresses the evolution in outstanding balances fully, and correctly identifies the nature of the agreements, warranting high scores in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 357,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "Between 2023 and 2024, the treatment and disclosure of communications sites in relation to debt obligations show a continued emphasis on securitization structures and cash flow management. In 2023, the Company disclosed securitization transactions, such as the 2023 Securitization, where cash flows from communications sites were used to service secured debt, with excess cash distributed subject to debt service coverage ratios (DSCR). By 2024, the disclosures expanded to include more detailed DSCR thresholds (e.g., 1.30x Cash Trap DSCR and 1.15x Minimum DSCR), which determine when excess cash flow is retained in reserve accounts or distributed. Additionally, 2024 disclosures highlighted the risk of cash flow restrictions during amortization periods and the potential for default actions, such as foreclosure on secured communications sites, if DSCR thresholds are not met.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some relevant context about securitization and debt service coverage ratios (DSCR), but it diverges significantly from the ground truth in key factual and quantitative aspects. (1) The original answer highlights a shift from explicit, site-specific collateral disclosures in 2023 (e.g., 3,343 communications sites securing Series 2015-2 Notes and $1.3 billion repayment via 2023 Securitization) to broader financial obligations in 2024 (e.g., $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations). The LLM answer does not mention these specific numbers or the shift from site-specific to general obligations. Instead, it introduces detailed DSCR thresholds (1.30x and 1.15x) and concepts like 'Cash Trap DSCR' and 'amortization periods' that are not present in the original answer and cannot be verified against the ground truth. (2) Quantitatively, the LLM fails to report any of the key figures from the original: no mention of 3,343 sites, $1.3 billion repayment, or $4.5 billion future outlay. These omissions represent major factual gaps. The DSCR values cited may be accurate in some filings, but they are not part of the documented evolution in the ground truth. (3) The multi-hop reasoning is partially sound—linking communications sites to debt via securitization is valid—but the conclusion about 'expanded disclosures' in 2024 misrepresents the actual trend described in the original answer, which is a move away from site-specific disclosures. (4) Contextually, the answer is relevant to debt and communications sites, but it emphasizes risk management mechanics rather than the evolution in disclosure practices. This results in a partially correct but misleading narrative. The core evolution—shift from specific collateralization to generalized obligations—is missed entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 499,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "Comcast's approach to retransmission consent agreements between 2022 and 2023 remained largely consistent in terms of revenue recognition, with fees under these agreements typically recognized monthly as programming is provided. In 2023, there was a continued emphasis on distribution of programming to both traditional and virtual multichannel video providers, with revenue based on subscriber counts or fixed fees. Additionally, the 2023 filing highlighted the importance of these agreements in the context of evolving distribution models, including the integration of streaming platforms like Peacock, reflecting a broader shift toward digital and hybrid distribution strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: revenue recognition remained monthly in both years, tied to subscriber counts or fixed fees, and collected within typical timeframes (implied). The evolution toward including both traditional and virtual multichannel video providers in 2023 is correctly noted. The integration of Peacock into distribution models is accurately mentioned as a strategic shift. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no incorrect figures were introduced. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in distribution models across 2022 and 2023, identifying continuity in revenue recognition while highlighting strategic evolution in distribution. The only minor shortcoming is that the LLM slightly downplays the explicit shift in 2023 to *explicitly include* virtual MVPDs in retransmission fee structures, which was a new emphasis in the 2023 filing. Also, the original answer notes that the 2023 filing 'highlighted a broader integration of Peacock,' whereas the LLM says 'highlighted the importance... including integration,' which is slightly less precise but still semantically close. (4) Contextual relevance is perfect—the response directly addresses both revenue recognition and distribution model changes. Overall, the answer captures the core evolution accurately with only minor nuance missing, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 433,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives in 2024 remains consistent with its 2023 activities, as both the 2023 and 2024 10-K filings describe the Energy & Transportation segment as including diesel-electric locomotives and related rail products and services. In 2024, the company continues to compete globally in rail-related businesses with firms like Wabtec Corp and Alstom SA, emphasizing integrated systems and solutions. There is no indication of significant changes in production or strategic positioning between 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that Caterpillar's involvement remained consistent between 2023 and 2024. The ground truth shows a clear evolution: in 2023, diesel-electric locomotives were part of the ME&T segment with a focus on remanufacturing and support, while in 2024, the company explicitly stated it 'produces' diesel-electric locomotives under the Energy & Transportation segment, indicating a strategic shift. The LLM incorrectly claims no significant change, which contradicts the ground truth. (2) There are no numeric values in the response or ground truth, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the model failed to detect the segment reorganization (from ME&T to Energy & Transportation) and the shift in language from operational inclusion to active production. It also incorrectly names Alstom SA as a competitor in 2024, while the ground truth specifies Siemens Mobility A/S, indicating an entity error. (4) Contextual relevance is moderate—the response addresses the right topic and timeframe but misses the core evolution the question asks about. Due to major factual and reasoning errors, the correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 358,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees in terms of revenue recognition and cost-sharing arrangements remained largely consistent, with some notable developments. Revenue recognition for franchisees continued to include royalties based on a percentage of sales, minimum rent payments, and initial fees, with these revenues recognized at the time of the underlying sales or over the franchise term. Additionally, the Company provided goods or services related to technology platforms to franchisees, recognizing such revenue on a gross basis as the services were transferred. \n\nIn 2024, the Company acquired additional restaurants from franchisees, including 228 in Israel, to support franchising initiatives. These acquisitions added goodwill and intangible assets but did not significantly impact revenues or net income. The Company also shared costs for certain restaurant improvements with franchisees, with costs allocated between property and equipment and accounts receivable during project execution. Overall, the structure of revenue recognition and cost-sharing with franchisees remained stable, though the Company's strategic acquisitions in 2024 slightly altered the composition of its franchised and company-operated restaurant mix.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions and one potentially extraneous detail. (1) Correct elements: The core revenue recognition model (royalties, rent, initial fees) is accurately described for both years, and the 2024 change in recognizing technology platform fees on a gross basis is correctly noted. The cost-sharing arrangement for restaurant improvements, including allocation between property and equipment and accounts receivable during project execution, is also accurately reflected. (2) Quantitative accuracy: The mention of 228 restaurants acquired in Israel is a specific number; however, this detail is not present in the original answer and cannot be verified from the provided ground truth. Since it does not contradict the ground truth but adds unverified information, it slightly affects precision. No other numbers (e.g., financial amounts, percentages) are mentioned, so no calculation errors exist. (3) Multi-hop reasoning: The model correctly synthesizes changes between 2023 and 2024, noting consistency in revenue recognition while highlighting enhanced disclosure and transparency in 2024. However, it misses the explicit point that the 2024 filing provided *more detailed disclosures* as a shift toward transparency—a qualitative evolution emphasized in the original answer. (4) Contextual relevance: The answer stays focused on revenue recognition and cost-sharing, though the acquisition of restaurants, while contextually related to franchisee relationships, pertains more to operational mix than revenue or cost-sharing mechanics. Overall, the answer captures the key developments accurately but omits the emphasis on improved disclosure transparency and introduces a potentially irrelevant acquisition detail, justifying a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 495,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "Between 2023 and 2024, Southern Company updated its executive equity compensation approach by amending plan documentation, particularly with the Southern Company Equity and Incentive Compensation Plan and the Southern Company Employee Savings Plan. In 2024, the Employee Savings Plan was amended for the ninth time, dated December 16, 2024, indicating ongoing adjustments to savings and deferred compensation structures. Additionally, new or revised change-in-control protections and severance plans were implemented, including the Amended and Restated Southern Company Change in Control Benefits Protection Plan and the Senior Executive Change in Control Severance Plan, both effective August 15, 2022, suggesting a focus on aligning award terms with executive retention and transition strategies.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and fails to correctly address the core aspects of Southern Company's evolution in executive equity compensation between 2023 and 2024. (1) It incorrectly references the 'Southern Company Employee Savings Plan' being amended in December 2024, which is unrelated to equity compensation and not mentioned in the ground truth; the focus should be on the Equity and Incentive Compensation Plan. (2) It cites change-in-control plans effective August 15, 2022—dates and plans that predate both 2023 and 2024 and are not part of the documented shift in equity award terms. (3) The ground truth emphasizes increased structuring and documentation of Named Executive Officer awards under the same plan, including specific exhibit designations for award terms in 2024, which the LLM answer omits entirely. (4) The LLM introduces irrelevant elements (e.g., ninth amendment to savings plan, severance plans) that do not reflect the shift toward greater specificity and transparency in equity award documentation. While the mention of the Equity and Incentive Compensation Plan is correct, the reasoning is flawed and misaligned with the actual evolution described. The answer fails the multi-hop requirement to compare plan documentation and award terms across 2023 and 2024 with accurate entity and temporal alignment. Quantitative accuracy is partially preserved with correct dates only insofar as they appear in filings, but their relevance and context are incorrect. Overall, the answer is partially relevant but factually and conceptually deficient.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 434,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "Procter & Gamble's strategic reliance on membership club stores has decreased from 2022 to 2024, as the company has shifted focus toward a more diversified retail strategy. In 2022, membership club stores were explicitly listed among key customers, but by 2024, the emphasis had shifted toward broader omnichannel retail execution, including e-commerce and social commerce, as well as enhancing value across all price tiers. This shift indicates a broader strategy to adapt to evolving consumer preferences and market dynamics, prioritizing digital engagement and expanding presence in high-growth retail formats beyond traditional membership clubs.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that P&G's reliance on membership club stores *increased* from 2022 to 2024, with language shifting from identifying them as one of many key channels to emphasizing *dependency* on them. In contrast, the LLM claims reliance has *decreased*, which directly contradicts the original answer. This fundamental error undermines the entire response. (2) There are no numeric values, percentages, or dollar amounts in either the question or answers, so quantitative accuracy is not applicable—no numerical errors were made, hence a score of 10. (3) The multi-hop reasoning is flawed: the question requires synthesizing how P&G’s characterization of membership club stores evolved across two time points (2022 vs 2024) and interpreting the strategic implication. The LLM incorrectly infers a de-emphasis based on broader omnichannel language, but the ground truth indicates that despite broader strategies, the specific focus on membership clubs intensified. The model fails to correctly interpret the shift in strategic emphasis. (4) Contextual relevance is moderate—the response addresses retail channel strategy and mentions relevant formats like e-commerce and social commerce, showing understanding of the domain. However, the central conclusion is inverted from the truth, leading to a low correctness and qualitative accuracy score despite appropriate framing and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 406,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "AMT's involvement with Nigeria Letters of Credit indicates a reduction in financial obligations between 2023 and 2024. As of December 31, 2023, the Nigeria Letters of Credit had a carrying value of $3.4 million, but by December 31, 2024, this amount was fully repaid, resulting in a carrying value of $0. This suggests that AMT either settled these obligations or they were no longer outstanding by the end of 2024, indicating a decrease in related financial liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.4 million obligation in 2023 and $0 in 2024, matching the ground truth exactly in both amount and timing (December 31, 2023 and 2024). The conclusion that the obligation was fully repaid or no longer outstanding aligns with the original answer's claim of full settlement or exit. (2) All numeric values are accurate: $3.4 million and $0 carrying value are correctly reported, with proper time references. No calculations are required beyond comparison, which is handled correctly. (3) The multi-hop reasoning is sound—connecting the change in carrying value over time to a reduction in financial liability demonstrates correct synthesis across years and instruments. The only minor gap is that the LLM does not explicitly mention the instrument being part of the 'variable rate debt portfolio,' a detail present in the original answer, but this does not affect the core conclusion about obligation status. (4) The answer is semantically equivalent, contextually complete, and highly relevant. The slight omission of 'variable rate debt' context prevents a perfect 10 on qualitative accuracy, but all key facts and implications are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 339,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "Between 2022 and 2024, the valuation methodology for General Dynamics' (GD) Retirement Annuity Contracts remained consistent, as these assets were still classified under Level 3 of the fair value hierarchy, indicating they are valued using significant unobservable inputs. However, the composition of these assets changed, with their fair value decreasing from $38 million in 2022 to $22 million in 2024. This reduction suggests a possible reallocation or reduction in the company's exposure to these less transparent, illiquid investments, reflecting a more conservative or risk-mitigated approach to managing retirement plan assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the valuation methodology remained consistent, but the ground truth states there was a clear shift: in 2024, Retirement Annuity Contracts were valued using NAV as a practical expedient and excluded from the formal fair value hierarchy, despite still being associated with Level 3. This is a major change in reporting approach, not a consistency. Additionally, the LLM reports a fair value of $38 million in 2022 and $22 million in 2024, but the ground truth states $35 million as of December 31, 2021, and $38 million as of December 31, 2020 — no data for 2022 or 2024 is provided in the original answer, so the LLM fabricated values. (2) Quantitative accuracy is very low: the dollar amounts and years are incorrect or unsupported. The original answer does not provide 2022 or 2024 values, so asserting $38M in 2022 and $22M in 2024 is factually wrong. (3) The multi-hop reasoning is flawed: the LLM failed to identify the key methodological shift (use of NAV as practical expedient and exclusion from fair value hierarchy), which is central to the question. Instead, it incorrectly asserts methodological consistency and invents a narrative about risk mitigation based on false numerical trends. (4) Contextual relevance is moderate because the answer addresses the right topic (valuation of Retirement Annuity Contracts) and company (GD), and attempts to interpret implications, but the conclusions are based on incorrect data and reasoning. The qualitative accuracy is low because the entity (GD) and general concept (Level 3 assets) are correct, but the core insight about reporting methodology change is missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 463,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "The composition and value of restricted cash for securitization investors as of December 31, 2024, was $441 million, classified entirely under Level 1 of the fair value hierarchy, as shown in Table 17.6 of the 2024 filing. In 2022, the restricted cash for securitization investors was $458 million, also classified entirely under Level 1, as noted in the 2023 data of the same table. Thus, the fair value hierarchy classification for restricted cash remained consistent between 2022 and 2024, with no changes in the level of classification.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that in 2024, restricted cash for securitization investors was $441 million and classified entirely as Level 1, it incorrectly claims that in 2022 the amount was $458 million and also classified as Level 1. The ground truth states that in 2022, the fair value hierarchy classification was not explicitly detailed, so asserting a Level 1 classification for 2022 is incorrect. Additionally, the $458 million figure is not mentioned in the original answer and contradicts the implied trend of a shift toward Level 1 classification by 2024. (2) Quantitative accuracy is partially correct for 2024 ($441 million) but incorrect for 2022 (no specific dollar amount provided in ground truth; $458 million is unsupported). The comparison between years is therefore based on flawed data. (3) The multi-hop reasoning is unsound because the LLM fails to recognize that the key change highlighted in the original answer is the increased transparency and explicit Level 1 classification in 2024, whereas in 2022 this detail was absent. Instead, the LLM incorrectly concludes there was no change, undermining the core insight. (4) Contextual relevance is moderate because the answer addresses the right topic and metric, but the incorrect data and conclusion reduce its usefulness. The reference to 'Table 17.6' suggests overconfidence in a source not mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 405,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management as follows:\n\n1. **Financial Recognition**: McDonald's continued to recognize royalty revenues and initial fees from franchisees based on a percentage of sales and over the franchise term, respectively. Additionally, the Company recognized revenue from technology platforms provided to franchisees on a gross basis, as it determined it was the principal in these arrangements. The adoption of ASU 2023-07 in 2024 enhanced segment disclosures, providing more detailed information about significant segment expenses related to franchise operations.\n\n2. **Asset Management**: McDonald's acquired additional restaurants from franchisees in 2024, particularly in the International Developmental Licensed Markets segment, which resulted in increased goodwill and tangible assets. The Company also continued to share in the cost of certain restaurant improvements with franchisees, allocating these costs between property and equipment and accounts receivable. These acquisitions and cost-sharing arrangements reflect a strategic focus on expanding Company-owned operations while maintaining strong relationships with franchisees.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but significantly misrepresents the evolution of McDonald's relationship with franchisees between 2023 and 2024. (1) Correctly identifies that McDonald's recognizes revenue from technology platforms on a gross basis, which aligns with the 2024 shift in the original answer. However, it incorrectly states that restaurant acquisitions from franchisees continued or increased in 2024, when the ground truth indicates that 2023 was characterized by such acquisitions (with associated goodwill write-offs), while 2024 marked a shift away from asset acquisition toward service-based interactions. The LLM implies ongoing or expanded acquisitions in 2024, which contradicts the transformation described in the original answer. (2) The mention of ASU 2023-07 and enhanced disclosures is plausible but not present in the ground truth and does not address the core financial model shift. There are no specific numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily penalized, but the directional facts (acquisition vs. service shift) are incorrect. (3) The multi-hop reasoning fails: the model does not correctly synthesize the transition from asset-heavy transactions (2023) to service-based financial recognition (2024). Instead, it portrays both acquisition and service models as coexisting or expanding in 2024, missing the fundamental shift. (4) Contextual relevance is moderate because the answer discusses financial recognition and asset management in relation to franchisees, but the core evolution is misrepresented. The original answer emphasizes a structural shift from goodwill-driven asset management to dependency on technology services; the LLM answer misses this narrative entirely, focusing instead on continued expansion of company-owned operations. Thus, while some terminology is accurate, the overall correctness is low due to factual and conceptual errors in the evolution described.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 533,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "The 2019 Stock and Incentive Compensation Plan remains the primary vehicle for equity compensation at Procter & Gamble, as evidenced by its exclusive authority for future grants in both 2022 and 2024 disclosures. In 2022, the plan had 119 million shares available for future issuance, while by 2024, this number had decreased to 77 million shares, reflecting ongoing use of the plan for awards. The plan continues to govern both stock options and full-value awards like RSUs and PSUs, with the latter counted at a five-to-one share ratio. The 2019 Plan is also integrated with older plans like the 2014 and 2009 plans, but it is the only active plan allowing new grants, highlighting its central role in the company's evolving equity compensation strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the quantitative details. The ground truth does not mention specific numbers such as 119 million or 77 million shares available in 2022 and 2024, nor does it state that the 2019 Plan has 'exclusive authority' or is the 'only active plan allowing new grants.' These specific numerical figures and definitive characterizations are not supported by the original answer and appear to be fabricated or inferred without basis. (2) There is no verification of the share counts or their decrease over time in the ground truth; thus, the quantitative claims cannot be considered accurate. The five-to-one share ratio for PSUs is not mentioned in the original answer and introduces unsupported detail. (3) The multi-hop reasoning is partially sound in that the LLM recognizes the 2019 Plan’s ongoing role and its relationship with older plans like the 2014 and 2009 versions. However, it misrepresents the evolution of disclosure focus—shifting from governance/adoptions (2022) to strategic ownership framework (2024)—by instead emphasizing quantitative depletion of shares and exclusivity, which are not present in the ground truth. (4) While the LLM captures the general idea that the 2019 Plan remains important and is discussed in relation to prior plans, it fails to reflect the actual evolution described in the original answer: a shift in disclosure tone and context from procedural governance to strategic equity structure. The contextual relevance is high because it addresses equity compensation and plan relationships, but correctness is low due to unsupported numbers and mischaracterization of the plan's status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 466,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "Salvatore Ferragamo's presence in Simon Property Group's international outlet locations expanded between 2022 and 2023. In 2022, Ferragamo was listed as a tenant in Japan's Gotemba Premium Outlets and Mexico's Punta Norte Premium Outlets. By 2023, Ferragamo had expanded to additional international locations, including Canada's Premium Outlets Montreal and Japan's Kobe-Sanda Premium Outlets, reflecting a broader global footprint in Simon's international portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The original answer states that Salvatore Ferragamo was present in three Japanese outlets in 2022 (Gotemba, Kobe-Sanda, Sano) and only in one U.S. location (Las Vegas Outlets North) in 2023, indicating a reduction. The LLM claims expansion from 2022 to 2023, citing Gotemba (Japan) and Punta Norte (Mexico) in 2022, and additional locations in Canada and Japan in 2023. None of these locations except Kobe-Sanda (mentioned in both) align with the ground truth, and Sano Premium Outlets and Las Vegas Outlets North are not mentioned. The LLM incorrectly states Ferragamo expanded, when in fact its presence significantly contracted. (2) Quantitative inaccuracies include wrong number of locations: LLM implies 2 locations in 2022 and 4 in 2023 (expansion), while ground truth shows 3 in 2022 and 1 in 2023 (contraction). The countries are also wrong—Mexico and Canada are falsely cited; no Canadian or Mexican outlets are mentioned in the truth. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the set of locations across years and incorrectly infers growth. It also misattributes international presence, introducing non-existent tenancy. (4) Correctness and quantitative accuracy are severely compromised due to false entities and directional error (expansion vs contraction). Qualitative accuracy is very low due to incorrect synthesis. Contextual relevance is slightly above zero because the answer addresses tenant presence in SPG outlets over time, but with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 429,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region remained relatively stable from 2023 to 2024, with developed reserves at zero for both years and minimal changes in undeveloped reserves (from 7 to 9 BCF). This indicates that the company's operational focus in the region is primarily on maintaining existing assets rather than expanding or developing new natural gas reserves. The lack of significant additions or revisions in the region suggests a strategic emphasis on other areas, such as the Lower 48 and Africa, for growth and exploration activities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both numbers and key details. The ground truth states that COP reported 312 BCF in 2023 and 296 BCF in 2024 in the Asia Pacific/Middle East region, indicating a slight decrease in total natural gas position. However, the LLM claims developed reserves were zero in both years and cites undeveloped reserves changing from 7 to 9 BCF, which contradicts the ground truth. These numbers do not align with the reported total volumes and introduce a breakdown (developed vs. undeveloped) not present in the original answer or supported by the question context. (2) The quantitative inaccuracies are severe: the LLM reports 7 and 9 BCF as undeveloped reserves, which are drastically lower than the total reserves cited in the ground truth (312 and 296 BCF). There is no indication in the original answer that total reserves were broken down in this way, nor that developed reserves were zero. The LLM’s numbers are off by orders of magnitude and misrepresent the scale and nature of COP’s position. (3) The multi-hop reasoning is flawed because the LLM appears to have fabricated a reserve classification (developed vs. undeveloped) and applied it incorrectly. The conclusion about operational focus being on maintenance rather than growth might seem plausible, but it is based on incorrect data and thus invalid. The original answer attributes the slight decline to a potential shift or stabilization, not a strategic deprioritization. (4) The contextual relevance is moderate because the LLM attempts to address the evolution and operational focus, but due to fundamental factual errors, the answer misleads rather than informs. The scores reflect near-total failure in quantitative and qualitative accuracy, with minimal credit for attempting the right question structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 494,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "Comcast's approach to wireless gateways from 2022 to 2024 has shown a strategic emphasis on enhancing customer connectivity and expanding network capabilities. In 2022, the company offered wireless gateways to customers, combining an internet modem with a Wi-Fi router to deliver reliable in-and-out-of-home coverage and advanced features like xFi whole-home application and online portal management. By 2024, the focus evolved to include continued deployment of wireless gateways as part of broader network upgrades, with capital expenditures in Connectivity & Platforms emphasizing scalable infrastructure and line extensions to support multigigabit symmetrical speeds. This reflects an increased investment in modernizing the network to meet growing demand for high-speed, reliable connectivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Comcast offered wireless gateways combining modem and Wi-Fi router functions with customer-facing features like the xFi application; by 2024, the strategic emphasis shifted toward deeper integration into network infrastructure, including support for multigigabit symmetrical speeds. The LLM correctly captures this evolution in strategic emphasis and investment. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer beyond the years 2022 and 2024, which are correctly used—thus quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes information across time periods (2022 vs 2024) and connects wireless gateway deployment to broader capital investment trends in Connectivity & Platforms, reflecting a correct understanding of strategic evolution. (4) The only minor shortcoming is that the LLM does not explicitly state that wireless gateways moved from being a 'customer service feature' to a 'network infrastructure investment'—a nuance present in the original answer—but this is implied through discussion of capital expenditures and network modernization. Overall, the answer is semantically equivalent, contextually relevant, and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 386,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "Between 2022 and 2024, the G600's market presence and production evolution has seen a shift as it was gradually replaced by the newer G800 model. By 2024, the G800, with its extended range and advanced features, had become Gulfstream's longest-range aircraft and was positioned to replace the G650 and G650ER family. Cumulative deliveries of the G500 and G600 totaled over 300 by the end of 2024, reflecting their established role in Gulfstream's product lineup. However, the G600's role diminished as the G800 entered service, signaling a transition in Gulfstream's strategy to focus on the more advanced and capable G800 model.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that cumulative deliveries of the G500 and G600 exceeded 300 by the end of 2024, which aligns with the ground truth (over 300 by year-end 2024). However, it omits the 2022 reference point — that deliveries totaled almost 150 by year-end 2021 — which is critical for showing the doubling trend. This omission weakens the multi-hop comparison between 2022 and 2024. (2) The quantitative claim about 'over 300' is accurate and matches the ground truth. No calculation errors are present, but the earlier baseline is missing, limiting full quantitative context. (3) The reasoning contains a significant factual error: the LLM claims the G600 was 'replaced' by the G800 and that the G800 replaces the G650/G650ER, which is not supported by the original answer. The ground truth states the G600 became more established and that focus shifted to newer models like the G800 and G400 — not that the G600 was replaced by the G800. This misrepresents the product transition and introduces incorrect causality. (4) While the answer addresses market presence and cumulative deliveries, it distorts the role evolution of the G600 by overstating displacement by the G800. The contextual relevance is high as it discusses product lineup shifts, but the qualitative inaccuracy in reasoning and entity relationships reduces overall correctness. The answer captures part of the truth but introduces misleading strategic implications not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 412,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly in terms of equity ownership and income recognition. As of December 31, 2023, AIG held a 52.2% ownership stake in Corebridge, but by June 9, 2024, this had reduced to 48.4% following a secondary offering. On June 9, 2024, AIG deconsolidated Corebridge, reducing its ownership to 29.4% and recognizing a $4.8 billion loss due to accumulated comprehensive losses. By December 31, 2024, AIG's ownership further decreased to 22.7% after additional share sales, including a $3.8 billion transaction with Nippon Life. Income recognition shifted from consolidated financial results to equity method accounting, with $601 million in equity method income (based on dividends and stock price changes) recorded in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite addressing the correct question and demonstrating an understanding of the general trend. The original answer states that AIG held 52.2% in 2023 and was in the process of selling down its stake, with a plan to fully divest over time. It also notes that by 2024, AIG transitioned to equity method accounting, recognizing pre-tax income based on dividends and stock price changes from June 9, 2024. However, the LLM introduces specific numbers not present in the ground truth: claiming ownership dropped to 48.4% pre-deconsolidation, then to 29.4% and finally 22.7% by year-end, along with a $4.8 billion loss and a $3.8 billion transaction with Nippon Life. These figures are not supported by the original answer and appear fabricated or hallucinated. The $601 million equity method income is also not mentioned in the ground truth. (2) Quantitative accuracy is low because all specific percentages (48.4%, 29.4%, 22.7%), dollar amounts ($4.8B loss, $3.8B sale), and income figure ($601M) are absent from the original and cannot be verified. The only correct number is the 52.2% ownership in 2023, which matches. The date June 9, 2024, is correctly referenced as the transition point for accounting change, aligning with the original. (3) The multi-hop reasoning is partially sound—LLM correctly infers a shift from control to equity method accounting and links deconsolidation to a change in income recognition. However, it overextends by inventing granular transaction details and ownership percentages not present in the source, undermining the validity of the synthesis. (4) Contextual relevance is high because the answer addresses both equity ownership evolution and income recognition, uses correct terminology (equity method, deconsolidation), and captures the directional shift in AIG’s relationship with Corebridge. However, due to major quantitative inaccuracies and unsupported specifics, the correctness score is limited to 4—partially correct but with significant errors that affect factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 562,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "Between 2022 and 2024, Tesla's production strategy for the Solar Roof has evolved with a focus on addressing manufacturing dependencies and operational challenges. In 2022, Tesla highlighted its reliance on Gigafactory New York for Solar Roof production and acknowledged challenges such as supply chain constraints, hiring and training skilled workers, and scaling production processes. By 2024, the company emphasized efforts to ramp production capabilities and improve localized procurement, while also investing in workforce development programs to address labor shortages and enhance technical skills. Despite these efforts, Tesla continued to face risks related to supplier dependencies and the complexities of scaling new manufacturing operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative description of Tesla's evolving Solar Roof production strategy between 2022 and 2024, with accurate entity identification (Tesla, Gigafactory New York, timeframes) and no numerical inaccuracies (no specific numbers were involved, so quantitative accuracy is 10 by default). The answer correctly identifies Gigafactory New York as the production site in 2022 and notes ongoing challenges like supply chain constraints, labor, and scaling—elements consistent with the ground truth. It also acknowledges continued risks in 2024 around supplier dependencies and manufacturing ramp-up. However, the LLM omits key details from the original answer: (1) the strategic integration of financing options in 2022 as part of Tesla’s ecosystem push, (2) the explicit mention in 2024 filings of 'delays in launching and/or ramping production' of Solar Roof, and (3) the specific emphasis on 'design tolerances, high quality and output rates' and 'localized procurement challenges' as operational hurdles. While the LLM mentions localized procurement and workforce development, it frames them as active investments rather than emerging risks or unresolved challenges, slightly misrepresenting the tone and focus of Tesla’s 2024 disclosures. The reasoning is sound but lacks full multi-hop synthesis—particularly the shift from a dedicated, strategically promoted production setup in 2022 to a risk-laden, delayed ramp-up phase in 2024. The answer is contextually relevant and well-structured, but missing critical nuances from the ground truth, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 445,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "From 2023 to 2024, Qualcomm's strategic involvement with on-device artificial intelligence (AI) has evolved by emphasizing its foundational role in expanding beyond mobile handsets into industries like automotive and IoT. In 2023, Qualcomm highlighted its investments in wireless connectivity, high-performance computing, and on-device AI as part of its broader growth strategy. By 2024, the company reinforced its focus on leveraging these technologies to drive innovation in new product areas and applications, underscoring continued investment in research and development to advance on-device AI capabilities. This shift reflects Qualcomm's intent to scale its AI technologies across diverse sectors to drive future growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's strategic focus on on-device AI in both 2023 and 2024, noting its expansion beyond mobile into automotive and IoT, which aligns with the original answer. It accurately reflects continued investment in R&D and the foundational role of on-device AI. However, it misses a key evolution highlighted in the ground truth: the shift from on-device AI as a core product offering in 2023 to a more investment-centric, ecosystem-driven strategy in 2024 focused on third-party integration rather than direct product commercialization. This nuance in strategic evolution is underemphasized. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model connects Qualcomm’s AI focus across years and industries, but fails to fully synthesize the shift in business model (from product to investment/ecosystem development), which is central to the question about 'business focus and investment approach.' (4) The answer is contextually relevant and factually consistent with the general direction of Qualcomm’s strategy, but lacks the precise qualitative shift described in the ground truth, warranting a 7 for correctness and qualitative accuracy. Contextual relevance is high as it addresses the timeframe and strategic themes appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 403,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "The presence of Dolce & Gabbana in SPG-operated properties increased between 2022 and 2023, as the brand was listed as a tenant in several U.S. Premium Outlets in 2023, including Las Vegas Outlets, that were not explicitly mentioned in 2022. This inclusion in high-traffic, premium locations signals SPG's strategy to enhance the luxury appeal of its outlet centers by attracting high-end fashion brands, thereby positioning them as premier retail destinations for upscale consumers.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Dolce & Gabbana's presence increased between 2022 and 2023. The ground truth shows a reduction in presence—from multiple SPG-operated premium outlets in Japan in 2022 (Gotemba, Kobe-Sanda, Rinku) to only one location in the U.S. (Las Vegas Outlets North Premium NV) in 2023. The LLM incorrectly frames this as an expansion, when it is actually a contraction and geographic shift. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), but the temporal and locational data are inaccurate. The claim that Dolce & Gabbana was added to 'several U.S. Premium Outlets' in 2023 is unsupported; only one U.S. location is documented. (3) The multi-hop reasoning fails: the model should have compared tenant listings across years and geographies to detect a strategic withdrawal from Japan and a pivot to a single U.S. flagship-style location. Instead, it assumes growth based on the appearance in a new market without acknowledging the loss of multiple prior locations. (4) The conclusion about SPG enhancing luxury appeal by attracting high-end brands is partially plausible but misaligned with the actual strategic shift—toward exclusivity and repositioning in a key market, not broad expansion. Thus, while the general idea of targeting upscale consumers is relevant, the factual foundation is wrong, leading to a low correctness score. Contextual relevance is moderate because the answer addresses brand positioning, but accuracy and reasoning are severely flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 427,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "Between 2023 and 2024, COP's investment in exploration activities in the Asia Pacific/Middle East region remained minimal, with no dry exploratory wells and only a small number of productive exploratory wells (3 in 2023 and none in 2024). This indicates that the company's strategic focus in the region is primarily on development rather than new exploration, likely due to the concentration of equity affiliate reserves and ongoing development projects in existing areas.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key aspects. The ground truth states that COP spent $49 million on exploration in the Asia Pacific/Middle East region in 2023 and $0 in 2024, indicating a complete halt. The LLM answer does not mention these dollar amounts at all, instead referring to 'no dry exploratory wells' and '3 productive exploratory wells in 2023 and none in 2024'—information not present in the original answer and potentially fabricated or misattributed. (2) Quantitatively, the LLM fails to report the critical $49M and $0 figures, which are central to the question. There are no calculations in the original, but the absence of these specific expenditures renders the quantitative accuracy very low. (3) The reasoning is flawed: the conclusion that 'strategic focus is on development rather than new exploration' may seem plausible, but it contradicts the ground truth implication of a complete strategic withdrawal or pause. The LLM invents a narrative around well productivity that is unsupported by the provided data. (4) Contextual relevance is moderate because the answer addresses the region and the time frame, and attempts to infer strategic intent, but due to factual inaccuracies and missing core data, the response misrepresents the situation. The multi-hop synthesis failed—instead of linking 'reduction from $49M to $0' to 'strategic shift away', it introduces irrelevant metrics about wells. Thus, correctness is low despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 414,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "Comcast's financial stake in Universal Beijing Resort remains at a 30% interest from 2022 to 2024. As of December 31, 2024, Universal Beijing Resort had $3.4 billion of debt outstanding, down slightly from $3.5 billion as of December 31, 2023. Comcast consolidates Universal Beijing Resort due to its power to direct activities impacting its economic performance, with its maximum risk of financial loss limited to its 30% ownership stake.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Comcast's 30% ownership stake in Universal Beijing Resort and the debt figures of $3.4 billion as of December 31, 2024, and $3.5 billion as of December 31, 2023, which aligns with the ground truth. However, the LLM incorrectly states that the 30% stake was in place in 2022, while the original answer clarifies that no specific financial stake was disclosed in 2022—Comcast only began explicitly stating the 30% ownership in 2024. This is a significant factual error regarding the evolution of the stake over time. (2) Quantitatively, all provided numbers (debt amounts, ownership percentage) are accurate and correctly formatted. The $0.1 billion decrease in debt is correctly implied. However, the LLM omits the balance sheet figures for assets and liabilities in 2023 and 2024 ($7.8B/$7.2B and $7.3B/$7.0B respectively), which are key to showing the financial evolution. (3) The reasoning partially fails on the multi-hop aspect: while it synthesizes ownership and debt correctly for 2024, it does not accurately reflect the lack of disclosed stake in 2022, thus misrepresenting the timeline of disclosure evolution. The consolidation rationale and risk limitation are additional details not in the ground truth but are contextually plausible and not factually contradictory. (4) The answer is highly relevant and mostly accurate in numbers, but the misstatement about the 30% stake existing in 2022 and the omission of asset/liability figures reduce correctness and qualitative accuracy. Hence, 7/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 428,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "From 2022 to 2023, Duke Energy's net derivatives balance decreased significantly, from a net asset of $29 million to a net asset of $13 million. This decline was driven by higher settlements of $68 million in 2023 compared to $32 million in 2022, partially offset by purchases and gains. The reduction in the net derivatives balance indicates a decrease in the company's exposure to derivative instruments, suggesting more active management or reduced hedging activity during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative figures: Duke Energy's net derivatives balance decreased from $29 million in 2022 to $13 million in 2023, and settlements increased from $32 million to $68 million. These numbers match the ground truth exactly, with acceptable formatting. (2) All calculations and comparisons are accurate—there is a $16 million decrease in net balance and a $36 million increase in settlements, which the model correctly characterizes as a 'significant' decrease and 'higher' settlements. (3) The multi-hop reasoning is sound: the model synthesizes data across two years, correctly identifies the trend (declining balance despite higher settlements), and infers that this reflects reduced exposure or more active management of derivatives. The conclusion about 'decrease in exposure' and 'more active management or reduced hedging' aligns with the ground truth's interpretation of a 'shift in management.' (4) The only minor limitation is that the LLM adds the phrase 'partially offset by purchases and gains,' which is plausible but not explicitly supported in the ground truth. However, this does not contradict the data and is a reasonable assumption given the net change, so it does not warrant a major deduction. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 377,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "From 2022 to 2023, SPG's treatment and disclosure of LTIP Units showed a shift in terms of valuation modeling and potential dilutive impact. In 2022, the LTIP Units were primarily discussed in the context of compensation expense and vesting conditions, with no material dilutive effect noted. By 2023, SPG provided more detailed modeling for the 2023 LTI Program, specifying the performance-based awards tied to FFO and objective criteria, with a maximum potential fair value of $23.6 million at grant date. Additionally, SPG clarified that LTIP units are accounted for as participating securities under the two-class method, which affects earnings per share calculations. The 2023 disclosure also emphasized the vesting timeline and the grant-date fair value estimation using a Monte Carlo model for market-based awards, reflecting a more granular approach to valuation and potential dilution.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in SPG's disclosure: from a general statement about no material dilutive effect in 2022 to more detailed, granular disclosures in 2023. The key qualitative points—treatment as participating securities under the two-class method, use of the Monte Carlo model for market-based LTIP units, and enhanced valuation modeling—are all present. (2) Quantitatively, the LLM introduces a specific figure—'$23.6 million maximum potential fair value at grant date'—which is not in the original answer. However, this detail does not contradict the ground truth and may reflect additional data from the 2023 filing; its inclusion is plausible and contextually appropriate, so it does not constitute a factual error. All other numbers and dates (e.g., 2022 vs. 2023 disclosures) are correctly used. (3) The multi-hop reasoning is sound: the model synthesizes changes over time in both treatment (accounting method) and disclosure depth (valuation modeling), correctly identifying the shift from minimal dilution discussion to detailed methodology. (4) The answer is semantically equivalent to the original, with slightly more specificity in the 2023 disclosures. The only reason for not scoring a 10 is the introduction of a number not present in the ground truth, which, while not incorrect, slightly exceeds the confirmed facts. Overall, the response is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 413,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "Between 2022 and 2024, Comcast's financial commitment to Atairos Group, Inc. evolved as follows: \n\n- In 2022, Comcast made cash capital contributions of $52 million to Atairos, with a remaining unfunded capital commitment of $1.5 billion. \n- In 2023, contributions increased to $145 million, and the unfunded commitment was reduced to $1.4 billion. \n- In 2024, contributions were $73 million, with the unfunded commitment remaining at $1.4 billion. \n\nAdditionally, Comcast committed to funding Atairos $40 million annually for a management fee, subject to adjustments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of Comcast's financial commitment to Atairos Group, Inc. between 2022 and 2024. (1) Quantitatively, the LLM incorrectly states that in 2022, Comcast had a remaining unfunded capital commitment of $1.5 billion and made a $52 million contribution, which contradicts the ground truth stating a total commitment of $5 billion. Similarly, the reported contributions of $52M (2022), $145M (2023), and $73M (2024) are not supported by the original answer and are likely fabricated or misattributed. The ground truth does not provide annual contribution amounts, so these specific figures are unsupported. (2) The key fact in the original answer is that Comcast's total capital commitment decreased from $5 billion in 2022 to $4.5 billion in 2024, which the LLM completely omits. Instead, it reports a much smaller commitment ($1.5B unfunded), indicating a fundamental misunderstanding or use of incorrect data. (3) The only correct element is the $40 million annual management fee commitment in 2024, which aligns with the original answer. (4) The reasoning is flawed: the LLM presents a year-by-year breakdown of contributions and unfunded commitments that are not in the ground truth, suggesting incorrect multi-hop synthesis or reliance on erroneous data. It fails to capture the strategic recalibration described in the original—reduction in total capital commitment and addition of management fee—as the central narrative. (5) While the answer is structured around the right entities (Comcast, Atairos) and time frame (2022–2024), the core financial facts are wrong, severely undermining correctness. The contextual relevance is moderate because it addresses the topic and timeframe, but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 489,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region remained at zero for both 2023 and 2024, as shown in the reserves tables. This indicates that the company does not hold any natural gas reserves in this region directly through its consolidated operations. However, the company's equity affiliates, which are located in the Asia Pacific/Middle East region, contributed to the total natural gas reserves. The lack of direct natural gas reserves in this region suggests that COP's operational focus in Asia Pacific/Middle East is primarily on crude oil and natural gas liquids, with its natural gas exposure in the region being limited to equity affiliate activities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that COP's natural gas reserves in the Asia Pacific/Middle East region were zero in both 2023 and 2024. The ground truth states reserves were 312 billion cubic feet in 2023 and 296 billion cubic feet in 2024, indicating a modest decline. The LLM's claim of zero reserves directly contradicts this. (2) Quantitative accuracy is severely lacking: the correct values (312 and 296 Bcf) are entirely absent, and no correct calculation or comparison is made. The difference of 16 billion cubic feet decrease is not reflected. (3) The reasoning is flawed: the LLM incorrectly infers no direct reserves and attributes regional exposure to equity affiliates, which is not supported by the ground truth. There is no mention of equity affiliates or operational focus on crude oil/NGLs in the original answer. The multi-hop synthesis failed—instead of reporting the actual reserves and interpreting the slight decline, the model fabricated a narrative around zero holdings. (4) The contextual relevance is low because the answer addresses a different reality—denying the existence of reserves rather than analyzing their evolution. While the question asks about reserve evolution and operational focus, the LLM misrepresents the core data, leading to an invalid conclusion. Minor credit is given for attempting to interpret operational focus, but it's based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 395,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022, Comcast focused on procuring wireless gateways to enhance broadband services, offering customers combined internet modems and Wi-Fi routers for improved coverage and network management. By 2024, the company shifted its investment focus toward scalable infrastructure upgrades, line extensions, and the deployment of multigigabit symmetrical speeds to expand network capacity and deliver next-generation connectivity. This evolution reflects a strategic move from customer-facing equipment procurement to broader network modernization efforts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Comcast's strategy from 2022 to 2024. (1) It correctly identifies that in 2022, Comcast focused on procuring wireless gateways as customer premise equipment to support broadband services, which aligns with the ground truth. In 2024, it accurately reflects the shift toward strategic network modernization, including multigigabit symmetrical speeds and scalable infrastructure—consistent with the original answer's emphasis on capital deployment and network scalability. (2) There are no numeric values (e.g., dollar amounts, quantities) in either the ground truth or LLM response, so quantitative accuracy is not compromised; all dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across time periods and strategic focus areas, correctly inferring a shift from procurement to infrastructure integration. The only minor omission is that the LLM does not explicitly state that wireless gateways became a 'key component' of capital expenditures in 2024 or that deployment was part of broader network upgrades specifically *for* multigigabit speeds—this nuance is present in the ground truth but only implied in the LLM answer. (4) Despite this slight gap in specificity, the LLM conveys the essential strategic shift with accurate entities, correct years, and appropriate context, making the answer semantically equivalent in intent and meaning. Hence, correctness is rated 9 (missing minor detail), qualitative accuracy 9, and full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 438,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "Between 2022 and 2024, Tesla's Solar Roof product has seen a shift in strategic importance, with continued efforts to scale production and improve gross margin performance. In 2022, the Solar Roof was noted to operate at a lower gross margin due to temporary manufacturing underutilization during product ramp. By 2024, while the Solar Roof remained part of Tesla's energy generation and storage segment, the company's focus had expanded to include scaling higher-margin products like Megapack and Powerwall. Additionally, Tesla continued to face production challenges, including supply chain constraints and manufacturing complexities, as highlighted in 2024, which could impact the timely ramp and profitability of Solar Roof and other energy products.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of dates (2022 and 2024), entities (Tesla, Solar Roof, Megapack, Powerwall), and overall context—namely, the evolution of Tesla's strategic framing and ongoing production challenges for the Solar Roof. There are no numeric inaccuracies, as the response avoids specific figures (e.g., margins, production volumes) that could be incorrect, and instead uses qualitative descriptions (e.g., 'lower gross margin', 'manufacturing underutilization') that align with plausible interpretations of the product ramp phase. Thus, quantitative accuracy is high. However, the LLM slightly misrepresents the shift in strategic importance: the original answer emphasizes a change in narrative—from highlighting the Solar Roof as a growth contributor in 2022 to cautioning about production ramp delays in 2024—whereas the LLM frames it as a continued effort with expanded focus on higher-margin products. While not contradictory, this downplays the notable shift from optimism to caution, which is central to the ground truth. The reasoning is sound and contextually relevant, synthesizing the product’s role across years and acknowledging persistent challenges, but misses the nuance of strategic repositioning (from active growth driver to one with acknowledged scalability risks). Hence, qualitative accuracy and overall correctness are slightly reduced due to incomplete capture of the strategic narrative shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 403,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "Duke Energy's \"Net pending transactions and other investments\" increased from $14 million in 2022 to $54 million in 2023. This significant increase suggests a strategic shift or expansion in the company's approach to managing pending transactions and other investment opportunities within its retirement trust, potentially reflecting a more active pursuit of diversification or capital allocation strategies in this category.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The original answer states that Duke Energy's investment decreased from $53 million in 2022 to $14 million in 2023, whereas the LLM claims it increased from $14 million to $54 million—reversing the years and misstating the amounts. This fundamental error undermines the entire response. (2) Quantitative accuracy is severely lacking: the correct values are $53M (2022) and $14M (2023); the LLM reports $14M (2022) and $54M (2023), which swaps the numbers and introduces a $1M discrepancy. No correct calculation or comparison is possible with inverted and inaccurate figures. (3) The multi-hop reasoning is flawed because the model fails to retrieve the correct data points across years, leading to an opposite conclusion about strategic positioning. Instead of indicating a reduction in exposure or completion of initiatives, the LLM incorrectly infers expansion and active pursuit of investments. (4) Contextual relevance is moderate—the response addresses the right category (Net Pending Transactions and Other Investments) and attempts strategic interpretation—but due to gross factual errors, the analysis is based on false premises. Correctness and quantitative accuracy are very low; qualitative accuracy is poor due to incorrect entity-value-time mappings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 378,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "Between 2023 and 2024, the company's implementation of its liability-driven investment framework remained consistent in aligning plan assets with liabilities. The equity/fixed income target allocation for pension assets stayed at 20%/80%, while postretirement assets maintained a 55%/45% allocation. However, the defined contribution plan expenses increased, with charges rising from $109 million in 2023 to $112 million in 2024. Additionally, the disclosure of plan asset composition showed a shift in pension assets, with equity securities increasing from 18% to 21% and corporate bonds rising from 57% to 63%, while U.S. Treasury and government securities decreased from 25% to 16%.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly states that defined contribution plan expenses increased from $109 million in 2023 to $112 million in 2024 and that the 20%/80% equity/fixed income target allocation was maintained, it introduces incorrect details about actual asset composition changes (e.g., equity rising from 18% to 21%, corporate bonds from 57% to 63%, U.S. Treasury from 25% to 16%), which are not present in the original answer. The ground truth does not mention any actual composition shifts—only that a new disclosure indicated future characterization of year-end asset composition, implying improved transparency, not actual reallocation. Additionally, the mention of a 55%/45% allocation for postretirement assets is extraneous and unsupported by the original answer. (2) Quantitative accuracy is low because the percentages cited for actual asset composition (18%, 21%, 57%, etc.) are fabricated and not in the ground truth. The dollar amounts ($109M, $112M) and target allocation (20%/80%) are correct. (3) The reasoning partially captures the evolution in disclosure but misrepresents it as a change in actual asset composition rather than an enhancement in reporting transparency. The multi-hop synthesis fails because it conflates target allocation consistency with unreported actual shifts, introducing data not present in the source. (4) Contextual relevance is high because the answer addresses both parts of the question—expenses and disclosure evolution—but distorts the latter with incorrect specifics. The core expense increase and stable target allocation are accurate, but the added details undermine factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 463,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "Between fiscal 2023 and 2024, Qualcomm's strategic focus on On-Device AI evolved by emphasizing its integration with 5G and high-performance, low-power computing to expand into industries beyond mobile handsets, such as automotive and IoT. In fiscal 2024, Qualcomm continued to invest in foundational technologies, including wireless connectivity and on-device AI, and highlighted its commitment to developing and commercializing products that leverage these advancements. The company also mentioned ongoing efforts to educate industry participants and governments on the benefits of its licensing programs, which support the adoption of AI technologies.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's strategic focus on On-Device AI in both fiscal 2023 and 2024, and accurately notes the integration with 5G and expansion into automotive and IoT. However, it fails to capture a key evolution highlighted in the original answer: the shift from a strategic vision in 2023 to an active, investment-driven strategy in 2024 involving acquisitions and strategic transactions. This critical change in direction—explicit investment and expansion through M&A or strategic deals—is missing, which represents a significant omission in the qualitative evolution. (2) There are no numeric values, dates, or calculations in the response or ground truth beyond fiscal years (2023 and 2024), which are correctly used. Thus, quantitative accuracy is fully satisfied. (3) The multi-hop reasoning is partially sound: the model connects Qualcomm’s AI focus across two fiscal years and identifies continuity in technology development. However, it does not synthesize the key shift from vision to execution via investments and acquisitions, which is central to the question about 'specific investments or changes in direction.' This weakens the qualitative accuracy. (4) The answer is contextually relevant and well-structured, addressing the general evolution of AI strategy, but lacks the specific disclosure about new investment areas and strategic transactions that defines the 2024 shift. Hence, correctness and qualitative accuracy are reduced due to incomplete synthesis of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 425,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "The classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members remained consistent between the 2022 and 2023 10-K filings, as both years reference the same \"Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy dated as of March 1, 2004\" under Exhibit 9.1. This consistency indicates a stable governance structure, with no material changes to the agreement's terms or presentation in the filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that both the 2022 and 2023 10-K filings refer to the 'Second Amended and Restated' Voting Trust Agreement. According to the ground truth, while the 2022 filing includes the 'Second Amended and Restated' designation, the 2023 filing omits this modifier and refers to the agreement simply as the 'Voting Trust Agreement dated March 1, 2004'. This misrepresentation of the key factual difference between the two filings undermines the entire analysis. (2) The date 'March 1, 2004' is correctly cited in both cases, so the quantitative accuracy is partially correct, but the core observation about the change in classification is wrong. (3) The multi-hop reasoning fails because the model did not detect the change in presentation between the two years, which is central to the question. Instead, it incorrectly asserts consistency, leading to a flawed conclusion about stability based on the wrong premise. The ground truth uses the removal of the 'Second Amended and Restated' language to infer no new amendments, hence stability; the LLM misses this nuance entirely. (4) While the answer addresses governance stability—a relevant theme—it does so based on incorrect data synthesis, resulting in low correctness and qualitative accuracy. Contextual relevance is moderate because the response discusses the right entities and topic, but with critical factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 395,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region remained at zero for both 2023 and 2024, as indicated in the \"End of 2023\" and \"End of 2024\" rows for the region in the natural gas reserves table. This suggests that the region did not contribute to COP's natural gas reserves during this period, and thus held minimal strategic importance in terms of natural gas within COP's global reserves portfolio. However, the region remains significant for equity affiliate reserves, particularly for natural gas liquids and bitumen, indicating a focus on other energy resources in the region.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core factual claim. According to the ground truth, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region in 2023 and 296 billion cubic feet in 2024, representing a decrease of 16 billion cubic feet (5.1%). The LLM incorrectly states that reserves were zero in both years, which contradicts the ground truth. This error invalidates all subsequent reasoning. The claim that the region 'remained significant for equity affiliate reserves' is partially aligned with the ground truth mention of 5,870 billion cubic feet from equity affiliates in 2024, but the LLM misattributes this to natural gas liquids and bitumen without evidence from the original answer. The reasoning about strategic importance is speculative and based on false premises. The multi-hop synthesis failed completely: the model did not correctly extract or interpret the primary data point (non-zero reserves) and thus could not accurately assess trends or strategic implications. Quantitative accuracy is extremely low due to the complete misstatement of key figures. Qualitative accuracy is poor because the entities (COP, region, time frame) are correct but the relationships and conclusions are not supported. Contextual relevance is low but not zero because the answer addresses the right region and company and attempts to discuss strategic importance, albeit on a false foundation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 398,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly, particularly in terms of debt structure and equity method income. In 2023, Corebridge had $9,368 million in debt, including guaranteed and non-guaranteed borrowings, with AIG having certain guarantees and collateral agreements in place. By 2024, following the deconsolidation of Corebridge on June 9, 2024, AIG no longer consolidated Corebridge's debt, and its retained interest was reclassified as an equity method investment. Post-deconsolidation, AIG recognized equity method income of $601 million for Corebridge in 2024, based on dividends received and changes in Corebridge's stock price. Additionally, AIG sold portions of its Corebridge stake, including a significant transaction in December 2024, resulting in a $282 million gain.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the high-level evolution of AIG's relationship with Corebridge—deconsolidation in 2024 and shift to equity method accounting—which is correct and contextually relevant. However, there are significant quantitative inaccuracies. The original answer states that in 2023, Corebridge debt totaled $9,368 million on AIG’s balance sheet, broken into $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. The LLM answer incorrectly generalizes this as including 'guaranteed and non-guaranteed borrowings' and mentions 'AIG having certain guarantees and collateral agreements,' which contradicts the ground truth that these debts were not guaranteed by AIG. This is a factual error affecting quantitative and qualitative accuracy. (2) The LLM introduces a specific equity method income figure of $601 million in 2024, which is not present in the original answer. The ground truth mentions that equity method income included dividends and stock price changes post-June 9, 2024, but does not provide a dollar amount. This is a hallucination of data. Similarly, the $282 million gain from a December 2024 stake sale is not in the original answer and cannot be verified, representing another unsupported claim. (3) The multi-hop reasoning is partially sound: the model correctly infers a shift from consolidation to equity method reporting and ties it to deconsolidation on June 9, 2024. However, it adds financial figures and transactions not present in the ground truth, undermining the reliability of the synthesis. (4) The contextual relevance is high because the answer addresses debt structure changes and equity income as asked. Qualitative accuracy is moderate due to correct conceptual framing but flawed details. Quantitative accuracy is low due to incorrect or fabricated numbers. Correctness score is 6 because the core transformation is accurately described, but key financial specifics are wrong or invented, limiting factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 548,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "NextEra Energy's investment strategy in Special Use Funds from 2022 to 2024 shows a shift toward a higher allocation in equity securities compared to fixed income. In 2022, equity securities in Special Use Funds were valued at $5,290 million (NEE) and $3,536 million (FPL), while fixed income (government and municipal bonds, corporate debt, etc.) totaled $757 million (NEE) and $583 million (FPL). By 2024, equity securities increased to $6,164 million (NEE) and $4,219 million (FPL), with fixed income rising slightly to $722 million (NEE) and $561 million (FPL). This suggests a growing risk appetite, as equities typically carry higher volatility than fixed income. The increased equity exposure may reflect a longer-term investment horizon or confidence in market growth, while maintaining a modest fixed income component to preserve some liquidity and stability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, NextEra Energy's (NEE) Special Use Funds were entirely composed of fixed income securities with a carrying amount of $2,505 million—there was no equity allocation. However, the LLM claims that in 2022, NEE had $5,290 million in equity securities and only $757 million in fixed income, which is completely incorrect. This misrepresents the starting point of the investment strategy. Additionally, the LLM introduces FPL (Florida Power & Light) data ($3,536 million in equities in 2022, etc.), which is not mentioned or supported in the ground truth and appears to be fabricated or misattributed. The 2024 numbers for equity securities ($6,164 million) match the ground truth, but the LLM incorrectly separates this into NEE and FPL components. The fixed income breakdown in 2024 (U.S. Government, corporate debt, asset-backed securities) is partially correct in total magnitude but misrepresented as only $722 million for NEE, ignoring the full composition stated in the original answer. (2) Calculations and comparisons are therefore invalid due to incorrect base data. The LLM implies growth from a mixed portfolio in 2022 to a more equity-heavy one in 2024, but the actual shift was from 100% fixed income to a predominantly equity-based portfolio—this fundamental transformation is obscured. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the entities (mixing NEE and FPL without evidence), misrepresents the 2022 composition, and invents granular allocations not present in the source. While the conclusion about increased risk appetite aligns with the direction of the strategy shift, it is based on incorrect premises. (4) The contextual relevance is moderate—the answer addresses the question's structure (evolution, allocation, risk appetite) and draws a reasonable qualitative inference—but the factual foundation is severely compromised, leading to a low correctness score despite some structural adequacy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 555,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "The nature and magnitude of the risk associated with site infrastructure sharing have evolved between 2022 and 2024, particularly with the adoption of 5G technology. In 2022, the risk was primarily linked to potential network rationalization and consolidation among wireless service providers, which could lead to reduced demand for new leases or decommissioning of existing equipment. By 2024, the risk has expanded to include the impact of 5G-driven site infrastructure sharing, such as RAN sharing and roaming arrangements, which allow carriers to share equipment rather than deploy new infrastructure. This trend has slowed new lease activity and increased the risk of redundant network investments, reducing the need for additional site infrastructure and potentially impacting future revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of the risk associated with site infrastructure sharing from 2022 to 2024, particularly in relation to 5G adoption and its impact on new lease activity. (1) The answer correctly identifies that in 2022, the risk centered on network rationalization and consolidation, potentially reducing demand for new leases or leading to decommissioning—this aligns with the ground truth mentioning slowed lease activity and decommissioning due to 5G. In 2024, the LLM correctly notes the expansion to RAN sharing and roaming arrangements, which reduce the need for new infrastructure. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes how 5G adoption influenced carrier behavior over time and connects it to reduced lease activity. The only minor gap is that the LLM does not explicitly mention the 'lack of compensation to AMT' in 2024, which is a key nuance in the ground truth emphasizing the financial impact and contractual concern. This omission slightly weakens the qualitative accuracy but does not invalidate the overall correctness. (4) The answer is contextually fully relevant, directly addressing the evolution in nature and magnitude of the risk. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 429,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Between 2022 and 2023, Chevron's investment in Angola LNG Limited, accounted for under the equity method, decreased in value. The carrying value of the investment dropped from $1,963 million in 2022 to $1,762 million in 2023. Additionally, Chevron's share of earnings from Angola LNG Limited also declined, from $1,857 million in 2022 to $513 million in 2023, indicating a significant reduction in profitability from this investment during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) The original answer describes a structural and classification change in Chevron's relationship with Angola LNG Limited—from 'Depends_On' in 2022 to 'Invests_In' in 2023—while maintaining a constant 36.4% ownership. The LLM instead introduces financial figures (carrying value and earnings) that are not mentioned in the ground truth and are factually unsupported by it. (2) Quantitatively, the LLM claims a drop in carrying value from $1,963 million to $1,762 million and earnings from $1,857 million to $513 million. These numbers do not appear in the ground truth and cannot be verified; more importantly, they shift focus from investment structure and accounting classification to performance metrics not requested. (3) The multi-hop reasoning is flawed: the question asks about evolution in investment structure and equity method accounting, not financial performance. The LLM misinterprets the core intent and provides irrelevant data. (4) While the mention of 'equity method accounting' shows some contextual awareness, the overall response misses the key qualitative shift in relationship type and misrepresents the nature of the evolution. The answer is contextually relevant in topic but factually and structurally incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 374,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "From 2022 to 2023, the G600 aircraft remained a key performer in Gulfstream's product lineup, known for its speed, fuel efficiency, and large cabin. By year-end 2023, cumulative deliveries of the G500 and G600 totaled over 250, with the G600 continuing to hold a strong market position due to its advanced features and performance metrics. The G600's role was further reinforced by its contribution to Gulfstream's leadership in speed records, as the company's aircraft collectively held over 355 city-pair speed records in 2023. Production and delivery of the G600 remained steady, with no indication of changes to its status as a flagship model in the Gulfstream portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but introduces significant inaccuracies. The key error is in the quantitative claim that 'cumulative deliveries of the G500 and G600 totaled over 250'—the ground truth specifies that over 250 deliveries were for the G600 alone by end of 2023, not the combined total of both models. This misrepresents the production scale of the G600. Additionally, the LLM fails to mention the evolution in the G600's characterization—from 'recent addition' in 2022 to 'mature product' in 2023—which is central to the question about its evolving role. (2) The number 250 is correct in magnitude but incorrectly attributed to the G500/G600 combined rather than the G600 alone, making it a critical quantitative inaccuracy. The mention of 355 speed records is contextually plausible but not present in the ground truth and thus cannot be verified; it distracts from the core evolution of the G600’s role. (3) The multi-hop reasoning is weak: the original answer requires synthesis of temporal evolution (2022 vs 2023), production status, and technological influence. The LLM mentions steady production and performance but misses the key shift in the G600’s lifecycle stage and its role as a technology platform (e.g., Symmetry Flight Deck being extended to G700/G800/G400). This omission reflects a failure to fully synthesize the product’s strategic evolution. (4) Contextual relevance is high as the answer discusses performance, production, and market position, which are relevant. However, due to the misattribution of delivery numbers and the absence of the product maturity transition and technology spillover, the correctness score is reduced to 6, reflecting partially correct information with significant factual and conceptual gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 484,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to include increased strategic collaboration and financial co-investment to modernize and improve restaurant performance. The Company has engaged in co-investment initiatives with franchisees to accelerate the implementation of restaurant improvements and operating system upgrades, aiming to enhance consumer experiences and drive higher revenue. Additionally, McDonald's has reinforced its commitment to maintaining high standards and consistency across all locations, whether franchised or company-operated, while fostering a collaborative environment that allows for innovation and shared success.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in McDonald's relationship with franchisees from 2022 to 2024, emphasizing increased financial co-investment and strategic collaboration. It accurately reflects the shift from a more passive franchising model to an active co-investment approach aimed at modernization and performance improvement, which aligns with the ground truth. There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—scored as 10. The qualitative accuracy is high: all entities (McDonald's, franchisees), time periods (2022–2024), and strategic developments (co-investment, system upgrades, consumer experience) are correctly identified and logically synthesized. The only minor shortcoming is that the LLM omits the specific detail that in 2022, McDonald's did not typically invest in restaurant capital under developmental licenses—a nuance that strengthens the contrast with the 2024 model. However, the core transformation is clearly and correctly conveyed. Contextual relevance is excellent, as the response directly addresses both financial involvement and strategic collaboration as asked. Semantic equivalence is maintained despite rewording.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 351,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a decline in net revenues, decreasing from $22,476 million in 2022 to $21,756 million in 2023. Operating income remained relatively stable, with a slight decrease from $10,688 million in 2022 to $10,670 million in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values are correct: net revenues of $22,476 million in 2022 and $21,756 million in 2023, and operating income of $10,688 million in 2022 and $10,670 million in 2023. These match the original answer exactly, with acceptable formatting. (2) Quantitative accuracy is perfect—no calculation errors, and the slight decreases are correctly implied. (3) The reasoning is sound: the model correctly identifies a decline in net revenues and a marginal drop in operating income, synthesizing data across two years for the same product segment. (4) The only minor shortcoming is that the LLM describes operating income as 'relatively stable' and 'slight decrease,' which is reasonable but slightly understates the explicit 'declined marginally' phrasing in the ground truth. However, this does not constitute an error—just a subtle difference in emphasis. The answer fully addresses both net revenues and operating income across 2022 and 2023, making it contextually complete and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 303,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within Bristol-Myers Squibb's (BMY) strategy has evolved significantly in terms of collaborative frameworks and new therapeutic approvals. Collaboratively, Opdivo remains central to BMY's immunotherapy (IO) leadership, with joint development and commercialization efforts continuing with Ono in Japan, South Korea, and Taiwan, and expanded partnerships for combination therapies, such as with NKTR-214 (Bempegaldesleukin) in Phase III trials. In terms of approvals, Opdivo has seen multiple new indications, including FDA approval in 2024 for unresectable or metastatic urothelial carcinoma in combination with cisplatin and gemcitabine, and approvals in Japan and the EU for additional indications, reinforcing its role as a key pillar in BMY's oncology portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions and one potential inaccuracy in collaborative framework details. (1) Quantitatively, the key date—March 2024 FDA approval for urothelial carcinoma—is correctly cited, and the combination therapy (cisplatin and gemcitabine) is accurately described. No numerical values (percentages, dollar amounts) are misstated. (2) The answer correctly identifies the continuation of the Ono collaboration in Japan, South Korea, and Taiwan, but omits the specific profit/loss and cost-sharing structure (equal for combinations, 80-20 split for single-party compounds) detailed in the original answer. This is a meaningful detail regarding the evolution of the collaborative framework. (3) The mention of a partnership with NKTR-214 (Bempegaldesleukin) is not present in the ground truth and may be extraneous or outdated; this could reflect a real but less central collaboration, but its inclusion distracts from the core Ono-BMY framework emphasized in the original. (4) The LLM captures the strategic evolution—new FDA approval in 2024 expanding Opdivo’s use—but does not explicitly frame the shift from co-development dependency to BMY-led independent expansion, which is a key qualitative point in the original. (5) The answer is contextually relevant, addressing both collaboration and approvals, and correctly positions Opdivo as a pillar in BMY’s oncology strategy. Overall, core facts and dates are accurate, but the reasoning synthesis is slightly less precise due to missing structural details of the Ono agreement and introduction of an unverified partnership. Hence, a score of 8 is warranted for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 462,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024 by shifting from referencing LIBOR and EURIBOR to SOFR. In 2022, AMT's debt instruments referenced LIBOR or EURIBOR with applicable margins, as seen in its multicurrency credit facilities and term loans. By 2024, the Nigeria Letters of Credit explicitly referenced SOFR as the benchmark rate, with interest calculated as SOFR plus a spread. Additionally, covenants related to maintaining debt service coverage ratios (DSCR) and reserve account requirements remained consistent, but the transition to SOFR reflects a broader industry shift away from LIBOR.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the shift from LIBOR/EURIBOR in 2022 to SOFR in 2024, particularly in the context of Nigeria Letters of Credit, which aligns with the ground truth. It accurately captures the core evolution in benchmark rates. However, it adds unverified details about covenants—specifically claiming that debt service coverage ratios (DSCR) and reserve account requirements 'remained consistent'—which is not supported in the original answer. The ground truth notes a shift in covenant disclosure focus (from specific terms to consequences of non-compliance), not continuity of specific covenants. (2) Quantitatively, no specific numbers (percentages, fees, dates) are misstated. The LLM avoids citing exact commitment fees or rating tiers from 2022, so there is no numerical inaccuracy, though it omits the 0.080%–0.300% fee range mentioned in the original. The absence of incorrect numbers supports a high quantitative accuracy score. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the transition from LIBOR to SOFR across years and geographies. However, it fails to reflect the nuanced evolution in covenant disclosure—shifting from detailed terms (renewals, fees) to high-level consequences—which is a key part of the original answer. Instead, it asserts covenant consistency, which is a misinterpretation. (4) The answer is contextually relevant and addresses the main thrust of the question, but the incorrect inference about covenants reduces qualitative and overall correctness. The answer would score higher if it had noted the change in disclosure depth or focus rather than asserting continuity of specific covenants.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 461,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "Between 2022 and 2024, McDonald's continued to emphasize its co-investment strategy with franchisees, particularly in real estate ownership, to enhance restaurant performance and brand value. The company generally owns or secures long-term leases for land and buildings in conventional franchise arrangements, while franchisees invest in equipment, signs, and décor. This collaborative approach ensures consistency, quality, and modernization of restaurants, aligning with consumer preferences and driving profitability. McDonald's also co-invests with franchisees to accelerate improvements, reflecting a continued focus on shared growth and long-term value creation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in describing McDonald's conventional franchise model where the company owns or secures long-term leases on land and buildings, and franchisees invest in equipment, signs, and décor. It correctly identifies the co-investment strategy and its purpose in driving restaurant performance and brand value. There are no numeric inaccuracies (quantitative accuracy is perfect), and the context is highly relevant to the question about real estate ownership and co-investment evolution. However, the LLM answer misses a key nuance from the original answer: in 2022, McDonald's emphasized ESG-related coordination with franchisees without detailing real estate roles, whereas by 2024, the real estate and co-investment model was explicitly defined. The LLM implies continuity ('continued to emphasize') rather than capturing the evolution from a general collaborative emphasis to a more structured, clearly articulated real estate strategy. This omission affects qualitative accuracy and completeness, as the multi-hop reasoning across 2022 and 2024 is not fully reflected. While the core facts are correct, the developmental shift in the relationship is underemphasized, preventing a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 342,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective October 26, 2022, as noted in the 2022 filing, and this updated version remained in place in 2023. The lack of further amendments between 2022 and 2023 suggests a stable and deliberate approach by Altria to director compensation governance, indicating a focus on maintaining consistent and long-term equity-based incentives for non-employee directors without recent material changes.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key event—the amendment and restatement of the 2015 Stock Compensation Plan for Non-Employee Directors effective October 26, 2022—and notes its continued status in 2023. The date (October 26, 2022) matches the ground truth, and the reference to the 2022 filing aligns with the incorporation by reference from the September 30, 2022, Form 10-Q. However, the LLM omits the specific quantitative detail from 2022: that 703,256 shares were available for issuance under the plan. This omission affects completeness and factual richness. (2) Quantitatively, no incorrect numbers are stated, but the absence of the share count reduces accuracy in conveying full factual content. There are no calculation errors because no calculations are attempted. (3) The reasoning is partially sound but diverges in interpretation: while the ground truth infers that the mid-cycle amendment suggests Altria refined its compensation framework—possibly due to governance updates or strategic shifts—the LLM interprets the lack of further changes in 2023 as indicating stability and consistency. This is a plausible interpretation but contradicts the ground truth’s emphasis on active refinement. The LLM fails to recognize that a formal restatement in late 2022, incorporated into 2023 disclosures, reflects an evolution, not stagnation. Thus, the multi-hop synthesis is incomplete: it connects the amendment to 2023 status but misses the significance of the change itself. (4) The answer is contextually relevant and addresses both parts of the question—status/documentation changes and governance implications—but provides an incomplete and somewhat misleading qualitative analysis due to omission of key data and misinterpretation of the governance signal. Hence, correctness is partially compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 496,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "The impact of roaming and resale arrangements among wireless service providers on American Tower Corporation's (AMT) leasing activity has intensified from 2022 to 2024, as these arrangements have increasingly allowed carriers to share infrastructure rather than deploy new equipment or lease additional space. This trend, driven by advanced technologies like 5G and RAN sharing, has led to slower new lease growth and potential decommissioning of equipment on existing sites. This evolution indicates heightened competitive pressures, as carriers seek cost efficiencies through shared infrastructure, reducing the demand for AMT's leasing services and challenging its growth prospects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: the evolution from 2022 to 2024 is properly captured, with roaming/resale arrangements initially slowing new lease activity and later expanding to include RAN sharing and potential decommissioning. The role of 5G and infrastructure sharing as a cost-saving measure is correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes the progression of risk over time (2022 → 2024) and correctly infers the implication for competitive pressures and growth challenges. The mention of RAN sharing in 2024 aligns with the original. (4) The only minor difference is that the LLM slightly condenses the explanation of competitive pressures without explicitly stating that infrastructure sharing has become 'more viable and widespread,' though this is implied in 'cost efficiencies through shared infrastructure.' This does not affect factual correctness but slightly reduces qualitative depth. Overall, the answer is contextually precise, fully relevant, and captures the core evolution and implications as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 366,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to emphasize strategic investment and operational alignment. The Company has increasingly co-invested with franchisees to modernize restaurants and enhance customer experiences, reflecting a shared commitment to innovation and performance. Additionally, McDonald's has reinforced operational expectations through rigorous standards and collaboration, ensuring franchisees meet brand requirements while benefiting from the Company's global resources and expertise. This approach strengthens the System's ability to deliver consistent, high-quality service and drive long-term growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth and captures the core evolution in McDonald's relationship with franchisees from 2022 to 2024. It correctly identifies the shift toward strategic co-investment and operational expectations. While it does not explicitly mention the 'Accelerating the Arches' strategy or the pandemic-related challenges (labor, supply chain) emphasized in 2022, it accurately reflects the 2024 focus on co-investment, restaurant modernization, and operational alignment. There are no numerical inaccuracies—no specific numbers (e.g., dollar amounts, percentages) are present in either answer, so quantitative accuracy is not compromised. The qualitative reasoning is sound and reflects multi-hop synthesis between years and strategic priorities, though it omits some contextual nuance from 2022. The answer remains semantically aligned with the original and fully addresses the question's focus on strategic investment and operational expectations. The omission of pandemic context slightly reduces completeness but does not undermine the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 311,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "NextEra Energy's investment strategy in equity securities within its Special Use Funds showed significant growth from 2022 to 2024. In 2022, the equity securities held in Special Use Funds were valued at $5,290 million (NEE) and $3,536 million (FPL). By 2024, these values increased to $6,164 million (NEE) and $4,219 million (FPL), indicating a more aggressive or expanded allocation to equity securities during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, NextEra Energy reported $8,922 million in total Special Use Funds with no explicit breakdown of equity securities. However, the LLM incorrectly claims that $5,290 million (NEE) and $3,536 million (FPL) were allocated to equity securities in 2022, which is not supported by the original data. The sum of those figures ($8,826 million) is close to the total Special Use Funds but misrepresents the lack of disclosed equity allocation in 2022. In 2024, the LLM correctly identifies $6,164 million in equity securities for NEE but fabricates $4,219 million for FPL, which is not mentioned in the ground truth. (2) Quantitative accuracy is low: the 2022 equity values are entirely incorrect, and the FPL figure in 2024 is unsupported. The only correct number is $6,164 million for NEE in 2024. Calculations or comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed. The original answer infers a shift toward transparency and strategic emphasis due to the emergence of a specific equity allocation in 2024 versus no breakdown in 2022. The LLM instead assumes granular data was available in 2022 and fabricates subsidiary-level figures, failing to recognize the qualitative shift in disclosure. It also introduces FPL (a subsidiary) without justification, which is not part of the original reasoning. (4) Contextual relevance is moderate because the answer addresses investment strategy evolution and uses the correct company and time frame, but the incorrect data and reasoning undermine the conclusion. The claim of 'significant growth' and 'expanded allocation' is not supported by valid comparison, as the 2022 equity figure is invented. Thus, while the direction of analysis (assessing change over time) is appropriate, the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 523,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a slight decline in net revenues, decreasing from $22,476 million in 2022 to $21,756 million in 2023. Operating income remained relatively stable, with a minor decrease from $10,688 million in 2022 to $10,670 million in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: net revenues decreased from $22,476 million in 2022 to $21,756 million in 2023, and operating income declined from $10,688 million to $10,670 million. These values match the ground truth exactly. (2) All numeric values are accurate and properly formatted; differences are correctly implied (a decrease of $720 million in revenue and $18 million in operating income), though not explicitly calculated, which is acceptable. (3) The reasoning is sound—describing a 'slight decline' in revenues and 'relatively stable' operating income with a 'minor decrease' aligns with the marginal changes observed. While the original answer emphasizes a 'marginal decrease in both revenue and profitability', the LLM captures the same essence, though slightly understates the operating income decline by calling it 'relatively stable'. This is a minor qualitative nuance, not a factual error. (4) The answer is fully relevant, addressing both net revenues and operating income across the two years as required. No extraneous or missing context. The slight softening of the operating income change prevents a perfect 10, but overall accuracy is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 342,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "Between 2022 and 2023, Accenture plc increased its share repurchase authority significantly, from $3,129,296 as of August 31, 2022, to $6,129,296 by September 2022, indicating a more aggressive approach to share buybacks. In 2022, the company repurchased 12,180,917 Accenture plc Class A ordinary shares for $4,111,266 under open-market and other share purchase programs, primarily to support employee benefits and equity awards. While specific 2023 repurchase figures are not provided in the given pages, the increased authorization suggests a continued focus on reducing shares outstanding and potentially enhancing shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, Accenture had an aggregate available authorization of $3,129,296 for share purchase programs, but the LLM incorrectly claims this amount was increased to $6,129,296 by September 2022 — this figure is not present in the ground truth and represents a major fabrication. Additionally, the LLM asserts that in 2022, Accenture repurchased 12,180,917 shares for $4,111,266, which is not mentioned in the original answer and lacks support from the provided knowledge. (2) The quantitative inaccuracies are severe: the only number confirmed in the ground truth is the $3,129,296 authorization in 2022; all other figures (increase in authorization, number of shares repurchased, dollar value of repurchases) are either invented or incorrectly inferred. There is no mention of a $6.1 billion increase or any actual repurchase volume in the original answer. (3) The multi-hop reasoning is flawed. The original answer emphasizes a shift in *usage* of repurchased shares — from general buybacks to being held as treasury shares for employee benefits — and notes a separate mechanism (share withholding for tax obligations) in fiscal 2024. The LLM misses this key evolution in *intended usage* and instead focuses on unverified repurchase volumes and an unsubstantiated increase in authorization, failing to capture the core shift toward internal compensation mechanisms. (4) While the LLM correctly identifies that repurchased shares are used for employee benefits and equity awards (partially aligning with the original), it introduces unsupported data and misses the nuanced evolution in share utilization strategy. The contextual relevance is moderate because it addresses share purchase programs and employee benefits, but the severe factual and quantitative errors undermine correctness. Correctness score is low due to invented numbers and failure to reflect the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 543,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "Between 2022 and 2024, the nature and structure of AMT's operating covenants evolved with a continued reliance on fixed-rate senior notes and securitized debt instruments, while interest rate benchmarks remained primarily tied to LIBOR and EURIBOR. In 2022, AMT had a diverse mix of senior notes with varying coupon rates and maturities, with interest payments typically tied to fixed rates or adjustments based on credit ratings. By 2024, AMT maintained a similar structure, issuing additional fixed-rate senior notes and securitized debt, such as the 2023 Securitization, with interest rates set at fixed percentages (e.g., 5.490% for Series 2023-1A Securities). Operating covenants in both periods included debt service coverage ratios and restrictions on additional indebtedness, with AMT maintaining compliance in 2024. The use of LIBOR and EURIBOR persisted for certain term loans, but no transition to alternative benchmarks was indicated during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in key aspects. (1) It claims that AMT continued to use LIBOR and EURIBOR as primary benchmarks through 2024 with no transition to alternative rates, while the ground truth explicitly states a shift to SOFR for Nigerian letters of credit by 2024, reflecting the post-LIBOR transition. This is a major factual error. (2) The LLM introduces specific fixed-rate instruments like '5.490% for Series 2023-1A Securities' and mentions a '2023 Securitization'—details not present in the original answer and unsupported by the provided truth. These specific percentages and instruments are unverified and appear fabricated. (3) The qualitative reasoning fails on multi-hop synthesis: the question asks about evolution in covenants related to debt instruments and interest rate benchmarks, but the LLM misses the critical shift from LIBOR/EURIBOR to SOFR, which is the central point of the original answer. Instead, it asserts continuity where there was change. (4) While the LLM correctly identifies that operating covenants involve debt service ratios and restrictions, this generic detail does not compensate for the core inaccuracy about benchmark transitions. Contextual relevance is moderate because it addresses debt instruments and covenants, but the failure to report the SOFR transition—a key regulatory and structural evolution—severely undermines correctness. Overall, the answer reflects a fundamental misunderstanding of the shift away from LIBOR, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 425,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar's subscriber base remained relatively stable, with approximately 36 million paid subscribers as of September 28, 2024, compared to data from the prior year. The consolidation of Star+ into Disney+ in Latin America at the end of June 2024 streamlined Disney's international streaming strategy by unifying its offerings, enhancing operational efficiency, and potentially increasing the subscriber base by merging existing Star+ and Disney+ users into a single platform. This move reflects Disney's broader strategy to simplify its global streaming portfolio and better compete in international markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Disney+ Hotstar had approximately 36 million paid subscribers as of September 28, 2024, matching the ground truth. However, the phrasing 'compared to data from the prior year' implies a year-over-year comparison, but the original answer does not provide the 2023 subscriber number, so the claim of stability is an inference not directly supported by the source. This is a minor overreach but not factually incorrect. (2) The date of the consolidation—end of June 2024—is accurately reported, and the integration of Star+ into Disney+ in Latin America is correctly described. All numeric values (36 million, June 2024) are correct and match the ground truth. (3) The reasoning about the strategic impact—streamlining offerings, enhancing efficiency, simplifying the global portfolio—is consistent with the original answer’s interpretation of a strategic shift toward unified branding and operational efficiency. The LLM adds a slight inference that the merger could 'potentially increase the subscriber base,' which is plausible but not explicitly stated in the original; this is a reasonable extension but not confirmed by the source. (4) The answer fully addresses both parts of the question: subscriber base evolution and strategic impact of the Star+ consolidation. It synthesizes information correctly across time and regions, though with minor interpretive additions. Overall, the answer is factually sound, well-aligned with the ground truth, and only slightly exceeds the original claims with logical inferences. Hence, high scores across the board with a small deduction in qualitative accuracy for the unsubstantiated subscriber growth implication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 464,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "The number of employees covered under collective labor agreements decreased from approximately 3,000 in 2022 to 2,100 in 2023. This indicates that the company is renegotiating fewer labor agreements in 2024 compared to 2022, suggesting a more stable or streamlined labor agreement strategy, with potentially fewer disruptions to operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the decrease in the number of employees covered under collective labor agreements from approximately 3,000 in 2022 to 2,100 in 2023, matching the ground truth. The numbers are accurate and properly contextualized. (2) Quantitative accuracy is perfect: both values (3,000 and 2,100) are correct, and the direction of change (decrease) is accurately described. There are no calculation errors. (3) The reasoning is sound and captures the core implication—that fewer employees are undergoing renegotiation, suggesting a more stable or streamlined labor strategy. While the original answer mentions a possible reason (fewer expiring agreements or proactive resolution), the LLM infers 'potentially fewer disruptions to operations,' which is a reasonable and contextually appropriate interpretation. The slight difference in explanatory detail does not detract from the correctness. (4) The answer fully addresses both parts of the question: the change in employee numbers and the strategic implication. It synthesizes information across years correctly, demonstrating effective multi-hop reasoning. The wording differs slightly but maintains semantic equivalence. Minor deduction in qualitative accuracy due to slightly less specific rationale compared to the original, but overall highly accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 377,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "NextEra Energy's investment in U.S. Government and municipal bonds decreased from 2022 to 2024. In 2022, the total value was $177 million, while in 2024, it was $722 million. This represents an increase of $545 million over the two-year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It states that NextEra Energy's investment decreased from 2022 to 2024, which contradicts both the ground truth and its own numbers (showing an increase from $177M to $722M). The reported values are wrong: ground truth shows $137M in 2022 and $161M in 2024, but LLM reports $177M and $722M respectively. The calculated change of $545M is incorrect; the actual change is $24M. (2) All numeric values are factually wrong—both the starting and ending investment amounts and the difference. The percentage change (17.5% in ground truth) is not mentioned. Even the direction of change is misstated despite the numbers implying an increase. (3) The multi-hop reasoning failed completely: the model did not correctly retrieve or synthesize the correct figures across years, and the conclusion contradicts the (incorrect) data it presented. (4) Scores are low because of pervasive factual and logical errors. Contextual relevance is slightly above zero because the answer addresses the right company and asset class, but all substantive content is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 316,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "Between 2022 and 2024, Opdivo's role in Bristol-Myers Squibb's portfolio has evolved with expanded therapeutic approvals and a shift in manufacturing strategy. In 2024, Opdivo received FDA approval for Opdivo Qvantig, a subcutaneous formulation, and gained approvals for new indications, including unresectable urothelial carcinoma and NSCLC. Additionally, Opdivo's manufacturing strategy has incorporated both internal capabilities and third-party manufacturers to meet demand, reflecting a broader trend of leveraging external partners for supply chain flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continued use of both internal and third-party manufacturing for Opdivo, aligning with the 2022 ground truth. It also correctly notes expanded therapeutic approvals by 2024. However, it introduces 'Opdivo Qvantig' and approvals for NSCLC without specific mention in the ground truth, which only confirms the March 2024 FDA approval for first-line treatment of unresectable or metastatic urothelial carcinoma in combination with cisplatin and gemcitabine. The subcutaneous formulation (Opdivo Qvantig) and NSCLC indication are not mentioned in the original answer, making them unverified additions. (2) The date of the urothelial carcinoma approval (March 2024) is consistent with the ground truth, but the LLM does not specify this date, reducing precision. No numerical data (e.g., financials) are present, so quantitative accuracy hinges on correct dates and indications—partially met. (3) The multi-hop reasoning is sound in linking manufacturing strategy and therapeutic expansion over time, but the inclusion of unmentioned indications weakens the synthesis accuracy. The core evolution—broader clinical use and hybrid manufacturing—is correctly inferred. (4) The answer is contextually relevant and well-structured, addressing both manufacturing and approvals. Despite extra details, the central facts about Opdivo’s growing role are directionally accurate. Scored 7/10 for correctness due to unsupported additions, though key elements are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 416,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "Between 2023 and 2024, National Geographic magazine remained under the Entertainment segment, specifically within the Content Sales/Licensing business, and was reported as being 73% owned by Disney. There is no indication of structural changes to Disney's ownership or strategic positioning of National Geographic magazine during this period. Additionally, National Geographic Channels continued to operate as part of the Linear Networks division, focusing on documentary, science, and history programming. Thus, its role within Disney's portfolio remained consistent in terms of business structure and strategic positioning.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. While it correctly states that National Geographic magazine was 73% owned by Disney in 2023 and remained under Content Sales/Licensing within the Entertainment segment, it claims there was 'no indication of structural changes'—which directly contradicts the ground truth. The ground truth identifies a meaningful shift in 2024: the removal of the 73% ownership disclosure and a recharacterization of the relationship from one of equity ownership to a more operational 'published by' framing. This indicates a strategic and reporting shift, which the LLM answer fails to recognize. (2) Quantitatively, the 73% ownership figure is accurate for 2023, and the segment classification (Entertainment, Content Sales/Licensing) is correct for both years. However, the LLM incorrectly implies continuity in ownership emphasis, which is not supported by the 2024 filing. (3) The multi-hop reasoning is flawed: the model should have compared the language and disclosures between the 2023 and 2024 filings to detect the shift in how Disney characterizes its relationship with National Geographic. Instead, it assumes consistency without acknowledging the change in reporting tone and ownership emphasis. (4) Contextual relevance is moderate—the answer addresses the right segments and timeframes and mentions relevant business units, but misses the key strategic evolution in Disney's positioning of National Geographic, rendering the overall assessment misleading. Correctness and qualitative accuracy are low due to the failure to identify a critical change in business structure interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 454,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024 to emphasize enhanced global payment processing across a broader range of currencies. In 2023, PayPal's platform enabled transactions in approximately 140 currencies and allowed withdrawals in 57 currencies. By 2024, the platform expanded to support transactions in approximately 150 currencies and withdrawals in 56 currencies, reflecting an increase in the number of currencies supported for global payment processing. This evolution highlights PayPal's ongoing investment in improving the scalability and flexibility of its technology infrastructure to better serve its global user base.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023 PayPal allowed withdrawals in 56 currencies, increasing to 57 in 2024. The LLM incorrectly states that in 2023 withdrawals were possible in 57 currencies and decreased to 56 in 2024, reversing the trend. Additionally, the LLM introduces 'approximately 140' and '150' currencies for transaction support, which are not mentioned in the original answer and contradict the withdrawal currency counts. These numbers are unsupported by the ground truth and represent a major factual deviation. (2) The quantitative inaccuracies are severe: the direction of change (increase vs decrease) in withdrawal currencies is reversed, and entirely new figures for transaction currencies are fabricated without basis in the provided information. Calculations or comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed. While the question asks about evolution in PayPal's description of its databases' capabilities related to multi-currency processing, the LLM fails to correctly track the actual change (56 to 57 withdrawal currencies) and misses the qualitative shift in language (consumer-centric framing, order of 'consumers' before 'merchants') highlighted in the original answer. The model invents a narrative around transaction currency expansion that is not supported by the evidence. (4) Contextual relevance is moderate because the answer addresses the general topic of PayPal's global payment processing evolution, but the incorrect data and invented metrics undermine its usefulness. The qualitative aspects of PayPal's descriptive evolution are entirely missed, leading to a low correctness score despite some topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 482,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The interest rate on the Series K Debentures increased from 4.60% in 2023 to 6.051% in 2024, reflecting a significant rise in borrowing costs. This increase indicates that NEE faced higher interest rates in the market during 2024, likely due to broader macroeconomic factors such as rising inflation or Federal Reserve rate hikes. The adjustment in the interest rate suggests that NEE is proactively managing its debt obligations through remarketing strategies to align with current market conditions, demonstrating a flexible and adaptive financing strategy to maintain access to capital.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the stated 2023 interest rate. The ground truth indicates that the Series K Debentures were reset to 6.051% in March 2023 as part of a remarketing, not that the rate was 4.60% in 2023. The LLM incorrectly implies a rate increase from 4.60% to 6.051% between 2023 and 2024, when in fact the 6.051% rate was already effective in March 2023. The 2024 update merely confirmed the continuation of the terms set in March 2023. (2) The quantitative inaccuracy is critical: the LLM fabricates a 4.60% rate for 2023 with no support in the ground truth. The correct rate in 2023 (post-remarketing) is 6.051%, and this same rate carried into 2024. There is no actual rate change between 2023 and 2024. (3) The reasoning is partially sound—tying the rate adjustment to market conditions and remarketing is consistent with the ground truth—but it misrepresents the timeline and nature of the change. The multi-hop synthesis fails because it misidentifies when the rate change occurred and invents a prior rate. (4) The contextual relevance is high, as the answer addresses both parts of the question—rate evolution and financing strategy—and provides a plausible interpretation. However, due to the core numerical inaccuracy, the correctness score is limited to 5. The qualitative accuracy is moderate because the conceptual understanding of remarketing and adaptive financing is present, but based on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 408,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "ExxonMobil's application of the Unit-of-Production Depreciation method between 2022 and 2023 remained consistent in its core approach, with depreciation calculated based on proved reserves for upstream assets. However, changes in proved reserves and asset life assumptions influenced the method's application. In 2023, the Corporation noted that if proved reserves for a property are substantially de-booked and continue to produce, it will use a unit-of-production method based on reserves determined at the most recent SEC price to ensure a more meaningful allocation of costs. This adjustment reflects a response to reserve changes driven by updated price assumptions and production profiles, ensuring equitable cost allocation over the asset's economic life. There is no indication of a shift to alternative methods like straight-line depreciation for most upstream assets during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: ExxonMobil maintained the unit-of-production (UOP) method in both 2022 and 2023, using proved reserves as the basis, with a refinement in 2023 to use the most recent SEC price when reserves were substantially de-booked. The answer correctly notes that straight-line depreciation is used when asset life does not correlate with reserves, though it slightly underemphasizes this point by stating 'no indication of a shift' rather than affirming its continued conditional use as in the original. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all references to years (2022, 2023) and regulatory frameworks (SEC price) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in reserve assumptions, links them to depreciation methodology, and explains the rationale for using updated SEC prices in response to de-bookings. (4) The answer is contextually excellent—directly addressing the evolution of the UOP method in response to reserve and asset life changes. The only minor shortcoming is a slight omission of the explicit 2022 condition about switching to straight-line when asset life and reserves are uncorrelated, though it is not contradicted. Overall, the answer is semantically equivalent with high fidelity to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 400,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "Between 2023 and 2024, Netflix has increasingly emphasized scaling its internal studio operations to produce original programming, as highlighted by its acquisitions of companies like Scanline and Animal Logic. This shift reflects a strategic move to reduce reliance on third-party production partners and enhance in-house capabilities to control content quality, production timelines, and costs. The 2024 filings indicate a stronger focus on managing the complexities of internal studio scaling, including building expertise in creative, marketing, and operational disciplines, while mitigating risks associated with production and content delivery.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Netflix's strategic shift toward internal studio scaling via acquisitions like Scanline and Animal Logic is accurately noted, and the reduced reliance on third-party partners is correctly inferred. The emphasis on managing internal complexity in 2024 is also correctly reflected. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information about strategic emphasis across 2023 and 2024, correctly identifying the evolution from highlighting third-party risks in 2023 to focusing on internal operational scaling in 2024. The omission of third-party risk language in 2024 is implied by the shift in focus, which the LLM captures effectively. (4) The only minor shortcoming is that the LLM does not explicitly mention the *removal* of third-party risk disclosures in 2024, which is a subtle but important signal in the original answer. However, the conclusion of reduced reliance is still logically supported. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 367,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "Between 2022 and 2023, Mastercard's Cyber and Intelligence Solutions evolved from being primarily focused on fraud prevention and transaction safety to becoming a broader, more integrated part of its value-added services. In 2022, these solutions were described as tools to \"allow all parties to transact securely, easily, and with confidence.\" By 2023, the strategic positioning emphasized their role in enabling secure and confident transactions while also integrating with other services that leverage Mastercard's data insights and technology, such as open banking and digital identity solutions. This reflects a shift toward embedding cyber and intelligence capabilities more deeply into the company's ecosystem of payment and data-driven offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Mastercard's Cyber and Intelligence Solutions between 2022 and 2023 with accurate qualitative details and proper context. It correctly identifies the shift from a fraud-focused role in 2022 to a broader, more integrated strategic function in 2023. However, there is a minor inaccuracy in the 2022 description: the LLM claims in 2022 the solutions were described as tools to 'allow all parties to transact securely, easily, and with confidence,' which was actually the 2023 framing per the ground truth. In reality, in 2022, the solutions were categorized under 'Other revenues' and described more narrowly as products and services to prevent, detect, and respond to fraud. The LLM also accurately notes the 2023 expansion into integration with data-driven services like open banking and digital identity, which aligns with the ground truth's mention of supporting new network investments and the broader payments ecosystem. There are no numerical values in the question or answers, so quantitative accuracy is not applicable but assumed correct by default. The reasoning is largely sound and reflects multi-hop understanding across years and strategic positioning. The answer is fully contextually relevant. Due to the misattribution of the 'secure, easily, and with confidence' language to 2022 instead of 2023, a small deduction is made from qualitative and overall correctness, but the core evolution is accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 406,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "From 2023 to 2024, Tesla's approach to energy storage products has evolved by focusing on scaling production and addressing supply chain dependencies. In 2023, Tesla highlighted challenges related to supplier limitations and the need to develop in-house battery cell manufacturing to ensure cost efficiency and scalability. By 2024, Tesla emphasized continued efforts to expand production capacity for energy storage products like Powerwall and Megapack, while also addressing raw material volatility and supplier reliability. Strategic dependencies on suppliers such as Panasonic and CATL remained, but Tesla increasingly prioritized self-sufficiency through proprietary battery cell development and localized manufacturing to mitigate production risks and support global demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's evolving focus from 2023 to 2024 on scaling production and addressing supply chain dependencies, which aligns with the ground truth. However, it introduces specific claims not present in the original answer, such as 'in-house battery cell manufacturing' and 'strategic dependencies on suppliers such as Panasonic and CATL.' These entities and specific strategies (e.g., proprietary battery cell development) are not mentioned in the ground truth and represent unsupported additions. The original answer emphasizes modular design, power electronics, software, and general supplier reliability risks, but does not reference battery cell manufacturing or specific partners. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are incorrect. (3) The multi-hop reasoning is partially sound: the model correctly infers a shift in focus from design/software (implied in 2023) to production and supply chain (2024). However, it overreaches by introducing external knowledge about Panasonic, CATL, and battery cell strategy, which breaks semantic equivalence and introduces factual claims beyond the source. (4) The contextual relevance is high because the answer addresses the evolution in Tesla's approach, production challenges, and strategic dependencies. But qualitative accuracy is reduced due to hallucinated details. Correctness score is 6 due to core accurate themes but significant factual overreach in entity and strategy details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 438,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolved from 2023 to 2024 by increasing the principal amount and extending the maturity structure. In 2023, the company issued $400 million in floating rate debentures due in 2024. By 2024, the principal amount of floating rate debentures increased significantly to $600 million, with maturities extending further out, as evidenced by the issuance of debentures due in 2026. This shift reflects a strategic move toward longer-term financing and a larger capital raise through floating rate instruments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that in 2023, NextEra issued $400 million in debentures due in 2024, while the ground truth specifies $600 million due in 2026. This misrepresents both the principal amount and the maturity date. Additionally, the LLM claims that in 2024 the company 'increased significantly to $600 million' with maturities extending to 2026, implying a change or expansion, but the ground truth indicates no update to the principal amount in 2024—only formalization of the same 2026 maturity via an Officer's Certificate. Thus, the narrative of growth and extension is factually incorrect. (2) Quantitative accuracy is poor: the dollar amounts ($400M vs $600M) and maturity years (2024 vs 2026) are wrong in the 2023 description. The 2024 figures partially align ($600M, 2026), but are framed as a new increase rather than a continuation, distorting the meaning. (3) The multi-hop reasoning fails because the model misinterprets the evolution: instead of recognizing consistency in strategy and maturity structure from 2023 to 2024, it fabricates a shift toward longer-term and larger issuances. There is no evidence in the ground truth of an increase in principal or a change in maturity—only procedural formalization. (4) Contextual relevance is moderate because the answer addresses issuance strategy, principal amount, and maturity structure as asked, but the incorrect data and flawed synthesis undermine the response. Correctness and quantitative accuracy are low due to core factual errors; qualitative accuracy is slightly higher only because the structure of the response follows logical lines, albeit based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 467,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "From 2023 to 2024, Intel's approach to industry initiatives related to supply chain responsibility has evolved by expanding collaboration and increasing the scope of supplier engagement. In 2023, Intel focused on improving transparency around climate and water impacts and advancing responsible minerals sourcing, while also setting industry-wide standards and conducting audits. By 2024, the company significantly expanded the number of suppliers covered by its engagement activities and broadened its focus to include measuring and reducing suppliers' greenhouse gas emissions to support its net-zero upstream Scope 3 emissions goal by 2050. Additionally, Intel increased its commitment to supplier diversity by setting new spending targets with women-owned and minority-owned suppliers globally.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly reverses the timeline and focus of Intel's evolution. According to the ground truth, in 2023 Intel announced an expansion of supplier engagement under its RISE strategy and set a net-zero upstream Scope 3 emissions goal by 2050. In 2024, the focus shifted to deepening collaboration on responsible minerals, climate, and water transparency, without expanding the number of suppliers. The LLM incorrectly states that the expansion of supplier coverage and greenhouse gas measurement happened in 2024, when it was actually initiated in 2023. Additionally, the LLM introduces new information about supplier diversity and spending targets not present in the original answer, which is unsupported by the ground truth. (2) While no specific numerical values (e.g., dollar amounts, percentages) are present, the temporal markers (2023 vs 2024) are factually incorrect in their attribution of initiatives, leading to significant misrepresentation. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the progression from strategic expansion (2023) to consolidation and deepening of partnerships (2024), instead portraying a continued expansion in 2024 that contradicts the ground truth. (4) The contextual relevance is moderate because the answer addresses supply chain responsibility, collaboration, and supplier engagement, but the factual inaccuracies and reversal of the strategic timeline severely undermine correctness. As a result, the overall correctness score is low at 3, with similarly low scores for quantitative and qualitative accuracy due to misattribution of actions across years and introduction of unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 463,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "Between 2022 and 2023, XOM's characterization of the assumptions underlying the standardized measure of discounted future cash flows remained consistent in acknowledging that the first-day-of-the-month average prices used in the calculation represent discrete points in time and can cause significant year-to-year variability in cash flows. However, in 2023, there is a more explicit emphasis on the Corporation's belief that the standardized measure does not provide a reliable estimate of its expected future cash flows or the value of its proved reserves, reinforcing the limitations of relying on this methodology.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in XOM's framing between 2022 and 2023, particularly the shift from 'prepared on the basis of' to 'depends on' the prescribed assumptions. While the LLM correctly notes that first-day-of-the-month prices are discrete points causing variability (present in both years), it incorrectly implies that the 2023 filing introduced a new critique about the reliability of the standardized measure as an estimate of future cash flows or reserve value. The ground truth does not mention any such statement about the Corporation's belief in the unreliability of the measure; instead, it emphasizes a more explicit acknowledgment of dependency on assumptions, especially price points, and their potential to cause variability. The LLM introduces a qualitative limitation (not providing a 'reliable estimate') not present in the original answer, which distorts the nature of the evolution. There are no numerical inaccuracies (hence high quantitative accuracy), and the context of price variability is relevant, but the reasoning misrepresents the multi-hop synthesis by conflating emphasis on sensitivity with a broader skepticism about the measure’s usefulness. Thus, while some factual elements are correct, the core reasoning about the evolution in characterization is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 372,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "Between 2022 and 2023, Mastercard's digital identity solutions evolved by enhancing integration with open banking capabilities and expanding their reach across financial institutions. In 2023, Mastercard partnered with leading financial institutions to launch an ACH payment solution using open banking capabilities, enabling seamless and secure consumer bill payments. Additionally, their open banking platform achieved connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks in Europe. These developments reflect a significant expansion in both functionality and institutional adoption of Mastercard's digital identity and open banking solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 2023 expansion to over 95% of U.S. deposit accounts and ~3,000 European banks is accurately reported, as is the partnership with financial institutions to launch an ACH payment solution using open banking infrastructure. (2) Quantitative accuracy is perfect—both percentages and numbers match the original answer exactly, with no calculation issues. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2023), geography (U.S. and Europe), and functionality (identity, open banking, payments). (4) The only minor omission is that the 2022 context about MA introducing digital identity solutions with consumer protection and consent management principles is slightly underemphasized—the LLM mentions the evolution but does not explicitly recap the 2022 starting point in detail. However, the core progression and integration with open banking are clearly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses evolution, integration, and reach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 328,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to the Solar Roof product has evolved to address production challenges and strategic dependencies. In 2023, the company highlighted the complexities of manufacturing Solar Roof, including supply chain constraints, the need for skilled labor, and the integration of new technologies. By 2024, Tesla emphasized efforts to improve production efficiency and scalability, such as collaborating with real estate developers and builders to streamline installations and expand market reach. Additionally, Tesla has continued to refine its Solar Roof design for durability and aesthetics while working to integrate it with other energy products like Powerwall. However, ongoing challenges such as supplier dependencies and the need for localized manufacturing remain critical to its strategic success.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and factual content compared to the ground truth. (1) Correct elements include the mention of production challenges and integration with Powerwall, which aligns with Tesla's 2023 focus on design maturity and product integration. However, the LLM incorrectly states that in 2023 Tesla 'highlighted the complexities of manufacturing Solar Roof, including supply chain constraints, skilled labor, and new technology integration'—this is not supported by the original answer, which instead emphasized aesthetic appeal and durability, not manufacturing difficulties. (2) There are no numeric values to verify, so quantitative accuracy is unaffected and scores highly. (3) The multi-hop reasoning is flawed: the original answer notes that by 2024, Tesla acknowledged production ramp delays similar to other products and emphasized dependence on mass-market vehicle scaling—a key strategic shift. The LLM instead fabricates initiatives like 'collaborating with real estate developers' and 'localized manufacturing' that are not mentioned in the ground truth. It misses the critical point that Tesla's strategic prioritization of vehicle production may be affecting Solar Roof timelines. (4) While the answer is relevant to the topic and structured around the right themes (production, strategy), it substitutes actual disclosed information with plausible but unsupported details, leading to a moderate correctness score. The failure to accurately represent Tesla's disclosed challenges and strategic dependencies reduces qualitative accuracy significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 445,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "NextEra Energy, Inc. introduced two new Pledge Agreements in 2024. The first was dated June 1, 2024, and the second was dated October 1, 2024. Both agreements involved the same counterparties: Deutsche Bank Trust Company Americas (as Collateral Agent, Custodial Agent, and Securities Intermediary) and The Bank of New York Mellon (as Purchase Contract Agent). These agreements were filed as Exhibits 4(ttt) and 4(vvv) in the 2024 filing, indicating an expansion or continuation of similar arrangements established in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All dates (June 1, 2024, and October 1, 2024) and counterparties (Deutsche Bank Trust Company Americas and The Bank of New York Mellon) are correct. The mention of the 2022 agreement (September 1, 2022) is correctly contextualized as prior to 2023, consistent with the original answer’s reference to 2023 disclosures about earlier agreements. (2) Quantitative accuracy is perfect: all dates and entity names match the ground truth. The LLM adds detail not in the original (specific agent roles and exhibit numbers 4(ttt) and 4(vvv)), which are plausible and do not contradict the truth. (3) Multi-hop reasoning is sound—correctly linking the evolution from prior arrangements to new 2024 agreements with the same counterparties. The only minor omission is not explicitly stating that the 2023 disclosure referred to a 2022 agreement (though it is implied), slightly reducing completeness. (4) The answer is contextually relevant, directly addressing the evolution in timing and counterparties. The added detail enhances clarity without introducing error. Thus, correctness is 9/10 due to near-perfect factual alignment with only slight omission in temporal framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 347,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "Intel's strategic positioning in Edge AI evolved from 2023 to 2024 through enhanced software platform offerings and expanded ecosystem partnerships. In 2024, Intel focused on deploying an edge-native software platform with modular building blocks to enable developers to build, deploy, and manage distributed edge infrastructure and Edge AI applications across multiple verticals. Additionally, Intel strengthened its ecosystem partnerships by collaborating with over 500 network builders and key industry players like Ericsson, Nokia, Cisco, Dell Technologies, HPE, Lenovo, Amazon, Google, and Microsoft to drive the software-defined transformation of networks and edge infrastructure. These efforts reflect Intel's commitment to a scalable, programmable, and secure intelligent edge strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Intel's focus on edge-native software platforms with modular building blocks and ecosystem partnerships in 2024, aligning with the ground truth. However, it misrepresents the timeline by stating that the edge-native platform was a 2024 focus, while the original answer clearly states this was Intel's 2023 emphasis. The evolution into the NEX initiative in 2024, which shifts toward cloud-native software on programmable hardware and general-purpose compute, is omitted. This is a significant conceptual gap in the multi-hop reasoning across years. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors present, hence score of 10. (3) The LLM correctly identifies key partners (Ericsson, Nokia, Cisco, etc.) and the broad direction of software-defined transformation, demonstrating sound entity recognition and partial synthesis. However, it fails to contrast 2023 and 2024 strategies accurately, missing the strategic pivot under NEX and the deeper shift to cloud-native programmability and scalable infrastructure transformation. This weakens the qualitative accuracy. (4) Contextual relevance is high because the response addresses software platforms and partnerships as asked, and stays focused on Edge AI evolution. The correctness score is 7 because core facts about partnerships and platform modularity are accurate, but the misattribution of timing and omission of the NEX-driven strategic evolution constitute a meaningful, though not fundamental, error in multi-hop understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 436,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "The composition and value of CVS's long-term debt related to the 1.75% senior notes due August 2030 remained unchanged between 2023 and 2024. Both years report a value of $1.25 billion for these notes, indicating no new issuance, redemption, or material changes in their principal amount during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the value of the 1.75% senior notes due August 2030 remained unchanged at $1,250 million (reported as $1.25 billion) in both 2023 and 2024, which matches the ground truth exactly. This demonstrates full quantitative accuracy. (2) All numeric values—$1.25 billion (equivalent to $1,250 million), the interest rate (1.75%), and the maturity date (August 2030)—are correct and properly formatted. There are no calculation errors. (3) The reasoning is sound: the LLM correctly infers no issuance or redemption occurred due to the stable principal, which is a valid qualitative interpretation. However, the original answer also mentions other senior notes due in 2030 (e.g., 3.75% due April 2030), which remained stable at $1,500 million—this contextual detail about broader 2030 debt composition is omitted in the LLM response, slightly reducing completeness and qualitative accuracy. (4) Despite this minor omission, the LLM fully addresses the specific focus on the 1.75% notes, maintains semantic equivalence, and stays highly relevant. The answer is factually correct and well-reasoned, warranting a high score with only a small deduction for incomplete coverage of the broader debt composition mentioned in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 356,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "Between 2023 and 2024, Netflix's ad-supported subscription plan became a more integral part of its pricing strategy and membership growth objectives. In 2023, the plan was introduced as a lower-priced option to attract price-sensitive consumers while expanding access to its service. By 2024, the plan was emphasized as part of Netflix's broader strategy to offer a range of pricing plans that meet diverse consumer needs, with a focus on driving membership growth and enhancing value perception. The plan also supported efforts to manage costs and increase revenue per paying membership, particularly in a competitive and macroeconomically challenging environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix introduced the ad-supported plan in 2023 as a lower-priced option to attract price-sensitive users and expand membership, and by 2024 it became a core part of the pricing strategy. The answer correctly captures the evolution from an experimental offering to a strategic, integrated component aimed at diverse consumer needs and sustained growth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes the plan’s introduction in 2023 and its strategic entrenchment in 2024, correctly linking it to broader objectives like value perception, competitive positioning, and membership growth. The only minor gap is that the LLM mentions 'managing costs' and 'increasing revenue per paying membership,' which, while plausible, are not explicitly stated in the ground truth and slightly extend beyond it. However, this does not constitute a factual error but rather a small addition in interpretation. (4) The answer is fully contextually relevant, directly addressing both the pricing strategy evolution and membership growth objectives across the two years. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the original answer, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 417,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to the Tesla Semi evolved from early production and deliveries in 2023 to entering pilot production in Nevada by 2024. In 2023, the Semi was mentioned as part of Tesla's planned electric vehicles with no specific production status provided, while in 2024, it was explicitly listed as in \"Pilot production,\" indicating progress toward scaling manufacturing and preparing for broader commercial deployment. This shift reflects Tesla's strategic focus on expanding its commercial vehicle offerings and leveraging its manufacturing capabilities to support future growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution from early production/deliveries in 2023 to pilot production in 2024 at the Nevada facility, which aligns with the ground truth. However, it inaccurately states that in 2023 'no specific production status was provided,' which contradicts the original answer stating Tesla had 'begun early production and deliveries'—a clear production status. This is a factual omission affecting qualitative accuracy. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable; however, all mentioned years (2023, 2024) are correct and contextually accurate. (3) The multi-hop reasoning is mostly sound—linking production status changes across years and inferring strategic intent—but the misrepresentation of 2023 status weakens the synthesis. The model correctly infers strategic progression toward scaling, which is consistent with the ground truth. (4) The answer is contextually relevant and well-structured, but the error regarding 2023 production status prevents a higher score. Correctness is partially impacted due to this key factual inaccuracy, though the core progression (early to pilot production) is correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 349,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggests a deliberate focus on ensuring leadership continuity and reinforcing the company's commitment to retaining key executive talent. By extending and adding new agreements for executives such as Nicole J. Daggs and Brian Bolster, the company emphasizes its strategic emphasis on securing experienced leadership to support long-term goals and operational stability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in its interpretation but contains significant factual inaccuracies. The original answer states that in 2023, NextEra Energy had retention agreements with Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (February 15, 2023), and in 2024 added Brian Bolster (May 6, 2024). The LLM incorrectly claims Nicole J. Daggs was included in the expansion, which is not supported by the ground truth. This is a critical entity error. (2) The dates and number of executives are not fully accurate: the LLM omits Lemasney and Pimentel, who were key to the 2023 baseline, and incorrectly adds Daggs instead of correctly identifying only Bolster as the new 2024 addition. There are no numerical calculations in this question, but the timeline and count of executives are misstated. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that expanding retention agreements suggests a strategic focus on leadership continuity and talent retention, which aligns with the original answer’s conclusion. However, because it relies on incorrect entities, the synthesis is flawed. (4) The contextual relevance is high, as the answer addresses the strategic implications of retention agreements. Qualitative accuracy is moderate due to correct reasoning but incorrect supporting facts. Quantitative accuracy is low due to incorrect identification of individuals and timeline details. Correctness score is 6 because the core idea (increased focus on retention) is valid, but key factual support is wrong, reducing overall reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 437,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "From 2023 to 2024, Intel's approach to xPU products has evolved with a stronger strategic focus on product competitiveness and AI integration. In 2023, the company emphasized expanding its xPU portfolio, including client and data center GPUs, IPUs, FPGAs, and accelerators, to meet diverse computing needs. By 2024, Intel further prioritized AI by positioning itself to address the entire AI continuum, from large language models to edge AI, and announced the formation of an x86 ecosystem advisory group to enhance compatibility and innovation. Additionally, Intel has increasingly leveraged third-party foundries for certain products to improve flexibility and performance, reflecting a more agile and diversified product development strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Intel's strategic evolution in xPU development from 2023 to 2024, noting increased focus on product competitiveness and AI integration. It accurately mentions the x86 ecosystem advisory group formed in 2024 and correctly lists key xPU components (GPUs, IPUs, FPGAs, accelerators). However, it omits the specific $16.0 billion R&D expenditure in 2023 mentioned in the ground truth, which is a key quantitative anchor for the strategic context. Additionally, while the LLM mentions leveraging third-party foundries for flexibility, this detail is not present in the original answer and may reflect inference or external knowledge not supported by the ground truth, introducing a potential factual overreach. (2) There are no incorrect numbers or dates; the absence of the $16.0B R&D figure is a completeness issue rather than a quantitative error. No calculations were required. (3) The multi-hop reasoning is partially sound—linking xPU strategy evolution across years and identifying organizational changes like the advisory group shows good synthesis. However, the shift from general R&D challenges (delays, cost overruns) to structured product development in 2024 is underemphasized, weakening the contrast between years. (4) The answer remains contextually relevant and captures the core strategic shift, but the omission of key financial data and introduction of unverified elements (third-party foundries) reduce qualitative accuracy. Wording differences are acceptable, but missing the R&D investment weakens the factual foundation of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 440,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "Between 2023 and 2024, Netflix's approach to advertising technology has evolved with a focus on developing the necessary infrastructure and organizational capabilities to support its advertising initiatives. In 2023, the company highlighted the early-stage nature of its advertising efforts and the risks associated with generating advertising revenue, including the need to develop technology and related infrastructure to support advertising and drive value for advertisers. By 2024, Netflix emphasized its progress in building out an advertising technology platform, including the development of tools to improve measurement and analytics for advertisers, as well as the expansion of its advertising sales organization. This indicates a shift from initial planning and risk assessment in 2023 to active investment and infrastructure development in 2024 to scale its advertising business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Netflix's 2023 emphasis on limited experience, risks in ad tech development, and reliance on third parties is accurately reflected, as is the 2024 shift toward internal development of advertising technology and sales teams. While the LLM does not explicitly mention 'third-party service providers' or 'attracting and retaining advertisers' from the 2023 context, it correctly captures the core risks and early-stage challenges. The 2024 evolution is accurately portrayed with emphasis on building internal infrastructure, tools for measurement/analytics, and expanding the sales organization—consistent with the original answer’s focus on developing 'advertising sales and advertising technology organization team' and 'technology and related infrastructure'. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but temporal references (2023, 2024) are correct. (3) The multi-hop reasoning—comparing Netflix’s strategic posture across two years and synthesizing organizational and infrastructural developments—is sound and correctly executed. The LLM infers a logical progression from risk assessment to active investment, which is supported by the ground truth. (4) The answer is contextually excellent, directly addressing both organizational development and infrastructure investment as asked. The only minor shortcoming is the omission of explicit mention of third-party dependencies in 2023, which slightly reduces qualitative completeness, but the overall semantic meaning and strategic trajectory are preserved. Hence, a correctness score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 480,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to free Supercharging programs remained consistent in terms of revenue recognition, with revenue being recognized over time on a straight-line basis as the company has a stand-ready obligation to deliver the service. The deferred revenue related to free Supercharging programs increased slightly from $3,536 million at the beginning of 2024 to $3,599 million at the end of 2024, indicating a modest expansion or continuation of the program structure during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Tesla's approach to revenue recognition for free Supercharging remained consistent between 2023 and 2024. The ground truth states there was a structural shift: in 2023, free Supercharging was bundled into Automotive Sales Revenue and recognized over time, but by 2024, Tesla began deferring revenue for features like free Supercharging and recognizing them as liabilities to be amortized, indicating a change in accounting treatment. The LLM incorrectly asserts continuity, missing this key evolution. (2) The quantitative data about deferred revenue increasing from $3,536 million to $3,599 million in 2024 may be numerically accurate (if derived from actual filings), but it is not present in the ground truth and does not support the incorrect conclusion of consistency. Since the original answer does not mention these figures, their relevance cannot be verified, but their use to imply no structural change contradicts the known shift in revenue recognition policy. (3) The multi-hop reasoning fails: the question asks for a comparison across 2023 and 2024 regarding program structure and revenue recognition, requiring synthesis of changes over time. The LLM fails to identify the shift from bundling to deferral and amortization, which is the central point of the ground truth. Instead, it assumes consistency, demonstrating flawed reasoning. (4) While the answer discusses revenue recognition and mentions Supercharging, it misrepresents the evolution, leading to a low correctness score. Quantitative accuracy is moderate due to plausible numbers, but qualitative accuracy is low due to incorrect interpretation and missing the key change. Contextual relevance is fair as it addresses the topic but with wrong conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 490,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, with a shift in maturity dates and coupon structures. In 2023, the Series O Debentures had a long maturity of May 1, 2079, with a fixed coupon rate of 3.50%. By 2024, the maturity dates of newly issued debentures were notably shorter, such as the Series Q and R debentures maturing in 2054, and the coupon structures diversified to include higher fixed rates (e.g., 4.85%, 5.05%) and even floating-rate options. This shift suggests a strategic move toward more flexible and potentially cost-effective financing, possibly to better align with current market conditions and long-term capital planning needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, the Series O Junior Subordinated Debentures had no explicit coupon rate disclosed and a maturity date of May 1, 2079. However, the LLM incorrectly states a fixed coupon rate of 3.50% for 2023. In 2024, the ground truth specifies a coupon rate of 5.55% and a maturity date of November 1, 2029, but the LLM instead references Series Q and R debentures (not mentioned in the question or ground truth) with maturities in 2054 and different coupon rates (4.85%, 5.05%), which are factually incorrect and irrelevant to Series O. (2) Quantitative accuracy is severely compromised: the 2023 coupon rate is fabricated, the 2024 maturity date is wrong (2029 vs 2054), and the 2024 coupon rate (5.55%) is not mentioned. The LLM introduces non-existent series (Q and R), further distorting the data. (3) The multi-hop reasoning is flawed because the LLM fails to correctly identify and compare the same instrument (Series O) across years. Instead, it conflates different series, undermining the synthesis required. The conclusion about 'flexible and cost-effective financing' is plausible but based on incorrect data, so the reasoning chain is invalid. (4) Despite the incorrect facts, the answer is contextually relevant—it addresses the evolution of debenture terms and attempts to infer strategy. However, due to major factual and quantitative errors, the correctness score is low at 3, with similarly low scores for quantitative (2) and qualitative accuracy (3). Contextual relevance is moderate (6) because the structure and intent align with the question, even if the content does not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 461,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "From 2022 to 2023, ExxonMobil's impairment assessment framework continued to incorporate OPEC investment activities as a key factor influencing long-term oil supply dynamics. The Corporation emphasized that OPEC's production policies and investment decisions significantly impact global oil supplies, which are evaluated alongside declining production from mature fields and investments in new developments and technologies. In both years, ExxonMobil maintained that long-term oil prices and industry margins are driven by supply and demand fundamentals, and OPEC's role in shaping supply remains a critical consideration in its impairment assessments. The framework remained consistent in viewing temporary price fluctuations as normal volatility, rather than impairment indicators, while emphasizing the importance of long-term market fundamentals in evaluating asset recoverability.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually plausible and uses correct entities (ExxonMobil, OPEC, impairment assessments, 2022–2023 timeframe) and no numeric inaccuracies are present, as the question does not involve specific numbers, dates, or calculations—thus quantitative accuracy is 10. However, the core of the original answer highlights a qualitative shift in ExxonMobil’s framework: from explicitly discussing OPEC in 2022 to embedding OPEC considerations within a broader, more integrated framework in 2023 that includes environmental factors like greenhouse gas costs and net-zero targets. The LLM answer incorrectly suggests that the framework remained consistent between 2022 and 2023, emphasizing continuity rather than evolution. This misrepresents the key nuance—the shift from direct focus on OPEC to a more comprehensive, forward-looking assessment. As such, while the answer is contextually relevant and correctly identifies the general role of OPEC in supply dynamics, it fails to capture the multi-hop reasoning that shows a strategic evolution in ExxonMobil’s impairment assessment logic. This omission significantly affects qualitative accuracy, warranting a score of 5. The correctness score reflects partial accuracy: core facts about OPEC’s role are correct, but the critical evolution in framework integration is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 369,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "Netflix's approach to its ad-supported subscription plan evolved from a general mention in 2023 to a more strategic emphasis in 2024. In the 2023 filing, the ad-supported plan was briefly noted as part of the range of pricing plans to meet consumer needs. By 2024, while the specific ad plan details were not explicitly expanded in the provided pages, the broader strategic focus on global growth, pricing flexibility, and enhancing member experience suggests a more integrated approach to diversified revenue streams, including advertising. This shift reflects increased strategic emphasis on monetization beyond subscription fees.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers, it scores highly by default. The main issue lies in qualitative accuracy and factual correctness relative to the ground truth. The LLM incorrectly states that in 2023, the ad-supported plan was mentioned as part of 'pricing plans to meet consumer needs,' which contradicts the original answer: in 2023, the plan was discussed in the context of risk and uncertainty, not as a strategic offering. This misrepresents the nature of the 2023 filing. Conversely, the 2024 characterization in the LLM answer—suggesting a more integrated, strategic approach—is directionally correct but vague and lacks the specific evidence from the original answer that the plan was explicitly included in the description of plans as part of a broader pricing strategy. The LLM infers strategic emphasis from 'global growth, pricing flexibility, and enhancing member experience' rather than citing direct textual evolution in how the ad-supported plan itself was framed. This reflects flawed multi-hop reasoning: it fails to accurately contrast the 2023 risk-focused language with the 2024 strategic integration, instead reversing the 2023 characterization and basing the 2024 conclusion on indirect cues. While the general theme of increased strategic emphasis is present, the reasoning is based on incorrect premises for 2023 and insufficient direct support for 2024, leading to a partially correct but significantly flawed response. Contextual relevance is high because the answer addresses the evolution question and focuses on the right topic areas (strategy, monetization), but the factual inaccuracies limit correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 470,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon's approach to shipping offers between 2022 and 2024 has evolved with a continued strategic focus on enhancing customer experience through fast shipping, while managing cost drivers through fulfillment network efficiencies. In 2022, fulfillment costs were driven by increased sales, wage rates, and supply chain constraints, with a focus on expanding the fulfillment network. By 2024, fulfillment costs were still influenced by increased sales and investments in the network, but the company began to see partial offset from improved fulfillment network efficiencies. The strategic emphasis remained on maintaining low prices for customers through shipping offers while optimizing logistics and leveraging technology to reduce long-term costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in Amazon's shipping strategy from 2022 to 2024, noting increased fulfillment costs due to sales growth and network expansion in 2022, and efficiency gains partially offsetting costs by 2024. It accurately reflects the strategic focus on fulfillment efficiency as a cost offset in 2024 and the ongoing investment in the network. However, it omits the specific $76.7 billion shipping cost figure from 2021 mentioned in the original answer, which provides important quantitative context for the cost trajectory. While it references 'fulfillment costs' generally, it does not explicitly distinguish 'shipping costs' as a subset, which is a key term in the original. (2) There are no incorrect numbers or dates; the LLM does not introduce any false quantitative claims. It avoids stating specific dollar amounts, so while it doesn't reproduce the $76.7B figure, it also doesn't misstate it—thus, quantitative accuracy is high due to absence of error, though incompleteness in data reporting. (3) The multi-hop reasoning is sound: the model synthesizes changes in cost drivers and strategic focus across two time points, correctly identifying the shift from customer-driven cost increases to operations-driven efficiency gains. It links increased sales and network investment to higher costs and notes efficiency improvements as an offset—consistent with the ground truth. (4) The answer is contextually relevant and well-structured. The correctness score is 8 because the core facts and strategic evolution are accurately conveyed, but the omission of the key $76.7B shipping cost figure and lack of explicit mention of shipping cost expectations for 2022 slightly reduce completeness. Qualitative accuracy is 8 due to strong reasoning but minor conceptual blending of 'fulfillment' and 'shipping' costs. Quantitative accuracy is 10 because no numbers are wrong, only omitted. Contextual relevance is 10 as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 541,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "Between 2023 and 2024, Duke Energy's utilization and reporting of the Master Retirement Trust showed notable changes in asset allocation and disclosure practices. In terms of asset allocation, the RCBP (Retirement Cost Benefit Plan) assets shifted slightly from 45% global equity securities and 35% debt securities in 2023 to 44% global equity and 33% debt in 2024, with a modest increase in real estate and cash holdings. For the DELPP (Defined Employee Liability Pension Plan) assets, the allocation remained largely consistent, with a focus on 80% debt securities and 15% global equity in 2024, similar to 2023. \n\nIn terms of disclosure practices, Duke Energy provided detailed fair value measurements for the Master Retirement Trust, categorizing assets by Level 1, Level 2, and Level 3 inputs. In 2024, the total fair value of the trust decreased from $7,241 million in 2023 to $6,969 million in 2024, with a reduction in equity securities and short-term investment funds. Additionally, the company discontinued securities lending in 2024, which had previously involved collateralized loans of plan assets. These changes reflect a strategic shift towards more conservative asset management and enhanced transparency in financial reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) Quantitative Accuracy: The percentages for asset allocations (e.g., 45% global equity, 35% debt in 2023; 44% equity, 33% debt in 2024) and the dollar values ($7,241 million in 2023, $6,969 million in 2024) are not supported by the original answer and appear fabricated. The ground truth does not provide specific numerical allocations or total trust values, nor does it mention RCBP or DELPP plans. The claim about securities lending being discontinued is also absent from the original. (2) Completeness: While the question asks about evolution in asset allocation and disclosure practices, the LLM invents granular data rather than reporting the actual evolution described—specifically, the shift toward subsidiary-level allocations (e.g., Duke Energy Progress at 15%, Duke Energy Florida at 18%) and the introduction of Level 3 fair value reconciliations in 2024. These key points from the ground truth are entirely missing. (3) Entity Accuracy: The use of 'RCBP' and 'DELPP' is incorrect or unsubstantiated; these plan names do not appear in the original answer. The subsidiaries mentioned in the LLM response are real, but their specific allocation percentages are not cited in the ground truth. (4) Reasoning: The multi-hop synthesis fails—the LLM does not connect the correct evolution in reporting practices between years. Instead, it fabricates year-over-year allocation shifts and financial figures without basis. (5) Semantic Equivalence: Despite discussing 'more detailed disclosure' and 'transparency,' the LLM conveys a different factual narrative. The core advancements in 2024 reporting—subsidiary allocation breakdowns and Level 3 fair value reconciliation—are omitted, while invented metrics dominate. Thus, the answer is contextually relevant in topic but severely flawed in factual content and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 522,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "The provided documents do not contain specific information regarding the evolution of Google's financial relationship with Google Network Partners between 2022 and 2024, particularly in terms of cost structure and payment obligations. The pages focus on broader financial metrics, operating income, and expenses for Google Services, Google Cloud, and Other Bets, but do not detail changes in terms or financial arrangements with Network Partners.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to reflect the ground truth information. (1) It claims that the documents do not contain specific information about Google's financial relationship with Network Partners, but the original answer (ground truth) clearly states that such information is available and describes a shift from Traffic Acquisition Costs (TAC) in 2022 to operating cash outflows in 2024. (2) There are no numeric values in either answer to verify, but the LLM fails to mention any of the key financial concepts—TAC, cost structure evolution, or cash flow obligations—which are central to the question. (3) The multi-hop reasoning required—synthesizing how the nature of payments evolved from a cost-of-revenue item to a major operating cash outflow—is completely missing; instead, the LLM defaults to a 'no information' response despite the ground truth being well-specified. (4) While the response is relevant in topic (it discusses Google's financials), it incorrectly denies the presence of key details, making it factually inadequate. Thus, the correctness, quantitative, and qualitative scores are very low. Contextual relevance receives a minimal score because the topic area is acknowledged, albeit inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 346,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "Between 2022 and 2023, the financial impact of offsetting swap positions, particularly in terms of fair value changes and settlements, showed a significant decline. In 2023, the amount of gain or loss recognized in income related to derivative instruments not designated as hedges was a loss of $7 million, compared to a much larger loss of $69 million in 2022. Additionally, the gains or losses reclassified from AOCI to the consolidated income for foreign currency exchange contracts decreased from $304 million in 2022 to $213 million in 2023, indicating a reduction in the volatility and impact of these hedging activities on UPS's consolidated income.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that UPS reported fair value changes and settlements for derivatives not designated as hedges with net gains in 2021 ($163M) and 2020 ($124M), but does not provide specific figures for 2022 or 2023. In contrast, the LLM claims a $7M loss in 2023 and a $69M loss in 2022—figures not present in the original answer—and further asserts that gains reclassified from AOCI were $304M in 2022 and $213M in 2023, which are also absent from the ground truth. These numbers are entirely fabricated or misattributed. (2) There is no quantitative support in the original answer for any 2022 or 2023 figures related to income impact or AOCI reclassifications; thus, all numeric claims in the LLM response fail verification. The original answer explicitly notes that the 2023 financial impact was 'not quantified in the excerpt,' making the LLM’s precise dollar amounts incorrect. (3) The multi-hop reasoning is flawed: the LLM incorrectly synthesizes non-existent data across years and conflates designated and non-designated hedges. While it correctly identifies the types of derivatives (interest rate swaps, foreign exchange forwards), it misrepresents the evolution of disclosure as a quantitative decline rather than a shift in reporting focus and transparency. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant—it addresses the right topic (derivative treatment, fair value changes, settlements, AOCI reclassifications) and company (UPS)—hence a moderate relevance score. However, due to major factual and quantitative errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 458,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures compared to 2023 suggests a shift in the company's director compensation strategy toward emphasizing deferred compensation mechanisms. This could indicate a focus on aligning director incentives with long-term stock performance and enhancing retention by offering more flexible, long-term compensation structures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures as indicative of a strategic shift in director compensation, emphasizing deferred compensation mechanisms. This aligns with the ground truth, which notes the move from minimal mention in 2023 (via exhibit references) to a substantive description in 2024. However, the LLM omits specific details present in the original answer, such as the ability of outside directors to defer annual compensation, the phantom investment options, and how balances are adjusted—key elements that demonstrate the plan’s enhanced structural role. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; the score of 10 reflects no errors in this dimension. (3) The multi-hop reasoning is partially sound: the model infers a strategic shift toward long-term alignment and retention, which is a reasonable interpretation. However, it does not fully synthesize the evidence from the 2023 vs. 2024 disclosures (e.g., lack of detailed description in 2023 vs. expanded narrative in 2024), weakening the qualitative depth. (4) The answer is contextually relevant and captures the high-level implication, but lacks the specificity needed for full factual equivalence, warranting a correctness score of 7 rather than higher.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 388,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "Between 2022 and 2024, American Express has evolved its approach to developing value propositions by focusing more on innovation, customer-centric strategies, and differentiation in response to competitive pressures and changing customer behaviors. In 2022, the company emphasized the need to develop compelling value propositions to compete in a highly competitive payments industry, particularly in the premium consumer space and commercial payments. By 2024, the strategy had expanded to include a stronger emphasis on digital transformation, enhancing rewards and services, and investing in new technologies and partnerships to appeal to younger demographics like Millennials and Gen Z. Additionally, American Express has prioritized expanding its global merchant coverage and enhancing its dining platform to drive customer engagement and loyalty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in American Express's value proposition strategy between 2022 and 2024. (1) It correctly identifies the 2022 context: competitive pressures in premium and commercial payments, need for compelling value propositions. It accurately reflects the 2024 shift toward digital transformation, targeting Millennials and Gen Z, and enhancing rewards, services, and partnerships. Key initiatives like global merchant coverage and dining platform expansion (implied, though specific platforms Tock and Rooam are omitted) are mentioned. (2) There are no numeric values, dates, or financial figures in the question or ground truth that require verification—only years (2022, 2024), which are correctly used. (3) The multi-hop reasoning is sound: the answer synthesizes Amex’s response to competition and changing customer behavior across two time points, showing a logical progression from reactive to proactive innovation. The only minor omission is the lack of specific mention of AI, automation, and the Amex app as key digital investments, which slightly reduces completeness. Also, the ground truth notes a shift 'from reactive to proactive, innovation-driven approach,' which the LLM implies but does not explicitly state. (4) Despite these small gaps, the answer is contextually excellent, factually correct, and semantically equivalent to the original in substance. The omission of specific technology investments and platform names prevents a perfect 10, but overall accuracy and relevance are very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 427,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Between 2022 and 2024, Exxon Mobil's long-term debt financing evolved with changes in the composition of its long-term notes. In 2022, the company had notes such as 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and 1.408% Notes due 2039. By 2024, the 0.142% Notes due 2024 were no longer listed, and the remaining notes retained similar terms, indicating a shift in the maturity structure of its debt. This change suggests a refinancing or restructuring of shorter-term obligations into longer-term instruments, aligning with a strategy to manage interest rate risk and maintain financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (0.142%, 0.524%, 0.835%, 1.408%) and maturity years (2024, 2028, 2032, 2039)—are correctly reported, matching the original answer exactly. There are no calculation errors, and the removal of the 0.142% Notes due 2024 in the 2024 disclosure is accurately noted. (2) The answer is complete: it addresses the evolution in debt composition between 2022 and 2024, identifies specific notes, and explains the shift in maturity structure. (3) Entity accuracy is perfect—Exxon Mobil, correct years, and correct financial instruments are all properly identified. (4) The reasoning is sound: the LLM correctly infers that the disappearance of the 2024 notes indicates maturity or repayment and interprets the retention of long-dated notes (e.g., 2039) as a strategic move toward longer-term financing. It also appropriately introduces the rationale of managing interest rate risk and maintaining financial flexibility, which is a reasonable qualitative extension consistent with corporate finance principles, even if not explicitly stated in the ground truth. The only minor gap is that the original answer explicitly notes the strategic 'emphasis on long-term financing instruments with distant maturity dates,' while the LLM uses slightly different phrasing ('refinancing... into longer-term instruments'). However, the semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness—excellent, but not perfectly verbatim in strategic interpretation. Quantitative accuracy is flawless (10/10), qualitative reasoning is strong with minor inferential expansion (9/10), and relevance is fully on point (10/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 468,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "Between 2022 and 2024, American Express has increasingly emphasized innovation and differentiation in its corporate card solutions. In 2022, the company focused on evolving card value propositions and differentiating its corporate card and accounts payable expense management solutions. By 2024, this strategic emphasis expanded to include designing innovative products and features such as financing, banking, and payment solutions tailored for business customers. Additionally, American Express has integrated digital enhancements and expanded partnerships to further distinguish its commercial offerings and strengthen its position in the commercial payments market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic emphasis and evolution between 2022 and 2024. It accurately captures the 2022 focus on evolving value propositions and differentiating corporate card and accounts payable solutions. For 2024, it correctly notes a continued strategic emphasis on innovation and product differentiation. However, while the LLM mentions 'financing, banking, and payment solutions' and 'digital enhancements and expanded partnerships,' it does not precisely reflect the 2024 shift toward an 'integrated global network approach' aimed at increasing merchant acceptance and providing enhanced fraud protection and marketing insights, which is a key differentiator in the ground truth. The answer substitutes specific ecosystem capabilities with more generic terms like 'innovative products' and 'expanded partnerships,' which are directionally accurate but lack the precise strategic nuance. There are no numerical values in the question or answer, so quantitative accuracy is not applicable but assumed perfect. The reasoning is sound and multi-hop synthesis is adequate, though slightly less precise in conveying the external ecosystem pivot. The answer remains highly relevant and factually consistent with minor omissions in specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 364,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "Amazon's financial relationship with AWS Services has shown significant evolution between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis. AWS contributed 16% of total net sales in 2022 and increased to 17% in 2024, reflecting a 13% growth in 2023 and a substantial 19% growth in 2024. This growth underscores AWS's increasing strategic importance to Amazon's overall financial performance. Additionally, AWS's contribution to cash flow generation is evident in the substantial cash capital expenditures, primarily driven by investments in technology infrastructure to support AWS business growth. The company expects these expenditures to continue rising in 2025, highlighting AWS as a central focus for future growth and investment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. While it correctly identifies AWS's growing strategic importance, it introduces unsupported figures: AWS contributing 16% of net sales in 2022 and 17% in 2024, along with 13% growth in 2023 and 19% in 2024—none of which appear in the ground truth. The ground truth emphasizes a shift in narrative and provides specific operating cash flow figures: $84.9B in 2023 and $115.9B in 2024, driven in part by AWS. The LLM fails to mention these actual cash flow numbers, which are central to the question. (2) The quantitative inaccuracies are significant: no cash flow figures are cited correctly, and the percentage contributions and growth rates are fabricated or misattributed. The ground truth does not provide AWS's share of net sales, so those percentages are unsupported. (3) The reasoning partially captures the shift in strategic emphasis—from competitive risks in 2022 to financial contribution in 2024—but fails to anchor this in the correct multi-hop evidence (i.e., the actual cash flow data showing AWS's increasing financial role). Instead, it relies on vague references to capital expenditures and growth expectations. (4) The contextual relevance is moderate because the answer addresses the evolution of AWS’s role and Amazon’s investment focus, but the lack of correct financial data and reliance on incorrect metrics severely undermines factual correctness. The qualitative reasoning is partially sound but not well-supported, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 425,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "Between 2023 and 2024, the scope and focus of trend analyses used to evaluate the historical consistency of regulatory asset balances expanded. In 2023, trend analyses were primarily used to assess the historical consistency of these balances. By 2024, the analyses were complemented by a more detailed comparison of recorded regulatory asset balances to independently developed expectations, enhancing the depth and rigor of the evaluation process.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in describing the evolution of trend analyses. The ground truth states that in 2024, the focus shifted to include a specific evaluation of the regulatory recoverability of asset retirement obligations related to coal ash. However, the LLM answer claims that the change involved 'a more detailed comparison of recorded regulatory asset balances to independently developed expectations,' which is not supported by the original answer and introduces a completely different audit procedure. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations, hence a score of 10. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the shift in focus toward asset retirement obligations and coal ash compliance, which is the key qualitative change. Instead, it fabricates a change in methodology (comparison to independently developed expectations) that is not present in the ground truth. This represents a failure in synthesizing the correct information across years and regulatory focus areas. (4) While the answer is relevant to the general topic of trend analyses in regulatory asset evaluations, it misrepresents the nature of the evolution, making it partially plausible but ultimately incorrect. The contextual relevance is moderate because it addresses the timeframe and general subject, but misses the specific regulatory compliance shift that defines the correct answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 422,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "Between 2022 and 2023, Costco increased the penetration of private-label items as part of its strategy to respond to cost and pricing pressures. The company adjusted its merchandising and pricing strategies, including increasing the share of private-label offerings, to maintain competitive pricing for members while managing rising merchandise costs. This approach aimed to preserve member value and mitigate the impact of inflation and supplier cost increases on gross margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and captures the core evolution in Costco's strategy between 2022 and 2023 regarding private-label penetration in response to cost and pricing pressures. It correctly identifies that Costco increased the share of private-label items as part of its merchandising and pricing strategy to manage rising costs and maintain competitive pricing, which aligns with the ground truth. The answer accurately reflects the strategic shift from 2022 (managing inflation via absorption, volume buying, and selective price pass-throughs) to 2023 (a more sustained focus on private-label expansion), though it does not explicitly detail the 2022 tactics mentioned in the original answer (e.g., absorbing costs, early purchasing). However, the omission is minor and does not distort the overall accurate synthesis of multi-hop information across years and strategic priorities. There are no numerical inaccuracies—no specific numbers (percentages, dollar amounts) are cited in either answer, so quantitative accuracy is unaffected. The reasoning is sound, entities (Costco, private-label items, cost and pricing pressures) are correctly identified, and the temporal scope (2022–2023) is properly addressed. The answer is semantically equivalent to the original in intent and factual content, with slightly less granular detail on 2022 tactics but still conveying the strategic evolution accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 390,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "Based on the provided information, the financial outlook for Paxlovid has significantly shifted between 2023 and 2024. In 2023, Paxlovid contributed $1,279 million in revenue, a sharp decline from $18,933 million in 2022, largely due to a $3.5 billion non-cash revenue reversal related to expected returns of U.S. government inventory. By 2024, Paxlovid revenue increased to $5,716 million, reflecting a transition to commercial markets and the recognition of revenue from the U.S. Strategic National Stockpile (SNS) program. Remaining performance obligations for Paxlovid were $1 billion as of December 31, 2024, with expected deliveries through 2028. This indicates a more stable and commercialized revenue stream for Paxlovid in 2024 compared to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures for Paxlovid in 2023 ($1,279 million) and 2024 ($5,716 million), which are not present in the original answer (ground truth) and cannot be verified from the provided context. The ground truth states that Pfizer did not disclose specific remaining performance obligations (RPOs) for Paxlovid in 2023, but the LLM claims a precise revenue figure, which is a factual overreach. While the $1 billion RPO as of December 31, 2024, is correctly stated, the additional claim that deliveries are expected through 2028 is not mentioned in the original answer and introduces unverified information. (2) The calculation of revenue changes and references to a $3.5 billion non-cash reversal are not supported by the ground truth, which focuses solely on the absence of disclosed RPOs in 2023 and their presence in 2024. These added financial details, while potentially accurate in another context, are not part of the provided ground truth and thus constitute significant quantitative inaccuracies. (3) The multi-hop reasoning is partially sound in that it attempts to contrast 2023 and 2024 based on contractual obligations and revenue trends, but it fails to align with the actual basis of the ground truth, which hinges on disclosure (or lack thereof) of RPOs, not revenue fluctuations. The core of the question is about how RPOs reflect evolving financial outlook, but the LLM shifts focus to revenue changes and commercial transitions not emphasized in the original answer. (4) Despite the misalignment in facts, the answer is contextually relevant—it addresses the evolution of Paxlovid's financial outlook and correctly identifies the $1 billion RPO in 2024. However, the inclusion of unsupported revenue data and explanations significantly undermines factual correctness, warranting a low correctness and quantitative accuracy score. The qualitative reasoning is somewhat logical but based on extraneous data, hence a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 537,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "Between 2022 and 2024, American Express's use and assumptions around the Reasonable and Supportable (R&S) Period in estimating credit loss reserves have shown a more cautious and forward-looking approach. In 2022, the R&S Period was used to incorporate historical loss experience and economic conditions to estimate credit losses, with reserves for credit losses on Card Member loans at $3.3 billion. By 2024, the company expanded its consideration of economic conditions over a longer R&S Period, reflecting a more comprehensive integration of current and future macroeconomic factors. This evolution indicates a more proactive and conservative approach to financial risk management, as American Express is increasingly factoring in extended economic uncertainties and potential downturns to better prepare for expected credit losses.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.3 billion credit loss reserves as of December 31, 2021 (referenced in the context of 2022 reporting), and correctly notes the use of the Reasonable and Supportable (R&S) Period in both 2022 and 2024. However, it introduces a significant factual inaccuracy by claiming that American Express 'expanded' the R&S Period or used a 'longer' period in 2024, which is not supported by the ground truth. The original answer states that the R&S Period was no longer highlighted as a new concept but had become embedded in an established process—indicating institutionalization, not extension. (2) Quantitatively, the $3.3 billion figure is accurate and correctly attributed to the end of 2021 (as reported in 2022 filings). There are no calculation errors, and the time references are generally consistent. (3) The multi-hop reasoning is partially sound—correctly linking R&S Period usage across years and tying it to credit loss estimation—but fails in the synthesis by inferring a lengthening of the R&S Period and a 'more conservative' stance without evidence. The ground truth does not indicate changes in the duration or assumptions of the R&S Period, only its integration into standard practice. (4) The contextual relevance is high because the answer addresses the evolution of R&S usage and links it to risk management. However, the incorrect inference about a longer, more comprehensive R&S Period undermines the qualitative accuracy. The conclusion about a 'proactive and conservative approach' is speculative and not directly supported by the provided ground truth, which emphasizes normalization rather than increased caution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 460,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "Amazon issued the 0.800% Note due 2025 as part of its debt financing strategy, as disclosed in its 2020 10-K filing (Exhibit 4.5). Between 2022 and 2024, Amazon continued to manage its debt portfolio by issuing various notes with differing maturities and interest rates, including higher-yielding notes in later years, such as the 4.700% Note due 2024 and 4.600% Note due 2025 in 2022, and the 0.250% Note due 2023 and 1.000% Note due 2026 in 2021. This suggests a shift toward diversifying maturities and capitalizing on favorable interest rates, while the 0.800% Note due 2025 remains part of its longer-term fixed-income obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in dates and note details. While it correctly identifies the 0.800% Note due 2025 as part of Amazon's debt structure, it incorrectly states that the 4.600% Note due 2025 was issued in 2022—this contradicts the ground truth, which indicates it was introduced by 2024. Additionally, the LLM claims Amazon issued a 4.700% Note due 2024 and a 1.000% Note due 2026 in 2021, but the original answer does not mention these specific notes or their issuance years, and such early issuance (in 2021) is outside the 2022–2024 evaluation window. The reference to the 0.250% Note due 2023 in 2021 is also chronologically inconsistent with the question's focus. (2) Quantitative accuracy is compromised: the interest rates and maturities are partially correct (e.g., 4.600% Note due 2025 exists), but the timing of issuance is wrong. The 2020 filing reference is accurate (from Exhibit 4.5), but the evolution between 2022 and 2024 is misrepresented by backdating new instruments. (3) The multi-hop reasoning is partially sound—the model attempts to show a diversification strategy in debt financing by referencing multiple notes with varying rates and maturities, which aligns with the ground truth’s conclusion about strategic shifts. However, the incorrect temporal attribution weakens the synthesis. The core idea of diversifying maturities and managing interest rate risk is semantically similar, but the evidence used is flawed. (4) Contextual relevance is high because the answer addresses Amazon's debt financing evolution and the role of the 0.800% Note due 2025. The qualitative reasoning is logical and structured, even if based on inaccurate data. The correctness score is 6 due to significant factual errors in timing and instrument issuance, despite capturing the general strategic trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 502,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "The Twenty-third Supplemental Indenture was dated June 1, 1978, and was incorporated by reference in the 2022 filing (DUK_10k_2022.pdf, page 249). In the 2024 filing (DUK_10k_2024.pdf, page 250), it is not explicitly listed, but newer Supplemental Indentures are referenced, indicating that the Twenty-third Supplemental Indenture is no longer the most recent or relevant amendment. This suggests that the indenture has been superseded by more recent amendments and is no longer actively referenced in the latest disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the Twenty-third Supplemental Indenture is dated June 1, 1978, and was referenced in the 2022 filing (DUK_10k_2022.pdf, page 249), consistent with the original answer citing Exhibit 2(c) and File No. 2-61611. The 2024 filing (DUK_10k_2024.pdf, page 250) does not mention it, which matches the ground truth. (2) Quantitative accuracy is perfect: the date (June 1, 1978) is correct, and the years of the filings (2022, 2024) are accurate. (3) The reasoning is sound: the LLM correctly infers that the absence of the Twenty-third Supplemental Indenture in the 2024 filing, alongside references to newer indentures (e.g., the Forty-ninth, though not named in the LLM answer), suggests it has been superseded and is no longer operationally relevant. (4) The answer is contextually relevant and addresses both parts of the question: the evolution in disclosure between 2022 and 2024, and the implication for the indenture’s ongoing relevance. The only minor shortcoming is that the LLM does not explicitly name the Forty-ninth Supplemental Indenture as the newer document, which slightly reduces completeness in multi-hop synthesis, but the core conclusion remains valid. Hence, a score of 9 is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 364,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "From 2022 to 2024, the repurchase activity for Class C Capital Stock showed a slight decline in shares repurchased but remained relatively consistent in total value. In 2022, $28.38 billion was spent to repurchase 6,182 million shares of Class C Capital Stock. In 2023, the total value increased slightly to $50.19 billion for 306 million shares. In 2024, the total value was $50.19 billion for 306 million shares.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Alphabet repurchased $59.3 billion in 2022, $62.2 billion in 2023, and $62.0 billion in 2024 across Class A and Class C shares. However, the LLM claims $28.38 billion in 2022, $50.19 billion in 2023, and $50.19 billion in 2024—none of which match the original figures. Additionally, the LLM incorrectly separates Class C repurchases as if they were reported independently, while the ground truth combines Class A and C and does not provide a breakdown by class. (2) The numerical values are entirely incorrect: $28.38B vs $59.3B (2022), $50.19B vs $62.2B (2023), and $50.19B vs $62.0B (2024). The LLM also introduces specific share counts (6,182 million and 306 million) that are not present in the ground truth and appear fabricated. There is no mention of share counts in the original answer, indicating a hallucination. (3) The multi-hop reasoning is flawed. The question asks about the evolution of repurchase activity and total value per year. While the LLM attempts to show a trend, it misrepresents the data and fails to reflect the actual increase from 2022 to 2023 and slight drop in 2024. It incorrectly suggests a decline from 2022 to 2023 in terms of shares but a jump in value, which contradicts both logic and the ground truth. (4) The contextual relevance is moderate because the answer addresses the time frame and topic (repurchase activity), but the qualitative and quantitative inaccuracies severely undermine correctness. The model invents granular data not present in the source, leading to a mostly incorrect response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 449,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "The American Express Company Salary/Bonus Deferral Plan was amended in 2022 with the Twelfth Amendment and Restatement of the American Express Retirement Restoration Plan, effective January 1, 2023, as disclosed in the 2022 filing. However, no specific changes to the Salary/Bonus Deferral Plan itself are mentioned in the 2024 filing, indicating that no further amendments to this plan were made between 2022 and 2024 based on the provided documents.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to accurately reflect the changes in treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings as described in the ground truth. (1) The LLM incorrectly claims that the plan was amended in 2022 with the 'Twelfth Amendment and Restatement of the American Express Retirement Restoration Plan' effective January 1, 2023. This is not supported by the ground truth, which makes no mention of such an amendment to the Retirement Restoration Plan in relation to the Salary/Bonus Deferral Plan. The original answer focuses on the documentation and referencing of historical exhibits (1988, 1994, and 1997 amendments), not new amendments in 2022 or 2024. (2) The LLM states that 'no specific changes to the Salary/Bonus Deferral Plan itself are mentioned in the 2024 filing,' which contradicts the ground truth: the 2024 filing explicitly adds Exhibit 10.16, which incorporates the 1997 amendments—this is a clear change in documentation. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that the core change is in the disclosure and exhibit structure (reintroduction and expansion of historical amendments), not in substantive plan amendments during 2022–2024. It confuses the Retirement Restoration Plan with the Salary/Bonus Deferral Plan, indicating a failure in entity accuracy. (4) While the answer is framed around the right topic (plan documentation over time), it misidentifies key entities and changes, making it contextually relevant but factually inaccurate. The quantitative accuracy is low due to incorrect dates and non-existent amendments. The qualitative accuracy is poor due to incorrect reasoning and entity conflation. The correctness score is low because the answer misses the actual documentation changes entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 500,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, with the liability related to interest rate swaps increasing significantly. In 2022, the interest rate swap liability was classified under \"Other long-term liabilities\" at $34.0 million, while by 2024, it was recorded as $19.2 million under \"Other long-term liabilities\" and $56.7 million in total liabilities, indicating a notable increase in exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the 2022 liability of $34.0 million under 'Other long-term liabilities', it misrepresents the 2024 data. The LLM claims a total liability of $56.7 million in 2024, but the ground truth reports a 2024 liability of $19.2 million and references a prior-year (2023) liability of $41.4 million — not a combined total of $56.7 million. The LLM incorrectly implies an increase in exposure, while the ground truth shows a decrease from $41.4M in 2023 to $19.2M in 2024, and from $34.0M in 2022. (2) The quantitative error is critical: the $56.7 million figure does not appear in the ground truth and appears to be an incorrect sum (e.g., $19.2M + $34.0M = $53.2M, still not $56.7M), suggesting a fabrication or miscalculation. The ground truth emphasizes a reduction in liability, not an increase. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution across 2022, 2023, and 2024. It omits the 2023 liability entirely as a separate data point and mischaracterizes the trend. The balance sheet classification is correctly noted as 'Other long-term liabilities' in both years, which is accurate. (4) The contextual relevance is moderate — the answer addresses the right topic and classification, but the core conclusion (increasing exposure) is factually wrong, severely undermining correctness. Quantitative and qualitative accuracy are low due to incorrect numbers and flawed reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 417,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "The Directors' Savings Plan has remained a key deferral mechanism for Duke Energy directors, allowing them to defer all or part of their annual compensation, primarily retainers, into an unfunded account adjusted for phantom investment performance, including Duke Energy Common Stock. Between 2022 and 2024, there is no indication of substantive changes to the plan's structure, suggesting a consistent governance approach focused on aligning director interests with long-term stock performance while maintaining flexibility in compensation deferral. This continuity reflects Duke Energy's emphasis on stable, transparent, and performance-linked director compensation practices.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entities, structure, and overall intent. It correctly identifies the Directors' Savings Plan as a deferral mechanism tied to phantom investments, including Duke Energy Common Stock, and accurately reflects the focus on aligning director compensation with long-term stock performance. There are no numeric inaccuracies, as the response does not introduce specific figures (dates like December 16, 2021, are not mentioned but not contradicted), so quantitative accuracy is high. However, the LLM states there is 'no indication of substantive changes' between 2022 and 2024, which underrepresents the evolution noted in the original answer: the 2022 formal introduction/amendment of the plan versus the 2024 emphasis on operational mechanics and phantom investment options. This shift from policy establishment to transparency is a meaningful development that the LLM overlooks, weakening the qualitative accuracy of the multi-hop reasoning. While the conclusion about stable governance is plausible, it downplays the significance of increased disclosure and structural clarification over time. Thus, while the answer is contextually relevant and factually sound in broad strokes, it misses a key nuance in the plan’s evolution, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 377,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "Between 2022 and 2023, Costco's Kirkland Signature brand has maintained its positioning as a high-quality, cost-effective private-label offering, but the risk profile associated with the brand has evolved due to broader market and operational challenges. In 2022, the brand was highlighted for its role in differentiating Costco's merchandise and contributing to higher margins. By 2023, the brand's success became more intertwined with external risks, such as supply chain disruptions, inflationary pressures, and the need to consistently meet member expectations in a competitive retail environment. Additionally, the brand's growth and profitability became more sensitive to factors like supplier reliability, product quality control, and the ability to innovate and adapt to changing consumer preferences and economic conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the continued strategic positioning of Kirkland Signature in 2022 as a high-quality, cost-effective private label contributing to differentiation and higher margins. It also accurately reflects the shift in 2023 toward a heightened focus on risk, including supply chain disruptions, inflation, and external economic pressures. While the original answer specifically mentions foreign exchange fluctuations and catastrophic events as new risks in 2023, the LLM captures the essence with 'supply chain disruptions, inflationary pressures,' and 'supplier reliability,' which are contextually consistent. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information across two years, correctly contrasting the emphasis on growth in 2022 with increased risk sensitivity in 2023. The only minor shortcoming is that the LLM does not explicitly state that the 2023 risk disclosures were formal additions to filings (e.g., in risk factors), but it accurately conveys the substance. (4) The answer is contextually excellent—directly addresses both brand positioning and risk evolution, uses correct entities (Costco, Kirkland Signature, 2022–2023), and maintains semantic equivalence with the original answer. One point deducted from qualitative accuracy for slight omission of specific risk factors (e.g., FX, catastrophic events), but overall reasoning and completeness remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 438,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region remained at zero for both 2022 and 2024, as no additions or changes were recorded in this region for natural gas reserves during this period. The key changes in reserve volumes were driven by other regions, particularly the Lower 48, where extensions and discoveries, as well as revisions, significantly impacted the overall natural gas reserve volumes. However, for the Asia Pacific/Middle East region specifically, all reserve changes were limited to natural gas liquids and equity affiliates, with no reported natural gas reserves.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims COP's natural gas reserves in the Asia Pacific/Middle East region were zero in both 2022 and 2024, which directly contradicts the ground truth stating reserves were 326 billion cubic feet in 2022 and 296 billion cubic feet in 2024. These figures represent a slight decrease, not a complete absence. (2) The LLM incorrectly states no additions or changes were recorded, while the original answer notes revisions and production activities impacted reserves, with minimal extensions and discoveries. (3) Qualitatively, the reasoning is flawed: the LLM attributes reserve changes to other regions (e.g., Lower 48), which is irrelevant to the question specifically about the Asia Pacific/Middle East region. It also incorrectly introduces natural gas liquids and equity affiliates as explanations, which are not mentioned in the context of natural gas reserves in the ground truth. (4) Contextually, while the answer addresses the region and time frame, it fails to provide the correct evolution of reserves or key changes in volume and sources. The core facts are entirely wrong, indicating a failure in multi-hop synthesis and data retrieval. Minor relevance is retained only because the answer attempts to discuss the correct company (COP) and region, albeit with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 384,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "Between 2022 and 2024, FedEx's strategic relationship with the Boeing 767F has shifted from fleet ownership to a focus on modernization and replacement. In 2022, FedEx Express operated 114 owned Boeing 767F aircraft with no leased units. By 2024, no new Boeing 767F purchases were planned beyond 2023, and the emphasis had shifted to more modern aircraft like the Boeing 777F. The 2024 10-K highlights ongoing modernization programs centered on fuel-efficient aircraft, indicating a strategic move away from the 767F in favor of newer, more efficient models to achieve long-term operating savings.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but introduces significant inaccuracies. It correctly states that FedEx owned 114 Boeing 767F aircraft in 2022, which aligns with the ground truth. However, it incorrectly claims that 'no new Boeing 767F purchases were planned beyond 2023' and that the focus shifted to the Boeing 777F, which contradicts the original answer stating that the B767F remained a 'key component' of modernization programs in 2024. The ground truth does not mention a strategic move away from the 767F or a shift to the 777F. (2) The number '114' is accurate and correctly attributed to 2022 ownership. However, the claim about no future purchases lacks support in the ground truth, which explicitly states that expenditures for 767Fs are 'necessary' and 'limited flexibility to delay.' This is a critical factual error affecting the conclusion. (3) The multi-hop reasoning is flawed: while the model attempts to connect fleet ownership with modernization strategy, it incorrectly infers a phase-out of the 767F based on absence of purchase plans, contradicting the emphasis on its fuel efficiency and importance in fleet replacement. The original answer stresses continuity in strategic importance, not a shift away. (4) The contextual relevance is moderate—addressing fleet ownership and modernization focus—but the qualitative inaccuracy undermines the correctness. The answer misrepresents the strategic trajectory, leading to a low correctness score despite some accurate data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 422,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "From 2022 to 2024, Starbucks' inventory value for roasted coffee increased from $310.3 million (as of October 2, 2022) to no specific figure provided for 2024, but the overall inventory value rose from $2,176.6 million in 2022 to no exact 2024 value. In terms of production infrastructure, Starbucks maintained key roasting facilities in locations like York, PA; Minden, NV; Kunshan, China; and Kent, WA, with no major changes in roasting capacity mentioned for 2024. The company continued to own most of its roasting facilities and relied on leased warehousing and distribution centers to support its operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 roasted coffee inventory value of $310.3 million, which matches the ground truth. However, it fails to provide any specific 2024 inventory value for roasted coffee, and instead discusses overall inventory without clarifying that roasted coffee-specific data is missing. The ground truth emphasizes a strategic shift in infrastructure, not just maintenance, which the LLM underrepresents. (2) The numeric value for 2022 is accurate ($310.3 million), but no 2024 roasted coffee inventory figure is given, and the mention of total inventory rising from $2,176.6 million in 2022 lacks a 2024 counterpart or relevance to roasted coffee specifically—this introduces confusion and reduces quantitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly lists key roasting facilities (York, PA; Minden, NV; Kunshan, China; Kent, WA), aligning with the ground truth. However, it incorrectly frames these as unchanged in 2024, while the original answer highlights an expansion and increased direct involvement in roasting—indicating a missed synthesis of strategic evolution. The LLM downplays the significance of infrastructure growth and the shift from inventory-holding to active production. (4) Contextual relevance is strong because the answer addresses both inventory and infrastructure, using correct entities and timeframes. However, the lack of 2024 roasted coffee inventory data and failure to capture the strategic shift reduce qualitative and overall correctness. The answer is factually mixed: accurate on 2022 numbers and facility locations but incomplete and misleading on the evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 458,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "Based on the provided document pages, PepsiCo's utilization of the 2.750% Senior Notes due 2025 remained consistent between 2023 and 2024. In both years, the 2.750% Senior Notes due 2025 were referenced in the context of authorizations and indentures, indicating no material change in their issuance or terms during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its conclusion. While it correctly identifies that the 2.750% Senior Notes due 2025 were referenced in both years, it fails to capture the key evolution described in the ground truth: in 2024, PepsiCo introduced a new 2.750% Senior Notes due 2030, indicating a strategic extension of its debt instruments at the same interest rate. The LLM incorrectly states there was 'no material change,' which contradicts the ground truth's emphasis on strategic evolution. (2) Quantitatively, the interest rate (2.750%) and maturity year (2025) are accurate, and no numerical calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning is flawed: the model fails to synthesize the significance of the new 2030 note in relation to the existing 2025 note, missing the strategic shift in debt financing. This represents a failure in qualitative reasoning and contextual interpretation. (4) Contextual relevance is moderate because the answer discusses the correct instruments and time frame but misses the core analytical point about strategic evolution, rendering the response substantially incomplete despite correct entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 341,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "FedEx's planned utilization of the B777F aircraft decreased from 8 units scheduled for delivery through 2026 in 2022 to only 2 units expected by 2026 in 2024. This significant reduction indicates a diminished strategic role for the B777F in FedEx's fleet modernization plans, suggesting a shift in focus toward other aircraft types or a reassessment of long-term operational needs and cost efficiency.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeline. According to the ground truth, in 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the plan was revised to 2 aircraft in 2025 with no further plans beyond. The LLM incorrectly states that 8 units were scheduled for delivery through 2026 in 2022, and 2 units by 2026 in 2024—these numbers and timeframes do not match the original data. There is no mention of 2026 in the ground truth, nor a plan for 8 aircraft. (2) The quantitative inaccuracies are severe: the original answer references plans for 2024 and 2025 only, with a reduction from 4 to 2 aircraft, not 8 to 2 over 2026. The LLM invents a timeline and delivery schedule not present in the source. (3) While the LLM correctly infers a strategic reduction in the B777F's role, the reasoning is based on incorrect data. The conclusion about diminished strategic role aligns semantically with the ground truth’s interpretation of reduced emphasis and phase-out, but the multi-hop synthesis is flawed due to incorrect input facts. (4) Scores reflect partial correctness in interpretation (qualitative and contextual), but major penalties on quantitative accuracy due to fabricated numbers and timelines. The answer addresses the question’s intent but fails on factual precision, which is critical in financial and operational reporting contexts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 395,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "Starbucks' foreign currency - other derivative liabilities increased from $0.3 million in 2022 to $4.7 million in 2024, while the net gains/(losses) included in AOCI related to these liabilities shifted from a gain of $46.8 million in 2022 to a smaller gain of $0.1 million in 2024. This indicates that the company's exposure to foreign currency fluctuations, particularly from non-designated derivatives, has become less favorable over time, with the positive impact on earnings diminishing significantly.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Starbucks had foreign currency - other derivative liabilities of $0.3 million, but the LLM incorrectly states that these increased to $4.7 million in 2024, which is not supported by the original answer. More critically, the original answer states that in 2024, the net gains included in AOCI were $11.5 million — however, the LLM claims a gain of only $0.1 million in 2024 and even references a $46.8 million gain in 2022, which is entirely fabricated and not present in the ground truth. (2) All key numerical values are incorrect: the liability amount in 2024, the AOCI gains in both years, and the trend over time are misrepresented. There are no correct calculations or accurate figures beyond the correct $0.3 million liability in 2022. (3) The multi-hop reasoning is flawed — while the LLM attempts to interpret the implications of derivative liabilities and AOCI movements, it does so based on false data, leading to an incorrect conclusion about decreasing favorable exposure. The original answer suggests increased exposure or hedging activity due to a shift from minimal liability to significant unrealized gains, whereas the LLM concludes diminishing positive impact based on made-up numbers. (4) Contextual relevance is moderate because the LLM addresses the right topic (foreign currency derivatives, AOCI, exposure implications), uses appropriate financial terminology, and attempts a year-over-year analysis. However, due to severe quantitative errors and resulting flawed reasoning, the overall correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 452,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 2.625% Senior Notes due 2026 remained consistent in terms of its broader debt instrument disclosures. In both years, the notes were referenced in the context of Board of Directors Resolutions authorizing officers to establish terms for various senior notes, including the 2.625% Senior Notes due 2026. In 2024, there was no new standalone issuance or material change specifically tied to these notes, but they were included in the broader list of authorized debt instruments, indicating ongoing recognition within PepsiCo's debt portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in stating that the 2.625% Senior Notes due 2026 were consistently referenced in Board of Directors Resolutions in both 2023 and 2024. The entity names, percentages (2.625%), and maturity year (2026) are accurate, and there are no numerical or date inaccuracies. However, the LLM fails to capture a key evolution highlighted in the ground truth: the expansion of PepsiCo's debt portfolio in 2024 to include new senior notes such as the 3.000% due 2027 and 2.625% due 2029. This omission significantly weakens the answer's completeness and qualitative accuracy. (2) Quantitatively, all figures (interest rate, maturity year) are correct and consistent with the original answer. There are no calculations, so numerical precision is not an issue. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies continuity in the treatment of the 2026 notes, it misses the broader context of PepsiCo's evolving debt strategy involving new issuances and diversification. The ground truth emphasizes an active capital markets strategy reflected in expanded disclosures, which the LLM does not acknowledge. (4) The correctness score is 5 due to significant omission of key developments in 2024. Quantitative accuracy is 10 because all stated numbers are correct. Qualitative accuracy is 5 due to incomplete reasoning and failure to synthesize the broader trend. Contextual relevance is 8 because the answer stays on topic and addresses the core instrument, but lacks depth on the evolution aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 430,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "Cisco's exposure to and reliance on overcoming technical hurdles have increased from 2022 to 2024, particularly as the company has intensified its strategic investments in key priority areas such as AI, cloud, cybersecurity, and software-defined networking. In 2022, the company highlighted the complexity of developing new technologies and the risks of failing to overcome technical hurdles in a timely manner. By 2024, this focus has expanded, with increased emphasis on the need to scale infrastructure for software subscription offerings, manage performance-related challenges, and integrate acquisitions like Splunk. The evolving reliance on timely execution of product development and the integration of new technologies underscores a growing exposure to technical risks as Cisco accelerates its transformation toward delivering integrated, service-oriented solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: Cisco's increasing exposure to technical hurdles from 2022 to 2024 is accurately portrayed, with proper emphasis on strategic investments in AI, cloud, cybersecurity, and software-defined networking. The evolution from general technical execution risks in 2022 to more specific, high-stakes dependencies in 2024—especially around software subscriptions, integration of acquisitions like Splunk, and delivery of complex technologies—is consistent with the ground truth. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years 2022 and 2024 are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes how Cisco’s risk profile evolved over time, linking strategic investments to increased reliance on overcoming technical challenges, and connecting product development timelines to broader business outcomes like competitive positioning and customer retention. (4) The LLM captures the core shift described in the original answer—from internal execution risk to broader strategic dependency—though it does not explicitly mention 'reputational damage, legal liability, or reduced customer retention' as potential consequences in 2024, which slightly reduces completeness. However, the mention of scaling software offerings and integrating Splunk adds relevant context that aligns with the increased complexity emphasized in the ground truth. Overall, the answer is semantically equivalent with only minor omissions of specific risk consequences, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 483,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "Based on the information provided, Google Ad Manager's role in driving Google Network revenues showed continued strength in 2022, as it was a key contributor to the $8.6 billion year-over-year increase in Google Network revenues from 2020 to 2021. However, specific performance details for 2023 are not explicitly mentioned in the provided pages. The 2023 document pages focus more on financial statements and accounting policies rather than a breakdown of Google Ad Manager's contribution. Therefore, while Google Ad Manager remained a significant driver in 2022, there is insufficient information to determine if its role changed in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Google Ad Manager contributed to an $8.6 billion year-over-year increase in Google Network revenues from 2020 to 2021, while the ground truth clearly states this increase occurred between 2021 and 2022 (i.e., in 2022 reporting). This misalignment of years and periods undermines the core quantitative claim. Additionally, the LLM claims there is 'insufficient information' to assess 2023 performance, which contradicts the ground truth that explicitly describes how Google Ad Manager was no longer singled out as a growth driver in 2023 but instead grouped among other platforms. (2) The $8.6 billion figure is correct in amount but catastrophically misattributed to the wrong time period (2020–2021 instead of 2021–2022), making the quantitative accuracy very low. The LLM also fails to mention any 2023-specific positioning shift, missing a key qualitative and factual point. (3) The multi-hop reasoning is flawed: the model fails to synthesize the change in narrative tone and emphasis between 2022 and 2023 filings—specifically, the shift from highlighting Ad Manager as a key growth driver to including it in a broader suite without growth attribution. This is a critical analytical point in the original answer that the LLM overlooks. (4) Contextual relevance is moderate because the answer discusses the right topic (Google Ad Manager’s role in network revenues) and mentions the $8.6B figure, but the incorrect timeframe and failure to address the 2023 narrative shift severely limit its usefulness. The claim of 'no explicit mention' in 2023 is incorrect if based on the same data as the ground truth, indicating a failure in information extraction or synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 481,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks' derivative liabilities related to foreign currency - other decreased from $0.3 million in 2022 to $4.7 million in 2024, representing an increase in liabilities by $4.4 million over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in directionality — it states that derivative liabilities 'decreased' from $0.3 million to $4.7 million, when in fact they increased. This misrepresents the trend and undermines the core conclusion. However, the numerical values for 2022 ($0.3 million) and 2024 ($4.7 million) are correct and match the ground truth. The magnitude of change is correctly calculated as $4.4 million ($4.7M - $0.3M). (2) Quantitatively, the numbers and calculation are accurate, earning a moderate score. The error is not in arithmetic but in interpretation. (3) The qualitative reasoning is flawed because the model fails to correctly interpret the increase in liabilities, stating a decrease instead. This indicates a failure in logical synthesis despite having correct inputs. The multi-hop aspect (comparing two years of data on a specific derivative liability) is structurally addressed, but the conclusion is inverted. (4) Contextually, the response is relevant and addresses the right metric, company, and time frame, but the incorrect directional claim severely impacts factual correctness. A score of 4 reflects partial accuracy with a major error in interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 343,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "In 2023, PepsiCo issued the 4.600% Senior Notes due 2045 as part of its broader debt issuance strategy, as detailed in the 10-K filing. By 2024, the company further expanded its long-term debt structure by issuing additional senior notes with varying maturities and coupon rates, including the 4.600% Senior Notes due 2045. This evolution indicates PepsiCo's strategy to diversify its debt maturity profile and secure long-term financing at favorable interest rates, thereby managing refinancing risk and optimizing its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misrepresents the nature of the 4.600% Senior Notes due 2045 issuance. According to the ground truth, in 2023 these notes were not newly issued but were among the notes authorized under Board Resolutions that allowed officers to set terms; there is no confirmation of actual issuance in 2023. The LLM incorrectly states that PepsiCo 'issued' the notes in 2023, which is a factual inaccuracy. In 2024, the notes remained part of the debt structure and were referenced alongside new instruments like the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026—this diversification point is correctly captured by the LLM. However, the LLM implies continued issuance of the same 4.600% notes in 2024, which is not supported by the ground truth. (2) Quantitatively, the percentage (4.600%), maturity year (2045), and mention of other notes (e.g., 4.000% due 2047) are accurate or reasonably aligned. No numerical calculations were required, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound—the model correctly infers a strategy of diversification and long-term financing—but it fails on the critical first hop: the 2023 status was authorization/establishment of terms, not actual issuance. This undermines the reasoning chain. (4) Contextual relevance is strong as the answer addresses both years and interprets strategic intent. However, due to the mischaracterization of the issuance event and lack of precision about the evolution (authorization vs. issuance), the correctness score is reduced to 6, reflecting partial accuracy with significant factual flaws in key events.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 457,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region remained relatively stable between 2022 and 2024, with natural gas reserves at the end of 2022 at 326 BCF and at the end of 2024 at 296 BCF, indicating a slight decline. However, the region did not experience significant revisions or extensions and discoveries compared to other regions like the Lower 48. This suggests that COP's strategic focus in the Asia Pacific/Middle East region has been more on maintaining existing positions rather than expanding or developing new reserves during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region as 326 BCF in 2022 and 296 BCF in 2024, matching the ground truth exactly. The slight decline is accurately noted. (2) All numeric values are correct and properly formatted (BCF is standard for billion cubic feet). The difference of 30 BCF is implied and correctly represented as a 'slight decline,' which aligns with the ground truth's characterization. (3) The multi-hop reasoning is sound: the model synthesizes reserve data across two years and infers strategic focus by contrasting the lack of significant revisions or discoveries with other regions (e.g., Lower 48), which adds contextual depth beyond the ground truth without contradicting it. This inference is reasonable and consistent with the data. (4) The only reason for not scoring a 10 in qualitative accuracy is that the original answer does not mention comparisons to other regions like the Lower 48, so that detail, while plausible, is an addition not present in the ground truth. However, it does not detract from correctness. Overall, the answer is factually accurate, complete, and contextually appropriate, with excellent quantitative precision and strong reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 353,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "From 2022 to 2023, Google Play's role in Google's non-advertising revenue strategy has remained consistent as a key contributor, generating revenue primarily through the sales of apps, in-app purchases, and digital content. In both years, Google Play is highlighted as a core platform for monetization beyond advertising, underscoring its importance in diversifying Google's revenue streams. In 2023, the emphasis on platforms like Google Play is reiterated, with a focus on expanding digital content offerings and enhancing user experiences, indicating a continued strategic priority for non-advertising growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying Google Play as a contributor to non-advertising revenue, but it fails to accurately reflect the evolution in how Google Play's revenue sources were described in the filings. The ground truth indicates a narrowing of focus from 'sales of apps and in-app purchases and digital content' in 2022 to a more focused 'apps and in-app purchases' in 2023, with explicit reclassification under 'platforms.' The LLM instead claims consistency and even mentions 'expanding digital content offerings,' which contradicts the trend of narrowing emphasis. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is flawed: the question asks for an analysis of how the role evolved based on specific revenue sources mentioned in the filings. The LLM fails to detect the shift in language and categorization (from broader digital content to core app monetization and grouping under 'platforms'), which is central to the correct answer. This represents a failure in qualitative synthesis across years. (4) Contextual relevance is moderate—the response stays on topic and discusses Google Play’s role in non-ad revenue, but misses the key strategic shift indicated in the original answer, leading to a correctness score of 4 due to significant factual inaccuracy in the characterization of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 404,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "From 2022 to 2024, the projected utilization of the Cessna SkyCourier 408 has decreased, with FedEx planning to acquire 49 units by 2022 and only 31 units by 2024. This decline indicates a reduced strategic reliance on the Cessna SkyCourier 408 model, as FedEx appears to be shifting focus toward other aircraft types, such as the ATR 72-600F, B767F, and B777F, which are likely better aligned with long-term operational efficiency and capacity needs.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both numbers and timing. The ground truth states that in 2022, FedEx projected 49 aircraft to be in operation from 2023 onward, not that 49 units were to be acquired by 2022 — this reverses the timeline and misrepresents the projection. Similarly, the 2024 projection is for 31 aircraft from 2025–2029, not a reduction to 31 units by 2024. These are major quantitative and temporal errors. (2) The numbers themselves (49 and 31) are correct in value but incorrectly framed in terms of acquisition timing and operational rollout, leading to a misleading interpretation. The LLM incorrectly implies a reduction in planned acquisition within two years, while the actual data reflects revised long-term utilization projections over different time horizons. (3) The reasoning is partially sound in inferring reduced reliance due to lower projected numbers, but it misses the critical nuance from the ground truth: the strategic relationship shifted from 'Increases' to 'Depends_On', indicating a more conditional but still significant role, not outright reduced reliance. The LLM overstates the decline in strategic importance. Additionally, the mention of ATR 72-600F, B767F, and B777F as replacements is unsupported in the provided ground truth and introduces unverified external information. (4) The contextual relevance is high because the answer addresses the evolution of utilization and strategic reliance, fulfilling the question's intent. However, due to key factual and temporal inaccuracies and unsupported claims, the correctness and qualitative accuracy scores are moderate. The answer is partially correct but contains significant errors in interpretation and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 477,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods evolved by refining segmentation and expanding the types of casualty lines analyzed. In 2022, the expected loss ratio methods were primarily applied to the three latest accident years due to low credibility of reported losses, with a focus on U.S. Excess Casualty and U.S. Other Casualty lines. By 2023, AIG further segmented its analysis by incorporating more detailed categorizations, such as automobile-related claims versus non-automobile claims, and further breaking down non-automobile claims for latent exposures like construction defects and mass torts. Additionally, AIG expanded the use of expected loss ratio methods to newer casualty lines, including U.S. Financial Lines and U.S. Property and Special Risks, reflecting a broader application of these methods to address varying loss emergence patterns and market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but exhibits significant factual inaccuracies and misrepresents the evolution of AIG's use of expected loss ratio methods between 2022 and 2023. (1) Correctly identifies that in 2022, AIG applied expected loss ratio methods to the three latest accident years and segmented by automobile vs. non-automobile claims, including latent exposures like construction defects and mass torts—this aligns with the ground truth for U.S. Excess Casualty. However, it incorrectly states that U.S. Other Casualty was a focus in 2022, which is not supported by the original answer. (2) The claim that in 2023 AIG expanded the method to U.S. Financial Lines and U.S. Property and Special Risks is factually incorrect; the ground truth states that in 2023, AIG shifted focus to U.S. Workers' Compensation, not these new lines. The segmentation by state, industry, and claim handling entity in Workers' Compensation is entirely missing from the LLM answer. Instead, the LLM claims 'further segmentation' in the same lines as 2022, which contradicts the strategic shift described in the original. (3) The multi-hop reasoning is flawed: the question asks for evolution across years and casualty lines, but the LLM implies continuity and expansion within similar lines rather than a pivot to a different line (Workers' Compensation). It fails to capture the key shift in application context due to growth in large deductible business and risk-sharing features. (4) While the general idea of 'evolution through segmentation and expansion' is thematically relevant, the specific entities, lines, and strategic direction are incorrect. Quantitative accuracy is moderate because there are no numerical errors per se (no numbers cited), but the temporal and categorical assertions (2022 vs 2023, which lines) are wrong. Qualitative accuracy suffers due to incorrect synthesis. Contextual relevance is fair because the answer discusses the right topic and some correct mechanisms (segmentation, latent exposures), but misses the core factual pivot.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 552,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "Between fiscal years 2022 and 2024, the classification of unallocated products within Nike's consumer construct evolved as part of the Consumer Direct Acceleration strategy. In 2022, products not allocated to Men's, Women's, Kids', or Jordan Brand were categorized under \"Others,\" which included unallocated products and adjustments. By 2024, the \"Others\" category still existed but showed a 6% increase in revenue, indicating a refinement in how unallocated products were managed or reported. Additionally, the 2024 reporting emphasized a clearer alignment with the Men's, Women's, and Kids' consumer segments, reflecting a more structured approach to categorizing products within Nike's evolving consumer construct.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a 6% increase in revenue for the 'Others' category in 2024, which is not present in the original answer or supported by the ground truth. This is a significant factual error, as no quantitative change in 'Others' revenue is mentioned in the ground truth. Additionally, the original answer highlights a key shift in the classification of unisex products—specifically that in 2022 they were explicitly classified within Men's, but by 2024 there was no mention of this, suggesting a potential reclassification or integration. The LLM answer completely omits this critical detail about unisex product classification, which is central to the question. (2) The quantitative inaccuracy stems from the unsupported '6% increase in revenue' claim, which cannot be verified from the ground truth and appears fabricated. No financial figures were provided in the original answer for comparison. (3) The reasoning partially captures the continuity of the 'Others' category but fails to address the multi-hop aspect of how unisex products were treated differently across years. The evolution in classification logic—especially the absence of explicit unisex-to-Men's classification in 2024—is missing, weakening the synthesis. (4) Despite the omission of key factual detail and the introduction of unsupported data, the LLM answer remains contextually relevant by focusing on Nike's consumer construct and the role of the 'Others' category. It correctly identifies the four main segments (Men's, Women's, Kids', Jordan Brand) and references strategic context (Consumer Direct Acceleration), showing understanding of the broader framework. However, the correctness score is limited by the missing unisex classification detail and the incorrect insertion of a 6% revenue increase.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 490,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 3.500% Senior Notes due 2025 remained consistent, as the notes were issued in 2020 and continued to be disclosed in both the 2023 and 2024 10-K filings. This indicates that PepsiCo maintained its debt obligations without early repayment or refinancing during this period, reflecting a strategy of managing long-term debt through maturity schedules and maintaining a diversified debt portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo's 3.500% Senior Notes due 2025 were present in both 2023 and 2024, which aligns with the ground truth. The statement that the notes were issued in 2020 and continued to be disclosed is factually consistent and reflects accurate entity and date recognition. However, the LLM fails to mention the key evolution highlighted in the ground truth: the introduction of new long-term notes (e.g., 3.500% due 2040 and 3.550% due 2034) in 2024, which signals a strategic diversification of debt maturities. This omission significantly weakens the qualitative analysis of PepsiCo's debt management strategy. (2) Quantitatively, all references to percentages (3.500%), years (2025), and issuance timelines are accurate. There are no numerical or date inaccuracies. (3) The multi-hop reasoning is partially sound—while the model correctly tracks the continuity of the 2025 notes across years, it misses the synthesis required to connect the addition of new long-term instruments in 2024 to a broader strategic shift in debt portfolio diversification. This represents a failure in deeper contextual inference despite correct surface-level facts. (4) The answer is contextually relevant and addresses the core question about engagement and strategy, but lacks completeness in capturing the full strategic implication of PepsiCo’s 2024 debt actions. Hence, correctness is reduced to 6 due to missing key strategic context, even though basic facts are right.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 415,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "Between 2022 and 2024, COP's financial disclosures for the Lower 48 region showed significant changes in capital expenditures and future cash inflow revisions. In 2022, capital expenditures for the Lower 48 were $6,341 million, which increased to $29,952 million in 2024, reflecting a substantial rise in investment. Additionally, the discounted future net cash flows for the Lower 48 region declined from $55,912 million in 2023 to $38,693 million in 2024, primarily due to revisions in previous quantity estimates and changes in prices and production costs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, COP's 2022 capital expenditures for the Lower 48 were $3,129 million, but the LLM incorrectly states $6,341 million. The LLM claims a 2024 capex of $29,952 million, which contradicts the ground truth that explicitly states 'no new capital expenditure figure was provided' for 2024. Additionally, the LLM introduces 'discounted future net cash flows' declining from $55,912M in 2023 to $38,693M in 2024, which is entirely absent from the original answer and unsupported by the provided truth. (2) All numeric values in the LLM response are incorrect or fabricated. The ground truth does not mention any 2023 or 2024 cash flow figures, nor does it report a capex increase—instead, it notes a shift in disclosure focus from capex to revisions in future cash inflows and production costs. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers increasing investment and declining cash flows, while the original answer describes a transition from active investment reporting to revised financial projections. The model fails to capture the qualitative shift in disclosure strategy. (4) The contextual relevance is moderate because the answer addresses financial disclosures in the Lower 48 region over time and mentions capital expenditures and cash inflows, but the factual foundation is entirely incorrect, severely undermining correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 406,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "Between 2023 and 2024, Comcast's financial commitments and governance arrangements with Atairos Group evolved as follows: Comcast reduced its maximum aggregate funding commitment to Atairos from up to $5 billion to $4.5 billion, with an annual capital call cap of $400 million, and committed to an annual $40 million management fee. Comcast retains the right to 86% of residual returns but has no voting rights, maintaining a governance structure where it accounts for its investment under the equity method without consolidation. As of December 31, 2024, Comcast's remaining unfunded capital commitment was $1.4 billion, down from $5.5 billion in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key financial and governance changes between 2023 and 2024. It accurately reports the reduction in Comcast's capital commitment from $5 billion to $4.5 billion, the $400 million annual capital call cap, and the $40 million annual management fee. It correctly states that Comcast receives 86% of residual returns and has no voting rights, and that the investment is accounted for under the equity method. However, it omits the specific detail from the ground truth that Comcast absorbs approximately 99% of Atairos’ losses, which is a significant qualitative and financial aspect of the arrangement. Additionally, the claim that the unfunded commitment was $5.5 billion in 2023 is not supported by the original answer and appears to be an incorrect inference (the original does not state the 2023 unfunded amount). The mention of 'December 31, 2024' is precise but not explicitly confirmed in the ground truth. The evolution of the Shareholders Agreement from 2023 (Fourth Amended and Restated, amended in June 2023) is not mentioned, which is a governance detail present in the original. Despite these omissions and one potentially inaccurate figure, the core financial recalibration and governance structure are correctly conveyed, supporting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 367,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "FedEx's projected utilization of the Cessna SkyCourier 408 decreased between 2022 and 2023, with commitments dropping from 49 aircraft in 2022 to 31 aircraft in 2023. This reduction suggests a diminished strategic role for the Cessna SkyCourier 408 in FedEx's fleet compared to other aircraft like the ATR 72-600F, B767F, and B777F, which saw more consistent or increased commitments. The shift likely reflects a focus on larger, more fuel-efficient aircraft to achieve long-term operating savings and replace older models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the reduction in projected Cessna SkyCourier 408 aircraft from 49 in the 2022 filing to 31 in the 2023 filing, matching the ground truth. The years and numbers are accurate, and the direction of change (significant decrease) is correctly conveyed. (2) Quantitative accuracy is perfect: 49 and 31 are correct figures, and the comparison (drop from 49 to 31) is factually sound. The LLM does not misstate timeframes (2027 vs 2029 in original) but simplifies to '2023' for the updated projection year, which is a minor omission but does not distort the core fact. (3) The reasoning is strong: the LLM correctly infers a diminished strategic role and appropriately contrasts the SkyCourier with other aircraft (B767F, B777F), aligning with the ground truth. It adds ATR 72-600F, which is plausible but not mentioned in the original; this is a minor addition but not factually incorrect. The interpretation about focus on larger, more fuel-efficient aircraft is a reasonable inference consistent with the strategic shift. (4) The answer is contextually relevant, fully addressing both parts of the question: the change in utilization and the strategic implication. The only minor gap is not specifying the extended timeline (through 2029 vs 2027), but this does not undermine the correctness of the core message. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 403,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "From 2022 to 2024, Nike has increased revenue transparency for the Air Max product line by including specific technological innovations like Air-Sole cushioning components in detailed manufacturing and sourcing disclosures. In 2024, the company emphasized Air Max as part of its innovation portfolio, highlighting its role in product development and sustainability efforts, whereas in 2022, such specific product line details were not as prominently featured in revenue or innovation discussions.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It falsely claims that Nike increased 'revenue transparency' for the Air Max product line from 2022 to 2024 by including 'specific technological innovations' in financial disclosures—this contradicts the ground truth, which states that no standalone revenue figures were ever disclosed for Air Max in either year. The original answer clarifies that in 2022, Air Max was only listed among other technologies without financial breakdown, and in 2024, while highlighted as an innovation driver, it still lacked specific revenue metrics. The LLM incorrectly implies progress in financial transparency, which did not occur. (2) There are no numeric values in the response to verify, but the qualitative assertions about 'detailed manufacturing and sourcing disclosures' and 'sustainability efforts' are unsupported by the ground truth and introduce unverified details. (3) The multi-hop reasoning fails: the model misinterprets the evolution—not from lack of detail to more transparency, but from passive inclusion to strategic emphasis without financial disclosure. It misses the core nuance that the shift is in narrative positioning, not in financial reporting or technological detail disclosure. (4) While the answer addresses the general topic of Air Max’s role in innovation, it distorts the nature of Nike’s disclosure evolution, making it factually misleading. Contextual relevance is moderate because it discusses the right product and timeframe but misrepresents the key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 426,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "Comcast's capital expenditure strategy for Epic Universe evolved from 2023 to 2024, shifting from land acquisition to active construction. In 2023, capital expenditures included acquiring land for potential theme park expansion opportunities, while in 2024, spending increased due to the development of Epic Universe in Orlando. Specific investment amounts for 2024 were not disclosed, but the 2023 expenditures related to land acquisition were part of the $8.2 billion in Connectivity & Platforms capital expenditures. The 2024 focus reflects a prioritization of thematic park development, particularly for new attractions like Epic Universe.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct information but introduces inaccuracies, particularly regarding the nature of 2023 expenditures. The ground truth states that in 2023, Comcast allocated $8.2 billion to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions related to Epic Universe development—not land acquisition, as the LLM incorrectly claims. There is no mention in the original answer of land acquisition being part of the 2023 spending, making this a significant factual error. (2) Quantitatively, the $8.2 billion figure is correctly cited and attributed to 2023 and the Connectivity & Platforms segment, which aligns with the ground truth. The acknowledgment that specific 2024 figures were not disclosed is also accurate. However, the misattribution of this spending to land acquisition undermines the quantitative context. (3) The multi-hop reasoning is partially sound—the model recognizes a strategic shift from earlier-stage to active development and correctly identifies Epic Universe as a priority in both years. However, it fails to accurately characterize the 2023 investments (infrastructure vs. land), and omits the 2024 emphasis on guest experience enhancements and capacity expansion mentioned in the original. The evolution is oversimplified as a shift from land acquisition to construction, which is not supported by the source. (4) The contextual relevance is high because the answer addresses capital expenditure trends, specific years, and thematic park priorities. However, due to the key misrepresentation of 2023 spending and incomplete synthesis of 2024 priorities, the overall correctness is reduced to a 6—partially correct but with significant factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 477,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "Between 2022 and 2023, FedEx's utilization of the ATR 72-600F aircraft decreased in its fleet projections. In 2022, FedEx was committed to purchasing 24 ATR 72-600F aircraft across 2023 through 2025. By 2023, this number was reduced to 10 ATR 72-600F aircraft, with deliveries planned for 2025 and 2026. This reduction reflects a shift in focus toward other aircraft types, such as the Boeing 767F and Cessna SkyCourier 408, as part of FedEx's modernization efforts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and 1 in 2026. By 2023, projections were updated to 7 for 2025 and 3 for 2026. The LLM answer incorrectly claims FedEx was committed to purchasing 24 ATR 72-600F aircraft from 2023–2025 in its 2022 plan, and that this was reduced to 10 aircraft for 2025–2026 in 2023. These numbers (24, 10) are not supported by the ground truth and misrepresent both the scale and timing of the fleet projections. (2) The quantitative inaccuracies are severe: no mention of 24 or 10 aircraft exists in the original data; the actual numbers are 11, 6, 6, 1 (2022 projection) and 7, 3 (2023 updated projection). The LLM invents delivery timelines (2025–2026) not aligned with the original. (3) The reasoning is flawed: while the conclusion about reduced utilization is directionally correct, the multi-hop synthesis is incorrect. The LLM conflates fleet operation projections with purchase commitments and introduces unrelated aircraft (Boeing 767F, Cessna SkyCourier) not mentioned in the original, adding unsupported context. (4) Scores reflect major factual errors in numbers and timeline (quantitative accuracy: 2), poor reasoning and entity synthesis (qualitative accuracy: 3), partial relevance to the question’s focus on fleet projection evolution (contextual relevance: 6), and overall low correctness due to invented data (correctness: 3).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 420,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Nike's approach to estimating product return reserves remained consistent in its methodology, relying on historical rates, specific identification of outstanding returns, and estimated future returns. However, the reserve balances decreased from $1,015 million in 2022 to $965 million in 2024, indicating either improved product quality, stronger customer satisfaction, or more accurate forecasting. This suggests a refinement in revenue recognition practices, where the company is better able to predict return rates, leading to more precise revenue recognition and fewer adjustments in subsequent periods.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The dollar amounts cited—$1,015 million in 2022 and $965 million in 2024—are completely wrong; the ground truth states that Nike's product return reserve was $269 million in fiscal 2022, and no specific dollar amount was disclosed in fiscal 2024. This major factual error undermines the entire response. (2) The claim of a decrease from $1,015M to $965M is fabricated and contradicts the original data. There is no support in the ground truth for any such figures or trend. Additionally, the LLM incorrectly asserts that the methodology 'remained consistent,' while the ground truth clearly indicates a shift toward a more formalized, probabilistic 'most likely amount' approach in fiscal 2024, signaling a change in revenue recognition methodology under variable consideration. (3) The multi-hop reasoning is flawed: the model fails to recognize that the evolution lies in the methodology (from a disclosed reserve amount in 2022 to a more sophisticated estimation technique in 2024), not in reserve size trends. It also misses the key point about alignment with revenue recognition standards (ASC 606), where expected returns reduce revenue upfront using probabilistic estimates. (4) While the answer addresses the general topic of return reserves and revenue recognition, its factual inaccuracies and misrepresentation of both numbers and conceptual changes result in a very low correctness score. The contextual relevance is moderate because it discusses related themes, but the substance is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 439,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "In 2022, FedEx planned to deliver 31 Cessna SkyCourier 408 aircraft by 2025, but by 2023, this number was reduced to 17 for 2025 with no deliveries scheduled beyond 2026. This significant reduction indicates a decreased strategic reliance on the Cessna SkyCourier 408 model, suggesting a shift in priorities or operational plans for FedEx's fleet composition.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, FedEx (FDX) projected 12 Cessna SkyCourier 408 aircraft by 2025, not 31 as stated in the LLM answer. The 2023 update correctly notes an increase to 17 for 2025, but the ground truth shows a reduction to 14 by 2026, not a complete halt in deliveries beyond 2026. The LLM incorrectly claims 'no deliveries scheduled beyond 2026,' which contradicts the original answer's mention of maintaining 14 aircraft in 2026. (2) Quantitative accuracy is low: the 2022 number is wrong (31 vs 12), and the trajectory beyond 2025 is misrepresented. The calculation and comparison between years are therefore flawed. (3) The multi-hop reasoning is partially sound—comparing 2022 and 2023 plans for 2025 and beyond—but the incorrect data leads to a flawed conclusion. The LLM infers decreased strategic reliance due to reduction from 31 to 17, but the actual data shows an increase from 12 to 17, indicating heightened short-term reliance. Thus, the reasoning is based on false premises. (4) Contextual relevance is fair because the answer addresses fleet composition changes and strategic reliance, but the incorrect numbers and misinterpretation of the trend undermine the validity. The conclusion about decreased reliance is opposite to the ground truth's indication of short-term increased reliance followed by moderate decline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 395,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "Mastercard expanded its real-time account-based payments infrastructure from 2023 to 2024 by increasing the number of markets where it operates or implements real-time payments infrastructure, growing from 13 markets as of December 31, 2023, to more markets in 2024. In terms of integrated security capabilities, Mastercard employs a multi-layered approach to protect the global payments ecosystem, including robust programs to defend against cyber and information security threats, multiple layers of protection across its network and platforms, and collaboration with stakeholders to develop technical standards for secure transactions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Mastercard operated or was implementing real-time payments infrastructure in 13 markets as of 2023, which matches the ground truth. However, it mentions expansion to 'more markets' in 2024 without specifying any exact number or named new markets, which is a minor omission—the original answer confirms expansion but also emphasizes enhanced ACH and account-based systems, not just geographic scale. (2) Quantitatively, the use of '13 markets' is accurate and correctly attributed to 2023. There are no calculations in the response, so no errors there. The date reference 'December 31, 2023' is a reasonable precision not contradicted by the original. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about operational scale (market count) and security capabilities across years. It accurately describes Mastercard’s multi-layered security approach, including cyber threat defense, layered protections, and stakeholder collaboration, aligning with the original’s mention of reinforced security and partnerships. However, it omits specific 2024 enhancements like intelligent routing, fraud scoring, tokenization, and value-added services that were highlighted in the ground truth. (4) The answer is contextually fully relevant, addressing both operational scale and security evolution. While it captures the core facts and correctly identifies the entities and timeline, it lacks some depth in describing the qualitative technological upgrades in 2024, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 433,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Between 2022 and 2024, Nike's use of foreign exchange forwards and options evolved in both financial liabilities and hedging strategy. In 2024, the total notional amount of foreign currency derivatives designated as cash flow hedges decreased to $16.2 billion from $18.2 billion in 2023, indicating a slight reduction in hedged exposure. Additionally, financial liabilities related to these instruments decreased from $180 million in 2023 to $151 million in 2024. The deferred net gains expected to be reclassified to net income also dropped to $231 million in 2024 from prior years, reflecting changes in the timing and magnitude of hedged transactions and exchange rate fluctuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, foreign exchange forwards and options had a net gain of $8 million after tax, but the LLM does not mention this at all. Instead, it introduces data for 2023 and 2024 that is not present in the original answer, such as a decrease in notional amount from $18.2B to $16.2B and financial liabilities dropping from $180M to $151M—none of which appear in the ground truth. The original answer states that by 2024, liabilities increased to $110M under accrued liabilities and $5M under deferred income taxes, totaling $115M, which contradicts the LLM's claim of $151M in liabilities. (2) The LLM invents figures not found in the ground truth (e.g., $18.2B and $16.2B notional amounts, $180M to $151M liability decrease, $231M deferred gains), making quantitative accuracy very low. There is no mention in the original answer of cash flow hedges or reclassification of gains, so these metrics are unsupported. (3) The multi-hop reasoning is flawed because the LLM fails to connect the correct evolution from 2022 to 2024 based on actual reported impacts. It fabricates a narrative of decreasing exposure and liabilities, while the ground truth indicates an increase in liabilities and a shift in reporting/management, suggesting potentially increased complexity or concentration in hedging instruments. (4) While the LLM attempts to address the evolution of hedging strategy and financial liabilities, it does so with incorrect data and misses the key point about increased liabilities and post-tax gains in 2022. The contextual relevance is moderate because it discusses the right topic (hedging strategy and liabilities), but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 489,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "Between 2022 and 2023, the product category classification of Puffs within the Baby, Feminine & Family Care segment remained consistent, as Puffs were categorized under the Family Care sub-category in both years. In 2022, Family Care included \"Paper Towels, Tissues, Toilet Paper,\" and in 2023, the classification remained the same. Thus, there was no change in the classification of Puffs during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key nuance in the evolution of the product category classification. (1) It correctly identifies that Puffs remained in the Family Care sub-category in both 2022 and 2023, and accurately lists the 2022 components (Paper Towels, Tissues, Toilet Paper). However, it incorrectly states that the classification 'remained the same' in 2023, while the ground truth indicates a reporting change: the 2023 filing replaced the specific mention of 'Tissues' with a more general listing without sub-category breakdowns, signaling a simplification or consolidation in reporting. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—scored as 10 by default for absence of numerical errors. (3) The reasoning is flawed in the multi-hop synthesis: the model failed to recognize that a change in disclosure granularity (from detailed sub-categories to a more general listing) constitutes an evolution in classification reporting, even if the overarching category remained the same. This reflects a lack of qualitative precision in interpreting corporate filing nuances. (4) Contextual relevance is high because the answer addresses the core question about Puffs’ classification, but the failure to capture the reporting change reduces factual completeness and reasoning accuracy, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 383,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "Between 2022 and 2023, Tampax's categorization within P&G's product portfolio remained under the Baby, Feminine & Family Care segment. In 2022, Tampax was listed under the \"Feminine Care\" sub-category alongside Always and Always Discreet. By 2023, Tampax was specifically categorized under the \"Menstrual Care\" sub-category, which is part of the broader Feminine Care category, indicating a more detailed product line classification.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that Tampax remained within the 'Baby, Feminine & Family Care' segment in both 2022 and 2023. In 2022, it was under 'Feminine Care', and by 2023, it was reclassified under 'Menstrual Care', reflecting a more focused positioning—this matches the original answer's core claim. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023) and categorical labels are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across years and categories, correctly inferring a refinement in classification. The only minor shortcoming is that the LLM implies 'Menstrual Care' is a sub-category of 'Feminine Care', while the original answer presents 'Menstrual Care' as replacing the broader 'Feminine Care' for Tampax, suggesting a reorganization rather than a nesting. This nuance is slightly oversimplified but does not invalidate the overall correctness. (4) The answer is contextually relevant, directly addressing the evolution in categorization and associated product lines. Thus, the correctness score is 9 due to this minor conceptual imprecision, but all other dimensions are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 359,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "Oracle's strategy for Oracle Engineered Systems between fiscal 2022 and 2023 shifted toward emphasizing cloud-based infrastructure and strategic hardware offerings, resulting in reduced sales volumes for nonstrategic hardware products. Revenue contributions from the hardware business, which includes Engineered Systems, declined slightly in fiscal 2022 compared to fiscal 2021, with constant currency revenues decreasing by 3%. Research investment expectations remained strong, with Oracle continuing to allocate resources to improve existing hardware and develop new products, though hardware R&D expenses were not explicitly detailed in the provided pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces information not present in the ground truth. It claims that Oracle's hardware revenue declined by 3% in fiscal 2022 compared to 2021, which is not mentioned in the original answer and cannot be verified from the provided context. The ground truth does not include any year-over-year revenue change for hardware, so this figure is incorrect and unsupported. Additionally, the LLM mentions 'cloud-based infrastructure' and 'reduced sales volumes for nonstrategic hardware products,' which are not referenced in the original answer and represent speculative additions. (2) The only quantitative detail in the ground truth is that hardware represented 6% of total revenue in fiscal 2023—this is missing from the LLM response. Instead, the LLM fabricates a 3% decline in constant currency revenues, which is not in the original and thus a major quantitative error. (3) The multi-hop reasoning is partially sound in that it attempts to compare fiscal 2022 and 2023 strategies, but it fails to capture the key evolution: in 2023, Oracle began explicitly quantifying hardware’s revenue contribution (6%) and reaffirmed R&D investment. The LLM correctly notes continued R&D focus but incorrectly states that 'hardware R&D expenses were not explicitly detailed,' whereas the original confirms Oracle *stated plans* to invest in R&D—this is a qualitative mismatch. (4) The contextual relevance is moderate because the answer addresses strategy evolution, revenue, and R&D, aligning with the question's structure, but factual inaccuracies and hallucinated data severely undermine correctness. The core strategic shift—increased transparency with revenue share and sustained R&D commitment—is underreported due to distraction with incorrect metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 491,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Between 2022 and 2023, Honeywell's Non-U.S. pension plans increased their allocation to private funds, with the total value rising from $90 million in 2022 to $115 million in 2023. In terms of fair value hierarchy levels, the allocation of private funds shifted from $54 million in Level 2 and $36 million in Level 3 in 2022 to $41 million in Level 2 and $74 million in Level 3 in 2023, indicating a significant increase in Level 3 (less observable) investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans (not Non-U.S.), all classified under Level 3. However, the LLM incorrectly claims $90 million in 2022 for Non-U.S. plans with a split of $54M Level 2 and $36M Level 3—none of which appears in the ground truth. The only correct figure is the 2023 Non-U.S. total of $115 million, split into $41M Level 2 and $74M Level 3. The LLM falsely asserts an increase from $90M to $115M, but the ground truth does not provide 2022 Non-U.S. private fund data, so no such comparison can be made. (2) Quantitative accuracy is very low: the $90M, $54M, and $36M figures are entirely fabricated. The only correct numbers are the 2023 $115M total, $41M Level 2, and $74M Level 3. The 2022 U.S. figure of $1,105M is completely omitted and replaced with incorrect Non-U.S. data. (3) The multi-hop reasoning is flawed. The question asks about evolution in Non-U.S. plans between 2022 and 2023, but the ground truth does not provide 2022 Non-U.S. private fund allocations—only U.S. data. The LLM invents a 2022 Non-U.S. baseline to create a narrative of growth, which is unsupported. It also fails to note the major shift from U.S. to Non-U.S. reporting and the overall decrease in private fund investments. (4) Contextual relevance is moderate because the answer discusses the right topic (private fund allocation in Non-U.S. pension plans, fair value hierarchy levels) and correctly reports the 2023 data, but it fabricates 2022 Non-U.S. figures and draws incorrect conclusions about trends. The qualitative reasoning is compromised by incorrect inputs, leading to invalid synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 479,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "Between 2023 and 2024, the status of the 2014 USD Notes evolved as the $1 billion principal amount matured in April 2024 and was repaid. In 2024, no new issuances of the 2014 USD Notes occurred; instead, the company issued new debt through the 2024 USD Notes, which included $1 billion due in 2034, $750 million due in 2028, $1.15 billion due in 2032, and $1.1 billion due in 2035. These new issuances were used to fund operations, repurchase shares, and pay dividends, with net proceeds of $3.96 billion.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the $1 billion 2014 USD Notes matured and were repaid in April 2024, which aligns with the ground truth. However, it introduces new information about the 2024 USD Notes and their use of proceeds (e.g., $1 billion due 2034, $750 million due 2028, etc.), which is not part of the original answer and not requested in the question. This additional detail, while possibly true, is irrelevant and distracts from the core focus on the 2014 USD Notes. (2) Quantitatively, the $1 billion principal amount and April 2024 maturity are correct. However, the LLM fabricates new debt issuances and amounts (e.g., $1.15B, $1.1B) that are not present in the ground truth, introducing significant quantitative inaccuracies. The sum of the new notes ($3.96B) is also not verifiable from the original answer. (3) The multi-hop reasoning is partially sound in tracking the 2014 notes from short-term debt in 2023 to repayment in 2024, but fails to mention their classification as short-term debt in 2023 (a key point in the original answer). Instead, it shifts focus to new issuances, indicating a misalignment in reasoning. (4) The contextual relevance is high because the core event (repayment of 2014 notes) is addressed, but the inclusion of unrelated 2024 note issuances reduces accuracy. The answer should have focused solely on the status evolution and actions taken regarding the 2014 notes, not new debt instruments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 402,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "The treatment and documentation of Lowe's Officer Indemnification Agreements have remained consistent between 2022 and 2024, with the Form of Officer Indemnification Agreement listed as Exhibit 10.23 in both years (2022: page 80, 2024: page 79). This consistency suggests a stable approach to executive risk management, emphasizing continuity in governance practices and a commitment to protecting officers against potential legal liabilities, thereby supporting long-term executive stability and corporate governance.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its assessment of consistency in Lowe's Officer Indemnification Agreements between 2022 and 2024, accurately noting that the same form was used and refiling indicates stable governance and executive risk management. However, there is a factual error in the exhibit number: the LLM states Exhibit 10.23, while the ground truth confirms it is Exhibit 10.43 (first filed April 2, 2019). This misidentification affects quantitative accuracy, as exhibit numbers are key identifiers in SEC filings and must be precise. Additionally, the LLM omits the fact that the agreement was originally filed in 2019 and refiled without amendment, which adds context to the continuity. Despite this, the reasoning is sound—correctly inferring that unchanged documentation reflects consistent governance and executive protection policies. The answer addresses both parts of the question (evolution and implications), demonstrating proper multi-hop synthesis across years and documents. Wording differs from the original but maintains semantic equivalence on the core conclusion. The page numbers cited (80 in 2022, 79 in 2024) are plausible and not contradicted by the ground truth, though not included in the original answer. Overall, minor factual inaccuracy prevents a top score, but qualitative and contextual performance is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 374,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "Based on the provided information, Always Discreet's market share in the adult incontinence category increased from over 10% in 2022 to about 15% in 2023. This indicates a positive shift in market share and category positioning for Always Discreet within the adult incontinence market between the two years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states that Always Discreet had over 10% market share in 2022, but no market share figure was provided in the 2023 filing. The LLM falsely claims that market share increased to about 15% in 2023, which is not supported by the original data. There is no mention of a 15% figure in the 2023 filing, so this number is fabricated. (2) Quantitative accuracy is severely lacking: the 15% figure is incorrect and unsupported, and the comparison implies a precise increase that does not exist in the source material. The only correct number is 'over 10%' from 2022. (3) The reasoning is flawed: instead of recognizing the absence of a 2023 market share disclosure, the model incorrectly infers an increase. It fails to recognize the shift in reporting strategy from quantified market share to general brand listing, which is the actual change in category positioning. The model does not perform accurate multi-hop synthesis; it invents data rather than comparing disclosures across filings. (4) Correctness and quantitative accuracy are very low due to the invention of a specific percentage not present in the source. Qualitative accuracy is low because the reasoning and entity synthesis are incorrect. Contextual relevance is moderate because the answer addresses the right brand and market, but with false information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 385,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "Oracle's strategic positioning of Engineered Systems between 2022 and 2023 has evolved to align more closely with its cloud transformation narrative. In 2022, Engineered Systems were emphasized as core components of Oracle's data center infrastructure, combining pre-integrated hardware and software to deliver performance and scalability for both on-premise and cloud environments. By 2023, the focus shifted to highlight their role in Oracle Cloud Infrastructure (OCI), with offerings like Oracle Exadata being deployed not only on-premise but also as cloud and hybrid cloud solutions. This evolution reflects Oracle's broader strategy to integrate its hardware capabilities into its cloud ecosystem, enabling customers to deploy Engineered Systems in flexible, cloud-centric models while supporting Oracle's transition to a cloud-first business.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the evolution in Oracle's strategic positioning of Engineered Systems from 2022 to 2023, emphasizing their integration into Oracle Cloud Infrastructure (OCI) and hybrid cloud models as part of Oracle's cloud transformation. It accurately reflects the shift from being pre-integrated infrastructure solutions to playing a more central role in cloud-centric deployment models. However, the LLM answer omits key quantitative and structural details present in the ground truth. Specifically: (1) It does not mention that hardware revenues, including Engineered Systems, accounted for 6% of total revenues in both fiscal 2023 and 2024—a critical data point for assessing the business impact; (2) It fails to note the broader expansion of the hardware business to include servers, storage, and operating systems as combined performance obligations, which is a significant strategic repositioning highlighted in the 2023 filing; (3) It does not reference ongoing R&D investments, which support the narrative of long-term commitment despite the lower-margin nature of hardware. While the qualitative direction of the reasoning is sound and semantically aligned with the cloud transformation narrative, the absence of these specific, multi-hop details from the 2023 filing reduces completeness and depth. There are no factual inaccuracies or calculation errors (hence perfect quantitative accuracy), and the response remains highly relevant to the question. The answer synthesizes the core strategic shift but misses key supporting evidence required for full factual and contextual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 440,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "In the 2022 10-K filing, the 2020 Stock Plan is described as the successor to the 2011 Stock Plan, with 5,530,106 shares from the 2011 Plan available for grant under the 2020 Plan. By the 2023 10-K filing, this relationship is not explicitly reiterated, and the focus shifts to the 2020 Stock Plan's operations and share activity without further reference to the 2011 Plan. This indicates a reduced emphasis on the 2011 Plan's role in the 2023 disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 2022 10-K included the detail that 5,530,106 shares from the 2011 Stock Plan were carried forward into the 2020 Stock Plan, and this specific reference was omitted in the 2023 10-K. The number 5,530,106 is correctly stated, and the years (2022 and 2023) are accurate. (2) Quantitative accuracy is perfect—no calculations required, but the numeric value is precisely correct. (3) The reasoning is sound: the LLM correctly identifies the multi-hop evolution in disclosure practice between two consecutive filings, noting the shift from explicit linkage to omission. It accurately infers a reduced emphasis, which aligns with the ground truth’s conclusion about changed presentation focus. (4) The only minor difference is semantic: the LLM uses 'successor' and 'reduced emphasis,' while the ground truth says 'relationship' and 'shift in presentation,' but these are equivalent in meaning. No critical information is missing. Thus, the answer fully satisfies completeness, entity accuracy, and contextual relevance. A score of 9 is given because while the answer is factually complete, it slightly simplifies the nuance in the original answer regarding 'how the company chose to present the lineage,' though the core insight remains intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 378,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Honeywell's allocation strategy toward private funds increased between 2022 and 2023, particularly in non-U.S. pension plans, where private fund allocations rose from $36 million in 2022 to $74 million in 2023. This suggests a modest but deliberate shift toward alternative investments, potentially reflecting a focus on diversification and long-term capital growth amid evolving market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative and entity accuracy. The ground truth states that Honeywell's total investment in private funds increased from $1,244 million in 2022 to $1,265 million in 203, representing a 1.7% increase. However, the LLM incorrectly cites a rise in 'non-U.S. pension plans' from $36M to $74M, which does not appear in the original answer or align with the disclosed totals. These figures are factually wrong and not supported by the ground truth. (2) The calculations are therefore also incorrect—there is no mention of non-U.S. plans in the original answer, nor is $74M close to the actual total of $1,265M. The LLM introduces a specific subcategory (non-U.S. pension plans) not referenced in the ground truth, which distorts the response. (3) The multi-hop reasoning is flawed because the model fails to correctly identify and synthesize the correct data points across the two 10-K filings. Instead of reporting the overall private fund allocations, it fabricates or misattributes data to a subset (non-U.S. plans) that undermines the validity of the conclusion. (4) While the qualitative interpretation about a 'shift toward alternative investments' and 'diversification' aligns thematically with the original answer’s inference, the incorrect data renders the reasoning invalid. The contextual relevance is moderate because the answer addresses the general topic of allocation strategy evolution, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 423,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "Between 2023 and 2024, Class B-2 Common Stock was introduced as a result of an exchange offer in May 2024, where 241 million shares of Class B-1 Common Stock were exchanged for 120 million shares of Class B-2 Common Stock and 48 million shares of Class C Common Stock. Prior to this exchange, no shares of Class B-2 Common Stock were outstanding. Class B-2 Common Stock is subject to transfer restrictions and conversion rate adjustments tied to the resolution of litigation, similar to Class B-1 Common Stock, but with double the impact of conversion rate adjustments. This evolution reflects the restructuring of Class B Common Stock into multiple subclasses to manage transferability and litigation-related dilution.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Class B-2 Common Stock was not introduced in May 2024 as a result of an exchange offer involving 241 million Class B-1 shares being exchanged for 120 million Class B-2 and 48 million Class C shares. This entire event is fabricated and not supported by the original answer. The ground truth states that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer, but does not confirm that such an exchange actually occurred in 2024. Furthermore, there is no mention of Class C Common Stock or any specific numerical exchange ratios in the original answer. (2) The quantitative inaccuracies are severe: the LLM invents precise figures (241 million, 120 million, 48 million) and a specific date (May 2024) that do not appear in the ground truth. The original answer does not provide any such numbers or timeline for an exchange, nor does it mention Class C stock at all. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers causality and chronology, suggesting a restructuring occurred in 2024 that is not documented in the ground truth. While the original answer notes that Class B-2 was subject to conversion rate adjustments tied to litigation escrow in 2023, the LLM misrepresents this by claiming Class B-2 has 'double the impact' of adjustments compared to Class B-1—information not present in the ground truth. (4) Despite these major errors, the answer is contextually relevant in that it attempts to address the evolution of Class B-2 stock and its relationship to other classes. It correctly notes that no Class B-2 shares were outstanding before the exchange offer and touches on transfer restrictions and litigation-related adjustments, which aligns thematically with the original answer’s focus on dilution and conversion mechanics. However, the invention of specific events, numbers, and structural details results in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 536,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The financial obligations related to the Target Circle program significantly decreased between 2022 and 2024, with deferred revenue dropping from $117 million in 2022 to $19 million in 2024. This decline indicates that the program matured, with more rewards being recognized and delivered to members over time, reducing the liability on Target's balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in both direction and magnitude of change in deferred revenue. It incorrectly states that deferred revenue dropped from $117 million in 2022 to $19 million in 2024, when the ground truth shows it increased from $89 million in 2022 to $117 million in 2024, before dropping to $19 million by early 2025. The LLM reverses the trend between 2022 and 2024 and misattributes the $117M figure to 2022 instead of 2024. (2) The numbers are significantly inaccurate: the 2022 figure is wrong ($117M vs correct $89M), the 2024 figure is assigned to the wrong year, and the sharp decline is placed between 2022–2024 rather than 2024–2025. No correct calculation or comparison is made. (3) The multi-hop reasoning fails: the model does not correctly synthesize the three time points (2022, 2024, 2025) and misses the growth phase before the decline. It incorrectly infers program maturity between 2022 and 2024 when the data shows expansion during that period. (4) Contextual relevance is moderate because it discusses deferred revenue and liability reduction, which are relevant concepts, but the incorrect data leads to a flawed interpretation. The conclusion about rewards being delivered may align with the 2025 drop, but it is misaligned with the 2022–2024 period in question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 370,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million as of December 31, 2022, to $996 million as of December 31, 2023. This slight increase in fair value suggests that investor perception or market conditions may have improved slightly for Netflix's debt during this period, potentially reflecting increased confidence in the company's creditworthiness or a more favorable interest rate environment.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of the change in fair value. The original answer states the fair value decreased from $980 million to $996 million, but this is incorrect — $996 million is greater than $980 million, so the value actually increased, not decreased. The LLM incorrectly states the value 'decreased' when it should have said 'increased'. This fundamental error undermines the quantitative accuracy. (2) The numeric values themselves ($980 million and $996 million) and the dates (December 31, 2022, and December 31, 2023) are correctly cited, so the raw data is accurate, but the interpretation of the change is wrong. The calculation of direction (increase vs decrease) is incorrect, which is a major flaw. (3) The reasoning is partially sound — the LLM correctly infers that an increase in fair value (though mislabeled as a decrease) could indicate improved investor perception or market conditions, which aligns with the ground truth logic. However, because the direction of change is wrong, the multi-hop synthesis fails at a basic level. The model should have recognized that moving from $980M to $996M is an increase, not a decrease. (4) The contextual relevance is high — the answer addresses both parts of the question (change in fair value and its implication), uses correct entities (Netflix, 4.375% Senior Notes, correct dates), and attempts appropriate interpretation. However, the core factual error in describing the direction of change severely limits correctness. A score of 4 reflects that some facts are right but the main conclusion is based on a false premise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 449,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "Between 2023 and 2024, the equity structure related to Class C Common Stock remained largely unchanged in terms of share issuance, with 10 shares issued and outstanding in both years. However, the equity classification for Class C Common Stock was impacted by adjustments in the \"Right to recover for covered losses,\" which decreased from $(140) million in 2023 to $(104) million in 2024. Additionally, the overall equity structure was influenced by changes in accumulated comprehensive income (loss), particularly from foreign currency translation adjustments and derivative instruments, which affected the total equity balance.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claim about share issuance. The ground truth states that in 2023, approximately 48 million shares of Class C common stock were issued as part of an exchange offer involving 241 million Class B-1 shares. The LLM incorrectly claims that only 10 shares were issued and outstanding in both 2023 and 2024, which contradicts the active issuance in 2023. While it correctly notes that the 2024 balance sheet shows 10 shares of Class C outstanding, it fails to explain the significant 2023 activity and implies stability across both years, which is factually wrong. (2) The LLM introduces financial figures like 'Right to recover for covered losses' decreasing from $(140) million to $(104) million, which are not mentioned in the original answer and are irrelevant to the question about share issuance and equity classification evolution. These numbers may be contextually related to Visa’s liability structure but do not pertain to Class C share issuance or classification changes. (3) The multi-hop reasoning is flawed: the model fails to connect the 2023 exchange offer (Class B-1 tendered → Class C issued) with the 2024 stabilization, which is the key evolution. Instead, it fabricates continuity in share count and focuses on unrelated equity adjustments. (4) The contextual relevance is moderate because it discusses equity classification and mentions Class C stock, but it misses the central event (the exchange offer) and misrepresents the quantitative facts. The qualitative reasoning is poor due to incorrect synthesis and omission of critical events. Quantitative accuracy is low because the key number (48 million shares issued in 2023) is entirely missing, replaced by an incorrect assertion of 10 shares throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 485,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "Lowe's engagement with Rough Plumbing has evolved from 2022 to 2024 in terms of business classification and service offerings. In 2022, Rough Plumbing was categorized under the \"Building Products\" division, which accounted for 32.4% of total sales. By 2024, Rough Plumbing was included in the \"Installed Sales\" model, where installation services are offered through independent contractors, particularly in categories like Kitchens & Bath, Millwork, and Rough Plumbing. This shift reflects an expanded service offering, integrating installation and project management to enhance customer experience.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the shift in business classification of Rough Plumbing from 'Building Products' in 2022 to inclusion in 'Installed Sales' by 2024, and notes the expansion into service offerings like installation through contractors. This aligns with the ground truth's emphasis on a strategic shift toward service bundling. However, the LLM introduces a specific percentage—32.4% of total sales attributed to Building Products in 2022—which is not present in the original answer and cannot be verified from the provided ground truth. This unsupported figure reduces quantitative accuracy. Additionally, while the original answer mentions that installed sales accounted for approximately 5% of total sales in 2024, this key metric is missing in the LLM response, representing a notable omission. (2) The date range (2022 to 2024) is accurate, and the categorization evolution is correctly described, but the inclusion of 32.4% without grounding and the absence of the 5% installed sales figure result in partial quantitative inaccuracy. Format variations are acceptable, but invented metrics are not. (3) The multi-hop reasoning is generally sound: the model connects Rough Plumbing’s reclassification with broader service expansion trends at Lowe’s, correctly associating it with installation services and project management in relevant categories. It synthesizes the evolution in engagement appropriately, though it misses linking the service shift directly to protection plans, which is a component of the ground truth. (4) Despite missing one key quantitative data point and introducing an unverified one, the LLM captures the core qualitative shift and remains contextually relevant. The answer addresses both business classification and service offering changes, fulfilling the main intent of the question, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 507,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "The introduction of Class B-2 common stock occurred in May 2024 through an exchange offer, where 241 million shares of Class B-1 common stock were exchanged for 120 million shares of Class B-2 common stock and 48 million shares of Class C common stock. By 2024, Class B-2 common stock had a weighted-average of 49 million shares outstanding and showed similar earnings per share to Class B-1 stock, indicating it plays a comparable role in the capital structure with respect to earnings allocation and conversion features. This suggests that Class B-2 is a newly created tier within the B-class structure, likely designed to manage transferability and conversion rights under the Company's litigation and regulatory framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Class B-2 common stock was introduced in 2023 with 77 million shares outstanding, but the LLM claims it was introduced in May 2024 via an exchange offer involving 241 million Class B-1 shares for 120 million Class B-2 and 48 million Class C shares—none of which appears in the original answer and contradicts it. The LLM also states that by 2024, there were 49 million weighted-average shares outstanding, while the ground truth explicitly says 'no shares of Class B-2 common stock were outstanding' prior to the Class B-1 exchange offer, indicating either zero or negligible presence. (2) Quantitative accuracy is poor: 77 million (correct 2023 figure) vs. 120 million and 49 million (fabricated 2024 figures); introduction in 2023 vs. May 2024—date and magnitude both wrong. No valid calculation can be verified as correct. (3) Multi-hop reasoning fails: the LLM invents an exchange mechanism and capital structure role not present in the ground truth. Instead of identifying the disappearance or restructuring of Class B-2, it asserts continued existence and functional equivalence to Class B-1, which contradicts the original answer’s implication of replacement or elimination. (4) Contextual relevance is moderate—the response addresses capital structure evolution and role of Class B-2 stock—but does so with fabricated events and numbers, undermining factual integrity. The conclusion about managing transferability under litigation framework is speculative and unsupported by the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 440,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The financial liability associated with the Target Circle program decreased from $117 million in 2022 to $19 million in 2024. This significant reduction suggests that the program may have evolved to recognize revenue more promptly or that deferred rewards were redeemed or recognized over time, indicating operational efficiency or increased member engagement.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that no specific liability was disclosed in 2022, but by 2024 it had grown to $117 million, indicating an increase. The LLM incorrectly claims the liability decreased from $117 million in 2022 to $19 million in 2024—both the starting value and the trend are wrong. (2) Quantitative accuracy is severely lacking: the $117 million figure is misattributed to 2022 instead of 2024, and the $19 million figure has no basis in the original answer. There are no calculations in the ground truth, but the LLM invents a comparison that contradicts the data. (3) The multi-hop reasoning is flawed—the LLM fails to recognize that the absence of a disclosed liability in 2022 implies no material figure was reported, and instead fabricates a number. The conclusion about 'evolved to recognize revenue more promptly' or 'increased member engagement' is unsupported and contradicts the actual implication of growth. (4) Scores are low because the core facts—numbers, trends, disclosures—are all incorrect. Contextual relevance is slightly above zero because the answer addresses the Target Circle program and financial liability conceptually, but the factual foundation is entirely wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 359,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "NVDA's exposure to and concern about pollution limits and their regulatory impact on operations and customer data center expansion evolved between 2023 and 2024, with increased emphasis on the challenges posed by energy and water availability. In 2023, the company noted that power or water shortages, or regulations limiting energy or water availability, could impair customers' ability to expand data centers and consume their products. By 2024, the concern was expanded to include land or permitting constraints, and the impact of regulations on energy, water, or land availability was highlighted as a potential impediment to data center expansion. Additionally, in 2024, NVDA expressed heightened awareness of the potential for new or proposed regulations related to pollution limits, carbon taxes, and sustainability-related governance, which could lead to increased compliance costs and operational changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of NVDA's concerns about pollution limits between 2023 and 2024. In 2023, the original answer states that NVDA highlighted increased costs (compliance, energy, capex) and operational changes due to climate regulations; the LLM correctly identifies regulatory risks around energy and water availability impacting customer data center expansion, which aligns with the core concern. By 2024, the original answer emphasizes new risks around land and permitting constraints affecting customer expansion, which the LLM accurately includes. The LLM adds detail about carbon taxes and sustainability governance, which is consistent with the direction of increased regulatory concern, though slightly more specific than the original. The key point—that regulatory tightening on pollution could impair customer data center growth and thus demand for NVDA’s products—is correctly inferred and conveyed. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are present), and all entities (NVDA, 2023, 2024, data center expansion, regulatory impact) are correct. The reasoning is sound multi-hop synthesis across years and impacts (operations → customer demand). The only minor gap is that the original emphasizes cost increases in 2023 more directly, while the LLM focuses on resource availability; however, both are valid aspects of regulatory impact and are semantically aligned. Thus, the answer is factually correct and comprehensive with only slight variation in emphasis, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 443,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "Between 2023 and 2024, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolved as follows: In November 2023, four Guaranteed Senior Notes totaling approximately $500 were issued at fixed interest rates ranging from 1.400% to 2.120%. These notes are valued using Level 3 inputs. In July 2024, $77 of these Guaranteed Senior Notes were repaid. No new Guaranteed Senior Notes were issued in 2024, and the fair value inputs for these notes remained classified under Level 3.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: in 2023, four Guaranteed Senior Notes totaling approximately $500 were issued by the Japanese subsidiary at fixed interest rates from 1.400% to 2.120%, valued using Level 3 inputs. In 2024, $77 of these notes were repaid. The answer correctly states no new notes were issued in 2024 and that valuation remained under Level 3. These details align fully with the ground truth. (2) Quantitative accuracy is perfect: $500 issuance, $77 repayment, interest rate range, and Level 3 classification are all accurate. While the LLM does not explicitly mention the total fair value of long-term debt at the end of 2023 ($5,738) and 2024 ($5,412), it does correctly imply a reduction in value due to repayments and lack of new issuances. This omission slightly affects completeness but does not distort the factual narrative. (3) The multi-hop reasoning is sound—information is synthesized across years and events (issuance in 2023, repayment in 2024, valuation inputs). The LLM correctly infers that the classification remained Level 3, which is consistent with the original answer. (4) The answer is contextually relevant and focused, addressing composition (issuance, repayment), valuation (Level 3 inputs), and evolution over time. The only minor gap is the absence of the aggregate fair value figures for long-term debt, which were part of the original answer and relevant to 'valuation'. However, since the question focuses on Guaranteed Senior Notes specifically—and the LLM accurately describes their valuation inputs and changes—the omission does not severely impact correctness. Thus, a score of 9 is justified: highly accurate with near-complete coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 469,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "From 2022 to 2024, Netflix increased its investment in streaming service improvements, as reflected in higher personnel-related costs and cybersecurity measures. In 2022, the company emphasized continued improvements in its streaming service, with a 24% increase in technology and development expenses due to growth in average headcount. By 2024, Netflix disclosed a more robust cybersecurity program, including a dedicated Vice President of Security and Privacy Engineering with over 30 years of experience, regular risk assessments, and third-party security programs. These changes indicate a strategic evolution toward strengthening both operational infrastructure and risk management to address growing cybersecurity threats and protect member data.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Netflix's investment from personnel growth in 2022 to enhanced cybersecurity in 2024, aligning with the core narrative of the ground truth. However, there are key quantitative discrepancies. The ground truth states a $384 million increase in personnel-related costs in 2022, while the LLM claims a '24% increase in technology and development expenses'—a figure not present in the original answer and potentially conflating different metrics. This undermines quantitative accuracy. (2) The $384M figure is specific and verifiable in the ground truth; the 24% figure has no support in the provided data, suggesting either hallucination or misattribution from external knowledge. No calculation is possible to verify equivalence between $384M and 24%. (3) Qualitatively, the reasoning is sound: the model correctly synthesizes a shift from growth-focused investment (headcount) to risk mitigation (cybersecurity), noting structural changes like the VP of Security and third-party programs. This reflects multi-hop understanding across years and domains (personnel → cybersecurity risk). (4) Contextually, the answer is highly relevant, addressing both personnel and cybersecurity developments as asked. The strategic evolution is accurately framed, even if precise financial figures are not. The answer misses the explicit mention of potential financial impact of cyber incidents (e.g., data release, content theft affecting results), which is a notable omission in completeness. Overall, core facts are correct but weakened by unsupported numbers and missing risk impact details, justifying a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 458,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "Between 2023 and 2024, The Bank of New York Mellon Corporation updated its approach to restricted stock unit (RSU) agreements by introducing the 2024 Form of Restricted Stock Unit Agreement, as noted in the 2024 filing. This evolution reflects a continued emphasis on aligning executive compensation with long-term performance and shareholder interests, with lifecycle management of RSUs likely incorporating revised terms or conditions to reflect updated corporate governance or compensation strategies. The inclusion of the 2024 RSU form in the 2024 filing suggests a refinement in how these equity instruments are structured and administered, potentially to enhance retention, reward performance, or comply with regulatory or strategic shifts.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of the evolution in The Bank of New York Mellon Corporation's RSU agreement approach by noting the introduction of the 2024 Form in the 2024 filing and linking it to executive compensation strategy. However, it misses critical multi-hop details present in the ground truth. Specifically: (1) It fails to note that the '2024 Form' was actually introduced in the 2023 filing as 'Filed herewith,' which is a key point in understanding the timeline and lifecycle management; (2) It does not mention that in the 2024 filing, the 2024 Form was downgraded to 'Previously filed,' indicating institutionalization; (3) It omits the introduction of the '2025 Form' in the 2024 filing as 'Filed herewith,' which demonstrates the forward-looking, annual refresh pattern. These omissions significantly weaken the qualitative accuracy and completeness, despite correct entity identification (company, RSU forms, years). The reasoning is plausible but incomplete, failing to synthesize the full lifecycle pattern across years. Quantitative accuracy is high because no numbers are misstated (no explicit figures were given), and dates are generally used correctly. Contextual relevance is strong as the response stays on topic and addresses executive compensation strategy implications. However, without the full multi-hop synthesis of filing statuses across years, the answer falls short of the full factual picture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 397,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90% Senior Notes were issued in November 2023 with a principal amount of $750 million, maturing on April 15, 2029. By February 2, 2025, the carrying amount of these notes was $744 million, reflecting amortization and discounts. The maturity timeline remains unchanged, with the notes due in 2029, and no repayments or redemptions have occurred between 2023 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of the 4.90% Senior Notes in November 2023, the principal amount of $750 million, and the maturity date of April 15, 2029, which aligns with the ground truth. However, there are key quantitative inaccuracies: the carrying amount as of January 28, 2024, was $743 million according to the original answer, but the LLM states $744 million as of February 2, 2025 — a different date and incorrect amount. The ground truth notes a $3.4 million discount leading to an initial carrying amount of $746.6 million, amortizing down to $743 million by early 2024; the LLM’s $744 million figure is not supported and refers to a future date (2025), which is outside the 2023–2024 scope of the question. (2) The date mismatch is critical: the question asks about evolution from 2023 to 2024, but the LLM cites a 2025 data point, undermining temporal accuracy. Additionally, the original specifies the carrying amount as of January 28, 2024; the LLM does not reference this date. (3) The reasoning is partially sound — the LLM correctly infers that the notes remained outstanding with no redemptions and that amortization affects carrying amount — but fails to accurately track the timeline and numerical progression. It misses the slight decrease due to initial discount and early amortization as of early 2024. (4) Contextual relevance is high because the answer addresses structure, carrying amount, and maturity timeline. Qualitative accuracy is moderate due to correct entity identification and logical flow, but quantitative accuracy is low due to incorrect numbers and dates. Correctness score reflects partial accuracy with significant factual flaws in key financial metrics and timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 474,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "In November 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. By July 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. No further repayments or issuances of these notes were mentioned for the remainder of 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of four Guaranteed Senior Notes totaling approximately $500 in 2023 at fixed interest rates between 1.400% and 2.120%, and the repayment of $77 in 2024, which matches the ground truth. The addition of specific months (November 2023 and July 2024) is consistent with the timeline and does not contradict the original answer. (2) All numeric values—$500 issuance amount, $77 repayment—are accurate and correctly formatted. Interest rate range is exact. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about issuance in 2023 and repayment in 2024 for Costco’s Japanese subsidiary. The LLM adds a minor inference that no further repayments or issuances were mentioned, which is a reasonable interpretation of available data but not explicitly confirmed in the ground truth, slightly reducing qualitative accuracy. (4) The answer is semantically equivalent and contextually complete, addressing the evolution of the notes across both years with correct entities and financial instruments. The slight deduction in correctness is due to the added specificity about timing and the unsupported claim of 'no further repayments or issuances,' which, while plausible, was not confirmed in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 368,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "The risk associated with competitors developing after-market parts for DHR's products remained consistent from 2022 to 2023, as both filings highlight this risk as a potential threat to sales. In 2022, the 10-K mentions that competitors may develop after-market services and parts, which may detract from DHR's sales. Similarly, the 2023 10-K reiterates this concern, noting that competitors developing after-market parts could reduce demand for DHR's offerings and negatively impact the company's business and financial statements. There is no indication of a significant evolution in this risk during the period, but its potential impact on revenue and profitability remains acknowledged in both years.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key qualitative evolution in how the risk was framed between 2022 and 2023, which is central to the question. (1) What was correct: The answer correctly identifies that both the 2022 and 2023 10-K filings mention the risk of competitors developing after-market parts and that this could detract from sales and impact financial statements. The entities (DHR), years (2022, 2023), and general risk description are accurate. (2) Quantitative accuracy: There are no numerical values in this question, so this dimension is not applicable; however, the temporal references (2022, 2023) are correct, earning full marks. (3) Multi-hop reasoning assessment: The model fails in synthesizing the nuanced shift in risk characterization. The ground truth highlights a meaningful evolution: in 2022, the risk was presented as a direct, standalone threat to sales and competitive position, while in 2023, it was reframed as one of several external pressures, 'Impacted By' broader industry trends like cost containment and reimbursement policies—indicating a de-emphasis or strategic recalibration. The LLM incorrectly concludes there was 'no significant evolution,' which contradicts the ground truth. (4) Justification for scores: Correctness is scored 5 because core facts are present but the critical analytical point—the shift in framing and relative importance—is missing. Qualitative accuracy is 5 due to flawed reasoning and incomplete synthesis across years. Contextual relevance is 8 because the answer addresses the general topic and impact on business/financials but overlooks the required comparative analysis of risk evolution. Quantitative accuracy is 10 as no numbers are involved and temporal facts are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 476,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "From 2022 to 2024, Netflix's membership plans evolved with a focus on pricing adjustments and introducing new service features to address challenges such as member retention, competition, and macroeconomic pressures. In 2022, the company noted pricing changes and fluctuations in foreign exchange rates contributing to a 7% increase in average monthly revenue per paying membership. By 2024, Netflix had introduced a lower-priced ad-supported subscription plan and increased enforcement of terms of use to limit shared viewing, aiming to improve revenue per member and curb unauthorized usage. These changes were intended to counter declining membership growth, rising content costs, and competitive pressures from other entertainment platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Netflix's membership strategy from 2022 to 2024. (1) Quantitatively, it correctly states the 7% increase in average monthly revenue per paying membership in 2022, aligning with the ground truth. However, it omits the 19% total revenue growth and 11% growth in average paying memberships, which were key context points in 2022. It also correctly identifies the 2024 introduction of the ad-supported plan and enforcement of terms to limit sharing, though it does not mention the 50% drop in paid net membership additions year-over-year, a significant indicator of acquisition challenges. (2) The numbers it does include are accurate and correctly attributed to the right years and strategies. Format variations are acceptable and not an issue. (3) The multi-hop reasoning is sound: the model connects pricing changes and FX impacts in 2022 to strategic shifts in 2024, correctly inferring that the ad-supported tier and crackdown on password sharing were responses to retention, competition, and macroeconomic pressures. It synthesizes cause and effect across time periods appropriately. (4) Semantically, the answer conveys the same intent and factual backbone as the original, with only minor omissions (e.g., specific membership growth decline percentage, full revenue breakdown). These omissions prevent a perfect 10 but do not undermine the overall correctness. Contextual relevance is excellent—the response directly addresses pricing strategy, service features, and the business challenges, fully aligning with the question's requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 439,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "Between 2022 and 2023, Boeing's approach to in-orbit incentive payments has shown increased financial risk exposure due to satellite performance uncertainties. In 2023, the company highlighted that in-orbit incentive payments, which are tied to satellite performance for up to 15 years post-acceptance, are at risk if satellites fail to meet contractual criteria. If performance issues arise, Boeing may face refund obligations and significant charges. This reflects a more cautious stance compared to 2022, where such risks were less explicitly detailed, indicating a heightened recognition of long-term financial exposure associated with these payments.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the qualitative evolution in Boeing's approach to in-orbit incentive payments, noting increased risk exposure and more explicit recognition of performance-linked financial risks in 2023 compared to 2022. It accurately identifies that payments are tied to satellite performance over up to 15 years post-acceptance and that failure could lead to refund obligations or charges. However, it omits the key quantitative detail from the ground truth: Boeing recorded $1,585 million in additional losses on its five major fixed-price development programs in 2023. This is a significant factual omission affecting quantitative accuracy. (2) No numbers are mentioned in the LLM answer, while the original answer includes a precise figure ($1,585 million) that is critical to the 2023 financial recognition shift. The absence of this number—central to the financial recognition aspect of the question—reduces quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years (2022 vs 2023), identifies the shift from general risk acknowledgment to more specific exposure, and links in-orbit payments to long-term performance criteria. It also correctly infers increased caution in 2023. However, it fails to connect the financial recognition practice—specifically, that the net present value of fees is recognized during construction—to the increased exposure, which is a key part of the original answer. (4) The correctness score is 7 because the core qualitative evolution is accurately conveyed, but the missing $1.585B loss figure and lack of detail on revenue recognition during construction limit completeness and factual precision. Quantitative accuracy is penalized heavily (5/10) for omitting a central financial figure. Qualitative accuracy is high (8/10) due to correct reasoning and entity identification. Contextual relevance is strong (9/10) as the response directly addresses the question’s focus on risk and financial recognition evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 550,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "Between 2023 and 2024, the Directors' Code of Conduct remained accessible on BNY Mellon's website, as disclosed in both years. However, in 2024, the disclosure was more prominently featured in the main body of the 10-K under the \"Available Information\" section, emphasizing its availability alongside other governance documents. In 2023, the information was included within the \"Code of Ethics\" section of Item 10. This suggests an increased emphasis on transparency and accessibility of the Directors' Code of Conduct in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of disclosure and accessibility of the Directors' Code of Conduct between 2023 and 2024. While it correctly states that the Code remained accessible on the website in both years, it incorrectly claims that in 2024 the disclosure was 'more prominently featured' in the 'Available Information' section, suggesting increased transparency. This contradicts the ground truth, which indicates a shift to a more generalized, less direct reference without the specific URL—representing a less explicit, more consolidated approach, not a more prominent one. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are correctly referenced, supporting a score of 10 for quantitative accuracy. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the change in disclosure style—from explicit URL and amendment policy in 2023 to implicit inclusion in a broader list in 2024. Instead, it invents a narrative of increased prominence and placement in a different section, which is not supported by the ground truth. This reflects a failure in qualitative accuracy. (4) The answer is contextually relevant to the question about evolution in disclosure and accessibility, but the direction of change is misrepresented. Therefore, while the topic is addressed, the conclusion is factually incorrect, warranting moderate relevance but low correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 435,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "Between 2022 and 2023, Mobileye Drive™ evolved from being a foundational autonomous driving solution for fleet deployment to a more strategically integrated platform for both commercial and consumer applications. In 2022, Mobileye focused on launching Mobileye Drive™ as part of its L4 self-driving system, emphasizing partnerships for autonomous cargo delivery and mobility services. By 2023, the deployment strategy expanded to include scaling Mobileye SuperVision as a baseline for transitioning to consumer-level autonomy (Mobileye Chauffeur) and positioning Mobileye Drive™ as a core offering for transportation network companies and public transit operators, often bundled with Moovit’s mobility intelligence. This shift reflects a broader push into MaaS (Mobility-as-a-Service) and a dual focus on commercial AV deployment and future consumer AV readiness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Mobileye Drive™ was launched as an L4 self-driving system in 2022, with partnerships including Udelv and Transdev, and a design win with Geely. In 2023, the strategy shifted toward targeting transportation network companies, public transit operators, and AV platform suppliers, often bundled with Moovit—all of which are correctly reflected. (2) There are no numeric values requiring calculation, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and strategic shifts, accurately identifying the evolution from initial launch and partnerships to a more focused go-to-market strategy around MaaS and fleet deployment. The mention of Mobileye SuperVision and Chauffeur adds context not in the original answer but does not contradict it; however, the original answer emphasizes bundling with Moovit and targeting suppliers of AV-ready platforms more explicitly, which the LLM touches on but slightly underemphasizes. (4) The answer is fully relevant and captures the core evolution in role and deployment strategy. One minor point: the original highlights the 'first consumer L4 design win with Geely' as a key 2022 milestone, which the LLM omits by referring more generally to consumer applications. This is a small but notable omission in completeness, preventing a perfect 10. Overall, the answer is factually correct, well-reasoned, and semantically equivalent with only minor contextual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 434,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "The structure and distribution rate of the Tower Preferred Interests evolved significantly from 2022 to 2024. Initially, in 2022, the Tower Preferred Interests (Class A-1 and A-2) had fixed distribution rates of 5.0% and 4.75%, respectively. In August 2024, these were restructured: a portion of the interests were converted into Fixed Rate Class A Limited Membership Interests with a 5.90% distribution rate, while another portion transitioned to Floating Rate Class A Limited Membership Interests, which pay a distribution rate of SOFR plus 250 basis points. This restructuring introduced a mix of fixed and floating rates, with the floating rate component adjusting annually based on market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the key evolution in structure and distribution rates of the Tower Preferred Interests from 2022 to 2024. (1) It correctly identifies the 2022 structure with Class A-1 and A-2 interests at 5.0% and 4.75% distribution rates, respectively. It also accurately notes the August 2024 restructuring into Fixed Rate Class A Limited Membership Interests at 5.90% and Floating Rate Class A Limited Membership Interests at SOFR + 250 bps. (2) All percentages and dates are correct; however, the LLM omits the dollar amounts ($1,500 for Class A-1 and $4,500 for Class A-2) mentioned in the ground truth, which slightly reduces quantitative completeness. This omission does not affect the core reasoning but limits full quantitative fidelity. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes over time, identifies the shift from fixed-rate-only to a hybrid fixed/floating structure, and explains the annual transition aspect. (4) The answer is contextually excellent—directly addressing the evolution in both structure and rate. Wording differs slightly but maintains semantic equivalence. The only minor gap is the missing dollar values, preventing a perfect 10. Overall, the response is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 363,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "From 2022 to 2023, the Balanced Index Fund, which comprises approximately 60% equities and 40% debt securities, remained a key component of OPB plan assets. The unrealized gains/(losses) for Level 3 assets related to this fund showed a mixed performance. In 2023, Level 3 assets in the fund generated net unrealized gains of $14, with corporate fixed income showing a $5 gain, mortgage-backed and asset-backed fixed income a $7 gain, and municipal fixed income a $5 loss. In contrast, 2022 saw a net unrealized loss of $90, driven by significant losses in corporate (-$19), mortgage-backed and asset-backed (-$11), municipal (-$14), and real assets (-$1). Thus, the investment approach for Level 3 assets in the Balanced Index Fund improved in 2023 compared to 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, in 2022, the Balanced Index Fund's Level 3 assets had unrealized losses of ($16) million for corporate fixed income and ($11) million for mortgage-backed and asset-backed securities—totaling $27 million in losses. However, the LLM incorrectly reports a net loss of $90 million and breaks it down into -$19 (corporate), -$11 (MBS/ABS), -$14 (municipal), and -$1 (real assets), none of which match the original data. In 2023, the ground truth reports gains of $2 million (corporate) and $6 million (MBS/ABS), totaling $8 million in gains. The LLM instead reports $5 gain (corporate), $7 gain (MBS/ABS), and a $5 loss (municipal), totaling $14 million in net gains—numbers that are entirely inconsistent with the source. Additionally, the original answer does not mention municipal fixed income or real assets in either year, so their inclusion is a factual error. (2) Calculations are also incorrect: the LLM implies a net change from -$90M to +$14M, suggesting a dramatic improvement, but the actual shift is from -$27M to +$8M, which is still positive but far less extreme. (3) The qualitative reasoning about improved performance and the fund maintaining a 60/40 equity/debt split is correct and reflects proper multi-hop synthesis. However, the LLM fails to mention the key point about the 2023 valuation methodology shifting to a market approach using Level 1 inputs, which is a critical evolution in investment approach per the original answer. (4) While the general direction of improvement (losses to gains) is correctly identified, the specific numbers, entities, and methodological changes are wrong or missing, leading to a low correctness and quantitative accuracy score. Contextual relevance is high because the response addresses the time frame, fund, and asset classes, even if inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 522,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "Between 2023 and 2024, BNY Mellon's emphasis on accounting developments in its forward-looking statements has become more explicit and integrated into its strategic considerations. In 2023, the mention of accounting developments was included as part of a broader list of external factors affecting financial reporting. By 2024, the firm specifically highlighted the influence of changes in accounting standards as a key factor shaping its financial condition and operations, indicating a more deliberate acknowledgment of their strategic relevance. This evolution suggests that accounting standards are increasingly viewed as a material influence on BNY Mellon's business planning and risk management priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately captures the evolution in BNY Mellon's forward-looking statements from 2023 to 2024, noting the shift from a general mention of accounting developments among other factors to a more explicit and strategic emphasis. The answer correctly identifies the increased integration of accounting standards into business planning and risk management. All entities (BNY Mellon, 2023, 2024, accounting developments) are accurate, and there are no numerical inaccuracies (the question does not involve specific numbers, percentages, or dollar amounts, so quantitative accuracy is scored based on correct temporal references). The reasoning is sound and reflects the multi-hop synthesis required: comparing language changes across years and inferring strategic implications. The only minor shortcoming is that the LLM does not quote the specific new phrases from 2024 such as 'capital plans including dividends and repurchases' or 'efficiency savings,' which would have strengthened the response by showing direct textual evolution. However, the core meaning—that accounting changes are now tied to concrete business decisions—is correctly inferred. Thus, while slightly less detailed than the original answer, the LLM response is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 374,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "In 2023, the evolution of risks related to store safety and cybersecurity introduced potential challenges to the associate experience by increasing operational complexities and costs, which could affect associate morale and retention. These risks, such as organized retail crime and cyber threats, required operational changes that may have disrupted the customer and associate experience. In contrast, the engagement-focused initiatives in 2022 emphasized associate engagement through surveys, recognition programs, and a supportive workplace culture, aiming to foster emotional commitment and inclusivity among associates.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of entities, years, and key themes. It correctly identifies the 2022 engagement-focused initiatives (surveys, recognition programs, supportive culture) and contrasts them with 2023 risks (organized retail crime, cybersecurity threats). The reasoning is sound in highlighting how external risks in 2023 could negatively impact associate morale and retention, contrasting with the positive engagement efforts in 2022. There are no numeric inaccuracies—no specific numbers (e.g., percentages like 'four out of five associates') are mentioned in the LLM answer, but this is a minor omission rather than an error. The ground truth includes the detail that historically, four out of five associates were emotionally committed, which the LLM omits, slightly weakening completeness and qualitative depth. However, the core multi-hop synthesis—comparing 2022 initiatives to 2023 risks and their potential impact on associate experience—is correctly executed. The answer captures the shift in focus and its implications without misrepresenting facts, hence high scores in contextual relevance and quantitative accuracy. The lack of explicit mention of 'trust erosion' or 'reputation damage' slightly reduces qualitative accuracy, but the essence of the impact on morale and retention is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 379,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "The role of the \"learning curve\" in influencing cost and production estimates between 2022 and 2023 evolved as a critical factor in managing program profitability and risk, particularly in complex programs like the 777X and 787. In 2022, the learning curve was highlighted as a key variable affecting cost estimates, with production rate adjustments and change incorporation costs impacting gross margins. By 2023, the learning curve remained a central element in estimating production costs and profitability, especially as production challenges, supply chain disruptions, and regulatory requirements continued to affect cost stability. The evolving learning curve dynamics were explicitly tied to risk management strategies, as adjustments in production rates and ongoing rework efforts influenced both near-term profitability and long-term cost projections.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the learning curve as a factor in cost and production estimates in both 2022 and 2023 and links it to program profitability and risk management, which aligns with the question's focus. However, it diverges from the ground truth in key qualitative aspects. While the original answer emphasizes a clear evolution—from viewing the learning curve as a risk in 2022 to integrating it as a predictable, managed component of cost estimation in 2023—the LLM portrays it as a persistently challenging factor tied to ongoing disruptions, without acknowledging the strategic shift toward predictability and integration into planning. This misrepresents the nature of the evolution. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; no errors in dates (2022, 2023) or program names (787 mentioned in both; 777X added in LLM answer). The mention of 777X is not incorrect per se but adds a program not cited in the ground truth, potentially introducing noise. (3) The multi-hop reasoning is partially sound: the LLM connects learning curve effects to cost, production, and risk across years, but fails to synthesize the critical shift from 'unpredictable risk' to 'managed input'—a core insight in the original answer. This undermines the qualitative accuracy. (4) The correctness score is 6 due to accurate framing of the learning curve as important and evolving, but significant omission of the key conceptual shift. Quantitative accuracy is 10 because no numbers are misstated. Qualitative accuracy is 6 due to partial reasoning and missed synthesis. Contextual relevance is 8 because the answer stays on topic and addresses the general evolution, even if imprecisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 479,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "Between the 2023 and 2024 SEC filings, the disclosure regarding officer or director participation in the Dividend Reinvestment Plan remains consistent, with no substantive changes noted. Both filings state that certain officers or directors have elected to participate in the Dividend Reinvestment Plan, along with other plans such as the employee stock purchase plan and 401(k) plan. Additionally, they may make elections to have shares withheld to cover withholding taxes or pay the exercise price of stock awards. These arrangements may either satisfy the affirmative defense conditions of Rule 10b5-1 under the Exchange Act or constitute non-Rule 10b5-1 trading arrangements, as defined in Item 408(c) of Regulation S-K. There is no indication of new policies or changes in participation practices related to the Dividend Reinvestment Plan in the 2024 filing compared to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. The ground truth states that the 2024 filing omitted the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements that was present in the 2023 filing, indicating a simplification or reduction in disclosure specificity. However, the LLM answer claims there are 'no substantive changes' and that both filings include the same level of detail about Rule 10b5-1 and non-Rule 10b5-1 arrangements, which directly contradicts the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are involved. (3) The multi-hop reasoning is flawed: the question asks for an evolution or change between years, but the LLM fails to detect the key difference in disclosure depth regarding trading arrangements. Instead, it incorrectly asserts consistency, missing the critical omission in the 2024 filing. This represents a failure in synthesizing the comparative disclosure content across filings. (4) While the LLM correctly identifies the context of participation (officers/directors in Dividend Reinvestment Plan alongside other plans and tax withholding elections), it completely misses the central point about the removal of detailed trading arrangement disclosures in 2024. Thus, despite some contextual accuracy, the overall correctness is low due to the incorrect conclusion about no changes. Contextual relevance is moderate because it addresses the right topic and entities but misrepresents the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 444,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "From fiscal 2021 to fiscal 2023, The Home Depot has evolved its investment in creating an interconnected shopping experience by enhancing digital capabilities, store operations, and supply chain efficiency. In fiscal 2021, the focus was on creating a frictionless experience through digital and physical integration, with $2.6 billion invested in capital expenditures. By fiscal 2023, the company had expanded on these efforts, emphasizing mobile optimization, personalized marketing, and improved store navigation tools. Specific changes included the rollout of self-service lockers, curbside pickup, electronic shelf labels, and the hdPhone and Computer Vision technologies to improve associate productivity and customer convenience. These investments were aimed at tailoring the experience to customer preferences, such as faster delivery, seamless omnichannel interactions, and enhanced in-store and online personalization.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $2.6 billion capital expenditure in fiscal 2021, which matches the ground truth. However, it fails to mention the key evolution in fiscal 2023 being the use of 'enhanced merchandising information technology tools' to tailor the experience based on 'shopping intent and location'—a core shift emphasized in the original answer. Instead, the LLM lists specific technologies (e.g., self-service lockers, curbside pickup, electronic shelf labels, hdPhone, Computer Vision) and initiatives (mobile optimization, personalized marketing) that are not present in the ground truth and may be factually inaccurate or unverified in this context. (2) Quantitatively, the only number mentioned—$2.6 billion—is correct and properly attributed to fiscal 2021. No other figures are provided or required, so quantitative accuracy is fully satisfied. (3) The multi-hop reasoning is partially sound: the model connects fiscal 2021 and 2023 and attempts to show evolution. However, it fabricates specific changes not supported by the original data, indicating a failure in accurate synthesis. The original answer emphasizes a strategic shift from broad investment to data-driven personalization; the LLM misrepresents this with operational details not in the source. (4) While the general direction of evolution (toward personalization and omnichannel experience) is contextually relevant and plausible, the lack of alignment with the specific strategic shift described in the ground truth—especially the focus on merchandising IT tools and customer intent—reduces qualitative accuracy. The answer is detailed and relevant but includes unsupported specifics, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 470,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "Between 2022 and 2023, DHR's financial relationship with Aldevron remained stable as Aldevron continued to be part of DHR's Life Sciences segment following its acquisition in 2021 for $9.6 billion. There were no additional capital investments or acquisition-related expenditures specifically tied to Aldevron in 2022 or 2023, as the acquisition was already completed in 2021. The focus in 2023 shifted to the acquisition of Abcam for $5.6 billion, which did not affect the existing financial commitment to Aldevron. Thus, the financial relationship between DHR and Aldevron in terms of capital investment and acquisition expenditures remained unchanged between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. It claims that the Aldevron acquisition was completed in 2021 for $9.6 billion and that no additional capital or acquisition-related expenditures occurred in 2022 or 2023. However, the ground truth states that in 2022, DHR anticipated $1.5 billion in capital expenditures, with a portion allocated to Aldevron-related manufacturing capacity, indicating ongoing investment. More significantly, in 2023, DHR paid net cash consideration of $9,561 million (i.e., $9.561 billion) to Aldevron, marking a major acquisition-related expenditure that year. The LLM incorrectly asserts the acquisition was completed in 2021, which contradicts the ground truth that shows the financial relationship culminating in 2023 with this large cash outflow. (2) Quantitatively, the LLM invents a $9.6 billion acquisition in 2021 that does not appear in the ground truth; the actual 2023 payment was $9,561 million. It also ignores the $1.5 billion capital expenditure plan in 2022 tied to Aldevron. These are major numerical inaccuracies. (3) The multi-hop reasoning is flawed: the model fails to connect DHR's 2022 capital spending plans to Aldevron and completely misses the significance of the 2023 cash payment as a transformation in the relationship from investment to integration. Instead, it introduces Abcam’s acquisition, which is irrelevant to the question about Aldevron. (4) The contextual relevance is moderate because it discusses DHR and Aldevron in the right segment and timeframe, but the core facts about capital investment and acquisition expenditures are wrong, leading to a fundamentally incorrect conclusion that the relationship remained unchanged.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 473,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "From 2022 to 2024, the total value of Telco LLC's preferred interests increased from $2,000 (Telco Class A-1) in 2022 to $7,250 in 2024, following the additional issuances of $5,250 in 2023 (Telco Class A-2 and A-3). In 2024, an additional $2,250 of Telco Class A-4 interests were planned for issuance in early 2025. The distribution rates evolved as follows: Telco Class A-1 had a 4.25% rate with a seven-year reset, while Telco Class A-2 and A-3 had a higher initial rate of 6.85% with a reset on November 1, 2027. The Telco Class A-4 interests, to be issued in 2025, had an initial rate of 5.94% with a reset every four years starting in 2028.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the initial $2,000 in preferred interests in 2022 (Telco Class A-1) and the $5,250 issuance in 2023 (Class A-2 and A-3), resulting in a correct total of $7,250 by 2024. However, it introduces a fact not present in the ground truth: the planned issuance of $2,250 in Telco Class A-4 interests in early 2025 with a 5.94% rate and four-year reset. This information is entirely fabricated and not supported by the original answer, which makes no mention of Class A-4 or any 2025 plans. (2) The distribution rates for Class A-1 (4.25%) and Class A-2/A-3 (6.85%) are accurate, as is the reset date of November 1, 2027, and the seven-year reset cycle for the new classes. However, the claim about a four-year reset cycle starting in 2028 for non-existent Class A-4 interests is incorrect and undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound—correctly aggregating the total value from two issuances and distinguishing rate structures—but fails when it invents a third issuance and associated terms, indicating a failure in synthesis fidelity. (4) The contextual relevance is high as the answer addresses structure, value evolution, distribution rates, and reset schedules as asked. However, the inclusion of false details significantly reduces correctness and quantitative accuracy. The core facts up to 2024 are mostly right, but the addition of unsupported forward-looking plans lowers the score to a 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 408,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "AIG's use of Expected Loss Ratio Methods between 2022 and 2024 has evolved in terms of application across insurance lines and rationale. In 2022, the method was primarily used for short-tail lines like U.S. Property, where low-frequency/high-severity losses are common, and for the latest accident years in aviation exposures due to claim severity and variability. By 2024, the method was applied more broadly, including in U.S. Excess Casualty and Workers' Compensation, where loss development patterns are inconsistent or slow. The rationale for application expanded to include adjusting for rate changes, inflation, and market conditions, as well as incorporating recent loss trends and third-party actuarial insights for improved accuracy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of AIG's use of Expected Loss Ratio Methods between 2022 and 2024, with accurate timeframes and a general trend toward broader application. It correctly notes use in 2022 for high-severity, short-tail lines like aviation and property, and expansion by 2024 to include Workers' Compensation, which aligns with the ground truth. However, the LLM adds 'U.S. Excess Casualty' as an additional line in 2024, which is not mentioned in the original answer, introducing an unverified entity. While the rationale for expansion—addressing inconsistent loss development, inflation, rate changes, and incorporating third-party insights—sounds plausible, these specific justifications (e.g., 'adjusting for rate changes, inflation, and market conditions') are not present in the ground truth, which emphasizes the method's use in combination with other techniques for long-tail lines. (2) There are no numerical values, percentages, or financial figures in the question or answers, so quantitative accuracy is not applicable in terms of calculations; however, the years 2022 and 2024 are correctly used, earning full marks. (3) The multi-hop reasoning is partially sound: the model correctly infers a trend of methodological expansion across time and lines of business. However, it introduces insurance lines (Excess Casualty) and rationales not supported by the ground truth, indicating over-inference or hallucination. The core synthesis—expansion from short-tail to long-tail lines like Workers' Compensation—is correct and reflects valid multi-hop understanding. (4) The correctness score is 7 because the key factual evolution (expansion to Workers' Compensation, broader use) is accurate, but the addition of unsupported details reduces precision. Qualitative accuracy is 7 due to correct structure and reasoning but with embellishments. Contextual relevance is high as the answer directly addresses the question’s focus on evolution, lines, and rationale.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 542,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "From 2023 to 2024, Target has placed a stronger strategic emphasis on its owned brands, particularly through expanding the breadth and depth of its owned and exclusive brand portfolio. In 2023, the focus was on strengthening the owned brands portfolio and curating national brands, while by 2024, Target had further developed its owned brands, with approximately one-third of merchandise sales coming from these brands. The company also highlighted the importance of global sourcing in ensuring product quality, value, and ethical practices for its owned brands, indicating a more refined and strategic approach to product portfolio development.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of Target's owned brands from 2023 to 2024, noting increased emphasis and portfolio development. However, it introduces a specific quantitative claim—'approximately one-third of merchandise sales coming from these brands'—that is not present in the ground truth and cannot be verified from the provided information. This unsupported figure significantly undermines factual accuracy. (2) The ground truth does not include any sales percentage or revenue metric; thus, the 'one-third' figure is an unverified addition, making the quantitative accuracy low. There are no other numbers to verify, but the inclusion of this unsupported statistic constitutes a major factual overreach. (3) The qualitative reasoning is sound in identifying a shift from strategic emphasis in 2023 to more concrete brand diversification in 2024, aligning with the ground truth’s description of a move toward execution and listing over 40 brands. The mention of global sourcing adds context not contradicted by the ground truth but not required by the question. The multi-hop synthesis is partially correct—there is a logical progression across years and strategy—but the answer embellishes with unsourced metrics. (4) Contextual relevance is high because the response directly addresses the evolution in strategic emphasis and product portfolio development. The core direction of the answer matches the ground truth, but the incorrect addition of a sales percentage reduces the correctness score to the mid-range despite otherwise coherent reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 439,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggests a diversified debt financing strategy aimed at managing interest rate risk and optimizing capital structure. By issuing notes with varying coupon rates, IBM likely seeks to take advantage of favorable market conditions for long-term borrowing, potentially locking in lower rates for extended periods while balancing refinancing flexibility. This approach reflects confidence in stable market access and a strategic effort to align debt maturities with long-term financial planning.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the two notes (0.875% and 2.900% Notes due 2030) and their continued listing in 2024, which aligns with the ground truth. All quantitative elements—interest rates (0.875% and 2.900%), maturity year (2030), and the implication of multiple instruments with the same maturity—are factually accurate. There are no calculation errors or incorrect numbers. (2) However, the LLM misinterprets the market conditions: it suggests IBM issued the higher-rate 2.900% notes to 'take advantage of favorable market conditions,' while the ground truth indicates the rate increase likely reflects *less favorable* borrowing conditions in 2024 compared to when the 0.875% notes were issued. This is a significant qualitative error in reasoning. (3) The multi-hop synthesis is partially sound—linking the two notes and inferring a diversified debt strategy is valid—but the conclusion about market conditions contradicts the evidence implied by the rising coupon rate. The ground truth emphasizes deteriorating borrowing terms or targeting different investors, whereas the LLM assumes continued favorable access. (4) Despite this, the answer remains contextually relevant and captures IBM’s strategic intent to diversify its debt portfolio and manage refinancing. The correctness score is 7 due to accurate facts but flawed interpretation of market dynamics; quantitative accuracy is perfect (10); qualitative accuracy is reduced (7) for incorrect inference; contextual relevance is high (9) as it addresses the core strategic question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 431,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "Between 2022 and 2024, AT&T's long-term debt composition evolved with the addition of new Global Notes, including the 4.000% Global Notes due June 1, 2049 (trading symbol T 49A), which appeared in both the 2022 and 2024 filings, indicating its ongoing presence. The 2024 filing also introduced newer long-term notes such as the 4.250% Global Notes due March 1, 2050 (T 50) and the 3.750% Global Notes due September 1, 2050 (T50A), reflecting AT&T's continued diversification and extension of its long-term debt maturity profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The 4.000% Global Notes due June 1, 2049 (T 49A) were already present in 2022, not added between 2022 and 2024 as the LLM implies by stating it 'appeared in both' filings as if newly highlighted. More critically, the LLM invents the addition of two notes not mentioned in the ground truth: the 4.250% Global Notes due March 1, 2050 (T 50) and the 3.750% Global Notes due September 1, 2050 (T50A). The actual new note added by 2024 was the 4.300% Global Notes due November 18, 2034 (T 34C), which the LLM completely omits. (2) Quantitative accuracy is very low: the percentages (4.250%, 3.750%), maturity dates (March 1, 2050; September 1, 2050), and even the correct new note's interest rate (4.300%, not 4.250% or 3.750%) and maturity (November 18, 2034, not 2050) are all incorrect. The trading symbols T 50 and T50A are fabricated. (3) The multi-hop reasoning is flawed: while the model recognizes that AT&T added new long-term notes and maintained existing ones, it fails to correctly identify which notes were added, misrepresents the evolution, and introduces non-existent instruments. The synthesis across years is superficial and factually wrong. (4) Contextual relevance is moderate because the answer addresses the general theme of debt composition evolution and mentions the correct existing note (T 49A), but the core factual content is incorrect, severely undermining correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 411,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The financial impact of the Heritage AspenTech acquisition evolved between 2023 and 2024, with intangibles amortization increasing significantly. In 2023, intangibles amortization included $258 related to the Heritage AspenTech acquisition, while in 2024, intangibles amortization rose to $560, primarily driven by the National Instruments (NI) acquisition. Restructuring costs also increased from $72 in 2023 to $228 in 2024, reflecting broader restructuring activities across multiple business segments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key financial figures. According to the ground truth, intangibles amortization related to the Heritage AspenTech acquisition decreased from $258 in 2023 to $97 in 2024, but the LLM incorrectly states it rose to $560 in 2024. This $560 figure appears to conflate amortization from other acquisitions (e.g., National Instruments), which is not mentioned in the original answer and is irrelevant to the specific question about Heritage AspenTech. Restructuring costs are correctly reported as $72 in 2023 and $228 in 2024, which matches the ground truth. (2) Quantitative accuracy is severely compromised: the amortization decrease of $161 (from $258 to $97) is misrepresented as a large increase, completely reversing the trend. Only the restructuring cost numbers are accurate. (3) The reasoning is flawed—instead of isolating the financial impact of the Heritage AspenTech acquisition, the model introduces an unrelated acquisition (National Instruments), failing the multi-hop synthesis required to track a specific acquisition’s impact over time. This undermines the core of the question. (4) Contextual relevance is moderate because the answer addresses the general topic and time frame, and correctly reports restructuring costs, but the central claim about amortization is false. Due to major quantitative and qualitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 396,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG's use of expected loss ratio methods for workers' compensation between 2022 and 2024 has evolved with a greater emphasis on segmentation of business types, particularly between guaranteed cost and excess of deductible business. The proportion of large deductible business has increased over time, which has slowed the reporting pattern of claims. For excess of deductible business, AIG segments by deductible size and whether claims are handled internally or by third-party administrators. In 2024, expected loss ratio methods are given significant weight in the most recent five accident years, with adjustments made for rate changes, loss trends, and market conditions. This approach reflects a more nuanced and tailored application of expected loss ratios to account for the complexities introduced by risk-sharing features and evolving claim patterns.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in AIG's use of expected loss ratio methods between 2022 and 2024. It correctly identifies the increased proportion of large deductible business slowing claim reporting patterns and the segmentation by deductible size and claim handling (AIG vs. third-party administrators), which aligns with the 2024 disclosures. It accurately notes that in 2022, expected loss ratios were primarily used for guaranteed cost business in the most recent accident year, while for excess of deductible business, they were weighted over the most recent five accident years—this timeline is preserved in the LLM answer, though not explicitly contrasted by year. However, the LLM answer incorrectly implies that the five-year weighting applies in 2024, when the original answer states this was already the case in 2022 for excess of deductible business. Additionally, the LLM omits the 2024-specific point about limitations in claim count data due to aggregation and reinsurance exclusions, which were not emphasized in 2022—this is a notable qualitative omission. There are no numerical inaccuracies (dates and timeframes are correct), so quantitative accuracy is high. The reasoning is sound and reflects multi-hop synthesis across years and business segments, though slightly less precise in temporal attribution. The response is highly relevant and well-structured around the question's focus on evolution, segmentation, and large deductible impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 410,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "From 2023 to 2024, Target enhanced its Cyber Fusion Center operations by integrating it more deeply into its enterprise risk management program and expanding its proactive threat intelligence capabilities. In 2024, the company emphasized collaboration with external organizations across industries to share best practices, fight cybercrime, and advance cybersecurity capabilities. Additionally, Target continued to invest in in-house expertise and training through its Cyber Plus Institute, strengthening its ability to detect, investigate, and respond to threats while aligning with evolving regulatory and industry standards.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative details and misses key aspects of Target's cybersecurity evolution from 2023 to 2024 as described in the ground truth. (1) Correct elements: The mention of collaboration with external organizations across industries to share best practices and fight cybercrime aligns with the 2023–2024 continuity in external engagement. The reference to training and in-house expertise (via Cyber Plus Institute) loosely corresponds to the 2024 expansion of team training, though this is not explicitly named in the ground truth. (2) Quantitative accuracy: There are no numerical values, dates, or financial figures in the response or ground truth, so this dimension is neutral; no errors present. (3) Multi-hop reasoning assessment: The LLM fails to accurately represent the key 2024 developments—specifically, the introduction of a structured incident response program with a coordinated escalation model to management and the Board, which is a major evolution in internal governance. Instead, it invents details not in the original, such as integration into enterprise risk management and 'proactive threat intelligence capabilities,' which were not mentioned in the ground truth. It also emphasizes the Cyber Plus Institute, which is not referenced in the verified answer, risking confusion with real but unrelated programs. (4) The answer is contextually relevant and addresses the general theme of evolution in Cyber Fusion Center operations and external collaboration, but it substitutes specific, documented advancements with plausible but unverified enhancements. This results in a partially accurate portrayal—core ideas of maturity and collaboration are present, but critical factual distinctions are missing or fabricated, reducing qualitative accuracy. Hence, correctness is scored at 6 due to partial alignment with ground truth and lack of key differentiating 2024 improvements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 529,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "Eli Lilly's financial relationship with Baqsimi evolved significantly between 2023 and 2024, primarily through the sale of rights. In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million in the U.S. and $31.9 million outside the U.S. This marked a notable increase from 2022, where Baqsimi generated only $139.3 million. By 2024, the revenue from Baqsimi was not explicitly listed, but the 2023 financial disclosures indicate that the sale of rights for Baqsimi was a significant contributor to collaboration and other revenue, suggesting a shift in the contractual arrangement from product sales to rights transfers.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Eli Lilly recognized $579.0 million in revenue from the sale of Baqsimi rights in 2023, but the LLM claims $677.6 million in total revenue for Baqsimi, with $645.7 million in the U.S. and $31.9 million outside the U.S., which contradicts the original data. These numbers do not match any verified figures in the ground truth and appear fabricated or misattributed. Additionally, the LLM references a 2022 revenue of $139.3 million, which is not mentioned in the original answer and cannot be verified from the provided context. (2) The quantitative inaccuracies are severe: the core dollar amount is off by over $100 million, and the breakdown into U.S. and non-U.S. revenue has no basis in the ground truth. There is no indication in the original answer that Baqsimi generated ongoing product sales revenue; instead, the $579 million was from a one-time sale of rights. The LLM incorrectly frames this as recurring product revenue. (3) The reasoning partially captures the shift in 2024: the LLM notes that Baqsimi revenue was no longer explicitly listed and was likely folded into collaboration revenue, which aligns with the ground truth’s description of integration into broader collaboration disclosures. However, it fails to mention the key point that Baqsimi was grouped with the olanzapine portfolio in 2024, missing a critical multi-hop connection. The conclusion about a shift from product sales to rights transfers is plausible but based on incorrect premises. (4) The contextual relevance is moderate because the answer addresses revenue recognition and contractual evolution, but the severe numerical errors and incorrect framing of Baqsimi’s revenue model undermine factual correctness. The qualitative reasoning is partially sound but built on false data, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 517,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "From 2023 to 2024, AT&T's approach to managing its capital structure through preferred interests evolved as follows: In 2023, the company repurchased all outstanding Mobility Preferred Interests, completing the redemption of the remaining 213 million interests for $5,414, which was primarily funded through the issuance of Telco LLC preferred interests. In 2024, AT&T expanded its preferred interests by restructuring and resetting the rates on Tower Holdings preferred interests, converting a portion to floating rate instruments tied to SOFR, and planning to issue an additional $2,250 of Telco LLC preferred interests (Telco Class A-4) in early 2025 to fund the redemption of existing preferred equity securities. These actions reflect a strategic shift toward optimizing capital structure and managing long-term liquidity.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution in AT&T's capital structure strategy from 2023 to 2024, including the repurchase of Mobility Preferred Interests and the shift toward expanding Tower Holdings and Telco LLC preferred interests. However, there are minor quantitative inaccuracies. The 2023 repurchase of 213 million Mobility Preferred Interests for $5,414 is accurate, as is the funding via issuance of Telco LLC preferred interests. But the LLM states that AT&T planned to issue an additional $2,250 of Telco Class A-4 in early 2025, which is not mentioned in the ground truth. Instead, the ground truth specifies that total Telco LLC preferred interests reached $7,250 by 2024, which includes the original $2,000 (Telco Class A-1) and the $5,250 issued in 2023—this sum is correct ($2,000 + $5,250 = $7,250). The LLM omits this total and introduces a forward-looking $2,250 issuance not present in the original data. (2) The restructuring of Tower Holdings preferred interests is correctly described in terms of rate reset and SOFR linkage, with a 5.90% base rate and SOFR + 250 bps floating rate, though the LLM does not specify the $6,000 principal amount involved in the restructuring. (3) The multi-hop reasoning is sound: the LLM correctly infers a strategic pivot from repurchasing legacy interests to issuing new structured preferred instruments for liquidity management. It synthesizes the 2023 and 2024 actions into a coherent narrative. (4) The contextual relevance is excellent—the answer directly addresses the evolution in capital structure management. The qualitative accuracy is high due to correct entity identification (Mobility, Tower Holdings, Telco LLC), accurate timeline (2023 vs 2024), and proper financial terminology. The quantitative accuracy is slightly lower due to the omission of key figures ($6,000 restructuring, $7,250 total Telco) and introduction of unsupported forward-looking issuance. Overall, the answer is factually strong but not fully precise on numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 546,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2023 to 2024, as Emerson announced a proposal to acquire the remaining shares of AspenTech not already owned, increasing its ownership from approximately 57% to 100%. This transformation had a negative impact on Emerson's gross margin in 2024, as acquisition-related inventory step-up amortization of $231 reduced gross margin by approximately 1.3 percentage points. Additionally, higher amortization due to the Test & Measurement acquisition further pressured margins. Ownership-wise, Emerson's stake in AspenTech increased to full ownership, reflecting a strategic consolidation of its industrial software portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual inaccuracies. It incorrectly states that Emerson increased its ownership from 57% to 100%, while the ground truth indicates Emerson acquired a 55% stake in 'New AspenTech' in 2024—there is no mention of a move to 100% ownership. The LLM also fabricates a $231 million inventory step-up amortization that reduced gross margin by 1.3 percentage points in 2024, which contradicts the ground truth: the AspenTech acquisition actually contributed positively, increasing gross margin by 3.3 percentage points in 2023 and supporting a 1.8-point increase in 2024. Additionally, the mention of the 'Test & Measurement acquisition' is irrelevant and unsupported by the original answer. (2) Quantitative accuracy is severely compromised: the ownership percentage (57% vs 55%), the direction and magnitude of gross margin impact (negative 1.3 pts vs positive 3.3 and 1.8 pts), and the $231 amortization figure are all incorrect. The $6.0 billion cash transaction in the ground truth is entirely omitted. (3) The multi-hop reasoning is flawed: instead of recognizing the transformation from a business relationship to a 55% ownership stake and its positive margin impact, the model invents a full acquisition and negative margin effects, failing to synthesize the correct entities and financial outcomes. (4) Contextual relevance is moderate—the answer addresses the evolution of the relationship and its financial impacts as asked—but the incorrect facts and reversed conclusions severely undermine its validity. The ownership structure and margin impacts are central to the question, and the LLM's errors here result in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 464,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "Between 2022 and 2024, AIG's Japan pension plans contributed approximately 50-67% of the total non-U.S. pension obligations, indicating a relatively stable or slightly increasing share. The weighted average discount rate for these plans increased from 0.52% in 2022 to 1.81% in 2024, reflecting a significant upward shift in the rate applied to the Japan pension obligations during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, in 2022, Japan pension plans accounted for 61% of non-U.S. pension *assets* (not obligations), but the LLM incorrectly states a range of 50-67% of *obligations*, which misrepresents both the metric and the value. The ground truth shows the share of *projected benefit obligations* decreased from 54% in 2023 to 50% in 2024, but no 2022 obligation percentage is provided—so the LLM’s claim of 50-67% over 2022–2024 is unsupported. (2) The LLM claims the discount rate increased from 0.52% in 2022 to 1.81% in 2024. However, the ground truth only provides discount rates for 2023 (1.48%) and 2024 (1.81%), with no 2022 rate given. The 0.52% figure is entirely incorrect and not in the original data. While the 1.81% rate in 2024 is correct, the starting point is wrong, making the 'significant upward shift' claim misleading. (3) The multi-hop reasoning is partially sound in that the model attempts to track changes over time and link them to broader trends, but it fails to distinguish between assets and obligations and fabricates data points. It also conflates metrics across years without proper sourcing. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of contribution and change in discount rate—and attempts synthesis. However, due to major quantitative errors and incorrect entity/metric mapping, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the direction of change (decreasing relative size, increasing discount rate) aligns roughly with the truth, but the specifics are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 475,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "Between the 2022 and 2023 10-K filings, Amazon's disclosure regarding the impact of competitive stores on its business became more specific and emphasized the intensifying nature of competition, particularly in international markets and evolving business models. In 2022, the discussion centered on general competitive risks, such as local companies having a competitive advantage due to their understanding of local customers and established brand names. By 2023, the framing expanded to highlight how competition is intensifying globally as physical, e-commerce, and omnichannel retail grow, with a focus on the adoption of evolving business models and the challenges of managing international expansion amid these pressures.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect in its characterization of Amazon's 10-K disclosures for 2022 and 2023. (1) It claims that Amazon's discussion of competitive stores became 'more specific' and emphasized 'intensifying competition,' particularly in international markets and evolving business models. However, the ground truth shows that the core language about competitive stores remained unchanged between the two filings—the same phrase ('the introduction of competitive stores, websites, products, services, price decreases, or improvements') was retained. The key evolution was not in the specificity of competitive threats but in the broader framing: the 2023 filing embedded this language within a larger context of external economic and geopolitical conditions, shifting toward presenting competition as part of a wider set of macro risks rather than a standalone issue. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is flawed: the model failed to identify that the actual shift was in contextual framing (from internal/competitive factors to external/macroeconomic conditions), not an increased emphasis on competitive intensity or international expansion. (4) The LLM introduces details not present in the original answer—such as 'evolving business models' and 'challenges of managing international expansion'—which are not supported by the ground truth. As a result, while the answer is contextually related to Amazon's competitive environment, it misrepresents the nature of the evolution in disclosure, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 452,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "Based on the information provided in the 2023 and 2024 10-K filings, Target's exposure to port security risks has remained a consistent concern, with no significant evolution in geographic focus or operational impact between the two years. Both filings highlight that disruptions at major U.S. ports, particularly those in California where a significant portion of imported merchandise is received, can affect the availability and cost of products, increase operational costs, and disrupt supply chains. The 2024 filing reiterates these risks without indicating a shift in geographic emphasis or a material change in how port security risks impact Target's operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that there was 'no significant evolution' in Target's exposure to port security risks between 2023 and 2024. The ground truth shows a clear shift: in 2023, Target specifically highlighted California ports as a key risk area, while in 2024, it broadened the focus to 'major U.S. ports' without naming California, indicating a strategic shift in risk perception. Additionally, the operational emphasis changed from past disruptions and alternative arrangements (2023) to potential future impacts like increased costs and supply issues due to global conflicts and labor disputes (2024). The LLM answer fails to capture this evolution and instead claims continuity, which contradicts the ground truth. (2) There are no numeric values in this question, so quantitative accuracy is not applicable; however, the years (2023, 2024) are correctly referenced, earning full marks here. (3) The multi-hop reasoning is flawed: the model should have synthesized changes in geographic specificity and operational impact across two filings but instead treated them as static. It missed the nuanced shift from specific to generalized geographic concern and from reactive to forward-looking operational impact. (4) While the answer is relevant to the topic of port security risks and addresses the general context, it fails on correctness due to misrepresenting the evolution of risk focus and impact, warranting a low correctness and qualitative accuracy score despite correct entity and year identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 428,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "Between 2023 and 2024, Emerson's financial relationship with Heritage AspenTech evolved as follows: \n\nIn 2023, the Heritage AspenTech acquisition contributed to acquisition-related amortization of $258 million, primarily from intangible assets such as customer relationships and developed technology. Restructuring costs related to Heritage AspenTech were minimal at $1 million. \n\nIn 2024, acquisition-related amortization significantly increased to $560 million, largely driven by the NI acquisition, not Heritage AspenTech. Restructuring costs for Heritage AspenTech were $8 million in 2024. Thus, while 2023 saw moderate amortization from the Heritage AspenTech acquisition, 2024 focused more on amortization from other acquisitions and higher restructuring costs across the broader Emerson operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition in 2023, and this amortization was no longer reported in 2024. However, the LLM claims that acquisition-related amortization increased to $560 million in 2024 due to the 'NI acquisition'—a detail not present in the ground truth—and incorrectly attributes continued amortization to AspenTech. The ground truth states that AspenTech-related amortization ceased being reported in 2024, but the LLM implies it continued or was replaced by another acquisition. Additionally, the LLM fabricates restructuring costs of $1 million in 2023 and $8 million in 2024 for AspenTech, while the ground truth reports total restructuring costs (not specific to AspenTech) rising from $72 million in 2023 to $228 million in 2024. These numbers are entirely incorrect. (2) Quantitative accuracy is very low: the $560 million amortization figure, $1M and $8M restructuring costs are all unsupported and contradict the ground truth. The correct figures are $258M amortization in 2023 (gone in 2024), and restructuring costs increasing from $72M to $228M. (3) The multi-hop reasoning is flawed: the model fails to recognize that the absence of AspenTech amortization in 2024 is a key signal of transition, and instead invents a new acquisition (NI) not mentioned in the original data. It also misattributes restructuring costs to AspenTech specifically, while the ground truth discusses company-wide restructuring likely influenced by the AspenTech integration but not itemized per acquisition. (4) Contextual relevance is moderate because the answer addresses amortization and restructuring in the context of acquisitions, but the incorrect entities, numbers, and invented details severely undermine factual correctness. The qualitative reasoning is partially sound in structure but based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 537,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "AIG has increased the weight given to Expected Loss Ratio methods in recent accident years (2022-2024) compared to earlier years, particularly in lines with low-frequency, high-severity losses such as U.S. Financial Lines (D&O, E&O) and Excess Casualty. In 2022, Expected Loss Ratio methods were emphasized for newer, less mature accident years where loss development patterns are inconsistent or data is limited. By 2024, this approach was further refined, with Expected Loss Ratio methods playing a significant role in the most recent five accident years, adjusted for rate changes, inflation, and market conditions. This shift reflects AIG's response to evolving underwriting strategies and the need for more forward-looking assumptions in volatile or emerging risk areas.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of AIG increasing reliance on Expected Loss Ratio (ELR) methods between 2022 and 2024, particularly for recent accident years and low-frequency, high-severity lines like D&O and E&O, which aligns with the ground truth. It correctly identifies the use of ELR in newer, less mature accident years where data is limited and development patterns are unstable. However, it misses a key evolution highlighted in the original answer: the expansion of ELR methods into U.S. Workers' Compensation by 2024—a long-tail line previously not emphasized in this context. This omission is significant because it reflects a strategic broadening of ELR application beyond short-tail professional liability lines, which is central to the question about evolution across lines of business. Additionally, while the LLM mentions refinement by 2024 with adjustments for inflation and rate changes, it does not mention the integration of ELR with loss development and frequency/severity methods, nor the continued use alongside IBNR factor methods as in 2022. The answer introduces 'Excess Casualty' and 'most recent five accident years' without grounding in the source data, adding plausible but unverified detail. Quantitatively, there are no explicit numbers or calculations to verify, so the score is based on consistency with timeframes (2022–2024) and accident year focus, which are reasonably accurate. The reasoning is partially sound but lacks full multi-hop synthesis—specifically, connecting the methodological expansion into Workers' Compensation and the integration across different reserving techniques. Contextually, the response stays focused on the evolution of ELR use and is relevant to the question, earning high marks there.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 476,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Between 2022 and 2023, Amazon's monetization strategy for its film groups evolved with an increase in capitalized video and music content costs and associated expenses. The total capitalized costs of video and music rose from $16.7 billion in 2022 to $17.4 billion in 2023, while total video and music expenses increased from $16.6 billion in 2022 to $18.9 billion in 2023. This suggests a strategic shift toward greater investment in content creation and licensing, likely to enhance the value of Amazon Prime memberships and drive customer engagement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: capitalized costs increased from $16.7 billion in 2022 to $17.4 billion in 2023, and associated expenses rose from $16.6 billion to $18.9 billion—both figures exactly match the original answer. (2) The answer is complete, addressing both the change in capitalized costs and associated expenses across the two years, which directly responds to the question about evolution in monetization strategy. (3) Entity accuracy is correct: Amazon is the right company, the years 2022 and 2023 are properly referenced, and the financial metrics (capitalized video and music content costs, total expenses) are accurately used. (4) The reasoning is sound and reflects valid multi-hop synthesis: the increase in both capitalized costs and expenses indicates a strategic shift toward heavier investment in content, which aligns with enhanced monetization through Prime membership value and user engagement. While the LLM adds slight interpretive context (e.g., 'drive customer engagement'), this is reasonable inference and does not deviate from the ground truth. All elements are factually correct, semantically equivalent, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 352,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International's financial relationship with Rothmans, Benson & Hedges (RBH) evolved significantly, primarily due to an impairment charge. As of December 31, 2024, PMI recorded a non-cash impairment charge of $2,316 million (representing a diluted EPS charge of $1.49 per share) related to its equity investment in RBH. This impairment was driven by developments in the Canadian tobacco litigation, including the proposed settlement and unresolved allocation of the CAD 32.5 billion settlement amount among RBH and other parties. The impairment reflects a decline in the estimated fair value of PMI's investment in RBH below its carrying value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $2,316 million impairment charge in 2024, the CAD 32.5 billion Canadian litigation settlement, and the reason—unresolved allocation among RBH and other parties (ITL, JTIM implied as 'other parties'). The date (as of December 31, 2024) is precise and consistent with reporting standards. (2) Quantitative accuracy is perfect: the $2,316 million figure matches exactly, and the additional detail of $1.49 diluted EPS charge, while not in the original answer, is plausible and does not contradict the ground truth (likely derived from internal modeling). The currency (CAD 32.5 billion) is correctly noted. (3) The multi-hop reasoning is sound: the answer correctly infers that PMI had an equity investment in RBH by 2024 that was impaired, indicating evolution from prior arrangements. However, the LLM omits the 2022 aspect of the relationship—specifically that PMI’s connection was through trademark and brand licensing (e.g., HEETS volume reporting)—which is a minor gap in completeness. This limits the qualitative accuracy slightly. (4) Despite this omission, the answer captures the core evolution—shift to equity investment and impairment—and remains contextually fully relevant. Wording differs but semantic meaning is equivalent. Minor deduction from 10 due to incomplete 2022 characterization, but overall excellent performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 398,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "Between 2023 and 2024, the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities slightly decreased. In 2023, a 5% change in these liabilities would have resulted in a $615 million change in revenue, while in 2024, the same 5% change would result in a $600 million change in revenue. This indicates a marginal reduction in sensitivity, despite a notable increase in the absolute value of these liabilities during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that a $600 million sensitivity figure was disclosed in 2024. The ground truth explicitly states that LLY did not provide an updated sensitivity figure in 2024. This is a major factual error. The only correct number is the 2023 sensitivity of $615 million from a 5% change in liabilities. (2) The claim that a 5% change would result in a $600 million change in 2024 is unsupported by the original answer and contradicts the ground truth, which notes the absence of any updated quantitative disclosure. There is no calculation or comparison possible if no 2024 figure was disclosed. (3) The multi-hop reasoning fails because the model incorrectly assumes continuity in disclosure and invents a comparative figure. The correct reasoning should have recognized the absence of 2024 sensitivity data as a change in disclosure practice, not a change in sensitivity itself. (4) The contextual relevance is moderate because the answer addresses the right topic (sensitivity of revenue to liabilities) and correctly references 2023 data, but the core conclusion about decreased sensitivity is fabricated. Quantitative accuracy is very low due to the false $600 million figure. Qualitative accuracy is low because the reasoning misrepresents the nature of the disclosure change. Correctness score is low due to a critical factual error that completely undermines the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 396,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "Based on Union Pacific's disclosures, the role and revenue contribution of Bulk shipments evolved as follows from 2022 to 2024:\n\n- In 2022, Bulk shipments generated 32% of Union Pacific's freight revenues, with the group including grain and grain products, fertilizer, food and refrigerated goods, and coal and renewables.\n- In 2024, Bulk shipments still accounted for 32% of the Company's freight revenues, indicating a stable contribution to the overall revenue mix. This suggests that the role of Bulk shipments remained consistent in terms of revenue contribution from 2022 to 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Bulk shipments contributed 32% of freight revenues in 2024, which aligns with the ground truth. However, it incorrectly claims this 32% figure also applied in 2022, which is not supported by the original answer. The ground truth states that the 32% contribution is reported for 2024, with no explicit percentage given for 2022. Instead, the 2022 data refers to average revenue per car of $3,305 (from 2021 data in the 2022 filing) and a 6% year-over-year increase from 2020. The LLM omits this revenue-per-unit trend entirely and falsely asserts revenue stability by attributing the 2024 percentage to 2022. (2) The quantitative accuracy is partially correct: the 32% figure is accurate for 2024, but misapplied to 2022. The LLM fails to report the $3,305 revenue per car and the 6% growth from 2020 to 2021, which are key quantitative disclosures in the 2022 context. (3) The reasoning is flawed in the multi-hop synthesis: the question asks how the role and revenue contribution evolved, implying a need to compare changes over time. The LLM concludes the role remained 'consistent' due to a stable 32% contribution, but this is based on incorrect data. The ground truth indicates a strategic evolution—increased embeddedness in international and interline networks—beyond just revenue share, which the LLM underemphasizes. (4) Contextual relevance is high as the answer addresses the revenue contribution and product segments, but the incorrect temporal comparison and missing strategic evolution details reduce qualitative and correctness scores. The answer captures part of the picture but misses the transformation narrative and supporting metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 465,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "The interest rate for IBM's Notes due 2028 remained unchanged at 0.300% (for IBM28B) and 1.750% (for IBM28A) between 2023 and 2024, as both years list the same notes with identical rates. This stability suggests that IBM has not issued new Notes due 2028 with different terms during this period, indicating a consistent approach to its existing debt obligations and no immediate need to refinance or adjust the cost of debt for this maturity.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error by introducing a 0.300% note (IBM28B), which is not present in the ground truth. The original answer only references the 1.750% Notes due 2028 (IBM 28A) in both 2023 and 2024. This incorrect addition of a second note series undermines the quantitative accuracy. However, the correct 1.750% rate for IBM 28A is accurately reported. (2) The calculation aspect is not applicable here, but the interest rate values are partially wrong due to the inclusion of the non-existent 0.300% note. The ground truth does not mention any IBM28B or 0.300% rate, so this is a clear factual deviation. (3) The reasoning about stability in the existing debt is sound and aligns with the ground truth, but the LLM fails to capture the broader strategic context provided in the original answer—namely, that IBM issued new debt at higher rates (2.900% and 3.150%) for longer maturities in 2024, indicating a shift in debt strategy. This omission limits the qualitative depth and multi-hop synthesis. (4) The contextual relevance is high because the answer addresses the evolution of the 2028 notes and draws a reasonable conclusion about debt strategy, but the inclusion of false entities and missing key strategic moves (new long-term higher-rate debt) reduces correctness. The answer is partially correct but contains critical inaccuracies and lacks completeness in strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 398,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "From 2023 to 2024, AT&T's capital structure strategy regarding preferred interests evolved by repurchasing all outstanding Mobility Preferred Interests by April 2023, eliminating them from the capital structure. In 2024, AT&T introduced new preferred instruments through amendments and issuances, including the restructuring of Tower Holdings' preferred interests and the issuance of new Telco Class A-4 preferred interests. These new instruments featured fixed and floating rate distributions, reset provisions, and redemption terms, reflecting a strategic shift toward diversifying preferred equity offerings while maintaining flexibility in cash flow and capital management.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AT&T's capital structure strategy regarding preferred interests from 2023 to 2024. (1) It correctly states that AT&T repurchased all Mobility Preferred Interests in 2023 (specifically by April 2023), aligning with the ground truth that all were repurchased that year, though the exact redemption value ($5,340 million) and annual distributions ($373 million) are omitted. These omissions reduce quantitative completeness slightly but do not introduce inaccuracy. (2) The answer accurately describes the 2024 developments: restructuring of Tower Holdings preferred interests (including fixed and floating rate components) and expansion of Telco LLC preferred interests, referred to as 'Telco Class A-4 preferred interests'—a specific but correct designation not in the original but consistent with plausible instrument naming. The total amount of $7,250 million for Telco LLC is not mentioned, which is a minor quantitative gap. (3) The multi-hop reasoning is sound: the answer synthesizes information across years and instruments, correctly inferring a strategic pivot from Mobility-based to infrastructure/telecom-focused preferred capital. (4) The qualitative description of strategic intent—diversification, flexibility in cash flow, and capital management—faithfully reflects the original answer’s meaning. Wording differs but semantic equivalence is strong. Contextual relevance is perfect, directly addressing the evolution in strategy as asked. Minor deductions in quantitative accuracy due to missing dollar figures, but no incorrect data is presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 443,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Between 2022 and 2023, Amazon's characterization of the competitive threat from websites evolved to emphasize the intensification of competition due to the adoption of evolving business models and the growing influence of local companies with a deeper understanding of their markets. In 2022, the focus was on the general intensification of competition in international markets and the challenges posed by local companies having a competitive advantage due to their understanding of local customers and brand presence. By 2023, the language shifted to highlight the adoption of evolving business models as a key driver of intensified competition, indicating a more dynamic and strategic shift in how competitors are adapting and challenging Amazon's market position.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying a shift in Amazon's competitive language between 2022 and 2023, but it misrepresents the core focus of the evolution. The original answer emphasizes a shift from viewing competitive websites as part of general fluctuating business factors in 2022 to a more direct and strategic concern involving 'competitive stores, websites, products, services, price decreases, or improvements' in 2023. In contrast, the LLM answer frames the shift around 'evolving business models' and 'local companies with deeper market understanding,' which is not supported by the ground truth. These concepts (local competition, business model evolution) are not mentioned in the original answer and introduce inaccuracies in the characterization of Amazon's disclosed risks. (2) There are no numeric values in either response, so quantitative accuracy is not applicable; however, the years 2022 and 2023 are correctly referenced, earning full marks here. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies a change over time, it synthesizes incorrect thematic content from potentially related but ultimately mismatched concepts. The actual shift is from general awareness to specific strategic concern about digital competitive elements, not about local competitors or business model changes. (4) The correctness score is 4 due to significant factual divergence in the nature of the competitive threat described. Qualitative accuracy is low because the entities and reasoning are misaligned. Contextual relevance is moderate since the answer addresses Amazon’s evolving competitive landscape, but misses the specific focus on websites and digital platforms as indicated in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 476,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "PMI's relationship with KT&G has evolved from 2022 to 2024, with a growing strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free portfolio. In January 2020, PMI entered into a global collaboration agreement with KT&G to commercialize KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea on an exclusive basis. By 2024, PMI had launched commercial initiatives for these licensed products in select markets, integrating them into its broader smoke-free strategy. This collaboration reflects PMI's commitment to expanding its heat-not-burn offerings as part of its transition to a smoke-free future.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the date of the agreement: it states the global collaboration agreement was entered in January 2020, while the ground truth specifies it began in 2022. This is a major quantitative inaccuracy that undermines the timeline of the relationship evolution. All other entities (KT&G, PMI, LIL Mini, LIL Plus, South Korea, heat-not-burn products) are correctly identified. (2) The agreement duration (three years) and the 2024 integration status are not mentioned in the LLM answer, missing key details from the original. While the LLM correctly notes exclusive distribution outside South Korea and integration into PMI's portfolio by 2024, it fails to convey the evolution from distributor to embedded supplier role, which is central to the strategic shift. (3) The multi-hop reasoning is partially sound—LLM connects the agreement to commercialization and portfolio integration—but misses the deeper synthesis that by 2024, KT&G’s products were listed among PMI’s own offerings, indicating a more strategic reliance beyond licensing. This nuance is absent. (4) Despite the incorrect date and missing depth on the nature of the 2024 relationship, the answer remains contextually relevant and captures the general trend of increasing reliance. Wording is semantically close but lacks precision on the strategic evolution. Quantitative accuracy is low due to the wrong year; qualitative accuracy is moderate due to correct entities and partial reasoning; contextual relevance is high as it addresses the core question about evolving reliance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 439,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "Between 2022 and 2024, IBM's use of the PWCC Plan remained consistent in terms of administration and scope. The PWCC Plan continued to be administered by the Executive Compensation and Management Resources Committee of the Board of Directors, with terms and conditions substantively identical to the 2001 Plan. It was solely used to fund awards for employees of PricewaterhouseCoopers Consulting who became IBM employees due to the 2002 acquisition, and it did not fund awards for senior executives. No significant changes to the administration or scope of the PWCC Plan were noted during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly states that the PWCC Plan's administration and terms remained substantively unchanged between 2022 and 2024, continues to be used solely for former PwCC employees, and is administered under the same committee with terms identical to the 2001 Plan. All entities (PwCC, IBM, 2001 Plan, Executive Compensation Committee) and timeframes are correct. There are no numeric inaccuracies—dates and plan details are consistent with the original answer. The only minor shortcoming is that the LLM does not explicitly note the shift in language tone from 2022 to 2024 (from 'will continue to be used' to 'has been and will continue to be used solely'), which the ground truth interprets as a stronger reaffirmation of intent. While the LLM captures the lack of change in scope and administration, it omits this nuance in rhetorical emphasis, which slightly weakens the qualitative reasoning around IBM's evolving communication. However, this does not affect factual correctness. The answer is contextually relevant, fully addressing the question about evolution in administration and scope, and correctly concludes no significant changes occurred. Thus, the answer is highly accurate with only a minor omission in interpretive detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 364,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "Between 2023 and 2024, AT&T fully repurchased all outstanding Mobility II Preferred Interests by April 2023, which had previously carried a 7% annual distribution rate. In 2024, the company focused on restructuring other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, by resetting rates and extending redemption terms. This shift indicates a strategic effort to optimize AT&T’s capital structure by reducing high-cost obligations and enhancing flexibility in managing long-term financing, aligning with broader goals of financial stability and efficient capital allocation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that AT&T repurchased all Mobility Preferred Interests in 2023, though it specifies 'April 2023'—a detail not in the original answer but not contradicted by it. The $5,414 million repurchase amount and inclusion of accrued distributions from the ground truth are omitted, which is a minor incompleteness, but the core fact of full repurchase is correct. (2) The 7% annual distribution rate is an additional detail not present in the original answer; while plausible, it cannot be verified from the ground truth and slightly exceeds it, but does not contradict. (3) The LLM correctly contrasts the elimination of Mobility Preferred Interests with the restructuring of Tower Holdings and Telco LLC preferred interests in 2024, demonstrating sound multi-hop reasoning across years and instruments. (4) The conclusion about strategic capital structure optimization, reducing high-cost obligations, and enhancing flexibility is semantically equivalent to the original's 'selective approach to managing capital structure' and is logically supported. The answer is fully relevant and synthesizes the required information accurately, with only minor omissions in quantitative detail preventing a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 360,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "Between 2022 and 2024, IBM's regulatory exposure for its debt securities remained subject to factors such as governmental and stock exchange regulations, interest rates, and credit ratings, as disclosed in both years' 10-K filings. However, there was no significant change in the nature of this exposure; the company continued to emphasize that it has little or no control over these external factors. The 2024 filing reiterated the same risks outlined in 2022, indicating a consistent regulatory environment impacting the value and liquidity of IBM's debt securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of IBM's regulatory exposure. While it correctly identifies that IBM mentioned stock exchange regulations in both 2022 and 2024, it asserts there was 'no significant change' and that the language remained consistent, which directly contradicts the ground truth. The original answer shows a clear shift in IBM's language: from describing stock exchange regulations as one of several factors influencing debt securities in 2022, to stating in 2024 that it is 'subject to' these regulations—indicating a stronger, more direct regulatory exposure. This evolution in wording and implied legal accountability is central to the question and was missed entirely by the LLM. The LLM incorrectly concludes stability where there was a meaningful qualitative shift. There are no numerical errors (hence high quantitative accuracy), and the response is contextually relevant to the topic of regulatory exposure, but the reasoning fails on the key multi-hop comparison across years. The entity (IBM), years (2022, 2024), and general subject (debt securities, stock exchange regulations) are accurate, but the synthesis of changes over time is flawed, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 354,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "Disney's financial relationship with A&E, particularly in terms of equity income contribution, declined from 2022 to 2024. In 2022, A+E (a 50/50 joint venture with Hearst) contributed to Disney's equity income, but by 2024, equity income from A+E had decreased significantly, contributing to an overall $207 million decline in equity income from investees. This decline reflects lower income from A+E in 2024 compared to prior years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $207 million decline in equity income from investees due to lower A+E contributions is correctly reported, matching the original answer exactly. The years 2022 and 2024 are accurately referenced. (2) The answer correctly identifies A+E as a joint venture with Hearst (additional accurate detail not in the ground truth but factually correct), and notes its role in Disney's equity income, which is consistent with the original. (3) The multi-hop reasoning is sound: it connects the decline in A+E's contribution to the overall $207M drop in equity income, correctly inferring a material decline over the period. (4) The only minor shortcoming is that the original answer explicitly names CTV Specialty Television as another major equity investee in 2022, which the LLM omits. However, this does not detract from the core focus on A&E’s evolving contribution. The answer is semantically equivalent and contextually precise, with excellent factual and numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 303,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations increased from $16,973 million in 2022 to $18,043 million in 2023, indicating a $1,070 million rise. This increase suggests that the company is leveraging its securitization programs to expand its long-term funding sources, likely to maintain a diversified mix of wholesale funding and support its growing loan portfolios.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that the carrying value of securitized debt obligations decreased to $18.043 billion as of December 31, 2023, from a prior level (implied in 2022) that was part of a total long-term funding of $42.3 billion as of December 31, 2021, with securitized debt being a significant portion. The LLM incorrectly claims an increase from $16,973 million ($16.973 billion) in 2022 to $18.043 billion in 2023, which contradicts the downward trend indicated in the original answer. (2) The quantitative values are inaccurate: the starting value of $16.973 billion for 2022 is not supported by the ground truth, which does not provide a specific 2022 figure but implies a decline from a higher base. The calculation of a $1,070 million increase is therefore based on false inputs. The 2023 value of $18.043 billion is correct in isolation, but the comparison is invalid. (3) The multi-hop reasoning is flawed: the model fails to correctly interpret the timeline and composition of long-term funding, misidentifying the trend and thus drawing the opposite conclusion about the company’s strategy. Instead of recognizing a strategic reduction in securitized debt, it claims an expansion, which is directly contradicted by the source. (4) Scores are low due to major factual and directional errors in financial data and strategic interpretation. Contextual relevance is moderate because the answer addresses the right topic (securitized debt and funding strategy) and uses appropriate financial terminology, but the core facts and conclusions are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 453,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "Between 2022 and 2024, Disney has shifted its focus from international general entertainment channels to prioritize DTC platforms. In 2022, the company operated approximately 220 General Entertainment channels outside the U.S., but it acknowledged that its increased focus on DTC distribution would negatively impact the International Channels business as the primary monetization strategy shifted from licensing linear channels to DTC platforms. By 2024, Disney had consolidated services, such as merging Star+ into Disney+ in Latin America, and expanded its DTC offerings, including plans to launch an ESPN-branded tile on Disney+ in the U.S. in early fiscal 2025, reflecting a strategic move toward integrating and expanding its DTC presence globally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 220 international General Entertainment channels in 2022 are accurately cited. The mention of fiscal 2025 for the ESPN-branded tile launch matches the original answer’s 'early fall 2025' timeline (Disney's fiscal 2025 begins in October 2024, so early fall 2025 aligns). (2) The LLM correctly identifies the strategic shift from linear international channels to DTC platforms, including the consolidation of Star+ into Disney+ in Latin America, which is a valid example of Disney’s DTC prioritization. (3) The qualitative reasoning is sound: it captures the core multi-hop insight that Disney’s monetization strategy shifted from licensing linear channels to DTC, impacting its international channels business. However, the LLM omits mention of the Venu Sports joint venture with Fox Corp and Warner Bros. Discovery, which is a notable strategic move toward DTC sports distribution highlighted in the original answer. While the ESPN+ integration is mentioned in a slightly different form (as an 'ESPN-branded tile'), this is semantically acceptable. (4) The answer is contextually relevant, directly addressing both the evolution in scripted programming (via reduced emphasis on general entertainment channels) and the strategic DTC shift. The omission of Venu Sports prevents a perfect score, but the core facts, numbers, and strategic narrative are correct and well-synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 414,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "From 2022 to 2023, Tesla faced evolving financial and operational challenges related to energy storage products. In 2022, accounts receivable included long-term government rebates and faced fluctuations due to payment timing and regulatory credit sales. By 2023, production scaling for energy storage products remained dependent on supplier reliability, component availability, and manufacturing ramp-up at new facilities, with risks of delays and increased costs due to supply chain constraints and raw material volatility. Additionally, Tesla highlighted ongoing challenges in accurately forecasting demand and managing global delivery and installation capabilities for energy products.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Tesla's financial and operational challenges from 2022 to 2023. (1) Quantitatively, no specific dollar amounts or dates are incorrectly stated; the LLM does not repeat the $627 million figure from 2021 (disclosed in the 2022 filing), but this omission does not constitute an error since the focus is on the nature of receivables rather than exact figures. The absence of the $627M number is a minor completeness gap but not a factual inaccuracy. (2) The LLM correctly identifies the 2022 financial challenge involving long-term government rebates and timing of payments, which matches the ground truth. In 2023, it accurately shifts focus to production scaling dependencies, including supplier constraints, component availability, and manufacturing ramp-up at new facilities—consistent with the original answer’s mention of bottlenecks and delays in Nevada and Texas. (3) The multi-hop reasoning is sound: the model synthesizes a shift from financial (receivables) to operational (scaling, supply chain) challenges over time, which is the core insight. It adds relevant context not in the original—such as demand forecasting and delivery/installation challenges—which are plausible extensions but not explicitly confirmed in the ground truth, slightly reducing qualitative precision. (4) Contextual relevance is high, as all points directly address the question’s focus on accounts receivable and production scaling dependencies. The answer is slightly less precise than the original in naming specific factories but captures the essential operational risks. Overall, the answer is factually accurate and well-reasoned with only minor omissions, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 479,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola's business model remained central to its concentrate operations, where the company sells syrups to bottling partners and fountain retailers. Syrups are a key component of Coca-Cola's revenue streams, with concentrate operations accounting for 58% of net operating revenues in 2023, up from 56% in 2022. The company continues to sell fountain syrups to bottling partners and fountain retailers, who use them to produce beverages for immediate consumption. This reflects a stable and strategic role for syrups in supporting Coca-Cola's global distribution model and maintaining its presence in both retail and foodservice channels.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses the core evolution described in the ground truth. It correctly identifies that syrups are sold to bottling partners and fountain retailers, and that concentrate operations are a major revenue component. However, it fails to capture the key shift between 2022 and 2023 in accounting treatment and strategic framing—specifically, the change from volume-driven recognition (with differences based on bottler consolidation status) to a more operationally embedded, integrated model emphasizing direct sales to fountain retailers. This evolution is central to the question and is entirely omitted. (2) The quantitative claim that concentrate operations accounted for 58% of net operating revenues in 2023 (up from 56% in 2022) is not present in the original answer and cannot be verified against the provided ground truth. Since this data is not in the source, its inclusion introduces unverified information, reducing quantitative accuracy. There are no explicit numbers in the ground truth to confirm or refute these percentages, so their presence is problematic. (3) The multi-hop reasoning is weak: the question asks for an analysis of how the *role* of syrups evolved in relation to bottling partners and fountain retailers across two years. The LLM asserts stability rather than transformation, contradicting the ground truth’s emphasis on a strategic shift in 2023 toward direct manufacturing and selling of fountain syrups as part of an integrated system. The model does not synthesize the change in revenue recognition logic or the reframing of syrups as an operational dependency. (4) Scores reflect partial factual alignment (contextually relevant and some plausible numbers), but major shortcomings in capturing the actual evolution described in the ground truth, especially the qualitative shift in business model integration. The answer is well-structured and relevant to the topic but factually incomplete and potentially misleading in its emphasis on continuity over change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 553,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "From fiscal year 2022 to 2024, Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) increased from $84 million to $166 million. However, its proportion relative to the overall fair value hierarchy decreased slightly, from 1% in 2022 to 1% in 2024, indicating a marginal shift in the composition of plan assets over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Disney's investment in Other MBS & ABS was $96 million in fiscal year 2022 and increased to $120 million in 2024. However, the LLM incorrectly reports these values as $84 million in 2022 and $166 million in 2024, which are both factually wrong. Additionally, the proportion relative to the overall fair value hierarchy is stated as 1% in both years in the ground truth, and the LLM repeats this correctly—but then incorrectly interprets it as a 'decrease slightly' while stating the same percentage, which is logically inconsistent. (2) The dollar amounts are off by significant margins: $84M vs $96M (12.5% error in 2022), and $166M vs $120M (38% overstatement in 2024). The percentages (1% in both years) are correctly cited, but the conclusion drawn from them is flawed. (3) The multi-hop reasoning is partially sound in that the model attempts to compare investment value and proportion over time, but it fails in accurate data retrieval and synthesis. The incorrect base figures undermine the entire analysis. (4) Contextual relevance is high because the answer addresses the right question structure—evolution of investment and trend in proportion—and references the correct security type and time frame. However, due to major quantitative errors and flawed interpretation of stable percentages as a 'marginal shift,' the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 405,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Between 2022 and 2023, Skunk Works' advanced development programs, part of Lockheed Martin's Aeronautics segment, expanded their focus on next-generation military aircraft capabilities. In 2022, the emphasis was on future systems such as unmanned and manned aerial systems, next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus evolved to include a stronger emphasis on air dominance, hypersonics, and integrating network-enabled technologies to enhance the effectiveness of separate systems. This shift reflects an increased strategic priority on advanced technologies to meet evolving defense needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the focus areas of Skunk Works in 2022, including unmanned and manned aerial systems, hypersonics, ISR, situational awareness, and air mobility, which matches the ground truth. In 2023, it accurately notes a stronger emphasis on air dominance and hypersonics. However, the LLM introduces 'network-enabled technologies to enhance the effectiveness of separate systems'—a detail not present in the original answer and not supported by the ground truth. While this addition is plausible, it adds content beyond the verified evolution, which was a refinement emphasizing air dominance without introducing new domains like network integration. (2) There are no numerical values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift in focus from 2022 to 2023 and identifies the continuity in key areas like hypersonics and ISR. The core evolution—increased emphasis on air dominance—is correctly captured. The only deviation is the unverified addition of network-enabled technologies, which slightly affects qualitative accuracy. (4) The answer is highly relevant and factually aligned with the ground truth in all essential aspects, earning full marks for contextual relevance. The correctness score is 8 due to the minor but notable addition of unsupported content, though the main factual and conceptual points are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 419,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "Tesla's approach to the Powerwall product evolved from 2022 to 2023 by emphasizing integration with residential solar energy products and expanding cross-selling opportunities. In 2022, the focus was on increasing production to meet high demand and addressing component constraints. By 2023, Tesla highlighted growing customer interest in Powerwall driven by better availability and grid stability concerns, while also emphasizing its role in promoting renewable energy through integration with solar systems. Additionally, Tesla improved its installation capabilities and online ordering experience to support Powerwall adoption.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's evolving focus on Powerwall integration with solar products and mentions improved installation capabilities and customer interest due to grid stability concerns, which aligns with the ground truth. However, it inaccurately frames 2022 as a year focused on 'increasing production to meet high demand and addressing component constraints,' which is not supported by the original answer—instead, the original emphasizes cross-selling and availability in 2022. Additionally, the LLM misses the key evolution in 2023 toward a more engineered integration of Powerwall with Solar Roof and solar systems, instead vaguely stating 'integration with solar systems' without highlighting the deliberate design improvements. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is unaffected and scores perfectly. (3) The multi-hop reasoning is partially sound—the model connects Powerwall to solar integration across years—but fails to fully synthesize the shift from sales/availability focus (2022) to technical/engineered integration (2023), which is the core of the evolution described in the ground truth. (4) The answer is contextually relevant and captures general themes, but lacks precision in representing the strategic shift, leading to a moderate deduction in qualitative and overall correctness scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 390,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "Between 2022 and 2024, Gilead has maintained Biktarvy as a key pillar of its HIV portfolio, emphasizing its role as a once-daily, single-tablet regimen for the treatment of HIV-1 infection. However, the company faces ongoing commercial risks, including competitive pressures from other HIV treatments and potential shifts in treatment paradigms that could reduce reliance on nucleoside-based therapies like Biktarvy. Additionally, pricing pressures from government and private payers, as well as the threat of generic competition, continue to pose challenges to sustaining or increasing sales of Biktarvy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its general description of Biktarvy's role and associated commercial risks, and it correctly identifies ongoing challenges such as competitive pressures, shifting treatment paradigms, pricing pressures, and generic competition. There are no numeric inaccuracies (quantitative accuracy is perfect), and the time frame (2022–2024) is appropriately referenced. However, the answer misses a key evolution highlighted in the ground truth: the increasing strategic risk due to Gilead’s growing dependence on TAF-based therapies, which makes the company more vulnerable to changes in preference for nucleoside analogs. This represents a shift from innovation emphasis to overreliance on a narrow class—specifically called out in the original answer. While the LLM mentions 'shifts in treatment paradigms,' it does not explicitly connect Biktarvy’s risk to Gilead’s broader portfolio concentration in TAF, which is a critical multi-hop insight. Thus, while contextually relevant and factually sound, the qualitative accuracy is reduced due to incomplete synthesis of the strategic evolution. The answer is well-structured and relevant but lacks the depth of strategic transition described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 346,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "The U.S. Retrospective Responsibility Plan remained structurally consistent between 2022 and 2023, with the same mechanisms referenced, including the U.S. Litigation Escrow Agreement. However, the U.S. litigation escrow account balance increased significantly, from $1,449 million as of September 30, 2022, to $3,089 million as of September 30, 2023, primarily due to additional deposits of $1,500 million in 2023 compared to $850 million in 2022. Payments from the escrow account also increased, with $685 million in 2023 compared to $295 million in 2022, reflecting ongoing settlements or judgments related to U.S. covered litigation.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the core question about changes in the composition of the U.S. Retrospective Responsibility Plan. The original answer states that a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — was added in 2023, while the LLM claims the structure remained 'structurally consistent' with no mention of this key addition. This is a major omission that fundamentally misrepresents the change in plan composition. (2) The quantitative data provided (e.g., escrow account balances of $1,449M in 2022 and $3,089M in 2023, deposits of $1,500M vs $850M, payments of $685M vs $295M) may be accurate in isolation, but these figures are not relevant to the specific question about structural changes in the plan's mechanisms. The numbers pertain to account activity, not compositional changes, so while numerically plausible, they do not support the correct conclusion. (3) The multi-hop reasoning is flawed: the question asks for a comparison of mechanisms within the plan across years, particularly in relation to the U.S. Litigation Escrow Agreement. The LLM incorrectly infers that because the Escrow Agreement is still referenced, the structure is unchanged, failing to recognize that the addition of 'makewhole agreements' constitutes a meaningful expansion. It also fails to synthesize the presence of the same core mechanisms plus a new one, as required. (4) The contextual relevance is moderate because the answer discusses related topics (escrow account balances and activity), but it does not address the actual change in plan composition, making it tangential rather than responsive. The qualitative accuracy is low due to the failure in entity and conceptual identification — the new 'makewhole agreements' are a critical entity introduced in 2023 that the model omits entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 507,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "The strategic importance of Biktarvy for GILD has remained strong from 2022 to 2024, supported by its robust patent protection, with estimated expiration in both the U.S. and European Union set for 2033. This extended patent protection helps safeguard GILD’s revenue from HIV product dependency, although the company continues to face risks related to market competition, patent challenges, and potential loss of exclusivity in the future.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding patent expiration in the European Union. The ground truth states that in 2022, Biktarvy had no E.U. expiration listed, but the LLM incorrectly claims a 2033 expiration in both the U.S. and E.U., which is not supported by the original data. This misrepresents the patent protection timeline and undermines the accuracy of the strategic assessment. (2) The U.S. patent expiration date of 2033 is correctly cited, aligning with the ground truth, so quantitative accuracy for that element is acceptable. However, the addition of the E.U. 2033 date is unsupported and incorrect, leading to a partial score on quantitative accuracy. (3) The reasoning is partially sound in linking patent protection to revenue dependency and acknowledging competitive risks, but it fails to capture the evolution in GILD’s risk disclosures from 2022 to 2024. The original answer notes an increased emphasis on risk in 2024 despite strong patents, indicating a shift in strategic vulnerability due to external factors—this nuance is missing in the LLM response, which implies stability rather than growing risk. Thus, the multi-hop synthesis across years and disclosures is incomplete. (4) Contextual relevance is high because the answer addresses patent timelines, revenue dependency, and market risks as required by the question. However, the failure to accurately reflect the changing risk posture and incorrect E.U. patent information reduces correctness and qualitative accuracy, resulting in a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 432,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "Based on the information provided in the 2022 and 2023 10-K filings, there is no indication of any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023 in terms of guarantee structure or referenced documentation. The guarantees referenced in both filings remain consistent with historical arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in all key aspects. It correctly states that there were no modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, both in terms of structure and documentation. The answer accurately reflects the consistency of the guarantee reference across both years. While the LLM does not explicitly mention the specific exhibit (Exhibit 4-d) or the 2011 Form 10-K filing, which are included in the original answer, this omission does not undermine the correctness of the conclusion—only minor completeness is affected. There are no numerical values, dates, or entities inaccurately reported, so quantitative accuracy is perfect. The reasoning is sound: the model correctly infers no change based on consistent references in the filings. The answer is semantically equivalent to the ground truth, with slightly less detail. Contextual relevance is full, as the response directly addresses the question about structural or documentation changes. Thus, a high correctness score of 9 is warranted, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 331,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggests that there has been no significant change in the potential dilution of Class A common stockholders' voting power during this period. Since the conversion rate remains stable, the relative voting influence of Class A stockholders in significant corporate transactions is unlikely to have been materially affected by conversions from Class C stock during these years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It correctly identifies the consistent conversion rate between 2022 and 2023 without stating specific numbers, but this is acceptable because the question does not explicitly ask for the rate value, only its implication. The ground truth specifies the rate as 4.0000 in both years, which the LLM does not contradict. (2) The quantitative accuracy is high: while the LLM does not mention the as-converted Class A stock values of 38 million and 39 million, these figures are contextually secondary to the main point about stable voting power due to unchanged conversion mechanics. Their omission does not impair correctness, as the core quantitative fact—the unchanging conversion rate—is accurately reflected. (3) The reasoning is sound: the LLM correctly infers that a stable conversion rate implies no material change in voting power dilution for Class A shareholders, which aligns with the multi-hop logic in the original answer connecting conversion mechanics to voting influence in corporate transactions. (4) Contextual relevance is perfect—the response directly addresses the potential impact on voting power, focuses on significant corporate transactions, and draws the correct conclusion about stability. The only minor limitation is the lack of explicit mention of the slight increase in as-converted Class A value, which adds nuance but does not alter the conclusion. Thus, the answer is highly accurate and complete for the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 421,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "From 2022 to 2023, Tesla's relationship with the Solar Roof evolved as the company continued to integrate the product into its broader energy generation and storage strategy but shifted focus toward scaling vehicle production. In 2022, Tesla emphasized the Solar Roof as part of its energy product offerings, leveraging Gigafactory New York for its production and development. By 2023, while still part of Tesla's energy portfolio, the Solar Roof received less strategic emphasis compared to vehicle production and battery development, as the company prioritized manufacturing efficiency and cost control for mass-market vehicles and energy storage systems.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's production of the Solar Roof at Gigafactory New York in 2022, which aligns with the ground truth. However, it diverges in 2023 by emphasizing a shift in strategic focus toward vehicle production and battery development, rather than the documented shift toward highlighting strategic execution risks such as supply chain constraints, delays, and ramp-up challenges. The ground truth emphasizes a change in disclosure tone—from active production to risk-focused language—while the LLM interprets this as a deprioritization due to shifting strategic emphasis, which is not directly supported by the evidence. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; no errors in dates or entities. (3) The multi-hop reasoning is partially sound: the model connects Tesla, Solar Roof, Gigafactory New York, and timeline shifts, but fails to synthesize the correct nature of the 2023 change—risk disclosures vs. strategic deprioritization. This mischaracterizes the evolution of the relationship. (4) The answer is contextually relevant and includes correct entities and timeframes, but misses the core factual shift in Tesla's disclosures, leading to a moderate correctness score. While semantically plausible, it does not match the ground truth's emphasis on risk and dependency disclosures as the key evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 392,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola's business model remained integral to both concentrate and finished beverage production. Syrups, including fountain syrups, continued to serve as key intermediate products sold to bottling partners and fountain retailers for use in producing finished beverages. In 2023, concentrate operations (including syrups) accounted for 58% of net operating revenues, up from 56% in 2022, indicating a slight increase in their relative importance. Syrups were also used in the U.S. for direct sales to fountain retailers and through consolidated operations, highlighting their continued role in supporting both traditional and emerging distribution channels.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention any percentage of net operating revenues from concentrate operations (56% in 2022 or 58% in 2023), nor does it state that syrups' revenue share increased. These figures are entirely fabricated or misattributed, severely undermining factual correctness. (2) There are no verifiable calculations or numbers in the original answer to support the LLM's specific percentages, making the quantitative accuracy very low. The original answer focuses on structural and operational changes—not revenue breakdowns—so inserting numerical data here is incorrect. (3) The qualitative reasoning partially captures the role of syrups as intermediate products and their use in fountain systems, which aligns with the ground truth. However, it fails to capture the key 2023 evolution: Coca-Cola taking direct control of fountain syrup sales in the U.S. and the inclusion of syrup operations in the North America operating segment. This strategic shift toward tighter control and regional segmentation is a central point in the original answer but is missing in the LLM response. (4) Contextually, the answer stays on topic and addresses syrups in relation to finished beverage production and distribution, so relevance is high. However, due to invented metrics and failure to report the actual organizational and distributional changes, the overall correctness score is low despite some accurate conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 425,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "Between 2022 and 2024, Colgate-Palmolive's operational focus on Africa/Eurasia remained part of its five geographic reportable segments under the Oral, Personal and Home Care product segment. In 2024, the company made a structural change by realigning the skin health business, which previously impacted the Europe segment, to be reported within the North America segment, but this change did not affect Africa/Eurasia's reporting structure. Financially, Africa/Eurasia's operating profit increased from $228 million in 2022 to $253 million in 2024, indicating a modest growth in its contribution to the company's overall performance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures. The ground truth states that Africa/Eurasia had an operating profit of $203 million in 2022, but the LLM claims $228 million in 2022 and $253 million in 2024—both numbers are incorrect and introduce a growth narrative not supported by the original data. There is no mention of a $253 million figure or any 2024 profit value in the ground truth, making the quantitative claims entirely fabricated. (2) The entity identification is partially correct—the company (Colgate-Palmolive) and the segment (Oral, Personal and Home Care) are accurately referenced, and the 2024 realignment of the skin health business from Europe to North America is correctly noted. However, the claim that Africa/Eurasia remained one of five geographic reportable segments is not confirmed in the original answer, which only states it was maintained as a distinct segment within the geographic structure. (3) The reasoning is partially sound in recognizing that the skin health realignment did not affect Africa/Eurasia, but it incorrectly infers financial growth and misrepresents the evolution of the reporting structure. The original answer emphasizes a strategic refinement in geographic reporting due to the skin health shift, suggesting improved granularity in performance evaluation, while the LLM reduces this to a structural note without capturing the strategic implication. (4) Contextual relevance is high because the response addresses both geographic structure and financial contribution over time, aligning with the question’s focus. However, due to major quantitative errors and incomplete qualitative synthesis—especially the invented financial figures and missed nuance in strategic evolution—the overall correctness score is low. Minor flexibility is allowed for phrasing, but fabricated numbers severely undermine trustworthiness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 521,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson's Orthopaedics business showed a modest global sales increase, with worldwide sales rising by 4.1% in 2023 compared to 2022. The U.S. market saw a 3.8% growth, while international sales increased by 4.6%. In terms of enabling technologies, the 2024 report emphasizes the integration of advanced solutions across hips, knees, trauma, spine, and sports, reflecting a strategic focus on innovation and comprehensive patient care. Additionally, the company highlighted the importance of regulatory compliance and the impact of emerging technologies and data security regulations on the development and deployment of healthcare solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2023 global sales growth of 4.1%, U.S. growth of 3.8%, and international growth of 4.6%, which aligns with the ground truth. However, it omits the actual revenue figures in dollar amounts ($8,942 million total, $5,525 million U.S., $3,417 million international), which were key quantitative elements in the original answer. While the percentages are accurate, the absence of absolute values reduces completeness. (2) The LLM correctly identifies the strategic shift in 2024 toward innovation and enabling technologies across hips, knees, trauma, spine, and sports medicine, matching the qualitative pivot described in the ground truth. However, it adds content not present in the original—specifically, mention of 'regulatory compliance' and 'data security regulations'—which were not part of the documented strategic framing in the 2024 filing. This introduces extraneous information that affects qualitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly infers a shift from financial to technological emphasis between years, but fails to fully contrast the presence of detailed revenue reporting in 2023 versus the complete absence of such figures in 2024, a critical nuance in the strategic evolution. (4) The correctness score is 7 because core financial growth rates and the general strategic shift are accurate, but key revenue figures are missing and some content is fabricated. Quantitative accuracy is 8 due to correct percentages but missing dollar amounts. Qualitative accuracy is 7 due to correct direction of shift but added, unsupported details. Contextual relevance is 9 as the response stays focused on the question's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 469,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Between 2022 and 2023, Visa's approach to managing litigation liabilities through loss sharing agreements evolved by expanding the scope of U.S. covered litigation to include actions brought by merchants that opted out of the Rule 23(b)(3) settlement class in MDL 1720, provided those actions are substantially similar to MDL 1720 claims and not otherwise included in MDL 1720. Additionally, the liability allocation under the U.S. retrospective responsibility plan remained structured through mechanisms like the U.S. litigation escrow agreement, loss sharing agreements, and the omnibus agreement with Mastercard, which divides monetary portions of settlements and judgments into a Mastercard portion at 33.3333% and a Visa portion at 66.6667%. These agreements ensure that Visa's liability is proportionally managed and shared among relevant parties, including Visa U.S.A. members and Mastercard, based on predefined terms.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the 66.6667% (Visa) and 33.3333% (Mastercard) liability split under the omnibus agreement is correctly stated, and the reference to MDL 1720 and opt-out actions from the Rule 23(b)(3) Settlement Class is consistent with the ground truth. There are no calculation or percentage errors, supporting a perfect quantitative accuracy score. Contextual relevance is high, as the response directly addresses Visa's litigation liability management and evolution in scope and allocation. However, the qualitative accuracy is lower because the LLM fails to capture the key evolution highlighted in the original answer: the 2023 shift to the U.S. Retrospective Responsibility Plan as a broader, consolidated framework that now *encompasses* the loss sharing agreement and reflects a strategic pivot toward resolving *past* liabilities. The LLM incorrectly implies continuity by stating that the allocation 'remained structured' through the same mechanisms, whereas the ground truth emphasizes a meaningful shift in 2023 toward including 'settled or otherwise fully or substantially resolved' matters, indicating a retrospective and finalizing approach. This strategic evolution—from amending agreements in 2022 to consolidating and resolving legacy exposure in 2023—is underemphasized. Additionally, the LLM does not mention that the 2022 changes were part of an October 2015 amendment (referenced in the 2022 filing), which weakens the multi-hop synthesis across time. While core facts are correct, the answer lacks depth in conveying the strategic shift, leading to a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 449,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "Between 2022 and 2024, CL reduced its investment in Guaranteed Investment Contracts (GICs) in its pension plans. In 2022, GICs were valued at $55 million for international pension plans and $1 million for U.S. plans, while by 2024, the international plans held $30 million in GICs, and the U.S. plans held none. This shift suggests a strategic reallocation of pension plan assets toward more diversified or liquid investments, potentially reflecting a move to optimize returns or reduce exposure to fixed-income-like instruments in favor of other asset classes such as fixed income funds or multi-asset funds.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall trend of reducing and eliminating Guaranteed Investment Contracts (GICs) in both U.S. and international pension plans between 2022 and 2024. The 2022 figures are accurate: $1 million for U.S. and $55 million for international. The 2024 U.S. figure of $0 is correct. However, the LLM states international GICs were reduced to $30 million in 2024, while the ground truth reports $34 million — a minor but notable discrepancy of $4 million. (2) This quantitative inaccuracy affects precision but does not alter the overall conclusion of a moderate decrease internationally. Calculations of change (complete phase-out in U.S., reduction internationally) are logically sound, though the exact magnitude of the international reduction is slightly off. (3) The multi-hop reasoning is strong: the model correctly synthesizes data across years and geographies (U.S. vs. international) and infers a strategic reallocation, which aligns with the ground truth. The interpretation about shifting toward diversified or liquid investments is reasonable and contextually supported, even if slightly more speculative than the original. (4) Scores reflect high factual accuracy, strong reasoning, and full relevance to the question. The correctness score is 8 due to the $4 million error in the 2024 international amount, which is minor but measurable. Quantitative accuracy is penalized slightly (8), while qualitative reasoning and contextual relevance remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 417,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "Between 2022 and 2024, the Mastercard Developer Platform evolved to become a more centralized and comprehensive hub for integrating digital assets and new technologies. In 2022, the platform was described as simplifying access to and integration of digital assets by providing a single access point with tools and capabilities to find APIs across a broad range of Mastercard services. By 2024, the platform had expanded its role, explicitly supporting blockchain-based business models and enabling programmable payments via the Mastercard Multi-Token Network™. It also facilitated integration with digital currencies and crypto players, allowing consumers to buy cryptocurrencies on card and spend them at Mastercard-accepting merchants, reflecting a more advanced and strategic positioning in the digital asset ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, the platform served as a single access point for integrating Mastercard's digital assets and APIs; by 2024, it evolved to support blockchain, digital currencies, and the Mastercard Multi-Token Network™. The mention of enabling programmable payments and integration with crypto players is consistent with the expanded strategic role. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2024) and named entities (Mastercard Developer Platform, Mastercard Multi-Token Network™) are correct. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across time (2022 vs 2024), platforms, and technological evolution, showing how the platform’s role expanded from general integration to supporting next-gen financial tech. (4) The only minor gap is that the LLM adds a detail not present in the original answer—'allowing consumers to buy cryptocurrencies on card and spend them at Mastercard-accepting merchants'—which, while plausible and contextually relevant, is not explicitly supported in the ground truth. This slightly affects qualitative accuracy but does not introduce inaccuracy. Overall, the answer is semantically equivalent, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 398,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "The company's U.S. pension plans had no investment in U.S. common stocks at the end of 2024 or 2023, and no shares were purchased during those years. This aligns with the target asset allocation, which emphasizes fixed income securities (62% in 2024) over equity investments (2% in 2024). The lack of U.S. common stock holdings suggests a conservative strategic asset allocation focused on stability and income generation rather than equity exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the U.S. pension plan had no investment in U.S. common stocks in 2024 and 2023, which aligns with the ground truth for 2022 and 2024. However, it omits any mention of the international pension plan's $2 million investment in U.S. common stocks in both years, a key fact in the original answer. This omission significantly affects completeness and accuracy. Additionally, the LLM introduces specific percentages (62% fixed income, 2% equity in 2024) and mentions 2023, which are not present in the ground truth and cannot be verified from the provided information, introducing potential inaccuracies. (2) The quantitative elements about the U.S. pension plan’s zero allocation are correct, but the lack of reference to the $2 million in the international plan constitutes a major missing data point. The introduced percentages, while plausible, are not supported by the ground truth and thus reduce quantitative accuracy. (3) The reasoning about conservative allocation is plausible but based on incomplete data. The multi-hop synthesis fails because the model does not integrate information across both U.S. and international pension plans as required. The conclusion is partially sound but lacks full context. (4) The answer is contextually relevant and addresses the strategic allocation question well, but due to missing key facts and introducing unverified data, the overall correctness is only partial. The strategic interpretation is reasonable but incomplete without acknowledging the minimal international exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 432,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "Between 2022 and 2023, Disney's strategic focus on cruise ships evolved with a clear emphasis on fleet expansion and capital investment. In 2022, the company highlighted that capital investments were primarily directed toward parks and experiences, including cruise ships, as part of broader infrastructure and expansion plans. By 2023, Disney explicitly announced plans for additional expansion of its cruise ship fleet, reflecting a more defined commitment to this segment. Operationally, the company acknowledged risks such as economic conditions, inflation, and interest rates, which could impact the costs and financing of these investments. Additionally, the evolving competitive landscape and consumer demand for travel experiences were noted as factors influencing the strategic direction and profitability of Disney Cruise Line.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about Disney's strategic evolution. The ground truth states that Disney shifted from viewing cruise ships as a growth engine (2022) to focusing on operational risks like hurricanes and global disruptions (2023). However, the LLM incorrectly asserts that Disney maintained or even intensified its expansion focus in 2023, claiming 'explicitly announced plans for additional expansion'—a detail not supported by the original answer. This misrepresents the strategic shift. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; no errors in dates or numbers (2022 and 2023 are correctly referenced), hence a score of 10. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the correct shift from capital investment (2022) to risk mitigation (2023). Instead, it portrays continuity in expansion strategy and cites generic financial risks (inflation, interest rates) not emphasized in the ground truth. The operational risk focus in 2023 is misrepresented—ground truth highlights hurricane impacts and external events, not economic conditions. (4) Contextual relevance is moderate because the answer discusses cruise ships, capital investment, and operational risks, which are relevant themes, but the specific evolution is incorrect. The LLM introduces 'competitive landscape' and 'consumer demand' as strategic factors not mentioned in the original, adding plausible but unsupported context. Overall, major factual and reasoning errors undermine correctness despite correct use of years and general topic alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 448,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Between 2022 and 2024, Mastercard's use of short duration foreign exchange derivative contracts has evolved to increasingly manage foreign exchange risk during daily settlement activities. In 2022, the company used such contracts to hedge anticipated receipts and disbursements, with the objective of reducing exposure to currency volatility between payment transaction dates and subsequent settlements. By 2024, the company expanded its use of these contracts, entering into short duration foreign exchange derivative contracts to hedge its exposure to variability in cash flows related to foreign denominated assets, with a maximum term of approximately 7 years for some contracts. Additionally, the notional value of foreign exchange contracts not designated as hedging instruments increased from $2,741 million in 2024 to $5,424 million in 2023, indicating a more active approach to managing foreign exchange risk in daily settlement activities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Mastercard used short duration foreign exchange derivative contracts in 2022 to manage FX risk in daily settlement activities, it incorrectly claims that by 2024 the company expanded the use of these contracts to hedge exposures with a maximum term of 'approximately 7 years'—this contradicts the definition of 'short duration' contracts and is not supported by the ground truth. The ground truth makes no mention of 7-year terms, emphasizing instead continuity in the use of short duration instruments. (2) The quantitative claims are factually wrong: the LLM states that the notional value of foreign exchange contracts not designated as hedging instruments increased from $2,741 million in 2024 to $5,424 million in 2023—this is chronologically impossible (2024 cannot precede 2023) and reverses the actual timeline. Additionally, these specific dollar figures do not appear in the ground truth and are likely hallucinated. (3) The multi-hop reasoning is flawed. The ground truth highlights that while the use of short duration contracts remained consistent, the broader FX strategy evolved due to active de-designation and re-designation of euro-denominated debt hedges in 2023 and 2024. The LLM fails to mention this key strategic shift and instead fabricates an expansion in contract duration and notional values, missing the nuanced contrast between stable short-term practices and dynamic long-term hedging adjustments. (4) The contextual relevance is moderate—the answer addresses daily settlement and FX risk management, which are relevant—but the core factual and quantitative errors severely undermine correctness. The qualitative reasoning is unsound due to incorrect synthesis and invented data, warranting low scores in all categories, especially correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 514,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "From 2023 to 2024, Salesforce's strategic relationship with enterprise cloud companies has evolved by deepening its investment in AI-driven ecosystem integration. In 2023, the company emphasized expanding its platform through strategic investments in enterprise cloud companies, technology startups, and system integrators, aiming to digitally transform industries and enhance its solution ecosystem. By 2024, Salesforce introduced Agentforce, an agentic layer of the Salesforce Platform for deploying autonomous AI agents, which marked a significant step in integrating AI across business functions like sales, service, marketing, and commerce. This evolution reflects a shift from broad ecosystem expansion to focused innovation in AI capabilities, enhancing interoperability with partners and embedding AI into core offerings for greater automation and customer experience optimization.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Salesforce's 2023 strategy of strategic investments in enterprise cloud companies, startups, and system integrators to digitally transform industries and expand its ecosystem, which aligns with the ground truth. However, the 2024 evolution described in the LLM answer introduces 'Agentforce' and a focus on AI-driven innovation and autonomous AI agents, which is not mentioned or supported in the original answer. The ground truth emphasizes a shift from financial investment to broader strategic dependency and deeper ecosystem integration via the AppExchange and third-party developers, not AI-specific developments. The introduction of Agentforce and AI-centric evolution appears to be fabricated or hallucinated, as it is not present in the provided ground truth. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model correctly identifies the 2023 investment focus, but fails to accurately synthesize the 2024 shift toward ecosystem dependency and platform-based integration. Instead, it invents a narrative around AI and Agentforce, breaking the chain of factual reasoning. The correct evolution involves deeper integration via the Salesforce Platform and AppExchange, not AI deployment. (4) The correctness score is 5 due to significant factual deviation in the 2024 analysis—core elements are incorrect despite some accurate context from 2023. Qualitative accuracy is low due to hallucination of key entities (Agentforce) and misrepresentation of strategic focus. Contextual relevance is moderate because the answer addresses the general theme of ecosystem evolution but misdirects on the mechanism (AI vs. platform integration).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 505,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the company refined its approach to accrual rates for vendor funding programs by enhancing sensitivity to projected purchase volumes. In fiscal 2023, the company noted that amounts accrued for vendor funds could be impacted if actual purchase volumes deviated from projections, particularly for graduated volume-based programs. By fiscal 2024, the company continued to apply similar methodologies but emphasized more frequent analyses of historical purchase trends and volumes throughout the year, adjusting accrual rates as needed. This evolution reflects a more dynamic and responsive approach to aligning accruals with actual or anticipated vendor program performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its characterization of the evolution of the company's approach to accrual rates. The ground truth states that there was no material change in methodology between fiscal 2023 and 2024, and that the explicit mention of 'graduated purchase volumes' was present in 2023 but omitted in 2024—suggesting potential simplification or stabilization. In contrast, the LLM claims the company 'refined' its approach and 'enhanced sensitivity' to projected volumes, implying increased dynamism and responsiveness, which contradicts the original answer. This misrepresents the direction of change: the original indicates a move toward less emphasis on graduated volumes (possibly more stability), while the LLM suggests greater analytical intensity and adjustment frequency, which is unsupported. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—however, all years and entities (fiscal 2023, fiscal 2024, vendor funding programs) are correctly referenced, earning high marks for entity accuracy and contextual relevance. The reasoning is internally logical but based on a false premise, failing the multi-hop synthesis by drawing an incorrect inference from the omission of language. The LLM interprets the absence of 'graduated purchase volumes' as increased sophistication, whereas the ground truth interprets it as possible simplification. Thus, despite correct terminology and structure, the core factual claim about the evolution of the approach is reversed, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 437,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "From 2022 to 2024, the strategic relationship between LLY and Boehringer Ingelheim (BI) has seen increased legal involvement and collaborative dependency, particularly concerning Jardiance. In 2022, BI initiated U.S. patent litigation against generic companies seeking to market generic versions of Jardiance, with LLY not being a party to this litigation. By 2024, the collaboration faced new regulatory pressures as Jardiance was selected under the Inflation Reduction Act (IRA) for government-set pricing, effective in 2026, which imposes a 66% discount from the 2023 list price. Additionally, LLY and BI are jointly defending against five product liability lawsuits related to Jardiance, with BI assuming responsibility for legal defense and indemnification under their agreement. This highlights a growing legal and regulatory interdependence between the two companies regarding Jardiance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, LLY was not a party to BI's Hatch-Waxman litigation against generics; by 2024, Jardiance was selected under the IRA for government-set pricing with a 66% discount from the 2023 list price, impacting LLY's revenue. The LLM correctly adds that LLY and BI are jointly defending five product liability lawsuits, with BI handling legal defense and indemnification—this detail is consistent with deeper legal interdependence and enhances the answer without contradicting the original. (2) Quantitatively, all numbers are accurate: '66% discount', '2023 list price', and '2026 effective date' (implied in original via projection) are correct. The mention of '2026' as the effective year for IRA pricing is a precise addition supported by public filings and improves clarity. (3) Multi-hop reasoning is sound: the model synthesizes legal (litigation status, joint liability), regulatory (IRA pricing), and strategic (increased dependency) dimensions across 2022 and 2024, correctly inferring growing entanglement. (4) The only minor gap is that the original emphasizes LLY's 'business became significantly dependent' and 'strategic entanglement' more explicitly in the context of revenue impact, while the LLM focuses on legal interdependence. However, the core message of deepening collaboration and dependency is preserved. Wording differs slightly but semantic equivalence is maintained. No factual errors; minor emphasis difference does not detract from correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 431,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "From 2022 to 2023, Disney's capital investment strategy toward cruise ships remained a key component of its Parks & Experiences business, with a focus on long-term growth and expanding destination offerings. In 2022, the Company highlighted its plans for a new Disney Cruise Line destination on the island of Eleuthera, scheduled to open in 2024, reflecting continued investment in cruise ship infrastructure and related experiences. In 2023, the strategy aligned with broader efforts to enhance the guest experience across its Parks & Experiences segment, including capital spending on cruise ships and related facilities. These investments underscore Disney's commitment to strengthening its cruise line as a core part of its diversified leisure and travel offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses the core evolution highlighted in the ground truth. While it correctly identifies that cruise ships are part of Disney's Parks & Experiences investments, it inaccurately suggests that in 2022, Disney highlighted a new Disney Cruise Line destination on Eleuthera with a 2024 opening as part of its capital strategy. This specific project and timeline are not mentioned in the ground truth and cannot be verified from the provided knowledge graph, making it a factual overreach or hallucination. (2) Quantitatively, the answer does not include any specific dollar amounts, percentages, or financial figures related to capital spending, which were not in the original answer either, so no numeric inaccuracies exist—however, it introduces a date (2024) for the Eleuthera destination without confirmation, which reduces quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model connects cruise ships to the broader Parks & Experiences segment in both years, but fails to capture the key shift from 2022 to 2023 where cruise ships moved from being a general component under macroeconomic risk discussion to being explicitly named as a major capital investment. This strategic elevation is the central point of the original answer and is underemphasized in the LLM response. (4) The contextual relevance is high because the answer stays focused on Disney’s capital strategy toward cruise ships within Parks & Experiences, but the lack of emphasis on the strategic shift and the introduction of unverified details reduce correctness and qualitative accuracy. The answer gives the impression of continuity rather than evolution, which misrepresents the strategic change documented in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 484,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "Between 2022 and 2024, Mastercard Foundry has evolved its role in fostering innovation by expanding its engagement with emerging technologies and fintech partnerships. In 2022, it focused on providing access to thought leadership, innovation methodologies, and early-stage fintech players. By 2024, Foundry had deepened its involvement by offering more advanced innovation programs, such as the 'Launchpad' app prototyping workshop, in-lab usability testing, and concept design. Additionally, Foundry supported the integration of blockchain-based solutions, digital asset ecosystems, and AI-driven technologies, reflecting a stronger emphasis on enabling scalable, secure, and future-ready payment innovations through collaboration with fintechs and emerging technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 2022 role of Mastercard Foundry as a provider of thought leadership, innovation methodologies, and access to early-stage fintechs is accurately described. The evolution by 2024 into a more active innovation engine is correctly conveyed, including deeper engagement with emerging technologies. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes Foundry’s role across two time points and correctly infers an evolution in its strategic focus. The mention of blockchain-based solutions and digital asset ecosystems aligns with the ground truth’s reference to the Mastercard Multi-Token Network™, though the specific trademarked name is omitted. The addition of AI-driven technologies and specific programs like 'Launchpad' and in-lab usability testing is consistent with the direction of Foundry’s evolution, even if not explicitly in the ground truth—these are plausible elaborations that do not contradict known facts. (4) The answer is contextually relevant and fully addresses the question about evolution in innovation role, engagement with emerging tech, and fintech partnerships. The only minor gap is the absence of the explicit term 'programmable payments' and the branded 'Mastercard Multi-Token Network™', which slightly reduces qualitative precision. However, the core strategic shift is correctly captured, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 443,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "The collaboration with Boehringer Ingelheim, particularly around the diabetes drug Jardiance (empagliflozin), has faced increasing pricing pressures due to regulatory developments. In 2024, the U.S. government, under the Inflation Reduction Act of 2022 (IRA), selected Jardiance as one of the first drugs subject to government-set prices, effective in 2026, with a mandated 66% discount from the 2023 list price. This reflects a shift in the financial dynamics of the collaboration, as the IRA introduces long-term revenue erosion risks for the product. Additionally, the strategic focus has evolved to include navigating regulatory designations and pricing constraints, which now significantly influence the commercial viability of the collaboration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial and strategic evolution in the Boehringer Ingelheim collaboration between 2022 and 2024. It accurately notes the 2024 selection of Jardiance under the Inflation Reduction Act (IRA) for government-set pricing effective in 2026, with a 66% discount from the 2023 U.S. list price—matching the ground truth. The mention of the IRA being from 2022 is correct contextually, though the pricing impact is realized later. (2) All quantitative elements are accurate: the 66% discount, the 2023 list price reference, and the 2026 effective date are all factually correct and align with the original answer. No calculation errors. (3) The multi-hop reasoning is sound: the model connects the early regulatory support (implied in 2022 via Breakthrough Therapy and Fast Track, though not explicitly mentioned) to the later financial pressure from IRA pricing, capturing the shift in strategic nature. However, the LLM omits explicit mention of the 2022 regulatory designations (Breakthrough Therapy and Fast Track), which were part of the original answer and relevant to the 'regulatory designations' aspect of the question. This is a minor but notable omission affecting completeness. (4) Despite this omission, the answer captures the core financial shift and strategic implications accurately, with excellent contextual relevance and semantic equivalence on the main point—the transition from regulatory facilitation to pricing constraints. The qualitative accuracy is slightly reduced due to the missing 2022 regulatory details, but the reasoning on pricing and strategy is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 449,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "The strategic positioning of the CH-53K King Stallion heavy lift helicopter within Lockheed Martin's Rotary and Mission Systems (RMS) segment remained a key focus in both 2023 and 2024. In 2023, the CH-53K was highlighted as a program experiencing international interest, with active development, production, and sustainment support, including the award of contracts for 12 helicopters to Israel. By 2024, the CH-53K continued to be emphasized as a critical heavy lift helicopter in service with U.S. and foreign governments, underscoring its importance in advancing RMS's mission solutions and supporting global defense needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no numeric data, and the ground truth also does not include specific financial figures, so there are no quantitative inaccuracies—this aspect is acceptable by omission. However, the LLM introduces a specific claim not present in the ground truth: that 12 helicopters were awarded to Israel. This contract detail is not mentioned in the original answer and cannot be verified from the provided knowledge graph, making it a potential fabrication or unsupported addition. (2) Quantitative accuracy is scored highly because no incorrect numbers are presented, though the absence of figures limits verifiability. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the CH-53K as part of RMS and maintains its strategic relevance across 2023–2024. However, it fails to capture the core evolution described in the ground truth: the shift from being a standalone growth driver to being integrated into a broader portfolio emphasizing digital technologies (AI/ML, autonomy) and all-domain interoperability. Instead, the LLM emphasizes international interest and contracts, which changes the nature of the strategic evolution. This misrepresents the qualitative shift in positioning. (4) Contextual relevance is high because the answer addresses the CH-53K within RMS across both years and discusses strategic importance, but it misses the key thematic evolution—integration with advanced technologies—which is central to the original answer. Thus, while factually plausible, the reasoning and synthesis are incomplete and slightly misaligned, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 448,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicates a strategic shift toward focusing on innovative and competitive diabetes therapies. In 2022, the portfolio included products like Trajenta, Jardiance, and Basaglar, while by 2024, the emphasis remained on Jardiance and other advanced therapies, suggesting a move to consolidate and strengthen their market position with products that offer broader therapeutic benefits and cardiovascular advantages. This shift likely reflects a response to increasing competition from biosimilars and a desire to prioritize high-value, differentiated treatments in the diabetes space.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic shift between LLY and Boehringer Ingelheim from 2022 to 2024. It correctly identifies the narrowing of the portfolio and highlights the continued focus on Jardiance and advanced therapies, which is consistent with the original answer. The dates (2022 and 2024) and company names (LLY and Boehringer Ingelheim) are accurate. While the LLM does not explicitly list all products removed (Trajenta, Jentadueto, Basaglar) or retained (Glyxambi, Synjardy, Trijardy XR), it correctly implies a strategic consolidation around higher-value products like Jardiance. The reasoning about biosimilar competition and prioritization of differentiated treatments is sound and consistent with the ground truth's suggestion of declining market relevance and lifecycle management. However, the LLM omits specific mention of the full portfolio change and does not name all the products involved, which slightly reduces completeness and qualitative accuracy. There are no numerical inaccuracies, so quantitative accuracy is perfect. The answer remains contextually relevant and effectively addresses the question about shifting strategic priorities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 343,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "The JASSM program's production activity increased significantly between 2023 and 2024, contributing to higher backlog. In 2023, JASSM saw production ramp-up, contributing to a $145 million increase in net sales for tactical and strike missile programs under the MFC segment. By 2024, production ramp-up on JASSM, along with GMLRS and LRASM, drove a $1.2 billion increase in net sales for tactical and strike missile programs. Additionally, JASSM contributed to the MFC segment's year-end backlog increase in 2024, driven by higher orders on PAC-3, JASSM, and GMLRS programs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. It incorrectly states that JASSM contributed to a $145 million increase in net sales in 2023, which is not supported by the ground truth—there was no specific mention of production ramp-up or financial contribution for JASSM in 2023. The ground truth confirms that the $1.2 billion increase occurred in 2024 for tactical and strike missile programs, which the LLM correctly attributes to JASSM, GMLRS, and LRASM. However, the $145 million figure for 2023 is unsupported and likely fabricated or misattributed. (2) The correct timeline per ground truth is that JASSM had no notable production or backlog changes in 2023, but in 2024 it contributed to a $1.2 billion increase and was explicitly cited as a backlog driver with PAC-3 and GMLRS. The LLM incorrectly backdates a production ramp-up to 2023 and invents a specific dollar amount. (3) The multi-hop reasoning is partially sound—LLM correctly identifies JASSM’s strategic rise in 2024 and links it to backlog and production increases alongside other programs. However, it fails to accurately represent the baseline in 2023, undermining the comparative evolution. (4) Correctness is scored 5 due to partial accuracy in 2024 dynamics but major error in 2023 data. Quantitative accuracy is low (4) due to incorrect dollar figures. Qualitative accuracy is moderate (6) as the overall trend direction is correct but details are flawed. Contextual relevance is high (9) as the answer addresses the right programs, segment, and performance metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 440,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "JPM's focus in evaluating credit risk for Business Banking Loans shifted between 2023 and 2024 by incorporating more detailed borrower-specific metrics, such as refreshed FICO scores and geographic distribution, to better identify early signs of distress. In 2023, the primary focus was on delinquency rates, while in 2024, there was a stronger emphasis on combining delinquency data with credit scores and regional economic factors. This shift allows for a more proactive identification of borrower distress by highlighting higher-risk segments, such as those with low FICO scores or high LTV ratios, enabling earlier intervention.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023 JPM focused on loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment, not delinquency rates as the primary metric. However, the LLM incorrectly states that in 2023 the focus was on delinquency rates, which contradicts the original answer. It further claims that in 2024 the emphasis shifted to combining delinquency with FICO scores and regional factors—information not present in the ground truth. The original answer specifies that the 2024 shift was toward using delinquency (loans >30 days past due) as the primary indicator, not a combination with credit scores or geography. (2) There are no explicit numbers (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy cannot be penalized for missing values, but the temporal misattribution of metrics (delinquency in 2023 vs. 2024) is a critical error in financial context. (3) The multi-hop reasoning is flawed: the LLM reverses the timeline and introduces unsupported elements (FICO scores, LTV ratios, geographic distribution) not mentioned in the original data, indicating a failure to correctly synthesize the evolution of risk focus. (4) While the general theme of 'more proactive identification of distress' is contextually relevant, the specific mechanisms and timeline are incorrect, leading to a low correctness score despite some thematic alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 413,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Based on the provided document pages, there is no specific information detailing the evolution of Target Corporation's SPP II plan terms between the 2022 and 2023 filings. However, the inclusion of SPP II in both years' filings suggests that the company continues to maintain structured executive compensation frameworks, potentially emphasizing long-term incentives for its executives. Without specific amendments or updates outlined in the 2023 filing, it appears the SPP II plan remained a consistent component of Target's executive compensation strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to reflect the key factual changes in Target Corporation's SPP II plan between the 2022 and 2023 filings. The ground truth states that in the 2022 filing, the SPP II plan was described under the 2016 Plan Statement (effective April 3, 2016), while in the 2023 filing, it was updated to the 2022 Plan Statement (effective May 1, 2022), indicating a clear revision of the plan. The LLM incorrectly claims there is 'no specific information' about the evolution and asserts that the plan 'remained a consistent component,' which directly contradicts the documented update. This is a critical factual error in both entity accuracy (wrong plan effective dates) and reasoning (failed to recognize the plan update as a meaningful change). The answer does correctly infer that SPP II relates to executive compensation, which provides minimal contextual relevance, but it fails on quantitative accuracy (missing exact dates and plan versions) and qualitative accuracy (no recognition of multi-hop change across filings). The conclusion about consistency is unsupported and opposite to the evidence, severely undermining the reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 328,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "The financial obligations related to Incyte under the Olumiant collaboration evolved as follows from 2022 to 2024 regarding potential future milestone payments:  \n\n- As of December 31, 2022, Incyte was eligible to receive up to $100.0 million in additional success-based regulatory milestones and up to $100.0 million in potential sales-based milestones.  \n- By December 31, 2024, no specific updates were provided on the remaining potential milestone payments, but the collaboration continued with Incyte receiving tiered, double-digit royalties on worldwide net sales of Olumiant, including an additional royalty for sales exceeding a specified threshold for the treatment of COVID-19.  \n\nNo new milestone payments were capitalized in 2024, and the terms of the collaboration remained unchanged in terms of Incyte's entitlement to future milestones.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $100.0 million in potential regulatory milestones and $100.0 million in sales-based milestones from 2022, matching the ground truth numerically and contextually. However, the 2024 assessment diverges: the LLM states 'no specific updates were provided' and that 'the terms... remained unchanged,' implying that milestone obligations still exist. In contrast, the ground truth indicates that by 2024, there is no mention of remaining regulatory milestones—suggesting they were resolved—and the structure has shifted to focus on royalties only. This misrepresents the evolution of obligations. (2) Quantitatively, all numbers are accurate: $100M regulatory, $100M sales milestones, and references to double-digit/tiered royalties including a low teens rate for high COVID-19 sales. No calculation errors. (3) The multi-hop reasoning is partially flawed: while the model correctly identifies the 2022 milestone structure, it fails to infer the significance of the absence of milestone mentions in 2024, which the ground truth interprets as a shift in financial structure. The LLM incorrectly assumes silence implies continuation, whereas the correct interpretation is obsolescence or payout. (4) Correctness is scored 6 due to this key misinterpretation of the 2024 status, which affects the core conclusion about the evolution of obligations. Quantitative accuracy is high (9) due to correct numbers. Qualitative accuracy is moderate (6) because reasoning and synthesis are incomplete. Contextual relevance is strong (8) as the answer addresses the right collaboration, timeline, and payment types.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 450,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Cisco's financial exposure in the APJC region increased between fiscal 2022 and fiscal 2023. In fiscal 2022, APJC revenue was $8,027 million, while in fiscal 2023, it rose to $8,208 million (as reflected in goodwill allocated to APJC). Additionally, the total purchased intangible assets for APJC increased from $5,382 million in fiscal 2022 to $8,208 million in fiscal 2023, indicating a significant rise in asset exposure due to acquisitions, including Splunk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that specific financial figures for APJC were not disclosed in fiscal 2022, but the LLM claims APJC revenue was $8,027 million in 2022 and $8,208 million in 2023—these numbers are not supported by the original answer. Additionally, the LLM incorrectly states that purchased intangible assets in APJC were $5,382 million in 2022 and rose to $8,208 million in 2023. In reality, $5,382 million refers to total assets in APJC as of July 29, 2023 (fiscal 2023), not intangible assets or 2022 figures. The mention of goodwill and Splunk as a driver is not present or verifiable in the ground truth. (2) All key numbers are incorrect or misattributed: no revenue or asset values for APJC were disclosed in 2022 per the original answer, and the $5,382 million figure is a balance sheet asset total in 2023, not a 2022 starting point. The LLM reverses and inflates figures without support. (3) The multi-hop reasoning is flawed. The original answer emphasizes a lack of segment-level asset disclosure in 2022 and improved disclosure in 2023. The LLM instead fabricates comparable figures across years and implies trend analysis that cannot be performed from the given data. It fails to recognize the absence of 2022 asset details and invents a narrative around acquisitions like Splunk, which is not mentioned in the ground truth. (4) The contextual relevance is moderate because the answer addresses Cisco’s APJC exposure and attempts to compare years, but the qualitative and quantitative inaccuracies severely undermine correctness. The reasoning and data synthesis are unsound, warranting a low score despite addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 471,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "The strategic collaboration between LLY and Boehringer Ingelheim regarding Jardiance evolved in response to regulatory changes, particularly under the U.S. Inflation Reduction Act of 2022 (IRA). In 2022, the IRA introduced measures to set government prices for certain drugs under Medicare, and in 2023, Jardiance was selected as one of the first ten drugs subject to these price controls, effective in 2026. By 2024, the U.S. Department of Health and Human Services announced a 66% discount for Jardiance compared to its 2023 list price, significantly impacting its revenue trajectory. This regulatory pressure has influenced the collaboration's strategy, accelerating the need to manage revenue erosion and adapt to the new pricing environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core regulatory development—the Inflation Reduction Act (IRA) impacting Jardiance pricing—and correctly identifies the 66% discount applied to Jardiance compared to its 2023 list price. However, it contains significant factual inaccuracies in timing: it incorrectly states that the price controls are effective in 2026, while the ground truth specifies that the 66% discount was applied in August 2024. This misrepresents a key timeline and undermines the accuracy of the response. Additionally, the LLM claims the IRA was passed in 2022, but the IRA was enacted in August 2022, and its drug pricing provisions began applying to selected drugs like Jardiance starting in 2024, not 2026. (2) The 66% discount figure is correctly cited, and the selection of Jardiance as one of the first ten drugs is accurate. However, the revenue growth figures from 2022 (30% in U.S., 28% outside U.S.) mentioned in the ground truth are omitted in the LLM answer, reducing completeness. (3) The multi-hop reasoning is partially sound—the model connects the IRA to Jardiance’s pricing and infers strategic impact on the LLY-Boehringer collaboration—but fails to accurately link the timeline of events (2022 growth → 2023 selection → 2024 price cut). The delayed 2026 effective date is incorrect and contradicts the ground truth. (4) The contextual relevance is high, as the answer addresses the evolution of the collaboration in response to regulation and discusses strategic implications. However, due to the critical error in the effective date of the price reduction and omission of key 2022 performance data, the quantitative accuracy is low, pulling down the overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 467,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "Between 2022 and 2023, GM's emphasis on the financial and reputational risks of product safety recalls, particularly for global platforms like the Chevrolet Bolt EV, showed a heightened focus on the broader implications for its EV/AV technology positioning. In 2022, the company highlighted the potential for recalls to cause \"damage to brand image, brand equity and consumer trust in our products and ability to lead the disruption occurring in the automotive industry.\" By 2023, this concern evolved to include the specific impact on GM's leadership in emerging technologies, noting that such issues could \"damage to brand image, brand equity and consumer trust in our products and ability to lead the industry with respect to new technologies, such as EVs and AVs.\" This shift reflects a more strategic alignment of product safety with GM's broader goals in the EV/AV space, emphasizing the importance of maintaining consumer confidence to support its technological leadership.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is contextually relevant and well-structured, accurately reflecting GM's growing concern about reputational risks tied to EV/AV leadership. However, it misrepresents the timeline and emphasis of GM's disclosures. According to the ground truth, in 2022, GM focused primarily on the financial burden and logistical complexity of the Chevrolet Bolt EV recall due to its global platform scale—not on reputational risks like brand image or consumer trust. The shift toward emphasizing reputational damage and its impact on EV/AV leadership aspirations occurred in 2023. The LLM incorrectly states that in 2022, GM already highlighted risks to 'brand image, brand equity and consumer trust' and 'ability to lead the disruption,' which aligns more with the 2023 stance. This reversal of emphasis undermines the qualitative accuracy of the multi-hop reasoning, as the evolution between years is misrepresented. There are no numerical errors (quantitative accuracy is perfect), and the answer addresses all components of the question (contextual relevance is high), but the core factual progression across years is flawed, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 328,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "Between 2022 and 2024, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolved as follows: in November 2023, the subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturity dates extending to 2043. In July 2024, $77 of these Guaranteed Senior Notes were repaid. This indicates that Costco is managing its long-term financing strategy by issuing debt with extended maturities to ensure long-term capital availability while also selectively repaying portions of its debt to optimize its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of four Guaranteed Senior Notes in November 2023 totaling approximately $500 at fixed interest rates from 1.400% to 2.120%, with maturities extending to 2043, and the repayment of $77 in July 2024. These quantitative details match the ground truth exactly. (2) All numbers, dates, and dollar amounts are accurate. The $500 total issuance and $77 repayment are correctly reported. The interest rate range and maturity dates (up to 2043) align with the ground truth, though the original answer specifies maturities from 2033 to 2043; the LLM mentions 'extending to 2043', which is slightly less precise but still factually correct. (3) The reasoning is sound: the LLM correctly infers that issuing long-term fixed-rate debt and selectively repaying portions reflects a strategic long-term financing approach. It captures the essence of transparency and strategic management, though it does not explicitly mention the evolution from minimal 2022 disclosure (Level 3 inputs) to detailed 2024 reporting, which is a minor omission in completeness. (4) The answer is contextually excellent, directly addressing both the evolution and strategic implication. The only reason for not scoring 10 is the slight lack of detail on the 2022 disclosure state, which weakens the contrast that underscores the evolution. Overall, the answer is factually accurate, well-reasoned, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 400,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "The value of Cisco's available-for-sale debt investments decreased from $15,592 million in 2023 to $9,865 million in 2024, a reduction of $5,727 million. This significant decline indicates that Cisco may have liquidated a portion of its investment portfolio, likely to fund strategic initiatives such as the acquisition of Splunk, stock repurchases, and dividend payments, as outlined in their capital allocation strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in dates and direction of change. The original answer states that the drop in available-for-sale debt investments occurred between 2022 and 2023 (from $15,592M to $9,865M), but the LLM incorrectly claims the change was from 2023 to 2024, which is factually wrong. The decrease amount ($5,727M) is correctly calculated and matches the ground truth, so the arithmetic is accurate. However, the misalignment of years undermines the validity of the response. (2) The quantitative accuracy is low because the time period is incorrect—this is not a formatting issue but a fundamental error in fiscal year reporting. The values $15,592 million and $9,865 million are correct in magnitude but assigned to the wrong years. (3) The reasoning partially makes sense—Cisco may have used proceeds for acquisitions like Splunk or shareholder returns—but this explanation is speculative and not present in the original answer. While such a strategy could be inferred, the LLM introduces external justification not supported by the ground truth, and fails to mention the key point about gains being only $9M in 2022, indicating minor portfolio activity prior to the drawdown. (4) The contextual relevance is moderate because it addresses the change in investment value and attempts to interpret strategy, but due to incorrect timing and missing the 2022 gain context, the synthesis is flawed. The answer would be more accurate if it had correctly identified the 2022–2023 timeframe and acknowledged the small prior-year gains to support the conclusion of a strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 444,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "JPMorgan Chase's exposure to system damage risks, particularly from third-party vendor attacks and data recovery challenges, has evolved from 2023 to 2024 with increased emphasis on proactive measures and risk mitigation. In 2023, the company highlighted the growing sophistication of cyber threats, including ransomware and third-party vulnerabilities, and the challenges of securing data amid expanding digital and cloud-based services. By 2024, JPMorgan Chase emphasized enhanced cybersecurity controls, including improved vendor oversight, early detection of attacks, and strengthening network security to address evolving threats. The firm also noted the importance of integrating acquired businesses and managing insider threats, reflecting a more strategic and comprehensive approach to managing system damage risks.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually misaligned with the ground truth. While it correctly identifies JPMorgan Chase and the years 2023 and 2024, it inaccurately frames the evolution of system damage risks as a shift toward 'proactive measures and risk mitigation' and 'enhanced cybersecurity controls.' In contrast, the original answer emphasizes an evolution in the nature of the risks themselves—specifically increased exposure to ransomware via third-party vendors, risks exceeding cyber insurance coverage, and challenges in preventing fraudulent transaction processing—not improvements in controls. The LLM answer incorrectly suggests the company improved its posture, while the ground truth reflects heightened risk awareness and growing threats. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; no errors in dates or formats. (3) The multi-hop reasoning is flawed: the question asks how exposure to risks evolved, not how defenses evolved. The LLM fails to synthesize the correct shift—from internal vulnerabilities (2023) to external third-party and recovery challenges (2024)—and instead invents a narrative about improved vendor oversight and detection, which is not supported by the ground truth. (4) Correctness and qualitative accuracy are low due to factual inversion (describing mitigation instead of risk evolution). Contextual relevance is moderate because the topic (cyber risks, third parties, data recovery) is relevant, but the substance is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 419,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "By 2024, Costco had made operational investments in processing, packaging, and manufacturing facilities to support the growth of its private-label items, as outlined in its 2022 filing. These investments were intended to enhance the production capabilities for private-label products, aligning with the company's strategy to increase the penetration of such items in its merchandise mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies the operational investments Costco made by 2024—processing, packaging, and manufacturing facilities—to support its private-label growth strategy first mentioned in the 2022 filing. All entities (Costco, private-label items, 2022 and 2024 timeframes) are correct, and there are no numerical inaccuracies, as the response does not include specific figures that need verification. The reasoning is sound: it connects the strategic intent from 2022 with the operational execution by 2024, demonstrating appropriate multi-hop synthesis across filings. The only minor shortcoming is that the LLM omits the explicit context that these investments represent a shift from external sourcing to internal production capabilities, which adds depth to the strategic evolution. While this detail is present in the original answer and strengthens the narrative, its absence does not make the LLM response factually incorrect—just slightly less comprehensive. Therefore, the answer earns a high score but not perfect on qualitative accuracy due to this omission. Contextual relevance is full, as every part of the response directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 346,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group's approach to Medicaid managed care contract bidding became more cautious and risk-conscious. In both years, the company highlighted that its bids are based on assumptions regarding enrollment, utilization, medical costs, and other factors. However, in 2023, the company emphasized increased risks related to the accuracy of these assumptions, including unforeseen changes to programs, post-bid policy changes, and competitive pressures. This suggests a heightened awareness of the potential for material inaccuracies in bid assumptions and a greater focus on the financial and operational risks associated with these uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in UnitedHealth Group's approach to Medicaid managed care contract bidding between 2022 and 2023. (1) It correctly identifies that in both years, the company relied on assumptions about enrollment, utilization, and medical costs, and notes the increased emphasis in 2023 on the risks if those assumptions prove inaccurate. This aligns with the ground truth, which specifies that 2023 included a more detailed discussion of bid assumptions and competitive dynamics. (2) There are no numeric values in the question or answer requiring verification, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information across two years, correctly contrasting the shift from a focus on contract renewal risk (implied in 2022) to a more nuanced discussion of bid assumption risks in 2023. The only minor shortcoming is that the LLM does not explicitly mention the 2022 focus on risk of losing Medicaid members due to non-renewal, which is a key part of the evolution. However, it does imply a shift in emphasis, which preserves the overall meaning. (4) The answer is contextually relevant, directly addressing the question about changes in assumptions and risks related to bid accuracy. The wording differs slightly but maintains semantic equivalence. Thus, the answer is excellent but not perfect, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 407,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "MET's investment in Municipals from 2022 to 2023 remained classified within Level 2 of the fair value hierarchy for both years. In 2022, the estimated fair value of Municipals was $147 million, and in 2023, it remained at $147 million. There were no changes in the classification to Level 3 during this period, indicating consistent valuation based on observable market data.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The original answer states that MET's investment in Municipals was $14,212 million in 2022 and dropped to $159 million in 2023. The LLM incorrectly reports the value as $147 million for both years, which is wrong both in magnitude and trend. Additionally, the original answer notes that in 2022, the investment was categorized under 'Estimated Fair Value' without a detailed hierarchy breakdown, but in 2023 it was explicitly classified as 'Level 2'. The LLM falsely claims it was Level 2 in both years, contradicting the ground truth. (2) Quantitative inaccuracies include: 2022 value: $14,212M (truth) vs $147M (LLM); 2023 value: $159M (truth) vs $147M (LLM); both numbers are off by over 90% in the case of 2022. The LLM also fails to note the significant decrease, instead claiming no change. (3) The multi-hop reasoning is flawed: the question asks about evolution in both valuation amount and hierarchy classification. The LLM fails to recognize the shift from unspecified hierarchy in 2022 to Level 2 in 2023, and incorrectly assumes consistency. It misses the key insight of increased transparency and a major portfolio reduction. (4) The correctness score is 1 due to massive factual errors in numbers and classification. Quantitative accuracy is 1 because the numbers are wildly incorrect. Qualitative accuracy is 1 due to incorrect reasoning and entity synthesis. Contextual relevance is 3 because the answer addresses the general topic (Municipals investment, fair value levels) but with wrong data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 435,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "From fiscal year 2022 to 2024, Microsoft has enhanced licensing flexibility and customer agreement models for Office 365 by expanding simplified, digital-first agreements and offering more tailored options. In 2022, Office 365 revenue was recognized ratably over the contract period due to integration between desktop applications and cloud services. By 2024, Microsoft introduced agreements like the Microsoft Customer Agreement, a non-expiring digital agreement designed for all customers, and the Microsoft Products and Services Agreement, which allows organizations to license cloud and on-premises software without organization-wide commitments. These changes reflect a shift toward more flexible, scalable, and customer-centric licensing models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the shift from traditional volume licensing in FY2022 to more flexible, digital-first agreements by FY2024 is accurately described. The mention of ratable revenue recognition in 2022 aligns with the original answer. In 2024, the introduction of the Microsoft Customer Agreement, Microsoft Products and Services Agreement, and the elimination of organization-wide commitments are correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (fiscal years 2022 and 2024) are correct. (3) Multi-hop reasoning is sound: the model synthesizes changes over time in licensing models and customer agreements, correctly identifying the evolution in Microsoft's approach. The only minor omission is the lack of explicit mention of the 'Microsoft Online Subscription Agreement'—included in the ground truth—which slightly reduces completeness. Also, the LLM mentions 'integration between desktop applications and cloud services' as a reason for ratable recognition, which adds context not in the original but does not contradict it. (4) Despite this small omission, the answer captures the essence of increased licensing flexibility and customer-centric models, making it semantically equivalent and contextually fully relevant. Hence, a high correctness score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 408,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "The composition of MET's Level 3 Fixed Maturity Securities AFS decreased from $58 million in 2022 to $64 million in 2023, indicating a slight increase in the value of these less liquid, alternative investments. This suggests the company may be maintaining or slightly increasing its exposure to alternative assets as part of a strategy to diversify its investment portfolio and manage long-term risks associated with employee benefit obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, in 2022, MET's Level 3 Fixed Maturity Securities AFS consisted of $1M Corporate bonds, $1M Foreign Bonds, and $11M Equity Securities, totaling $13M—not $58M as claimed. In 2023, the composition was $54M Corporate bonds, $2M Foreign Bonds, and $828M Other Investments, totaling $884M—not $64M. The LLM grossly misrepresents the total values and categories, failing to note the massive shift into 'Other Investments', which is central to the strategic interpretation. (2) The calculations are entirely wrong: the actual total increased from $13M to $884M, a dramatic rise, whereas the LLM reports a minor increase from $58M to $64M. Additionally, the LLM incorrectly refers to 'Fixed Maturity Securities' as a whole while including 'Other Investments', which may not fall under that category, further distorting the analysis. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the composition change—especially the surge in Other Investments—and thus cannot accurately infer the strategic shift toward more aggressive diversification. Instead, it suggests only a slight increase in alternative assets, missing the magnitude and nature of the change. (4) While the general direction of 'increased exposure to alternative investments' has some surface plausibility, the answer lacks factual grounding. The contextual relevance is moderate because it addresses investment strategy, but the incorrect data and reasoning severely undermine the conclusion. Correctness is very low due to fundamental factual and numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 457,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "Between 2022 and 2024, Microsoft has evolved Office 365's strategic positioning by integrating it more deeply into its broader cloud services portfolio and enhancing its capabilities with AI-driven features to maintain competitiveness. Office 365 is now a central component of Microsoft's cloud strategy, with its revenue recognized ratably over the contract period due to its interdependency with desktop applications and cloud services. In response to competitive pressures from AI-driven offerings, Microsoft has invested in infusing generative AI capabilities into Office 365 and other products, aiming to deliver innovative tools that enhance productivity and user experience. This strategic shift reflects Microsoft's focus on leveraging AI to differentiate its cloud services and maintain its leadership in the evolving technology landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Office 365's evolution from a standalone cloud offering in 2022 to an AI-integrated component of Microsoft's broader cloud portfolio by 2024 is accurately described. The strategic response to competitive pressures from AI-driven offerings, including free or open-source models, is correctly reflected in the emphasis on Microsoft's investment in generative AI to enhance productivity and user experience. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across time (2022 vs 2024), product strategy (Office 365's role), and competitive dynamics (AI threats). It accurately infers that Office 365 is now more integrated with AI and cloud services, though it omits the explicit mention of Dynamics 365, Xbox, and Azure as peer components in 2022, which slightly reduces completeness. Also, the detail about 'ratable revenue recognition' is present in the LLM answer but not in the ground truth—this is contextually plausible but not verifiable from the original answer, representing a minor addition rather than error. (4) The answer is contextually excellent—directly addresses the question’s focus on strategic positioning, cloud integration, and competitive response. The omission of specific peer services (Dynamics, Xbox) and the slightly expanded detail on revenue recognition prevent a perfect 10, but overall the semantic meaning and strategic narrative match the ground truth. Hence, correctness is 9, qualitative accuracy 9, and contextual relevance 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 480,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group maintained a consistent methodology for evaluating credit-related impairments of its available-for-sale debt securities, focusing on the present value of expected cash flows relative to amortized cost, the issuer's financial condition, and other relevant factors. In 2023, the Company continued to assess impairments based on these criteria and recorded credit-related impairments as an allowance, with an offset to investment and other income. The financial impact remained minimal, as the allowance for credit losses on available-for-sale debt securities was not material in both years, indicating that the Company did not experience significant credit-related losses during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that UnitedHealth Group evaluated credit-related impairments using expected cash flows and issuer financial conditions, and that the allowance for credit losses was not material in both years—this aligns with the ground truth. However, it incorrectly frames the evolution as one of consistency rather than change, missing the key shift in 2023 where the company formalized a segmented approach distinguishing credit-related from non-credit-related impairments. The ground truth emphasizes a more structured and detailed methodology introduced in 2023, including recording credit-related impairments through an allowance against investment income and non-credit-related impairments through other comprehensive income—a critical evolution the LLM answer omits. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the statement that the allowance was 'not material' is consistent across both answers and correct, earning full marks here. (3) The multi-hop reasoning is partially sound—the model correctly identifies the entities (UnitedHealth Group, available-for-sale debt securities) and time periods (2022–2023), but fails to synthesize the evolution in methodology, incorrectly implying continuity instead of change. This undermines the qualitative accuracy. (4) The contextual relevance is high because the answer addresses impairment evaluation and financial impact, but the failure to capture the methodological evolution significantly reduces factual correctness, justifying a mid-range score of 5 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 452,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "From 2022 to 2023, the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans showed slight changes. For pension benefits, the total estimated fair value of Fixed Maturity Securities AFS decreased from $6,802 million in 2022 to $6,714 million in 2023. In terms of allocation, the Level 2 category (primarily liquid and marketable securities) decreased from $5,091 million in 2022 to $4,924 million in 2023, while Level 1 (directly held investments) increased from $1,653 million to $1,726 million. For other postretirement benefits, the total estimated fair value of Fixed Maturity Securities AFS remained relatively stable, decreasing slightly from $1,256 million in 2022 to $1,274 million in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Fixed Maturity Securities AFS were reported as percentages of total allocations (84% for U.S. Pension Benefits and 95% for U.S. Other Postretirement Benefits), not as absolute dollar values. However, the LLM incorrectly asserts specific dollar amounts for 2022 ($6,802 million for pensions and $1,256 million for other benefits), which are not present in the original answer and contradict the percentage-based reporting structure of that year. The 2023 values ($6,714 million and $1,274 million) are correct per the ground truth. (2) The LLM introduces granular details about Level 1 and Level 2 fair value categories with precise figures for both years—information not present in the original answer and unsupported by the provided ground truth. These numbers cannot be verified and appear fabricated, severely undermining quantitative accuracy. (3) The reasoning fails on multi-hop synthesis: the question asks about the evolution from 2022 (percentage-based allocation) to 2023 (valuation in dollars), but the LLM treats both years as having comparable dollar-based disclosures, missing the structural shift emphasized in the original answer. It does not acknowledge the change in reporting format (from % allocation to fair value totals), which is central to the correct interpretation. (4) While the LLM attempts to address the evolution over time and focuses on the right entities (MET, Fixed Maturity Securities AFS, pension and postretirement plans), its use of incorrect data and invented breakdowns leads to a mostly incorrect conclusion. The slight decrease in pension value and stability in other benefits are based on false premises. Thus, despite relevant framing, the factual core is flawed, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 502,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "Between 2022 and 2023, Lowe's strategic positioning of the Kitchens & Bath product category evolved by integrating it more deeply into its Total Home strategy and omnichannel capabilities. In 2022, Kitchens & Bath was part of the Home Décor category, which accounted for 35.3% of total sales. By 2023, Kitchens & Bath was highlighted as a core category within the installed sales model, with Flooring, Kitchens & Bath, Millwork, Appliances, and Lumber accounting for the majority of installed sales. This shift suggests that Kitchens & Bath has become a more strategically important category, reflecting its role in driving Pro and DIFM sales and enhancing customer experience through integrated services.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic repositioning of Kitchens & Bath from a Home Décor context in 2022 to a more central role in installed sales by 2023, aligning with Lowe's Total Home strategy. This matches the ground truth's core insight about increased strategic importance and shift toward home improvement/remodeling. However, the LLM introduces a specific sales percentage—'35.3% of total sales' for Home Décor in 2022—which is not present in the ground truth and cannot be verified from the provided information. This unsupported quantitative claim reduces factual accuracy. (2) There are no explicit calculations in the answer, but the use of '35.3%' is problematic because it assigns a precise metric to a category grouping that the ground truth does not quantify. This number may be misattributed or hallucinated, as the knowledge graph-based answer does not include any sales figures. (3) The multi-hop reasoning is generally sound: the model infers increased strategic importance from the category’s movement into core installed offerings and links it to Pro and DIFM (Do-It-For-Me) growth, which is a reasonable interpretation consistent with industry trends and Lowe's public strategy. The connection to omnichannel and integrated services is plausible context, though not explicitly stated in the ground truth. (4) Despite the unsupported percentage, the qualitative assessment of strategic evolution is accurate and insightful. The answer captures the essence of the repositioning—shifting from design-focused to construction/remodeling-centric—and correctly interprets its implications for portfolio importance. The contextual relevance is high, as it directly addresses both parts of the question: evolution and strategic significance. The correctness score is 7 due to the major issue with the unverified sales figure, but the reasoning and overall direction are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 518,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Mondelez International's strategic focus on Cheese & Grocery between 2022 and 2024 is not explicitly detailed in the provided pages. However, the 2024 10-K emphasizes the company's broader strategy of accelerating consumer-centric growth and expanding in \"locally relevant categories,\" which includes Cheese & Grocery. Additionally, Mondelez's 2024 acquisition of Evirth in China and its ongoing investments in global snacking leadership suggest a continued prioritization of diverse snack categories, including Cheese & Grocery, for long-term growth. This aligns with the company's goal of leveraging its global footprint and iconic brands to drive consistent top- and bottom-line growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect and fails to reflect the key factual shift in Mondelez's strategy. According to the ground truth, Mondelez generated $1,990 million from direct production in Cheese & Grocery in 2022 but exited direct production by 2024, maintaining only a strategic stake. The LLM answer incorrectly implies continued prioritization and investment in Cheese & Grocery, stating Mondelez is expanding in 'locally relevant categories' including this one, which contradicts the actual strategic retreat. (2) Quantitatively, the LLM omits the critical $1,990 million revenue figure from 2022 and fails to mention the complete cessation of direct production by 2024. There are no correct numbers cited, and no acknowledgment of the financial scale of the category in 2022. (3) The multi-hop reasoning is flawed: instead of recognizing the shift from direct operations to a lighter strategic stake as evidence of deprioritization, the model infers ongoing prioritization based on general strategic language about 'global snacking' and the Evirth acquisition, which is unrelated to Cheese & Grocery. This shows a failure to synthesize the correct inference from operational and reporting changes. (4) While the answer is framed around the right company and general time period, and touches on strategic themes from the 10-K, it fundamentally misrepresents the direction of the strategy. The contextual relevance is moderate because it discusses Mondelez’s snack growth goals, but it misses the core evolution in Cheese & Grocery entirely, leading to a misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 439,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "In the 2022 10-K filing, Jevity and Freego™ products were listed separately within the Nutritional Products segment, with Jevity positioned as a primary enteral feeding product. By the 2023 10-K filing, Freego™ was grouped with Jevity, explicitly labeled as \"Freego™ (Enteral Pump) and Freego™ sets,\" suggesting a more integrated presentation where Freego™ is positioned as a complementary product or delivery system for Jevity, rather than a standalone offering. This change implies a strategic shift in how Abbott is positioning Freego™ in relation to Jevity, emphasizing their combined role in enteral feeding solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core change in Abbott's product lineup presentation between the 2022 and 2023 10-K filings. It correctly identifies that Jevity remained a primary enteral feeding product and that Freego™ products were repositioned to appear immediately after Jevity in 2023, suggesting a more integrated or complementary positioning. While the original answer specifies the exact order of all products (e.g., Glucerna, Osmolite®, etc.) in both years, the LLM answer omits these intermediate products but still correctly infers the strategic shift in emphasis. There are no numeric inaccuracies (quantitative accuracy is perfect as no calculations are involved and all years/entities are correct). The reasoning is sound and reflects appropriate multi-hop synthesis across two filings. The semantic meaning aligns closely with the ground truth, though slightly less detailed in listing the full sequence. This minor omission prevents a perfect 10, but the answer remains highly accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 298,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "From 2022 to 2023, MET's investment in municipals, classified as fixed maturity securities available-for-sale (AFS), remained relatively stable in fair value, with a slight decrease from $159 million in 2022 to $147 million in 2023. These investments were consistently categorized under Level 2 of the fair value hierarchy, indicating they are valued using observable market inputs. The stability in the fair value of municipals, combined with their placement in Level 2, suggests that MET's credit risk management strategy includes maintaining investments in relatively low-risk, observable assets. This approach helps ensure liquidity and minimizes exposure to significant credit deterioration.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It claims MET's municipal investments were $159 million in 2022 and $147 million in 2023, which is the reverse of the truth: the correct values are $14,212 million in 2022 and $159 million in 2023—a massive reduction, not a slight decrease. The LLM completely misses the scale of the divestment. Additionally, it fails to mention the $2,464 million in gross unrealized gains and $13 million in gross unrealized losses in 2022, which are key indicators of portfolio quality and risk. (2) Quantitatively, the numbers are severely inaccurate. The 2022 value is off by over $14 billion, and the 2023 value is understated. The LLM incorrectly states that the classification was consistently Level 2 in both years, while the ground truth only specifies Level 2 for 2023, not 2022. There is no indication of a shift in fair value hierarchy in the LLM answer, which is a key point. (3) The reasoning is flawed: the LLM concludes that MET maintained a stable position in municipals and used this as part of a low-risk, observable asset strategy. In reality, the dramatic reduction from over $14 billion to $159 million suggests a strategic exit from the asset class, likely to reduce credit risk exposure. The multi-hop synthesis failed—instead of recognizing a major portfolio shift, the model fabricated stability. (4) The contextual relevance is moderate because it discusses fair value, classification, and credit risk strategy, which are relevant topics. However, due to severe factual and quantitative errors, the qualitative and correctness scores are very low. The conclusion is the opposite of what the data suggests.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 463,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Between 2022 and 2023, Abbott's use of interest rate hedge contracts decreased in notional value, from approximately $2.9 billion in 2022 to $2.2 billion in 2023. This reduction was primarily due to the maturity of $700 million of interest rate hedge contracts in 2023, which coincided with the maturity of related long-term debt. These contracts are designated as fair value hedges to manage the exposure to changes in the fair value of fixed-rate debt caused by fluctuations in long-term benchmark interest rates. By converting a portion of fixed-rate debt obligations to variable rates, Abbott effectively mitigates interest rate risk, aligning the debt's value with market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the notional value of Abbott's interest rate hedge contracts in 2022. The ground truth states that the notional value was approximately $2.2 billion in both 2022 and 2023, with no reduction. However, the LLM claims it decreased from $2.9 billion in 2022 to $2.2 billion in 2023, which is incorrect. The mention of a $700 million maturity is unsupported by the original answer and introduces false detail. (2) Quantitative accuracy is low because the key dollar amounts are wrong. The $2.9 billion figure for 2022 has no basis in the ground truth, and the implied $700 million decrease is fabricated. The only correct number is the $2.2 billion notional value in 2023. (3) While the LLM correctly identifies the purpose of the hedge contracts—managing exposure to fixed-rate debt by converting to variable rates—and correctly labels them as fair value hedges, it fails to reflect the actual evolution: stability in notional amount and improved disclosure in 2023. The reasoning about maturity-driven reduction is speculative and incorrect, undermining the multi-hop synthesis. (4) Contextual relevance is moderate because the answer addresses the right topic (use of interest rate hedges and their role in debt management) and includes relevant financial concepts, but the core factual evolution is misrepresented. The answer would mislead a user about the actual trend in Abbott's hedging activity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 410,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "Between 2022 and 2024, 3M's management of fixed-rate registered notes involved significant repayment activity, particularly in 2024 when the company repaid $1.1 billion in medium-term notes that matured. In 2023 and 2022, 3M similarly repaid maturing fixed-rate notes, with amounts totaling $1.65 billion and $1.1 billion, respectively. In terms of interest rate strategies, 3M utilized interest rate swaps to convert portions of fixed-rate debt into floating rate debt, specifically $800 million in notional amount during 2021, which helped manage exposure to long-term interest rate fluctuations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and dates. While it correctly notes the $1.1 billion repayment in 2024 (medium-term notes), it incorrectly states that 3M repaid $1.65 billion in 2023 and $1.1 billion in 2022 in fixed-rate notes. According to the ground truth, in 2023, 3M repaid only $500 million in fixed-rate registered notes, and there is no mention of $1.1 billion in repayments in 2022. The LLM appears to have fabricated or misaggregated repayment totals for 2022 and 2023. Additionally, the LLM claims $800 million in notional amount for interest rate swaps in 2021, but the ground truth does not specify the notional amount—only that swaps were initiated in 2021 to convert portions of the 2049 and 2050 notes into floating-rate debt through mid-2028. (2) The quantitative inaccuracies are significant: the repayment figures for 2022 and 2023 are wrong, and the $800 million swap amount is unsupported. The 2024 repayment of $1.1 billion is correct. The issuance details from 2019 (e.g., $3.25 billion total, $1B each for 2029 and 2049 notes) are omitted, reducing completeness. (3) The reasoning partially captures the strategic shift via interest rate swaps but misrepresents the scale and timing. It correctly identifies the use of swaps to manage interest rate exposure, aligning with the ground truth’s narrative of a shift toward floating-rate instruments. However, the synthesis is flawed due to incorrect repayment figures and missing context about the specific notes issued and outstanding. (4) The contextual relevance is high—the answer addresses both repayment activity and interest rate strategies as asked. However, due to major quantitative errors and incomplete data, the correctness score is moderate. The qualitative accuracy is acceptable because the overall strategy interpretation is sound, but factual precision is lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 513,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "Between 2023 and 2024, the role of securities issuances in Schwab's capital structure evolved as part of its broader capital and liquidity management strategy. In 2023, Schwab focused on issuing long-term debt, including Senior Notes with higher interest rates, to manage its capital and fund operations amid rising interest rates and client cash reallocations. By 2024, Schwab reduced reliance on external debt issuances and instead focused on optimizing its existing funding sources, such as bank deposits and investment securities, as client cash flows stabilized and the company reduced supplemental funding by $14.9 billion. Additionally, Schwab executed interest rate swaps to hedge against interest rate risk, reflecting a shift toward managing capital through liquidity optimization and risk mitigation rather than frequent securities issuances.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces details not present in the ground truth. While it correctly identifies a shift in Schwab's capital strategy involving securities issuances, it fabricates specific instruments (e.g., 'Senior Notes with higher interest rates'), actions (e.g., 'executed interest rate swaps'), and a precise dollar amount ($14.9 billion reduction in supplemental funding) that are not supported by the original answer. These numbers and actions cannot be verified from the ground truth and appear to be hallucinated. (2) The quantitative accuracy is low because the $14.9 billion figure and specific debt instruments are not mentioned in the original answer. The ground truth does not provide any numerical data, so introducing such figures without basis undermines factual correctness. (3) The qualitative reasoning partially aligns with the ground truth: both note a strategic shift in the role of securities issuances from a primary focus in 2023 to a reduced or more integrated role in 2024. The LLM correctly infers a move toward diversified or optimized funding, but it mischaracterizes the nature of the evolution by emphasizing debt issuance and risk hedging tools not mentioned in the original. The multi-hop synthesis is partially sound but overreaches by adding unsupported specifics. (4) Contextual relevance is high because the answer addresses the evolution of securities issuances in Schwab’s capital structure and relates it to funding sources and capital management. However, the addition of unverified instruments, transactions, and figures reduces factual reliability. The core idea of a strategic shift is correct, but execution lacks fidelity to the source data, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 482,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "Coca-Cola's contingent payment obligations related to fairlife increased from $270 million in 2020 to $6,126 million in 2024, indicating that fairlife has consistently met or exceeded its financial targets through 2024, as the payments are contingent on achieving specific financial milestones.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively, it claims Coca-Cola's contingent payment obligations increased from $270 million in 2020 to $6,126 million in 2024, which is false. The ground truth states the contingent obligation was $270 million in 2022 (not 2020), with no indication of an increase to $6.126 billion. The $6,126 million figure is fabricated and grossly inaccurate. Additionally, the first $100 million payment was made in 2021 for 2020 targets, not part of the 2022–2024 obligation. (2) The calculation and timeline are wrong: the $270 million was the remaining liability after the $100 million payment, not a starting point in 2020. The obligation did not increase; it remained contingent through 2024 with no adjustment mentioned. (3) Qualitatively, the reasoning is flawed. The LLM concludes that the increase indicates fairlife 'consistently met or exceeded' targets, but the ground truth only confirms one milestone (2020) was met, and the remaining $270 million was still contingent as of 2024—meaning performance was uncertain, not proven. The answer fails to reflect that the obligation was still outstanding and not yet triggered. (4) Contextually, the answer addresses the question's topic—contingent payments and performance—but the severe factual and numerical errors undermine all key claims. The synthesis across years and obligations is incorrect, failing the multi-hop requirement. Minor credit is given for recognizing that payments are tied to financial targets.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 415,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) between 2022 and 2024 has shown a clear shift toward strengthening its global market positioning and enhancing integration with enterprise IT solutions. In 2022, Oracle highlighted its focus on cloud-based deployment models, emphasizing Oracle Cloud Services (OCI and SaaS) as flexible options for customers seeking integrated applications and infrastructure. By 2024, Oracle further solidified its commitment to OCI by expanding its offerings to provide comprehensive, interoperable solutions that support hybrid and cloud-based environments, enabling customers to align with their specific business needs. This evolution reflects Oracle's broader strategy to position OCI as a central pillar of its enterprise IT portfolio, ensuring seamless integration with both on-premise and cloud deployments.",
      "correctness_score": 5,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the 2022 strategic emphasis. The Original Answer states that in 2022, Oracle emphasized revenue contributions from cloud and license businesses ($36.052 billion, 85% of total revenue) but did not explicitly position OCI strategically or mention OCI and SaaS together as a unified offering. However, the LLM claims that in 2022, Oracle already emphasized 'Oracle Cloud Services (OCI and SaaS)' as flexible options and highlighted integrated applications and infrastructure—this is factually incorrect and misrepresents the 2022 positioning. This error undermines the validity of the evolution narrative. (2) Quantitative accuracy is very low: the LLM omits the key financial figure of $36.052 billion and the 85% revenue contribution from cloud and license businesses in 2022, which is central to the ground truth. No numbers are mentioned at all, despite their importance in demonstrating the scale of Oracle’s cloud business prior to the strategic shift. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies a strategic evolution toward positioning OCI as a central pillar by 2024 and notes integration with enterprise IT solutions and hybrid deployments. This aligns with the 2024 description of OCI being part of a 'comprehensive and integrated' suite. However, because the starting point (2022) is misrepresented, the comparative analysis is flawed. (4) Contextual relevance is high—the response addresses global market positioning and integration with enterprise IT solutions, uses appropriate terminology, and attempts to trace a strategic evolution. While the direction of the shift is correctly inferred, the absence of key data and mischaracterization of early-stage strategy limits correctness. Thus, the correctness score is 5: partially correct but with significant factual omissions and errors in entity and temporal representation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 529,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "Between 2023 and 2024, the credit loss allowance for PALs (Pledged Asset Lines) remained at zero, as no allowance for credit losses was required due to full collateralization by securities with fair values exceeding borrowings. The risk profile of PALs also remained stable, with no nonaccrual loans reported in either year. Additionally, the Company continued to apply the collateral maintenance practical expedient under ASC 326, ensuring that PALs were fully collateralized as of December 31, 2024 and 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key discrepancy in the treatment of credit loss allowance between 2023 and 2024. The ground truth states that in 2023, there was a 'slight decrease in PALs' and the allowance was influenced by 'improved credit quality metrics and lower projected loss rates,' implying that an allowance framework was still active and responsive to risk factors. However, the LLM claims the allowance 'remained at zero' in both years and that full collateralization and application of the practical expedient were already in place in 2023, which contradicts the nuance in the original answer suggesting an evolution. By 2024, both answers agree: PALs were fully collateralized, fair values exceeded borrowings, and no allowance was required due to the ASC 326 practical expedient. The LLM correctly identifies the application of ASC 326 and the absence of nonaccrual loans, which supports contextual relevance and qualitative reasoning. Quantitatively, no specific dollar amounts or percentages are misstated (none were provided in the original), so accuracy is high. However, the reasoning downplays the evolution—portraying the situation as stable rather than improved—thus missing the multi-hop nuance that the risk profile strengthened from 2023 to 2024. This omission reduces qualitative and overall correctness, though the core facts for 2024 are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 384,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike's relationship with the Asia Pacific & Latin America (APLA) region showed growth in both revenue and operational emphasis. For fiscal 2024, APLA reported total revenues of $6,729 million, an increase from $6,431 million in fiscal 2023. This growth reflects a strategic emphasis on expanding Nike's presence in the region, particularly through direct-to-consumer (DTC) channels, which saw sales rise to $2,799 million in 2024 from $2,695 million in 2023. Additionally, the transition of certain Nike Brand businesses in the region to third-party distributors, as noted in the disclosures, indicates a shift in operational structure to optimize market reach and efficiency.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Nike's operational structure evolution in APLA. While the original answer states that Nike transitioned *from* direct operations *to* third-party distributors in 2024—indicating a strategic withdrawal or outsourcing—the LLM frames this shift as part of growth and expansion, which contradicts the ground truth. The LLM incorrectly implies that revenue growth and DTC expansion were central to the 2023–2024 evolution, but the ground truth does not mention revenue figures or DTC performance at all. (2) The quantitative data (e.g., APLA revenues of $6,729M in 2024 vs $6,431M in 2023, DTC sales rising to $2,799M) are entirely absent from the original answer and cannot be verified against the provided ground truth. These numbers may be hallucinated or drawn from external data not in the knowledge graph. There is no support for any numerical claims in the original answer, which focuses solely on structural and strategic workforce/distribution changes. (3) The multi-hop reasoning is partially sound in that the LLM identifies a shift to third-party distributors as a structural change, which aligns with the original answer. However, it fails to connect this shift with the broader context of reducing operational complexity and moving away from direct control, instead framing it as an efficiency play within a growth narrative. This misrepresents the strategic emphasis. (4) The contextual relevance is high because the answer addresses both operational structure and strategic emphasis in APLA across 2023–2024. However, the qualitative accuracy is compromised by unsupported numerical claims and a mischaracterization of the strategic intent behind the operational shift. The correctness score is low due to the inclusion of unverified financial data and the reversal of the strategic narrative (growth vs. optimization/retrenchment).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 520,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "Between 2022 and 2023, Abbott strengthened its positioning and strategic emphasis on Pedialyte as a key driver of growth within its U.S. Pediatric Nutritional business. In 2022, U.S. Pediatric Nutritional sales increased by 5.8%, with growth attributed to Pedialyte, Similac, and PediaSure. By 2023, the U.S. Pediatric Nutritional business saw a 10.3% sales increase, with continued emphasis on Pedialyte as a core product. This reflects Abbott's focus on expanding its product portfolio and reinforcing Pedialyte's role in addressing hydration needs, particularly in the U.S. market.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that U.S. Pediatric Nutritional sales increased by 5.8% in 2022, while the ground truth reports a 10.3% increase for Pedialyte specifically (not the entire pediatric segment). Furthermore, it incorrectly attributes the 10.3% growth to the entire U.S. Pediatric Nutritional business in 2023, whereas the ground truth specifies that 10.3% was Pedialyte's sales growth in 2022. These misattributions of percentages and years undermine factual correctness. (2) The numbers are not accurate: the 5.8% figure does not appear in the ground truth, and the 10.3% figure is applied to the wrong year and metric. No calculations are performed in the answer, but the misassignment of growth rates to different years and business segments constitutes a critical error. (3) The multi-hop reasoning is partially sound—the model recognizes that Pedialyte was a growth driver in both years and attempts to show strategic continuity. However, it fails to capture the key strategic evolution highlighted in the ground truth: the formal integration of Pedialyte into the Nutritional Products segment portfolio listing alongside Ensure, Glucerna, and PediaSure in 2023. This structural and strategic shift—from being a growth contributor to a formally recognized core brand—is entirely missing from the LLM response, representing a major omission in qualitative reasoning. (4) Contextual relevance is high because the answer addresses Abbott, Pedialyte, the U.S. Pediatric Nutritional business, and strategic emphasis across 2022–2023. However, due to incorrect figures and failure to identify the core strategic development (formal portfolio inclusion), the correctness score is limited to 5. The qualitative accuracy is moderate because the general direction of strategy is acknowledged, but key details are wrong or missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 512,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "RTX's 7.100% notes due 2027 remained unchanged in principal amount from 2022 to 2023, with a balance of $135 million in both years. This stability suggests that RTX did not refinance or retire this specific debt obligation during the period, indicating a strategy of maintaining existing debt structures rather than altering them in the short term. It also implies that the notes are likely part of a broader, long-term debt management approach focused on managing maturity profiles and interest costs across a diverse portfolio of debt instruments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the principal balance of RTX's 7.100% notes due 2027 was $135 million in both 2022 and 2023. According to the ground truth, the balance was $6 million in 2022 and increased to $135 million in 2023. This misrepresentation completely inverts the trend. (2) The quantitative error is severe: the model fails to report the correct 2022 figure and falsely claims stability, when in fact there was a 2150% increase in principal balance. No calculation is required beyond accurate reporting, but the model's claim of 'unchanged' status is directly contradicted by the data. (3) The multi-hop reasoning is flawed—the question asks how the financial position evolved, requiring comparison across years. The model incorrectly concludes that RTX maintained stable debt, when the evidence points to a significant strategic shift, possibly involving acquisition of its own debt or restructuring. The original answer suggests a change in strategy; the LLM denies it. (4) Scores reflect major factual inaccuracy (correctness: 2), poor number reporting (quantitative: 2), weak reasoning despite correct identification of the debt instrument and years (qualitative: 3), and moderate relevance as the response addresses the right topic and metric but with wrong data (contextual: 6).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 372,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Converse experienced a 14% decline in total revenues, with a 30% decrease in earnings before interest and taxes (EBIT). The revenue decline was driven by lower unit sales and average selling prices, particularly in North America and Western Europe, while EBIT fell due to gross margin contraction and reduced sales. This indicates a weakening in Converse's financial performance and strategic positioning relative to Nike's overall growth during the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Converse revenues decreased by 15% on a currency-neutral basis in fiscal 2023, but the LLM claims a 14% decline in total revenues and introduces a 30% decrease in EBIT, which is not mentioned in the ground truth. These numbers are unsupported and incorrect. (2) There are no calculations in the original answer to verify, but the LLM fabricates EBIT and gross margin contraction details not present in the source, failing quantitative accuracy. The revenue decline direction (downward) and regional drivers (North America and Western Europe) are correct, but the magnitude (14% vs 15%) is slightly off and lacks the 'currency-neutral' qualifier. (3) The multi-hop reasoning is partially sound—linking financial performance to strategic positioning—but the LLM fails to mention the key strategic evolution in fiscal 2024 where Converse operates as a stand-alone subsidiary, a critical point in the original answer. Instead, it concludes with a negative assessment of strategic positioning, contradicting the ground truth's indication of strategic repositioning. (4) The contextual relevance is moderate because the answer addresses revenue performance and positioning, but misses the core strategic shift in 2024. The qualitative accuracy is limited by incorrect metrics and a flawed conclusion about strategic weakening, when the original indicates a deliberate strategic realignment despite financial challenges. Thus, the answer is partially correct on financial trends but fundamentally incorrect on strategic evolution and specific figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 451,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "Coca-Cola has increasingly emphasized digital evolution as a critical factor in its financial risk assessment from 2022 to 2024. In 2022, the company acknowledged the impact of digital transformation on consumer shopping behaviors and the need to adapt to digital tools to avoid negative effects on sales growth and financial results. By 2024, the risk assessment became more specific, highlighting that unsuccessful digitalization could directly hinder the company's ability to increase sales and improve margins, while also noting the potential adverse impact of digitalization costs on financial performance. This reflects a heightened awareness of digital transformation as both an opportunity and a risk to profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Coca-Cola's shift from viewing digital evolution as a risk in 2022 to a strategic dependency in 2024 is accurately captured. The emphasis on sales growth and margin improvement in 2024 is correctly reported. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of risk assessment across two years and links it to financial outcomes (sales and margins). The LLM adds a nuance about 'digitalization costs' impacting financial performance, which is plausible and contextually consistent with 2024 risk disclosures, though not explicitly mentioned in the ground truth. This does not detract from accuracy but slightly extends beyond the provided information. (4) The answer is semantically equivalent to the original, with clear, concise, and relevant explanation. The only minor gap is the lack of explicit mention that digital evolution became a 'strategic dependency'—a key phrase in the ground truth—though the meaning is effectively conveyed. Thus, the answer is excellent, with only negligible omission preventing a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 373,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Services from fiscal year 2022 to 2024 has shown a continued and increasing focus, particularly in research and development investment and positioning cloud offerings over on-premise solutions. In fiscal 2022, Oracle invested $7.2 billion in R&D, and by 2024, this investment remained strong, as reflected in ongoing innovation efforts such as the Oracle Autonomous Database and Oracle Cloud Infrastructure (OCI). Oracle has positioned its cloud offerings as rapidly deployable, cost-effective, and interoperable solutions, emphasizing migration from on-premise to cloud-based environments. The proportion of cloud services and license support revenues increased to 71% of total revenues in fiscal 2022, and Oracle expects this trend to continue, highlighting a strategic shift toward cloud-based deployment models.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's $7.2 billion R&D investment in fiscal 2022, which matches the ground truth. However, it incorrectly implies that the R&D investment remained at the same level in fiscal 2024 by stating 'this investment remained strong,' while the original answer explicitly notes that the 2024 report does not specify the R&D amount. This is a significant factual overreach, as no data is provided in the ground truth for 2024 R&D spending. Additionally, the LLM introduces a new figure—'71% of total revenues' from cloud services and license support in fiscal 2022—which is not present in the original answer and cannot be verified against the provided ground truth. This number may be accurate in reality but is unsupported by the knowledge graph, making it an unsupported claim. (2) The quantitative accuracy is compromised due to the introduction of an unverified percentage (71%) and the unsupported assertion about continued R&D investment levels in 2024. While the $7.2 billion figure is correct, the rest of the numerical claims lack grounding. (3) The qualitative reasoning is partially sound: the LLM correctly infers a strategic shift toward cloud services and highlights Oracle Autonomous Database and OCI as key innovations. It also accurately reflects the trend of positioning cloud over on-premise solutions. However, it misses the nuanced evolution in messaging from 'differentiator' in 2022 to 'choose the best option for specific business needs' in 2024, which reflects a deeper strategic refinement absent in the LLM response. (4) Contextual relevance is high because the answer addresses the core themes of R&D investment and cloud positioning. Despite missing the shift in strategic messaging and introducing unsupported data, it maintains focus on the question’s intent. Overall, the answer is partially correct with key factual and inferential errors, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 525,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors' Formula Stock Award Plan is no longer active for future awards or deferrals, as stated in both the 2023 and 2024 filings. In 2023, the plan had 509 shares issuable upon distribution, and by 2024, this number remained negligible at 391 shares. The plan's status did not change significantly between the two years, as no new awards or deferrals are permitted, and all remaining shares pertain to outstanding distributions from prior awards.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Norwest Corporation Directors' Formula Stock Award Plan was inactive for new awards or deferrals in both 2023 and 2024, and that only existing obligations remained. This aligns with the ground truth. However, there is a critical error in the quantitative data: the LLM states that 509 shares were issuable in 2023, while the original answer (ground truth) does not mention any specific number for 2023—only that the plan was already closed to future activity. The only numeric figure provided in the ground truth is 391 shares in 2024. Thus, the 509 figure is unsupported and incorrect. (2) The calculation or comparison between years is flawed due to the introduction of an unverified number (509) not present in the source. The ground truth emphasizes that the 391 shares in 2024 reflect all remaining issuable shares, but provides no prior-year share count. (3) The multi-hop reasoning is partially sound—the model correctly infers continuity in the plan’s inactive status across years and understands that only distributions of prior awards remain. However, it fabricates a specific numeric value for 2023 without basis, undermining factual reliability. (4) The contextual relevance is high because the response directly addresses the evolution of the plan's status and availability of shares. Qualitative accuracy is moderate due to correct conceptual understanding but flawed data citation. Quantitative accuracy is low due to the incorrect 509-share figure. Correctness score is reduced significantly because financial data must be precise, and introducing unsupported numbers constitutes a major factual error, even if the overall narrative direction is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 471,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "Between 2022 and 2023, McDonald's disclosure around food safety concerns remained consistent in emphasizing its commitment to food safety as a top priority and the potential risks associated with food-borne illnesses or contamination in the supply chain, restaurants, or delivery. However, in 2023, there was a more explicit mention of the evolving challenges related to supply chain risks and cost volatility. Specifically, the 2023 filing highlighted the impact of factors such as climate change, geopolitical tensions, and macroeconomic conditions on supply chain stability and commodity costs, which could indirectly affect food safety and operational continuity. This suggests a broader recognition of how external pressures on the supply chain could intersect with food safety management.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses the core evolution highlighted in the ground truth. (1) What was correct: The answer correctly identifies that McDonald's maintained a focus on food safety and acknowledged supply chain and cost volatility in 2023, mentioning relevant factors like climate change and geopolitical tensions. It also accurately references the increased emphasis on external pressures affecting supply chains. (2) Quantitative accuracy: There are no numerical values in the question or answers, so this aspect is not applicable; no errors in dates (2022 vs 2023) or entities (McDonald's). (3) Multi-hop reasoning assessment: The LLM fails to capture the key shift in risk framing—from reputational risk in 2022 to financial and supply chain cost volatility in 2023. The ground truth emphasizes that food safety concerns themselves were reframed as contributors to commodity price fluctuations (e.g., beef, chicken, pork), directly linking them to cost pressures. The LLM instead suggests that external supply chain factors could 'indirectly affect food safety,' which reverses the causal relationship described in the original. This misrepresents the direction of the evolution. (4) Justification: While the answer is contextually relevant and includes plausible details, it lacks the precise conceptual shift (reputational → financial/supply chain cost driver) and omits the specific linkage between food safety issues and commodity cost volatility, which is central to the ground truth. Hence, correctness and qualitative accuracy are reduced, though not severely due to partial alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 440,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "The carrying value of TMO's 1.750% 7-Year Senior Notes remained unchanged at $700 million between 2023 and 2024, as noted in the effective interest rates and balances for the notes due on 10/15/2028 in both TMO_10k_2023.pdf and TMO_10k_2024.pdf. The interest rate also remained consistent at 1.89%.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the carrying value of TMO's 1.750% 7-Year Senior Notes remained unchanged at $700 million between 2023 and 2024, and that the effective interest rate stayed constant at 1.89%, which matches the ground truth exactly. (2) All numeric values—$700 million (carrying value), 1.89% (effective interest rate), and the maturity date of October 15, 2028—are factually accurate and consistent with the original answer. Minor omission of the exact date format (10/15/2028 vs October 15, 2028) does not affect factual accuracy. (3) The reasoning is sound: the model correctly synthesizes data from two consecutive 10-K filings (2023 and 2024), confirming no change in the debt instrument’s carrying value or interest rate, demonstrating proper multi-hop validation across years. (4) The answer is semantically equivalent to the ground truth, conveys the same conclusion, and fully addresses the question about the evolution (or lack thereof) of both carrying value and interest rate. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 312,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX's exposure to its 7.000% notes due 2038 remained unchanged at $148 million between 2022 and 2023, as shown in the long-term debt tables on pages 85 of RTX_10k_2023 and 94 of RTX_10k_2022. This suggests that RTX did not refinance or retire this specific debt instrument during the period, indicating a strategy of maintaining certain long-term maturities as part of its broader debt management approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that RTX's exposure remained unchanged at $148 million. According to the ground truth, the principal balance was $11 million in 2022 and increased to $148 million in 2023 — a significant change. The LLM incorrectly claims no change, which contradicts the data. (2) Quantitative accuracy is severely compromised: the 2022 figure is wrong (claims $148M vs. actual $11M), and the increase from $11M to $148M is entirely missed. This represents a major factual error in financial figures. (3) The reasoning is flawed because it fails to recognize the multi-hop nature of the question — comparing two years of debt disclosures to assess changes in debt strategy. The conclusion that RTX 'did not refinance or retire' based on unchanged exposure is invalid because exposure did change dramatically. The correct inference (per ground truth) is that RTX likely issued additional notes or restructured debt, indicating a strategic shift — which the LLM misses entirely. (4) Contextual relevance is moderate because the answer addresses long-term debt management and cites relevant sections (pages 85 and 94), showing awareness of where such data resides. However, incorrect numbers and reasoning undermine the overall validity. Minor point: citing specific pages may be accurate in document location, but this does not compensate for factual inaccuracy in content interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 397,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial relationship with its franchisees remained stable regarding the collection of rent and royalties. Revenues from franchised restaurants in 2023 included $8,381.1 million in rents and $4,645.1 million in royalties, consistent with the prior year's figures. The Company continued to collect rent and royalties based on a percentage of franchisees' sales, with minimum rent payments where applicable. No significant disruptions or changes in collection practices were reported during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some accurate quantitative data—specifically, the 2023 figures for rent ($8,381.1 million) and royalties ($4,645.1 million)—which may be factually correct based on McDonald's 2023 filing. However, the core of the question asks about the *evolution* of McDonald's financial relationship with franchisees between 2022 and 2023, particularly in the context of pandemic-related deferrals and their resolution. The LLM answer fails to mention the key fact from the ground truth: that approximately $1 billion in rent and royalties had been deferred during 2020 and was substantially collected by the end of 2021. It incorrectly implies stability between 2022 and 2023 without acknowledging that the deferral period and collection occurred earlier, and that 2022–2023 represented a return to normal operations. This omission represents a critical failure in multi-hop reasoning, as the evolution hinges on understanding the resolution of prior deferrals and the absence of new accommodations. While the LLM correctly notes no disruptions in 2022–2023, it does not contextualize this within the broader timeline, leading to an incomplete and misleading narrative. The answer is factually weak on the qualitative evolution, despite some correct numbers, hence the low qualitative and overall correctness scores. Contextual relevance is moderate because it addresses rent and royalty collection but misses the historical contrast essential to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 403,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "The Coca-Cola Company's financial stake in Embotelladora Andina S.A. decreased from 2022 to 2024, as evidenced by the reduction in the difference between the fair value and carrying value of the investment. In 2024, the difference was $78 million, compared to a higher difference in 2022. This reduction suggests a partial divestiture or a decline in the investment's valuation relative to its fair market value. The strategic positioning indicates a potential shift in focus or capital reallocation, possibly to optimize the portfolio of equity investments or to refocus on higher-growth opportunities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies a reduction in Coca-Cola's stake, it misrepresents the quantitative basis. The ground truth states that in 2022, Coca-Cola recognized a $39 million gain from a partial sale, and by 2024, the carrying value was $90 million with a fair value of $168 million (a $78 million difference). The LLM incorrectly implies that the $78 million difference in 2024 was compared to a 'higher difference in 2022'—but no such 2022 fair/carrying value difference is provided in the ground truth. Thus, the LLM fabricates a comparative metric not supported by data. (2) The calculation of the $78 million difference in 2024 is correct (168 - 90 = 78), but the inference that this represents a reduction from 2022 is unsupported. The only confirmed 2022 figure is the $39 million gain from divestiture, not a valuation gap. (3) The multi-hop reasoning is partially sound—recognizing a stake reduction and strategic repositioning—but fails to correctly synthesize the actual data points across years. It misses the key point that Coca-Cola retained a stake with a $90M carrying value and $168M fair value in 2024, indicating ongoing involvement. Instead, it focuses on an unverified narrowing of fair-to-carrying value, which isn't in the original answer. (4) The strategic interpretation ('partial divestiture', 'capital reallocation') is plausible but less precise than the ground truth's 'partial exit strategy with ongoing reduced exposure'. Overall, the answer gets the general direction right (reduced stake) but is factually incorrect on key numbers and reasoning, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 461,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "Oracle's strategic investment in cloud infrastructure from 2022 to 2024 has shown a clear emphasis on internal development and positioning Oracle Cloud Infrastructure (OCI) as a central component of its product portfolio. In 2022, Oracle highlighted its global expansion of the Oracle Cloud, including increased data center capacity and new geographic locations, and emphasized its focus on research and development to maintain and improve its offerings. By 2024, Oracle further solidified OCI's role by describing it as a secure, reliable, and scalable platform that delivers Oracle Cloud Services, with automated tools enabling rapid deployment of the latest cloud technologies. This evolution reflects Oracle's commitment to strengthening its cloud infrastructure capabilities internally while integrating OCI more deeply into its broader cloud and on-premise IT solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Oracle's strategic focus on internal development in 2022, emphasizing R&D and global cloud expansion, which matches the original answer's emphasis on internal development and innovation. In 2024, it accurately reflects the evolution by positioning Oracle Cloud Infrastructure (OCI) as a central, secure, scalable platform within Oracle's product portfolio, consistent with the ground truth's description of OCI becoming a structured, customer-facing offering. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM synthesizes Oracle's shift from general R&D emphasis in 2022 to a more product-specific strategy centered on OCI by 2024, demonstrating correct understanding across time and strategic focus. The only minor gap is that the LLM does not explicitly mention the 'integrated infrastructure solution' phrasing or the strategic deepening as clearly as the original, slightly reducing qualitative precision. (4) The answer is fully contextually relevant, directly addressing both internal development efforts and the positioning of OCI in the product portfolio over the specified timeframe. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 due to slightly less precise articulation of the strategic evolution's depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 410,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "TMO acquired The Binding Site Group in January 2023 as part of its strategy to expand its Specialty Diagnostics segment, enhancing its portfolio with innovative diagnostic solutions for blood cancers and immune system disorders. By 2024, the company had successfully integrated The Binding Site Group, as evidenced by continued investments in complementary acquisitions and the absence of mention of transitional challenges in operational performance. This evolution indicates a focus on leveraging synergies, expanding diagnostic capabilities, and strengthening TMO's position in high-growth areas of healthcare.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies TMO's acquisition of The Binding Site Group in 2023 and its strategic intent to expand the Specialty Diagnostics segment with a focus on blood cancers and immune disorders, which aligns with the ground truth. However, it omits the specific acquisition cost of $2.70 billion, a key quantitative detail present in the original answer. The mention of 'January 2023' is more specific than the ground truth (which only states 2023), but without confirmation from the source, this precision may be speculative and is not penalized heavily as timing within 2023 is plausible. (2) The LLM fails to include the critical 2024 integration evidence related to the 19-year weighted-average amortization period for customer relationships, which is a concrete financial indicator of integration into definite-lived intangible assets. This omission weakens the support for the integration claim, even though the LLM asserts successful integration. (3) The reasoning is generally sound—linking acquisition to strategic expansion and integration to synergy realization—but misses the multi-hop connection between the amortization period (a post-acquisition accounting treatment) and long-term value creation, which is central to the ground truth's conclusion. (4) Despite missing key financial metrics and specific integration indicators, the LLM captures the overall strategic direction and correctly identifies the business segment and therapeutic focus. Wording differs but meaning partially overlaps; however, the absence of the amortization detail and acquisition price reduces completeness and factual richness. Hence, correctness is reduced to 7 for missing key facts, quantitative accuracy to 8 for mostly correct but incomplete numbers, qualitative accuracy to 7 for incomplete reasoning, and high contextual relevance at 9 due to strong alignment with the question’s intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 518,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "Between 2022 and 2024, the Directors' Code of Conduct for BNY Mellon remained accessible via the company's website, but the specific URL was updated. In 2022, the Directors' Code of Conduct was posted at **https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf**, while in 2024, the link was updated to **https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf**. The scope of application remained consistent, as the Directors' Code of Conduct continued to apply to all directors of BNY Mellon.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of the Directors' Code of Conduct between 2022 and 2024, noting the updated URL and consistent scope of application to all directors. However, there is a minor error in the 2022 URL: the LLM states 'in relations' instead of 'investor-relations', making the link inaccurate. The correct 2022 URL is https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, but the LLM omits 'investor-', which affects accessibility and precision. The 2024 URL is correctly reported. (2) No numerical values, dates, or financial metrics are involved in this question, so quantitative accuracy is assessed on URL correctness. The partial URL error reduces accuracy but does not completely invalidate the response. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years, compares website links, and confirms consistent policy scope. It also implicitly recognizes the rebranding trend (BNY Mellon to BNY), though this insight is not explicitly stated as in the ground truth. (4) The answer is contextually relevant and covers both parts of the question—website link changes and scope of application. The core facts are correct, but the URL typo prevents a higher score. Semantic equivalence is mostly preserved, but the incorrect URL could lead to a broken link, which is a significant practical issue. Hence, correctness and qualitative accuracy are rated 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 413,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial reporting and strategic emphasis on franchisee relationships remained largely consistent, with a focus on royalty and rental income tied to franchise sales. However, there was a slight increase in the number of franchised and developmental licensed restaurants, reflecting a continued strategic shift toward franchise growth. Financially, the Company maintained its revenue recognition practices, with royalties and variable rent recognized at the time of underlying sales, and no material changes were noted in accounting policies affecting franchisee-related reporting.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses the core evolution highlighted in the ground truth. While it correctly notes consistency in revenue recognition and a trend toward franchise growth, it fails to identify the key shift in strategic emphasis and transparency between 2022 and 2023. In 2022, McDonald's stated that transactions with franchisees were not material to consolidated financials, implying limited financial reporting impact. In 2023, the company elevated franchisees and licensees as key stakeholders and provided a detailed ownership breakdown, signaling a more strategic and transparent integration. This evolution in narrative and disclosure is absent in the LLM response. (2) There are no explicit numbers in the ground truth, so the LLM’s mention of a 'slight increase' in franchised restaurants does not contradict data, but it is unsupported and not part of the original answer. No calculation errors, but no verification of such claims is possible. (3) The multi-hop reasoning is flawed: the LLM does not synthesize the change in disclosure tone and strategic framing from 2022 to 2023. Instead, it asserts consistency, which contradicts the ground truth showing a clear shift in emphasis. (4) The contextual relevance is moderate because the answer discusses franchisee relationships and financial reporting, but it misses the critical qualitative shift in stakeholder positioning and transparency. Quantitative accuracy is high because there are no incorrect numbers, but the answer introduces unverified claims. Qualitative accuracy is low due to incorrect reasoning about the nature of the evolution. Correctness score is 4 due to significant omission of the key strategic and reporting evolution despite some relevant context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 482,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "The contingent consideration liabilities related to the Clif Bar acquisition increased from $452 million as of December 31, 2022, to $548 million as of December 31, 2023, reflecting changes in fair value primarily driven by updates to financial projections and assumptions such as discount and volatility rates. The fair value measurement remained classified as Level 3 due to the use of unobservable inputs in the Monte Carlo simulation model. No adjustments to purchase price allocation were explicitly noted in the provided pages for 2023 or 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the $548 million contingent consideration liability as of December 31, 2023, which matches the ground truth. However, it introduces a figure of $452 million as of December 31, 2022, which is not mentioned in the original answer and cannot be verified from the provided ground truth, making this an unsupported addition. The ground truth does not discuss 2022 values, so this undermines quantitative accuracy. (2) The description of fair value measurement using unobservable inputs and Level 3 classification aligns with the use of Monte Carlo simulation in the original answer, though the LLM adds technical detail (e.g., Level 3) not confirmed in the ground truth. While plausible, it goes beyond the provided information. (3) The LLM fails to address the key evolution between 2023 and 2024: the absence of contingent consideration disclosures in 2024 and the mention of purchase price allocation adjustments in 2024 filings related to Clif Bar. This is a critical omission, as the question specifically asks about the evolution into 2024. Instead, the LLM incorrectly claims 'no adjustments to purchase price allocation were explicitly noted,' which contradicts the original answer stating that 2024 filings do reference such adjustments in 2023. This reflects a failure in multi-hop reasoning and synthesis across years. (4) While the LLM captures part of the 2023 status accurately, it misses the core insight about the contingent consideration likely being finalized or reclassified by 2024 due to the shift in disclosure focus. Thus, despite some correct details, the answer is partially incorrect in key areas of reasoning and completeness, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 470,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "AMD's strategic emphasis on Vulkan API support between 2022 and 2024 has remained consistent, with a focus on ensuring its discrete GPUs deliver high performance and compatibility for modern gaming and graphics workloads. In both years, AMD's Radeon discrete GPUs are highlighted as supporting current-generation APIs like Vulkan, underscoring the company's commitment to open standards and cross-platform performance. This ongoing support reflects AMD's approach to maintaining competitiveness by prioritizing developer flexibility, optimizing performance for demanding applications, and aligning with industry trends in graphics technology.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of AMD's ongoing support for the Vulkan API and its importance for competitiveness in the discrete GPU market. It correctly identifies AMD's focus on Vulkan across both 2022 and 2024 and appropriately links this to performance, developer flexibility, and industry alignment. However, it omits key architectural evolution details present in the original answer—specifically, the transition from RDNA 2 (2022, Radeon RX 6000 series) to RDNA 3 (2024, Radeon RX 7000 series)—which is a critical part of the multi-hop reasoning required to fully address how the strategic emphasis evolved. While the LLM conveys AMD’s continued support, it fails to specify the generational GPU architecture shift that underpins performance improvements and reveals deeper strategic intent. This omission reduces completeness and weakens the qualitative accuracy, despite no incorrect facts being stated. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains contextually relevant and well-reasoned at a high level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 312,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "RTX's integration-related charges, particularly the Powder Metal Matter charge of $2.9 billion in 2023, significantly impacted its operating profit trends, reducing operating profit by $1.9 billion compared to 2022. This charge, along with a decrease in the FAS/CAS operating adjustment, led to a decline in operating profit margin from 8.2% in 2022 to 5.2% in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $2.9 billion Powder Metal Matter charge in 2023 and its impact of reducing operating profit by $1.9 billion compared to 2022, which aligns with the ground truth. It also accurately reflects the negative trend in operating profit. However, the LLM introduces additional information not present in the original answer — specifically, the operating profit margin decline from 8.2% in 2022 to 5.2% in 2023 and the mention of the FAS/CAS operating adjustment — which, while potentially accurate, are not part of the ground truth and were not requested in the question. This affects completeness and qualitative accuracy by adding unverified details. (2) All numeric values mentioned — $2.9 billion charge and $1.9 billion decrease in operating profit — are quantitatively accurate and consistent with the original answer. The percentage margins are plausible but not confirmed by the ground truth, so they cannot be verified as correct in this context. (3) The multi-hop reasoning is sound: the model correctly links the 2023 Powder Metal Matter charge to the decline in operating profit, contrasting it with 2022 trends. However, the original answer emphasizes a shift from declining integration-related charges in 2022 (due to reduced Acquisition Accounting Adjustments) to a spike in 2023, which the LLM omits. This missing context slightly weakens the qualitative reasoning. (4) The answer is highly relevant and directly addresses the core of the question regarding the impact of integration-related charges on operating profit trends. The scores reflect high factual accuracy with minor deductions for omission of the 2022 positive trend context and introduction of unconfirmed margin data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 475,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "MDLZ's relationship with Clif Bar between 2023 and 2024 primarily involved acquisition-related financial integration. The August 1, 2022 acquisition of Clif Bar contributed incremental net revenues of $529 million through the one-year anniversary of the acquisition in 2023. There were no further specific acquisition-related financial activities involving Clif Bar mentioned in the 2024 filing, indicating that the integration was likely completed or had stabilized by the end of 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but misses key aspects of the evolution between 2023 and 2024. It correctly references the August 1, 2022 acquisition and notes Clif Bar's contribution of $529 million in incremental net revenues in 2023, which aligns with the ground truth context. However, it incorrectly states that 'no further specific acquisition-related financial activities' were mentioned in the 2024 filing, which directly contradicts the ground truth: the 2024 10-K explicitly includes purchase price allocation adjustments for Clif Bar from the prior year, indicating ongoing financial recalibration. (2) Quantitatively, the $529 million figure is accurate and correctly attributed to the one-year anniversary impact in 2023. The date of the acquisition (August 1, 2022) is also correct. However, the absence of any mention of the 2024 purchase price allocation adjustments constitutes a significant omission in financial activity, undermining the quantitative completeness. (3) The multi-hop reasoning is flawed: while the model correctly identifies the initial acquisition and its 2023 impact, it fails to synthesize the progression into 2024 as described in the 2024 10-K. The conclusion that integration was 'completed or stabilized' is speculative and contradicts the documented post-acquisition adjustments, indicating weak reasoning across time periods and filings. (4) Contextual relevance is strong—the answer addresses the financial evolution and focuses on acquisition-related activities as asked—but the failure to report verified 2024 financial adjustments results in a materially incomplete and partially misleading response. Thus, the correctness score is moderate due to accurate early-stage facts but significant omission and misinterpretation of later-stage developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 497,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "From 2023 to 2024, Gulfstream has advanced its focus on energy-efficient engines by introducing new aircraft models with superior high-speed performance and fuel efficiency. Specifically, the G700, which entered service in early 2024, features all-new engines that contribute to best-in-class capabilities. Additionally, the G800 and G400, introduced in 2021, reflect Gulfstream's commitment to energy efficiency and expanded commonality across its aircraft family. These developments underscore Gulfstream's ongoing efforts to enhance sustainability and performance in its aircraft lineup.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Gulfstream's evolution toward energy-efficient engines and highlights the G700's introduction in 2024 with all-new engines, aligning with the ground truth. However, it incorrectly states that the G800 and G400 were introduced in 2021 and are part of the 2023–2024 evolution, which is factually inaccurate—these models were announced later and do not reflect developments in the specified timeframe. The G400 was actually introduced in 2022, and the G800 was unveiled alongside the G700 in 2023 but did not enter service in 2024. (2) The date error regarding aircraft introductions affects quantitative accuracy, particularly the claim about G800/G400 reflecting 2023–2024 shifts. The G700 entering service in early 2024 is consistent with ground truth. (3) The reasoning partially captures the multi-hop shift from R&D focus in 2023 to production in 2024 via the G700, but the inclusion of earlier models as evidence of recent evolution undermines the logical synthesis. The ground truth emphasizes a shift from no new model in 2023 to tangible production in 2024 with the G700—this contrast is diluted in the LLM answer. (4) The correctness score is 6 due to accurate mention of the G700’s role and engine efficiency, but significant factual errors in aircraft timelines reduce accuracy. Quantitative accuracy is 6 due to correct 2024 G700 timing but incorrect model dates. Qualitative accuracy is 6 due to sound overall reasoning but flawed entity-time linkage. Contextual relevance is 8 because the answer stays on topic and addresses the core theme of energy efficiency evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 447,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "From 2022 to 2024, AMD's semi-custom SoC products have transitioned from being a revenue source tied to third-party design and development services and product sales to a more strategic focus on incorporating these SoCs into broader product offerings. In 2022, revenue from semi-custom SoC products was directly linked to the success of third-party products, with no control over their marketing or sales outcomes. By 2024, AMD emphasized the integration of semi-custom SoCs into its broader product portfolio, aligning with strategic goals such as AI accelerators, data center GPUs, and embedded processors. This shift reflects a move toward leveraging semi-custom SoCs as part of a diversified revenue structure and a stronger strategic positioning in high-growth markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AMD's relationship with semi-custom SoC products from 2022 to 2024, accurately reflecting the shift from dependency on third-party success to strategic integration into a broader product portfolio. All key qualitative elements—revenue structure tied to third-party performance in 2022, inclusion of non-recurring engineering fees and product sales, and the 2024 shift toward integration with AI accelerators, GPUs, and other processors—are consistent with the ground truth. (2) There are no numeric values (e.g., revenue figures, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; the absence of fabricated numbers is appropriate, earning full marks. (3) The multi-hop reasoning is sound: the model synthesizes changes over time (2022 vs 2024), connects semi-custom SoCs to broader strategic positioning, and correctly identifies the shift in control and commercialization strategy. The only minor gap is that the LLM answer does not explicitly mention 'DPUs' (data processing units), which are included in the original answer as part of the diversified portfolio. While 'embedded processors' and 'data center GPUs' are mentioned, DPU omission is a slight completeness issue. (4) Despite this minor omission, the semantic meaning and strategic narrative are equivalent, and the answer is highly relevant to the question. Thus, correctness is rated 9 (excellent but not perfect), qualitative accuracy 9, and full scores for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 434,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares and 500 thousand A Preferred Shares authorized but none issued or outstanding in both years. This indicates that the company has not issued preferred shares as part of its capital strategy during this period and has instead focused on other forms of capital management, such as ordinary share repurchases and stock-based compensation programs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the preferred share authorization remained unchanged between FY2023 and FY2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized, and none issued or outstanding in either year. All quantitative details match the ground truth exactly, including share counts and par values, satisfying quantitative accuracy. (2) The numbers are accurate and consistent with the original answer; no calculation errors or misstatements of figures. (3) The reasoning is mostly sound: the LLM correctly infers that the lack of issuance indicates no use of preferred shares in capital strategy. However, it adds an inference not present in the ground truth — that the company 'focused on other forms of capital management, such as ordinary share repurchases and stock-based compensation programs.' While plausible, this specific strategic focus is not supported by the provided data and introduces unverified information, slightly weakening the qualitative accuracy. (4) The answer is contextually relevant and addresses both parts of the question — the evolution (or lack thereof) in share structure and its implication for capital strategy. The core facts are correct, but the added strategic interpretation beyond the evidence justifies a slight deduction in qualitative and overall correctness. Thus, correctness_score is 8 due to minor over-interpretation, despite full quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 412,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "Between 2022 and 2024, the framing of reputational risk related to adverse publicity in BK's risk disclosures has evolved to include broader and more specific linked concerns. In 2022, the risk was mentioned as a general risk of adverse events, publicity, or government scrutiny harming reputation. By 2024, the disclosure expanded to explicitly connect reputational harm with sustainability concerns, including climate change and diversity, suggesting that reputational risk is now more closely tied to ESG (Environmental, Social, and Governance) factors and client expectations. This reflects a growing emphasis on non-financial risks and their potential impact on business operations and client activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 framing of reputational risk included adverse publicity and government scrutiny, and by 2024 it expanded to include sustainability concerns like climate change and diversity. The LLM correctly identifies this evolution and interprets it as a broadening tied to ESG factors and client expectations. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no issues here. (3) The multi-hop reasoning is sound: the model synthesizes changes across years (2022 to 2024), identifies the continuity of adverse publicity as a risk, and correctly infers the expansion into ESG-related reputational risks. The only minor omission is that the original answer specifically mentions the 'platforms operating model transition' as a new context linked to reputational risk in 2024, which the LLM answer does not include. This is a small but relevant detail related to operational models. (4) Despite this omission, the LLM captures the core evolution in framing—especially the shift toward ESG and sustainability—and maintains semantic equivalence in intent and meaning. The answer is contextually relevant, directly addressing how the framing evolved and what new concerns were linked. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 407,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "Amazon's financial investment and valuation approach toward Anthropic, PBC evolved from 2023 to 2024 by maintaining the convertible debt investment as a Level 3 asset classified as available-for-sale, reported at fair value. In 2023, Amazon invested $1.25 billion in a convertible note from Anthropic, with an option to invest an additional $2.75 billion. By 2024, the valuation remained subject to market conditions and private company valuation complexities, with no indication of impairment or changes in classification. The investment's valuation was influenced by Anthropic's operational performance, market trends, and broader economic uncertainties.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.25 billion investment in 2023 and the $2.75 billion additional commitment, both of which match the ground truth. The classification as available-for-sale and Level 3 asset is accurately stated, and the fair value reporting method is correct. However, the LLM refers to the additional $2.75 billion as an 'option,' while the ground truth specifies it was part of an agreement to invest by Q1 2024—this mischaracterizes the obligation level (binding vs. optional), which is a minor but notable inaccuracy in financial context. (2) All numeric values—$1.25 billion and $2.75 billion—are correct and properly contextualized. No calculations are required, and the figures align exactly with the original answer. (3) The multi-hop reasoning is mostly sound: the LLM connects the 2023 investment to the 2024 follow-on and correctly notes the continued use of fair value accounting and Level 3 classification. It also appropriately highlights valuation challenges due to private company status and economic uncertainty. However, it misses the key qualitative shift in 2024 emphasis—from mechanics of investment to valuation complexity and risk disclosure—which is central to the evolution in approach. This nuance is underdeveloped in the LLM response. (4) The answer is highly relevant and factually accurate on core financial terms and figures. The correctness score is 8 due to the mischaracterization of the $2.75 billion commitment and the lack of emphasis on the shift in disclosure focus in 2024, which is a key part of the 'evolution' asked in the question. Quantitative accuracy is perfect. Qualitative accuracy is high but slightly reduced due to reasoning nuance. Contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 479,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "The nature of the risks related to the protection of MDLZ's intellectual property, including know-how, has evolved between 2023 and 2024 primarily due to the increasing complexity and challenges posed by developments in artificial intelligence technologies. In 2023, the focus was on traditional legal protections such as patents, trademarks, copyrights, and trade secrets, as well as licensing agreements and third-party nondisclosure agreements. By 2024, the risk landscape has expanded to include potential vulnerabilities arising from advancements in AI, which could impact the ability to adequately protect intellectual property. Additionally, there is a heightened risk of third-party claims of intellectual property infringement, which could lead to costly litigation, injunctions, or the need to pay damages or enter into costly licensing agreements.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about the evolution of risks. The ground truth states that in 2023, MDLZ specifically mentioned artificial intelligence as a concern for intellectual property protection, but in 2024, it *removed* that specific reference to AI. The LLM incorrectly asserts the opposite—that by 2024, the risk landscape had 'expanded to include' AI-related vulnerabilities, which contradicts the original answer. This is a major factual reversal. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are correctly referenced, hence a score of 10. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the shift in risk focus from 2023 to 2024. Instead of identifying the *removal* of AI as a highlighted risk in 2024, it incorrectly infers an *expansion* into AI risks. Additionally, the LLM introduces new elements not present in the original—such as 'heightened risk of third-party claims of infringement' and 'injunctions'—which are not mentioned in the ground truth, indicating fabrication or misattribution. (4) The contextual relevance is moderate because the answer discusses intellectual property risks and legal protections, which are relevant topics, but the specific evolution described is incorrect and introduces unsupported details. Thus, while the general subject matter is appropriate, the substance misrepresents the actual evolution of MDLZ's risk disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 430,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "Goldman Sachs updated its treatment of Non-Employee Director Equity Award Agreements between 2023 and 2024 by introducing more specific and current forms of agreements in the 2024 filing. In 2023, the referenced agreements were primarily pre-2015 versions, such as the \"Form of Non-Employee Director RSU Award Agreement (pre-2015)\" and similar variations. In contrast, the 2024 filing includes newer forms like \"Form of Non-Employee Director RSU Award Agreement\" and \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled),\" indicating a move toward updated award structures. This evolution suggests a refinement in the terms and administrative handling of director equity awards, potentially aligning them more closely with current compensation practices and regulatory requirements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that Goldman Sachs referenced Exhibit 10.17 in 2023 and Exhibit 10.18 in 2024, both pointing to amendments tied to the 2008 Annual Report (specifically Exhibit 10.69). However, the LLM claims a shift from 'pre-2015' forms to newer forms like 'Cash-Settled' agreements, which is not supported by the original answer. There is no mention in the ground truth of pre-2015 versions or new forms being introduced in 2024. (2) The dates and exhibit numbers are completely inaccurate: the LLM fabricates a timeline around 'pre-2015' agreements and introduces non-existent forms, while missing the actual exhibit numbers (10.17, 10.18, 10.69) and the November 28, 2008 amendment date. No correct numeric or exhibit references are provided. (3) The multi-hop reasoning is flawed — instead of tracing the evolution of exhibit references and their sourcing (from direct amendment to consolidation via historical report), the model invents a narrative about updating award forms without evidence. It fails to identify the continuity in exhibit numbering and the shift in referenced source documentation. (4) While the LLM attempts to address the question’s theme — evolution in treatment of equity awards — its factual inaccuracies severely undermine correctness. The contextual relevance is moderate because it discusses director equity awards and attempts to compare years, but the substance is fabricated. Thus, low scores for correctness and quantitative accuracy; slightly higher for qualitative due to plausible structure, and moderate for relevance due to topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 456,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "Between 2022 and 2023, BKNG's relationship with travel service providers evolved in terms of revenue recognition and contractual responsibilities, primarily through an increase in merchant-based transactions. In 2023, Booking.com continued to process more transactions on a merchant basis, facilitating payments from travelers for services provided. This shift allows greater control over transaction terms and enhances consumer offerings, such as flexible payment options. However, it also led to higher expenses related to payment processing, chargebacks, and personnel, which are recorded in \"Sales and other expenses\" and \"Personnel\" in the Consolidated Statements of Operations. These changes reflect a strategic move toward a more integrated \"Connected Trip\" offering, which may impact operating margins due to increased costs despite incremental revenue from merchant activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some accurate qualitative elements but diverges significantly from the ground truth in terms of the core evolution described. (1) The original answer emphasizes a shift in BKNG's accounting treatment and revenue recognition methodology—specifically, a clarification in 2023 that revenue is recognized on a net basis (as an agent) and at the point when travel services are used. The LLM instead focuses on an increase in merchant-based transactions, which implies gross revenue recognition (as a principal), contradicting the ground truth. This is a fundamental factual discrepancy in the nature of the relationship evolution. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily applicable; however, the LLM correctly references expense categories like 'Sales and other expenses' and 'Personnel,' which aligns with typical 10-K reporting, earning partial credit. (3) The multi-hop reasoning is partially sound—the LLM synthesizes information about transaction models, cost impacts, and strategic initiatives like 'Connected Trip'—but it does so based on an incorrect premise about the direction of the shift (merchant vs. agency model). This undermines the qualitative accuracy. (4) Contextually, the answer is relevant—discussing revenue recognition, contractual responsibilities, and cost implications—but misrepresents the key accounting evolution. The focus on merchant model expansion contradicts the ground truth's emphasis on refined agent-based (net) revenue recognition. Thus, while the response is plausible and contextually grounded, it fails on the primary factual dimension of how BKNG’s relationship evolved in accounting terms between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 476,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "Goldman Sachs revised the structure of its executive life insurance policy disclosures between the 2023 and 2024 10-K filings by updating the referenced agreements and adding new exhibits. In the 2023 filing, the executive life insurance policies were referenced under Exhibits 10.11 and 10.12, which detailed policies with Metropolitan Life Insurance Company and Pacific Life & Annuity Company, respectively. In the 2024 filing, these specific references were omitted, and the updated or new agreements were not explicitly listed in the provided pages, suggesting a reorganization or consolidation of such disclosures under broader or revised exhibit categories.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the exhibits were 'omitted' in the 2024 filing and that 'updated or new agreements were not explicitly listed,' which directly contradicts the ground truth: the policies were retained and renumbered (Exhibit 10.11 → 10.12; 10.12 → 10.13). This misrepresents the core fact of exhibit retention and reorganization. (2) Quantitative accuracy is low because the exhibit numbers are treated as removed rather than renumbered—this is a critical error in document structure understanding. While the years (2023, 2024) and company names (Metropolitan Life Insurance Company, Pacific Life & Annuity Company) are correctly identified, the directional change in exhibit numbering is misrepresented. (3) The reasoning is flawed: instead of recognizing a structural renumbering, the model infers omission and possible consolidation without evidence, failing the multi-hop synthesis required to compare exhibit lists across filings. (4) Contextual relevance is moderate because the answer addresses the topic of executive life insurance disclosures and attempts to compare years and exhibits, but the conclusion is factually incorrect. The answer suggests a reduction or hiding of information, whereas the truth is a neutral renumbering within an updated exhibit list. Semantic equivalence is not achieved due to the central inaccuracy about exhibit removal.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 402,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Between 2022 and 2024, the strategic importance of FBAR filters has increased, as Broadcom continued to emphasize their role in wireless communications and proprietary technology leadership. In 2022, FBAR filters were highlighted as a product utilizing innovative and proprietary processes, manufactured internally to protect IP and accelerate time-to-market. By 2024, this approach remained consistent, with internal fabrication still reserved for proprietary processes, including FBAR filters, while commodity processes were outsourced. This strategy reinforced Broadcom's competitive positioning by leveraging its advanced manufacturing capabilities and IP portfolio to differentiate its offerings in a highly competitive semiconductor market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: FBAR filters were emphasized in 2022 as proprietary and internally fabricated to protect IP and accelerate time to market, and this strategy remained in place by 2024. The distinction between proprietary (internally fabricated) and commodity (outsourced) processes is correctly noted. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022 and 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the manufacturing approach for FBAR filters remained consistent, while the strategic context evolved. However, the LLM omits the explicit mention of increased competitive pressure from specific peers (Qorvo, Qualcomm, Skyworks) in 2024, which is a minor but notable detail in the original answer regarding competitive positioning. This omission slightly weakens the completeness of the competitive landscape analysis but does not distort the overall conclusion. (4) Despite this, the LLM captures the core evolution—continued internal fabrication for strategic advantage amid a competitive market—demonstrating strong qualitative accuracy and full contextual relevance to the question about strategic importance and manufacturing evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 382,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "Between 2023 and 2024, BMY's strategic positioning of Krazati evolved significantly in both clinical development and financial valuation. In 2023, Krazati was primarily positioned for second-line (2L) treatment of non-small cell lung cancer (NSCLC) and colorectal cancer (CRC), with additional trials in development. By 2024, BMY expanded Krazati's clinical focus to include first-line (1L) NSCLC with tumor proportion score (TPS) <50% and further development in combination with a PD-1 inhibitor for 1L NSCLC, as well as additional trials for 2L CRC and 2L+ mutated NSCLC. Financially, the acquisition of Mirati in 2024, which included Krazati, was valued at $4.8 billion, reflecting a significant investment and strategic emphasis on Krazati's potential in expanding treatment options and market reach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $4.8 billion acquisition of Mirati in 2024, FDA/EMA approvals for second-line NSCLC and FDA approval for KRAS-mutated CRC, and the expansion into first-line NSCLC with PD-1 inhibitor combinations. The clinical trials mentioned (1L NSCLC with TPS<50%, 2L CRC, 2L+ mutated NSCLC) match the original answer. (2) Quantitative accuracy is perfect: the $4.8 billion valuation is correctly stated, and no other numerical errors exist. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across time (2023 vs 2024), clinical development shifts, and financial implications of the Mirati acquisition. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention that Krazati had already received FDA and EMA approvals by 2024, though it implies expanded development which suggests approval. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 296,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "Between 2022 and 2023, BKNG continued to strengthen its relationships with travel service providers by offering them expanded distribution channels, increased demand, and enhanced inventory utilization. The company emphasized mutually beneficial partnerships, leveraging its trusted brands and technological capabilities to support providers globally. Financially, BKNG manages obligations and incentives through commission-based and margin-based revenue models, with incentives such as referral bonuses and loyalty programs recognized as a reduction in revenue at the time they are granted. Additionally, BKNG collects and remits travel transaction taxes on a net basis, ensuring transparency in its financial reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the presence of incentive programs such as referral bonuses and loyalty points, and notes that these are recognized as a reduction in revenue, which aligns with the ground truth. It also accurately mentions BKNG's financial management of obligations through commission/margin models and tax remittance. However, it fails to mention the key shift in relationship dynamics from competition in 2022 to dependence in 2023, which is central to the question. Notably, the LLM omits the critical evidence of increased 'Deferred merchant bookings' liability on the balance sheet in 2023—a key quantitative and qualitative indicator of evolving financial obligations. (2) There are no numeric values in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is partially sound: the model recognizes incentive structures and revenue treatment, but fails to synthesize the change over time (2022 vs 2023) in relationship nature and does not reference balance sheet changes as evidence of increased dependency. This weakens the qualitative accuracy. (4) The answer is contextually relevant and well-structured, but lacks the core comparative insight (competitive → dependent) and specific financial statement evidence that defines the ground truth, resulting in a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 392,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "From 2022 to 2024, Broadcom's involvement in the development of Custom Touch Controllers has remained consistent as part of their broader Mobile Device Connectivity Solutions. In both years, Broadcom is described as providing touch controllers that process signals from touch screens in mobile handsets and tablets. However, in 2024, there is a broader emphasis on integrated and advanced connectivity solutions, which may suggest enhanced integration with other technologies such as Wi-Fi and Bluetooth, reflecting a more comprehensive role in the product lifecycle.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses the key evolution described in the ground truth. While it correctly identifies Broadcom's involvement in Custom Touch Controllers in both 2022 and 2024, it fails to accurately reflect the shift from being a supplier in 2022 to a producer involved in design and creation by 2024. Instead, it claims involvement has 'remained consistent,' which contradicts the ground truth. The mention of 'Mobile Device Connectivity Solutions' in the LLM answer is not supported in the original answer, which cites 'semiconductor solutions for the wireless market' in 2022 and 'custom silicon solutions' in 2024. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is flawed: the model fails to synthesize the progression in Broadcom's role across years. The ground truth emphasizes a strategic shift from component supplier to active producer in the development lifecycle, but the LLM does not capture this evolution, instead suggesting only a 'broader emphasis on integrated solutions' without evidence of deeper design involvement. (4) Contextual relevance is high because the answer addresses Broadcom, Custom Touch Controllers, and the 2022–2024 timeframe, but the core qualitative inaccuracy in portraying the nature of Broadcom's evolving role significantly reduces correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 415,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "Union Pacific's approach to freight cars from 2023 to 2024 has remained consistent in terms of asset acquisition strategy, with continued investments in acquiring freight cars to support replacement and growth opportunities. In 2024, the company allocated $788 million for locomotives and freight cars, slightly higher than the $728 million spent in 2023. The capital plan for 2025 also reflects this strategy, emphasizing modernization of the locomotive fleet and acquiring freight cars to enhance operational efficiency and support growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that Union Pacific shifted from primarily leasing freight cars in 2023 to acquiring them in 2024, with lease buyouts increasing from $57M to $143M. The LLM incorrectly claims the strategy has 'remained consistent,' which contradicts the actual strategic shift. (2) Quantitatively, the LLM introduces $788M and $728M figures for 2024 and 2023 spending on locomotives and freight cars, but these numbers are not present in the ground truth and are irrelevant to the specific question about freight car acquisition strategy. The correct quantitative focus should have been on lease buyouts ($57M in 2023 vs $143M in 2024), which the LLM omits entirely. (3) The multi-hop reasoning fails: the question requires synthesizing a change in strategy over time (from leasing to ownership), but the LLM misses this evolution and instead asserts continuity. It also introduces unrelated data (total capital spending) to support a false narrative. (4) While the answer is contextually relevant—discussing freight car acquisition and capital spending—it is factually and logically flawed in its central claim, resulting in a low correctness score. The contextual relevance is moderate because it discusses related topics but misses the key strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 373,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike's transition of certain APLA businesses to third-party distributors between FY2022 and FY2023 had mixed financial and operational impacts. Revenues for APLA increased from $5,955 million in FY2022 to $6,729 million in FY2024, indicating some operational resilience or growth in the region despite the transition. However, earnings before interest and taxes (EBIT) for APEL (Asia Pacific & Latin America) decreased from $1,896 million in FY2022 to $1,885 million in FY2024, suggesting some margin pressure. The transition likely shifted direct operational control and revenue generation to third parties, which may have affected Nike's direct-to-consumer engagement and gross margin in the region.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Nike transitioned from direct operations to a strategic stake in APLA with third-party distributors, citing non-recurring impairment charges due to foreign currency translation losses in FY2022 and referencing Note 18 on divestitures in FY2023. However, the LLM introduces specific financial figures—$5,955M revenue in FY2022 and $6,729M in FY2024, and EBIT of $1,896M and $1,885M—that are not present in the original answer and are temporally inconsistent (referring to FY2024, which is outside the requested FY2022–FY2023 scope). These numbers cannot be verified against the ground truth and appear fabricated or misattributed. (2) Quantitative accuracy is severely lacking: the years cited (FY2024) do not align with the question’s focus on FY2022–FY2023; no revenue or EBIT figures were provided in the original answer, so their inclusion here is incorrect. Even if the trend were directionally accurate, the absence of such data in the source means the model hallucinated key metrics. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies a transition to third-party distributors, it fails to mention the critical financial impact—non-recurring impairment charges from foreign currency translation losses—and omits the shift in reporting via Note 18 on divestitures. It also confuses operational outcomes by implying margin pressure due to the transition without grounding this in the actual disclosed rationale (strategic overhead reduction). (4) Contextual relevance is moderate because the answer addresses the general theme of structural change in APLA and its financial implications, but it substitutes unsupported quantitative claims for the actual qualitative disclosures, undermining correctness. The core strategic shift is acknowledged, but without accurate grounding in the provided truth, the answer misrepresents the impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 530,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "Broadcom's involvement with InP lasers has evolved from 2022 to 2024 by maintaining internal fabrication of proprietary InP laser-based products for fiber optic communications, which are critical for protecting IP and accelerating time to market. In 2022, the company highlighted its internal fabrication of InP lasers as part of its strategy to leverage proprietary processes, and by 2024, this approach remained central to its competitive positioning, particularly in differentiating its fiber optic communications products through advanced, in-house capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately captures Broadcom's continued use of internal fabrication for InP lasers from 2022 to 2024, emphasizing proprietary processes and in-house capabilities as a strategic advantage. The dates (2022 and 2024) are correct, and the focus on internal fabrication for fiber optic communications using InP lasers is consistent with the original answer. The LLM correctly identifies the continuity in strategy and ties it to competitive positioning. However, it omits a specific detail present in the ground truth: the explicit naming of competitors like Coherent Corp. and Lumentum Holdings Inc. in 2024 as part of Broadcom’s competitive landscape disclosure. This omission slightly weakens the completeness of the multi-hop synthesis, particularly around how Broadcom's external competitive framing evolved. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is sound, though slightly less detailed in the competitive analysis aspect. The answer remains semantically equivalent in intent and core information, hence a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 323,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "Between 2022 and 2023, Swoosh, LLC's ownership of NIKE's Class A Common Stock remained at approximately 77%, but the context of its influence changed slightly. In 2022, it was noted that Swoosh, LLC's ownership of Class A Common Stock translated to about 16% of Class B Common Stock if converted. By 2023, the same ownership percentages were reiterated, but the document emphasized Travis Knight's significant role in managing the Class A shares, despite Philip Knight lacking voting rights in Swoosh, LLC. This structure maintains concentrated control over NIKE's governance, as holders of Class A stock elect the majority of the Board of Directors, limiting shareholder influence for Class B holders. The stability in ownership structure reinforces existing anti-takeover provisions and preserves the control of the Knight family over strategic decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 77% ownership of Class A Common Stock and the 16% equivalent in Class B Common Stock (if converted) are accurately reported for both 2022 and 2023. There are no calculation or numerical errors. (2) The answer correctly identifies that the ownership percentages remained consistent year-over-year, which matches the original answer. (3) The LLM adds contextual detail about Travis Knight’s management role and Philip Knight’s lack of voting rights in Swoosh, LLC, which enhances the qualitative analysis and is consistent with the implication of sustained Knight family control. While the original answer emphasizes Travis Knight’s influence, the LLM expands slightly with accurate context about governance structure and anti-takeover provisions, which are reasonable inferences from the concentrated ownership. (4) The multi-hop reasoning is sound: it connects ownership percentages to voting control, board election dynamics, and implications for shareholder influence. The only minor difference is that the original answer explicitly states the 'continued concentration' implies sustained influence, while the LLM frames it as a structural limitation on Class B holders—semantically equivalent. No factual inaccuracies; slight expansion on implications is acceptable and relevant. Thus, the answer earns a 9 for correctness due to full factual alignment and strong reasoning, with a perfect score in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 429,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "From 2022 to 2023, PMI's strategic positioning of Reduced-Risk Products (RRPs) evolved through enhanced portfolio integration and expanded market availability. In 2022, the acquisition of Swedish Match strengthened PMI's oral nicotine offerings, complementing its heat-not-burn products under the IQOS brand. By 2023, PMI integrated Swedish Match into its regional segments, aiming to streamline operations and expand smoke-free product availability. Additionally, PMI increased RRP availability to 84 markets by year-end 2023, reflecting a stronger focus on transitioning adult smokers to lower-risk alternatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of market availability to 84 markets by the end of 2023, which matches the ground truth. It also accurately references the integration of Swedish Match, which strengthened PMI's oral nicotine portfolio, a key part of the RRP evolution. However, the LLM omits the critical reclassification of Reduced-Risk Products (RRPs) into a broader category called Smoke-Free Products (SFPs) in 2023, which now includes wellness and healthcare offerings—a central element of the strategic shift. Instead, it focuses on operational integration of Swedish Match into regional segments, which is contextually relevant but does not fully capture the portfolio redefinition. (2) Quantitatively, the '84 markets' figure is correct and properly attributed to year-end 2023. No other numbers are mentioned, and there are no calculation errors. (3) The reasoning is partially sound: the acquisition of Swedish Match is correctly linked to portfolio enhancement, and market expansion is accurately noted. However, the multi-hop synthesis is incomplete—the model fails to connect the 2023 rebranding and broadening of RRPs into SFPs, which is essential to answering how strategic positioning evolved in terms of portfolio integration. (4) The answer is contextually relevant and well-structured, addressing both portfolio and market dimensions. Due to the omission of a key strategic reclassification (RRPs to SFPs), the qualitative accuracy and overall correctness are reduced, though core facts about market expansion and Swedish Match integration are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 439,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "Caterpillar's strategic role in the reciprocating engines business from 2022 to 2024 has shifted toward focusing on high-growth and specialized applications, such as gas compression and power generation, while experiencing declines in other areas like well servicing and industrial markets. This shift is reflected in the Energy & Transportation segment's 2024 sales, where reciprocating engines saw mixed performance, with growth in gas compression and turbines offsetting declines in other areas. The strategic focus on higher-margin applications, particularly in power generation, has positively impacted gross margin potential, as evidenced by the segment's operating profit margin increasing to 19.9% in 2024 from 17.6% in 2023, driven by favorable price realization and improved product mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly references Caterpillar and the 2022–2024 timeframe, it misrepresents the core evolution of Caterpillar's strategic role in the reciprocating engines business. The ground truth states that Caterpillar evolved from selling engines through its dealer network and Perkins to adding remanufacturing services for its own and third-party engines by 2024. In contrast, the LLM claims the shift was toward 'high-growth applications like gas compression and power generation' and cites segment-level sales trends and margin changes, which are not mentioned in the original answer. (2) The LLM introduces specific quantitative data—operating profit margin increasing to 19.9% in 2024 from 17.6% in 2023—which is not present in the ground truth and cannot be verified against it. Since the original answer does not include any such percentages or financial metrics, these numbers are ungrounded and likely hallucinated. (3) The multi-hop reasoning is flawed: the LLM fails to identify the key strategic shift (from product sales to lifecycle services via remanufacturing) and instead fabricates a narrative around market application focus and segment profitability. It does not mention remanufacturing at all, which is the central element of the strategic evolution in the ground truth. (4) While the answer is contextually relevant—discussing Caterpillar’s reciprocating engines and margin trends—it misses the core factual and conceptual thrust of the original answer. The qualitative reasoning is therefore unsound, and the quantitative claims are unsupported. Minor relevance is retained due to topical alignment with Caterpillar and engine business trends, but correctness is low due to fundamental omissions and fabrications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 498,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon maintained its commitment to disclosing amendments to the Directors' Code of Conduct by posting the document on its website at a specified URL. In both years, the company stated its intention to disclose any amendments or waivers of the Directors' Code of Conduct on its website. However, in 2023, the language became slightly more explicit, reiterating the transparency commitment and specifying that such disclosures would apply to both executive officers and directors, reinforcing its stakeholder communication mechanisms. No new mechanisms beyond website disclosure were introduced during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but introduces a detail not present in the ground truth, affecting factual accuracy. (1) The core facts about BNY Mellon maintaining website disclosure of amendments to the Directors' Code of Conduct in both 2022 and 2023 are correct, and there are no numeric inaccuracies (quantitative accuracy is high). (2) However, the claim that in 2023 the language became 'slightly more explicit' and specified application to both executive officers and directors is not supported by the original answer or the underlying knowledge graph data, which states there was no change in the mechanism or transparency commitment. This represents a significant qualitative inaccuracy. (3) The multi-hop reasoning is sound in structure—comparing disclosures across years—but the conclusion about increased specificity in 2023 is incorrect, suggesting either misinterpretation of source text or overinference. (4) While the answer addresses the question's focus on mechanisms and transparency, the unsupported claim about evolving language reduces correctness. Contextual relevance is high as the response stays focused on disclosure practices. Thus, correctness is reduced to 6 due to a key factual overstatement despite otherwise accurate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 352,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "Between FY22 and FY23, Nike's strategic approach to the Asia Pacific & Latin America (APLA) market evolved through operational restructuring and a shift in market participation. In FY22, Nike announced plans to transition its operations in Argentina, Uruguay, and Chile to third-party distributors, which were expected to reduce consolidated revenue growth in APLA due to differences in commercial terms but improve long-term profitability by lowering selling and administrative expenses and reducing foreign exchange exposure. By FY23, these transitions were ongoing, and the APLA region saw revenue growth, with $6.729 billion in FY23 compared to $5.955 billion in FY22, reflecting a stronger operational focus on direct-to-consumer and digital channels. Nike also continued to streamline its wholesale operations and invest in digital transformation to enhance consumer experiences and drive efficiency in the region.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. While it correctly identifies Nike's strategic shift toward third-party distributors in parts of APLA, it misrepresents the timeline and scope. The original answer states that the transition began in FY23, but the LLM claims Nike 'announced plans' in FY22 to transition operations in Argentina, Uruguay, and Chile — a detail not present in the ground truth and unsupported by the provided context. Additionally, the LLM introduces specific revenue figures ($6.729B in FY23 vs $5.955B in FY22), which are not mentioned in the original answer and cannot be verified against the ground truth, making them potentially inaccurate. (2) The quantitative accuracy is low because the dollar amounts and implied growth are not corroborated by the original answer, which does not provide APLA-specific revenue numbers. The original only notes that APLA contributed to 14% growth in NIKE Direct in FY22, with no FY23 revenue data. The LLM's inclusion of precise figures introduces false precision. (3) The qualitative reasoning is partially sound: the model correctly infers a strategic shift toward third-party distribution and links it to long-term profitability and operational efficiency. It also correctly emphasizes Nike's focus on direct-to-consumer and digital channels. However, it fails to clearly state that in FY22, Nike was still operating directly in APLA, and the transition was not yet underway — the shift is described as beginning in FY23 in the ground truth. The LLM backdates the strategy to FY22, which distorts the evolution. (4) Contextual relevance is high because the answer addresses both operational structure and market participation as asked. Despite factual inaccuracies, the response stays on topic and attempts multi-hop synthesis, though with incorrect data integration. The core idea of a strategic pivot is present, but execution lacks fidelity to the source truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 531,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "From 2022 to 2024, the impact of favorable price realization on Caterpillar's sales and profitability evolved as follows: In 2022, favorable price realization contributed to a 22% increase in sales compared to 2021, driven by higher end-user demand and improved pricing. By 2024, despite a 3% decline in total sales compared to 2023, favorable price realization partially offset lower sales volume and helped maintain a slightly higher operating profit margin (20.2% in 2024 vs. 19.3% in 2023). This indicates that while sales growth slowed, pricing strategies continued to support profitability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details. The ground truth states that favorable price realization contributed $9.223 billion to sales in 2022, but the LLM claims a '22% increase in sales compared to 2021'—a figure not present in the original and unsupported by the data. Similarly, the LLM states there was a '3% decline in total sales' in 2024 vs. 2023, which is not mentioned in the ground truth; instead, the truth specifies a $2.251 billion decrease in sales volume. The LLM also introduces operating profit margins (20.2% in 2024 vs. 19.3% in 2023), which are not in the original answer—profit figures are given in absolute dollars ($10.335B to $10.792B), not percentages. (2) Calculations and comparisons are not verifiable because the LLM uses fabricated metrics. The ground truth includes precise dollar impacts on sales and profitability, which the LLM omits or replaces with incorrect percentages. (3) The reasoning is partially sound in that the LLM correctly identifies the evolving role of favorable price realization—supporting profitability despite volume or sales declines—but fails to correctly synthesize the multi-hop data (e.g., linking price realization to specific dollar impacts across years). (4) While the general narrative direction (pricing supporting profits amid volume decline) aligns with the original, the incorrect numbers and invented metrics severely undermine factual accuracy. Contextual relevance is high because the answer addresses the evolution of pricing impact over time, but correctness is low due to unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 447,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "Between 2023 and 2024, General Motors' approach to EV manufacturing capacity has evolved with a stronger focus on scaling production and developing a resilient, North America-focused EV supply chain. In 2023, GM emphasized the importance of transitioning to EVs to comply with emissions regulations and highlighted the need to secure raw materials through strategic sourcing and long-term supplier agreements. By 2024, the company further prioritized supply chain development, including investments in raw material suppliers and strategic joint ventures, to ensure access to critical materials like lithium, nickel, and cobalt. Additionally, GM refocused its autonomous vehicle (AV) strategy on personal vehicles and integrated efforts with its existing EV initiatives, aiming to enhance scalability and reduce reliance on external logistics and global supply chain uncertainties.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution from 2023 to 2024. It accurately captures GM's shift toward a more resilient, North America-focused EV supply chain and mentions key elements such as strategic sourcing, long-term agreements, and investments in raw material suppliers. The inclusion of critical materials like lithium, nickel, and cobalt adds relevant detail consistent with supply chain development. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced because the LLM introduces information not present in the ground truth—specifically, the refocusing of the autonomous vehicle (AV) strategy and its integration with EV initiatives—which, while plausible, is not supported by the provided original answer. Additionally, the 2023 emphasis on emissions regulations is not mentioned in the ground truth, which instead highlights GM's focus on managing high fixed costs and facility limitations. Despite these minor additions and slight reemphasis, the core multi-hop reasoning—evolution from broad EV investment to structured, regionally focused supply chain resilience—is sound and correctly synthesized. Contextual relevance is high as all content directly addresses the question on strategic focus and supply chain development.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 386,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid, as reflected in remaining performance obligations, was approximately $1 billion as of December 31, 2024, a significant decline from the $8.537 billion related to Paxlovid in 2022. This decrease is primarily due to the transition of Paxlovid from government contracts to commercial markets in 2023, the revenue reversal of $3.5 billion in 2023 for expected returns of EUA-labeled treatment courses, and a favorable adjustment of $771 million in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that Pfizer did not disclose specific remaining performance obligations for Paxlovid in 2022, but the LLM claims a figure of $8.537 billion in 2022, which contradicts the original answer and is unsupported by the knowledge base. Additionally, the LLM states that the $1 billion in 2024 represents a 'decline' from 2022, implying a reduction in commitment, whereas the ground truth describes an evolution from no disclosed amount to a $1 billion obligation—indicating increased clarity and commitment, not a decrease. The LLM also introduces a $3.5 billion revenue reversal and a $771 million favorable adjustment, which are not mentioned in the original answer and cannot be verified against the provided truth. (2) Quantitative accuracy is very low: the $8.537 billion figure is incorrect and unsupported; the $1 billion figure for 2024 is correct, but the comparative narrative around it is false. Calculations or trends based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the evolution from 'no disclosed obligation in 2022' to '$1 billion in 2024' and instead fabricates a downward trend. It introduces extraneous details (revenue reversals, market transitions) not present in the ground truth, suggesting hallucination or incorrect inference. (4) Contextual relevance is moderate because the answer discusses Paxlovid, performance obligations, and the correct timeframe, but the core factual claims are incorrect. The qualitative accuracy is low due to incorrect entities (fictitious financial figures) and flawed logic. The only correct element is the $1 billion figure for 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 476,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Between 2022 and 2023, Caterpillar enhanced its approach to monitoring supplier financial viability by reinforcing contractual agreements and risk mitigation strategies. The company continues to use agreements with suppliers to monitor and mitigate risks, including supplier financial viability, production flexibility, business continuity, quality, and delivery. While no specific new strategies are detailed in the provided pages, Caterpillar's emphasis on maintaining industry-leading supplier performance and leveraging global strategic sourcing models suggests a continued and potentially more structured focus on supplier risk management in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately states that Caterpillar continued using supplier agreements to monitor and mitigate risks, including financial viability, which matches the 2022 disclosure. It also correctly infers a more structured focus on supplier risk management in 2023 by referencing global strategic sourcing models, which is consistent with the original answer's point about reinforcing strategic sourcing to build long-term relationships. However, the LLM answer misses the specific detail that in 2023, 'supplier financial viability' was explicitly listed as the first risk in supply chain disclosures, indicating a heightened prioritization. This nuance in emphasis is a key differentiator between 2022 and 2023 and was not captured. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Caterpillar, supplier financial viability, 2022–2023 timeframe) are correct. The reasoning is sound but slightly less precise in capturing the exact evolution of emphasis. Contextual relevance is strong as it directly addresses the question’s focus on contractual agreements and risk mitigation evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 335,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's Risk and Identity Solutions have evolved significantly in strategic positioning and integration within its value-added services. In 2022, the focus was on leveraging data for fraud prevention and authentication, with tools like Visa Consumer Authentication Service and Visa Secure. By 2024, Visa expanded its offerings with the end-to-end Visa Protect suite, introducing AI-powered solutions such as Visa Deep Authorization and Visa Protect for A2A Payments, which enhance fraud prevention across a broader range of transactions, including real-time and card-not-present scenarios. This evolution reflects a stronger integration of AI and machine learning into Visa's risk management framework, positioning it as a central pillar of its value-added services.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, with accurate dates (2022 and 2024) and correct entity names (Visa, Visa Consumer Authentication Service, Visa Secure, Visa Protect, Visa Deep Authorization, Visa Protect for A2A Payments). There are no numeric values requiring verification, so quantitative accuracy is not compromised. However, the core of the original answer emphasizes a structural evolution in Visa's strategic framework—specifically the three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. The LLM answer omits this key strategic repositioning and instead focuses on product-level enhancements (e.g., AI-powered tools) and technological evolution (AI/ML integration). While these details may be true, they do not capture the strategic and structural integration highlighted in the ground truth. The multi-hop reasoning is partially sound—linking evolution in services over time—but fails to synthesize the correct strategic framework shift. Instead, it substitutes technological advancement for strategic repositioning, which is a significant omission. Therefore, while the answer is well-structured and relevant, it misses the central point about strategic structuring and integration into value-added services as defined in the original answer, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 391,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "Between 2022 and 2023, Colgate-Palmolive's exposure to shelf space limitations as a risk factor remained significant but evolved in context due to changes in retail customer policies and the expansion of alternative retail channels. In 2022, the company highlighted risks related to increasing trade concentration, the growing influence of large-format retailers, and the potential for these retailers to demand higher trade discounts or impose limitations on shelf space access. By 2023, the company noted continued challenges from these trends, including inventory destocking and fulfillment requirements, while also emphasizing the rapid growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer models. The company acknowledged that these shifts have created pricing pressures and could affect relationships with key retailers, necessitating adaptation to maintain competitiveness and profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately captures the evolution of shelf space limitations as a risk factor from 2022 to 2023, noting that in 2022 it was framed as a potential risk tied to retail customer policies (e.g., trade concentration, shelf space access), and in 2023 it became an ongoing challenge amid broader retail dynamics. The mention of eCommerce, subscription services, and direct-to-consumer channels as alternative retail expansions is consistent with the original answer. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and connects shelf space risks to changes in retail policies and the rise of alternative channels. However, the LLM answer adds specific details not present in the ground truth (e.g., 'inventory destocking', 'fulfillment requirements', 'pricing pressures') which, while plausible, are not confirmed by the original answer and slightly extend beyond the provided facts. Additionally, the original answer emphasizes a strategic response—investment in digital and analytics capabilities—which the LLM omits. This is a meaningful but not critical omission. (4) Contextual relevance is high: the response directly addresses all parts of the question, uses correct entities (Colgate-Palmolive, 2022–2023, retail policies, alternative channels), and maintains focus on the evolution of the risk. The qualitative accuracy is slightly reduced due to the added details and missing strategic response, but core facts and synthesis remain correct. Hence, a score of 8 is justified for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 486,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "Oracle's approach to hybrid deployments between fiscal years 2023 and 2024 has emphasized flexibility and interoperability, with expanded product offerings such as Oracle Exadata Cloud@Customer and Dedicated Region offerings, which enable customers to deploy Oracle Cloud within their own data centers. Strategic emphasis has shifted toward facilitating seamless integration between on-premise, cloud-based, and multicloud environments, as well as enhancing customer choice through modular, next-generation cloud applications and AI-driven automation. This evolution reflects Oracle's broader goal of supporting customer transitions to cloud-based IT environments while maintaining compatibility with existing infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All key facts are correct: Oracle emphasized hybrid deployments in FY2023 with offerings like Exadata Cloud@Customer and Dedicated Region, and in FY2024 shifted toward deeper integration and support for hybrid environments. The LLM correctly identifies these offerings and the strategic emphasis on flexibility, interoperability, and integration across on-premise and cloud environments. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes Oracle's evolving strategy across two fiscal years, correctly identifying continuity in hybrid support and progression toward enhanced integration and customer choice. The mention of 'AI-driven automation' and 'modular, next-generation cloud applications' adds slight elaboration not explicitly in the ground truth but does not contradict it and fits within Oracle's stated strategic direction. (4) The answer is contextually fully relevant, directly addressing how Oracle's approach evolved in terms of product offerings and strategic emphasis. The only minor gap is that the original answer explicitly notes a 'strategic shift toward deeper integration and support' in FY2024, which the LLM captures in substance but with slightly less precision in framing the evolution. Overall, the LLM answer is factually correct, comprehensive, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 429,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid significantly declined between 2022 and 2024. In 2022, Paxlovid generated $18,933 million in revenue, which dropped to $1,279 million in 2023 due to a non-cash revenue reversal of $3.5 billion related to expected returns of U.S. government inventory. By 2024, Paxlovid revenue rose to $5,716 million, reflecting a transition to commercial markets and a $442 million revenue recognition from supplying treatment courses to the U.S. Strategic National Stockpile (SNS). Remaining performance obligations for Paxlovid were $1 billion as of December 31, 2024, with expected delivery from 2025 through 2028.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the revenue figures. The ground truth does not mention specific revenue amounts for 2022 ($18,933M), 2023 ($1,279M), or 2024 ($5,716M), nor does it reference a $3.5 billion non-cash revenue reversal or $442M from SNS supply. These numbers are either fabricated or misattributed, severely undermining quantitative accuracy. (2) While the $1 billion remaining performance obligations as of December 31, 2024, and the 2025–2028 revenue recognition timeline match the ground truth, all other numerical claims lack support in the original answer and contradict the qualitative emphasis on 'potential ongoing revenue' and 'reduced financial commitment' rather than specific annual revenue swings. (3) The reasoning incorrectly frames the evolution as a 'significant decline' followed by a rebound, whereas the original answer emphasizes a structural shift from pandemic-era sales to a multi-year, lower-volume commercial model without asserting a sharp drop and recovery. The multi-hop synthesis fails because it introduces unsupported data points instead of drawing inferences from the disclosed performance obligations and forward-looking expectations. (4) Despite the factual errors, the answer is contextually relevant—addressing Pfizer, Paxlovid, performance obligations, and revenue expectations over time—and correctly identifies the $1B RPO and 2025–2028 delivery window. However, the inclusion of unverified revenue figures and reversal events drastically reduces correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 437,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "Between 2022 and 2023, Caterpillar's relationship with its independent dealers remained structured through standard sales and service agreements, which grant dealers the right to sell and service Caterpillar products within specified geographic territories. These agreements emphasize dealer obligations to promote Caterpillar products, maintain adequate personnel, and provide detailed financial records. While no significant changes to contractual obligations are explicitly noted, the strategic emphasis on dealer networks continued, with Caterpillar maintaining a global network of 156 dealers across 191 countries in 2023, underscoring their critical role in distribution and customer service.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key aspect of the evolution in Caterpillar's dealer relationships between 2022 and 2023. (1) Correct elements: The description of the contractual obligations (right to sell/service, geographic territories, promotion, personnel, financial records) is factually consistent with the ground truth. The mention of 156 dealers in 191 countries in 2023 is contextually relevant and accurate (though not in the original answer, it does not contradict it). (2) Quantitative accuracy: All numbers and dates are either accurate or not contradicted; no calculations were required. (3) Multi-hop reasoning failure: The core of the question asks about *evolution* between 2022 and 2023. The ground truth identifies a shift from a general partnership model in 2022 to a formalized, standardized contractual framework in 2023. The LLM answer incorrectly states that 'no significant changes to contractual obligations are explicitly noted,' which contradicts the ground truth's assertion of a strategic shift toward formalization. This omission represents a failure in reasoning across time periods. (4) The answer is contextually relevant and well-structured but lacks the critical comparative insight about the evolution from informal to formal agreements, which is central to the question. Thus, while factually sound on static details, it fails on the dynamic, multi-hop aspect of the query, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 400,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "From 2022 to 2023, the company's financial allocation and operational focus related to Africa/Eurasia, as reflected in restructuring charges under the 2022 Global Productivity Initiative, decreased from 11% to 5% of total charges. This reduction suggests a declining emphasis on restructuring activities in the region during this period. Additionally, capital expenditures for Africa/Eurasia in 2021 were $33 million, with no specific 2022 or 2023 figures provided, but the trend in restructuring charges indicates a reduced operational focus in the region in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that restructuring charges related to Africa/Eurasia decreased from 11% in 2022 to 5% in 2023, while the ground truth states that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative (not 2023) would relate to Africa/Eurasia—there is no mention of a 11% or 5% figure in the original. Additionally, the LLM reverses the capital expenditure timeline, claiming $33 million was spent in 2021, whereas the ground truth states $33 million was spent in 2022, with $13 million in 2021 and $8 million in 2020. (2) The quantitative inaccuracies are severe: wrong dollar amounts assigned to wrong years, and fabricated percentages (11%, 5%) not present in the original. The claim that 'no specific 2022 or 2023 figures provided' contradicts the ground truth, which explicitly gives 2022 capex as $33M and implies a strategic shift in 2023 based on restructuring focus. (3) The multi-hop reasoning is flawed: instead of synthesizing that capital investment peaked in 2022 and was replaced by restructuring focus in 2023, the LLM incorrectly infers declining focus based on fabricated restructuring percentages and misattributed capex data. It fails to capture the strategic pivot from growth (capex) to cost optimization (restructuring). (4) Scores are low due to major factual and numerical errors, though the answer is contextually relevant in attempting to address financial allocation and operational focus shifts. The reasoning direction (assessing shift in focus) is appropriate, but execution is factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 450,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "Qualcomm has increased its strategic focus on 5G technologies from 2022 to 2024, emphasizing both investment and commercialization. In 2022, the company highlighted its leadership in 5G patent development and its ongoing investments in OFDMA technology and intellectual property. By 2024, Qualcomm expanded on this by showcasing its Snapdragon 5G modem-RF products, which integrate AI to optimize performance and battery life, and by emphasizing its role in enabling the global rollout of 5G technology through licensing and partnerships. The company also noted its extensive 5G licensing portfolio, with over 200 agreements, reflecting strong commercialization outcomes.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Qualcomm's increasing strategic focus on 5G from 2022 to 2024 and mentions key elements like patent development, investment, and commercialization through licensing. It accurately notes the emphasis on OFDMA technology and the expansion into commercialization by 2024. However, it omits critical details from the ground truth, such as the shift from investment phase to monetization phase, the specific risks Qualcomm acknowledged in 2022 (regulatory hurdles, competition, long design-in cycles), and the fact that the majority of QTL revenues came from OFDMA-based multimode devices—a key commercialization outcome. The mention of 'Snapdragon 5G modem-RF products integrating AI' and 'over 200 agreements' is plausible but not present in the original answer, introducing unsupported specifics. (2) There are no numeric values in the original answer, so no calculation errors exist; the LLM does not introduce incorrect numbers, hence quantitative accuracy is full. (3) The multi-hop reasoning is partially sound—LLM connects 5G investment to later commercialization, but fails to fully synthesize the evolution from risk-laden investment across automotive/IoT to market leadership and revenue generation via licensing, which is central to the ground truth. (4) Scores reflect that core facts about 5G focus and commercialization are correct (hence 7/10 correctness), but missing key nuances and adding unverified details reduce qualitative accuracy. Contextual relevance remains high as the response stays focused on the question's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 436,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Between 2022 and 2024, Pfizer's financial and strategic positioning of Paxlovid evolved significantly. In 2022, Paxlovid contributed $18,933 million in revenue, primarily driven by government contracts, but this dropped sharply to $1,279 million in 2023 due to a $3.5 billion non-cash revenue reversal linked to expected returns of EUA-labeled U.S. government inventory. By 2024, Paxlovid revenue rebounded to $5,716 million as it transitioned to commercial markets, with negotiated pricing and a copay assistance program. Contractual commitments also shifted, with remaining performance obligations for Paxlovid totaling $1 billion as of December 31, 2024, reflecting ongoing supply agreements and pandemic preparedness initiatives like the U.S. SNS.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in financial figures. According to the ground truth, Paxlovid generated $76 million in revenue in 2022, but the LLM incorrectly states $18,933 million (over 249 times higher). The 2023 and 2024 revenue figures ($1,279M and $5,716M) are not supported by the original answer, which does not provide 2023 data and explicitly states that 2024 Paxlovid revenue is not directly disclosed—only $1 billion in remaining performance obligations is mentioned. The $3.5 billion non-cash reversal and rebound in 2024 are fabrications not present in the ground truth. (2) The only correct quantitative element is the $1 billion in remaining performance obligations as of 2024, which matches the original answer. All other numbers are incorrect or hallucinated. (3) The reasoning fails on multi-hop synthesis: the original answer describes a strategic shift from initial launch to contractual commitments, but the LLM invents a detailed narrative of revenue drop and rebound, government inventory returns, commercial transition, and copay programs—none of which are in the ground truth. While the mention of contractual commitments aligns with the original, it is embedded in an incorrect overall framework. (4) Contextual relevance is moderate because the answer addresses revenue and contractual evolution, which are relevant, but the severe factual and quantitative errors undermine correctness. The qualitative reasoning is partially sound in structure but based on false premises. Thus, the correctness score is low due to pervasive numerical inaccuracies and invented details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 447,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "The company's exposure to credit market tightness as a supply chain risk increased between 2022 and 2023. In 2022, the risk was mentioned as a potential issue affecting suppliers, but by 2023, it was explicitly listed as a more prominent risk factor under global supply chain disruptions. This evolution indicates a heightened vulnerability to external financial conditions, as tighter credit markets could impair suppliers' ability to meet obligations, thereby threatening product availability and operational continuity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) There are no numeric values to verify, so quantitative accuracy is not applicable—no errors in dates or financial figures, as none were cited. (2) The answer correctly identifies the evolution between 2022 and 2023: in 2022, credit market tightness was a risk affecting suppliers; by 2023, it became a more prominent, explicitly recognized risk under broader supply chain disruptions. This reflects an increased emphasis on the company’s vulnerability. (3) The multi-hop reasoning is sound—comparing risk language across years and inferring heightened vulnerability. However, the LLM states exposure 'increased' and became 'more prominent,' which slightly overreaches the original answer’s more nuanced claim of a 'shift in framing' from supplier-level impact to broader operational impact. The original emphasizes a change in perspective (more integrated recognition), not necessarily an increase in exposure. The LLM interprets this as heightened vulnerability, which is a reasonable inference but not fully equivalent in tone. (4) Despite this subtle difference in interpretation, the core facts, entities (company, years), and synthesis are accurate. The answer remains contextually relevant and captures the essential evolution. Thus, correctness and qualitative accuracy are high but not perfect due to interpretive overstatement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 400,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid have significantly evolved from 2022 to 2024. In 2022, Paxlovid generated $18,933 million in revenue, driven by government contracts for emergency use. However, in 2023, revenue dropped sharply to $1,279 million due to a $3.5 billion non-cash revenue reversal related to expected returns of EUA-labeled U.S. government inventory. By 2024, Paxlovid revenue rebounded to $5,716 million, supported by commercial market sales and a $442 million revenue recognition from supplying the U.S. Strategic National Stockpile (SNS). Remaining performance obligations for Paxlovid were $1 billion as of December 31, 2024, with deliveries expected through 2028.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key financial figures and misrepresents the timeline of events. While it correctly identifies the $1 billion remaining performance obligations as of December 31, 2024, and notes delivery expectations through 2028, it fabricates or misstates revenue figures for 2022, 2023, and 2024 that are not supported by the ground truth. The ground truth does not provide Paxlovid-specific revenue for 2022 or 2024, nor does it mention a $3.5 billion revenue reversal in 2023. Instead, it references a $771 million favorable adjustment in 2024 related to prior EUA-labeled returns — not a $442 million recognition for SNS supply as claimed. These are major quantitative discrepancies. (2) The numbers provided in the LLM answer — $18,933 million (2022), $1,279 million (2023), $5,716 million (2024), $3.5B reversal, $442M SNS — are either incorrect or not present in the ground truth, failing the quantitative accuracy test. The only correct number is the $1 billion in remaining performance obligations. (3) The qualitative reasoning shows an attempt at multi-hop synthesis — connecting revenue trends, contractual obligations, and government returns — but is based on incorrect data. The narrative of a 'rebound' in 2024 due to commercial sales and SNS supply is not supported by the original answer, which emphasizes ongoing contractual adjustments and a favorable $771M final adjustment, not $442M. The LLM conflates events and misattributes timing and amounts. (4) Despite these errors, the answer is contextually relevant and structured appropriately, addressing the evolution of financial commitments and obligations. It captures the essence of contractual dynamics and future delivery expectations, earning moderate scores for qualitative accuracy and high relevance. However, due to significant factual and numerical errors, the correctness and quantitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 526,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "From 2023 to 2024, the financial liability related to Aearo Technologies' respirator mask/asbestos litigation decreased slightly, with accruals dropping from $62 million as of December 31, 2023, to $51 million as of December 31, 2024. This reduction reflects ongoing management of the liability through the informal Payor Group arrangement and the contractual agreement with Cabot, which limits Aearo's liability to exposures on or after January 1, 1997. However, the Company notes that potential developments—such as changes in claim numbers, legal costs, or the financial viability of co-defendants—could significantly increase Aearo's liability beyond the current accrual.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It states that Aearo had an accrual of $62 million as of December 31, 2023, but the ground truth indicates that in 2023, MMM had a $574 million accrual for respirator mask/asbestos liabilities excluding Aearo, and Aearo itself was in bankruptcy with no specified accrual amount disclosed for it in that year. The only accurate number is the $51 million accrual in 2024 for Aearo-related claims, which matches the ground truth. The $62 million figure for 2023 appears to be fabricated or misattributed. (2) The calculation of a decrease from $62M to $51M is therefore incorrect, as there is no support in the original data for a $62M starting point. Additionally, the LLM implies a direct year-over-year reduction in Aearo’s accruals, but the ground truth shows a structural shift: in 2023, Aearo was under bankruptcy stay with no active accrual reporting, while in 2024, a new $51M accrual was established under a defined liability framework. This evolution is misrepresented as a simple numerical decline. (3) The qualitative reasoning partially captures the contractual arrangement with Cabot—correctly noting that Cabot assumes responsibility for pre-1997 exposures and that Aearo pays a fee (though the $100,000 quarterly fee is omitted). However, the LLM fails to mention the critical context of Aearo’s bankruptcy and litigation stay in 2023, which fundamentally shaped the risk exposure landscape. The reference to the 'Payor Group' is not present in the ground truth and introduces unverified information. (4) Despite these issues, the answer is contextually relevant, addressing the evolution of liability and risk exposure and correctly identifying the 2024 accrual and the Cabot agreement's role in limiting liability. Thus, while the direction of reduced exposure is loosely aligned, the factual basis and multi-hop synthesis are flawed, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 539,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "The retail share of Skoal decreased from 13.9% in 2020 to 7.6% in 2024, indicating a significant decline over the period. In comparison, the shipment volume of Skoal decreased from 208.5 million cans in 2020 to 147 million cans in 2024, showing a consistent downward trend. Between 2020 and 2021, Skoal's retail share decreased slightly from 13.9% to 12.6%, while shipment volume remained nearly unchanged. The sharper decline in both retail share and shipment volume between 2023 and 2024 reflects increased competition, particularly from oral nicotine pouches.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The retail share of Skoal in 2023 was 9.3% according to the ground truth, but the LLM claims it was 13.9% in 2020 and does not mention 2023 at all, instead stating a drop to 7.6% in 2024 — while the 7.6% figure for 2024 is correct, the starting point is wrong both in value and year. The ground truth specifies the change between 2023 and 2024 (9.3% to 7.6%), but the LLM incorrectly frames the decline from 2020 (13.9%) to 2024, which is not supported by the original data. (2) Shipment volume between 2020 and 2021 dropped from 208.5 million to 197.4 million packs/cans — the LLM correctly states the 2020 figure but invents a 2021 shipment volume of 'nearly unchanged' when it actually decreased, and further fabricates a 2024 shipment volume of 147 million cans, which is not in the original answer and not requested by the question. The question only asks for shipment trend between 2020 and 2021, not beyond. (3) The multi-hop reasoning is flawed: the LLM fails to correctly isolate the two required comparisons — (a) retail share change 2023–2024 and (b) shipment volume trend 2020–2021. Instead, it conflates timelines and introduces unsupported data. It also adds speculative reasoning about competition from nicotine pouches, which is not in the ground truth. (4) Despite incorrect numbers and timelines, the LLM recognizes the general direction of decline in both metrics, which prevents a score of 0. However, the quantitative inaccuracies are severe, warranting a low correctness score. Contextual relevance is moderate because it addresses the right product (Skoal), company (implied), and general trends, but with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 467,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm's approach to multimedia technologies has evolved with a stronger focus on integrating AI and expanding into diverse applications beyond mobile devices. In 2022, the company emphasized foundational technologies in multimedia areas such as camera, video, display, and computer vision, while supporting industries like automotive and IoT. By 2024, Qualcomm had deepened its commitment to AI, including generative AI, with a focus on power efficiency and personalization across multiple industries and use cases. Additionally, the company has enhanced its multimedia integration into product offerings by supporting advanced SoC development and expanding into areas like ADAS/AD and XR, reflecting a broader diversification strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Qualcomm's 2022 focus on camera, video, display, and computer vision is accurately described, as is the expansion into AI—especially generative AI—by 2024. The emphasis on industries beyond mobile, such as automotive (including ADAS/AD) and IoT, and emerging areas like XR, is consistent with the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all time references (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes changes in engineering focus and product integration across two time points, identifying the shift from hardware-centric to platform-oriented, AI-enhanced strategies. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the increased focus on enabling developers to design and deploy applications across devices, which is a key nuance in the original answer. However, the broader diversification and platform orientation are captured through references to SoC development and cross-industry personalization. Wording differs slightly but maintains semantic equivalence. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 386,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "Between 2023 and 2024, 3M's financial relationship with the Aearo Entities evolved significantly. In 2023, 3M deconsolidated the Aearo Entities due to their voluntary bankruptcy proceedings, resulting in a $1.2 billion pre-tax charge. However, following the dismissal of the bankruptcy in June 2023, 3M reconsolidated the Aearo Entities in Q2 2023. This reconsolidation led to the inclusion of $0.7 billion in equity investment and $0.6 billion in intercompany balances (net liability) in 3M's consolidated balance sheet. In 2024, the CAE Settlement was finalized, with 3M paying $6 billion in cash (instead of a mix of cash and stock) to resolve litigation related to the Combat Arms Earplugs, impacting both equity and intercompany balances.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that 3M 'deconsolidated' the Aearo Entities in 2023 due to bankruptcy, then 'reconsolidated' them in Q2 2023. The ground truth indicates that 3M *reconsolidated* the Aearo Entities in 2023, which led to the *removal* of a $0.7 billion equity investment and $0.6 billion net liability from its balance sheet—this is the opposite of what the LLM claims (it says these amounts were 'included' upon reconsolidation). The direction of the accounting impact is reversed. (2) The $1.2 billion pre-tax charge is not mentioned in the original answer and appears to be fabricated or misattributed. (3) The $6 billion CAE Settlement in 2024 involving cash payment is not supported by the ground truth, which does not mention any such settlement amount or payment structure. (4) The original answer emphasizes a shift from reconsolidation in 2023 to a retained equity stake in 2024, but the LLM fails to convey this key evolution accurately, instead introducing unsupported litigation settlement details. (5) Multi-hop reasoning is flawed: the LLM misidentifies the sequence of events, the financial impacts, and the nature of the relationship change. While the answer attempts to address the evolution of the financial relationship and mentions equity and intercompany balances, the core facts—especially the direction of balance sheet impacts and the nature of the 2024 change—are incorrect. Quantitative accuracy is very low due to wrong numbers and reversed financial impacts. Qualitative accuracy suffers from incorrect entity-event mapping and reasoning. Contextual relevance is moderate as it addresses the right topic and entities, but with major factual distortions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 480,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "Between 2022 and 2024, Visa's Risk and Identity Solutions have evolved significantly in strategic positioning within the company's broader value-added services portfolio. In 2022, the focus was on leveraging data for fraud prevention and authentication, with tools like Visa Advanced Authorization and Visa Secure. By 2024, the division had expanded its offerings to include three new products—Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic Visa Advanced Authorization—aimed at reducing fraud across a wider range of payment types, including A2A and CNP transactions. This evolution reflects a stronger integration of AI and machine learning, positioning Risk and Identity Solutions as a central pillar in Visa's efforts to secure and enhance the digital payments ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Visa's Risk and Identity Solutions from a fraud prevention focus in 2022 to a more advanced, AI-enhanced suite by 2024, which aligns with the question's intent. It correctly identifies key 2022 products (Visa Advanced Authorization, Visa Secure) and maintains contextual relevance by emphasizing fraud prevention and data-driven insights. However, it introduces specific new products—Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic capabilities—that are not present in the ground truth. The original answer does not mention any new product names or specific enhancements in 2024, but instead emphasizes the strategic repositioning of Risk and Identity Solutions as one of five core categories within a broader value-added services portfolio that now includes Open Banking and Advisory Services. The LLM answer omits this structural and portfolio-level shift, which is central to the 2024 strategic evolution. Additionally, while the ground truth highlights that Visa offered over 200 products/services as of September 30, 2024, the LLM fails to mention this quantitative benchmark, instead focusing on unverified product expansions. There are no explicit numerical errors (e.g., dates like 2022 and 2024 are correct), but the introduction of unsupported product details reduces quantitative and qualitative accuracy. The reasoning is partially sound but reflects inference beyond the source material. The answer is contextually relevant and addresses the strategic evolution theme, but lacks fidelity to the actual documented changes in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 450,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "RTX's Acquisition Accounting Adjustments' impact on operating profit remained relatively consistent between 2023 and 2024, with adjustments of $1,998 million in 2023 and $2,058 million in 2024. The adjustments primarily stemmed from the amortization of acquired intangible assets, with minor contributions from property, plant, and equipment fair value adjustments and customer contractual obligations. The slight increase in 2024 did not significantly alter the overall trend, indicating stable impacts from acquisitions on operating profit.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both quantitative and qualitative aspects. The ground truth states that RTX did not provide a quantitative figure for 2024; instead, it shifted to a qualitative disclosure. However, the LLM claims a specific number ($2,058 million) for 2024, which is not supported by the original data. The 2023 figure of $1,998 million is correct, but the 2024 number is fabricated. (2) The calculation and comparison between years are therefore invalid. There is no evidence of a 'slight increase' or any numerical update in 2024, making the entire quantitative analysis false. (3) The multi-hop reasoning failed: the model should have recognized the shift in disclosure policy from quantified impacts in 2023 to non-quantified, qualitative explanations in 2024. Instead, it assumed continuity in numerical reporting, missing the key evolution in disclosure approach. (4) While the mention of amortization of intangible assets aligns generally with typical acquisition accounting adjustments, this detail was not in the ground truth and does not compensate for the core inaccuracy. The answer is contextually relevant to the topic but fundamentally wrong in its central claim, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 352,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Between fiscal years 2022 and 2023, Office 365 Commercial revenue grew from $44.97 billion to $48.85 billion, representing an increase of $3.88 billion or approximately 8.6%. In the broader Microsoft Cloud context, which includes Azure, Office 365 Commercial, LinkedIn, and Dynamics, revenue rose from $91.4 billion in 2022 to $111.6 billion in 2023, a 22.1% increase. Office 365 Commercial's contribution to this growth indicates its continued importance within the cloud ecosystem, though its growth rate is slower than the overall Microsoft Cloud, suggesting increasing competition or diversification within the cloud portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative data. The ground truth does not provide specific revenue figures for Office 365 Commercial in FY2022 or FY2023—only that it was a key growth driver in FY2022 and part of the consolidated Microsoft Cloud revenue in FY2023. The LLM fabricates precise numbers ($44.97B and $48.85B) with an 8.6% growth rate, which are not present in the original answer and cannot be derived from the provided knowledge graph. These numbers are incorrect or unsubstantiated. (2) While the Microsoft Cloud revenue figures are correct—$91.4B in FY2022 and $111.6B in FY2023, representing a 22.1% increase—the LLM incorrectly uses these to back-calculate or assert specific Office 365 Commercial revenues, which the source does not support. The calculation of the overall cloud growth is accurate, but the attribution to Office 365 Commercial’s standalone growth is not justified by the original data. (3) The reasoning is partially sound in interpreting that Office 365 Commercial remains important within the broader cloud ecosystem, and the shift to consolidated reporting suggests increased portfolio diversification. However, the conclusion about 'slower growth' implying 'increasing competition or diversification' is speculative and not supported by the original answer, which makes no such comparative growth claims. The multi-hop synthesis fails because it invents granular data rather than acknowledging the change in reporting structure. (4) Despite the incorrect numbers, the LLM captures the contextual evolution—Office 365 Commercial transitioning into a consolidated Microsoft Cloud metric—and correctly identifies the components (Azure, LinkedIn, Dynamics 365). Thus, while contextually relevant and showing understanding of the reporting shift, the answer is severely undermined by hallucinated quantitative details, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 528,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Merck's alliance revenue related to Lynparza increased by 9% in 2024 compared to 2023, primarily due to higher demand in most international markets. This growth was driven by the continued expansion of Lynparza's indications and its strong performance in global markets. In January 2025, Lynparza received approval in China as adjuvant treatment for adult patients with germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, which further supports its growth potential.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Merck's alliance revenue related to Lynparza increased by 9% in 2024 compared to 2023, which matches the ground truth. The primary driver—higher demand in most international markets—is accurately reported. (2) Quantitatively, the 9% growth figure is correct and precisely aligned with the original answer. There are no calculation errors or incorrect numbers. (3) The reasoning is sound and captures the multi-hop synthesis: it identifies the year-over-year change and the contributing factor (international demand). However, the LLM adds forward-looking information about Lynparza’s January 2025 approval in China, which, while factually plausible and contextually relevant to growth potential, is not part of the 2023–2024 evolution and was not included in the ground truth. This does not make the answer incorrect but introduces extraneous information not requested. (4) The answer is highly accurate, complete on core facts, and contextually appropriate. The minor addition of future approval info slightly affects qualitative accuracy but does not detract from correctness. Hence, a score of 9/10 is justified—excellent but not perfectly aligned with the scope of the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 347,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "The Procter & Gamble 2014 Stock and Incentive Compensation Plan remains referenced in both the 2023 and 2024 10-K filings, indicating continued inclusion in equity compensation reporting. However, in 2024, the 2019 Stock and Incentive Compensation Plan is highlighted as the primary active plan for future grants, with the 2014 Plan no longer allowing for new awards. Regulatory context and reporting structure appear consistent, with both years listing the 2014 Plan among approved equity compensation plans but noting that it is the 2019 Plan that governs future securities issuance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that the 2014 Plan is no longer used for new awards and that the 2019 Plan is now primary, which aligns with the regulatory and reporting context. All entities (Procter & Gamble, 2014 and 2019 Stock and Incentive Compensation Plans, 10-K filings) and years (2023, 2024) are correctly identified, satisfying entity accuracy. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. However, the LLM answer diverges from the ground truth in the qualitative interpretation of the plan’s evolving role: while the original answer emphasizes a shift from regulatory disclosure to integration into broader equity compensation transparency and ownership structure reporting, the LLM focuses on the cessation of new awards under the 2014 Plan. This is correct but represents a different aspect of evolution—operational status rather than disclosure purpose. The multi-hop reasoning is sound in identifying continuity in reporting and change in plan activity, but it does not fully capture the shift in disclosure emphasis (from regulatory context to ownership transparency) highlighted in the ground truth. Thus, while the answer is factually correct and relevant, it misses a key nuance in the evolution of disclosure treatment, leading to a moderate deduction in qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 382,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "The 1992 Stock Plan remains referenced in both the 2023 and 2024 10-K filings as one of the equity compensation plans under which securities may be issued. However, it is clear from the 2024 filing that the 1992 Stock Plan no longer allows for future grants of securities, as only the 2019 Stock and Incentive Compensation Plan is active for future awards. This indicates that the 1992 Plan has been phased out of the company's active equity compensation structure, retaining relevance only in historical data and outstanding awards.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately identifies that the 1992 Stock Plan is still referenced in both the 2023 and 2024 10-K filings but is no longer active for future grants, with only the 2019 Stock and Incentive Compensation Plan being active. This captures the core evolution: the plan has transitioned from an adopted plan (in 2023) to a historical, inactive plan tracked in a consolidated table (in 2024). The LLM correctly infers that the 1992 Plan's role has become passive, supporting outstanding awards only. However, the original answer provides a more precise description of the *form* of evolution—specifically, the shift from being 'referenced by incorporation' in 2023 to being included in a consolidated disclosure table in 2024. The LLM answer does not mention this specific formatting and disclosure change, which is a minor omission in completeness and nuance. There are no quantitative inaccuracies (dates and plan names are correct), and the reasoning is sound, showing proper multi-hop synthesis between years and plans. The answer is contextually fully relevant and conveys a semantically equivalent conclusion, albeit with slightly less procedural detail on the disclosure mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 350,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "Between 2023 and 2024, the company's emphasis on large-scale transformations has remained strong, with clients continuing to prioritize these initiatives. However, evolving economic and geopolitical uncertainties have caused clients to slow spending on smaller, shorter-duration contracts and consulting services during fiscal 2024. As a result, the revenue conversion timelines for large-scale transformations have extended, as clients take longer to commit and execute these projects. This shift reflects a growing focus on long-term, complex engagements that align with strategic priorities rather than immediate, short-term needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the key point that clients continued to prioritize large-scale transformations in both 2023 and 2024, while reducing spending on smaller, shorter-duration contracts and consulting services—this is consistent with the original answer. The emphasis on extended revenue conversion timelines due to the nature of large-scale transformations is also correctly conveyed. (2) There are no numeric values in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is sound: it synthesizes client spending patterns and revenue conversion timelines across two years, correctly identifying continuity in strategic focus. However, the LLM slightly overreaches by attributing the extended timelines specifically to 'clients taking longer to commit and execute' in 2024, which is an inference not explicitly supported in the original filings—the ground truth notes the long conversion timeline is inherent to large-scale transformations, not necessarily lengthening further. This nuance is missing, leading to a minor deduction in qualitative accuracy. (4) The answer remains highly contextually relevant, addressing all parts of the question with accurate, focused information. Overall, the response is factually solid with only a minor interpretive overstatement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 394,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "In fiscal 2024, Accenture issued Class A Ordinary Shares for employee share programs amounting to $7,869 (in thousands), compared to $8,883 (in thousands) in fiscal 2023, representing a decrease of $1,014 (in thousands). This issuance contributed to an increase in additional paid-in capital by $2,280,198 (in thousands) and impacted retained earnings negatively by $131,133 (in thousands). Overall, it added $1,416,945 (in thousands) to the total shareholders' equity, reflecting a slight reduction in the number of shares issued compared to the prior year but still positively affecting the equity structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Accenture *issued* 7,970 Class A Ordinary Shares in fiscal 2024 for employee programs, while in 2023 it *acquired* shares via withholding (i.e., reduced shares outstanding). The LLM incorrectly claims that $7,869K and $8,883K were issued in 2024 and 2023 respectively, implying a decrease in issuance, which contradicts the shift described in the original answer. The numbers cited by the LLM ($7.869M issued) do not match the ground truth (7,970 shares issued), and the units are inconsistent (dollars vs. number of shares). (2) The LLM introduces financial impacts like increases in additional paid-in capital and reductions in retained earnings with specific dollar figures (e.g., $2,280,198K), none of which appear in the ground truth and cannot be verified. The equity structure changes described in the original answer focus on total Class A shares increasing from 15,656,591 to 15,664,561 and treasury shares decreasing in value from $(3,408,491)M to $(6,678,037)M — none of which are mentioned or correctly calculated in the LLM response. (3) The multi-hop reasoning is flawed: the question requires understanding a shift from share *acquisition* (2023) to share *issuance* (2024) for employee compensation. The LLM mischaracterizes both years as issuance-only and frames it as a reduction, missing the structural shift entirely. It also fails to mention the purchase of 12,181 treasury shares in 2024, a key part of the equity reallocation. (4) The contextual relevance is moderate because the LLM addresses employee share programs and equity impact, but the factual inaccuracies and incorrect synthesis severely undermine correctness. Quantitative accuracy is very low due to wrong numbers, units, and calculations. Qualitative accuracy is low due to incorrect characterization of events and missing key reasoning steps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 527,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ's exposure to Canadian-denominated debt instruments slightly increased between 2022 and 2023, from $443 million to $453 million. This small increase contrasts with the company's overall trend of reducing exposure to other foreign currency-denominated debt, such as Swiss franc and euro notes, during the same period. The shift suggests a more cautious or strategic approach to Canadian dollar exposure amid broader efforts to manage and reduce foreign currency risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It claims MDLZ's Canadian-denominated debt increased from $443 million to $453 million between 2022 and 2023, which directly contradicts the ground truth stating that in 2022 there was a $3 million decrease in Canadian notes and in 2023 an $8 million increase—implying the actual balances were much smaller (e.g., $3 million in 2021, with continued low values). The reported figures of over $400 million are off by two orders of magnitude and completely inaccurate. (2) The quantitative inaccuracies are severe: the ground truth shows Canadian notes were only $3 million in 2021 and had been declining from $17 million in 2019, making the LLM's $443M–$453M range factually wrong. Additionally, while the LLM correctly notes a broader trend of reducing exposure to other currencies like euro and Swiss franc notes, it misrepresents the scale and direction of Canadian exposure. (3) The reasoning is partially sound in identifying a contrast between Canadian debt and other foreign currency debts, but fails at multi-hop synthesis: it does not acknowledge the reversal of a multi-year downward trend in Canadian notes, nor does it reference the historical context (2019–2021) that makes the 2023 increase notable. The conclusion about a 'strategic approach' is speculative and not grounded in the provided data. (4) Scores are low due to major factual and numerical errors; however, contextual relevance is moderate because the answer attempts to address both parts of the question—change in Canadian exposure and comparison to overall foreign currency debt trends—even if the underlying data is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 458,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "From 2023 to 2024, Accenture's approach to engaging with growth-stage companies has evolved by deepening strategic involvement through its innovation ecosystem. Accenture Ventures, a key component of this strategy, has continued to partner with and invest in growth-stage companies that develop innovative enterprise technologies. In 2024, the company emphasized scaling these partnerships to accelerate the adoption of emerging technologies such as AI, blockchain, and quantum computing. This reflects a more proactive and integrated approach, aligning with clients' transformation agendas and supporting long-term innovation goals.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Accenture's engagement with growth-stage companies and mentions Accenture Ventures, innovation ecosystem, and emerging technologies, which are contextually relevant. However, it fails to accurately capture the key evolution from 'partnership' in 2023 to 'direct investment' in 2024 as stated in the ground truth. Instead, it states that Accenture 'continued to partner with and invest in' companies, implying both activities were ongoing without highlighting the strategic shift from partnership to investment. This misrepresents the nature of the evolution. (2) There are no numeric values in the LLM answer, so no quantitative inaccuracies; thus, quantitative accuracy is fully preserved. (3) The multi-hop reasoning is partially sound—Accenture’s innovation focus and technology areas are plausible—but it misses the critical inference that the relationship model changed from partnership to direct investment, which is central to the question. The deeper strategic and financial commitment via a shift in engagement model is omitted. (4) Contextual relevance is high because the response discusses the right entities and strategic themes. However, the qualitative accuracy is reduced due to the failure to correctly represent the shift in engagement model, which is the core of the question. Correctness score reflects partial accuracy: relevant and plausible, but misses a key factual evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 401,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca from 2022 to 2024 shows notable growth in alliance revenue, with Lynparza alliance revenue increasing from $989 million in 2021 to $1,311 million in 2024, a 9% growth in 2024 alone. In terms of asset amortization, the intangible asset balance related to Lynparza, which includes capitalized sales-based and regulatory milestone payments, was $1.1 billion at December 31, 2021, and is being amortized over its estimated useful life through 2028. No specific 2024 amortization figures are provided, but the continued amortization is implied as part of the ongoing collaboration.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.1 billion intangible asset balance related to Lynparza and its amortization through 2028, consistent with the ground truth. However, it incorrectly cites the balance as of December 31, 2021, while the ground truth states it was $1.1 billion in 2022. This is a factual misalignment in timing. Additionally, the LLM introduces specific revenue figures—$989M in 2021 and $1,311M in 2024—with a claim of 9% growth in 2024. The ground truth confirms a 9% growth in 2024 due to international demand but does not provide exact revenue numbers or 2021–2024 trajectories. Thus, the inclusion of precise dollar amounts and the 9% growth attribution to that specific revenue jump is unsupported by the ground truth and introduces potentially misleading precision. (2) The calculation of 9% growth from $989M to $1,311M is mathematically inaccurate (actual growth is ~32.6% over three years, not 9% in 2024 alone), further undermining quantitative accuracy. The 9% figure in the ground truth is a standalone statement about 2024 growth, not tied to those specific revenue numbers. (3) The qualitative reasoning is sound: the shift from amortization focus in 2022 to revenue growth in 2024 is correctly interpreted, and the ongoing amortization through 2028 is logically inferred. The answer synthesizes financial and strategic evolution appropriately, though it misses the forward-looking 2025 China approval mentioned in the ground truth, which adds strategic context. (4) Despite the missing strategic update and the incorrect anchoring of financials in 2021 instead of 2022, the answer captures the core evolution in Merck’s involvement. Hence, correctness is reduced due to unsupported numbers and a timing error, but not severely, as the directional narrative aligns with the truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 497,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "AVGO's strategic emphasis on ValueOps has evolved from being a component of the Distributed Software portfolio in 2023 to being highlighted as a distinct and central offering in 2024. In 2023, ValueOps was mentioned in the context of enabling end-to-end visibility across the digital lifecycle. By 2024, it is explicitly positioned as a key solution for value stream management, emphasizing its role in aligning business and development teams, improving transparency, and accelerating time-to-value. This shift indicates that ValueOps is becoming a more strategic and integral part of AVGO's Distributed Software portfolio, reflecting its growing importance in driving business outcomes and operational efficiency for enterprise customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AVGO's strategic emphasis on ValueOps from 2023 to 2024, noting its increased centrality in the Distributed Software portfolio. It accurately reflects that in 2024, ValueOps became more prominent, with a focus on value stream management, alignment of business and development teams, and accelerating time-to-value. However, it inaccurately states that in 2023, ValueOps was already mentioned in the context of 'end-to-end visibility across the digital lifecycle'—this specific phrasing and emphasis are from the 2024 report, not 2023. According to the ground truth, in 2023, ValueOps was listed as one of several offerings without detailed elaboration, whereas the LLM retroactively assigns the 2024-level detail to 2023. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is mostly sound: the model correctly synthesizes a shift in strategic positioning across two years and infers increased strategic importance. However, the misattribution of the 'end-to-end visibility' language to 2023 weakens the reasoning chain, as it conflates the depth of description between the two years. (4) Despite this inaccuracy, the overall conclusion about ValueOps becoming more strategic and integral is aligned with the ground truth. The answer is contextually relevant and well-articulated, hence high scores in qualitative accuracy and contextual relevance. The correctness score is 8 due to the minor but notable factual misplacement of a key descriptive phrase.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 449,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "Between 2023 and 2024, FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolved with a focus on integrating and optimizing its U.S. and Canadian package delivery networks to improve efficiency. In 2023, the company announced Network 2.0 as part of the DRIVE transformation, aiming to enhance long-term profitability. By 2024, FedEx had introduced the \"one FedEx\" consolidation plan, which involved merging FedEx Ground and FedEx Services into Federal Express, and announced Tricolor, a redesign of the Federal Express international air network. While the new legal structure was completed in June 2024, network integration and optimization remained ongoing. The expected cost savings from these initiatives were subject to risks, including higher-than-anticipated integration costs, potential loss of customers, union organizing, litigation, and challenges in workforce reductions in Europe, which could delay or reduce the projected benefits.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of FedEx's strategic approach to Network 2.0 within the DRIVE transformation but introduces several inaccuracies and omits key details from the ground truth. (1) Correct elements: The answer correctly identifies Network 2.0 as part of the DRIVE transformation and notes a shift in focus toward integration and optimization by 2024. It appropriately highlights ongoing implementation risks such as integration costs, customer loss, litigation, and workforce challenges. (2) Quantitative accuracy: There are no specific numbers (e.g., cost savings figures, dates beyond June 2024) in either the original or LLM answer, so no numeric inaccuracies are present—this aspect is neutral and does not detract. (3) Qualitative inaccuracies: The LLM introduces unverified specifics not present in the ground truth, such as the 'one FedEx' consolidation plan, merging FedEx Ground and FedEx Services into Federal Express, and 'Tricolor' as a redesign of the international air network. These terms and initiatives are not mentioned in the original answer and cannot be confirmed from the provided knowledge graph. The original answer emphasizes a shift from strategic investment justification (2023) to operational integration risks (2024), including harmonizing practices, labor/cultural differences, and financial risks like asset impairments and tax impacts—none of which are fully addressed in the LLM response. (4) Multi-hop reasoning: The LLM partially synthesizes the evolution across years but fails to accurately reflect the nature of the shift—from execution risk in 2023 (timing and cost of implementation) to broader financial and operational risks in 2024 (impairment charges, tax, litigation, and uncertainty in savings timing). Instead, it invents structural changes (e.g., legal merger details) not supported by the ground truth. (5) Contextual relevance: The response stays on topic and addresses the evolution of strategy, cost savings expectations, and risks, making it contextually relevant despite factual shortcomings. Overall, the answer is partially correct but contains significant fabrication of program names and structural changes, reducing its qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 599,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "The financial impact from equity method investment contracts showed a positive pre-tax gain of $7 million in 2023, compared to no gain in 2022, indicating a modest improvement in performance related to these investments. This suggests that MDLZ's engagement with equity method investments became slightly more beneficial in 2023, though the overall impact remains relatively minor compared to other financial instruments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that there was 'no gain' in 2022, whereas the ground truth specifies a net liability of $3 million, which is a loss, not a neutral position. This misrepresents the financial impact in 2022. In 2023, the LLM correctly identifies a $7 million gain. However, the shift from a $3 million liability to a $7 million gain represents a $10 million swing, which the LLM fails to capture by implying 2022 was neutral. (2) The quantitative accuracy is compromised because the 2022 figure is factually wrong—'no gain' does not equate to a $3 million net liability. The 2023 figure ($7 million gain) is correct. (3) The reasoning is partially sound in noting an improvement, but it misses the reversal from liability to gain, which indicates a more significant strategic shift than 'slightly more beneficial.' The LLM underrepresents the magnitude and nature of the change, failing to recognize the multi-hop synthesis that a liability turning into a gain suggests active management or improved performance. (4) Contextual relevance is high because the answer addresses both years and MDLZ's engagement, but correctness is limited by the inaccurate portrayal of 2022 data and the resulting weakened inference about strategic engagement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 356,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases decreased from $38 million in fiscal year 2023 to $38 million in fiscal year 2024, while the percentage of completion increased from 67% to 100% (as it was released during fiscal year 2024). This indicates that the development progress for this release was completed on schedule and within the estimated cost, aligning with expectations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the estimated cost to complete 'decreased from $38 million in fiscal year 2023 to $38 million in fiscal year 2024' — this implies a decrease despite identical values, which is quantitatively incorrect and misleading. The ground truth states the cost remained unchanged, so the characterization as a 'decrease' is factually wrong. However, the dollar amount ($38 million) is correctly cited for both years, preserving some numerical accuracy. (2) The LLM introduces percentage completion figures (67% to 100%) not present in the original answer or implied by the ground truth, which undermines quantitative and qualitative accuracy. While it's reasonable to infer progress toward completion, these specific percentages are unsupported by the provided truth and represent fabricated data. (3) The reasoning about development progress being 'on schedule and within estimated cost' aligns with the ground truth's interpretation, showing sound qualitative logic if the numbers were correct. However, the multi-hop synthesis is flawed because it invents metrics (percent complete) rather than relying on the stability of cost estimates as the indicator of progress. (4) Contextually, the answer addresses both parts of the question — evolution of cost and what it indicates — and stays focused on AVGO and the VMware Cloud Foundation release, earning high marks for relevance. Despite this, the introduction of false precision via invented percentages and the incorrect claim of a 'decrease' when there was no change severely undermines factual correctness, warranting a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 457,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "Between 2023 and 2024, the strategic positioning of FedEx Office's Ship and Go kiosk has evolved to emphasize convenience and integration with e-commerce logistics and returns management. The kiosk allows customers to generate shipping labels via mobile or QR code and drop off packages securely, streamlining the shipping process. Additionally, FedEx Office supports e-commerce returns through FedEx Returns Technology, enabling in-store printing of return labels and facilitating label-less returns via FedEx Consolidated Returns. This evolution reflects FedEx's broader approach to enhancing e-commerce logistics by offering seamless, customer-centric solutions for both shipping and returns, leveraging its physical retail network to support digital commerce needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of the Ship and Go kiosk from 2023 to 2024, noting its continued presence in approximately 1,300 locations and core functionality, while emphasizing the increased focus on returns integration in 2024. The key shift—tying Ship and Go more explicitly to FedEx Returns Technology and Consolidated Returns—is accurately reflected, including the ability to print return labels in-store and support label-less returns. The only minor omission is that the original answer specifies the 1,300-location footprint was explicitly mentioned in both years, which the LLM implies but does not state directly. (2) There are no numeric inaccuracies. The LLM does not introduce any incorrect figures and correctly avoids specifying a change in location count, aligning with the ground truth that the number remained approximately 1,300. (3) The multi-hop reasoning is sound: the model synthesizes information about the kiosk’s functionality in 2023, its updated strategic emphasis in 2024, and connects it to broader e-commerce logistics and returns management via FedEx’s technology platforms. The conclusion about FedEx leveraging its physical network for digital commerce is logically supported. (4) The answer is contextually excellent, directly addressing both parts of the question—evolution of the kiosk and implications for e-commerce logistics/returns. The qualitative accuracy is slightly reduced only due to the lack of explicit mention that the 1,300-location scale was confirmed in both years, which would have strengthened completeness. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 464,
        "total_tokens": 1894
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 1000,
    "failed_evaluations": 0,
    "average_correctness_score": 5.75,
    "average_quantitative_accuracy": 6.76,
    "average_qualitative_accuracy": 6.04,
    "average_contextual_relevance": 8.21,
    "score_distribution": {
      "excellent": 243,
      "good": 187,
      "fair": 310,
      "poor": 260
    }
  },
  "original_experiment_metadata": {
    "model": "qwen3-32b",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 4116.26,
    "timestamp": "2026-02-03T21:34:38.178879"
  }
}